Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,muscle contraction (GO:0006936),0.9031445757922189,2.636818243356716,0.0,0.0,0.0,54/126,2.90%,MYH11;MYOM1;ACTA2;LMOD1;MYL1;TPM2;MYBPC1;MYLK2;DMD;MYLK;TRDN;RYR1;TPM1;MYOT;NEB;TTN;MYL9;MYH2;TCAP;TNNI2;SMTN;CACNA1S;SCN4A;TNNC2;ACTG2;EDNRA;MYOM2;CALD1;LMOD2;ACTA1;TNNT3;MYL2;VCL;MYOM3;ROCK1;HRC;LMOD3;SGCA;MYL6;CKMT2;SNTB1;KCNJ12;GJC1;CACNA1H;ITGA1;DTNA;DYSF;DES;MYL3;MYBPC2;VIM;SLC8A1;ASPH;SNTA1
prerank,actin-myosin filament sliding (GO:0033275),0.9471859371236961,2.438554979123147,0.0,0.0,0.0,19/38,2.61%,MYL1;TPM2;MYBPC1;DMD;TPM1;NEB;TTN;MYH2;TCAP;TNNI2;TNNC2;ACTA1;TNNT3;MYL2;MYL6;DES;MYL3;MYBPC2;VIM
prerank,muscle filament sliding (GO:0030049),0.9471859371236961,2.438554979123147,0.0,0.0,0.0,19/38,2.61%,MYL1;TPM2;MYBPC1;DMD;TPM1;NEB;TTN;MYH2;TCAP;TNNI2;TNNC2;ACTA1;TNNT3;MYL2;MYL6;DES;MYL3;MYBPC2;VIM
prerank,myofibril assembly (GO:0030239),0.9083728424081384,2.2950832000340275,0.0,0.0,0.0,17/42,2.55%,LMOD1;TPM1;OBSCN;TTN;MYOZ2;TCAP;MYPN;MYOM2;LMOD2;TNNT3;MYL2;CASQ1;CSRP1;SYNPO2L;LMOD3;CSRP3;WDR1
prerank,sarcomere organization (GO:0045214),0.9437223514059285,2.272360072685921,0.0,0.0,0.0,14/27,2.55%,TPM1;OBSCN;TTN;MYOZ2;TCAP;MYPN;MYOM2;LMOD2;TNNT3;CASQ1;CSRP1;SYNPO2L;CSRP3;WDR1
prerank,striated muscle contraction (GO:0006941),0.820152737562648,2.208676783034725,0.0,0.0,0.0,15/53,2.70%,MYLK2;DMD;TPM1;TTN;TCAP;RYR2;TNNI2;TNNC2;TNNT3;STAC;LMOD3;CSRP3;DTNA;MYL3;SLC8A1
prerank,actomyosin structure organization (GO:0031032),0.7778921287006338,2.157048115322438,0.0,0.00013115322562086082,0.001,24/75,6.28%,LMOD1;TPM1;OBSCN;TTN;MYOZ2;TCAP;PDLIM1;MYPN;MYOM2;LMOD2;TNNT3;ROCK1;CASQ1;CSRP1;SYNPO2L;LMOD3;CSRP3;MYH9;WDR1;ITGB1;TNFAIP1;MYO18A;ITGB5;SORBS1
prerank,cardiac muscle cell development (GO:0055013),0.9158135169620162,2.125209751323572,0.0,0.0006885544345095193,0.005,11/20,2.70%,MYH11;SORBS2;TTN;TCAP;PDLIM5;HEY2;MYL2;ALPK3;CSRP3;ALPK2;SLC8A1
prerank,heart contraction (GO:0060047),0.8288204022708895,2.1023947613366643,0.0,0.0010200806437178065,0.009,13/41,2.70%,MYLK2;DMD;TRDN;TPM1;TTN;TCAP;RYR2;TNNI2;SGCG;MYL2;CSRP3;MYL3;SLC8A1
prerank,cardiac muscle contraction (GO:0060048),0.8321381122925021,2.0798794899518307,0.0,0.002203374190430462,0.022,11/34,3.15%,MYLK2;DMD;TPM1;TTN;TCAP;RYR2;TNNI2;CSRP3;MYL3;SLC8A1;CAMK2D
prerank,cardiac muscle cell differentiation (GO:0055007),0.903427957446452,2.077377058679882,0.0,0.002169989732999697,0.023,8/21,2.70%,MYH11;MYOCD;TTN;TCAP;MEF2C;ALPK3;ALPK2;SLC8A1
prerank,skeletal muscle tissue development (GO:0007519),0.854696109612993,2.0498546653416643,0.0,0.005202411282960813,0.057,9/32,1.72%,MYLK2;RYR1;MYOZ2;MEF2C;KLHL40;ACTA1;LMOD3;CSRP3;MYL6
prerank,muscle cell differentiation (GO:0042692),0.8214416115711624,2.0334871134431984,0.0014204545454545455,0.008121411278830228,0.093,11/32,3.40%,MYOCD;DMD;NEB;MEF2C;NRAP;HEY2;SPEG;SYNE1;FBXO40;RORA;MRTFA
prerank,regulation of muscle contraction (GO:0006937),0.8340516930467874,2.02748051473841,0.0,0.00937745563189155,0.118,10/26,2.58%,MYLK2;TPM1;CNN1;MYL9;TNNC2;PPP1R12B;TNNT3;MYL2;PLCE1;MYL3
prerank,mesonephric tubule development (GO:0072164),-0.7577756505112719,-2.0056294115136075,0.0,0.1314999651008585,0.098,8/15,10.88%,BMP7;BMP4;SLIT2;PKD2;OSR1;SALL1;FGFR2;SIX1
prerank,smooth muscle contraction (GO:0006939),0.9478082085962749,2.0026055242924667,0.0,0.0178106080393129,0.214,7/14,2.70%,MYH11;ACTA2;MYLK;SMTN;EDNRA;ROCK1;SLC8A1
prerank,regulation of heart contraction (GO:0008016),0.7213061349536904,2.002561164242485,0.0,0.016697445036855843,0.214,23/90,3.42%,PLN;TRDN;RYR1;TPM1;ATP2A1;RYR2;ATP2B4;HSPB7;TNNI3K;TBX2;TMIGD3;CASQ1;HRC;ATP2A2;ITPR1;KCNJ12;CACNA1H;DES;SLC8A2;SLC8A1;ASPH;CAMK2D;STIM1
prerank,calcium ion transport into cytosol (GO:0060402),0.8790591069354838,1.9928260650490635,0.0,0.01960354978250631,0.254,7/21,2.87%,JPH2;RYR2;CACNA1C;ATP2B4;CACNA2D1;SLC8A1;GRIN2C
prerank,muscle cell development (GO:0055001),0.8139925262202435,1.9805318816272883,0.0,0.02570603222168872,0.317,12/30,2.70%,MYH11;DMD;NEB;TTN;TCAP;NRAP;HEY2;ALPK3;FER1L5;ALPK2;DYSF;SLC8A1
prerank,muscle organ development (GO:0007517),0.7584420248609307,1.9776265167166458,0.0,0.025850991050006517,0.325,19/54,6.21%,SOX6;TAGLN;DMD;NEB;SMTN;MEF2C;SGCG;SGCA;ITGA7;CACNA1H;SPEG;LARGE1;FHL3;FHL1;ITGB1BP2;ANKRD2;UTRN;MEF2A;CHD2
prerank,regulation of cation channel activity (GO:2001257),0.7050736563944403,1.976950115006896,0.0,0.025109285045113804,0.331,15/89,5.72%,JPH2;KCNAB1;CACNB2;DMD;FGF13;MEF2C;STAC;HRC;FGF14;CAMK2D;SHISA9;ITGB1;CACNB4;JPH1;CNIH2
prerank,skeletal muscle contraction (GO:0003009),0.8616162389684761,1.96656827910386,0.0,0.03130190318151212,0.385,5/19,1.37%,TCAP;TNNI2;TNNC2;TNNT3;STAC
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.7281428323944307,1.9655298658355256,0.0,0.030671970264514948,0.39,11/54,7.03%,KCNAB1;FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;FHL1;KCNN2;KCNIP3;CAV1;NEDD4
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.803508884472793,1.9650030859533718,0.0,0.02969765213188883,0.395,6/29,2.58%,MYLK2;TPM1;TTN;TCAP;MYL2;MYL3
prerank,cellular response to alkaloid (GO:0071312),0.8889271672957885,1.9635001603211688,0.003289473684210526,0.029454828587351663,0.406,5/17,2.70%,RYR1;RYR2;CACNA1S;HTR1B;SLC8A1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.8482748562334304,1.954036570330209,0.0,0.035878276400842686,0.457,7/22,1.44%,JPH2;TRDN;ATP2A1;RYR2;AKAP6;STAC;CASQ1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.701618357612864,1.9527700594018653,0.0,0.035663588659211,0.464,10/76,4.00%,LMOD1;SYNPO2;NTF3;NTRK3;LMOD2;SYNPO2L;CDC42EP3;SEMA5A;WDR1;NUP62
prerank,actin filament organization (GO:0007015),0.6623600775171894,1.9494282792761262,0.0,0.036722903173841026,0.482,26/151,5.53%,LMOD1;TPM2;FLNA;TPM1;NEB;TTN;TCAP;ACTN1;ENAH;PLS3;NRAP;XIRP1;DSTN;LMOD2;ACTA1;MYO1E;MYO1D;LMOD3;HIP1;FAT1;LCP1;RHOBTB3;MYO1B;ERMN;ARHGEF2;MYO5C
prerank,regulation of calcium ion transport (GO:0051924),0.7335699832566274,1.947821211972322,0.0,0.036755691480246246,0.502,12/54,4.50%,PLN;CACNB2;MYLK;TRPC6;CAMK2G;CASQ1;CACNA2D1;HRC;PACSIN3;STIM1;CCL5;BCL2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.8604172541415804,1.94029377766476,0.0016260162601626016,0.041756473522669244,0.557,3/17,4.10%,KCNAB1;AKAP6;KCNE4
prerank,vasoconstriction (GO:0042310),0.9283702582509764,1.935357106237614,0.0,0.04446531525965919,0.582,4/11,2.70%,ACTA2;EDNRA;EDNRB;SLC8A1
prerank,regulation of blood circulation (GO:1903522),0.7855491783453049,1.934133700663358,0.001392757660167131,0.04424517527557943,0.592,10/34,3.15%,PLN;TPM1;AGTR1;HSPB7;TBX2;TMIGD3;KCNJ12;CACNA1H;DES;CAMK2D
prerank,cardiac cell development (GO:0055006),0.9321042214357611,1.9337385530347269,0.0,0.04314941122926321,0.594,7/11,3.14%,MYH11;TTN;TCAP;ALPK3;ALPK2;SLC8A1;JAG1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.8255589725055206,1.9272620751415483,0.0014970059880239522,0.04701644421499344,0.633,6/24,3.15%,JPH2;DMD;TRDN;AKAP6;HRC;CAMK2D
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.8118773735409581,1.925970250109033,0.0,0.04671369300790072,0.641,8/27,3.15%,PLN;CTNNA3;ATP2A1;FGF13;RYR2;CACNA1C;ATP2A2;CAMK2D
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.8193777787406289,1.922891136344197,0.0,0.04818569509310427,0.658,8/27,5.30%,JPH2;PLN;CACNB2;DMD;HRC;CAMK2D;CACNB4;JPH1
prerank,calcium ion import (GO:0070509),0.7974118614726634,1.9131732262415364,0.0,0.05615543943666524,0.722,7/28,2.70%,CACNB2;ATP2A1;CACNA1S;CACNA1C;ATP2A2;CACNA1H;SLC8A1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6576239038420266,1.909073074020507,0.0,0.058781457850560416,0.743,19/140,7.66%,JPH2;AGTR1;RYR2;CACNA1C;GPR20;EDNRA;PTGER3;CACNA2D1;ADCY5;CD36;S1PR3;PLCE1;SLC8A1;ADRA1D;JPH1;CXCR6;CAV1;GPR17;C1QTNF1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.8020808703327271,1.8944823443129006,0.0015105740181268882,0.07465379658366368,0.814,6/23,1.60%,MYOCD;MEF2C;RBM24;AKAP6;SMYD1;LMOD3
prerank,cellular response to copper ion (GO:0071280),-0.6956850603004257,-1.8894033782155717,0.0024813895781637717,0.4667074654249219,0.497,11/16,18.89%,SNCA;MT2A;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;HSF1
prerank,cytosolic calcium ion transport (GO:0060401),0.8005191844452118,1.8893129205743067,0.0014814814814814814,0.0794956692423469,0.834,10/28,7.87%,JPH2;RYR2;CACNA1C;CACNA2D1;ATP2A2;SLC8A2;SLC8A1;JPH1;AFG3L2;ATP2B1
prerank,extracellular matrix assembly (GO:0085029),0.808175561231968,1.8873233640530511,0.003205128205128205,0.07996412166103885,0.84,6/23,6.92%,MYH11;NTN4;HAS2;EMILIN1;PXDN;LAMB2
prerank,muscle tissue morphogenesis (GO:0060415),0.8750364108805357,1.8819826783861664,0.0,0.08625403843026565,0.866,5/16,1.06%,MYLK2;MYLK;TTN;TCAP;HEY2
prerank,divalent inorganic cation homeostasis (GO:0072507),0.8006990722610053,1.8774361269716706,0.0015105740181268882,0.09134822164492956,0.885,4/25,2.99%,JPH2;CNNM2;SLC8A1;FAM20A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.8424279911146233,1.8770794455960436,0.0,0.0897789580500009,0.887,5/17,3.63%,TPM1;CNN1;MEF2C;PRKG1;TGFB3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.8187298193761444,-1.8719026546272366,0.0,0.40232727417762665,0.582,3/10,0.84%,PRKCB;PID1;APPL2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7807996219394288,1.8682265740442003,0.0,0.1017808645920435,0.92,4/32,1.44%,JPH2;TRDN;AKAP6;CASQ1
prerank,striated muscle cell development (GO:0055002),0.8909555714482338,1.8668709069097975,0.0033222591362126247,0.10151842566279609,0.925,3/14,1.60%,LMOD1;LMOD2;LMOD3
prerank,embryonic skeletal system development (GO:0048706),-0.5593951500492413,-1.8655191294535578,0.0,0.33021754629121836,0.616,15/35,10.88%,PDGFRA;HOXB3;SULF1;COL1A1;PCSK5;HOXA3;KIAA1217;WNT5A;DSCAML1;RBP4;HOXB4;MEGF8;WNT9A;OSR1;SIX1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.6368866360528701,1.8512971953410415,0.0,0.12617510536142554,0.965,26/142,8.89%,PLN;RYR1;AGTR1;RYR2;CACNA1C;EDNRA;HCRTR1;ATP2B4;TRPC6;PTGER3;HRC;ADCY5;CD36;S1PR3;PLCE1;SLC8A2;SLC8A1;ADRA1D;CXCR6;CAV1;CALB1;FZD9;C1QTNF1;ATP2B1;TRPM4;TRPC5
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.9115701556659845,1.849620926452226,0.0,0.12726048626466718,0.967,3/11,0.71%,MYOCD;SOX6;MEF2C
prerank,heart development (GO:0007507),0.6229928328418382,1.847640161017882,0.0,0.12831976947567683,0.973,21/150,2.23%,MYOCD;PDLIM3;LDB3;TCAP;CACNA1C;PDLIM1;MEF2C;NTRK3;PDLIM5;CRIP1;DLC1;SGCG;MYL2;TBX2;MICAL2;ALPK3;SYNPO2L;CSRP3;PLCE1;PDGFB;ALPK2
prerank,positive regulation of cation channel activity (GO:2001259),0.7352426003636188,1.8463686286118999,0.00535475234270415,0.12774324175471846,0.975,5/40,1.44%,JPH2;TRDN;AKAP6;STAC;CASQ1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.7200724900244384,1.8456321286438078,0.0,0.1267307388529254,0.976,7/48,3.15%,JPH2;DMD;TRDN;AKAP6;CASQ1;HRC;CAMK2D
prerank,protein kinase A signaling (GO:0010737),0.8910719020435164,1.8388164732646843,0.0,0.1371168399387976,0.979,3/12,3.35%,MYOM1;TTN;LCP1
prerank,response to muscle stretch (GO:0035994),0.8574038539395226,1.8381381917822903,0.0,0.13571584456601732,0.979,6/15,2.70%,DMD;TTN;TCAP;RYR2;CSRP3;SLC8A1
prerank,skeletal muscle organ development (GO:0060538),0.7779240607201672,1.8350676538155055,0.0057553956834532375,0.1395123878123187,0.983,6/26,6.08%,MYOZ2;MEF2C;CSRP3;MYL6;LARGE1;CAV1
prerank,cardiac muscle tissue development (GO:0048738),0.7052895472115379,1.8302096753040415,0.0026954177897574125,0.14582052801946044,0.99,8/50,1.66%,MYOCD;MYLK2;TTN;TCAP;HEY2;SGCG;TBX2;CSRP3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.80125837771917,1.8281660983440196,0.0015408320493066256,0.14757599407269478,0.994,9/21,3.15%,DMD;TRDN;RYR2;CACNA1C;AKAP6;CASQ1;HRC;SLC8A1;CAMK2D
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.7104413110216543,1.82478493697443,0.0027100271002710027,0.15187543526895683,0.994,7/41,4.09%,FLNA;KCNMA1;AKAP6;STAC;KCNJ12;KCNMB1;KCNN2
prerank,activation of adenylate cyclase activity (GO:0007190),0.7319210506057722,1.8237335550665132,0.0029239766081871343,0.15119205793545865,0.994,8/35,4.27%,CAP2;LHCGR;EDNRA;TMIGD3;ADCY5;ADCY2;ADCY9;TSHR
prerank,positive regulation of heart rate (GO:0010460),0.8303543853276253,1.820495793016048,0.0,0.15551832917370179,0.994,5/17,2.89%,TPM1;RYR2;HRC;ATP2A2;ADRA1D
prerank,modified amino acid transport (GO:0072337),-0.6853149324203723,-1.815160244221215,0.004866180048661801,0.5295221808972072,0.85,5/15,7.66%,SLC6A13;SLC16A12;PDPN;SLC25A32;CTNS
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.8928853897709,1.8134006965790033,0.0,0.1687697490777457,0.998,3/10,6.08%,KCNAB1;KCNE4;CAV1
prerank,ureteric bud development (GO:0001657),-0.664191478445611,-1.8116956689433101,0.0025974025974025974,0.4624024070436439,0.858,8/17,10.88%,BMP7;BMP4;SLIT2;PKD2;OSR1;SALL1;FGFR2;SIX1
prerank,chordate embryonic development (GO:0043009),-0.4920813859665355,-1.806133268808397,0.0,0.42502667291527485,0.874,18/55,11.77%,ALDH1A2;CHD7;SULF1;COL1A1;BMP7;PCSK5;KIAA1217;PTCH1;WNT5A;RBP4;PKD2;ARNT2;ADAM10;FUT8;IGF2;TGFB1;FGFR2;TGFBR1
prerank,regulation of cardiac conduction (GO:1903779),0.6922678075666755,1.8040079426502411,0.0025477707006369425,0.18682776989691624,0.999,13/54,3.42%,TRDN;RYR1;ATP2A1;RYR2;ATP2B4;TNNI3K;CASQ1;ATP2A2;ITPR1;SLC8A2;SLC8A1;ASPH;STIM1
prerank,heart morphogenesis (GO:0003007),0.6820929191362375,1.7987895279526738,0.003942181340341655,0.19571501347238884,0.999,14/50,7.86%,MYLK2;TTN;TCAP;RYR2;DLC1;HEY2;TBX2;SYNPO2L;ALPK2;HEYL;BMPR1A;VEGFA;SOX9;TGFB2
prerank,epithelial cell development (GO:0002064),0.8087722740018406,1.7970731295546993,0.009708737864077669,0.19677849204724737,0.999,2/20,3.53%,ACTA2;TMEM79
prerank,regulation of smooth muscle contraction (GO:0006940),0.8043765842633258,1.791887902088636,0.0049833887043189366,0.20599799970849875,0.999,7/20,8.18%,MYOCD;CNN1;PLCE1;CAV1;ATP2B1;SETD3;DAPK3
prerank,platelet aggregation (GO:0070527),0.7282969388373958,1.7916560845644518,0.008264462809917356,0.20349652516566752,0.999,11/33,7.51%,FLNA;MYL9;ACTN1;VCL;CSRP1;MYH9;ACTG1;ACTB;TLN1;ITGB3;PLEK
prerank,cellular response to purine-containing compound (GO:0071415),0.8938875582616069,1.7912560340018258,0.0035650623885918,0.20138275132793285,0.999,4/10,2.70%,RYR1;RYR2;CACNA1S;SLC8A1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.7158342156645595,1.7903669274131666,0.005471956224350205,0.2005571280153182,0.999,8/38,6.08%,CACNB2;CTNNA3;CACNA1C;CACNA2D1;CAMK2D;KCNA5;KCNE4;CAV1
prerank,calcium ion homeostasis (GO:0055074),0.6350790231430855,1.7902006090503613,0.001152073732718894,0.19793370759184092,0.999,12/95,3.64%,JPH2;TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;FAM20A;STIM1;CCL5
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.8439606948421594,1.7899613129268979,0.005172413793103448,0.1955629604680468,0.999,2/13,1.06%,RYR2;HEY2
prerank,cardiac myofibril assembly (GO:0055003),0.8188606555656022,1.7888318951353823,0.005025125628140704,0.1948708840159695,0.999,6/15,1.66%,NEB;TTN;TCAP;NRAP;MYL2;CSRP3
prerank,negative regulation of cell development (GO:0010721),-0.5989046824076614,-1.783150035810856,0.002777777777777778,0.49165723558914737,0.931,5/25,4.16%,IGF1;FBN1;APPL2;B2M;PCM1
prerank,smooth muscle cell differentiation (GO:0051145),0.8656183771694691,1.7816360927497796,0.0035778175313059034,0.2094123553488285,0.999,6/12,5.24%,MYOCD;MEF2C;HEY2;EDNRB;MRTFA;TBX18
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.7195227745173358,1.7775460159182848,0.008695652173913044,0.21713063031518964,0.999,7/33,5.98%,TPM1;CNN1;MEF2C;PRKG1;IGFBP5;TGFB3;OGN
prerank,negative regulation of neurogenesis (GO:0050768),-0.5384652135055413,-1.7762537318638698,0.0,0.4710777519634921,0.945,6/34,5.75%,PTN;NF1;APPL2;B2M;PCM1;RUFY3
prerank,sensory perception of taste (GO:0050909),0.8683909825444366,1.7758021396796655,0.006932409012131715,0.21847577186826117,1.0,3/10,5.34%,ASIC3;CD36;PKD1L3
prerank,calcium ion transport (GO:0006816),0.6195271222820211,1.7733281402193026,0.0011013215859030838,0.2216956634070102,1.0,17/113,3.64%,CACNB2;RYR1;ATP2A1;RYR2;CACNA1S;CACNA1C;ATP2B4;TRPC6;CACNA2D1;ATP2A2;ITPR1;CACNA1H;ANO6;SLC8A2;SLC8A1;STIM1;CCL5
prerank,anion transport (GO:0006820),-0.5518817930934217,-1.771303884789241,0.0,0.45144407661857233,0.953,8/33,8.18%,SLC13A4;SLC13A3;ABCG2;SLCO2B1;LRRC8B;SLC26A7;SLC22A6;SLC4A2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.84893143003062,1.7703997891066978,0.00859106529209622,0.2260567630846478,1.0,8/12,11.18%,TRDN;HRC;GJD3;CAMK2D;CAV1;CALM1;SRI;PDE4D
prerank,negative regulation of reproductive process (GO:2000242),-0.6538173638504116,-1.7678230050813033,0.004914004914004914,0.4266277276851717,0.959,6/17,15.51%,IGF1;SULF1;GJA1;ARHGDIB;CALR;DUSP1
prerank,blood circulation (GO:0008015),0.6913717339707282,1.7662804705631572,0.007863695937090432,0.23334956773431056,1.0,8/49,1.43%,PLN;GUCY1A1;TRDN;AGTR1;ELN;SGCG;MYL2;ROCK1
prerank,actin nucleation (GO:0045010),0.7987701385858972,1.7650374912625477,0.009188361408882083,0.23339579349400744,1.0,7/21,8.93%,LMOD1;LMOD2;LMOD3;ACTR3;WHAMM;SPIRE1;WASHC1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.7100438000989121,1.7612756723714866,0.008797653958944282,0.2401415561117962,1.0,11/35,7.68%,PDE3A;CAP2;AKAP6;CD36;IRAG1;ADCY2;GUCY1B1;NUDT4;KSR1;CAP1;SOX9
prerank,response to purine-containing compound (GO:0014074),0.7920783277360738,1.7612458177144796,0.00980392156862745,0.23712166901929535,1.0,2/17,0.51%,RYR1;RYR2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.8507671308741146,1.7602788964634892,0.008710801393728223,0.23657219617401326,1.0,2/11,0.71%,MYOCD;MEF2C
prerank,dendrite self-avoidance (GO:0070593),0.8113214177396205,1.759793999775295,0.012216404886561954,0.234934773054648,1.0,4/16,1.61%,NEXN;PALLD;MYPN;ROBO3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6281953632057842,-1.7578906409002923,0.010752688172043012,0.4374526368794185,0.974,9/19,11.87%,ROBO1;JCAD;DCN;SEMA6A;CCBE1;XDH;PIK3CB;CD63;SPRY2
prerank,metal ion homeostasis (GO:0055065),0.6968473289476299,1.7573031340792744,0.006811989100817439,0.23796214572061494,1.0,4/40,2.99%,JPH2;CNNM2;SLC8A1;FAM20A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.755523510278957,1.7555404320421852,0.01386748844375963,0.23952737515279116,1.0,5/22,6.29%,CACNB2;DMD;STAC;CACNB4;STAC3
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.8372362991403431,1.750202218975572,0.008896797153024912,0.25082185312349975,1.0,8/13,11.18%,TRDN;HRC;SLC8A1;CAMK2D;CAV1;CALM1;SRI;PDE4D
prerank,regulation of amyloid-beta clearance (GO:1900221),0.7838260068819181,1.749155100337327,0.01386481802426343,0.25072124964521225,1.0,2/16,1.43%,MYOCD;ROCK1
prerank,amino acid import (GO:0043090),-0.6018254101375498,-1.7426503212357243,0.0,0.47813242805216,0.987,8/21,9.92%,SLC6A13;SLC1A3;SLC47A1;SLC6A1;SLC6A6;SLC7A5;SLC22A4;SFXN2
prerank,zinc ion homeostasis (GO:0055069),-0.5669146238178246,-1.7411929698948168,0.002898550724637681,0.4506054288819597,0.989,15/28,17.81%,SLC39A10;SLC30A10;SLC39A8;PRKN;SLC30A1;SLC39A6;MT2A;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,positive regulation of potassium ion transport (GO:0043268),0.6822715312332347,1.7383393616263019,0.019746121297602257,0.2766746728532682,1.0,7/38,4.09%,FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;FHL1;KCNN2
prerank,homotypic cell-cell adhesion (GO:0034109),0.6845407079676561,1.7311572689617805,0.014647137150466045,0.2933028385759542,1.0,11/39,7.51%,FLNA;MYL9;ACTN1;VCL;CSRP1;MYH9;ACTG1;ACTB;TLN1;ITGB3;PLEK
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6936574276675812,1.7281221472475758,0.013966480446927373,0.29863740224704055,1.0,9/37,5.14%,TPM1;CNN1;MEF2C;PRKG1;HTR1B;PDGFB;IGFBP5;TGFB3;BMPR1A
prerank,calcium ion import into cytosol (GO:1902656),0.8048420987442827,1.7280946453446104,0.01001669449081803,0.2953376891898482,1.0,5/15,6.55%,ATP2B4;CACNA2D1;SLC8A2;SLC8A1;TRPV2
prerank,hepaticobiliary system development (GO:0061008),-0.6028650966504822,-1.7258743989466856,0.0028169014084507044,0.4973516537207471,0.995,6/20,6.56%,TGFBR3;NF1;COBL;WNT4;PKD2;LSR
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.6832933672461735,1.7220680098207142,0.013605442176870748,0.30934919755065127,1.0,8/41,2.87%,RYR1;RYR2;ATP2B4;CACNA2D1;ITPR1;SLC8A2;SLC8A1;GRIN2C
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.8322074107839399,1.720165338966782,0.01079136690647482,0.30836141085397006,1.0,3/12,1.59%,MYOZ2;ATP2B4;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.8322074107839399,1.720165338966782,0.01079136690647482,0.30836141085397006,1.0,3/12,1.59%,MYOZ2;ATP2B4;DYRK2
prerank,positive regulation of calcium ion transport (GO:0051928),0.6873983874738397,1.719889254860913,0.011095700416088766,0.3058678546688591,1.0,7/36,7.87%,CACNB2;MYLK;TRPC6;PDGFB;CCL5;CAV1;ATP2B1
prerank,positive regulation of calcium ion import (GO:0090280),0.8174759750043065,1.7198865299390085,0.010434782608695653,0.3025986965020831,1.0,2/12,2.09%,ATP2A1;PDGFB
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.716930839682962,1.7188912277517054,0.013533834586466165,0.3018993776613298,1.0,5/26,1.59%,MYOZ2;ATP2B4;AKAP6;LMCD1;DYRK2
prerank,striated muscle cell differentiation (GO:0051146),0.786350454565426,1.7160926203085538,0.011884550084889643,0.306810192095554,1.0,3/16,3.56%,MYOCD;MEF2C;SORT1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.7967222220306431,1.7146767505118305,0.019230769230769232,0.30751606105677926,1.0,9/16,12.40%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1;AOAH;PHKA1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.8462128678706515,1.7144054657146879,0.020484171322160148,0.3050745716501077,1.0,5/10,9.21%,GABRE;GABRA4;GABRA5;GABRB2;GABRG1
prerank,negative regulation of cation channel activity (GO:2001258),0.7305388353304685,1.7141227338260168,0.013574660633484163,0.30281406178347897,1.0,2/26,0.28%,KCNAB1;TRDN
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7859013212813261,1.7123581909121925,0.024077046548956663,0.3048835574864575,1.0,6/16,7.86%,SOX6;SOX5;RBM24;SP7;SOX9;TGFB2
prerank,regulation of cation transmembrane transport (GO:1904062),0.7089946463027171,1.7122337665464338,0.01908957415565345,0.30226621602388554,1.0,6/29,5.31%,KCNAB1;ATP2B4;HRC;SNTA1;KCNN2;KCNIP3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.7500383754417859,1.71131434427103,0.025806451612903226,0.30185499222695866,1.0,3/18,1.89%,FLNA;POLR2L;RASL11A
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.8358396909914625,1.710855627946846,0.01733102253032929,0.3001377277536527,1.0,3/10,2.95%,SOX6;SOX5;LOXL2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.5878233552454537,-1.709130817409217,0.0031446540880503146,0.560489248571628,0.999,13/24,24.17%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;RNF34;TAB1;AAMP;UBB;CYLD
prerank,cellular calcium ion homeostasis (GO:0006874),0.5915700762307148,1.708921094217781,0.002224694104560623,0.30324026429059364,1.0,33/133,12.68%,PLN;TRDN;RYR1;ATP2A1;RYR2;HCRTR1;ATP2B4;TRPC6;HRC;ATP2A2;CSRP3;SLC8A2;SLC8A1;CAMK2D;STIM1;CCL5;BCL2;ATP1B1;CAV1;AFG3L2;CALB1;RMDN3;FZD9;ATP2B1;TRPC5;PTH1R;ATP2A3;CCL14;GPER1;HTR2B;DMPK;CHRNA7;CALB2
prerank,cAMP-mediated signaling (GO:0019933),0.7168949918546436,1.7076559775213707,0.02047244094488189,0.3035995398929665,1.0,7/24,7.68%,PDE3A;CAP2;AKAP6;ADCY2;KSR1;CAP1;SOX9
prerank,calcium ion import across plasma membrane (GO:0098703),0.8130362495412994,1.7071389794003076,0.01721170395869191,0.30199341731459417,1.0,5/14,6.55%,ATP2B4;CACNA2D1;SLC8A2;SLC8A1;TRPV2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7384308122226441,1.7061021069330318,0.008746355685131196,0.3020805228531197,1.0,10/25,8.74%,CTNNA3;FGF13;RYR2;CACNA1C;ATP2A2;CAMK2D;TBX18;CAV1;CALM1;TRPM4
prerank,striated muscle tissue development (GO:0014706),0.7071350651219861,1.7059008837796426,0.012802275960170697,0.29987510886115515,1.0,6/29,1.72%,MYOZ2;MEF2C;SGCG;TBX2;CSRP3;MYL6
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.8325851714934247,1.7047455137163894,0.017421602787456445,0.29982720320475625,1.0,3/11,3.15%,CACNB2;CACNA2D1;CAMK2D
prerank,sulfur compound transport (GO:0072348),-0.553774973431228,-1.704386650298168,0.012987012987012988,0.554109359245897,1.0,16/27,30.54%,SLC6A13;SLC13A4;ABCG2;SLC6A6;SLC26A7;SLC25A14;SLC35F3;SLC25A30;SLC25A11;LRRC8D;SLC36A1;SLC26A6;SLC25A19;SLC5A6;SLC35B2;RACGAP1
prerank,circulatory system development (GO:0072359),0.5829338390523376,1.7024021469176454,0.0022123893805309734,0.30330085855275585,1.0,21/118,7.86%,PDLIM3;LDB3;CACNA1C;PDLIM1;MEF2C;NTRK3;PDLIM5;CRIP1;HEY2;MYL2;MICAL2;ALPK3;PLCE1;PDGFB;HDAC9;PDLIM7;MEF2A;FBXW7;SMYD4;SOX9;TGFB2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7558635817210705,1.6981888231155422,0.017133956386292833,0.31199444691921036,1.0,9/20,7.02%,DMD;RYR2;CACNA1C;HRC;ATP2A2;SLC8A1;CAMK2D;ATP1B1;CALM1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8173886912656848,1.6978070834364218,0.013745704467353952,0.31001904947411785,1.0,3/12,0.63%,CTNNA3;RYR2;CACNA1C
prerank,positive regulation of ATPase activity (GO:0032781),0.6736951369212817,1.6948474553053396,0.017142857142857144,0.31574319360562114,1.0,6/41,2.58%,TPM1;ATP2A1;RYR2;DYNLL1;TNNT3;MYL3
prerank,positive regulation of reproductive process (GO:2000243),0.6801738335178436,1.6945536862729624,0.022792022792022793,0.3137939578060314,1.0,7/31,11.73%,PDE3A;CACNA1H;TACR3;VEGFA;PLCB1;SIRT2;ACVR1B
prerank,regulation of glucose import (GO:0046324),-0.5463523289710441,-1.6882852664807961,0.006802721088435374,0.6188847563873737,1.0,14/30,16.75%,IGF1;OSBPL8;PID1;PRKAG2;APPL2;PTPN11;OCLN;CREBL2;ENPP1;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5612587248419914,-1.6877481738806341,0.0084985835694051,0.5889690636166741,1.0,14/26,17.81%,SLC39A10;SLC30A10;SLC39A8;SLC30A1;SLC39A6;MT2A;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.6001019727899799,1.6873848144787367,0.00468384074941452,0.33127118904735764,1.0,7/86,2.55%,LMOD1;SYNPO2;LMOD2;SYNPO2L;CDC42EP3;SEMA5A;WDR1
prerank,nerve growth factor signaling pathway (GO:0038180),0.8368752382424389,1.6863451617664111,0.019011406844106463,0.3314880670624785,1.0,2/10,0.72%,NTF3;RAP1A
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.6197827294659646,-1.686226539726697,0.016574585635359115,0.568854759744339,1.0,6/18,11.67%,PTN;SLIT2;CAMK1D;PTK2B;IL6R;LYN
prerank,glycerolipid metabolic process (GO:0046486),0.8285054544764615,1.6842350428349606,0.012567324955116697,0.3346928561031387,1.0,2/11,0.44%,DGKB;DGKG
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7694592566385271,1.6814192812385,0.02640845070422535,0.33989871726095555,1.0,4/15,6.50%,NTF3;NTRK3;CDH13;VEGFA
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6039173055873399,-1.6788816716080623,0.01278772378516624,0.5840901936261348,1.0,9/18,17.36%,TSHZ3;NLGN1;PTK2B;SHANK3;CACNG4;NRXN1;NLGN2;NLGN3;CACNG8
prerank,metal ion transport (GO:0030001),0.606938116735281,1.6775765706290975,0.002366863905325444,0.3482062566833168,1.0,20/86,12.48%,RYR1;ATP2A1;RYR2;CACNA1S;CACNA1C;CACNA2D1;ITPR1;SLC8A2;SLC8A1;CCL5;CAV1;RAMP1;TRPC5;SLC30A5;MRS2;ATP2A3;PANX1;CACNA1B;CHRNA7;TRPM2
prerank,glucan catabolic process (GO:0009251),0.7958848416025681,1.6772342590126335,0.024752475247524754,0.34622908584782314,1.0,7/15,8.25%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1
prerank,response to calcium ion (GO:0051592),0.5938244254172296,1.6748924091447042,0.009195402298850575,0.35008402631912333,1.0,17/102,7.03%,KCNMA1;RYR1;TTN;RYR2;MEF2C;PPP3CA;RASGRP2;KCNMB1;CAMK2D;STIM1;D2HGDH;SYT10;MEF2A;KCNH1;CAV1;CALM1;NEDD4
prerank,diacylglycerol metabolic process (GO:0046339),0.7082749830918253,1.674712157780039,0.03211009174311927,0.34766877463465784,1.0,3/23,1.83%,DGKB;DGKG;PLCE1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.513973886115015,-1.6747038727961452,0.01107011070110701,0.5819834088574928,1.0,9/36,13.46%,AFDN;SPTBN1;VAMP5;GOLGA4;OPTN;GCC2;GOLPH3;BLZF1;RILPL2
prerank,renal system development (GO:0072001),0.6327994943346704,1.672668603584545,0.016774193548387096,0.35060589790418595,1.0,8/52,7.86%,MYOCD;ITGA8;AGTR1;CEP290;TBX18;HAS2;VEGFA;TGFB2
prerank,response to metal ion (GO:0010038),0.6149118051993194,1.6699546850420581,0.018820577164366373,0.356271872823939,1.0,17/67,9.57%,KCNMA1;TTN;CRIP1;PPP3CA;LOXL2;D2HGDH;FXN;BCL2;CAV1;MAPT;NDRG1;CALM1;NEDD4;PPP1CA;AHCYL1;SLC30A5;HIF1A
prerank,regulation of histone modification (GO:0031056),0.7883480409342943,1.6699256521240815,0.012089810017271158,0.3534653468593437,1.0,1/13,0.03%,MYOCD
prerank,cardiac ventricle morphogenesis (GO:0003208),0.660422347331786,1.6698038705083282,0.012534818941504178,0.3509754747936683,1.0,8/41,5.14%,TPM1;MEF2C;HEY2;MYL2;MYL3;HEYL;JAG1;BMPR1A
prerank,focal adhesion assembly (GO:0048041),0.7476125515496329,1.6678023132185666,0.018461538461538463,0.3541501406278856,1.0,8/21,9.97%,ARHGEF7;ACTN1;DLC1;FERMT2;PEAK1;SORBS1;WHAMM;ACTN2
prerank,peptidyl-arginine modification (GO:0018195),0.7872307509829057,1.666540587487741,0.024834437086092714,0.3549543290633745,1.0,6/15,10.66%,ART1;PADI3;PADI2;ART4;PRMT7;KRTCAP2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5958633915981686,-1.662537947393809,0.02077922077922078,0.6298317427850902,1.0,9/18,16.07%,PUM1;UFD1;BIRC2;SEC14L1;DDX60;RNF125;BIRC3;ANKRD17;NOP53
prerank,carbohydrate biosynthetic process (GO:0016051),-0.5694097262190317,-1.6619477413839845,0.012755102040816327,0.606279414990677,1.0,8/21,22.30%,ST3GAL4;B4GALT1;ST3GAL6;FUT8;ST3GAL3;MPDU1;ST6GALNAC5;B3GALT2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5987672641793923,1.66167053067832,0.013268998793727383,0.3662679245069074,1.0,7/76,2.89%,AGTR1;LHCGR;GPR20;PTGER3;ANO1;PLCE1;ADRA1D
prerank,regulation of cell communication (GO:0010646),0.6636377579272463,1.6607635347872198,0.023415977961432508,0.3662611412671618,1.0,12/35,10.88%,TRDN;RYR2;IGFBP7;SLC8A1;ANXA1;CAMK2D;NUP62;TBX18;PTPN1;MGLL;SRI;CDC42SE2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.8529065401265193,1.6602756339462124,0.016822429906542057,0.3650115333544514,1.0,1/10,0.03%,MYOCD
prerank,positive regulation of ion transport (GO:0043270),0.6513340226117001,1.6592049848167851,0.014844804318488529,0.365448952080747,1.0,15/48,11.09%,CACNB2;MYLK;TRPC6;PLA2G3;ANO6;CCL5;FHL1;GDNF;PRSS8;KIF5B;ATP2B1;CNKSR3;AHCYL1;ACTN2;GPD1L
prerank,lipid phosphorylation (GO:0046834),0.81417833516444,1.6581114870585156,0.027777777777777776,0.3655458986762759,1.0,2/10,0.44%,DGKB;DGKG
prerank,second-messenger-mediated signaling (GO:0019932),0.5948024825925375,1.6574799528869202,0.008215962441314555,0.3647578288556593,1.0,12/82,5.56%,GUCY1A1;AGTR1;RYR2;RCAN2;CD36;PLCE1;EDNRB;GUCY1B1;INPP5A;NUDT4;CAMKK2;CXCR6
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.7465142721829732,1.657415252627053,0.03114754098360656,0.3622001864157239,1.0,3/20,6.71%,MYOCD;NR2F2;HEXIM1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.7206224774771236,1.6536018539546005,0.029605263157894735,0.3703776806586859,1.0,8/21,9.99%,GUCY1A1;ADCY5;ADCY2;ADCY9;GUCY1B1;AMPD2;ADCY6;NPR2
prerank,cellular response to zinc ion (GO:0071294),-0.6288434586726003,-1.65130509465229,0.019704433497536946,0.6494689347784901,1.0,11/15,20.84%,GLRA2;MT2A;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;GLRA1
prerank,cell-matrix adhesion (GO:0007160),0.589368009865768,1.6506647466573172,0.010309278350515464,0.3768080390184986,1.0,20/95,8.29%,ITGA8;ARHGEF7;ACTN1;ITGB6;DLC1;VCL;BCAM;ITGA7;ITGA1;FERMT2;ITGA3;ITGB1;PEAK1;EMILIN1;ITGB5;SORBS1;SGCE;ITGB3;ITGA4;WHAMM
prerank,supramolecular fiber organization (GO:0097435),0.5422474282128832,1.6493322641903114,0.0010121457489878543,0.3778773334068836,1.0,53/333,8.56%,MYH11;LMOD1;TPM2;TRDN;TPM1;TTR;FGF13;ACTN1;MFGE8;COL18A1;XIRP1;COL4A2;COL4A1;LMOD2;MYO1E;MYO1D;LMOD3;ADAMTS14;CD36;HIP1;P3H2;FAT1;DES;VIM;LOXL2;HOOK2;KIF2A;CRTAP;COL4A6;RHOBTB3;MYO1B;ERMN;DST;MAP7D3;ARHGEF2;EMILIN1;MYO5C;TUBGCP6;PXDN;MAPT;TPPP;CALB1;PIN1;HDGFL3;CORO1C;NAT8;TGFB2;ARHGAP17;WHAMM;COL27A1;RHOF;COL4A5;TPM4
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.5698754890704404,-1.6479297482195379,0.01507537688442211,0.6453523355962806,1.0,8/20,22.30%,ST3GAL4;B4GALT1;ST3GAL6;FUT8;ST3GAL3;MPDU1;ST6GALNAC5;B3GALT2
prerank,cellular response to cadmium ion (GO:0071276),-0.5619751274563611,-1.6478337753432155,0.01977401129943503,0.6219722224991995,1.0,14/24,18.89%,EGFR;CHUK;MAPK9;AKT1;MT2A;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;HSF1
prerank,negative regulation of cell junction assembly (GO:1901889),0.7074043910357477,1.645634552829017,0.016591251885369532,0.38636219650796955,1.0,7/25,6.96%,SLIT1;DLC1;ROCK1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,cellular response to organonitrogen compound (GO:0071417),0.5779550191185118,1.6454413608593976,0.01053864168618267,0.3842497010691636,1.0,26/99,13.20%,PDE3A;MEF2C;RAP1A;AKAP6;NR1H4;HTR1B;P2RY2;IGFBP5;TSHR;ACTB;LARS1;TAF1;CPEB1;SOX9;RELA;IMPACT;GABRB2;CAPN2;RRAGB;SH3BP4;GABRB3;TRPM2;CPEB3;HCN2;DMTN;ZFP36L1
prerank,cGMP-mediated signaling (GO:0019934),0.8096731552979257,1.6448005062925963,0.021739130434782608,0.3834133397800245,1.0,4/13,3.85%,PDE3A;CD36;IRAG1;GUCY1B1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6690320066199062,1.6445385512092825,0.024793388429752067,0.38150147921306626,1.0,7/30,4.10%,RYR2;CACNA1C;CACNA2D1;GJC1;SNTA1;KCNA5;KCNE4
prerank,filopodium assembly (GO:0046847),-0.6078008355984936,-1.644280542075084,0.009569377990430622,0.619509083035741,1.0,5/16,4.56%,DNM3;FGD6;FGD5;FGD4;SRGAP2
prerank,negative regulation of catalytic activity (GO:0043086),0.7150669859608222,1.6433666801764855,0.0256797583081571,0.38236429869791067,1.0,2/24,0.41%,PLN;PPP1R12A
prerank,action potential (GO:0001508),0.6431669168706562,1.6408178459136136,0.01891891891891892,0.38750366953963233,1.0,15/44,16.58%,DMD;SCN4A;AKAP6;CACNA1H;KCNE4;KCNB1;SLC4A3;SRI;GPER1;KCNA2;GNAQ;CHRNA4;YWHAH;CACNA1I;KCNH2
prerank,positive regulation of cartilage development (GO:0061036),0.7533308140986059,1.638346654583029,0.029780564263322883,0.3924887786784725,1.0,5/17,7.68%,SOX6;SOX5;LOXL2;TAPT1;SOX9
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.7268620289338746,1.6371573774328876,0.03079416531604538,0.39342259215740694,1.0,3/22,6.71%,MYOCD;NR2F2;HEXIM1
prerank,sympathetic nervous system development (GO:0048485),-0.6144250833257331,-1.6371061702596328,0.024630541871921183,0.6411028163091423,1.0,6/15,12.08%,NF1;NRP2;NRP1;CTNNB1;SEMA3A;SOX4
prerank,regulation of striated muscle contraction (GO:0006942),0.6903734620842094,1.635059367155529,0.019287833827893175,0.3975631558669393,1.0,6/27,2.58%,DMD;RYR2;TNNI3K;TNNT3;MYL2;MYL3
prerank,neurotransmitter uptake (GO:0001504),-0.6659526202929478,-1.6347894445548241,0.009280742459396751,0.6323739393153786,1.0,3/12,1.14%,ATP1A2;SLC1A3;GLUL
prerank,bicellular tight junction assembly (GO:0070830),-0.46183277683044577,-1.6303493316295108,0.0,0.6366688978529469,1.0,8/46,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;CLDN11
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6312323704465506,-1.6288565479299482,0.023923444976076555,0.6251018151292763,1.0,4/14,6.44%,KIT;WNT5A;SEMA7A;PLCG2
prerank,actin filament-based transport (GO:0099515),0.715053569221433,1.6284494977741077,0.04186046511627907,0.4157807067849138,1.0,7/21,7.99%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C;SYNE2;SUN2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.6870157660707141,1.6255047746223121,0.03736920777279522,0.42211488431985383,1.0,4/26,3.59%,SYNPO2;ROCK1;SYNPO2L;ACTG1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.6557690763073402,1.6253102277387679,0.02661064425770308,0.41989805461257024,1.0,7/34,7.02%,PLN;RYR2;TNNI3K;ATP2A2;SLC8A1;ATP1B1;CALM1
prerank,regulation of cartilage development (GO:0061035),0.7385458052168992,1.624886019528561,0.0390015600624025,0.4184085177950201,1.0,4/18,7.68%,SOX6;SOX5;TAPT1;SOX9
prerank,mesenchyme development (GO:0060485),-0.6301481444690945,-1.6231904764148337,0.0166270783847981,0.6373976933933659,1.0,8/15,21.93%,BMP7;BMP4;PKD2;BMPR2;FGFR2;TGFBR1;HMGA2;CRELD1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5731471881608948,-1.6228097526936258,0.014619883040935672,0.6208262533044209,1.0,8/20,14.61%,NUPR1;CASP8;BIRC2;PELI1;SDCBP;OGT;STUB1;BIRC3
prerank,myotube cell development (GO:0014904),0.8048129030620508,1.6222903337001524,0.04308797127468582,0.42365097568762305,1.0,4/10,1.60%,RYR1;KLHL40;ACTA1;LMOD3
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.7555634278455206,1.621474963164899,0.02471169686985173,0.4235092968327937,1.0,6/16,3.15%,DMD;RYR2;CACNA1C;HRC;SLC8A1;CAMK2D
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6862904219329283,1.621203076681606,0.03880597014925373,0.4215453257791961,1.0,9/25,9.69%,CTNNA3;ITGA7;ITGB1;JAM3;CD200R1;CD200;ITGB3;ITGA4;PARVA
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.760993242964976,1.620839972349182,0.0387858347386172,0.42001224354055133,1.0,4/14,6.45%,FLNA;LIMS1;LIMS2;SLC2A10
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5993635001192175,1.6194797333121078,0.022556390977443608,0.42194023441853445,1.0,12/59,6.20%,NEXN;PALLD;MYOT;MYPN;IGFN1;ROBO3;CDH13;ITGB1;CDH4;KIRREL3;IGSF21;DSCAM
prerank,negative regulation of macroautophagy (GO:0016242),-0.5399739840104539,-1.6191511345577447,0.016574585635359115,0.6229475387558527,1.0,13/26,23.99%,PIK3CA;NUPR1;SMG1;NRBP2;AKT1;SCFD1;QSOX1;FEZ1;LZTS1;CHMP4B;CHMP4A;SMCR8;PHF23
prerank,artery development (GO:0060840),-0.5403651440320401,-1.6184146146575675,0.011527377521613832,0.6092962172654361,1.0,9/23,11.77%,ROBO1;NF1;NRP1;ENG;ACVRL1;PKD2;BMPR2;HES1;TGFBR1
prerank,regulation of microtubule depolymerization (GO:0031114),0.6852669468528713,1.6183176703559974,0.02773497688751926,0.4230019409336814,1.0,7/25,7.13%,FGF13;TRIM54;CLASP2;MAP1B;ARHGEF2;HDGFL3;TPX2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6902142978309184,1.617564707443982,0.029197080291970802,0.4225472903410435,1.0,6/24,7.71%,SOX6;SOX5;CHADL;LOXL2;SOX9;SNAI2
prerank,B cell proliferation (GO:0042100),0.7533240581831062,1.6171304811967957,0.03420195439739414,0.4211570798960715,1.0,5/17,11.11%,MEF2C;CD79A;BCL2;RASGRP1;CD180
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.7095987094326102,1.6167816851839152,0.03542673107890499,0.4196400053404473,1.0,3/22,0.77%,NTF3;RAP1A;NTRK3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.4974928916601139,-1.616598376114947,0.0035335689045936395,0.6031418524787687,1.0,10/37,11.20%,ALCAM;HMCN1;CADM1;CXADR;NLGN1;VCAM1;NECTIN1;TENM3;PTPRD;CADM3
prerank,ether lipid metabolic process (GO:0046485),-0.6356829833853788,-1.6164002034144476,0.017857142857142856,0.5879185469781805,1.0,7/14,16.25%,AGMO;GNPAT;PAFAH1B1;PLA2G6;PLAAT3;PLA2G7;LIPE
prerank,response to cadmium ion (GO:0046686),-0.5495544183141385,-1.615805392244695,0.021406727828746176,0.5757338215633742,1.0,14/26,18.89%,EGFR;CHUK;MAPK9;AKT1;MT2A;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;HSF1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.6131692281855462,1.6155701110773137,0.02759526938239159,0.4209592294446365,1.0,6/51,3.74%,SYNPO2;TPM1;SYNPO2L;FERMT2;TGFB3;PPM1E
prerank,regulation of metal ion transport (GO:0010959),0.734577687247856,1.6151298009508597,0.03758169934640523,0.41958768033192095,1.0,5/16,4.50%,PLN;CAMK2G;CACNA2D1;STIM1;BCL2
prerank,microtubule polymerization (GO:0046785),0.6795079509109997,1.6150380650454743,0.03125,0.41735466114776587,1.0,9/28,7.13%,FGF13;CLASP2;MAP7D3;TUBGCP6;MAPT;TPPP;PIN1;HDGFL3;TPX2
prerank,heart trabecula morphogenesis (GO:0061384),-0.579938981354833,-1.613944354031675,0.017766497461928935,0.5706452726620068,1.0,8/18,11.77%,TGFBR3;BMP7;TEK;ENG;ADGRG6;RBP4;FKBP1A;TGFBR1
prerank,osteoclast differentiation (GO:0030316),-0.5596358820321312,-1.6138208041946693,0.011695906432748537,0.5572425568156808,1.0,5/22,2.87%,GAB2;FOXP1;MAPK14;ANXA2;SBNO2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.7571215977005392,1.6104570578549122,0.03697478991596639,0.42893139435642086,1.0,1/14,0.09%,CCDC3
prerank,vesicle transport along actin filament (GO:0030050),0.7168058175904485,1.6092712326659773,0.04285714285714286,0.43000504335296114,1.0,5/19,5.53%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C
prerank,neurotrophin signaling pathway (GO:0038179),0.7048699626682119,1.609191236942487,0.032915360501567396,0.4277049763742404,1.0,3/21,3.56%,NTF3;RAP1A;SORT1
prerank,superoxide anion generation (GO:0042554),0.7536696668903418,1.6091721332567754,0.042105263157894736,0.42521139873758945,1.0,1/13,0.36%,NCF2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7549244551584268,1.6088550406833184,0.046357615894039736,0.4235668029548059,1.0,4/15,3.34%,AGTR1;CD36;PLA2G3;LPL
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7700332840500203,1.6087593327586514,0.028021015761821366,0.4213953139198258,1.0,5/13,4.09%,CACNB2;CACNA1C;GJC1;KCNA5;KCNN2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.6321836633664529,1.6079022423839606,0.03062583222370173,0.42174298637590957,1.0,4/44,1.71%,LMOD1;LMOD2;LMOD3;CDC42EP3
prerank,response to cholesterol (GO:0070723),-0.5860474842314205,-1.607793067781397,0.022388059701492536,0.5745855192778584,1.0,10/17,26.84%,PTCH1;GRAMD1C;TGFB1;TGFBR1;GRAMD1A;SMAD2;PMVK;ABCA2;SMO;OSBPL7
prerank,metanephros development (GO:0001656),-0.5264636925316911,-1.6066464917690355,0.0125,0.5669024658272476,1.0,10/26,14.31%,NF1;FOXD1;BMP7;BMP4;PTCH1;PKD2;CTSH;OSR1;SIX1;SOX17
prerank,regulation of receptor recycling (GO:0001919),-0.6067598706831933,-1.6065319925142232,0.028985507246376812,0.5546053722922573,1.0,9/16,24.73%,ANXA2;TBC1D16;LAMTOR1;ECE1;OPTN;SNCA;RAB29;SCRIB;INPP5F
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.7373991933457437,1.606215134862321,0.043029259896729774,0.4242737414774225,1.0,4/17,1.77%,PPP1R12A;VCL;ROCK1;S1PR3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.773233700855317,1.6054597873959973,0.02888086642599278,0.42392404014714735,1.0,5/12,3.49%,TPM1;MEF2C;PRKG1;PDGFB;IGFBP5
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.8085679763793996,1.6039070920391445,0.024734982332155476,0.4261297928609882,1.0,2/11,2.32%,AGTR1;PLA2G3
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.6148007249259901,-1.6027483267468814,0.020050125313283207,0.5602837798761579,1.0,4/14,8.32%,IL18;LGALS9;CD55;PTPN22
prerank,endodermal cell fate commitment (GO:0001711),-0.6829884636001987,-1.6025913516749577,0.02262443438914027,0.5490225639207039,1.0,4/10,14.31%,CTR9;RTF1;LEO1;SOX17
prerank,ganglioside biosynthetic process (GO:0001574),-0.6075246970212417,-1.6024248001749564,0.02403846153846154,0.5380407006729275,1.0,6/15,11.00%,ST8SIA4;ST3GAL1;ST3GAL5;ST6GALNAC3;B4GALT6;ST8SIA2
prerank,actin filament depolymerization (GO:0030042),0.7944900509408963,1.5976394115934884,0.02877697841726619,0.4439862675052364,1.0,5/11,12.33%,DSTN;MICAL2;WDR1;CFL2;MICAL3
prerank,cGMP biosynthetic process (GO:0006182),0.7829202348899051,1.5964199002653705,0.04887218045112782,0.44508053121111496,1.0,2/10,3.85%,GUCY1A1;GUCY1B1
prerank,negative regulation of viral life cycle (GO:1903901),-0.6169125395133703,-1.5940724164044549,0.012285012285012284,0.5656748870763493,1.0,10/15,30.45%,LY6E;TRIM5;BST2;IFITM1;MID2;SNX3;IFITM3;IFITM2;GSN;PPIA
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.5455504590632857,-1.5934785617615075,0.011111111111111112,0.5578445130308104,1.0,11/23,17.38%,TGFBR3;SMAD3;DKK3;ENG;LTBP4;LATS2;SMURF2;TGFB1;TRIM33;SMAD2;SMAD4
prerank,endothelial tube morphogenesis (GO:0061154),-0.6899380569695757,-1.5933675556407794,0.018907563025210083,0.5471807476393223,1.0,4/10,7.11%,STARD13;BMP4;ACVRL1;CTNNB1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.6170261263367527,1.593014468988061,0.033647375504710635,0.4535173619388871,1.0,8/44,5.82%,FLNA;KCNMA1;AKAP6;KCNJ12;KCNMB1;ANO6;KCNN2;ATP1B1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6834079405192051,1.5929153975020973,0.038461538461538464,0.4512326727485716,1.0,2/24,0.71%,MYOCD;MEF2C
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5556747250625261,-1.5919303443801758,0.026737967914438502,0.5431049854156781,1.0,12/20,31.51%,SULF1;SPRY2;DSTYK;CREB3L1;FGF2;GPC1;SULF2;PRKD2;SPRY4;SPRY1;FGFBP3;SMOC2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5560036885316265,-1.5918842071430364,0.04143646408839779,0.5328638695707866,1.0,9/20,18.20%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;PKDCC;NUMB;TMBIM1
prerank,regulation of muscle cell differentiation (GO:0051147),0.65187060372869,1.5917108096222703,0.05232558139534884,0.45232450482739844,1.0,4/31,5.32%,MYOCD;MEF2C;HDAC9;MEF2A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.6964834863463921,1.5890348210712537,0.03793626707132018,0.45843799518310197,1.0,5/21,4.10%,FLNA;CACNA2D1;SNTA1;KCNA5;KCNE4
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7233091028570695,1.588689061084201,0.03420195439739414,0.45701550421903336,1.0,6/17,5.82%,RYR2;CACNA1C;GJD3;GJC1;SLC8A1;ATP1B1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6137426338351062,-1.5881028127623007,0.031862745098039214,0.5399119187058833,1.0,6/15,13.81%,ADGRV1;KIT;COL11A1;WHRN;PIEZO2;TMEM120A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.7442056208090878,1.5877358046244867,0.04695652173913043,0.4575775743524964,1.0,5/14,5.14%,TPM1;MEF2C;PRKG1;IGFBP5;BMPR1A
prerank,histone lysine demethylation (GO:0070076),-0.5219238978750905,-1.587145170826649,0.01483679525222552,0.5341968655031404,1.0,9/25,21.49%,KDM7A;KDM5C;KDM5B;KDM2A;KDM3B;RIOX2;KDM4D;KDM1A;KDM6A
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6955955860005014,1.5869462242753802,0.048465266558966075,0.4574283946031085,1.0,6/21,7.13%,FGF13;TRIM54;CLASP2;ARHGEF2;HDGFL3;TPX2
prerank,UV protection (GO:0009650),-0.6720273221544967,-1.585403577588679,0.022123893805309734,0.5322119529106337,1.0,7/10,22.60%,SCARA3;ERCC5;CAT;XPA;GPX1;MFAP4;ERCC2
prerank,negative regulation of ATPase activity (GO:0032780),0.7342404136806936,1.5846700326977163,0.057096247960848286,0.46237565257151325,1.0,2/16,6.42%,PLN;TP53
prerank,spinal cord development (GO:0021510),-0.6434155185404133,-1.5842122016944553,0.028503562945368172,0.5283271078725341,1.0,9/12,29.13%,NF1;VIT;GLI2;PKD2;SOX4;LOXL3;SOX11;RELN;SOX12
prerank,mesoderm formation (GO:0001707),0.7282166872663327,1.582154521392168,0.04292527821939587,0.46840263669836274,1.0,4/17,7.48%,ITGA8;ITGA3;ITGB1;ITGB3
prerank,lipid modification (GO:0030258),0.6411103866995759,1.58205294330083,0.03730272596843615,0.46623118456114854,1.0,6/37,9.50%,DGKB;DGKG;ALOX5;PLPPR1;LPCAT3;DGKD
prerank,regulation of multicellular organism growth (GO:0040014),-0.6054347853705442,-1.5812262795023304,0.03233256351039261,0.5323441569653177,1.0,4/15,3.58%,IGF1;GHR;APP;PTCH1
prerank,primary alcohol metabolic process (GO:0034308),-0.5177532382718383,-1.5810385091021282,0.024691358024691357,0.5241779704928617,1.0,12/25,24.49%,IGF1;GPD2;RBP4;ALDH3A2;NAAA;NAPEPLD;CYP1B1;GDPD1;GDE1;PECR;ADH1A;RDH10
prerank,heart process (GO:0003015),0.750574840951768,1.5799439849126173,0.05201342281879195,0.4708223565700227,1.0,3/14,1.34%,TRDN;SGCG;MYL2
prerank,cell-substrate junction assembly (GO:0007044),0.656131759077531,1.5789572340701834,0.031767955801104975,0.47157340984257684,1.0,10/33,9.97%,ARHGEF7;ACTN1;DLC1;FERMT2;PEAK1;DST;SORBS1;LAMC1;WHAMM;ACTN2
prerank,morphogenesis of an epithelium (GO:0002009),0.6776061910298761,1.578775175919149,0.04819277108433735,0.4696211264701788,1.0,8/25,10.07%,VCL;LAMA5;ACTG1;ACTB;TBX18;SOX9;LIN7C;ARHGAP12
prerank,epiboly involved in wound healing (GO:0090505),0.7206125414953546,1.5759964250399474,0.04715447154471545,0.47607434940353566,1.0,4/16,3.40%,FLNA;CCN1;LCP1;MRTFA
prerank,cardiocyte differentiation (GO:0035051),0.7836924609426452,1.5759672916857264,0.04695652173913043,0.473642872985677,1.0,1/10,0.03%,MYOCD
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.7730371225266095,1.57578860522674,0.06037735849056604,0.47173951499459554,1.0,1/10,0.08%,PDE3A
prerank,detection of mechanical stimulus (GO:0050982),0.6968597992215755,1.5756529153170236,0.040783034257748776,0.4697455342111435,1.0,4/19,5.34%,TTN;TCAP;CSRP3;PKD1L3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.5624208892586203,-1.5752801425825327,0.014962593516209476,0.5393727382103011,1.0,3/19,0.54%,AFDN;BMP6;TJP1
prerank,mitochondrion localization (GO:0051646),0.7039240256964961,1.574173189808948,0.05855161787365177,0.47202797299636273,1.0,9/19,14.40%,ATP2A1;MARK1;MEF2A;TRAK1;ATCAY;MFN2;NECTIN2;MUL1;LRRK2
prerank,connective tissue development (GO:0061448),0.6428018564012209,1.5729296200840435,0.03389830508474576,0.4737254509425493,1.0,6/35,7.68%,SOX6;SOX5;SNORC;ARID5B;DYRK1B;SOX9
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.7124583563956277,1.5706628193734358,0.05149501661129568,0.4786802034712879,1.0,1/18,0.10%,SOX6
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.6406079434065892,1.569519796158422,0.03672316384180791,0.4798600589983846,1.0,4/34,2.33%,FLNA;ARHGEF7;LIMS1;FERMT2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5777264373419794,1.5659168512663195,0.02360248447204969,0.4892530560473048,1.0,11/67,6.36%,FLNA;ARHGEF7;CD36;LIMS1;PDGFB;CDK6;FERMT2;CDH13;RSU1;UTRN;LIMS2
prerank,platelet degranulation (GO:0002576),0.5467907617642112,1.5654537230353214,0.020247469066366704,0.48850781755009043,1.0,22/118,7.86%,FLNA;TTN;STXBP2;ACTN1;ACTN4;VCL;ITIH4;CD36;PDGFB;ENDOD1;WDR1;LGALS3BP;TGFB3;TAGLN2;RARRES2;VEGFA;PCDH7;CALM1;TLN1;ITGB3;PLEK;TGFB2
prerank,aorta morphogenesis (GO:0035909),0.7142148578011387,1.5627826685847712,0.04567699836867863,0.49514714446062325,1.0,5/17,5.14%,MYLK;HEY2;TBX2;JAG1;BMPR1A
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.7898364326231504,1.5617454750343434,0.053763440860215055,0.4961697881210338,1.0,5/10,9.97%,SEMA5A;WDR1;PLEK;CFL2;ACTN2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.6451364095136787,-1.561163898611053,0.045454545454545456,0.5941763304051292,1.0,6/11,23.13%,CRY1;SIK1;EP300;C1QTNF3;CLK2;PGP
prerank,embryonic heart tube morphogenesis (GO:0003143),0.6100455208159654,1.5606066537157894,0.05298913043478261,0.49755402473947546,1.0,4/43,1.52%,RYR2;MEF2C;TBX2;MICAL2
prerank,relaxation of muscle (GO:0090075),0.7589907772293374,1.5602926136441164,0.06551724137931035,0.49612002734321387,1.0,5/13,5.82%,PLN;ATP2A1;SLC8A1;CAMK2D;ATP1B1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7608474197511454,1.5599557627561917,0.0425531914893617,0.4947684016473617,1.0,3/12,1.44%,TRDN;RYR2;CASQ1
prerank,embryonic hemopoiesis (GO:0035162),-0.6448505184550198,-1.5589570577929495,0.02506265664160401,0.5950796869179219,1.0,8/12,27.64%,KIT;FLT3LG;THOC5;KDR;ATF4;TAL1;ZFPM1;KMT2A
prerank,regulation of protein secretion (GO:0050708),0.53648747105749,1.5570952266759732,0.022598870056497175,0.5014892320489791,1.0,15/119,8.37%,MYOM1;TTN;CACNA1C;RAP1A;ITPR1;KCNA5;TGFB3;CCL5;ALOX5;KCNB1;MYO18A;ENSA;TGFB2;FRMD4A;DPH3
prerank,positive regulation of protein transport (GO:0051222),0.5692699738229248,1.5570557714169868,0.032663316582914576,0.4991884639520582,1.0,9/67,8.36%,MYOM1;TTN;OAZ2;TGFB3;CEP290;MYO18A;CNST;TGFB2;FRMD4A
prerank,N-glycan processing (GO:0006491),-0.5635754361876137,-1.556389564743884,0.03787878787878788,0.5975446282823286,1.0,9/18,12.19%,MAN1C1;ST8SIA4;ST8SIA1;FUT8;MGAT4B;GANAB;MAN2A1;ST8SIA2;GNPTAB
prerank,negative regulation of vascular permeability (GO:0043116),0.7553687729060039,1.5562057518497137,0.07027027027027027,0.4996643601111941,1.0,3/12,2.33%,PDE3A;ANGPT1;FERMT2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5342606211177725,-1.5557855775356477,0.05013927576601671,0.5910043782990966,1.0,8/20,18.20%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;NUMB;TMBIM1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.549781686113759,-1.5546150104966088,0.04129793510324484,0.5869066522749254,1.0,9/20,32.41%,WNT4;CRY1;SIK1;EP300;C1QTNF3;CLK2;PGP;NCOR1;CDA
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5841282586395982,1.5529278511303946,0.04271356783919598,0.5081709993200514,1.0,6/57,3.81%,FLNA;ADCY5;HTR1B;NPY1R;ADCY2;ADCY9
prerank,cell differentiation in spinal cord (GO:0021515),0.7747721745298498,1.5511769533039657,0.07037037037037037,0.5115571374247793,1.0,1/10,0.10%,SOX6
prerank,cation transport (GO:0006812),0.518879118770273,1.5504897394367885,0.009656652360515022,0.5113046333490496,1.0,27/167,11.35%,KCNAB1;KCNMA1;FGF13;SCN4A;TRPC6;ANO1;KCNJ12;SLC6A17;KCNMB1;ANO6;SLC8A2;SLC8A1;KCNA5;KCNQ4;KCNN2;PKD1L3;KCNH1;ATP1B1;SLC25A29;SLC23A1;ANO10;TRPM4;ABCC8;SLC7A8;PANX1;KCNK3;KCNA2
prerank,glycogen catabolic process (GO:0005980),0.7281077070638542,1.550470095367365,0.06351791530944625,0.5089372681484715,1.0,7/15,8.25%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1
prerank,detection of calcium ion (GO:0005513),0.7395938589281067,1.55018148870632,0.05631399317406143,0.507558611378544,1.0,4/13,7.02%,RYR2;KCNMB1;STIM1;CALM1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5933700340105899,1.5496296596203452,0.03363518758085381,0.507024073927076,1.0,8/47,6.96%,FLNA;ARHGEF7;ACTN4;LIMS1;FERMT2;KANK1;LIMS2;CORO1C
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.498515105085939,-1.5490894664983086,0.025396825396825397,0.6050624081021233,1.0,12/29,13.52%,TJP1;PIK3CA;PLEKHH2;SLIT2;KANK3;SHANK3;CYRIB;PRKN;SSH2;PFN2;PFN1;SSH1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.6746036268674345,1.547747512182711,0.05754276827371695,0.5087199639552741,1.0,5/20,6.00%,BCAT2;MCCC2;HSD17B10;HIBADH;DLD
prerank,branched-chain amino acid catabolic process (GO:0009083),0.6746036268674345,1.547747512182711,0.05754276827371695,0.5087199639552741,1.0,5/20,6.00%,BCAT2;MCCC2;HSD17B10;HIBADH;DLD
prerank,tight junction assembly (GO:0120192),-0.43493530961634036,-1.547176105027503,0.00823045267489712,0.6054121769903162,1.0,9/49,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;LSR;CLDN11
prerank,epithelial cell-cell adhesion (GO:0090136),0.7444575378790261,1.5469475089261338,0.06445672191528545,0.5093029084215989,1.0,3/11,6.24%,SERPINB8;VCL;ITGB5
prerank,atrioventricular valve development (GO:0003171),0.7401117037476035,1.5467728692192306,0.06086956521739131,0.507548952807665,1.0,4/14,7.86%,SLIT3;HEYL;BMPR1A;TGFB2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.6569939380183,1.544218482661176,0.039816232771822356,0.5139888840172941,1.0,5/25,7.51%,ITPR1;CDH13;SLC8A2;MAPT;PLEK
prerank,regulation of actin filament-based movement (GO:1903115),0.7675819111652782,1.543029699674219,0.046762589928057555,0.5154702534329052,1.0,2/10,0.21%,PLN;MYLK2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6974474332243572,1.5427556078993858,0.057003257328990226,0.5139985155126687,1.0,5/19,7.86%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6192128342129287,1.542482634771948,0.060781476121562955,0.5125360260091497,1.0,6/31,7.86%,TPM1;RYR2;MYL2;MYL3;BMPR1A;TGFB2
prerank,regulation of epithelial cell migration (GO:0010632),-0.44645166163589883,-1.5424821004183145,0.03349282296650718,0.6185440122821166,1.0,18/51,13.52%,PTN;MCC;SASH1;DOCK5;GLUL;PTPRG;PTK2;RAB11A;BMPR2;CTSH;PLCG2;ENPP2;PRKCE;BMPER;RTN4;PPM1F;PFN2;PFN1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.6626396062945212,1.540024996707479,0.07822085889570553,0.5184898353000258,1.0,9/21,13.00%,VCL;ROCK1;ACTG1;PEAK1;DUSP3;CORO1C;DAPK3;ROCK2;CLASP1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6748056430531398,1.5380239534071365,0.048286604361370715,0.5230645822769056,1.0,5/23,3.15%,TRDN;CASQ1;CACNA2D1;HRC;CAMK2D
prerank,sensory perception of sound (GO:0007605),-0.3800845780921899,-1.5376538740893408,0.013888888888888888,0.6323428600169041,1.0,17/88,9.94%,EYA1;COL1A1;CEMIP;ADGRV1;KIT;COL11A1;USP53;GRM7;GSDME;COL4A3;DCDC2;ATP6V0A4;ALDH7A1;EML2;WHRN;RIPOR2;CLIC5
prerank,regulation of adenylate cyclase activity (GO:0045761),0.6674799896774466,1.5362758077839704,0.05451713395638629,0.5265022178687384,1.0,4/22,3.42%,CAP2;CACNA1C;EDNRB;STIM1
prerank,protein autoubiquitination (GO:0051865),-0.4247918029547887,-1.5357273777077491,0.004807692307692308,0.6323331008169,1.0,20/61,15.22%,RNF220;SH3RF1;RNF146;ITCH;CUL3;RNF185;UBE2D3;RNF13;RNF213;MDM2;SH3RF3;PRKN;UBE3A;RNF181;STUB1;DTX3L;SH3RF2;RNF115;RNF10;OBI1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.670816720495721,1.5350345252433533,0.061514195583596214,0.5284928030638056,1.0,4/20,4.50%,ATP2A1;ATP2A2;CAMK2D;BCL2
prerank,Notch signaling pathway (GO:0007219),0.5787964828301518,1.535033075603264,0.04539722572509458,0.5261457558078871,1.0,12/59,8.65%,SUSD5;SORBS2;NOTCH3;HEY2;PLXND1;HEYL;JAG1;MAML2;NLE1;SNAI2;MAML3;ADAM17
prerank,neuron remodeling (GO:0016322),-0.6679432203203258,-1.5344431681768718,0.027253668763102725,0.629941860879202,1.0,6/10,13.30%,APP;ADGRB3;ANKS1A;SCARF1;CX3CL1;EPHA8
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5931725611830585,-1.5338517892264727,0.03341288782816229,0.6241948796148147,1.0,6/15,13.94%,GRM3;GRM7;HOMER3;DAGLA;GRIK3;GRM5
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.6436821026019788,1.5338155343338709,0.06396255850234009,0.5279325363497135,1.0,5/24,11.18%,PDE3A;CGAS;PEX5L;PRKAR1B;PDE4D
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6311894003462312,-1.5322342050476478,0.034934497816593885,0.6227821387855763,1.0,4/12,17.85%,NUPR1;IL18;IL33;TTBK1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.6599190821834114,1.532015666862445,0.060882800608828,0.5318158840604615,1.0,8/23,14.87%,RYR2;ATP2B4;GABPA;ADCY6;SIRT2;MAPK1;LRRK2;PRKACA
prerank,cGMP metabolic process (GO:0046068),0.731803260304937,1.5320152587493443,0.0718132854578097,0.5294730828090939,1.0,2/12,3.85%,GUCY1A1;GUCY1B1
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.4816724849173968,-1.5313560134599562,0.038834951456310676,0.6183361250369993,1.0,7/30,10.98%,SPTBN1;VAMP5;GOLGA4;OPTN;GCC2;GOLPH3;BLZF1
prerank,calcium-mediated signaling (GO:0019722),0.5470934858877958,1.528713962788554,0.029036004645760744,0.5384173547134845,1.0,24/93,14.87%,AGTR1;RYR2;CACNA1C;RCAN2;ATP2A2;PLCE1;PPP3CA;EDNRB;SLC8A1;NUDT4;CAMKK2;CXCR6;ATP1B1;RCAN3;TRPM4;SAMD14;HTR2B;DMPK;TRPM2;DMTN;PPP3CB;LRRK2;PPP1R9A;PRKACA
prerank,microtubule polymerization or depolymerization (GO:0031109),0.6526698959316592,1.5263189007837235,0.0705521472392638,0.5439439715855434,1.0,7/24,6.89%,FGF13;KIF2A;MAP7D3;MAPT;TPPP;PIN1;HDGFL3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7322023112426644,1.5259339364108973,0.06872852233676977,0.5428603077872153,1.0,5/14,8.12%,DMD;ACTN4;TESC;ATP1B1;WNK2
prerank,myotube differentiation (GO:0014902),0.685025727451771,1.5253100111284927,0.05573770491803279,0.5425093562704354,1.0,6/17,5.58%,MEF2C;KLHL40;CACNA1H;ADAMTS5;SORT1;KCNH1
prerank,positive regulation of secretion by cell (GO:1903532),0.5543577284705368,1.5248826090179621,0.04411764705882353,0.5416746934423364,1.0,10/70,8.36%,MYOM1;TTN;CLASP2;TGFB3;UNC13D;KCNB1;MYO18A;RAB3A;TGFB2;FRMD4A
prerank,ceramide biosynthetic process (GO:0046513),-0.4584890950297286,-1.524247746017511,0.027586206896551724,0.6433312119865482,1.0,12/40,11.00%,SGMS1;SGMS2;CERS5;ST8SIA4;ST3GAL5;SPTLC2;ST6GALNAC3;SPTSSA;B4GALT6;CERS6;ASAH2;ST8SIA2
prerank,regulation of DNA binding (GO:0051101),-0.44399489448527085,-1.522268938917154,0.022988505747126436,0.644381138509707,1.0,22/44,27.56%,IGF1;LEF1;HMGB1;HJURP;NFKBIA;ILRUN;PRKN;TGFB1;HES1;SP100;PPARG;KDM1A;MDFI;BCL3;SUMO3;HMGA2;NME1;SMO;TFAP4;MAPK8;HMGB2;EGF
prerank,dopamine metabolic process (GO:0042417),-0.5615281954080004,-1.5213596098724305,0.03667481662591687,0.6398573254872366,1.0,6/18,14.69%,SNCAIP;MOXD1;MAOA;PRKN;SNCA;GCH1
prerank,positive regulation of phospholipase activity (GO:0010518),0.6535047907426572,1.5206236178343018,0.06614173228346457,0.5541415164870688,1.0,4/22,3.64%,NTF3;AGTR1;NTRK3;CCL5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6888523703203446,1.5198234497884313,0.06688963210702341,0.5543432088929858,1.0,2/17,0.77%,NTF3;NTRK3
prerank,regulation of calcium ion import (GO:0090279),0.6588417103776635,1.5191432703858512,0.07496012759170653,0.5543244100254764,1.0,2/21,2.09%,PLN;PDGFB
prerank,positive regulation of vasoconstriction (GO:0045907),0.7111483214331195,1.5180901126904083,0.07008547008547009,0.5556323075447975,1.0,5/13,19.21%,ADRA1D;CAV1;TRPM4;TBXA2R;ADRA1A
prerank,positive regulation of dendrite development (GO:1900006),-0.6348603081746228,-1.5179880246703192,0.05104408352668213,0.6477257673375891,1.0,6/10,13.62%,PTN;COBL;BMP7;ZDHHC15;ALK;LRP8
prerank,lymphocyte proliferation (GO:0046651),0.6714158630518967,1.5176512152610333,0.06230529595015576,0.5549032103213482,1.0,6/22,13.12%,MEF2C;CD79A;BCL2;RASGRP1;LMBR1L;PPP3CB
prerank,regulation of potassium ion transport (GO:0043266),0.6168443152440571,1.5163641724404013,0.060781476121562955,0.5569653172858597,1.0,6/31,7.78%,KCNAB1;KCNA5;FHL1;KCNN2;KCNIP3;KIF5B
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6228508212163346,-1.5163122216103795,0.04805491990846682,0.6477005492587959,1.0,8/12,28.39%,LY6E;TRIM5;IFITM1;MID2;SNX3;IFITM3;IFITM2;GSN
prerank,positive regulation of glucose import (GO:0046326),-0.5295400698816832,-1.5151655193288271,0.0335195530726257,0.6449710652669481,1.0,10/21,16.75%,IGF1;OSBPL8;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,negative regulation of calcium ion transport (GO:0051926),0.6741122338570604,1.514129139134463,0.08869565217391304,0.562129310110204,1.0,2/15,2.84%,PLN;PACSIN3
prerank,actin filament network formation (GO:0051639),0.7465448084979538,1.513866048145393,0.0625,0.5607013519283435,1.0,3/11,3.35%,ACTN1;PLS3;LCP1
prerank,regulation of cellular respiration (GO:0043457),0.682172112669731,1.5134680748208187,0.07177033492822966,0.5598680867796932,1.0,1/17,0.27%,PRDM16
prerank,negative regulation of biomineral tissue development (GO:0070168),0.6674467017448159,1.5123617007752455,0.058208955223880594,0.5616138288173815,1.0,6/21,10.88%,ASPN;HEY2;ROCK1;SOX9;TRPM4;ROCK2
prerank,aortic valve morphogenesis (GO:0003180),0.6326578636529462,1.51213281800801,0.06609195402298851,0.5599789364835771,1.0,9/30,7.71%,SLIT3;HEY2;ELN;ROCK1;HEYL;JAG1;EMILIN1;SOX9;SNAI2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.7523053067994655,1.510199967747412,0.09107142857142857,0.5643775929678927,1.0,4/10,10.24%,CACNB2;CACNA2D1;CALM1;SRI
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6491415095545443,1.509611611713874,0.07132018209408195,0.5640975178653579,1.0,1/22,0.09%,CCDC3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.589620395474561,-1.508540241206245,0.04218362282878412,0.6690501014567899,1.0,8/14,29.19%,SULF1;SPRY2;CREB3L1;FGF2;GPC1;SULF2;SPRY4;SPRY1
prerank,RNA stabilization (GO:0043489),0.6123509523192685,1.5084703140220115,0.0703012912482066,0.5656707929642892,1.0,9/33,10.29%,RBM24;TENT5B;TRDMT1;PARN;CIRBP;GDNF;NAF1;FUS;HNRNPU
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6802638098660274,1.508022632053727,0.06209150326797386,0.564911987740509,1.0,5/17,10.07%,PPP1R12A;ITGA1;CALM1;CD300A;PDGFRB
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6589509385389548,1.5080202128163287,0.07153965785381027,0.5626415206333243,1.0,10/21,15.34%,DMD;CAV1;CNKSR3;GPD1L;PDE4D;DMTN;NCK2;MLXIPL;INPP5J;PTEN
prerank,negative regulation of complement activation (GO:0045916),-0.6335050815747778,-1.5077899880085646,0.04017857142857143,0.6642255732784106,1.0,6/10,32.53%,CD55;CD46;SERPING1;A2M;CR1L;CR2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6361779415721744,1.5065333028578154,0.07704160246533127,0.565753931185428,1.0,3/23,2.58%,TPM1;MYL2;MYL3
prerank,positive regulation of phosphatase activity (GO:0010922),0.6566945182870817,1.5063741049341937,0.0764525993883792,0.5639572963309941,1.0,6/21,10.07%,MEF2C;ITGA1;CALM1;PLEK;CD300A;PDGFRB
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3793441589171074,-1.5050751909572586,0.020689655172413793,0.6695558980886701,1.0,17/85,9.94%,EYA1;COL1A1;CEMIP;ADGRV1;COL11A1;USP53;GRM7;GSDME;COL4A3;DCDC2;ATP6V0A4;ALDH7A1;EML2;WHRN;RIPOR2;PIEZO2;CLIC5
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4960772008458937,-1.5050010082404568,0.03821656050955414,0.661870897924276,1.0,11/28,17.15%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;IRGM;TAB1;AAMP
prerank,cytoskeleton organization (GO:0007010),0.5236903526071006,1.5035129955735473,0.02880184331797235,0.5716373428808512,1.0,15/114,4.93%,PALLD;TPM1;WTIP;MAST4;MICAL2;PLCE1;LIMD1;CNN2;DES;PACSIN3;PACSIN2;RHOBTB3;ARHGAP10;DST;MARK1
prerank,negative regulation of defense response to virus (GO:0050687),-0.6488572862067001,-1.5028796014755248,0.04883720930232558,0.6649777678224218,1.0,4/10,7.42%,ITCH;PPM1B;ILRUN;PCBP2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.6267219598007305,1.5021016830849119,0.06814814814814815,0.5741523903165674,1.0,2/27,0.65%,AGTR1;GPR20
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.4742487283218631,-1.5020999910132786,0.025889967637540454,0.6608702027610793,1.0,15/30,18.97%,TGFBR3;SMAD3;FSTL1;DKK3;ENG;LTBP4;LATS2;FKBP1A;SMURF2;SFRP4;TGFB1;TRIM33;SMAD2;SMAD4;TWSG1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.4964801368489663,-1.5017635163940442,0.05952380952380952,0.6548512589314555,1.0,9/24,18.87%,DAB2;PID1;BCL2L1;TGFB1;RHOQ;TMEM59;NUMB;TMBIM1;ITGB1BP1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.687924110162208,1.500435631365151,0.06645569620253164,0.5776853771310247,1.0,4/17,2.70%,CACNB2;CACNA1C;CACNA2D1;SLC8A1
prerank,positive regulation of cytokinesis (GO:0032467),-0.4667255345267439,-1.500313150661342,0.043333333333333335,0.6538830366447863,1.0,12/32,21.44%,PKP4;CDC14B;CUL3;SPAST;PRKCE;CDC25B;GIPC1;CIT;CDC42;SVIL;CSPP1;DRD2
prerank,V(D)J recombination (GO:0033151),-0.618180646861223,-1.4992215889217027,0.04121475054229935,0.6517226862095816,1.0,8/11,35.66%,HMGB1;PRKDC;LIG3;DCAF1;LIG1;HMGB2;TCF3;LIG4
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.632114609483713,1.499076219280071,0.06966618287373004,0.579914641133915,1.0,5/28,6.25%,ATP2A1;MAP3K5;ITPR1;BCL2;DAB2IP
prerank,positive regulation of ruffle assembly (GO:1900029),-0.6009405337672835,-1.4985163612285473,0.05250596658711217,0.647922279892011,1.0,11/13,37.26%,EPS8;NLGN1;PLEKHM1;PFN1;EPS8L2;EPS8L1;NDEL1;DEF8;HRAS;FAM98A;P2RY12
prerank,regulation of histone acetylation (GO:0035065),0.6112512173857043,1.4978913575936401,0.06811594202898551,0.5819896098975075,1.0,5/33,9.41%,MYOCD;SET;PPARGC1A;CHEK1;PAXIP1
prerank,cardiac muscle cell action potential (GO:0086001),0.6217302407252506,1.4966801715567408,0.06267806267806268,0.5840806439567521,1.0,6/30,5.82%,DMD;CACNA1C;CACNA2D1;SLC8A1;SLC4A3;ATP1B1
prerank,cardiac muscle cell contraction (GO:0086003),0.667622615654415,1.496206075093008,0.07197549770290965,0.5834583439088965,1.0,3/19,3.15%,CACNA1C;CACNA2D1;CAMK2D
prerank,cellular response to organic cyclic compound (GO:0071407),0.5102825015532781,1.4949819497138572,0.015435501653803748,0.5853353209083947,1.0,28/141,13.20%,PDE3A;MEF2C;RAP1A;AKAP6;ADCY5;NR1H4;PDGFB;ADCY2;ABCB4;RORA;P2RY2;IGFBP5;CCL5;ACTB;TAF1;ARL6IP5;AR;MED1;IMPACT;GABRB2;ADCY6;GPER1;ROCK2;GABRB3;TRPM2;HCN2;DMTN;ZFP36L1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5498701340412163,1.4943829605633252,0.04457831325301205,0.5852694969922047,1.0,16/70,11.19%,NTN4;ITGA8;ACTN1;MEF2C;LAMA5;FERMT2;PEAK1;LAMC1;LAMB2;YTHDF2;ITGB3;ITGA4;EPHA2;PARVA;TBCD;RB1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6466914565499571,-1.4939550453800932,0.03333333333333333,0.6611004197868161,1.0,6/10,20.22%,LRP1;APOD;SNCA;HGS;NDRG4;PTPN2
prerank,cellular metal ion homeostasis (GO:0006875),0.5237215412278573,1.4938703534520197,0.048642533936651584,0.5847945778015079,1.0,15/102,7.87%,TRDN;KCNMA1;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;STIM1;CCL5;ATP1B1;CAV1;RMDN3;ATP2B1
prerank,skeletal system morphogenesis (GO:0048705),-0.43992198917200037,-1.492726668267101,0.040145985401459854,0.6595770914365177,1.0,13/42,11.77%,PDGFRA;HOXB3;FBN2;HOXA3;CYP26B1;DSCAML1;WWOX;HOXB4;MEGF8;SFRP4;FGFR2;SIX1;TGFBR1
prerank,protein localization to cilium (GO:0061512),-0.4714487450939368,-1.4921925029980443,0.03754266211604096,0.6550367535648065,1.0,18/32,37.16%,BBS9;ZNF423;RABEP1;IFT122;TULP3;RAB29;EHD1;TCTN2;BBS1;TCTN1;BBS4;ARL6;TULP1;CSNK1D;ATP6V1D;IFT20;TMEM107;INVS
prerank,thyroid hormone generation (GO:0006590),0.7396066560800911,1.491995553753279,0.08487084870848709,0.5895010864850592,1.0,2/10,7.65%,TG;DIO2
prerank,dicarboxylic acid transport (GO:0006835),-0.4832221983779462,-1.4918568603963733,0.03927492447129909,0.6493315769040376,1.0,7/28,7.83%,SLC1A3;SLC13A3;PDPN;GJA1;SLC26A7;SLC25A32;SLC22A6
prerank,phasic smooth muscle contraction (GO:0014821),0.7368551902774306,1.4917052812804454,0.06343283582089553,0.588277781825759,1.0,4/10,11.68%,PTGER3;EDNRB;GDNF;HTR2B
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.68570539574342,1.4916922619549748,0.0766721044045677,0.5860968365004501,1.0,5/17,8.51%,NOTCH3;PLXND1;HEYL;MAML2;MAML3
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.6740756858645446,1.4913814846341997,0.08196721311475409,0.584961767592327,1.0,6/17,7.05%,CACNA1H;SLC4A8;UNC13D;SYT10;KCNB1;RAB3A
prerank,protein-DNA complex disassembly (GO:0032986),0.6855448111763667,1.491362414697977,0.07863247863247863,0.5828132599178235,1.0,4/16,6.18%,SMARCD3;ARID1A;SET;SMARCB1
prerank,positive regulation of heart contraction (GO:0045823),0.6626338940715605,1.4911931113756047,0.0880503144654088,0.5812607417496325,1.0,5/19,8.74%,RYR2;HRC;ATP2A2;TGFB2;TRPM4
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5066390360656572,-1.4905854655731217,0.0379746835443038,0.6481069708542312,1.0,13/26,24.32%,ITCH;NOD1;IRAK1;CASP8;IKBKG;TAB2;IRAK2;UBC;TAB1;AAMP;UBB;CYLD;ALPK1
prerank,regulation of focal adhesion assembly (GO:0051893),0.5674088646893442,1.4896821648551635,0.05025773195876289,0.5842036231312676,1.0,14/54,8.18%,DLC1;VCL;ROCK1;LIMS1;FERMT2;PHLDB2;CLASP2;ACTG1;PEAK1;ARHGAP6;DUSP3;VEGFA;CORO1C;DAPK3
prerank,glycogen metabolic process (GO:0005977),0.6327930458655755,1.486888347667454,0.06607929515418502,0.5915299208348271,1.0,11/27,12.40%,PYGM;PHKG1;AGL;PYGB;PHKA2;CALM1;STBD1;NR1D1;NHLRC1;GYS1;PHKA1
prerank,sulfate transport (GO:0008272),-0.5713108350221388,-1.486077166619657,0.03731343283582089,0.6616771740197147,1.0,6/14,17.16%,SLC13A4;SLC26A7;SLC25A14;SLC26A2;SLC25A30;SLC25A11
prerank,regulated exocytosis (GO:0045055),0.5031654798474249,1.4839582587179139,0.024442082890541977,0.5995730654065097,1.0,28/173,7.97%,FLNA;TTN;STXBP2;ACTN1;ACTN4;VCL;ITIH4;CD36;PDGFB;ENDOD1;MYH9;WDR1;LGALS3BP;TMEM79;TGFB3;TAGLN2;RIMS3;SYT10;RARRES2;VEGFA;PCDH7;CALM1;TLN1;RAB3A;ITGB3;PLEK;TGFB2;ARHGAP17
prerank,inhibitory synapse assembly (GO:1904862),0.729568837687605,1.4833026370066218,0.08585858585858586,0.5995557986139531,1.0,5/11,11.98%,FGF13;PLXNB1;GABRB2;CBLN4;GABRB3
prerank,glucose transmembrane transport (GO:1904659),0.6639076971436203,1.4832952186325765,0.08455284552845528,0.5973671296451024,1.0,4/18,6.45%,SLC2A4;SLC5A3;SORT1;SLC2A10
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3979191031626984,-1.4824144278602518,0.01932367149758454,0.6715157258024309,1.0,13/65,7.13%,LEF1;GAB2;FOXP1;IL31RA;PIR;IL15;MAPK14;BMP4;KIT;SBNO2;LGALS9;PML;CASP8
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.7476122980386347,1.481657518795722,0.0913884007029877,0.6008211236457647,1.0,4/10,11.23%,PFKP;HK2;GFPT1;PFKM
prerank,macrophage chemotaxis (GO:0048246),0.7323256932255504,1.4814246433949319,0.11552346570397112,0.5993937814098814,1.0,2/10,3.64%,EDNRB;CCL5
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6517920435215669,1.4797995977731742,0.06595092024539877,0.6026107788152656,1.0,3/25,1.44%,CACNB2;AKAP6;CASQ1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6250749541357649,1.4796536996845717,0.0732484076433121,0.6009436028739639,1.0,5/26,7.03%,KCNAB1;ITGB1;FHL1;ATP1B1;NEDD4
prerank,chromatin disassembly (GO:0031498),0.7018057261222254,1.4774176549426432,0.08981001727115717,0.6042641029646525,1.0,4/14,6.18%,SMARCD3;ARID1A;SET;SMARCB1
prerank,nucleosome disassembly (GO:0006337),0.7018057261222254,1.4774176549426432,0.08981001727115717,0.6042641029646525,1.0,4/14,6.18%,SMARCD3;ARID1A;SET;SMARCB1
prerank,membrane depolarization during action potential (GO:0086010),0.6250566196054116,1.4772791830614176,0.08034433285509325,0.6025528297925079,1.0,4/26,2.70%,SCN4A;CACNA1C;CACNA1H;SLC8A1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3936779584099646,-1.4760718527376089,0.004524886877828055,0.6951559734634946,1.0,20/67,14.92%,FLT1;PDGFRA;EFEMP1;IL15;KIT;GHR;EPHA4;TEK;EGFR;PTK2;ABI1;EPHA3;PTK2B;ABL2;FGFR2;LYN;PRLR;KDR;INSR;PKDCC
prerank,neural tube development (GO:0021915),-0.5613527795783899,-1.4753366443613878,0.062034739454094295,0.6914890202010069,1.0,5/15,12.08%,ALDH1A2;PTCH1;PKD2;TGFB1;SOX4
prerank,cartilage development (GO:0051216),0.5770753901372471,1.475049155158619,0.05695364238410596,0.6081490457055045,1.0,5/49,4.90%,SOX6;SOX5;MEF2C;SNORC;OSR2
prerank,blood vessel diameter maintenance (GO:0097746),0.603255649135995,1.4750371487596259,0.08392603129445235,0.6060197096263117,1.0,4/34,2.26%,AGTR1;EDNRA;ROCK1;EDNRB
prerank,positive regulation of wound healing (GO:0090303),0.5863941911721903,1.4722363142396928,0.06695156695156695,0.6139912586880425,1.0,6/36,3.63%,MYLK;FERMT2;ANXA1;KANK1;ACTG1;ITGB1
prerank,protein autoprocessing (GO:0016540),0.6829754770005414,1.4719386800575607,0.07482993197278912,0.6127027571117072,1.0,3/17,6.32%,HJV;FXN;AFG3L2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6228211672727559,1.4714302510800097,0.07302533532041729,0.6122116712241836,1.0,8/26,13.12%,ANO1;ADCY5;NR1H4;KLF7;TRPM4;NR1D1;LRP5;PPP3CB
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.6098006370978071,-1.4696092738191007,0.05411764705882353,0.7127777238931005,1.0,5/11,24.69%,DAB2;RDX;PRKN;EIPR1;MTMR2
prerank,regulation of acrosome reaction (GO:0060046),0.7270089674703445,1.4695910005170953,0.08679245283018867,0.6165891818285291,1.0,2/10,8.04%,CACNA1H;PLCB1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5171721219769148,-1.4681312486976696,0.05235602094240838,0.7125771769585896,1.0,8/21,12.96%,PRKCB;FOXP1;ELF1;PRKCH;SLC39A10;PTPN22;LYN;ELF2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5083666820001407,-1.4680268196156327,0.03529411764705882,0.7061961969512072,1.0,15/23,29.52%,PTCH1;IFT122;MEGF8;TULP3;HERC4;MGRN1;ENPP1;GLIS2;GPR161;BTRC;GPC3;RFX4;RACK1;ULK3;PTCH2
prerank,positive regulation of cell development (GO:0010720),0.6046417845106441,1.467888790879002,0.08415147265077139,0.6204398917366362,1.0,2/31,1.60%,PDE3A;LMOD3
prerank,aortic valve development (GO:0003176),0.602290892604135,1.4678330414883891,0.0896358543417367,0.6184631241248324,1.0,9/34,7.71%,SLIT3;HEY2;ELN;ROCK1;HEYL;JAG1;EMILIN1;SOX9;SNAI2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5716777316663975,1.4671364287720918,0.06827309236947791,0.618672157267731,1.0,10/42,8.34%,ROCK1;CD36;LIMS1;CDK6;FERMT2;CDH13;UTRN;RRAS;VEGFA;RIN2
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.6240690644027985,-1.4663207603330408,0.07223476297968397,0.7072497247660146,1.0,3/10,16.14%,IL18;LGALS9;RARA
prerank,T-helper cell differentiation (GO:0042093),-0.5747672529889668,-1.4662576311390163,0.050239234449760764,0.7006795990654968,1.0,3/14,1.71%,LEF1;FOXP1;HMGB1
prerank,acylglycerol metabolic process (GO:0006639),0.5861726010592246,1.4660620079761866,0.07563025210084033,0.6203939209971002,1.0,9/37,13.67%,DGKB;DGKG;LPL;CAV1;MGLL;DGKD;DGAT1;PNPLA3;DGKZ
prerank,amide transport (GO:0042886),-0.483539295745129,-1.4641551896069127,0.049132947976878616,0.704204440513071,1.0,9/26,21.80%,ABCG2;PDPN;PLTP;SLC25A32;CERT1;PLEKHA3;SLC38A5;ABCB9;TAP1
prerank,response to fatty acid (GO:0070542),0.6693569016529504,1.46358592134741,0.08771929824561403,0.627116636293076,1.0,6/17,7.68%,NR1H4;CD36;PDK4;LPL;IRS1;SOX9
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3841807969103596,-1.4633704271303147,0.023255813953488372,0.7011654176572563,1.0,24/74,19.27%,EYA2;IGF1;EYA1;EYA4;SH3RF1;TCF7L2;BMP4;DDX3X;ITGA6;BIRC6;TNFSF10;ITGAV;CASP8;BCL2L1;NOS3;RNF34;TGFBR1;FAIM;AKT1;GPX1;SERPINE1;SIAH2;TMBIM1;PARK7
prerank,membrane lipid metabolic process (GO:0006643),-0.5170725186457166,-1.4629676637769966,0.06336088154269973,0.6960127448654521,1.0,7/22,13.96%,AGMO;ST3GAL6;CERK;SERINC1;CYP1B1;ARV1;B4GALT4
prerank,acidic amino acid transport (GO:0015800),-0.5336342006705115,-1.4617130512934802,0.050761421319796954,0.6958722702604426,1.0,5/17,3.81%,SLC6A13;SLC1A3;GJA1;SLC6A1;SLC6A6
prerank,regulation of interleukin-13 production (GO:0032656),-0.5828634185550324,-1.4615342035920007,0.06382978723404255,0.6903204599817638,1.0,3/13,5.31%,LEF1;IL18;LGALS9
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7036275939134977,1.461043327426174,0.1266540642722117,0.6339924313887305,1.0,5/11,11.59%,DLC1;PTGIS;TP53;SIRT2;BOK
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4549843750426633,-1.4607560653524772,0.039568345323741004,0.6878973436493305,1.0,10/33,13.20%,MCC;DCN;PTPRG;SLIT2;APOE;ACVRL1;PTPRM;ADAMTS9;SP100;PFN2
prerank,negative regulation of developmental process (GO:0051093),0.5354558124406437,1.4607482497850377,0.06666666666666667,0.6328674960282936,1.0,17/69,14.00%,HEY2;TBX2;ROCK1;ALPK2;CDK6;LOXL2;KANK1;PTPRS;KLF7;MAPT;SOX9;ROCK2;MUL1;FOXJ1;GAS6;ADCK1;HOPX
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.6341775356301973,1.4597730773884654,0.08662613981762918,0.6341523460149157,1.0,11/23,12.26%,TUBA1C;HOOK2;KIF1A;F8A1;KIF5B;HOOK1;KIF1C;DYNC1I2;KIF5C;MYO10;KIF5A
prerank,peripheral nervous system development (GO:0007422),0.6383285140038216,1.4594660854912882,0.08125,0.6331348109228533,1.0,2/23,0.99%,NTF3;SERPINI1
prerank,chondrocyte differentiation (GO:0002062),0.6085968197927498,1.4581799496196166,0.06787330316742081,0.6355872675337804,1.0,3/32,0.71%,SOX6;SOX5;MEF2C
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.6219285478012774,1.4581642211636523,0.09836065573770492,0.6335043129635809,1.0,2/26,0.28%,PLN;TRDN
prerank,vasodilation (GO:0042311),0.6936189892531158,1.4575512896567624,0.09682804674457429,0.6333801334487544,1.0,1/13,0.29%,KCNMA1
prerank,cellular response to growth factor stimulus (GO:0071363),0.49498208073285116,1.457221555587102,0.038876889848812095,0.6324283610307794,1.0,26/151,7.89%,PDE3A;SOX6;SOX5;HJV;MEF2C;RAP1A;NTRK3;LIMS1;PDGFB;NR4A1;ANXA1;CCL5;ACVR2A;BMPR1A;MTSS2;HAS2;MAPT;DAB2IP;MAPKAPK2;DUSP3;VEGFA;MED1;GAREM1;SOX9;SNAI2;RELA
prerank,nitric oxide mediated signal transduction (GO:0007263),0.667454330917058,1.4570028618287787,0.09816971713810316,0.631048586301221,1.0,3/16,3.85%,GUCY1A1;CD36;GUCY1B1
prerank,ganglion development (GO:0061548),-0.6228767827933549,-1.4569601325458539,0.059322033898305086,0.7001732719712757,1.0,4/11,7.32%,NRP2;NRP1;CTNNB1;SEMA3A
prerank,negative regulation of ion transport (GO:0043271),0.630840540981408,1.4568209338016702,0.10142630744849446,0.6296811113109217,1.0,7/24,9.97%,PLN;HTR1B;PACSIN3;NEDD4;WNK2;HRH3;ACTN2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6160525058076184,-1.4566942855252611,0.061946902654867256,0.6949866237923752,1.0,5/10,11.87%,DCN;SEMA6A;XDH;PIK3CB;SPRY2
prerank,BMP signaling pathway (GO:0030509),-0.3903850697004244,-1.4554544304172414,0.02912621359223301,0.6940753499173103,1.0,17/62,10.61%,BMP6;TGFBR3;SMAD3;DDX5;BMP7;BMP4;SMAD6;ENG;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;SMAD9;TMEM100;TGFB1;PDCD4
prerank,ceramide metabolic process (GO:0006672),-0.4106630757438984,-1.4550683112080507,0.03180212014134275,0.6897721778749678,1.0,11/49,9.94%,SGMS1;SGMS2;CERS5;CERK;SPTLC2;ST6GALNAC3;PPP2CA;SPTSSA;ACER2;CERS6;ASAH2
prerank,cellular response to drug (GO:0035690),0.6263238992368899,1.455010022922202,0.0838235294117647,0.6339138148287751,1.0,6/25,9.85%,MEF2C;HTR1B;PPM1E;TP53;CERS1;RAP2A
prerank,oligodendrocyte differentiation (GO:0048709),0.6396567102878927,1.4547987814988848,0.10912052117263844,0.6325215064192674,1.0,3/19,7.68%,SOX6;TPPP;SOX9
prerank,granulocyte differentiation (GO:0030851),-0.5414110505999025,-1.4547086710837405,0.07106598984771574,0.6854003115207576,1.0,11/18,30.45%,LEF1;LBR;PML;EP300;RARA;CBFA2T3;CDK2;TAL1;CDKN1A;RXRA;E2F1
prerank,protein monoubiquitination (GO:0006513),-0.4460129935750969,-1.45237595499052,0.020618556701030927,0.6909261365089674,1.0,13/36,15.22%,CUL3;RNF20;KLHL12;UBE2D3;CTR9;TOPORS;TRIM25;PRKN;MGRN1;KLHL22;DTX3L;LEO1;OBI1
prerank,xenobiotic transport (GO:0042908),-0.5310550365706135,-1.4512274710610664,0.05825242718446602,0.6901015332929213,1.0,6/17,13.70%,ABCG2;SLC47A1;GJA1;SLC7A5;SLC22A4;SLC22A18
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.7158841522546738,1.449428416031336,0.1037037037037037,0.6497430682164376,1.0,4/11,13.97%,TRDN;LPCAT3;STX18;BNIP1
prerank,renal filtration (GO:0097205),0.7014237560643071,1.4489070827789838,0.10256410256410256,0.6493803078482495,1.0,3/10,2.73%,MCAM;MYO1E;ITGA3
prerank,amino acid import across plasma membrane (GO:0089718),-0.488037061667526,-1.447283729465504,0.04105571847507331,0.7022363063055462,1.0,8/24,9.67%,SLC6A13;SLC1A3;SLC47A1;SLC6A6;SLC3A2;SLC7A5;SLC6A9;SLC22A4
prerank,negative regulation of nervous system development (GO:0051961),0.6402350419816235,1.446951318671039,0.08967851099830795,0.6541931522470223,1.0,1/17,0.19%,SLIT1
prerank,response to glucocorticoid (GO:0051384),0.6155686856517234,1.4469121984371238,0.08571428571428572,0.6521837099972636,1.0,6/26,14.26%,SLIT3;ANXA1;GOT1;HNRNPU;ZFP36L1;PDCD7
prerank,telomere capping (GO:0016233),-0.5476343433441208,-1.446683808456192,0.05813953488372093,0.6992701685349678,1.0,14/16,35.57%,PRKDC;STN1;MRE11;RAD50;NBN;CTC1;TERF2IP;DCLRE1A;DCLRE1B;TINF2;TEN1;ACD;TFIP11;DCLRE1C
prerank,peptidyl-threonine modification (GO:0018210),0.5283493698043956,1.4459009101962403,0.07833537331701346,0.6536376741224963,1.0,27/66,18.87%,MYLK2;ROCK1;DYRK2;CAMK2D;GALNT16;DYRK1A;TAF1;DYRK1B;CHEK1;MAP3K10;MAP2K1;ROCK2;PRKCD;GALNT3;ACVR1B;GALNT2;CDC42BPB;MAPK1;GALNT1;LRRK2;PRKCA;HIPK2;MARK2;GALNT11;GALNTL6;PRKD1;ULK1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6297900031525273,1.4448433852089302,0.11267605633802817,0.655252622641124,1.0,6/22,6.59%,LMCD1;ROCK1;MLIP;CAMK2D;MEF2A;PARP1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.4048044404792923,-1.4441214079505165,0.022935779816513763,0.7052139484955704,1.0,23/56,22.01%,FLT1;PDGFRA;EFEMP1;KIT;EPHA4;TEK;EGFR;PTK2;ABI1;EPHA3;PTK2B;TPST1;ABL2;FGFR2;LYN;KDR;INSR;PKDCC;TTBK1;ABI2;FGFR4;FLT4;EPHB2
prerank,activation of protein kinase B activity (GO:0032148),0.590193559639522,1.4440404026422224,0.08620689655172414,0.6558644930235199,1.0,4/29,2.09%,NTF3;NTRK3;FGF1;PDGFB
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.38731086330042597,-1.4434612633338948,0.03888888888888889,0.7021550219864592,1.0,16/63,11.77%,IGF1;SH3RF1;TCF7L2;DEPTOR;BMP4;ITGA6;WWOX;BIRC6;TNFSF10;ITGAV;PML;CASP8;STX4;MADD;SP100;TGFBR1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6152257950777404,1.4427012177389615,0.11674347158218126,0.6585492080408608,1.0,3/24,1.66%,RYR1;RYR2;ITPR1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.655156908539115,1.4424333509217144,0.10628019323671498,0.6574140049229921,1.0,5/16,6.59%,AKAP6;ROCK1;CAMK2D;MEF2A;PARP1
prerank,embryonic heart tube development (GO:0035050),0.670884994117458,1.440795699808833,0.11986863711001643,0.6612041372502238,1.0,2/14,1.35%,RYR2;TBX2
prerank,regulation of microtubule nucleation (GO:0010968),0.7259016281945005,1.4404010204636877,0.12811387900355872,0.6605149678153261,1.0,1/10,0.35%,ARHGEF7
prerank,ketone body metabolic process (GO:1902224),-0.623301714408359,-1.438624972369438,0.07415254237288135,0.7191161757397155,1.0,6/10,17.29%,ACSS3;HMGCL;HMGCLL1;HMGCS2;BDH2;AACS
prerank,positive regulation of protein polymerization (GO:0032273),0.5255293316052148,1.4368127898943275,0.0722291407222914,0.6713603723365915,1.0,6/65,7.53%,LMOD1;LMOD2;CDC42EP3;MAPT;TPPP;TOGARAM1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7040252359886425,1.4360523654900172,0.1013745704467354,0.6721519275982735,1.0,2/11,2.78%,MEF2C;ANXA1
prerank,negative regulation of organelle assembly (GO:1902116),-0.4452182465738096,-1.4357279508307523,0.05802047781569966,0.7269261097722663,1.0,19/35,29.37%,NUPR1;LIMK2;CEP97;TBC1D30;MDM1;SMAD4;SCFD1;ODF2L;NBDY;TBC1D7;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23;CCP110;KAT2A;TESK1;STYXL1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.4565863567580267,-1.4356468152214261,0.05642633228840126,0.7214075103438867,1.0,11/29,18.55%,IL31RA;IFNAR2;IL15;GHR;PKD2;SOCS2;CTR9;STAT2;IFNAR1;STAT5A;STAT6
prerank,apoptotic mitochondrial changes (GO:0008637),0.5758759409817111,1.4337607134452182,0.09738372093023256,0.6784031748464647,1.0,10/32,12.48%,ATP2A1;HK2;BCL2;NDUFS1;FZD9;THEM4;DNM1L;GGCT;BOK;CLU
prerank,androgen metabolic process (GO:0008209),0.647037638502215,1.4336083522896983,0.1136,0.6767676609196244,1.0,5/18,11.04%,HSD17B10;HSD17B7;HSD17B4;MED1;SRD5A3
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.5489123049322018,1.433509575011595,0.0731070496083551,0.6749629057559835,1.0,5/53,4.27%,LHCGR;HTR1B;NPY1R;ANXA1;TSHR
prerank,purine ribonucleotide transport (GO:0015868),-0.5375014657820112,-1.432733119347549,0.09743589743589744,0.7287037236579833,1.0,10/16,36.44%,SLC25A17;ABCC4;LRRC8D;LRRC8A;ABCC5;SLC25A24;SLC35B2;SLC17A9;SLC25A4;SLC19A1
prerank,mitochondrion distribution (GO:0048311),0.6955014741607016,1.4324511254221757,0.11130742049469965,0.6764780269642224,1.0,6/12,14.40%,MEF2A;MAPT;TRAK1;ATCAY;DNM1L;LRRK2
prerank,protein localization to cell surface (GO:0034394),0.6034328262894683,1.4319452215323711,0.08695652173913043,0.6762194530829454,1.0,4/26,4.90%,FLNA;ANGPT1;VCL;JAM3
prerank,response to ketone (GO:1901654),0.6050779188146199,1.4315797348306065,0.09034267912772585,0.6755407556972894,1.0,6/24,7.86%,SLIT3;ABCB4;TGFB3;CAV1;YAP1;TGFB2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5742613647585229,-1.4314626007380287,0.06060606060606061,0.7287352351703575,1.0,4/12,5.38%,EPHA4;GLI2;MYCBP2;PAFAH1B1
prerank,ruffle organization (GO:0031529),0.6584737227105669,1.4308307059148662,0.10902896081771721,0.6760217427877303,1.0,3/16,7.51%,TPM1;CYFIP1;PLEK
prerank,outflow tract septum morphogenesis (GO:0003148),-0.47860392999461115,-1.4308153177237555,0.06140350877192982,0.7261664385164969,1.0,9/24,5.55%,ROBO1;SEMA3C;NRP2;BMP4;SMAD6;NRP1;ENG;ZFPM2;BMPR2
prerank,positive regulation of behavior (GO:0048520),0.6999267636057934,1.4305947580107383,0.11296296296296296,0.6746664483791016,1.0,1/10,0.71%,MEF2C
prerank,SNARE complex assembly (GO:0035493),-0.6099372292031686,-1.4299288215141137,0.06711409395973154,0.7243222205935084,1.0,5/10,20.21%,STXBP1;SNCA;VAMP8;UVRAG;VAMP1
prerank,mitotic spindle assembly (GO:0090307),0.5648794092587014,1.4295184370130936,0.08551724137931034,0.676426212540264,1.0,11/42,10.69%,FLNA;CLASP2;KIF2A;TOGARAM2;KIF3B;TPX2;PIBF1;TOGARAM1;CEP192;WRAP73;AAAS
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.49850313757240045,1.4287576378789226,0.0665163472378805,0.6770133554487898,1.0,22/107,12.38%,TRDN;ATP2A1;RYR2;ATP2B4;ATP2A2;CSRP3;SLC8A2;SLC8A1;STIM1;CCL5;ATP1B1;CAV1;RMDN3;ATP2B1;PTH1R;SLC30A5;ATP2A3;CCL14;SLC39A14;HTR2B;DMPK;CHRNA7
prerank,positive regulation of protein depolymerization (GO:1901881),0.6963509130447871,1.4286814458808297,0.11443661971830986,0.6751759983994186,1.0,4/11,8.01%,SEMA5A;WDR1;PLEK;CFL2
prerank,positive regulation of protein secretion (GO:0050714),0.5253977565845396,1.4286662075570107,0.08188585607940446,0.6731809430658079,1.0,2/69,0.37%,MYOM1;TTN
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5801575756420616,-1.428226316773543,0.08747044917257683,0.7264510837118229,1.0,7/13,23.99%,NUPR1;SCFD1;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.5834386050261005,1.4278922045075666,0.09302325581395349,0.6739551152049342,1.0,11/33,10.84%,HIP1;BCAR3;NUP62;FBXW7;DOK1;NEU3;AREG;ADAM17;DGKD;HBEGF;GPER1
prerank,regulation of wound healing (GO:0061041),0.5588582338410188,1.42711127064725,0.11050477489768076,0.6746154057133511,1.0,8/42,6.76%,MYLK;ANXA1;KANK1;ACTG1;ITGB1;ALOX5;CAV1;AJAP1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.40621413751160235,-1.4266617946842333,0.04642857142857143,0.7278097113296064,1.0,23/47,22.35%,BMP7;CARM1;MEDAG;ASXL2;SOX13;NOCT;TMEM64;NAPEPLD;SIX1;CREBL2;AAMDC;CREB1;PTGS2;CEBPB;AKT1;TFE3;PPARG;LMO3;CDS1;ZC3H12A;METRNL;SYAP1;CCDC71L
prerank,regulation of cellular localization (GO:0060341),0.5474869855381989,1.4257084536116533,0.09431524547803617,0.6774231532967191,1.0,12/46,14.51%,STXBP2;ADCY5;NR1H4;CAMK2D;UNC13D;PARP1;BRSK1;NR1D1;LRP5;CSNK1E;LRRK2;DVL1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6746114260573736,1.424793917317836,0.12121212121212122,0.6785975200807938,1.0,5/12,17.10%,IRS1;PPARGC1A;PPARA;IRS2;MTLN
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5039914400354044,-1.4239137766925252,0.09950248756218906,0.7345392968168148,1.0,7/18,20.94%,UNC13C;UNC13B;GRIK3;SLC17A6;GRID2;GRIK1;SLC1A4
prerank,inorganic cation transmembrane transport (GO:0098662),0.46743137499299353,1.4233698847904863,0.017346938775510204,0.6816231252171153,1.0,28/268,5.82%,KCNAB1;ATP2A1;SCN4A;CACNA1C;ASIC3;ATP2B4;TRPC6;ATP2A2;KCNJ12;CACNA1H;SLC6A17;ANO6;SLC8A2;SLC8A1;KCNQ5;ATP5MF;KCNA5;SLC4A8;SLC6A2;SLC6A5;KCNQ4;KCNN2;UCP3;KCNB1;CCDC51;ATP6V1H;KCNH1;ATP1B1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5477461915345663,1.4220802642607473,0.0859375,0.6842986703540569,1.0,5/48,2.58%,FLNA;ARHGEF7;LIMS1;FERMT2;SS18L2
prerank,RNA destabilization (GO:0050779),0.6248394133824235,1.42161368350152,0.12379421221864952,0.6838400077507154,1.0,8/18,14.01%,RBM24;ROCK1;YTHDF2;CELF1;FTO;ROCK2;DXO;GIGYF2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6898745098535798,1.420332415626754,0.11049723756906077,0.6861025760042,1.0,2/11,2.43%,ATP2B4;MLIP
prerank,glucose import (GO:0046323),0.6637658322134767,1.4198928184137054,0.12626262626262627,0.6856933366801544,1.0,3/13,6.45%,SLC2A4;SORT1;SLC2A10
prerank,epithelial structure maintenance (GO:0010669),-0.5904598867492497,-1.4197253479764627,0.08705882352941176,0.747655097379261,1.0,2/11,4.19%,CXADR;RBP4
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.4590712928728604,-1.418831990237434,0.06349206349206349,0.7460203647821433,1.0,8/29,11.67%,IGF1;NOTCH2;GRB2;RASGRF1;RAPGEF1;ITGAV;RASGEF1A;LYN
prerank,positive regulation of transporter activity (GO:0032411),0.6704529666562282,1.418594372540596,0.12605042016806722,0.6883385781590183,1.0,2/13,2.04%,TRPC6;KCTD7
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6084458223031494,1.418138305378826,0.10648148148148148,0.6879959630591753,1.0,3/26,1.66%,RYR1;RYR2;ITPR1
prerank,calcium ion transmembrane transport (GO:0070588),0.5118203383277419,1.4180515234559374,0.06635071090047394,0.6862755502075332,1.0,15/86,8.89%,ATP2A1;CACNA1C;ATP2B4;TRPC6;CACNA2D1;ATP2A2;ANO6;SLC8A2;SLC8A1;GRIN2C;AFG3L2;TRPV2;ATP2B1;TRPM4;TRPC5
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.6003941409442348,-1.4178492029274288,0.08533916849015317,0.7449928541102679,1.0,3/10,18.64%,RC3H2;NFKBIZ;ZC3H12A
prerank,diol metabolic process (GO:0034311),-0.5007205364031525,-1.4166814494045588,0.07692307692307693,0.7448043065987058,1.0,10/19,22.94%,NAAA;SGPP1;NOS3;ASAH2;GCH1;PRKG2;AKT1;PTS;SPR;SPHK1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.6059245916627599,1.4159951851290713,0.1263318112633181,0.6915605128666701,1.0,5/25,5.28%,NDST3;CSGALNACT1;EXT2;HS2ST1;HAS2
prerank,regulation of membrane repolarization (GO:0060306),0.6676771942457811,1.4155602467350725,0.12874779541446207,0.6911601405067809,1.0,3/13,6.08%,AKAP6;CACNA2D1;CAV1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.710167448489355,1.4147822577880387,0.13295880149812733,0.6918094191090189,1.0,2/10,1.91%,CD36;MYD88
prerank,embryonic digit morphogenesis (GO:0042733),0.6372689394025992,1.4134556620065377,0.10316139767054909,0.6945729103074544,1.0,3/18,4.90%,MAP3K20;TBX2;OSR2
prerank,metanephric mesenchyme development (GO:0072075),-0.5972109234696084,-1.411535957534358,0.111358574610245,0.7630824694410929,1.0,4/10,10.88%,WNT4;PKD2;OSR1;SIX1
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.43320410617875266,-1.4113025611901315,0.053691275167785234,0.758550711238638,1.0,21/35,38.61%,ACSS3;PAM;FAR2;HMGCL;HMGCLL1;PPT1;HMGCS2;ACLY;BDH2;AACS;GGT7;HPGD;ALOX12;HSD17B8;BDH1;GCDH;SLC25A1;SCD;ACACA;AWAT2;GGT1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6236731600770793,1.4112970795239295,0.13290113452188007,0.7003582248153968,1.0,5/20,11.08%,PLN;CAMK2D;NEDD4;ACTN2;GOPC
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.5788373165050732,1.4109758421539103,0.12209302325581395,0.6995232667801942,1.0,11/32,14.26%,FGF13;TRIM54;CLASP2;ARHGEF2;DYRK1A;HDGFL3;TPX2;TBCD;CLIP3;CLASP1;STMN2
prerank,basement membrane organization (GO:0071711),0.6613175311609663,1.4109614038966436,0.12956810631229235,0.6975568679469907,1.0,4/14,6.92%,NTN4;COL4A1;PXDN;LAMB2
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.6768565030157312,1.4098924756153743,0.12717770034843207,0.6993590343450599,1.0,3/12,4.69%,LAMA5;ACTG1;ACTB
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5576456663287852,1.4098734386949074,0.09873060648801128,0.6974229627111558,1.0,3/40,0.77%,NTF3;EDNRA;NTRK3
prerank,neuromuscular junction development (GO:0007528),0.6168001631904598,1.4095485426408703,0.11674347158218126,0.6964873202741558,1.0,7/24,7.03%,CACNB2;PDZRN3;MUSK;CACNB4;DOK7;PPFIBP2;NEDD4
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.565126261207082,1.4093922551603355,0.0994236311239193,0.695096688105031,1.0,9/34,15.30%,MEF2C;GABRE;GRIN2C;GABRA4;GABRA5;GABRG1;INSYN2A;LRRK2;CHRNA4
prerank,mesenchymal cell development (GO:0014031),0.6342675481123514,1.409292051385018,0.13029315960912052,0.6934779265993265,1.0,5/18,8.70%,HEY2;HEYL;TAPT1;SNAI2;CDH2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4739780186292656,1.408082220163091,0.032119914346895075,0.6957577732090034,1.0,19/159,6.20%,NEXN;PALLD;MYOT;CDH6;MYPN;IGFN1;ROBO3;CDH13;MILR1;ITGB1;CDH4;KIRREL3;PTPRS;IGSF21;GPC4;CDHR3;PCDHB14;PTPRF;DSCAM
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.5121923641053168,1.406673474252943,0.0855106888361045,0.6988175470087427,1.0,11/78,9.52%,MYOCD;PDGFB;CCNA2;CCND2;NR2F2;ACTB;HEXIM1;CCND1;ADAM17;CCNT1;CDK7
prerank,adenine nucleotide transport (GO:0051503),-0.5215790258949643,-1.406582023968259,0.09921671018276762,0.7754504263699805,1.0,10/17,36.44%,SLC25A17;ABCC4;LRRC8D;LRRC8A;ABCC5;SLC25A24;SLC35B2;SLC17A9;SLC25A4;SLC19A1
prerank,cellular response to fatty acid (GO:0071398),0.6721576153010791,1.4065673427724892,0.1443661971830986,0.6972488159054223,1.0,4/12,5.88%,NR1H4;PDK4;LPL;IRS1
prerank,Notch signaling involved in heart development (GO:0061314),0.6814272362709354,1.4065315068549336,0.13414634146341464,0.6954347920038837,1.0,4/11,7.71%,HEY2;HEYL;JAG1;SNAI2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4611035013056847,1.4063337092166872,0.011088709677419355,0.6940758005853046,1.0,39/348,7.68%,MYOM1;ACTA2;NTF3;MYLK2;TTN;ACTG2;MEF2C;NTRK3;HEY2;ACTA1;ANGPT1;ROCK1;FGF1;CD36;LIMS1;MYD88;PDGFB;GABPA;HINFP;ACTG1;MUSK;RBMS3;UBR5;OSR2;SLC38A2;EMILIN1;TESC;TP53;SLC2A10;VEGFA;PTPN1;AR;PPARGC1A;MED1;CELF1;YAP1;NAT8;C1QTNF1;SOX9
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.6312657997952277,1.4057939096566952,0.1287758346581876,0.6939287694964775,1.0,4/17,4.11%,ANGPTL8;LPL;SORT1;HDAC9
prerank,negative regulation of protein depolymerization (GO:1901880),0.6043277742657501,1.4055227606602587,0.1321928460342146,0.6929596399112553,1.0,6/24,7.13%,FGF13;TRIM54;CLASP2;ARHGEF2;HDGFL3;TPX2
prerank,acetyl-CoA metabolic process (GO:0006084),0.6601304037938098,1.4050656658510015,0.13598673300165837,0.6925729253805674,1.0,4/15,8.57%,ACSS1;NUDT7;ACACB;MVD
prerank,regulation of synapse assembly (GO:0051963),0.5359540257359512,1.404139363956801,0.10884353741496598,0.6938327125144502,1.0,5/46,5.68%,SLIT1;MEF2C;PDLIM5;MUSK;GPC4
prerank,cellular response to BMP stimulus (GO:0071773),-0.3706573694662817,-1.4039358495645646,0.024509803921568627,0.7830526842642156,1.0,17/66,10.61%,BMP6;TGFBR3;SMAD3;DDX5;BMP7;BMP4;SMAD6;ENG;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;SMAD9;TMEM100;TGFB1;PDCD4
prerank,import into cell (GO:0098657),-0.41269438313838014,-1.4034436259924632,0.08571428571428572,0.7797505317545962,1.0,8/41,5.98%,ATP1A2;SLC6A13;SLC1A3;GLUL;SLC47A1;SLC12A7;SLC6A6;SLC7A5
prerank,retinoic acid metabolic process (GO:0042573),-0.5504143218730385,-1.4029404783955193,0.0861244019138756,0.7763110503502022,1.0,2/14,2.98%,ALDH1A2;CYP26B1
prerank,response to interferon-beta (GO:0035456),-0.481306232436286,-1.402484967641806,0.07162534435261708,0.7729619909100995,1.0,16/22,37.77%,IFNAR2;IRGM;BST2;IFITM1;SHFL;IFITM3;PNPT1;IFITM2;IKBKE;HTRA2;CDC34;XAF1;NDUFA13;TRIM6;PLSCR1;IRF1
prerank,relaxation of cardiac muscle (GO:0055119),0.6766636086725335,1.4019032350507674,0.12351945854483926,0.6995687552600623,1.0,4/13,5.82%,PLN;SLC8A1;CAMK2D;ATP1B1
prerank,protein localization to synapse (GO:0035418),-0.5666390656092458,-1.4016897238932222,0.0945054945054945,0.7713468463464532,1.0,5/12,15.29%,NLGN1;ZDHHC15;NRXN1;NLGN2;PCLO
prerank,liver development (GO:0001889),-0.43487018066271255,-1.4014370430625704,0.0627177700348432,0.7671187087498946,1.0,9/32,13.45%,TGFBR3;NF1;COBL;WNT4;PKD2;LSR;PCK2;CEBPB;CCDC39
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6776400873352035,1.4006224007142805,0.15265866209262435,0.7021932800580865,1.0,6/13,18.00%,HEY2;TAF1;TMSB4X;SIN3A;MAD2L2;DDIT3
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5636318644119345,-1.4002938350204666,0.07476635514018691,0.7667977565668551,1.0,6/12,19.76%,SLIT2;NBL1;CCN3;DUSP1;AKT1;MIA3
prerank,negative regulation of transmembrane transport (GO:0034763),-0.6055594149870077,-1.4000343698554574,0.1079913606911447,0.7628455487778253,1.0,3/10,15.80%,PRKCB;CTTNBP2NL;AKT1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4912487637168635,-1.3999323421509984,0.1,0.7581432980603863,1.0,5/21,9.32%,PRKCB;FOXP1;PRKCH;SLC39A10;IKBKG
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6946361934933479,1.3997283639874818,0.15858208955223882,0.7034059069533047,1.0,1/10,0.53%,AOC3
prerank,spindle assembly (GO:0051225),0.5149678368181895,1.3970377924238295,0.0959409594095941,0.7110661811452189,1.0,22/67,17.27%,FLNA;CLASP2;KIF2A;TOGARAM2;HAUS8;KIF3B;MAPRE2;TUBGCP6;TPX2;PIBF1;TOGARAM1;CEP192;WRAP73;AAAS;CLASP1;HAUS7;HAUS2;MAPRE3;ABRAXAS2;MAP9;INO80;STARD9
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.46658518525860343,-1.3948727063056963,0.06060606060606061,0.7762763063725425,1.0,6/25,6.44%,KIT;B2M;WNT5A;CD55;SLC7A5;PLCG2
prerank,regulation of cellular component organization (GO:0051128),0.47451386597001793,1.394518820208885,0.06104328523862375,0.7178091703552186,1.0,22/135,7.03%,AGTR1;RAP1A;PAPPA2;STK38L;ROCK1;CD36;PLCE1;HIP1;RASGRP2;CDH13;PACSIN3;PACSIN2;CAMK2D;NET1;ERMN;ATAD3A;PRKCQ;SLITRK4;DAB2IP;SLC2A10;PTPN1;NEDD4
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.39206846192890576,-1.39412440544875,0.072,0.7742996557516345,1.0,11/45,5.66%,PIK3CA;EFEMP1;GRB2;TGFA;PDPK1;PTPN11;EGFR;PTK2;SLC30A10;GAB1;PTK2B
prerank,regulation of protein acetylation (GO:1901983),-0.5730476345224852,-1.3935868682889525,0.09502262443438914,0.7717033846010533,1.0,5/12,19.27%,DDX3X;CAMK1;TAOK1;TERF2IP;PARK7
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6612680316996666,1.3926212455949651,0.12310286677908938,0.7228048298874777,1.0,4/14,8.72%,ATP2B4;PKIB;PKIA;PRKAR1B
prerank,oligosaccharide metabolic process (GO:0009311),-0.40170208983669625,-1.3925527817471317,0.058823529411764705,0.7714194976517863,1.0,12/46,11.00%,ST3GAL4;B4GALT1;ST3GAL6;ST8SIA4;ST6GALNAC3;ST8SIA1;AMY1B;AMY1C;AMY1A;FUT8;ST3GAL3;ST8SIA2
prerank,modification-dependent protein catabolic process (GO:0019941),-0.31074049511237845,-1.392165778195453,0.0,0.7681691137777387,1.0,64/193,19.46%,TTC3;NEDD4L;ARRB1;FBXL7;TRIP12;RNF146;ATXN3;AREL1;ITCH;FBXO10;CUL3;RNF185;ANAPC1;RNF20;UBQLN1;BIRC6;RC3H2;RNF144B;RNF217;UBL7;RNF6;UFD1;RNF13;WDR91;PSMD9;PSMD13;RNF213;MDM2;TOPORS;CDC23;FBXO7;TRIM25;SMURF2;RNF144A;PRKN;DDB1;UBE4B;UBC;RNF34;STUB1;RNF125;DTX3L;RNF166;SIAH1;OS9;BUB3;PSMC2;UBE2H;CDC26;TOLLIP;RNF43;KLHL3;UBQLN2;UBE2S;ANAPC4;SIAH2;SYVN1;RNF130;HERPUD1;CHFR;ARRDC1;ARIH1;SPSB4;BTRC
prerank,regulation of cell junction assembly (GO:1901888),0.6011078559896811,1.3919506982161856,0.11801242236024845,0.723285672033085,1.0,8/27,11.11%,MEF2C;RAP1A;PDLIM5;ROCK1;CBFB;SNAI2;ROCK2;RUNX1
prerank,regulation of cell motility (GO:2000145),0.4787412451917574,1.391750275632545,0.07264472190692395,0.7220878484771854,1.0,12/121,3.95%,NEXN;FLNA;ROCK1;FGF1;CAVIN1;CDK6;PLXND1;PLXNB1;KIF2A;SERPINE2;DOCK10;NTN1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5759816476296581,1.3903208462499368,0.12874251497005987,0.7253920967557786,1.0,7/29,10.29%,RBM24;TENT5B;CIRBP;GDNF;NBAS;FUS;HNRNPU
prerank,entry into host (GO:0044409),-0.5569794945088676,-1.3902045040025297,0.1016949152542373,0.7721992487762996,1.0,5/13,7.11%,GRB2;CDH1;ITGAV;CTNND1;CTNNB1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4814447053790599,1.3892125237691568,0.06749156355455568,0.727434435044588,1.0,17/116,9.46%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;CYSLTR2;RAMP1;PRKACB;ADAM17;PRKAR1B;PTH1R;ADCY6
prerank,protein N-linked glycosylation (GO:0006487),-0.3688887587307208,-1.3891557796661456,0.04838709677419355,0.7720711653126385,1.0,28/66,25.73%,MAN1C1;TUSC3;MGAT4C;B4GALT1;ST3GAL1;MGAT1;PGM3;SLC39A8;FUT8;MGAT4B;UGGT2;ENTPD5;OSTC;MGAT5;MCFD2;PMM2;MPDU1;LMAN1;ALG14;B4GALT7;ALG1;ALG12;GFPT2;RPN2;MGAT2;DPM3;MGAT4A;STT3B
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4252942037987398,-1.3890779345245834,0.08163265306122448,0.7673855512115442,1.0,12/36,15.51%,MECOM;DLG1;ITCH;FOXO1;PTPN22;PRKN;SIRPA;SH3RF2;PER1;IGBP1;AIDA;DUSP1
prerank,positive regulation of receptor internalization (GO:0002092),0.5940849887216982,1.389059082110646,0.12223858615611193,0.7261184906682205,1.0,5/22,10.44%,NTF3;ANGPT1;VEGFA;ATAD1;SCYL2
prerank,microvillus organization (GO:0032528),0.6572691516155086,1.3888051614986872,0.135,0.7250323533562572,1.0,6/13,12.21%,RAP1A;RAP2C;STK26;RAPGEF6;RAP2A;TNIK
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.3471622304000679,-1.3881845189817679,0.007194244604316547,0.7667447849907317,1.0,39/91,25.38%,SEC62;RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;SEC63;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SSR1;SEC61A1;RPS7;RPL27;RPL11;SRPRA;SRP9;RPL18A;RPL37A;SSR2;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27
prerank,"wound healing, spreading of cells (GO:0044319)",0.59605603780378,1.3874252738505803,0.1238244514106583,0.7278365883951394,1.0,4/24,3.40%,FLNA;CCN1;LCP1;MRTFA
prerank,heart looping (GO:0001947),0.5490530335188798,1.386234498933935,0.12689655172413794,0.7300892194330157,1.0,3/39,1.52%,MEF2C;TBX2;MICAL2
prerank,transepithelial transport (GO:0070633),-0.5255757818219629,-1.3860807218337043,0.10336538461538461,0.7713505565070791,1.0,4/15,4.09%,SLC1A3;ABCG2;SLC12A2;CXADR
prerank,regulation of activated T cell proliferation (GO:0046006),-0.43805554225193977,-1.385936656902759,0.0634441087613293,0.7671030721215688,1.0,6/30,8.50%,IGF1;IGFBP2;HMGB1;IL18;LGALS9;IGF2
prerank,sodium ion homeostasis (GO:0055078),-0.4835999650767921,-1.3857983175744655,0.0891891891891892,0.7628499049140389,1.0,4/21,3.01%,ATP1A2;ATP1B3;NEDD4L;SLC12A2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5373927245476701,1.3850645966350663,0.10638297872340426,0.7325040908213141,1.0,10/46,9.69%,NTN4;ITGA8;LAMA5;FERMT2;PEAK1;LAMC1;LAMB2;ITGB3;ITGA4;PARVA
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.456769562495793,-1.3841867408934838,0.08757062146892655,0.7655619598981585,1.0,10/26,16.75%,IGF1;OSBPL8;PTPN11;OCLN;CREBL2;APPL1;RHOQ;INSR;AKT1;CAPN10
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5334457597856415,1.383140090035515,0.11241830065359477,0.7376676452142142,1.0,3/48,3.36%,CCDC3;SLIT3;PADI2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.41340111200817053,-1.3829580524095888,0.05693950177935943,0.7663321905941829,1.0,9/39,10.30%,AFDN;EPHA7;PTPRG;NF2;PTK2;PODXL;CDH1;TENM3;TGFB1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5866659116215827,-1.3824073755274449,0.08974358974358974,0.763949747341983,1.0,8/10,34.79%,FN1;HSP90AB1;FURIN;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6874187182952614,1.3817995924396669,0.14462081128747795,0.7404890189847585,1.0,4/10,11.28%,PRKG1;SERPINE2;C1QTNF1;PRKCD
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5136413055002492,1.3817262433588464,0.10201511335012595,0.7388341282648438,1.0,17/59,14.87%,MYLK2;ROCK1;DYRK2;CAMK2D;DYRK1A;TAF1;DYRK1B;CHEK1;MAP3K10;MAP2K1;ROCK2;PRKCD;ACVR1B;CDC42BPB;MAPK1;LRRK2;PRKCA
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4900335063230355,1.3814988285629317,0.08421052631578947,0.7377344653539047,1.0,22/93,16.16%,NTF3;DMD;NTRK3;ATP2B4;HRC;BCAR3;CAV1;VEGFA;CNKSR3;GPD1L;PDE4D;PDCD10;FNIP2;DMTN;NCK2;GAS6;MLXIPL;INPP5J;PTEN;RAF1;NOS1;MAD2L2
prerank,pharyngeal system development (GO:0060037),-0.5168691960839765,-1.3814341074941907,0.09859154929577464,0.7632998966320667,1.0,6/15,11.77%,BMP7;BMP4;PTCH1;BMPR2;HES1;TGFBR1
prerank,regulation of ossification (GO:0030278),-0.4130218918397469,-1.3814021550924434,0.0695970695970696,0.7587755435870089,1.0,9/36,5.55%,PTN;SGMS2;BMP4;CHSY1;SMAD6;PTPN11;BMP2K;WNT5A;BMPR2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4865596050141466,1.3809563369237632,0.07551487414187644,0.7377403546246145,1.0,14/112,7.86%,PDE3A;SOX6;SOX5;MEF2C;LIMS1;FERMT2;LRRC32;TGFB3;ITGB1;GCNT2;BMPR1A;ITGB5;SOX9;TGFB2
prerank,protein depolymerization (GO:0051261),0.5833309092115343,1.3803893147749593,0.11879699248120301,0.7378984196688962,1.0,8/27,14.26%,DSTN;MICAL2;WDR1;KIF2A;CFL2;MICAL3;KIF18A;STMN2
prerank,positive regulation of B cell proliferation (GO:0030890),0.5808885429195241,1.3802212977711945,0.11621233859397417,0.7366339677790502,1.0,4/29,4.50%,MEF2C;IL2;TNFSF13B;BCL2
prerank,protein localization to Golgi apparatus (GO:0034067),-0.4396706346492233,-1.3798462334066923,0.11075949367088607,0.761000206354854,1.0,12/27,22.43%,VPS13A;GBF1;ZDHHC15;OPTN;ARL5B;GCC2;TMED10;GOLPH3;COG7;OBSL1;SYS1;GBP5
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4783591022137184,1.379472664450103,0.07432432432432433,0.737438194362656,1.0,17/117,9.46%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;CYSLTR2;RAMP1;PRKACB;ADAM17;PRKAR1B;PTH1R;ADCY6
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.5611994142142047,-1.3792679067889506,0.11349036402569593,0.7589568873229096,1.0,6/12,10.30%,PTPN14;BMP4;KHDRBS1;UHMK1;SIRT7;TGFB1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5545724419610266,1.3791757637006445,0.12585499316005472,0.7365171348754062,1.0,7/39,8.12%,DMD;FGF13;FGF14;CAMK2D;UTRN;NEDD4;WNK2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6516930128774069,1.378978434162934,0.13471502590673576,0.7353139748919401,1.0,4/13,11.08%,FLNA;NFKBIE;GET4;GOPC
prerank,positive regulation of GTPase activity (GO:0043547),0.46176280880491105,1.378883845206888,0.0505795574288725,0.7337760667035922,1.0,36/188,10.64%,NTF3;ARHGEF7;RAP1A;NTRK3;RALGAPA2;TBC1D1;RGS6;ABR;LIMS1;RASGRP2;FERMT2;DOCK8;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;ARHGEF16;LARS1;MTSS2;MAPRE2;RABGAP1;PIN1;CORO1C;RAPGEF6;RASGRP1;RALGAPA1;EVI5;RALGAPB;EPHA2;AGRN;CCL14;SNX18
prerank,protein K48-linked ubiquitination (GO:0070936),-0.38288933362971744,-1.3788342767581523,0.03404255319148936,0.7563228414460522,1.0,19/54,15.67%,TTC3;NEDD4L;RNF146;ITCH;CUL3;UBE2D3;RNF6;PELI1;TOPORS;UBE2E2;UBE2E3;PRKN;UBE3A;RNF34;SKP2;DTX3L;UBE2H;RNF115;KLHL3
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.41648788891976973,-1.3787951291075198,0.0898876404494382,0.7520119101306207,1.0,15/39,27.18%,TCF7L2;MYRIP;RBP4;MCU;PSMD9;NNAT;SOX4;NLGN2;CAPN10;ACSL4;AACS;DRD2;HFE;ADCYAP1;LRRC8A
prerank,positive regulation of interferon-beta production (GO:0032728),-0.4219624650585051,-1.378218100374079,0.07232704402515723,0.7499817046592491,1.0,13/33,25.15%,DDX3X;PTPN11;RNF135;POLR3F;RIOK3;POLR3B;POLR3A;TRIM56;TLR3;OAS2;POLR3C;TOMM70;POLR3D
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5059882923232843,-1.3777231327698447,0.09343434343434344,0.7475308931153464,1.0,5/17,8.83%,ATP1A2;BMP7;BMP4;TFPI;NR3C1
prerank,actin crosslink formation (GO:0051764),0.6505385980097813,1.3773949538206403,0.14711033274956217,0.7371171441600042,1.0,2/12,3.35%,FLNA;LCP1
prerank,mitotic chromosome condensation (GO:0007076),0.577398892470438,1.3771723385237795,0.12262773722627737,0.7360925647873359,1.0,6/26,11.64%,TTN;SET;NCAPD3;TENT4A;RB1;NCAPD2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.662103483694897,1.3765191834993755,0.15873015873015872,0.7363391657979034,1.0,4/12,6.50%,NKD1;CEP290;DSCAM;VEGFA
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.36439410488229695,-1.3758889340872018,0.05154639175257732,0.7511521115740217,1.0,12/66,5.39%,TGFBR3;ROBO1;MCC;NF1;SULF1;SPARC;NUPR1;APOE;B2M;XDH;MTSS1;PTPRM
prerank,potassium ion transport (GO:0006813),0.4702498679304061,1.375580198719678,0.07311586051743532,0.7378164626552509,1.0,11/120,5.58%,KCNAB1;KCNMA1;KCNJ12;KCNMB1;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNB1;CCDC51;KCNH1
prerank,cellular response to misfolded protein (GO:0071218),-0.4828565225577456,-1.375429937717971,0.09239130434782608,0.74875058449502,1.0,8/20,11.28%,ATXN3;CUL3;RNF185;DNAJB12;DERL1;UFD1;UGGT2;STUB1
prerank,receptor-mediated endocytosis (GO:0006898),-0.32311761110501774,-1.3754181081158932,0.01020408163265306,0.7444178620298965,1.0,39/132,19.15%,DAB2;DNM3;LRP1;SPARC;GRB2;FCHO2;DNAJC6;CALCRL;APOE;LDLR;FNBP1L;CTSL;SCARB2;CXCL16;CANX;DNM1;TMEM108;PPT1;EPS15;SCARF1;ARHGAP27;DNAJC13;RAMP2;RABEPK;HSP90B1;AP2S1;GRK2;CALR;SNCA;INSR;NLGN3;CLN3;LMBRD1;STAB1;CLTB;M6PR;AP2A2;CUBN;CLTA
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5667758030406924,-1.3753463573161102,0.12,0.7404677793316045,1.0,5/11,11.08%,DDX5;BMP4;EGFR;TGFB1;MAP2K2
prerank,lamellipodium organization (GO:0097581),0.5745546395807904,1.3747976202108172,0.13505747126436782,0.7387659425029828,1.0,7/29,9.04%,ARHGEF7;VCL;CDH13;ITGB1;CYFIP1;WHAMM;ARHGEF4
prerank,positive regulation of intracellular transport (GO:0032388),0.5371943701748134,1.3746756783119998,0.11806543385490754,0.7373602059527073,1.0,10/38,12.63%,ATP2A1;OAZ2;EHD2;TBC1D20;CEP290;NEDD4;ACTN2;STX18;KIF20B;PDCD10
prerank,microvillus assembly (GO:0030033),0.6444824603152292,1.3745906160726948,0.15235008103727715,0.735788331908118,1.0,6/14,12.21%,RAP1A;RAP2C;STK26;RAPGEF6;RAP2A;TNIK
prerank,regulation of chemotaxis (GO:0050920),-0.4286092124239485,-1.3743653188526057,0.08231707317073171,0.7404295551373771,1.0,12/30,12.72%,PDGFRA;EFNB2;ADGRA2;MYCBP2;STX3;ZSWIM6;CYRIB;STX4;TGFB1;ZSWIM5;ZSWIM4;PPM1F
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5772196212635956,-1.3740250311732545,0.11258278145695365,0.7377013858520305,1.0,3/11,11.77%,TGFBR3;TGFB1;TGFBR1
prerank,regulation of monooxygenase activity (GO:0032768),-0.4848268994173613,-1.3739666861596471,0.09451219512195122,0.733790085289876,1.0,13/23,21.39%,POR;EGFR;NOS1AP;LYPLA1;NOSTRIN;NOS3;DDAH1;SNCA;AKT1;NOSIP;DDAH2;CYGB;SPR
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.4459642993058374,-1.3733236725570834,0.08099688473520249,0.7325298953820071,1.0,16/26,36.52%,ITCH;PPM1B;MAPKBP1;ILRUN;PCBP2;IRAK3;TRIB1;TRIM21;NLRC3;NFKBIL1;TNFAIP3;NMI;SIGIRR;TYRO3;LYAR;DHX58
prerank,eye morphogenesis (GO:0048592),-0.49683185350156556,-1.3713397203791031,0.09283819628647215,0.7369631119995798,1.0,9/19,9.35%,SHROOM2;FBN1;NF1;EFEMP1;FBN2;MFAP5;IFT122;COL5A1;TENM3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5223637616090535,1.369984108384832,0.10904255319148937,0.7503316084555898,1.0,10/48,9.99%,GUCY1A1;AMPD1;ADCY5;ADCY2;ADCY9;GUCY1B1;AMPD2;NUDT2;ADCY6;NPR2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.54921433242723,1.3694519415580466,0.12005649717514125,0.750321612005216,1.0,3/33,3.36%,NTF3;ABR;SLC4A8
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4483358867141392,1.3692103245356095,0.019250253292806486,0.7492820303402863,1.0,49/291,11.28%,PDE3A;TPM1;MEF2C;RAP1A;ATP2B4;AKAP6;NR1H4;MYD88;PDGFB;ABCB4;PDK4;RORA;VIM;FZD4;LPL;P2RY2;IGFBP5;GUCY1B1;TSHR;CAMKK2;ACTB;UPF1;CD14;LARS1;TESC;IRS1;TAF1;MAPT;DAB2IP;CHMP5;CPEB1;SOX9;NFKBIB;RELA;ADNP2;IMPACT;GSTP1;CAPN2;NR1D1;ADCY6;RRAGB;CERS1;AXL;BRINP1;SH3BP4;GPER1;ROCK2;CD180;PRKCD
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.46442227609473863,-1.3687913527444908,0.08163265306122448,0.7432752167465076,1.0,9/25,19.68%,SDF2;DNAJB12;HSPA5;BAG1;HSPA13;HSPA9;HSPE1;DNAJB4;ST13
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.4579499889100146,-1.3687756161843971,0.08737864077669903,0.7391980925126385,1.0,10/25,11.28%,ATXN3;CUL3;RNF185;NGLY1;DERL1;UFD1;ZER1;UGGT2;ZYG11B;STUB1
prerank,negative regulation of heart contraction (GO:0045822),0.6554939349611927,1.3682677266740761,0.17025089605734767,0.7509161373171677,1.0,1/11,0.13%,PLN
prerank,positive regulation of DNA repair (GO:0045739),-0.3929496983299481,-1.368090636923636,0.029045643153526972,0.7379099265002595,1.0,13/46,17.42%,EYA2;EYA1;EYA4;HMGB1;EGFR;SLF2;SMCHD1;XRCC1;BRCC3;SLF1;NPAS2;FAM168A;WRAP53
prerank,positive regulation of viral life cycle (GO:1903902),0.601683077070748,1.3677187598769307,0.14751552795031056,0.7509764323288828,1.0,6/22,13.43%,TMPRSS4;AXL;CHMP2B;TSG101;KPNA2;CHMP2A
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5209883544161569,-1.3671732199417408,0.12850467289719625,0.7376551957151524,1.0,8/14,18.55%,PXN;GHR;PTK2;SOCS2;LYN;PRLR;STAT5A;STAT6
prerank,vasculature development (GO:0001944),-0.5143821811197141,-1.3670696319127587,0.11822660098522167,0.734220970248441,1.0,6/16,9.24%,PIK3CA;PDGFRA;CDH5;ACVRL1;BMPR2;STK11
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5061550161366767,-1.3665493713742054,0.12158808933002481,0.7322278967046107,1.0,7/16,17.73%,AUTS2;CTR9;CTNNB1;SNW1;BCOR;SMAD4;KDM1A
prerank,cellular protein catabolic process (GO:0044257),-0.3678119901165714,-1.365482897559365,0.051643192488262914,0.7325157322365391,1.0,20/59,20.63%,DENND3;RAB12;CTSL;CTSH;CASP8;MDM2;AFG1L;PRKN;AP2S1;CTSB;TCIRG1;YME1L1;CLPX;CHEK2;SIAH2;AP2A2;CLTA;BNIP3L;CLPP;CTSS
prerank,positive regulation of filopodium assembly (GO:0051491),-0.45091980753926136,-1.3647968719469752,0.09593023255813954,0.7313296830225166,1.0,14/24,28.38%,PALM;DOCK11;NRP1;NLGN1;FNBP1L;RIPOR2;DPYSL3;RHOQ;CDC42;FMR1;GPM6A;FSCN1;ARAP1;TENM1
prerank,motor neuron axon guidance (GO:0008045),0.6307569968772265,1.3645377838609745,0.1558872305140962,0.7604778089417029,1.0,3/15,4.73%,SLIT1;NTN1;CHN1
prerank,positive regulation of lyase activity (GO:0051349),0.6308569941528128,1.3617600494942077,0.16776315789473684,0.7684198461112751,1.0,3/14,4.46%,CACNA1C;STIM1;FXN
prerank,axon extension (GO:0048675),0.5912359206321497,1.3616017162000817,0.14946070878274267,0.7671184954870555,1.0,4/23,3.78%,SLIT3;SLIT1;SEMA5A;MAP1B
prerank,vascular process in circulatory system (GO:0003018),0.6463356566217647,1.3610107992712877,0.155668358714044,0.7653002778650497,1.0,2/13,1.43%,AGTR1;ROCK1
prerank,regulation of tube diameter (GO:0035296),0.6463356566217647,1.3610107992712877,0.155668358714044,0.7653002778650497,1.0,2/13,1.43%,AGTR1;ROCK1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.6495426698482814,1.360608035680546,0.15789473684210525,0.7648957005305236,1.0,2/15,2.63%,RYR2;ZFAND2B
prerank,regulation of endothelial cell migration (GO:0010594),-0.3481563302469215,-1.3603383124995643,0.025157232704402517,0.7457587545256242,1.0,24/85,10.07%,PTN;SASH1;NF1;DCN;FOXP1;GLUL;NRP2;SPARC;BMP4;SLIT2;APOE;TEK;NRP1;PTK2;WNT5A;ACVRL1;PTPRM;BMPR2;PTK2B;FOXC2;PIK3CB;BMPER;ANXA3;ADAMTS9
prerank,Rho protein signal transduction (GO:0007266),0.510811881654918,1.3587802195446061,0.1196808510638298,0.7694334473102729,1.0,13/53,11.25%,AGTR1;ROCK1;CDC42EP3;CDH13;MYO9B;NTN1;ARHGAP6;ARHGDIG;RHOJ;GNA12;ARHGAP1;ROCK2;ARHGAP5
prerank,neural crest cell migration (GO:0001755),-0.4199573102994083,-1.3587513456536704,0.07046979865771812,0.7486117646597079,1.0,10/36,7.79%,SEMA3D;SEMA3C;SEMA6A;FN1;NRP1;RADIL;ANXA6;SEMA7A;SEMA3A;SEMA4D
prerank,regulation of DNA repair (GO:0006282),-0.386505844109287,-1.3585525129613398,0.060836501901140684,0.7453714716849258,1.0,9/44,9.53%,EYA2;EYA1;EYA4;TRIP12;EGFR;PML;SIRT7;SMCHD1;BRCC3
prerank,negative regulation of protein catabolic process (GO:0042177),0.5367361932990746,1.357804547211484,0.12876712328767123,0.7709860179054178,1.0,12/40,16.28%,FLNA;ROCK1;DAB2IP;PIN1;TIMP4;SF3B3;SIRT2;ADGRB1;CTSA;AZIN2;MAD2L2;AGAP2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3878718257548678,-1.3568699964061577,0.06477732793522267,0.7484436688496561,1.0,13/44,15.51%,NF1;BMP7;BMP4;APOE;STK38;PIK3CB;PTPN22;IRAK3;PDCD4;LYN;SPRY2;AIDA;DUSP1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5160813315152833,1.3566007589264109,0.11772315653298836,0.7735598148119228,1.0,11/47,11.28%,AGTR1;CD36;PDGFB;SLC5A3;DHRS4;MAPT;TP53;CBR1;GSTP1;PDGFRB;PRKCD
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5160410464382224,-1.356119328170482,0.1152073732718894,0.7475187806715032,1.0,7/14,21.87%,PIK3CA;NRP1;GAB1;KDR;VEGFC;VEGFB;FLT4
prerank,negative regulation of cell cycle (GO:0045786),0.4989655730360064,1.3561143321064792,0.1095066185318893,0.7733712577429097,1.0,14/73,11.38%,MYOCD;CDK6;NR4A1;GMNN;BTG2;NR2F2;RPS6KA2;HEXIM1;HECA;BTG1;BRINP1;GPER1;RB1;TRIM35
prerank,C4-dicarboxylate transport (GO:0015740),-0.5092574566778528,-1.355409890264855,0.12376237623762376,0.7464567633912992,1.0,10/14,31.81%,SLC25A14;SLC25A30;SLC25A11;LRRC8D;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC13A5;SLC1A6
prerank,lamellipodium assembly (GO:0030032),0.5763031063867919,1.3551849786758103,0.13988095238095238,0.7748060032323442,1.0,7/26,9.04%,ARHGEF7;VCL;CDH13;ITGB1;CYFIP1;WHAMM;ARHGEF4
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6764269461093761,1.3551486534282158,0.1783876500857633,0.7730575159815499,1.0,2/11,1.88%,WTIP;LIMD1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5844942787317394,-1.3550520416873435,0.12153518123667377,0.7440978086284008,1.0,5/10,21.44%,APP;RAB5A;SHANK3;SYP;DRD2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5248741121312739,-1.3546179662837607,0.10073710073710074,0.741920527510546,1.0,6/14,17.22%,SPRED2;XDH;ZEB1;OSR1;SPRY2;NOTCH4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6117975815277851,1.3546080355274914,0.1847457627118644,0.7731066798658753,1.0,4/16,5.14%,MEF2C;AKAP6;TBX2;BMPR1A
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4654262163129477,-1.3545268126205243,0.09788359788359788,0.7384228809509747,1.0,5/21,4.90%,LRP1;PLTP;APOE;PTCH1;NFKBIA
prerank,B cell homeostasis (GO:0001782),0.6597961835826438,1.3544433414856836,0.15819209039548024,0.7718108850627676,1.0,2/10,3.54%,MEF2C;DOCK10
prerank,triglyceride homeostasis (GO:0070328),0.5891865347250435,1.3542179181456313,0.14540059347181009,0.7707598119965441,1.0,4/26,3.34%,NR1H4;ANGPTL8;RORA;LPL
prerank,mRNA splice site selection (GO:0006376),-0.4340683054882578,-1.354112511039145,0.07926829268292683,0.7361829542214836,1.0,8/30,11.14%,CELF2;KHDC4;SRSF6;SRSF5;CELF4;SETX;SFSWAP;ISY1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5034395347965187,1.3540984644576126,0.1136919315403423,0.7693492673640246,1.0,13/65,9.18%,ASPN;PRDM16;LTBP1;VASN;TGFB1I1;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI
prerank,embryonic limb morphogenesis (GO:0030326),0.5431127838086154,1.353763508283375,0.1357142857142857,0.7687283379725054,1.0,7/34,10.15%,MAP3K20;CACNA1C;TBX2;OSR2;TGFB2;SKI;MBNL1
prerank,protein targeting to ER (GO:0045047),-0.33466692553708005,-1.3536730767505547,0.03225806451612903,0.7340670867284916,1.0,44/99,25.38%,SEC62;RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;SRPRB;RPS13;SEC63;RPLP0;SGTA;RPS29;RPL28;RPS10;RPLP1;SGTB;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SEC61A1;RPS7;RPL27;RPL11;SRPRA;SRP9;RPL18A;RPL37A;RPL38;ZFAND2A;RPL29;RPL10A;CHMP4B;CHMP4A;RPL32;SPCS1;RPS4X;RPS27
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6264462451674855,1.3533104033370629,0.16498316498316498,0.766610465901081,1.0,5/16,6.96%,DLC1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6264462451674855,1.3533104033370629,0.16498316498316498,0.766610465901081,1.0,5/16,6.96%,DLC1;PHLDB2;CLASP2;ARHGAP6;CORO1C
prerank,macrophage migration (GO:1905517),0.6333963954276797,1.35311171656521,0.18620689655172415,0.7654193456910727,1.0,2/13,3.64%,EDNRB;CCL5
prerank,ERAD pathway (GO:0036503),-0.3518236039163199,-1.3529922129448373,0.0736196319018405,0.7332830846127418,1.0,28/83,18.63%,ECPAS;ATXN3;SEL1L;RNF185;UBXN4;UBQLN1;DNAJB12;DERL1;UFD1;HSPA5;DNAJC10;USP19;UGGT2;TRIM25;PRKN;SGTA;UBE4B;STUB1;RCN3;DNAJB2;HSP90B1;SGTB;OS9;UBQLN2;SYVN1;UBXN8;DNAJB9;HERPUD1
prerank,regulation of phospholipase C activity (GO:1900274),0.6210825716911061,1.3527151072097745,0.16694772344013492,0.7651036775907324,1.0,2/15,0.77%,NTF3;NTRK3
prerank,synaptic vesicle recycling (GO:0036465),-0.42279542317793123,-1.3507595044546274,0.09294871794871795,0.7386488976506139,1.0,13/31,16.01%,FCHO2;RAB5A;NLGN1;SYT1;CANX;STON2;OPHN1;TBC1D24;SNCA;NLGN2;NLGN3;PLD2;STX1A
prerank,DNA integrity checkpoint signaling (GO:0031570),0.5323227770217898,1.3503072676742502,0.13704206241519673,0.7719675729895286,1.0,12/36,14.23%,MAP3K20;HINFP;BRIP1;TIPIN;CHEK1;RAD9A;ERCC6;HUS1B;FBXO6;RHNO1;CLOCK;INTS7
prerank,barbed-end actin filament capping (GO:0051016),-0.4853160670281942,-1.3496670333338665,0.12195121951219512,0.7359663780629205,1.0,3/18,3.49%,ADD3;EPS8;CAPZA1
prerank,actin filament capping (GO:0051693),-0.4853160670281942,-1.3496670333338665,0.12195121951219512,0.7359663780629205,1.0,3/18,3.49%,ADD3;EPS8;CAPZA1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5723054832885159,-1.3493828427489716,0.11612903225806452,0.7334970869829758,1.0,3/11,1.66%,AFDN;TJP1;TJP2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.5499395065245878,-1.3489347854550346,0.1403118040089087,0.731636285420848,1.0,8/12,23.57%,SEC62;HSPA5;SEC63;SGTA;SGTB;SEC61A1;CHMP4B;CHMP4A
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6467552902922211,1.3486914257114606,0.16106194690265488,0.7739853403728445,1.0,2/12,1.15%,AKAP6;LMCD1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6467552902922211,1.3486914257114606,0.16106194690265488,0.7739853403728445,1.0,2/12,1.15%,AKAP6;LMCD1
prerank,sphingoid metabolic process (GO:0046519),-0.54535436569222,-1.3484372455478153,0.12028301886792453,0.7302368947858336,1.0,9/12,43.93%,NAAA;SGPP1;ASAH2;SPHK1;DEGS2;PLPP2;SPHK2;PLPP1;SPTLC3
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4950980408533505,1.3479784496620033,0.10467980295566502,0.7746400552790034,1.0,10/69,7.62%,NTF3;MEF2C;PLA2G3;CRLF1;TGFB3;SET;BCL2;GDNF;PPARGC1A;FZD9
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5423803964401975,-1.3475282287799455,0.12441314553990611,0.7304719969045557,1.0,3/13,9.72%,ATP1A2;ATP1B3;ATP1B2
prerank,reticulophagy (GO:0061709),-0.5420687663369568,-1.3473863414447675,0.13317757009345793,0.7275415674913094,1.0,5/12,13.03%,RB1CC1;RETREG1;TEX264;ATG2B;ATG2A
prerank,negative regulation of inflammatory response (GO:0050728),0.45420383426267297,1.3468839990036787,0.055853920515574654,0.7766807205893445,1.0,34/182,11.28%,LHCGR;GPR20;ADCY5;CRHR2;NR1H4;FCGR3A;ADCY2;VIPR2;MYH9;RORA;FEM1A;ADCY9;PTGIS;TSHR;ALOX5;MFHAS1;CYSLTR2;CD200R1;TNFAIP6;CD200;RAMP1;LPCAT3;PRKACB;PPARA;ADAM17;PRKAR1B;GSTP1;NR1D1;PTH1R;ADCY6;AOAH;GPER1;RB1;PRKCD
prerank,excitatory postsynaptic potential (GO:0060079),0.5932324898834349,1.3465544704832082,0.16071428571428573,0.7760441530025748,1.0,2/19,2.87%,MEF2C;GRIN2C
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.3213037354270699,-1.3461286961015781,0.02857142857142857,0.7290409340195242,1.0,35/128,13.67%,BMP6;TGFBR3;SMAD3;APPL2;DDX5;BMP7;BMP4;COL1A2;CDH5;PXN;SMAD6;ENG;PTK2;RUNX2;ACVRL1;RGMB;BMPR2;MEGF8;ID1;SMAD9;CLDN5;ZMIZ1;FURIN;FKBP1A;SMURF2;ZMIZ2;TMEM100;TGFB1;PDCD4;UBC;STUB1;TGFBR1;ZYX;ARHGEF18;APPL1
prerank,regulation of actin filament polymerization (GO:0030833),0.49783766191279466,1.3454977605791,0.12054120541205413,0.7779358206638736,1.0,4/69,3.29%,LMOD1;LMOD2;CDC42EP3;KANK1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5142083498605936,-1.3452497564781298,0.12322274881516587,0.7291655001660585,1.0,4/15,3.01%,ATP1A2;ATP1B3;NEDD4L;SLC12A2
prerank,regulation of cytoskeleton organization (GO:0051493),0.4680503918234186,1.3446760012717343,0.08944954128440367,0.7789501019758786,1.0,30/108,17.15%,NEXN;DLC1;ROCK1;PHLDB2;PLXNB1;RHOBTB3;BICD2;MAPT;TPPP;ARHGAP17;RHOF;CAPN2;PAK2;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;DMTN;CLASP1;MAPK1;PRKAA2;RHOG;CDK2AP2;CLIC4;S100A8;S100A9;MARK2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5337696478049794,-1.3444302106812427,0.12272727272727273,0.728654070120128,1.0,7/13,19.06%,BMP7;SOX13;NAPEPLD;SIX1;PTGS2;TFE3;METRNL
prerank,positive regulation of acute inflammatory response (GO:0002675),0.612461303057695,1.3432560710754395,0.14235500878734622,0.7821591366509915,1.0,1/14,1.47%,PTGER3
prerank,sensory organ development (GO:0007423),-0.38040795303827224,-1.342092013559564,0.05752212389380531,0.734666599242475,1.0,8/51,9.46%,SHROOM2;SMOC1;CHD7;PBX3;RBP4;ECE1;SMCHD1;MEIS2
prerank,regulation of vasoconstriction (GO:0019229),0.5609464832208075,1.3418166146789805,0.15582450832072617,0.7854432670713899,1.0,5/27,8.74%,AGTR1;ADRA1D;CAV1;ATP2B1;TRPM4
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5254684240931553,-1.3416188046604172,0.09761904761904762,0.7332658852881995,1.0,6/14,17.38%,KMT2E;AUTS2;CTR9;CTNNB1;SNW1;SMAD4
prerank,proteoglycan metabolic process (GO:0006029),-0.43670299127988277,-1.3407887559017277,0.10610932475884244,0.7329915718102984,1.0,10/26,20.00%,IGF1;CHST11;SULF1;BMPR2;CHST9;CANT1;XYLT1;FOXL1;CHST12;B4GALT7
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3763062247057477,-1.3407483712681836,0.06692913385826772,0.7297101517459613,1.0,13/46,10.73%,LGR4;ALDH1A1;ZNF423;IL15;NRDC;NPR3;IP6K1;ID1;FOXC2;NOVA1;STK11;LAMA4;RHEB
prerank,DNA damage checkpoint signaling (GO:0000077),0.5601262165275321,1.3406248098782108,0.1497005988023952,0.7876656125217628,1.0,11/28,14.23%,MAP3K20;HINFP;BRIP1;CHEK1;RAD9A;ERCC6;STK33;FBXO6;RHNO1;CLOCK;INTS7
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5329750385990977,1.3403806759245973,0.15167785234899328,0.7867006633466297,1.0,9/39,8.64%,ACTN4;MYO1E;MYO1D;MYO1B;MYO5C;KIF1A;F8A1;KIF5B;TRAK1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5399146501697676,1.3403356278988448,0.1438953488372093,0.7850223486009875,1.0,5/33,5.38%,MEF2C;ATP2B4;ANGPT2;ANGPT4;MMRN2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.33760201465520695,-1.3393915822606126,0.0273972602739726,0.7318471230293982,1.0,32/88,22.19%,VPS13A;ARRB1;DNAJC6;APP;RABEP1;MON2;SCAMP2;GBF1;PUM1;STX4;COMMD1;SORCS1;DTNBP1;FTL;AP1M1;EPS15;FTH1;EXOC2;HGS;STEAP2;VAMP8;EXOC1;SCFD1;SH3GL2;CLINT1;CLTA;ACBD3;SCAMP3;AP1B1;VAMP7;SCAMP1;SYS1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.514127798485412,-1.3382367975569733,0.1466346153846154,0.7326699675148125,1.0,8/14,27.38%,ERN1;NCBP2;CPSF2;CPSF6;CSTF2T;CPSF4;CSTF2;CPSF1
prerank,positive regulation of peptidase activity (GO:0010952),-0.4567299860176184,-1.3378593552701354,0.11653116531165311,0.730854324059025,1.0,11/20,35.24%,CTSH;APH1A;RCN3;NCSTN;APH1B;GRN;PSME3;PSENEN;PSME1;PSME2;NDUFA13
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3366992063438539,-1.3374955381804186,0.0449438202247191,0.7289363807720112,1.0,24/87,13.67%,TGFBR3;SMAD3;APPL2;COL1A2;CDH5;PXN;SMAD6;ENG;PTK2;ACVRL1;ID1;SMAD9;CLDN5;ZMIZ1;FURIN;FKBP1A;ZMIZ2;TGFB1;UBC;TGFBR1;ZYX;ARHGEF18;FMOD;APPL1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.4831656361432499,-1.3359206859543602,0.11809045226130653,0.7319317356326455,1.0,5/18,8.50%,IGF1;IGFBP2;HMGB1;IL18;IGF2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.49652909865505357,1.3352206292331448,0.13553113553113552,0.8018535165064515,1.0,13/64,8.18%,VCL;ROCK1;CD36;CDK6;CDH13;JAG1;ACTG1;PEAK1;UTRN;DUSP3;AJAP1;CORO1C;DAPK3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.49994318078131356,-1.3350973344765416,0.11910669975186104,0.73201003893269,1.0,4/16,24.31%,CLDN5;CLDN11;CLDN1;CLDN14
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6473466524481788,1.3350886687969397,0.17975567190226877,0.8004023899498462,1.0,2/11,3.06%,ANXA1;SOCS5
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.625532359144576,1.334859112861291,0.18696397941680962,0.7994064100290349,1.0,3/13,4.75%,CACNA1H;SYT10;KCNB1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4669817445759044,1.3345854507760517,0.10783200908059024,0.7985353084918199,1.0,19/104,10.68%,ASPN;PRDM16;RBPMS2;VASN;CRIM1;FST;ACVR2A;TGFB1I1;BMPR1A;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI;VWC2L;UBE2D1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5733638133992004,1.3344869692860757,0.16055045871559634,0.797101777319812,1.0,2/27,1.23%,MAP3K20;MAP3K5
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.597149686000996,1.3343759199288525,0.15604026845637584,0.7956895128992902,1.0,4/18,6.86%,AGTR1;SIRT3;FXN;GDNF
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5341134176749865,-1.333723294614612,0.14666666666666667,0.734217033228515,1.0,5/12,16.54%,F3;APOD;SNCA;HGS;NDRG4
prerank,regulation of stress fiber assembly (GO:0051492),0.48282693331452964,1.3333666681781868,0.11524163568773234,0.7974508379678847,1.0,11/74,4.86%,TPM1;DLC1;ROCK1;SYNPO2L;FERMT2;PHLDB2;CLASP2;ACTG1;TGFB3;PPM1E;ARHGAP6
prerank,polyol biosynthetic process (GO:0046173),-0.5158688459560267,-1.3332872934473763,0.11822660098522167,0.73258422299825,1.0,9/16,25.06%,CYP27A1;IP6K1;ISYNA1;IP6K2;PPIP5K2;FGF2;ITPKB;IPPK;CYP2R1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6577921996677221,1.3323840717367554,0.19848771266540643,0.7991309439239183,1.0,4/11,7.86%,HEY2;JAG1;BMPR1A;TGFB2
prerank,protein import into mitochondrial matrix (GO:0030150),-0.48085141010785215,-1.3323525923649433,0.12694300518134716,0.7329970102619645,1.0,12/18,40.31%,TIMM44;DNAJC19;TIMM17B;TOMM70;TIMM21;TIMM23;GRPEL1;DNLZ;TOMM40L;TOMM40;TIMM50;GRPEL2
prerank,neural crest cell differentiation (GO:0014033),0.6048447191966662,1.3322744538047466,0.16693944353518822,0.797679879736331,1.0,5/18,11.68%,MEF2C;TAPT1;SNAI2;CDH2;HTR2B
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.5139148506894506,-1.3321845288778515,0.11738148984198646,0.7303944850503121,1.0,9/15,30.53%,USP46;STXBP1;NLGN1;SYN3;NLGN2;CLN3;DRD2;BAIAP3;CNTNAP4
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.6568236623679926,1.3315462223115304,0.17719298245614035,0.7965110460740209,1.0,3/11,10.24%,TRDN;CALM1;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.6568236623679926,1.3315462223115304,0.17719298245614035,0.7965110460740209,1.0,3/11,10.24%,TRDN;CALM1;SRI
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4981690835410132,-1.3313769977027217,0.13283208020050125,0.7302682413004987,1.0,6/16,18.64%,APPL2;APOD;ADCY7;PDCD4;SIRPA;ZC3H12A
prerank,oogenesis (GO:0048477),-0.49125877069725277,-1.3303091258146436,0.13819095477386933,0.7314737741261089,1.0,3/15,8.81%,PTN;MARF1;METTL3
prerank,regulation of endocytic recycling (GO:2001135),0.6480600710192119,1.3302695280924424,0.18297101449275363,0.7991666373312231,1.0,4/11,9.97%,PLA2G3;EHD2;ARHGAP1;ACTN2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6612968824664487,1.3297464428505572,0.18292682926829268,0.7991821803207154,1.0,3/11,6.96%,ARHGEF7;KANK1;CORO1C
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4377745613261246,-1.3291973572776965,0.12130177514792899,0.7326114917269622,1.0,11/26,22.94%,SPTLC2;ACER2;CYP1B1;NOS3;ASAH2;GCH1;AKT1;DDAH2;SPR;ABCA2;SPHK1
prerank,positive regulation of response to wounding (GO:1903036),0.5675650570396586,1.328789781283964,0.15501519756838905,0.8007016420166442,1.0,5/24,3.63%,MYLK;ANXA1;KANK1;ACTG1;ITGB1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6341709869089072,1.3285234768819356,0.1811722912966252,0.7998594132323854,1.0,2/12,2.86%,CD36;SLC5A3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5634690897805477,1.3282112815450158,0.1582089552238806,0.7991893688084731,1.0,6/27,8.61%,AGTR1;CD36;PLA2G3;LPL;ITGB3;PPARA
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.44179337239044325,-1.3280640339714533,0.125,0.733651256678771,1.0,12/24,31.53%,APOE;EPHA4;PTK2B;UBE3A;GPX1;NUB1;PSME3;UBB;PSME1;CTSC;USP14;PSME2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.3575028880587257,-1.32734851504835,0.04371584699453552,0.7332966608081593,1.0,24/69,18.63%,ECPAS;SEL1L;RNF185;UBXN4;UBQLN1;DNAJB12;DERL1;UFD1;HSPA5;DNAJC10;USP19;TRIM25;SGTA;UBE4B;STUB1;DNAJB2;HSP90B1;SGTB;OS9;UBQLN2;SYVN1;UBXN8;DNAJB9;HERPUD1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.48041227501683587,1.3271914247742467,0.11084043848964677,0.8010183254794074,1.0,16/75,11.23%,MEF2C;SDC2;MAP1B;CDHR1;SLITRK5;ACTB;KLF7;MEF2A;SLITRK4;AFG3L2;RAB3A;BRSK1;S100A6;TBCD;RB1;ZDHHC17
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.576698515284241,1.326848697872156,0.15477996965098634,0.800367086912544,1.0,7/25,10.84%,HIP1;BCAR3;NUP62;DOK1;NEU3;DGKD;GPER1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5742116464721281,1.3267621213448877,0.17142857142857143,0.7988924774178996,1.0,6/24,6.50%,ROCK1;LIMS1;FERMT2;MAPRE2;DUSP3;VEGFA
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6367769453004778,1.3263982102714613,0.18947368421052632,0.7984809031509046,1.0,4/13,3.63%,CD36;CDH13;LPL;ITGB1
prerank,cellular response to glucagon stimulus (GO:0071377),0.6062191770676337,1.3261825725408405,0.17862838915470494,0.7974902456778056,1.0,7/17,9.46%,ADCY5;ADCY2;ADCY9;CYSLTR2;PRKACB;PRKAR1B;ADCY6
prerank,chromosome condensation (GO:0030261),0.5369293013203607,1.3256681095171516,0.15096952908587258,0.7975720066688602,1.0,8/36,11.64%,TTN;H1-0;SET;NCAPD3;TENT4A;GPER1;RB1;NCAPD2
prerank,modulation by symbiont of host process (GO:0044003),-0.5748527705083326,-1.3256322458125431,0.12008733624454149,0.7364726094425538,1.0,7/10,30.62%,B2M;UBC;PGK1;HGS;UBB;ENO1;MRC1
prerank,regulation of hemopoiesis (GO:1903706),-0.5597338909508454,-1.324978751468531,0.12684989429175475,0.7358280655861084,1.0,2/10,0.40%,PTN;PRKCB
prerank,cAMP metabolic process (GO:0046058),0.6312742354357876,1.3245115142336519,0.20767888307155322,0.7999445445551062,1.0,6/13,11.18%,ADCY5;ADCY2;ADCY9;ADCY6;EPHA2;PDE4D
prerank,vascular transport (GO:0010232),-0.33804587665884767,-1.3242346353075074,0.07878787878787878,0.7355804711397049,1.0,25/81,10.48%,SLC24A3;ATP1A2;SLC6A13;LEPR;SLC16A12;SLC1A3;SLC13A3;LRP1;SLC22A8;ABCG2;SLC2A13;ATP8A1;SLC2A1;SLC12A2;SLCO2B1;SLC6A1;SLC6A6;SLC16A1;SLCO1C1;SLC7A5;SLC6A9;SLCO3A1;ABCC4;ATP1B2;SLC5A5
prerank,phosphatidic acid metabolic process (GO:0046473),0.5163880184287888,1.324045531545554,0.15816993464052287,0.7999176472551586,1.0,3/48,2.32%,DGKB;DGKG;PLA2G3
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.5340781432532543,-1.3239197173690342,0.14320388349514562,0.7335283036335335,1.0,9/13,39.21%,GAB2;STX4;LAMP1;SYK;AP1G1;ITGB2;ITGAM;FGR;SPHK2
prerank,positive regulation of vascular permeability (GO:0043117),0.6597372922775221,1.3236274425777474,0.1967509025270758,0.7997781221704664,1.0,2/12,1.26%,PDE3A;ANGPT1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.6158783475478602,1.3234991414389181,0.16910569105691056,0.7985081904949592,1.0,2/15,2.51%,FGF1;SEMA5A
prerank,triglyceride biosynthetic process (GO:0019432),-0.47488438926422555,-1.3232421703350576,0.12718204488778054,0.7329399687264321,1.0,6/18,18.53%,AGMO;LPGAT1;LPIN2;PCK2;GPAM;LPIN3
prerank,regulation of gastrulation (GO:0010470),0.6057090219078765,1.3228385196195729,0.19337979094076654,0.7989817277924739,1.0,2/14,2.63%,PHLDB2;CLASP2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6044592115197255,1.3225225191538241,0.18493150684931506,0.7982811090854313,1.0,2/16,6.50%,AGTR1;VEGFA
prerank,regulation of telomere maintenance (GO:0032204),-0.4364984454773004,-1.322126154015926,0.09855072463768116,0.7340576119629655,1.0,15/26,25.43%,XRCC5;SMG1;MRE11;PML;RAD50;USP7;GNL3;NBN;HNRNPD;TERF2IP;SMG6;YLPM1;ERCC1;ERCC4;TINF2
prerank,regulation of innate immune response (GO:0045088),-0.35181191550522084,-1.322063398779228,0.04672897196261682,0.7311687839166087,1.0,37/57,38.59%,APPL2;IFNAR2;PTPN11;RNF135;POLR3F;CASP8;HSP90AB1;BIRC2;PTPN22;IRAK3;SAMHD1;RIOK3;POLR3B;LRP8;APPL1;BIRC3;TIRAP;SLC15A4;GBP5;RNASEL;TRIM21;POLR3C;NLRC3;POLR3D;USP18;TNFAIP3;NMI;TYRO3;LYAR;PTPN6;PLSCR1;DHX58;ADAM8;XIAP;IRF1;FGR;FCGR2B
prerank,epithelial tube morphogenesis (GO:0060562),0.5367993142651053,1.3216665110373655,0.17903930131004367,0.7996013004112864,1.0,3/32,0.87%,RYR2;MEF2C;COL4A1
prerank,determination of heart left/right asymmetry (GO:0061371),0.5181719386903069,1.3215151300457775,0.15552523874488403,0.7983925582432518,1.0,3/42,1.52%,MEF2C;TBX2;MICAL2
prerank,synapse organization (GO:0050808),0.4567135935123867,1.3210897285655396,0.11602209944751381,0.7981150699849822,1.0,24/125,8.70%,CACNB2;MYOT;IGFN1;FZD5;PLXND1;SLC8A2;PDZRN3;MUSK;CACNB4;KIRREL3;PTPRS;DOK7;GPC4;PPFIBP2;PCDHB14;PTPRF;MAPT;DSCAM;PIN1;NEDD4;CYFIP1;PCDHB11;ARHGAP39;CDH2
prerank,positive regulation of gene expression (GO:0010628),0.4350509783141325,1.3202791645312022,0.022110552763819097,0.7991494628313868,1.0,52/442,8.44%,MYOM1;ACTA2;MYLK2;TTN;ACTG2;MEF2C;NTRK3;RBM24;HEY2;ACTA1;ANGPT1;ROCK1;FGF1;CD36;POLR2L;LIMS1;MYD88;PDGFB;VIM;GABPA;HINFP;SAMD4A;ACTG1;NAT10;MUSK;RBMS3;UBR5;ACTB;OSR2;SLC38A2;EMILIN1;DYRK1A;TESC;U2AF2;MYBBP1A;TP53;SLC2A10;VEGFA;RPS27L;CIRBP;AR;PPARGC1A;MED1;CELF1;YAP1;NAT8;ERCC6;C1QTNF1;SOX9;PYM1;CUX2;TENT4A
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.423978917680468,-1.3198147748396827,0.12413793103448276,0.7369659628588633,1.0,11/29,20.82%,SMAD3;AGO3;SRRT;PUM1;METTL3;ADAR;SMAD2;ZC3H7A;TUT4;TUT7;ZC3H7B
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.40908667090075546,-1.3197099628510276,0.09287925696594428,0.7342230005915815,1.0,10/31,11.77%,PDGFRA;HOXB3;HOXA3;DSCAML1;HOXB4;MEGF8;OSR1;FGFR2;SIX1;TGFBR1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5215146140600284,1.3185053679397043,0.14965034965034965,0.8035667683289716,1.0,15/37,18.37%,ROCK1;PHLDB2;CLASP2;BICD2;MAPRE2;MAPT;TPPP;CLASP1;STMN2;PRKAA2;MAPRE3;CDK2AP2;MARK2;BICD1;MAP6
prerank,neuronal action potential (GO:0019228),0.5677279625715288,1.3183345217929276,0.1873065015479876,0.8023638447542984,1.0,2/22,1.95%,SCN4A;CACNA1H
prerank,heterochromatin organization (GO:0070828),0.6271496490690084,1.3182082200927858,0.18855218855218855,0.8011109207824746,1.0,2/14,2.95%,PRDM16;LOXL2
prerank,cellular defense response (GO:0006968),0.5228135372569314,1.3180522717874321,0.14423076923076922,0.7999203735831233,1.0,5/40,7.89%,NCF2;LGALS3BP;ITGB1;VEZF1;RELA
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.48806862173582255,1.3176176784524865,0.15049751243781095,0.7997608799166708,1.0,16/65,12.03%,ARHGEF7;HIP1;ITGA1;CDH13;BCAR3;NUP62;DAB2IP;DUSP3;DOK1;NEU3;AREG;DGKD;HBEGF;STAM2;GPER1;TSG101
prerank,cell junction assembly (GO:0034329),0.4659521316806041,1.3175227800251732,0.1093210586881473,0.7983864521682545,1.0,19/100,8.70%,FLNA;CDH6;IGFN1;LIMS1;GJC1;FERMT2;FZD5;PLXND1;ACTG1;FLNC;KIRREL3;ACTB;CDHR3;PCDHB14;DSCAM;LIMS2;TLN1;PCDHB11;CDH2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.2931008397260238,-1.3174688876013707,0.02,0.7399783637891535,1.0,49/173,19.76%,SPTBN1;ANK2;SPTAN1;TGFA;DCTN4;CUL3;SPAST;PROS1;CAPZA1;DYNC1I1;KLHL12;DYNC1LI2;USO1;CD55;GBF1;VTI1A;TMED5;KDELR1;NRBP2;STX5;ERGIC3;TMED7;TMED10;COPB2;COG6;ARFGAP2;SEC24B;RAB2A;ACTR10;MCFD2;ARFGAP1;COPE;TRAPPC11;ARFGAP3;RAB1A;RAB29;F8;YKT6;LMAN1;COG7;COG2;TMED3;SCFD1;TRIP11;RAB1B;TRAPPC3;TFG;TMED4;MIA3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4844601392770539,-1.3169631496981316,0.1260053619302949,0.7386753120302411,1.0,10/17,19.76%,ROBO1;EFNB2;SLIT2;NRP1;PIK3R3;KDR;AKT1;FGF2;EPHB4;MIA3
prerank,regulation of cell adhesion (GO:0030155),0.44937873489373126,1.3165081412671136,0.10078387458006718,0.8001471332019856,1.0,20/129,6.97%,TPM1;PPP1R12A;ZFHX3;ANGPT1;ROCK1;PPP3CA;SEMA5A;PLXND1;PLXNB1;CDH13;CYTIP;CCL5;RSU1;ARHGDIG;TESC;CBLL1;ZDHHC2;DSCAM;VEGFA;YTHDF2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6190078213552495,1.3164228101575908,0.20714285714285716,0.79876407720337,1.0,9/13,19.53%,UBA2;ATG7;SAE1;UBA3;SENP6;UBA1;DESI2;DESI1;ATG10
prerank,keratan sulfate metabolic process (GO:0042339),-0.41758378280928077,-1.3163941431405026,0.10819672131147541,0.7378870065510674,1.0,15/31,23.36%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL1;B4GALT6;ST3GAL3;HEXA;FMOD;B4GALT4;GALNS;CHST2;SLC35D2;OMD;B3GNT2;B4GALT3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.49536148508983635,-1.3160063991242874,0.15,0.7362916503255797,1.0,7/15,18.63%,SEL1L;DERL1;UFD1;HSP90B1;OS9;SYVN1;HERPUD1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.453798854411402,-1.3154493207020745,0.11506849315068493,0.7353159390023989,1.0,14/21,35.39%,COA8;COX10;COX20;SMIM20;COX14;TIMM21;BCS1L;COX17;COX16;COA3;SURF1;COA6;COX18;FASTKD3
prerank,positive regulation of hydrolase activity (GO:0051345),0.4511744224683904,1.3136837574667986,0.10784313725490197,0.8068982691390749,1.0,23/137,8.17%,ARHGEF7;RAP1A;RGS6;LIMS1;RASGRP2;FERMT2;DOCK8;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;LARS1;MAPRE2;PIN1;CD200;CALM1;RAPGEF6;RASGRP1;EVI5
prerank,cell junction organization (GO:0034330),0.4857309143540573,1.3132175037315184,0.13242574257425743,0.8066946537210512,1.0,14/71,7.86%,FLNA;MYOT;LIMS1;FERMT2;SLC8A2;ACTG1;TGFB3;FLNC;ACTB;PPFIBP2;MAPT;LIMS2;PIN1;TGFB2
prerank,axon guidance (GO:0007411),0.4379566440851062,1.313120805538675,0.06969376979936642,0.805260053219424,1.0,26/201,7.09%,NTN4;NEXN;SLIT3;SLIT1;NOTCH3;PALLD;ENAH;MYPN;ROBO3;LAMA5;SEMA5A;PLXND1;PLXNB1;NTN1;PDLIM7;CHN1;SEMA6C;KLF7;PRKCQ;DOK4;DSCAM;DOK2;VEGFA;DOK1;GDNF;CYFIP1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.4114919090797598,-1.3131176680318462,0.10891089108910891,0.7414122260740534,1.0,22/33,37.60%,STN1;MRE11;HSP90AB1;RAD50;ANKRD28;CTC1;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;DCLRE1B;GAR1;TINF2;PPP6C;NOP10;ZBTB48;ACD;RAD51;RPA1;RFC1;NHP2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.5095965159618908,1.3130174223735593,0.16326530612244897,0.803982250322412,1.0,4/47,6.81%,SERPINB8;SERPINI1;SERPINE2;TIMP4
prerank,protein glycosylation (GO:0006486),-0.32093516728662475,-1.3129738083352025,0.06756756756756757,0.7388837141807716,1.0,45/125,25.73%,MAN1C1;ST3GAL4;TUSC3;MGAT4C;B4GALT1;ST3GAL6;ST8SIA4;ST3GAL1;GALNT10;ST3GAL5;ST8SIA1;TET3;MGAT1;PGM3;SLC39A8;SERP2;FUT8;MGAT4B;TET2;ENTPD5;ST3GAL3;FUT10;OGT;ST8SIA2;B3GALNT1;PLOD2;MGAT5;PMM2;COG7;B4GALT7;ALG1;PLOD3;ALG12;B3GNT2;POMT1;B3GALT2;GFPT2;RPN2;NPC1;EOGT;MGAT2;DPM3;MGAT4A;SERP1;STT3B
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.48804962466492885,-1.3119235539455845,0.11650485436893204,0.7398694100579937,1.0,4/18,5.54%,PRKCB;PRKAG2;SLC2A1;OCLN
prerank,regulation of vasculogenesis (GO:2001212),0.6247322432769364,1.311826084059961,0.18485915492957747,0.8064766141339228,1.0,4/14,8.34%,RAP1A;HEY2;RRAS;RIN2
prerank,protein localization to cell periphery (GO:1990778),0.45364739382416225,1.3114629825468616,0.11135371179039301,0.8059541685186798,1.0,40/133,16.59%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;CAV1;TTC7A;RAB3A;RAMP1;RAPGEF6;LIN7C;EPHA2;RAP2A;ACTN2;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;TSPAN17;RAB34;RAB8B;FLOT1;PRAM1;ANK1;LIN7A;SMURF1;RAB8A
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6214913514306072,1.310463393297412,0.20242214532871972,0.8077482968560362,1.0,6/13,7.03%,MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.510364944471475,1.3103959787503414,0.1640625,0.8063034719043484,1.0,8/49,8.05%,MYL9;MEF2C;THPO;CBFB;CNOT4;PRKCQ;TESC;KMT2D
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.34790766014686775,-1.3103830279875306,0.07920792079207921,0.7429041654982953,1.0,18/61,17.42%,EYA2;EYA1;EYA4;HMGB1;EGFR;MRE11;PML;RAD50;PARP3;USP7;SMCHD1;BRCC3;RGCC;GNL3;NBN;FGF2;NPAS2;WRAP53
prerank,cellular response to virus (GO:0098586),-0.40815521434547053,-1.310281867775344,0.12883435582822086,0.740357542814626,1.0,12/30,18.65%,MAPK14;DDX3X;GSDME;LGALS9;GBF1;RIOK3;CHUK;IRGM;LGALS8;BAX;ZC3H12A;FMR1
prerank,presynaptic endocytosis (GO:0140238),-0.42986162191579524,-1.3102444829971176,0.12968299711815562,0.7375568679098051,1.0,10/24,16.01%,FCHO2;NLGN1;SYT1;CANX;STON2;OPHN1;SNCA;NLGN2;NLGN3;STX1A
prerank,negative regulation of hippo signaling (GO:0035331),0.6254437819562069,1.3097857893154954,0.1973018549747049,0.8068060080317013,1.0,2/12,1.88%,WTIP;LIMD1
prerank,negative regulation of hemostasis (GO:1900047),-0.5384673489822684,-1.3097466437539387,0.16859122401847576,0.7366412273349298,1.0,5/12,8.27%,APOE;VTN;TFPI;CD34;THBD
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4450810013702529,1.309642369070934,0.10287610619469026,0.8056115513883394,1.0,33/140,11.60%,OBSCN;ARHGEF7;DLC1;KALRN;ABR;PLCE1;ARHGEF17;MYO9B;DEPDC1B;ITSN1;NET1;NUP62;ARHGAP21;ARHGAP10;ARHGEF16;CHN1;ARHGAP6;ARHGEF2;ARHGDIG;RHOJ;ARHGAP17;RHOF;ARHGAP39;ARHGAP30;ARHGEF4;ARHGAP1;ARHGAP12;VAV1;INPP5B;ARHGAP15;ARHGAP5;RHOH;ARHGAP35
prerank,protein localization to cell junction (GO:1902414),-0.451119391937475,-1.3093576050444353,0.12605042016806722,0.735080108486474,1.0,9/22,15.29%,TJP1;CGNL1;TJP2;HEG1;NLGN1;NECTIN1;ARHGEF18;NLGN2;PCLO
prerank,estrogen metabolic process (GO:0008210),0.6197064437572872,1.3083787928219206,0.18466898954703834,0.8083114788120132,1.0,3/15,5.63%,HSD17B10;HSD17B7;HSD17B4
prerank,regulation of neuron differentiation (GO:0045664),0.47063358066439553,1.308219471737076,0.13493975903614458,0.8071473628129505,1.0,7/76,5.09%,NTF3;MEF2C;ZFHX3;ROCK1;HEYL;MMD;ARHGEF2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5355261970852627,1.3078092963066184,0.1569767441860465,0.807063567856217,1.0,13/33,19.07%,MAP3K5;ANXA1;NET1;FXN;RELA;IMPACT;PRKCD;TRPM2;PLEKHA1;ANKZF1;SIGMAR1;HDAC6;ABL1
prerank,mesenchyme morphogenesis (GO:0072132),0.5845023684093384,1.3072108228652812,0.19224555735056542,0.8074949962633919,1.0,5/17,7.86%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,sphingosine metabolic process (GO:0006670),-0.4846608369774624,-1.3069471520547247,0.13367609254498714,0.7415022576784963,1.0,5/17,9.94%,SPTLC2;ACER2;NAAA;SGPP1;ASAH2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6300651715518466,1.3065869409352802,0.19262981574539365,0.8080058778888746,1.0,6/14,14.92%,PMAIP1;IRS1;PPARGC1A;ARPP19;NNMT;IRS2
prerank,peptidyl-amino acid modification (GO:0018193),-0.5557925059258859,-1.305052296028186,0.1575492341356674,0.7457348857041247,1.0,3/10,11.03%,METAP1D;TTLL4;FKBP10
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.6486744087252161,1.3030001368445052,0.20863309352517986,0.8188585305197383,1.0,1/11,0.93%,AKAP6
prerank,positive regulation of axonogenesis (GO:0050772),-0.3810890005625853,-1.302948532770909,0.10067114093959731,0.7509689388970223,1.0,9/43,8.24%,PLXNA2;ROBO1;SLIT2;SEMA7A;RUFY3;TIAM2;GOLGA4;SEMA4D;PLXNA4
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.47303765455464025,1.3025378577662132,0.14047619047619048,0.8188511328146965,1.0,14/75,11.28%,MYOCD;SLC8A1;NR2F2;DAB2IP;PKIB;HEXIM1;PTPN1;PKIA;CD300A;PRKAR1B;GSTP1;RB1;LRP5;PRKCD
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5460292379114133,-1.3025028299287933,0.16930022573363432,0.7496348544831422,1.0,10/11,44.05%,PARP11;PARP10;PARP3;PARP14;PARP12;PARP4;PARP16;PARP6;PARP8;PARP9
prerank,positive regulation of protein binding (GO:0032092),-0.36608952564948327,-1.3021538308012224,0.08597285067873303,0.7479935339809128,1.0,15/56,10.06%,LRP1;TCF7L2;BMP4;APOE;APP;VTN;B2M;PPP2CA;NVL;CLDN5;PPP2CB;DERL1;NMD3;FKBP1A;PRKN
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5335263768193166,1.301821014574312,0.16988950276243095,0.8196717203916619,1.0,6/33,6.51%,ATP2B4;TCIM;FAM83D;MN1;TAF1;FBXW7
prerank,amino sugar metabolic process (GO:0006040),0.6391949947623174,1.3016200619714373,0.19826086956521738,0.8186528134728867,1.0,4/10,10.21%,CSGALNACT1;GNE;GFPT1;ST6GAL1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5202156166307675,1.3003628865853114,0.1721194879089616,0.82156090061787,1.0,6/36,6.25%,MEF2C;ATP2B4;ANGPT2;ANGPT4;NR2F2;DAB2IP
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5115069239160168,1.3001766168930429,0.17623497997329773,0.8205348317952207,1.0,2/46,0.44%,DGKB;DGKG
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4615560373371523,-1.3001246494986598,0.12365591397849462,0.7529602145113122,1.0,5/20,4.13%,NBL1;GLI2;PTCH1;DSCAML1;ACVRL1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5544764810033191,-1.2995660581066182,0.15521064301552107,0.7520131411659992,1.0,4/10,12.71%,UFD1;SEC14L1;RIOK3;RNF125
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.45579889289934694,1.298455558655224,0.12485811577752554,0.8247811351117502,1.0,23/102,11.28%,LHCGR;SLC2A4;ADCY5;ADCY2;NR4A1;ADCY9;HDAC9;TSHR;CYSLTR2;IRS1;CAV1;SORBS1;CPEB1;PARP1;GOT1;RELA;PRKACB;PRKAR1B;NR4A2;ADCY6;SLC39A14;GPER1;PRKCD
prerank,necroptotic process (GO:0070266),0.5895179926078263,1.297128552154807,0.20294599018003273,0.8278542931833682,1.0,3/16,10.73%,ITPK1;CD14;DNM1L
prerank,hexose transmembrane transport (GO:0008645),0.5626499966150954,1.2970365798451866,0.19440124416796267,0.8265101407659154,1.0,3/21,6.45%,SLC2A4;SLC5A3;SLC2A10
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.4383732395243475,-1.2962526538430117,0.14730878186968838,0.7620726971146411,1.0,8/25,5.55%,FOXD1;SULF1;ZNF423;BMP4;CDH5;ENG;ACVRL1;BMPR2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3868208410476932,-1.2956690898797012,0.14814814814814814,0.7615465436163619,1.0,15/39,21.40%,BMP6;WNK1;NF2;PTK2;PODXL;CDH1;FXYD5;RDX;TGFB1;RGCC;PPM1F;AKT1;NOTCH4;MIA3;ASS1
prerank,Golgi inheritance (GO:0048313),-0.5378783493858854,-1.2949768928053726,0.16331096196868009,0.7612276482504025,1.0,6/11,23.80%,GBF1;STX5;VCPIP1;STK25;YWHAZ;PLK5
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5377530793686216,1.2947741596669726,0.17655786350148367,0.8328954342727487,1.0,15/28,20.86%,CLASP2;MAP1B;PRUNE1;MAPRE2;MAPT;CLASP1;STMN2;MAPRE3;FKBP4;MAP1A;MAP1S;ABL1;CAMSAP1;STMN3;MAPRE1
prerank,negative regulation of developmental growth (GO:0048640),0.5422209965706251,1.293633438796087,0.1897590361445783,0.8351689629254028,1.0,3/30,4.99%,FGF13;NKD1;PTPRS
prerank,negative regulation of peptidase activity (GO:0010466),0.49831771623836973,1.2934688114444153,0.17825537294563842,0.8340726253743357,1.0,4/47,6.81%,SERPINB8;SERPINI1;SERPINE2;TIMP4
prerank,sodium ion transport (GO:0006814),0.4634100403906405,1.2927138822099542,0.14911242603550295,0.8350468052214804,1.0,10/85,3.95%,FGF13;SCN4A;ASIC3;SLC6A17;ANO6;SLC8A2;SLC8A1;SLC4A8;SLC6A2;SLC6A5
prerank,polyol metabolic process (GO:0019751),0.5005497675518848,1.2915230624204663,0.16853932584269662,0.8375337442503162,1.0,13/46,12.09%,ITPK1;PLCE1;INPP4B;PLCB4;SLC5A3;INPP5A;NUDT4;CALM1;PLCB1;INPPL1;PLCD1;INPP5B;ITPKC
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.36857241805787755,-1.2911173099619127,0.124,0.7732415675021028,1.0,17/46,15.11%,ATP1A2;TSHZ3;GRM3;GRM7;NLGN1;PTK2B;SHANK3;SYT1;DGKI;CACNG4;NRXN1;GRIK3;OPHN1;GRM5;NLGN2;NLGN3;CLN3
prerank,negative regulation of leukocyte migration (GO:0002686),0.6532624112956015,1.2907938532495529,0.2109090909090909,0.8383798480023545,1.0,4/10,8.34%,EMILIN1;CD200R1;CD200;CD300A
prerank,cAMP biosynthetic process (GO:0006171),0.6427708718881281,1.2902753405378133,0.2199630314232902,0.8386007786777359,1.0,4/10,9.46%,ADCY5;ADCY2;ADCY9;ADCY6
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4927348270848662,1.288859645411396,0.18324607329842932,0.841883506424274,1.0,6/54,2.09%,MEF2C;ATP2B4;ANGPT2;ANGPT1;ANGPT4;PDGFB
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6077597825217459,1.2888249840446113,0.21754385964912282,0.840344255867307,1.0,3/13,5.14%,MEF2C;TBX2;BMPR1A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6006017899759833,1.2869582122254324,0.20168067226890757,0.8451539829944038,1.0,2/14,7.40%,AGTR1;ENPEP
prerank,macrophage differentiation (GO:0030225),-0.5076312438093846,-1.286726226230122,0.18706697459584296,0.7873506634528503,1.0,4/13,7.13%,IL31RA;IL15;BMP4;CASP8
prerank,intestinal lipid absorption (GO:0098856),0.6400962536303829,1.2866620221140115,0.22099447513812154,0.8445614555816313,1.0,1/11,1.72%,CD36
prerank,presynapse organization (GO:0099172),-0.557880620880755,-1.2859210678351647,0.1935483870967742,0.7876828266689495,1.0,4/10,14.47%,WNT5A;NLGN1;NLGN2;NLGN3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5085401538358942,-1.2855313519713771,0.15914489311163896,0.7860067076603163,1.0,10/13,44.78%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;GAL3ST3;B3GNT6;B4GAT1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.43922779933036343,-1.2849729086355688,0.15476190476190477,0.7851894816433338,1.0,7/23,11.47%,PRKAG2;CEMIP;BMP7;APP;WNK3;TGFB1;IRGM
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5528046671749766,-1.2845219613041274,0.15418502202643172,0.7838840394118141,1.0,2/10,7.11%,WNT5A;CTNNB1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.39911956132285276,-1.2830809926773117,0.11464968152866242,0.786620795115599,1.0,16/32,26.51%,CDC14B;MRE11;RINT1;BRCC3;BLM;NBN;TAOK1;FOXN3;NOP53;ATM;HMGA2;TAOK2;TRIM39;CLSPN;CDKN1A;DONSON
prerank,regulation of platelet aggregation (GO:0090330),0.5714121116218547,1.2824932146639347,0.18433931484502447,0.857425465287925,1.0,7/17,14.87%,PRKG1;SERPINE2;PRKCQ;C1QTNF1;PRKCD;DMTN;PRKCA
prerank,axonogenesis (GO:0007409),0.42281342019760043,1.2821557248340263,0.08618899273104881,0.8568906322964581,1.0,27/237,7.09%,NTN4;NEXN;SLIT3;SLIT1;NOTCH3;PALLD;ENAH;MYPN;ROBO3;LAMA5;SEMA5A;MAP1B;PDLIM7;SLITRK5;ACTB;SEMA6C;KLF7;PRKCQ;SLITRK4;DOK4;DSCAM;DOK2;AFG3L2;DOK1;GDNF;RAB3A;CYFIP1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5256773281609756,-1.281998307635215,0.16519823788546256,0.7848489519563554,1.0,5/11,27.84%,AGO3;TNRC6A;NOTCH4;AGO4;ZFP36
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.5256773281609756,-1.281998307635215,0.16519823788546256,0.7848489519563554,1.0,5/11,27.84%,AGO3;TNRC6A;NOTCH4;AGO4;ZFP36
prerank,catecholamine biosynthetic process (GO:0042423),-0.5322766047845886,-1.281314881654657,0.17130620985010706,0.784520790471094,1.0,4/11,18.31%,MOXD1;SNCA;GCH1;DDC
prerank,cell-cell junction assembly (GO:0007043),0.4732280368392645,1.2812705411973901,0.17223650385604114,0.8582571747313849,1.0,15/63,11.42%,CDH6;VCL;GJD3;GJC1;WDR1;ACTG1;ACTB;JAM3;CDHR3;TLN1;CDH2;PKN2;PAK2;TBCD;GJA4
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4938722719914309,-1.2800994227661615,0.16105769230769232,0.7861186797461609,1.0,4/15,6.92%,APOE;APP;LDLR;IAPP
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5012007258250798,-1.2800786729995937,0.17674418604651163,0.783306235787398,1.0,2/14,0.77%,ANK2;ATP1B3
prerank,regulation of lipid metabolic process (GO:0019216),0.45459753022099786,1.2799448083870686,0.16125290023201855,0.8613158923770045,1.0,19/88,15.94%,CCDC3;SMARCD3;ANGPTL8;RORA;RARRES2;CAV1;ACACB;IDI1;MED1;MVD;PPARA;NR1D1;SREBF2;TGS1;ZFP69;EDF1;IRS2;SIN3A;SP1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.4106595941020938,-1.279910558958769,0.14046822742474915,0.7811165018809925,1.0,11/30,19.27%,DDX3X;TNFSF10;CASP8;BCL2L1;NOS3;RNF34;FAIM;GPX1;SERPINE1;TMBIM1;PARK7
prerank,mitochondrion disassembly (GO:0061726),-0.3907868116870965,-1.2796986797432386,0.15358361774744028,0.7789556066180416,1.0,20/34,28.28%,RB1CC1;CISD2;ATG3;FBXO7;ATG5;PRKN;ATG2B;AMBRA1;WIPI2;ATG2A;FIS1;GABARAPL2;WDR45B;MAP1LC3A;ULK2;GABARAPL1;WIPI1;SQSTM1;MAP1LC3B;ATG12
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4633482346468358,1.2785862952532858,0.15450121654501217,0.8643374858515829,1.0,6/73,6.50%,NTF3;NTRK3;ATP2B4;BCAR3;CAV1;VEGFA
prerank,Golgi to plasma membrane transport (GO:0006893),-0.36486996172976577,-1.2784325678744566,0.08658008658008658,0.7809304745648712,1.0,12/47,17.50%,SPTBN1;VAMP5;RABEP1;GOLGA4;COMMD1;OPTN;GCC2;GOLPH3;BLZF1;EXOC2;STEAP2;EXOC1
prerank,sterol metabolic process (GO:0016125),-0.3498727697752004,-1.2779103170133626,0.08333333333333333,0.7802705615553658,1.0,33/60,36.88%,PRKAG2;CYP27A1;APOE;ABCA1;LBR;CYP26B1;CYP1B1;CYP51A1;HMGCR;SOAT1;ARV1;INSIG1;PIP4P1;SQLE;GBA2;PMVK;LIPA;FDXR;CLN8;RXRA;INSIG2;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;SC5D;TM7SF2;SCAP;DHCR7;CH25H;LCAT
prerank,monosaccharide transmembrane transport (GO:0015749),0.5859824427940109,1.2778966744437454,0.22115384615384615,0.8651578882981718,1.0,4/16,8.03%,SLC5A3;SLC2A10;SLC23A2;SLC23A1
prerank,negative regulation of neuron death (GO:1901215),0.4542922895698416,1.2773980240330132,0.1598119858989424,0.8652520877682519,1.0,13/93,7.62%,NTF3;MEF2C;PLA2G3;CRLF1;TGFB3;INPP5A;SET;BCL2;CD200R1;GDNF;CD200;PPARGC1A;FZD9
prerank,histone monoubiquitination (GO:0010390),-0.42877768061490495,-1.2772643766969343,0.15472779369627507,0.7800138466258506,1.0,7/24,16.65%,RNF20;RYBP;CTR9;DDB1;DTX3L;LEO1;BCOR
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4559064862635904,1.2771303224004404,0.16090584028605484,0.8644867905270373,1.0,13/90,7.65%,PRDM16;PRKAB2;CD36;PDGFC;EBF2;TSHR;CAV1;VEGFA;TRPV2;FABP4;PPARGC1A;PPARGC1B;DIO2
prerank,gliogenesis (GO:0042063),0.590400432897269,1.277067724080008,0.21247892074198987,0.86299892057648,1.0,5/15,11.79%,CDK6;ANXA1;TGFB2;CDH2;NDUFS2
prerank,negative regulation of microtubule polymerization (GO:0031115),0.6155246413940093,1.2768468529525596,0.2310405643738977,0.8620932817414444,1.0,5/12,14.26%,ARHGEF7;DYRK1A;TBCD;CLIP3;STMN2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6414345212237071,1.2765936988376654,0.2210144927536232,0.8613207774827383,1.0,1/10,0.13%,PLN
prerank,positive regulation of mitochondrial translation (GO:0070131),0.6047747582024805,1.2763660252872762,0.2170138888888889,0.860510492025562,1.0,9/14,20.37%,RPUSD3;TRMT10C;RCC1L;RPUSD4;FASTKD2;TRUB2;RMND1;UQCC2;C1QBP
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.42425182607703077,-1.2761298488794326,0.1305732484076433,0.7814863515662755,1.0,17/29,28.65%,DCPS;LSM1;DIS3;EXOSC1;DCP2;EXOSC9;EDC4;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;EXOSC5;LSM3;LSM6
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4895449138706613,1.2734174152175781,0.18315508021390375,0.869289138896691,1.0,5/44,3.74%,TPM1;SYNPO2L;FERMT2;TGFB3;PPM1E
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.4644940962013294,-1.272394055645823,0.18407960199004975,0.7932459332314556,1.0,5/19,18.64%,IGF1;PYDC1;CX3CL1;GIT1;ZC3H12A
prerank,membrane assembly (GO:0071709),-0.3947035526294651,-1.272360011890076,0.1611842105263158,0.7905219362471031,1.0,10/34,15.07%,SPTBN1;ANXA2;SPAST;NLGN1;STX4;PTPRD;NRXN1;NLGN2;NLGN3;S100A10
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3996046890800163,-1.2723259550404757,0.13261648745519714,0.787813148825517,1.0,13/33,16.01%,DNM3;FCHO2;DNAJC6;NLGN1;SYT1;CANX;DNM1;STON2;OPHN1;SNCA;NLGN2;NLGN3;STX1A
prerank,regulation of synapse organization (GO:0050807),0.5346315953363002,1.2721733959762787,0.20615384615384616,0.8720012255805747,1.0,6/26,11.33%,MEF2C;PDLIM5;SLITRK4;NEDD4;ABHD17B;IL1RAPL1
prerank,neuromuscular process (GO:0050905),-0.47945790397913446,-1.271975261135196,0.17359413202933985,0.7864017669785384,1.0,7/16,25.87%,MYCBP2;PAFAH1B1;NRXN1;GCH1;CLN3;TPP1;UBA5
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6322036428261809,1.2715961417090262,0.2333931777378815,0.8721830474624763,1.0,4/10,14.21%,GALNT16;GALNT3;GALNT2;GALNT1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.590844927258257,1.2715676756019998,0.20862068965517241,0.8706230005755727,1.0,5/16,8.04%,MEF2C;RBM24;SMYD1;BTG1;PLCB1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.3527619656042831,-1.2714170160435294,0.11914893617021277,0.7857346949295334,1.0,24/58,25.05%,HMGB1;KDM2A;PRKDC;XRCC5;MRE11;RAD50;HERC2;BRCC3;LIG3;MDC1;POLM;XRCC6;NBN;SMC5;ATM;DCLRE1A;IFFO1;UVRAG;NSMCE2;PRPF19;SMARCAL1;ERCC1;ERCC4;DCLRE1B
prerank,regulation of gluconeogenesis (GO:0006111),-0.4046120126379813,-1.2712641850191793,0.13719512195121952,0.7834971983783766,1.0,12/27,23.13%,CRY1;USP7;SIRT7;SIK1;DDB1;OGT;EP300;DGKQ;C1QTNF3;PTPN2;CLK2;PGP
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5895611708934634,1.2708504000023753,0.209106239460371,0.8715580722570946,1.0,5/17,7.71%,HEY2;HEYL;JAG1;BMPR1A;SNAI2
prerank,negative regulation of JNK cascade (GO:0046329),-0.40249528576051524,-1.270419220234955,0.1461038961038961,0.7838419598938017,1.0,13/31,24.17%,MECOM;ITCH;PTPN22;PRKN;PDCD4;SIRPA;SH3RF2;PER1;AIDA;HIPK3;DACT1;MAPK8IP1;CYLD
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.34792656653071635,-1.2698101078952715,0.10714285714285714,0.7834043094477937,1.0,14/57,12.18%,IGF1;IL31RA;IL15;KIT;GHR;NF2;IL18;PPP2CA;ARL2BP;TNFRSF1A;IL6R;HES1;LYN;PARP14
prerank,cellular response to hormone stimulus (GO:0032870),0.46973772293453986,1.2695871509578036,0.17135862913096694,0.8742941832770961,1.0,9/69,7.29%,SLIT3;LHCGR;MEF2C;CACNA1H;CAV1;ARID5A;AR;RAMP1;MED1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4250198123151636,-1.2689362349277444,0.14619883040935672,0.7839188126106493,1.0,6/23,9.36%,UACA;BMP7;DDX3X;PPM1B;HDAC7;CCN3
prerank,actin polymerization or depolymerization (GO:0008154),0.4944370108184144,1.2688314302339705,0.17829457364341086,0.8753568481161489,1.0,7/50,8.53%,ENAH;DSTN;MICAL2;WDR1;ARHGAP6;CFL2;SPIRE1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.38152772307465205,-1.2685623310726066,0.11016949152542373,0.7825462797930647,1.0,14/39,11.13%,PIK3CA;PI4KA;PIK3R3;IP6K1;EFR3A;SMG1;SOCS7;PIP4K2B;PI4K2A;SOCS2;EFR3B;PIK3CB;TTC7B;IP6K2
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5490724107219231,1.2682783355872649,0.21293375394321767,0.875527071372378,1.0,4/22,5.51%,NR1H4;MYD88;IL2;PRKCQ
prerank,negative regulation of secretion (GO:0051048),0.6221291660389167,1.2679562446258068,0.24904214559386972,0.8749911089717806,1.0,1/10,1.47%,PTGER3
prerank,somite development (GO:0061053),-0.5245116898913728,-1.2673575551181833,0.18028846153846154,0.7845186839100743,1.0,5/11,26.30%,PTCH1;MEOX2;SMO;LOXL3;SOX11
prerank,regulation of receptor binding (GO:1900120),0.6430581541138871,1.266954137546728,0.23943661971830985,0.8766897623224739,1.0,4/10,10.32%,ATP2A2;GREM2;PTPRF;ATP2A3
prerank,protein localization to plasma membrane (GO:0072659),0.43448923368423675,1.2662839398711223,0.1511500547645126,0.8773320239582224,1.0,18/129,7.19%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;TTC7A;RAB3A;RAMP1;RAPGEF6
prerank,regulation of cholesterol esterification (GO:0010872),0.6194040571180515,1.2660463809172524,0.2634508348794063,0.8764648371650984,1.0,1/10,0.46%,AGTR1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.3906213730528759,-1.2656547147110695,0.11643835616438356,0.7882507914196937,1.0,16/33,28.23%,NEDD4L;STX3;GBF1;CTNNB1;HSP90AB1;STX4;COMMD1;RAB11FIP5;ABCA2;RIC3;LEPROTL1;KCNAB2;TOR1A;HFE;EGF;TAX1BP3
prerank,regulation of protein export from nucleus (GO:0046825),-0.42808214147668106,-1.2655087336856603,0.15466666666666667,0.7860625061613175,1.0,8/23,14.82%,PTPN14;TCF7L2;CAMK1;UHMK1;SIRT7;RANGAP1;SP100;EMD
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.42383249806280254,-1.265113542318316,0.1504424778761062,0.7848301029886641,1.0,13/26,23.36%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL1;B4GALT6;ST3GAL3;FMOD;B4GALT4;CHST2;SLC35D2;OMD;B3GNT2;B4GALT3
prerank,regulation of myotube differentiation (GO:0010830),0.5335363263718641,1.2650086683345358,0.19825072886297376,0.8785280293746466,1.0,3/24,4.11%,RBM24;SMYD1;HDAC9
prerank,blood vessel morphogenesis (GO:0048514),-0.35218324920726846,-1.264085181223605,0.0958904109589041,0.7859022323097171,1.0,20/54,14.31%,TGFBR3;FLT1;NF1;EFNB2;LAMA1;CCBE1;RASA1;NRP1;ENG;ID1;CYP1B1;RASIP1;CUL7;TGFB1;HES1;ITGB8;TGFBR1;RAMP2;KDR;SOX17
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4267804053969466,1.2640384459314848,0.1362162162162162,0.8802935475658694,1.0,20/152,9.65%,LHCGR;PTGER3;ADCY5;CRHR2;S1PR3;HTR1B;NPY1R;ADCY2;VIPR2;ADRA1D;ADCY9;TSHR;GNAO1;GNAZ;RAMP1;PRKACB;GNA12;PTH1R;ADCY6;ADGRL2
prerank,ear morphogenesis (GO:0042471),-0.4448397199688548,-1.2637612567930971,0.1443850267379679,0.7844910606306957,1.0,9/20,26.21%,ZIC1;CHD7;OSR1;FGFR2;SIX1;MYO6;EPHB2;PAX8;TWIST1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.48191110337086585,-1.2637425325385154,0.18586387434554974,0.781895449270253,1.0,5/15,23.38%,EDA;GLI2;HDAC2;WNT6;ANKRD11
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5408131563744488,-1.262883811765924,0.18421052631578946,0.7823597404851331,1.0,3/10,9.30%,ADGRV1;WHRN;IFT88
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.402781872118509,-1.262715012492355,0.15644171779141106,0.780342235182746,1.0,10/30,19.68%,SDF2;DNAJB12;HSPA5;ENTPD5;BAG1;HSPA13;HSPA9;HSPE1;DNAJB4;ST13
prerank,lipoprotein catabolic process (GO:0042159),-0.5220063850763353,-1.2625405825644738,0.19495412844036697,0.7784682887261184,1.0,8/11,31.36%,APOE;LYPLA1;PPT1;NOTUM;ABHD17C;LYPLA2;CTSD;ABHD10
prerank,T cell migration (GO:0072678),-0.49463900007339706,-1.2624793384277666,0.1784037558685446,0.7760885422400168,1.0,2/13,6.66%,SLC12A2;CXCL16
prerank,regulation of myoblast differentiation (GO:0045661),0.515545818941457,1.2621729633454908,0.20605187319884727,0.8852148823036153,1.0,7/32,8.04%,MEF2C;RBM24;SMYD1;ANKRD2;BTG1;SOX9;PLCB1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.44763531886131336,1.2621393093546125,0.15895610913404506,0.8836775231243092,1.0,21/88,15.51%,SYNPO2;SYNPO2L;EMILIN1;MPP7;TPPP;DAB2IP;VEGFA;TRABD2B;PLEK;SLX4;SYNPO;HRK;STX18;TSG101;CLU;FNIP2;CHMP2A;HYAL1;PRKCA;STAM;FLOT1
prerank,activation of protein kinase activity (GO:0032147),0.4406133679757072,1.2618183383881958,0.15600448933782268,0.8832561782949014,1.0,25/106,13.74%,NTF3;NTRK3;ANGPT1;FGF1;ADCY5;PDGFB;ADCY2;ADCY9;VEGFA;TPX2;PIBF1;ITGB3;TGFB2;PRKACB;PRKAR1B;PAK2;ADCY6;PRR5;PRKCD;COPS8;RICTOR;TNIK;TAOK3;GAS6;TNFRSF10B
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.44204042576860036,-1.2616984077286475,0.19602977667493796,0.776272472554318,1.0,7/20,11.11%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;SEMA3A;SEMA4D;SEMA6D
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.41067637104168014,-1.2614545549320284,0.16379310344827586,0.774555546099679,1.0,11/27,16.03%,FLT1;PDGFRA;KIT;TEK;PTK2;PTK2B;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5170866353359711,1.2612503671090616,0.21865443425076453,0.8836705499501956,1.0,11/27,18.84%,CAMK2G;MARK1;NCS1;BRSK1;IL1RAPL1;FRMD7;HOMER1;PTEN;VPS35;ULK4;BRSK2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.5725138282720145,1.2610359959778685,0.22824302134646962,0.8827857673577539,1.0,5/18,13.52%,PMAIP1;BCL2;HEBP2;THEM4;MUL1
prerank,membrane depolarization (GO:0051899),0.5062046275536127,1.2610349186030754,0.1900138696255201,0.8811500209829961,1.0,11/32,19.07%,SCN4A;CACNA1H;CACNB4;CAV1;CACNA1B;CHRNA4;YWHAH;CACNA1I;KCNH2;P2RX4;ABL1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6101799192845894,1.2606602660003314,0.24645390070921985,0.8808420961561456,1.0,4/12,9.38%,GMNN;TIPIN;WRNIP1;KAT7
prerank,negative regulation of protein transport (GO:0051224),-0.4158370972250274,-1.2594138292195134,0.15921787709497207,0.7795641704744811,1.0,10/25,29.16%,APOE;ERP29;CYP51A1;HMGCR;PPM1F;PKDCC;SNX3;DRD2;SNX12;RHBDF2
prerank,cellular response to nitrogen compound (GO:1901699),0.5749960976540829,1.2593355444716,0.2086677367576244,0.8838896769750421,1.0,2/20,1.64%,ATP2B4;NR1H4
prerank,cellular response to reactive oxygen species (GO:0034614),0.4689729057261877,1.2581307415990395,0.19089759797724398,0.8865085313315413,1.0,14/59,14.24%,TPM1;MAP3K5;ANXA1;NET1;FXN;CAMKK2;MAPT;RELA;IMPACT;PRKCD;TRPM2;PDK2;MAPK1;PLEKHA1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.38069407635781094,-1.2578751418548146,0.14022140221402213,0.7824898913427324,1.0,10/37,14.56%,PRKAG2;CEMIP;BMP7;APP;SPRED2;WNK3;TGFB1;IRGM;SPRY2;DGKQ
prerank,plasma membrane tubulation (GO:0097320),0.6035934937369175,1.2576871655246373,0.2328042328042328,0.8864346464363854,1.0,6/13,12.59%,PACSIN3;PACSIN2;EHD2;WHAMM;PACSIN1;SNX9
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5751488008358232,1.2573024574338447,0.23615635179153094,0.8860905150533749,1.0,1/16,0.89%,ACSS1
prerank,positive regulation of metabolic process (GO:0009893),0.44004075654807606,1.256798049913008,0.16303099885189437,0.8863062555206025,1.0,15/103,7.65%,PRDM16;PRKAB2;CD36;PDGFC;EBF2;TSHR;PIGA;CAV1;VEGFA;TRPV2;ACACB;FABP4;PPARGC1A;PPARGC1B;DIO2
prerank,negative regulation of hormone secretion (GO:0046888),-0.5339926530489232,-1.256299016781518,0.17721518987341772,0.7859332089471953,1.0,3/10,13.40%,GJA1;RAB11FIP5;RAB11FIP1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6158075467898955,1.255708446847045,0.2569832402234637,0.888507273217398,1.0,6/11,12.63%,MAP3K5;ARL6IP5;STK24;PRKCD;DIABLO;PDCD10
prerank,positive regulation of cellular component movement (GO:0051272),0.5319062187810804,1.2554109833511757,0.2222222222222222,0.8878972487435647,1.0,6/24,8.65%,ACTN4;CAVIN1;NTN1;VEGFA;TUBB2B;ADAM17
prerank,regulation of response to biotic stimulus (GO:0002831),-0.4019929759367192,-1.2545916020125765,0.1402439024390244,0.7896195650308314,1.0,13/28,14.61%,APPL2;FOXP1;RNF135;CD55;CASP8;BIRC2;PTPN22;SAMHD1;TRIM5;CX3CL1;LRP8;APPL1;BIRC3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.505900406451293,-1.2543022716384165,0.1935483870967742,0.7879446292371907,1.0,9/12,44.78%,B3GALNT1;B3GNT2;B3GALT2;B3GALT1;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,cellular response to cAMP (GO:0071320),0.5208772920003311,1.2542514760442374,0.20485584218512898,0.8903592074444507,1.0,3/30,3.49%,RAP1A;AKAP6;IGFBP5
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.573563602891587,1.2539031983602387,0.2559241706161137,0.8898770291445777,1.0,4/16,13.20%,RBM24;UPF1;CPEB3;ZFP36L1
prerank,triglyceride catabolic process (GO:0019433),0.5645320640990408,1.2534475293141165,0.23557692307692307,0.8898431017286483,1.0,3/19,13.34%,LPL;FABP4;PNPLA3
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.419908224755432,-1.2532938508521385,0.1510989010989011,0.789187188763886,1.0,11/24,24.63%,NIBAN2;DACH1;XRCC5;ACVRL1;BMPR2;BLM;TERF2IP;MSH6;CDKN1A;ERCC1;ERCC4
prerank,sodium-independent organic anion transport (GO:0043252),-0.5294686235103564,-1.252980504818255,0.20276497695852536,0.7877761273167301,1.0,4/10,8.85%,SLCO2B1;SLCO1C1;SLCO2A1;SLCO3A1
prerank,phospholipid transport (GO:0015914),-0.3609439587996304,-1.252618160546343,0.1072961373390558,0.7866477772441528,1.0,13/52,8.34%,OSBPL8;PITPNA;ATP8A1;PLTP;APOE;ABCA1;ABCA4;LDLR;ATP11C;ATP8A2;SCARB2;PITPNC1;TMEM30A
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4992900700356262,-1.252347448984177,0.20659340659340658,0.7850191897030485,1.0,2/13,5.81%,NFAT5;IRAK1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5196149293136898,1.2521709983191152,0.22254335260115607,0.8926553226811133,1.0,4/30,3.96%,ABRA;GPR20;SYNPO2L;NET1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.41695697770663953,1.251309920952937,0.11320754716981132,0.8940044152649853,1.0,22/199,7.87%,MYOCD;MEF2C;ATP2B4;HEY2;VASN;ROCK1;NR1H4;ALPK2;ADAMTS5;LOXL2;PLCL1;HDAC9;ASB1;KLF7;TBX18;LNPEP;PROCR;SDHAF2;DAB2IP;CORO1C;SOX9;ATP2B1
prerank,gastrulation (GO:0007369),-0.4869211943996608,-1.25105522168637,0.19799498746867167,0.7870895074649056,1.0,6/15,25.08%,MEGF8;UGDH;LMBRD1;SMAD2;GPC3;MKKS
prerank,inorganic ion transmembrane transport (GO:0098660),0.5983590035903937,1.250772687772954,0.2356020942408377,0.8942609034067196,1.0,3/12,9.36%,CACNA1H;TRPM4;ABCC8
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5004970301468915,1.2504893271042448,0.21335268505079827,0.8936847200501974,1.0,5/35,8.09%,CDH6;CDH13;CDHR3;PCDHB14;PCDHB11
prerank,negative regulation of histone methylation (GO:0031061),-0.5294128518491203,-1.250392164525365,0.21396396396396397,0.7870090774201021,1.0,6/10,37.71%,BCOR;KDM1A;JARID2;BRCA1;DNMT3B;AASS
prerank,regulation of neuroinflammatory response (GO:0150077),-0.4528611015532259,-1.2499259410119292,0.19230769230769232,0.7861151639174926,1.0,6/19,12.31%,IGF1;NUPR1;IL18;DAGLA;PTGS2;IL33
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4230494491396656,1.2492670272333364,0.15064102564102563,0.8963570142201227,1.0,35/166,13.03%,NOTCH3;NR1H4;CAVIN1;POLR2L;POLR2I;RORA;NR4A1;TEAD3;HDAC9;GTF2H4;NR2C1;POLR2G;TAF1;RXRG;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;MAML3;PPARA;NR4A2;NR1D1;CDK7;POLR1E;NAT14;NR2C2;TEAD1;TFB2M;ESRRA;POLR1H;NR6A1;SMARCA5;POLR2J
prerank,regulation of ion transmembrane transport (GO:0034765),0.49772906070506595,1.2480877985197045,0.21246458923512748,0.898922081596316,1.0,5/33,9.41%,AKAP6;KCNJ12;ANO6;NEDD4;AHCYL1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.5554253366063187,1.2479545417560194,0.250814332247557,0.8978072830037348,1.0,6/18,9.57%,LTBP1;ITGB6;LRRC32;CD200;TGFB2;HIF1A
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.4199455392024134,-1.2472052387524268,0.17615176151761516,0.7935316934060566,1.0,9/24,11.11%,SEMA3D;SEMA3C;SEMA6A;NRP1;SEMA7A;MEGF8;SEMA3A;SEMA4D;SEMA6D
prerank,neuromuscular process controlling balance (GO:0050885),-0.5170005250950207,-1.2470255232085947,0.19230769230769232,0.7917095546252284,1.0,8/12,39.01%,PAFAH1B1;NRXN1;CLN3;TPP1;PCDH15;CDH23;MYO7A;SHANK1
prerank,regulation of mast cell degranulation (GO:0043304),0.5964568431861853,1.2466186738431806,0.2424778761061947,0.9009934625288202,1.0,3/14,8.34%,STXBP2;UNC13D;CD300A
prerank,endothelial cell differentiation (GO:0045446),-0.49914987713134096,-1.245247157777,0.21728395061728395,0.7956951719656774,1.0,5/12,6.40%,FSTL1;ACVRL1;BMPR2;SCUBE1;TIE1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5595141052747044,1.2451526970244515,0.24394184168012925,0.9046108054316725,1.0,3/17,4.10%,RYR2;SNTA1;KCNE4
prerank,negative regulation of immune response (GO:0050777),0.4201155739217984,1.2447418790312665,0.14673913043478262,0.9044821489451521,1.0,21/154,9.92%,LHCGR;GPR20;ADCY5;CRHR2;FCGR3A;ADCY2;VIPR2;MYH9;ADCY9;TSHR;HAVCR2;CYSLTR2;RAMP1;PRKACB;CD300A;ADAM17;PRKAR1B;PTH1R;ADCY6;SAMSN1;SIRT2
prerank,protein homotetramerization (GO:0051289),0.4831322492636216,1.2444094189706743,0.19544846050870146,0.904003117067548,1.0,10/49,12.48%,RYR1;KCNJ12;HSD17B10;CRYZ;ACACB;TRPM4;ALDOA;GLS;OSBPL2;TRPM2
prerank,regulation of store-operated calcium entry (GO:2001256),0.6084631228213032,1.2429728931285964,0.2665441176470588,0.9074468302235771,1.0,4/10,12.68%,CASQ1;STIM1;GRAMD2A;HOMER1
prerank,mRNA stabilization (GO:0048255),0.48062648921096535,1.2423791405714788,0.21059602649006623,0.9078986362425258,1.0,9/40,11.70%,RBM24;TENT5B;MYD88;MAPKAPK2;CIRBP;GDNF;FUS;HNRNPU;HNRNPC
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.5642350273925694,1.2423153806044818,0.2670250896057348,0.9065159534671177,1.0,6/16,10.74%,PDGFB;PDGFC;PDGFD;PTPN1;PDGFRB;PDGFA
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3963843691070823,-1.242144739341361,0.1553398058252427,0.804940976099577,1.0,6/28,8.38%,PTN;APOE;APP;EPHA4;SHANK3;ADCY1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.46190165658447174,1.2416608652294392,0.19853836784409257,0.9071354700186748,1.0,7/63,4.50%,MEF2C;ANXA1;IL2;TNFSF13B;CCL5;CD276;BCL2
prerank,response to glucagon (GO:0033762),0.5507743097264151,1.2413747656561587,0.23483670295489892,0.9066137336300113,1.0,7/19,9.46%,ADCY5;ADCY2;ADCY9;CYSLTR2;PRKACB;PRKAR1B;ADCY6
prerank,positive chemotaxis (GO:0050918),0.5506496274216564,1.2411856476696668,0.25963149078726966,0.9056867097066508,1.0,3/17,6.50%,ANGPT1;SEMA5A;VEGFA
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.45263658570829046,1.241074199124284,0.19852034525277434,0.9045184601895786,1.0,15/72,10.84%,NTF3;NTRK3;PDGFB;PDGFC;ROR1;PLXNB1;CCL5;PDGFD;PIK3AP1;NEDD4;SOX9;TGFB2;PDGFRB;PDGFA;GPER1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.4677415881037914,-1.240758832492764,0.2,0.8076378135114048,1.0,6/17,4.01%,DOCK4;IGF1;DOCK5;VTN;NRP1;ADAMTS1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.43803166856977155,1.240504274456895,0.17981438515081208,0.9049059961922358,1.0,22/94,14.19%,ATP2A1;CRIP1;MAP3K5;PMAIP1;ITPR1;BCL2;CUL2;MYBBP1A;DAB2IP;ARL6IP5;TP53;BCL2L2;EPHA2;STK24;ATP2A3;PRKCD;BOK;DIABLO;FNIP2;PDK2;TNFRSF10B;MCL1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.35026128800587897,-1.2403047662561568,0.1645021645021645,0.8067438941584214,1.0,17/49,21.02%,LDLRAD4;HMGB1;DDX3X;SMAD6;HSPA5;IAPP;PYDC1;PEX5;RIOK3;EP300;AIDA;NOP53;CDC42;PMEPA1;HSF1;PARK7;DACT1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.591309432413492,1.2401364693578236,0.2358974358974359,0.9030677299614861,1.0,3/12,6.96%,ACTN4;KANK1;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.591309432413492,1.2401364693578236,0.2358974358974359,0.9030677299614861,1.0,3/12,6.96%,ACTN4;KANK1;CORO1C
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.39720070918015193,-1.2392932041635973,0.20055710306406685,0.8079249250914856,1.0,5/24,16.45%,RBBP4;PPHLN1;AEBP2;PPM1D;MPHOSPH8
prerank,reverse cholesterol transport (GO:0043691),-0.4746158535326296,-1.238481741832244,0.22144522144522144,0.8085426342170193,1.0,2/13,2.40%,APOE;ABCA1
prerank,negative regulation of platelet activation (GO:0010544),0.5656639262708966,1.2379681628319457,0.2427843803056027,0.9088822065552344,1.0,6/16,11.28%,PRKG1;PDGFB;SERPINE2;C1QTNF1;PDGFA;PRKCD
prerank,regulation of protein kinase C signaling (GO:0090036),0.5867708345801028,1.2374811272172574,0.26495726495726496,0.908968894608175,1.0,4/14,11.09%,DGKG;VEGFA;DGKD;GPD1L
prerank,substrate-dependent cell migration (GO:0006929),-0.47812271485925617,-1.237422317902429,0.2,0.8099842154930016,1.0,8/14,18.87%,NRP1;ANKS1A;CD2AP;SDCBP;OPHN1;EPHA8;VEGFC;ITGB1BP1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5342523071644315,1.23697536717421,0.24018126888217523,0.9091690377693664,1.0,6/25,9.97%,DMD;TRPC6;STAC;ATP1B1;WNK2;ACTN2
prerank,wound healing (GO:0042060),0.45626930986755865,1.2366888701775958,0.20154043645699615,0.9085655699180941,1.0,10/62,7.86%,TPM1;FGF1;FER1L5;PPP3CA;DYSF;MYH9;DST;RAB3A;ITGB3;TGFB2
prerank,neuron migration (GO:0001764),0.485218957293631,1.23664562605028,0.19528178243774574,0.9071626838074669,1.0,10/48,9.09%,FGF13;MEF2C;ASTN2;MAP1B;MARK1;VEGFA;TUBB2B;CEP85L;ASTN1;NR4A2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.35898144576295055,-1.236008408680546,0.14901960784313725,0.8129108578993088,1.0,6/41,9.04%,AFDN;TJP1;BMP7;PODXL;CD44;PIEZO1
prerank,RNA catabolic process (GO:0006401),-0.34672815965676324,-1.2345263040477907,0.13389121338912133,0.8159390195667853,1.0,20/46,28.65%,AGO3;RNASEH2B;METTL3;ERN1;DCP2;HNRNPD;PNPT1;METTL16;PABPC4;LSM2;LSM5;PPP1R8;EXOSC7;CNOT10;SND1;NUDT12;AGO4;DNA2;ZFP36;LSM6
prerank,regulation of peptide hormone secretion (GO:0090276),0.45598792463819277,1.234390288150858,0.1873479318734793,0.9133690512528833,1.0,7/67,4.75%,CACNA1C;RAP1A;ITPR1;KCNA5;CCL5;ALOX5;KCNB1
prerank,protein polymerization (GO:0051258),0.47051408315711196,1.2339193122804095,0.20636942675159237,0.9134297096986571,1.0,9/55,8.53%,FGF13;CASQ1;ARHGAP6;MAP7D3;MAPT;TPPP;PIN1;HDGFL3;SPIRE1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5875315902996829,1.2337954471952424,0.25,0.9122480600580295,1.0,3/11,13.57%,MERTK;AXL;GAS6
prerank,positive regulation of protein sumoylation (GO:0033235),0.5949043364819226,1.2329379140322922,0.26519337016574585,0.9137739700841828,1.0,3/10,6.07%,UBA2;PIAS4;SAE1
prerank,regulation of autophagosome assembly (GO:2000785),-0.3794940818493685,-1.2328109419743867,0.16065573770491803,0.8199022824038529,1.0,17/33,24.88%,NUPR1;RAB5A;PIP4K2B;NPRL3;IFT88;RAB3GAP2;UBQLN2;SCFD1;RAB1B;RALB;TBC1D14;FEZ1;CHMP4B;CHMP4A;SMCR8;PHF23;LRSAM1
prerank,protein deacetylation (GO:0006476),0.49351451059046003,1.2326044881986673,0.20488466757123475,0.9133571686324536,1.0,16/41,18.90%,FLNA;HDAC9;SIRT3;MSL3;MTA3;SIRT2;MIDEAS;BAZ2A;MORF4L1;SIRT4;MTA1;SIN3A;SIRT6;HDAC1;RBM14;HDAC6
prerank,leukocyte tethering or rolling (GO:0050901),0.5522385614984198,1.2323374682752826,0.25938009787928223,0.9127600836287085,1.0,4/17,8.26%,ROCK1;ITGB1;ADD2;ITGA4
prerank,replication fork processing (GO:0031297),-0.36436419161574324,-1.2319833985772053,0.14901960784313725,0.820369332016974,1.0,18/38,37.93%,ATR;MRE11;FBH1;SAMHD1;BLM;MMS22L;PRIMPOL;SMARCAL1;NUCKS1;ALYREF;DNA2;ATRX;BOD1L1;RFWD3;TRAIP;RAD51;CENPX;GEN1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.4601868934698054,-1.2318958542528313,0.1876484560570071,0.818162162725869,1.0,3/16,5.81%,NFAT5;ST3GAL4;IRAK1
prerank,acylglycerol homeostasis (GO:0055090),0.5547677816290902,1.2318476320892582,0.25821596244131456,0.9127897184040501,1.0,3/20,3.34%,ANGPTL8;RORA;LPL
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5478532447015595,1.2314890216604495,0.24960998439937598,0.9123877731514475,1.0,4/19,6.50%,ROCK1;LIMS1;FERMT2;VEGFA
prerank,regulation of actin filament-based process (GO:0032970),0.44364943309828414,1.231431255126279,0.19226118500604594,0.9110502673392815,1.0,15/70,12.98%,DLC1;ROCK1;CNN2;ABRACL;RHOBTB3;ARHGAP17;RHOF;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;DMTN
prerank,positive regulation of developmental process (GO:0051094),0.4193705455439417,1.2312989999697075,0.1632208922742111,0.9099856938735983,1.0,33/164,13.00%,SOX6;ARHGEF7;SOX5;PDGFB;PHLDB2;CLASP2;FST;FZD4;TMEM79;BMPR1A;TAPT1;DAB2IP;VEGFA;GDNF;CORO1C;PA2G4;AR;SOX9;MIEF2;PLCB1;MIEF1;SPIRE1;TRPM4;RBM19;PAXIP1;RIF1;NR2C2;DNM1L;ACVR1B;BMPR1B;PACSIN1;CPEB3;CLASP1
prerank,C-terminal protein amino acid modification (GO:0018410),0.6150324966927455,1.2312033301229008,0.2556131260794473,0.9087743527958232,1.0,2/11,5.48%,AGBL1;ATG7
prerank,glycoprotein biosynthetic process (GO:0009101),-0.31577320083450444,-1.231124556850711,0.08588957055214724,0.8187855922603189,1.0,24/79,20.02%,IGF1;CHST11;ST3GAL4;ST3GAL6;ST8SIA4;ST3GAL5;ST8SIA1;BMPR2;MGAT1;CHST9;SERP2;GOLPH3;ST3GAL3;FUT10;ST8SIA2;B3GALNT1;PMM2;CANT1;XYLT1;FOXL1;COG7;CHST12;B4GALT7;ALG1
prerank,female gonad development (GO:0008585),0.5578388252775814,1.2309662701169228,0.26003210272873195,0.9080551093788856,1.0,4/19,10.61%,LHCGR;NR2F2;VEGFA;NUP107
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4219113023538683,1.2307462741076363,0.1810344827586207,0.9073024013658748,1.0,26/138,10.69%,NOTCH3;NR1H4;POLR2L;POLR2I;RORA;NR4A1;TEAD3;HDAC9;GTF2H4;NR2C1;POLR2G;TAF1;RXRG;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;MAML3;PPARA;NR4A2;NR1D1;CDK7;NR2C2;TEAD1
prerank,regulation of hydrolase activity (GO:0051336),-0.31931846975852307,-1.2306540234890937,0.1111111111111111,0.8180669642847671,1.0,20/71,12.34%,PLXNA2;NF1;FGD6;FGD5;EPHA4;PTK2;FGD4;CHN2;TBC1D15;SIPA1L1;EPHA3;PAFAH1B1;VAV2;SCARB2;PLXNA4;RDX;RASIP1;RAB3GAP2;ARHGAP27;RALBP1
prerank,defense response to tumor cell (GO:0002357),0.6119213949283924,1.2304200989662848,0.27611940298507465,0.9068702234415098,1.0,2/10,4.20%,DLEC1;RBMS3
prerank,regulation of glycogen metabolic process (GO:0070873),0.6049083480294459,1.2302231731139939,0.2641509433962264,0.9059742500165083,1.0,1/12,1.10%,PPP1R3A
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5086492434229046,1.2300138458083967,0.23809523809523808,0.9051729605661791,1.0,5/32,7.09%,ARHGEF7;PLCE1;ACTR3;CORO1C;CYFIP1
prerank,endocardial cushion morphogenesis (GO:0003203),0.5475942051945712,1.229827323131482,0.2625418060200669,0.9042596191023855,1.0,5/18,7.86%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,neuron projection extension (GO:1990138),-0.3835768601666105,-1.2297901937720563,0.19877675840978593,0.8188861463098918,1.0,9/32,9.11%,ALCAM;NRP2;AUTS2;NRP1;CTNNB1;HSP90AB1;SEMA3A;TMEM108;CDKL3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5674600813852805,1.2297784705164532,0.2569558101472995,0.9028709694698055,1.0,5/15,10.88%,ROCK1;CAMK2D;MEF2A;PARP1;ROCK2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.41907205432292494,-1.2294879803590768,0.19498607242339833,0.817359259233263,1.0,3/21,5.06%,OSBPL8;OSBPL10;PLA1A
prerank,fatty acid transmembrane transport (GO:1902001),0.5517717551201785,1.2292775877241913,0.24172185430463577,0.9030913040739702,1.0,7/19,14.41%,PRKAB2;CD36;ACACB;CPT1B;ABCD4;CPT1A;PRKAA2
prerank,water transport (GO:0006833),-0.499673248357867,-1.2292003291007045,0.2191142191142191,0.8160042477240773,1.0,1/12,1.63%,PDPN
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.48126460355231165,-1.2291708308461338,0.22985781990521326,0.8136948183713033,1.0,7/13,27.38%,NCBP2;CPSF2;CPSF6;CSTF2T;CPSF4;CSTF2;CPSF1
prerank,aminoglycan metabolic process (GO:0006022),-0.526022034422905,-1.229039187596685,0.2076749435665914,0.8117718386676875,1.0,9/10,44.74%,CHST9;XYLT1;B4GALT7;B3GAT1;CLN6;B3GAT3;B3GALT6;B3GAT2;GAL3ST3
prerank,T cell mediated immunity (GO:0002456),-0.48236395112339475,-1.2289214363960344,0.21770334928229665,0.8098287962713132,1.0,5/13,12.26%,CADM1;CD55;CTSH;CD46;GNL1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.539559215169421,1.22808292535603,0.22770700636942676,0.9055682765174204,1.0,4/22,7.51%,DYNLL1;ROCK1;TP53;PLEK
prerank,programmed necrotic cell death (GO:0097300),0.5536397644769118,1.2265261616320662,0.2560386473429952,0.9094402324757992,1.0,3/18,10.73%,ITPK1;CD14;DNM1L
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3933465921801183,-1.2263085293394493,0.1834319526627219,0.8171573883619198,1.0,11/29,16.03%,FLT1;PDGFRA;KIT;TEK;PTK2;PTK2B;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5639037986826002,1.226047983076471,0.28109028960817717,0.9095900192996729,1.0,4/13,7.85%,D2HGDH;DLST;GOT1;GOT2
prerank,negative regulation of axon extension (GO:0030517),-0.39574000241984286,-1.2247729538996759,0.2037037037037037,0.8203383394097883,1.0,10/30,12.47%,SEMA3D;SEMA3C;SEMA6A;SEMA7A;RNF6;SEMA3A;SEMA4D;CDKL3;SEMA6D;RTN4
prerank,regulation of insulin secretion (GO:0050796),0.4282117964344916,1.2243032572932364,0.19886363636363635,0.9137109669749187,1.0,23/101,15.87%,CACNA1C;RAP1A;ADCY5;NR1H4;ITPR1;KCNA5;CCL5;ALOX5;KCNB1;IRS1;ENSA;NR1D1;ABCC8;GPER1;LRP5;PPP3CB;SIRT4;CLOCK;PRKCA;IRS2;GIPR;HADH;RFX3
prerank,pentose-phosphate shunt (GO:0006098),-0.5072312201439146,-1.2242462401450769,0.22350230414746544,0.8197940422592906,1.0,5/11,26.79%,PGD;TKT;SHPK;DERA;PGLS
prerank,smooth muscle tissue development (GO:0048745),0.6031388366543157,1.224124212801481,0.26958105646630237,0.9127541956226022,1.0,1/10,0.26%,MYLK
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5169375018667204,1.2239935382384441,0.2469879518072289,0.9116965652824677,1.0,5/25,12.03%,CNRIP1;SOCS5;SOCS4;PPARA;TSG101
prerank,histone H2B ubiquitination (GO:0033523),-0.5242845117491948,-1.2237549099155212,0.25,0.8191871509037996,1.0,4/10,13.87%,RNF20;CTR9;DTX3L;LEO1
prerank,regulation of interferon-beta production (GO:0032648),-0.3529623676710019,-1.2232834912444182,0.15057915057915058,0.818369727663523,1.0,18/46,25.15%,DDX3X;PTPN11;PPM1B;RNF135;POLR3F;RIOK3;POLR3B;POLR3A;SIRPA;RELB;TRIM56;TLR3;OAS2;TIRAP;POLR3C;TOMM70;NLRC3;POLR3D
prerank,response to hydrogen peroxide (GO:0042542),0.48058354555629906,1.222792115305346,0.21908602150537634,0.9143025242281788,1.0,12/45,14.24%,MAP3K5;ANXA1;NET1;FXN;STK26;RELA;IMPACT;STK24;PRKCD;TRPM2;PDCD10;PLEKHA1
prerank,positive regulation of cell killing (GO:0031343),-0.4742654463393144,-1.2226056030457721,0.2202247191011236,0.8185005159137014,1.0,6/13,37.67%,WNT5A;SYK;DVL2;MAPK8;NOXO1;NOX1
prerank,positive regulation of nervous system development (GO:0051962),-0.35370382197669775,-1.2216627963387359,0.16205533596837945,0.8196570245324346,1.0,20/42,28.55%,NLGN1;SPEN;PTPRD;SNW1;NRXN1;FAIM;NLGN2;NLGN3;NUMB;LRRC4B;GRID2;NAP1L1;IL1RAP;EPHB2;SRPX2;MME;TRIM32;SOX11;EPHB3;SYNDIG1
prerank,L-serine metabolic process (GO:0006563),-0.5256027889338797,-1.2215858385742595,0.24312896405919662,0.8175138136499801,1.0,5/10,26.81%,SERINC5;SRR;PSPH;PSAT1;CBS
prerank,acute inflammatory response (GO:0002526),0.5177713612236657,1.2214979686771943,0.25,0.917335986230039,1.0,4/23,7.82%,ITIH4;ANO6;MBL2;IL22
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.40923204775020733,1.2210288686440574,0.16842105263157894,0.9173356852690714,1.0,47/190,15.38%,PDE3A;DGKG;WTIP;ATP2B4;NR1H4;ITPR1;LIMD1;RORA;BCL2;CARD19;CAV1;DAB2IP;DUSP3;PPM1A;PHLDA3;PLEK;BCL2L2;RELA;TNIP1;OTUD7A;PPARA;GSTP1;NR1D1;NDUFS3;DGKD;EPHA2;THEM4;EPM2A;NPRL2;ARHGAP12;RTKN2;SH3BP4;GPER1;GPD1L;PDE4D;RHOH;SHANK2;MUL1;MAP2K3;TMSB4X;MCL1;PLEKHA1;PRKAA2;VGLL4;URI1;PTEN;STAT1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.4443283852753918,-1.2202580614441019,0.2144927536231884,0.8175254817924026,1.0,10/20,21.64%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C;PFKFB3;PRKAA1
prerank,positive regulation of glycolytic process (GO:0045821),-0.4443283852753918,-1.2202580614441019,0.2144927536231884,0.8175254817924026,1.0,10/20,21.64%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C;PFKFB3;PRKAA1
prerank,protein mannosylation (GO:0035268),-0.4189043280305481,-1.219897213185114,0.18997361477572558,0.8165166469481234,1.0,6/22,7.46%,TMTC1;TMTC2;DPY19L4;RXYLT1;TMTC4;DPY19L1
prerank,ovarian follicle development (GO:0001541),0.5846917529338556,1.2192726243196166,0.2892416225749559,0.9216764702162733,1.0,2/13,6.50%,LHCGR;VEGFA
prerank,activation of GTPase activity (GO:0090630),0.4329702540886765,1.219272450798807,0.2009626955475331,0.9201530380340975,1.0,14/89,9.51%,NTF3;NTRK3;RALGAPA2;TBC1D1;ABR;ARHGEF16;MTSS2;RABGAP1;CORO1C;RASGRP1;RALGAPA1;EVI5;RALGAPB;EPHA2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.49871397580964993,-1.2190868412966895,0.20947630922693267,0.8172020397075506,1.0,7/12,20.87%,CTSL;CTSH;RDX;CTSB;THRB;CTSS;LMO2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.3435337498391042,-1.2186398893033032,0.14107883817427386,0.8164968327739729,1.0,12/49,12.18%,IGF1;IL31RA;IL15;KIT;GHR;IL18;ARL2BP;TNFRSF1A;IL6R;HES1;LYN;PARP14
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4704828780508859,-1.218611837673344,0.22879177377892032,0.8119049375875149,1.0,3/14,11.22%,ABCG2;SLCO2B1;BLVRB
prerank,heme catabolic process (GO:0042167),-0.4704828780508859,-1.218611837673344,0.22879177377892032,0.8119049375875149,1.0,3/14,11.22%,ABCG2;SLCO2B1;BLVRB
prerank,activin receptor signaling pathway (GO:0032924),0.5732370070945938,1.2183999098144453,0.2607260726072607,0.9216418516182028,1.0,2/15,4.04%,HJV;ACVR2A
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5279763850179505,1.2183483757802127,0.24251497005988024,0.920273231080702,1.0,8/25,15.82%,CHMP4C;SORT1;LYST;CHMP5;DENND10;CHMP2B;CHMP2A;LEPROT
prerank,organic acid transport (GO:0015849),-0.31135000355315195,-1.21811756501522,0.1015625,0.8113780661068998,1.0,19/94,9.39%,SLC7A11;SLC6A13;SLC13A3;ABCG2;PDPN;SLCO2B1;SLC6A12;SLC6A6;SLC26A7;SLC16A1;SLCO1C1;NCOA1;SLC25A17;SLC7A14;SLC3A2;SLC25A32;SLC22A6;SLC25A14;ABCC4
prerank,positive regulation of cell adhesion (GO:0045785),0.4386016440851134,1.21811350243251,0.2289156626506024,0.919578037177618,1.0,10/74,9.26%,TPM1;ZFHX3;LIMS1;PDGFB;PPP3CA;CCL5;RSU1;VEGFA;TGFB2;MAGI1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5198586648547318,1.2175932685808188,0.2586989409984871,0.9198906344046323,1.0,8/22,10.74%,PDGFB;PDGFC;PDGFD;RAP2C;VEGFA;CALM1;RAP2A;PDGFA
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5060000004849868,-1.2163626181834224,0.2494061757719715,0.8155706287238971,1.0,6/11,30.78%,LGALS9;PARK7;PIH1D1;HTRA2;GSN;PLAUR
prerank,substantia nigra development (GO:0021762),0.48354672659505965,1.2157290912880736,0.24966622162883845,0.9247489235459914,1.0,8/37,9.92%,DYNLL1;SYPL2;PADI2;ACTB;CALM1;MBP;NDUFS3;SIRT2
prerank,histone H3-K36 demethylation (GO:0070544),-0.5193770289186531,-1.2153696445887385,0.20920502092050208,0.816712703120842,1.0,3/10,12.77%,KDM7A;KDM2A;RIOX2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32578494640736533,-1.214716197402869,0.13930348258706468,0.8167405520080865,1.0,19/67,8.28%,ELMO1;FLT1;PIK3CA;SULF1;NRP2;MAPK14;CYFIP2;PXN;NRP1;PTK2;ABI1;BAIAP2;PTK2B;VAV2;WASF2;ITGAV;NCK1;PIK3CB;CLEC14A
prerank,inositol phosphate metabolic process (GO:0043647),0.46810882212379906,1.214592891224279,0.22833562585969738,0.9270925297450671,1.0,12/46,12.09%,ITPK1;PLCE1;INPP4B;PLCB4;INPP5A;NUDT4;CALM1;PLCB1;INPPL1;PLCD1;INPP5B;ITPKC
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.4377415978717595,-1.2144503538496452,0.2,0.8155312976483876,1.0,12/18,35.39%,COA8;COX20;SMIM20;COX14;TIMM21;BCS1L;COX17;COX16;COA3;SURF1;COX18;FASTKD3
prerank,mitotic nuclear division (GO:0140014),0.4449160395122811,1.2133932539135825,0.21776155717761558,0.9298740123226846,1.0,22/71,17.20%,FLNA;CLASP2;KIF2A;TOGARAM2;NUP62;KIF3B;TPX2;PIBF1;TOGARAM1;ZWINT;CEP192;WRAP73;AAAS;CLASP1;CHMP2A;KIF18A;KNSTRN;ABRAXAS2;MAP9;INO80;DSN1;CENPK
prerank,regulation of kinase activity (GO:0043549),0.428263880790369,1.2133879209860654,0.20430107526881722,0.9283705680174503,1.0,17/89,11.19%,TTN;NTRK3;MERTK;PLCE1;MST1R;ROR1;SMG8;MUSK;CAMKK2;MAPT;ANKRD54;EPHA2;AXL;NPRL2;PDGFRB;HNRNPU;RB1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4420296573487414,1.2127959419028345,0.2300357568533969,0.928945908005642,1.0,14/75,10.88%,RGS6;ROCK1;PLCE1;RGS4;CCL5;SAG;RPGRIP1L;CALM1;PLEK;PLCB1;MGLL;SLC39A14;GPER1;ROCK2
prerank,negative regulation of bone remodeling (GO:0046851),-0.5039305699536426,-1.2126810721311392,0.2396088019559902,0.819707961127174,1.0,9/11,44.91%,GPR137B;TMEM119;GPR137;TNFAIP3;UBASH3B;GREM1;CALCA;SFRP1;CARTPT
prerank,positive regulation of protein acetylation (GO:1901985),-0.5045956291856729,-1.2125111712687044,0.24883720930232558,0.817993980589374,1.0,6/12,28.00%,DDX3X;CAMK1;TAOK1;TERF2IP;PRKAA1;RAPGEF3
prerank,myoblast fusion (GO:0007520),0.5769845696724081,1.212411726183023,0.27288428324697755,0.9287132644607875,1.0,3/12,5.58%,CACNA1H;ADAMTS5;KCNH1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4406907286453615,-1.2123298076583509,0.2194513715710723,0.8163879642024493,1.0,7/17,18.63%,SEL1L;DERL1;UFD1;HSP90B1;OS9;SYVN1;HERPUD1
prerank,odontogenesis (GO:0042476),-0.3715638195601539,-1.212288440978349,0.1649122807017544,0.814280698141702,1.0,10/35,16.65%,EDA;BMP4;COL1A2;GLI2;OSR1;LAMB1;FGFR2;HDAC2;WNT6;BCOR
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5418326380204956,1.2121544312289747,0.2689873417721519,0.9281102722387133,1.0,3/20,7.56%,WTIP;LIMD1;CELF1
prerank,hyaluronan catabolic process (GO:0030214),-0.43550720121832515,-1.2120100607303979,0.21937321937321938,0.8130526736066102,1.0,6/18,16.03%,CEMIP;CD44;TGFB1;HEXA;CEMIP2;FGF2
prerank,negative regulation of lipid storage (GO:0010888),-0.4249518711083206,-1.2114687419011534,0.20887728459530025,0.8126380411580062,1.0,5/19,6.78%,OSBPL8;ABCA1;NFKBIA;ITGAV;ABHD5
prerank,generation of neurons (GO:0048699),0.40708648731230856,1.2111889437416024,0.17157894736842105,0.9299539562440452,1.0,28/190,9.13%,FGF13;MEF2C;HEY2;CDK6;FZD5;ASTN2;HEYL;IRX5;FZD4;MAP1B;PRUNE1;MARK1;FZD8;ITM2C;MAPT;EML1;TUBB2B;PIN1;YTHDF2;CEP85L;YAP1;ERCC6;TGFB2;ADNP2;ASTN1;MAP2K1;NR4A2;BRSK1
prerank,sulfur amino acid catabolic process (GO:0000098),0.5900754149175738,1.2111591734717453,0.2787456445993031,0.9285323674223614,1.0,2/10,5.94%,TXN2;BLMH
prerank,regulation of microtubule-based process (GO:0032886),0.48613856285286194,1.210728519830473,0.24930747922437674,0.9284724580639164,1.0,13/36,18.90%,ROCK1;PHLDB2;CLASP2;BICD2;MAPT;TPPP;CLASP1;PRKAA2;CDK2AP2;MARK2;BICD1;MAP6;HDAC6
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3761139807242112,-1.2107069103617851,0.1901639344262295,0.8132084463745082,1.0,13/34,16.03%,FLT1;PDGFRA;KIT;TEK;PIK3R3;PTK2;PTK2B;WDR91;TGFB1;AMBRA1;EPHA8;TNFAIP8L3;FGF2
prerank,negative regulation of blood coagulation (GO:0030195),-0.36238652983423053,-1.2099749711352106,0.15498154981549817,0.8136592685156426,1.0,9/38,9.33%,PDGFRA;APOE;VTN;TFPI;PLAT;F3;CD34;THBD;NOS3
prerank,organic substance transport (GO:0071702),-0.28911350863616647,-1.2094862914021878,0.07692307692307693,0.8131657476924654,1.0,38/121,23.08%,ABCG2;SLC47A1;ATP8A1;ABCA9;PLTP;CALCRL;ABCA1;SLCO2B1;CHKA;ABCA4;SLCO2A1;SCAMP2;SLC22A6;PPT1;SLC22A4;SLC35F3;SPNS2;RCN3;RAMP2;HSP90B1;TOM1;ABCA6;ABCD3;SLC22A18;NDC1;PICK1;ABCB9;SLC50A1;ARRDC1;CUBN;SCAMP3;MIA3;TAP1;SCAMP1;ABCA2;MFSD2A;TXNIP;ARRDC4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.5811042242477142,1.2093131398732802,0.2722419928825623,0.9318836486162845,1.0,2/11,6.73%,PRKCQ;IL12RB1
prerank,positive regulation of vasculogenesis (GO:2001214),0.6034020879681109,1.2090558593712433,0.27056672760511885,0.9312818844932991,1.0,3/10,8.34%,RAP1A;RRAS;RIN2
prerank,gonad development (GO:0008406),0.4790413337506231,1.2086426267458559,0.242914979757085,0.9312370316534008,1.0,8/41,10.61%,LHCGR;IRX5;NR2F2;CSDE1;AR;SOX9;TGFB2;NUP107
prerank,cytoplasmic translation (GO:0002181),-0.2963431378384452,-1.2085529174336518,0.12686567164179105,0.8143379810430049,1.0,40/91,29.91%,RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;RPLP0;ZC3H15;RPS29;RPL28;RWDD1;EIF2B3;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;RPS7;RPL27;RPL11;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27;GSPT2;RPL4;RPS5;RPS15;RPL35A
prerank,response to thyroid hormone (GO:0097066),-0.47996802041215575,-1.2084547930803793,0.22938144329896906,0.8124402239821996,1.0,7/13,20.87%,CTSL;CTSH;RDX;CTSB;THRB;CTSS;LMO2
prerank,digestive tract development (GO:0048565),-0.38053007136172756,-1.208372651603771,0.21328671328671328,0.8104440360817726,1.0,10/32,14.92%,CLMP;COBL;KIT;PCSK5;GLI2;MEGF8;SALL1;FGFR2;CCDC39;PKDCC
prerank,activation of protein kinase A activity (GO:0034199),0.5507277573537986,1.2082150714016826,0.26357827476038337,0.9311716919588778,1.0,6/16,9.46%,ADCY5;ADCY2;ADCY9;PRKACB;PRKAR1B;ADCY6
prerank,epithelial cell migration (GO:0010631),0.47596575098703825,1.207796813038183,0.25487465181058494,0.9311389296299554,1.0,7/37,3.29%,PTP4A3;ROCK1;ZEB2;PLXND1;CDH13;LOXL2;KANK1
prerank,nucleic acid-templated transcription (GO:0097659),0.4705372705257157,1.2076789051831864,0.2452316076294278,0.9300295566194283,1.0,11/42,13.03%,POLR2L;POLR2I;MLF1;PWP1;MEF2A;POLR2G;TERT;NFKBIB;NR4A2;BAZ2A;POLR2J
prerank,regulation of neutrophil migration (GO:1902622),0.5878536493549104,1.2075810742103519,0.28136200716845877,0.9288899968304608,1.0,4/10,15.30%,JAM3;RHOH;MPP1;RHOG
prerank,positive regulation of cell differentiation (GO:0045597),0.39850359644497424,1.2075678164328842,0.1444906444906445,0.9274597616525447,1.0,38/237,8.81%,SOX6;AGTR1;SOX5;MEF2C;RAP1A;RBM24;SMYD1;CD36;CCN1;PLA2G3;FERMT2;LOXL2;HEYL;LPL;TGFB3;GCNT2;MMD;ACVR2A;TGFB1I1;SP7;ARHGEF2;BMPR1A;MEF2A;RARRES2;RRAS;GDNF;PA2G4;AR;BTG1;YAP1;SOX9;TGFB2;PLCB1;RIN2;CDH2;TRPM4;SUCO;IMPACT
prerank,regulation of receptor internalization (GO:0002090),0.48727162133655527,1.2072676477284767,0.2395543175487465,0.9269682348322051,1.0,6/35,10.44%,NTF3;ANGPT1;ATXN2;VEGFA;ATAD1;SCYL2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4578968408554597,-1.205582987822367,0.24010554089709762,0.8179887435095184,1.0,4/14,5.71%,WNK1;WNT5A;PTK2B;ADAM10
prerank,cellular macromolecule catabolic process (GO:0044265),-0.3478395301915138,-1.2049911440770975,0.18018018018018017,0.817712907258997,1.0,19/49,27.91%,NGLY1;DENND3;RAB12;RNASEH2B;PRKN;ADAMTS9;HNRNPD;CHEK2;SIAH2;PNPT1;FBXO17;PABPC4;MAGEC2;PPP1R8;EXOSC7;STT3B;SND1;HTRA2;FBXO44
prerank,skin development (GO:0043588),0.44491677371661836,1.2048699692019074,0.23655913978494625,0.933603915302816,1.0,12/65,12.43%,RYR1;ITGA3;ANXA1;JAG1;TMEM79;FA2H;SLC2A10;MED1;EPHA2;PDGFA;BCR;COL3A1
prerank,response to interleukin-6 (GO:0070741),-0.5122079868214036,-1.2038674634784803,0.26666666666666666,0.8193742516559575,1.0,3/10,2.87%,PID1;ST3GAL6;SBNO2
prerank,postsynaptic membrane organization (GO:0001941),-0.4403747553633083,-1.203854621532267,0.23857868020304568,0.8172100016397357,1.0,10/17,28.36%,APOE;NLGN1;SHANK3;NRXN1;NLGN2;NLGN3;DNAJA3;CHRNB1;SHISA7;LHFPL4
prerank,protein ADP-ribosylation (GO:0006471),0.5089290335222267,1.2034053083770304,0.2451708766716196,0.9370140196418031,1.0,7/28,13.71%,ART1;SIRT3;PARP1;ART4;SIRT2;HPF1;SIRT4
prerank,membrane lipid catabolic process (GO:0046466),-0.519757615571584,-1.2033633445796752,0.24190064794816415,0.8167996104162197,1.0,4/10,20.45%,ENPP2;CYP1B1;PPT1;NAGA
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4429405511323582,1.2033025585180275,0.22057001239157373,0.935856416330727,1.0,18/66,14.41%,MAP3K5;FGF1;MST1R;PDGFB;PDGFC;PDGFD;TNFRSF11A;DAB2IP;VEGFA;RASGRP1;MAP3K10;PDGFRB;PDGFA;HTR2B;PDCD10;TAOK3;LRRK2;DIRAS2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4726571493212607,1.2028822227433111,0.2503276539973788,0.9357745294281631,1.0,13/44,14.01%,RBM24;ROCK1;BTG2;UPF1;POLR2G;YTHDF2;CELF1;FTO;ROCK2;CNOT7;CPEB3;ZFP36L1;GIGYF2
prerank,regulation of blood coagulation (GO:0030193),-0.3914177900043918,-1.2024622102507803,0.23867069486404835,0.8177984592356508,1.0,6/27,8.27%,ST3GAL4;APOE;VTN;TFPI;CD34;THBD
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.4269015879312664,-1.2020411841329393,0.22572815533980584,0.8172474196630563,1.0,6/18,11.08%,DDX5;BMP4;EGFR;ESR1;TGFB1;MAP2K2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5857489638543777,1.2015705207873988,0.2654109589041096,0.9387241361506199,1.0,3/12,5.71%,MYO1E;JAG1;KLF15
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5253649891492237,1.2015472650364425,0.2782874617737003,0.9373245902961921,1.0,6/21,15.26%,FZD5;CAV1;AMER1;PPP1CA;DVL1;CSNK1A1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4923725495103397,1.201364888550083,0.2514367816091954,0.9364398140673043,1.0,7/30,12.98%,NTF3;CAV1;PIBF1;CD300A;SAMSN1;PRKCD;DMTN
prerank,plasma membrane repair (GO:0001778),0.5695350853582483,1.200960923860635,0.2864583333333333,0.9363142195743209,1.0,4/13,7.05%,FER1L5;DYSF;MYH9;RAB3A
prerank,positive regulation of histone methylation (GO:0031062),-0.3960117454687447,-1.1998304837319587,0.22063037249283668,0.8227827578298716,1.0,7/24,17.38%,AUTS2;CTR9;CTNNB1;OGT;SNW1;CHTOP;SMAD4
prerank,regulation of histone methylation (GO:0031060),-0.461296802724176,-1.1996997301087657,0.24186046511627907,0.821031673251537,1.0,8/13,37.75%,NSD1;CTR9;CHTOP;PIH1D1;JARID2;PAF1;AASS;TTLL12
prerank,response to cAMP (GO:0051591),0.47807098641719614,1.1996898734433392,0.2611832611832612,0.9389490021275442,1.0,3/37,3.49%,RAP1A;AKAP6;IGFBP5
prerank,negative chemotaxis (GO:0050919),0.48505241168667,1.1996063576258553,0.2474074074074074,0.937772287200645,1.0,4/33,4.74%,SLIT3;SLIT1;NTN1;SEMA6C
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4637580908955021,-1.199548514089525,0.25692695214105793,0.8194175662573889,1.0,4/15,7.39%,DAB2;AAK1;BMP2K;PIK3CB
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.48553567174824663,-1.1994086156789436,0.2394678492239468,0.8177529835600512,1.0,3/12,6.84%,UNC13C;UNC13B;SYT1
prerank,presynapse assembly (GO:0099054),-0.4532850584260333,-1.199376545736465,0.2602040816326531,0.8156913590962224,1.0,6/16,15.29%,WNT5A;NLGN1;PTPRD;NLGN2;NLGN3;PCLO
prerank,early endosome to Golgi transport (GO:0034498),-0.5131346046317186,-1.1990838433606983,0.21615720524017468,0.8145520629591009,1.0,5/11,19.16%,STX5;SURF4;RBSN;LMAN1;EHD3
prerank,negative regulation of cell differentiation (GO:0045596),0.40372375380949777,1.1990789524833865,0.1917808219178082,0.937967025365125,1.0,32/181,11.57%,MYOCD;VASN;CHADL;CRIM1;LIMD1;CDK6;FERMT2;RORA;RUNX1T1;JAG1;ANKRD2;ASXL1;SDHAF2;CAV1;DAB2IP;BBS12;YTHDF2;MED1;ITGB3;YAP1;SOX9;SNAI2;PPARA;TRPM4;IQCB1;SKI;SIRT2;HNRNPU;GPER1;RB1;LRP5;ABCG1
prerank,fatty acid elongation (GO:0030497),-0.4658756180219979,-1.1990278981452478,0.24651162790697675,0.8126144379750396,1.0,7/13,22.84%,ELOVL7;HACD4;ELOVL4;ELOVL6;HACD2;ELOVL1;HACD3
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4156844855564892,-1.1988752182757436,0.21407624633431085,0.8109543589184325,1.0,7/22,5.65%,ROBO1;EFNB2;CDH5;SLIT2;NRP1;PIK3R3;ID1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4967253787904405,1.1987657767023034,0.25630252100840334,0.9375873596107498,1.0,7/32,6.96%,DLC1;PHLDB2;CLASP2;JAG1;ARHGAP6;AJAP1;CORO1C
prerank,protein localization to chromosome (GO:0034502),-0.373095449635304,-1.1984433131289538,0.18685121107266436,0.8103421711775164,1.0,18/34,34.08%,ATR;TNKS2;XRCC5;PARP3;SLF2;ESR1;SLF1;LEMD2;TERF2IP;IFFO1;TPP1;TINF2;CHMP7;BOD1;ATRX;ACD;MCM8;RPA2
prerank,positive regulation of cyclase activity (GO:0031281),0.5606730438185068,1.1978110112886962,0.2883959044368601,0.9393658477346957,1.0,2/14,3.42%,CACNA1C;STIM1
prerank,autophagy of mitochondrion (GO:0000422),-0.3570214133883168,-1.1972346034139745,0.18149466192170818,0.8123107033174127,1.0,20/38,28.28%,RB1CC1;CISD2;ATG3;FBXO7;ATG5;PRKN;ATG2B;AMBRA1;WIPI2;ATG2A;FIS1;GABARAPL2;WDR45B;MAP1LC3A;ULK2;GABARAPL1;WIPI1;SQSTM1;MAP1LC3B;ATG12
prerank,regulation of necroptotic process (GO:0060544),-0.40114614563535,-1.1969852375969932,0.21597633136094674,0.8110638501483958,1.0,8/23,14.61%,YBX3;CASP8;BIRC2;PELI1;SDCBP;OGT;STUB1;BIRC3
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.504835908149313,-1.1968822875004863,0.25301204819277107,0.8093367809517542,1.0,6/11,14.61%,YBX3;NUPR1;CASP8;BIRC2;PELI1;BIRC3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4972993247751071,1.1968704210548102,0.26212121212121214,0.9410544242411504,1.0,2/25,2.87%,MEF2C;GRIN2C
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5193803703627017,1.196280203374051,0.27529761904761907,0.9415698117539534,1.0,6/25,11.23%,PFKP;ENO3;HK2;ADPGK;ALDOA;PFKM
prerank,cellular response to calcium ion (GO:0071277),0.4404909064729787,1.196154751494264,0.22316043425814233,0.9405482505975312,1.0,7/67,5.58%,RYR1;MEF2C;RASGRP2;CAMK2D;SYT10;MEF2A;KCNH1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5200450761133318,-1.1960673443022252,0.23684210526315788,0.8100639346088255,1.0,3/10,23.33%,BMP4;SALL1;PAX8
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.25073367151596343,-1.1957556357058456,0.0,0.809008023513078,1.0,57/248,14.82%,RNF220;BICC1;MCC;DAB2;MLLT3;LRRK1;LGR4;TLE1;IGFBP2;COL1A1;TCF7L2;ADGRA2;DKK3;APOE;WNK1;RNF146;FZD6;DDX3X;PTK7;CUL3;EGFR;LYPD6;TNKS2;WNT5A;KLHL12;SOX13;PPM1B;CTNND1;TMEM64;CTNNB1;LATS2;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;STK11;SMURF2;KREMEN1;PRKN;SFRP4;TGFB1;IGFBP6;FGFR2;PSMB3;CCNY;SOX4;WWTR1;ZBED3;PSMC5;PSMA5;NOTUM;PSMA1;PSMC2;SOX17;HECW1;EMD
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4716246610523462,1.1957273041161067,0.25616438356164384,0.9405475654357525,1.0,2/35,0.77%,NTF3;NTRK3
prerank,regulation of interleukin-17 production (GO:0032660),0.4949298987297014,1.1956081584573393,0.26777609682299547,0.9394838509875539,1.0,4/31,5.51%,NR1H4;MYD88;IL2;PRKCQ
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.516239839773645,-1.1955181222685127,0.2520833333333333,0.8077160797070246,1.0,8/10,44.88%,KIT;LYN;CD24;BTLA;FGR;BAG6;CD40;LILRB1
prerank,endothelial cell development (GO:0001885),0.5127024319576896,1.1953779011740375,0.24705882352941178,0.9388122220349306,1.0,2/25,0.72%,COL18A1;RAP1A
prerank,positive regulation of cellular respiration (GO:1901857),-0.49524269230445045,-1.1951538731679237,0.2511415525114155,0.8068943829256525,1.0,4/11,22.47%,NUPR1;IFNAR1;PARK7;ISCU
prerank,negative regulation of transposition (GO:0010529),-0.44427577914978317,-1.19513944821473,0.2205128205128205,0.8048877682117606,1.0,7/16,30.99%,UBR2;SIRT7;TUT4;TEX15;TUT7;MOV10;SMYD5
prerank,response to laminar fluid shear stress (GO:0034616),-0.510415774257956,-1.1944529395192516,0.2645739910313901,0.8051946774332384,1.0,5/10,24.59%,ABCA1;SMAD6;KLF2;ASS1;MAPK7
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.41346547227554603,1.194089594299305,0.21428571428571427,0.9416081066424706,1.0,26/118,13.33%,WTIP;MEF2C;PDLIM5;SDC2;INF2;FERMT2;PLXND1;PHLDB2;CLASP2;CHN1;KIF1A;MAPT;GDNF;NEDD4;CDH2;BRSK1;PAK2;EPHA2;RAP2A;TSPAN12;ARHGAP35;TNIK;SARM1;CLASP1;BCL6;CAPZB
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4948646210817349,-1.1940567735419452,0.26146788990825687,0.8045708969779627,1.0,3/12,6.92%,APOE;LDLR;IAPP
prerank,regulation of cellular amide metabolic process (GO:0034248),0.499681343198532,1.1940478884536128,0.2608695652173913,0.9403057792375227,1.0,8/32,11.38%,ROCK1;NR1H4;ATXN2;CYFIP1;SAMD8;PRKCD;DDX25;RBM3
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3734014362194583,-1.1934582981534256,0.17363344051446947,0.8046267353338699,1.0,9/31,26.69%,HMGB1;MAPK14;LGALS9;PLCG2;TLR3;TIRAP;HSPD1;SYK;LAPTM5
prerank,cellular response to heat (GO:0034605),0.4825804224488289,1.193206358130313,0.27507163323782235,0.9416529204416904,1.0,5/35,9.67%,FGF1;ANO1;TCIM;MAPT;BAG3
prerank,regulation of intracellular transport (GO:0032386),0.4803326686347535,1.1929256919023952,0.2609308885754584,0.9411188805621129,1.0,4/38,6.82%,MYLK2;PLA2G3;LCP1;PTPN1
prerank,response to muramyl dipeptide (GO:0032495),0.5720577856778575,1.1924725252478157,0.293015332197615,0.9411975885033874,1.0,3/12,6.34%,VIM;ARHGEF2;CHMP5
prerank,histone H3-K9 demethylation (GO:0033169),-0.4997398027939747,-1.1922431220306346,0.26252983293556087,0.8066738139435261,1.0,4/11,17.73%,KDM7A;KDM3B;KDM4D;KDM1A
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5436862422386664,1.1916523729584416,0.2886762360446571,0.942539986847341,1.0,5/17,10.29%,FERMT2;THPO;TERT;KAT7;HNRNPU
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.49537505482774236,-1.1915358991240954,0.24413145539906103,0.8072162359870882,1.0,6/12,15.44%,KDELR1;HSPA5;ANKRD13C;OS9;RER1;INSIG1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.38094124984844274,-1.1914279462949553,0.2145214521452145,0.8055555841602654,1.0,10/32,16.29%,IGF1;ZBTB20;PID1;NUPR1;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C
prerank,regulation of neuron apoptotic process (GO:0043523),0.4233733150893019,1.1913807171099056,0.23431952662721894,0.942009847882736,1.0,13/96,7.86%,NTF3;MEF2C;TRIM2;PLA2G3;CRLF1;TGFB3;SET;BCL2;KCNB1;GDNF;PPARGC1A;FZD9;TGFB2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5349625927453605,1.1912501559450006,0.27848101265822783,0.9410328036548306,1.0,4/18,4.36%,DLC1;ITGA3;KANK1;TNFAIP1
prerank,positive regulation of cell motility (GO:2000147),0.40047663844415443,1.191033912818602,0.18730489073881373,0.9403568319084142,1.0,34/205,10.88%,NTF3;MYLK;NTRK3;ACTN4;FGF1;CAVIN1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;SEMA5A;CDH13;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;NTN1;SEMA6C;HAS2;SYNE2;CBLL1;CAV1;VEGFA;SNAI2;SUN2;ADAM17;WASHC1;PDGFRB;HBEGF;PDGFA;GPER1;ROCK2
prerank,cell chemotaxis (GO:0060326),0.4441632933295523,1.1898851850585999,0.24521072796934865,0.9427739020021897,1.0,13/60,11.28%,AGTR1;PDGFB;SEMA5A;NR4A1;ARHGEF16;PRKCQ;CXCR6;VEGFA;EPHA2;PARVA;PDGFRB;HBEGF;PRKCD
prerank,mesenchymal cell differentiation (GO:0048762),0.4522886928875663,1.1894365993875213,0.2565789473684211,0.9427796146576662,1.0,14/51,11.68%,MEF2C;HEY2;ROCK1;LIMS1;FAM83D;LOXL2;HEYL;SOX9;SNAI2;TGFB2;AKNA;HIF1A;ROCK2;HTR2B
prerank,response to UV-B (GO:0010224),0.5636223840498759,1.1884378985993125,0.2943396226415094,0.9448220658346799,1.0,4/12,16.73%,CRIP1;RELA;HYAL1;MSH2
prerank,protein insertion into membrane (GO:0051205),-0.3843413842170841,-1.1882650158387065,0.20567375886524822,0.8145970895368667,1.0,10/32,16.39%,APP;EGFR;ALDH3A2;CYB5A;STX5;SGTA;MAIP1;EMD;STX1A;TRAM2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.40947904456427053,-1.1881995716284932,0.23404255319148937,0.8128085584540378,1.0,6/23,20.37%,IGF1;PYDC1;CX3CL1;GIT1;ZC3H12A;CEACAM1
prerank,cellular response to osmotic stress (GO:0071470),0.5206766650027426,1.187939292099237,0.2990506329113924,0.9450458299310239,1.0,3/21,8.14%,MYLK;ARHGEF2;RCSD1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.4894479780722061,-1.1872961809333749,0.24770642201834864,0.8139935897755487,1.0,4/11,16.30%,SCARA3;CASP8;UNC93B1;TLR3
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.482327770564618,-1.1861104433613392,0.23644251626898047,0.8160305992489686,1.0,4/12,7.33%,TNKS2;PARP11;PARP10;PARP3
prerank,positive regulation of bone mineralization (GO:0030501),0.47834092112979665,1.1856297435247052,0.2723463687150838,0.9513606966065191,1.0,11/35,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1
prerank,negative regulation of GTPase activity (GO:0034260),-0.4000313062301142,-1.1844245980833792,0.20833333333333334,0.8198478412313787,1.0,8/22,18.42%,CPEB2;WNK1;GMIP;GPSM1;RDX;RCC2;LRCH1;ARL2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4609843545363279,-1.1842886060602282,0.26136363636363635,0.8183087601397717,1.0,6/14,33.17%,MOXD1;DAGLA;SLC5A7;DAGLB;ALDH9A1;SLC22A2
prerank,regulation of lymphocyte migration (GO:2000401),-0.516747515913822,-1.1841765845810595,0.2775423728813559,0.8166407066251801,1.0,4/10,19.76%,JAM2;AKT1;SLC8B1;MIA3
prerank,regulation of establishment of protein localization (GO:0070201),0.5592117900119822,1.1837382891590729,0.3019538188277087,0.9562655081000886,1.0,5/13,19.23%,PTP4A3;CEP290;CEP120;CEP295;CEP135
prerank,negative regulation of protein metabolic process (GO:0051248),0.4548455771118646,1.183610433803532,0.25407608695652173,0.95521228470144,1.0,12/48,16.28%,FLNA;ROCK1;EDNRB;PIN1;ITGB3;SF3B3;SIRT2;CLU;ADGRB1;AZIN2;MAD2L2;AGAP2
prerank,regulation of macrophage migration (GO:1905521),0.5970107558406843,1.1835011083632676,0.3108348134991119,0.9541649989412799,1.0,3/10,6.99%,EMILIN1;CD200R1;CD200
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5573866183111347,1.1832736153468213,0.3052064631956912,0.9520646990668871,1.0,5/11,15.34%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5573866183111347,1.1832736153468213,0.3052064631956912,0.9520646990668871,1.0,5/11,15.34%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5280625677816372,1.1827870961423963,0.29983792544570503,0.95223946935668,1.0,3/18,4.35%,RAP1A;SLC4A8;RIMS3
prerank,regulation of cell migration (GO:0030334),0.38791141072337976,1.1827788516266715,0.15879396984924624,0.9508345765712513,1.0,44/382,7.06%,NTF3;NEXN;FLNA;MYLK;TPM1;NTRK3;DLC1;ACTN4;VCL;TMIGD3;ROCK1;FGF1;NKD1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;SEMA5A;PLXND1;PLXNB1;CDH13;ANXA1;JAG1;KIF2A;KANK1;SERPINE2;IGFBP5;DOCK10;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;SEMA6C;HAS2;SYNE2;CBLL1;CAV1;RAP2C;DUSP3;VEGFA;CORO1C;STK26
prerank,mRNA destabilization (GO:0061157),0.4732795090135151,1.1824055789986256,0.2540106951871658,0.9506387682555332,1.0,11/38,14.01%,RBM24;ROCK1;UPF1;YTHDF2;CELF1;FTO;DIS3L2;ROCK2;CPEB3;ZFP36L1;GIGYF2
prerank,nitrogen compound transport (GO:0071705),-0.27956901847146454,-1.181971937291944,0.11904761904761904,0.8219762479028201,1.0,43/141,23.08%,SLC7A11;SLC6A13;ABCG2;PDPN;CALCRL;SLC12A2;SLC6A12;SLC6A6;SLC7A14;SCAMP2;SLC3A2;SCARB2;SLC52A1;SLC7A5;SEC14L1;TMEM30A;CERT1;PPT1;SLC22A4;SLC35F3;RCN3;RALBP1;SLC43A2;RAMP2;HSP90B1;TOM1;NDC1;SLC38A5;PICK1;SLC7A7;ARRDC1;CUBN;SLC15A4;LRRC8D;SCAMP3;MIA3;SLC1A4;SLC36A1;SLC43A1;SCAMP1;SLC5A7;TXNIP;ARRDC4
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.530414125805492,1.1816360009404947,0.2962962962962963,0.9516644439470225,1.0,6/19,11.08%,FZD5;CAMKK2;FBXW7;VDAC1;DNM1L;SREBF2
prerank,histone ubiquitination (GO:0016574),-0.41663256028055856,-1.181427039300629,0.25555555555555554,0.8218198359941739,1.0,6/21,13.87%,RNF20;UBR2;CTR9;PHC1;DTX3L;LEO1
prerank,organelle organization (GO:0006996),0.38494715950330505,1.181408174715795,0.1469098277608916,0.9510109985340679,1.0,71/388,14.14%,PALLD;TPM1;ARHGEF7;WTIP;MAST4;MICAL2;CHMP4C;PLCE1;LIMD1;SYNE1;ATP8B1;CNN2;DES;CLASP2;HSD17B10;PACSIN3;GABPA;PACSIN2;ARMC2;SORT1;GEM;TBC1D20;ARHGAP21;ARHGAP10;SIRT3;ATAD3A;DST;MARK1;LNPK;MYO18A;PEX2;CAV1;PITPNB;SEC31B;CHMP5;TERT;PARP1;ABCA3;YTHDF2;PPARGC1A;OPA1;MREG;MTX1;AUP1;MIEF2;ABCD4;LONP1;NSFL1C;DNM1L;TFB2M;PEX19;LONP2;KIF5C;KIFAP3;ESRRA;NECTIN2;CHMP2B;TNIK;PACSIN1;MICAL3;CDC42BPB;DMTN;CLASP1;MAST1;CAPZB;PNPLA3;CHMP2A;SIRT4;ADCK1;BNIP1;RAB14
prerank,insulin secretion (GO:0030073),0.520391496410303,1.1808605495996523,0.2937595129375951,0.9514510752665349,1.0,2/19,2.78%,CAMK2G;ANXA1
prerank,chloride transmembrane transport (GO:1902476),0.45128399006608855,1.180776420500512,0.2559366754617414,0.9502774195439471,1.0,10/48,11.98%,ANO1;GABRE;ANO6;SLC4A8;GABRA4;GABRA5;GABRB2;GABRG1;ANO3;GABRB3
prerank,camera-type eye development (GO:0043010),-0.4013753784602894,-1.1804903452677085,0.2471590909090909,0.823135432212699,1.0,9/25,9.35%,SHROOM2;FBN1;NF1;EFEMP1;LAMA1;FBN2;IFT122;CYP1B1;TENM3
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5414512351776244,1.1804026827340763,0.3092948717948718,0.9501874119917842,1.0,4/17,8.61%,PRKAB2;PDK4;CAV1;PPARA
prerank,secondary palate development (GO:0062009),-0.46185952255467616,-1.1794609538884278,0.2644230769230769,0.8247812718302928,1.0,4/14,3.76%,TGFBR3;LEF1;CHD7;WNT5A
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5023294046139329,1.1794556033267702,0.2818590704647676,0.9518658109111094,1.0,5/24,8.26%,ROCK1;ITGB1;CCL5;TNIP1;ITGA4
prerank,positive regulation of endocytosis (GO:0045807),-0.3517385627111927,-1.178719880226473,0.2037735849056604,0.8251961549947059,1.0,9/45,4.37%,DAB2;APPL2;LRP1;NEDD4L;APOE;VTN;B2M;HNRNPK;NLGN1
prerank,regulation of cholesterol efflux (GO:0010874),-0.3693120148462334,-1.1781776775497854,0.2326283987915408,0.8250935528031308,1.0,6/30,4.90%,LRP1;PLTP;APOE;PTCH1;LAMTOR1;NFKBIA
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4279661257706133,-1.177884950696671,0.24806201550387597,0.8241030138228985,1.0,6/19,19.38%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.3199253855972604,-1.1775164435180223,0.19004524886877827,0.8234279086353061,1.0,21/59,19.27%,LEF1;AGO3;MED13;TCF7L2;CDK8;RUNX2;MED15;MED17;CTNNB1;MED25;MED27;SETX;TNRC6A;MED6;CEBPB;MED7;PPM1D;BAX;TNRC6B;MED24;MECP2
prerank,renal water homeostasis (GO:0003091),0.5081212541658042,1.1774074440909876,0.27204783258594917,0.9571979535152265,1.0,9/23,15.25%,ADCY5;ADCY2;ADCY9;PRKACB;PRKAR1B;ADCY6;MYO5B;PRKACA;RAB11FIP2
prerank,kidney development (GO:0001822),0.4345414614535343,1.1774074209609666,0.25308641975308643,0.9557840717522794,1.0,8/65,7.86%,ITGA8;AGTR1;OSR2;CEP290;HAS2;VEGFA;GDNF;TGFB2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4399224237275562,-1.1770188587304196,0.2542372881355932,0.8231739751536944,1.0,6/17,19.38%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,positive regulation of macrophage activation (GO:0043032),-0.4369219121370158,-1.176994076130189,0.2365038560411311,0.8212763844373817,1.0,5/17,21.37%,LBP;WNT5A;IL33;TTBK1;HSPD1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.5041276424155897,1.1765523872753243,0.2679938744257274,0.9571759715972862,1.0,4/24,6.28%,PPP1R3A;DYRK2;IRS1;SORBS1
prerank,regulation of interleukin-12 production (GO:0032655),-0.3339240226956991,-1.1760607055546224,0.171875,0.8225056874788488,1.0,6/47,8.66%,FOXP1;HMGB1;MAPK14;LGALS9;PLCG2;IRAK3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5680141729148245,1.1753039499509343,0.32194244604316546,0.9598185158516349,1.0,2/10,5.44%,CHADL;EMILIN1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5333510859970577,1.1752112901459562,0.2948717948717949,0.9587094419426964,1.0,5/19,9.35%,NDST3;CSGALNACT1;EXT2;HS2ST1;HS6ST1
prerank,angiogenesis involved in wound healing (GO:0060055),0.5757539545228124,1.174039254531748,0.3273381294964029,0.9611343625023705,1.0,3/11,7.48%,MCAM;VEGFA;ITGB3
prerank,negative regulation of protein modification process (GO:0031400),0.4253501592718975,1.1736783927708823,0.24940898345153664,0.9609016074757518,1.0,13/79,9.37%,DMD;NTRK3;ATP2B4;SNTA1;CRTAP;MFHAS1;MAPT;TPPP;DAB2IP;CORO1C;ENSA;IMPACT;CDYL
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5543368995668617,1.1735696387973868,0.3315972222222222,0.9598334562056486,1.0,3/15,7.16%,ENTPD1;AK7;ENTPD7
prerank,telomere maintenance (GO:0000723),-0.3387358693525288,-1.1734552662665678,0.19313304721030042,0.829568568471732,1.0,25/50,28.38%,ATR;PRKDC;XRCC5;STN1;MRE11;RAD50;PARP3;SP100;BLM;XRCC6;NBN;CTC1;SMC5;TPRKB;TERF2IP;LTO1;HUS1;ATM;NSMCE2;ERCC4;DCLRE1B;TINF2;RPA3;DNA2;TEN1
prerank,telomere organization (GO:0032200),-0.34861750447992523,-1.1732916835245928,0.2177121771217712,0.8281451317921423,1.0,16/43,18.12%,ATR;PRKDC;XRCC5;STN1;MRE11;RAD50;PARP3;SP100;BLM;XRCC6;NBN;CTC1;TERF2IP;LTO1;HUS1;ATM
prerank,regulation of leukocyte migration (GO:0002685),0.5307302756324404,1.173215614352796,0.31290322580645163,0.9595764394316074,1.0,4/16,15.30%,ANXA1;VEGFA;RHOH;RHOG
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.44255515456818917,-1.1729447870164516,0.23471882640586797,0.827427913950692,1.0,7/16,19.06%,BMP7;SOX13;NAPEPLD;SIX1;PTGS2;TFE3;METRNL
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5846819167914872,1.172498378139349,0.31203007518796994,0.9604875325118123,1.0,2/10,6.44%,ACTN4;RXRG
prerank,regulation of axon guidance (GO:1902667),-0.5028224422324227,-1.1724356826052194,0.2505263157894737,0.8272101026601142,1.0,5/10,12.48%,NRP1;MYCBP2;ZSWIM6;ZSWIM5;ZSWIM4
prerank,carnitine shuttle (GO:0006853),0.5730263254377873,1.1721721379739265,0.3212996389891697,0.9602209435062644,1.0,5/11,14.41%,PRKAB2;ACACB;CPT1B;CPT1A;PRKAA2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.45577128236880277,1.1720632590735358,0.25891677675033026,0.9591947473396734,1.0,10/43,12.03%,ARHGEF7;ITGA1;SOCS5;SOCS4;DAB2IP;DUSP3;AREG;HBEGF;STAM2;TSG101
prerank,sprouting angiogenesis (GO:0002040),-0.32125142511873556,-1.1718368143958384,0.2074688796680498,0.8273791065249999,1.0,25/51,19.76%,ROBO1;EFNB2;ADGRA2;BMP4;SLIT2;CCBE1;TEK;NRP1;ENG;PIK3R3;ACVRL1;RECK;PTK2B;JMJD6;RNF213;BMPER;RAMP2;KDR;VEGFC;AKT1;FGF2;VEGFB;ITGB1BP1;EPHB4;MIA3
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.492457881324499,-1.1715507296577476,0.2793427230046948,0.826401089213219,1.0,5/11,22.31%,RASA1;PCBP2;NOVA1;NOVA2;PCBP4
prerank,regulation of cellular biosynthetic process (GO:0031326),0.49939267142126287,1.1706179592041792,0.29829545454545453,0.9625457231315554,1.0,5/28,7.29%,PRKAB2;NR1H4;PDK4;CCL5;MED1
prerank,protein localization to organelle (GO:0033365),-0.2711738583418203,-1.1703757040066853,0.17117117117117117,0.8284714816360812,1.0,39/133,17.26%,ANK2;COL1A1;BBS9;ZNF423;BMP7;BMP4;APP;DDX3X;RAB11A;CEP68;IFT122;GBF1;ALDH3A2;CEP250;CYB5A;TULP3;STX5;CNTLN;OPTN;TMEM30A;MDM2;GCC2;TOPORS;SSB;TOR1AIP1;SCG3;SGTA;SIX1;CALR;EMD;TOLLIP;EHD1;STX1A;LMBRD1;TRAM2;XPA;GABARAPL2;COG7;OBSL1
prerank,regulation of coagulation (GO:0050818),0.5727512133417554,1.1699118800603712,0.3263157894736842,0.963447217291556,1.0,2/11,6.08%,PROCR;CAV1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4883387355051157,1.1696472559857714,0.28530259365994237,0.9629437092965553,1.0,3/32,6.08%,AKAP6;CASQ1;CAV1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.41123878079963466,1.1695062007012436,0.2565011820330969,0.9619806294216083,1.0,15/100,7.86%,NTF3;NTRK3;PIP5K1B;PDGFB;PDGFC;ROR1;PIP4K2A;PLXNB1;CCL5;PDGFD;PIK3AP1;DAB2IP;NEDD4;SOX9;TGFB2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.39626650633415794,-1.1691408443955815,0.28034682080924855,0.8307707922685,1.0,9/23,18.63%,SEL1L;DERL1;UFD1;SURF4;HSP90B1;OS9;LMAN1;SYVN1;HERPUD1
prerank,positive regulation of telomerase activity (GO:0051973),0.4651618338788563,1.169006363862016,0.2867756315007429,0.9622103779620127,1.0,5/33,8.19%,PARM1;PARN;PRKCQ;PKIB;NAF1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4174798993216376,-1.168933044400059,0.2572178477690289,0.8295701660408965,1.0,8/20,12.38%,ITCH;DCUN1D3;UBQLN1;ZMIZ1;HSP90AB1;PRKN;TGFBR1;DNAJB2
prerank,histone H3-K4 trimethylation (GO:0080182),-0.49159531626392744,-1.1685592783917353,0.2679324894514768,0.8289802001627061,1.0,8/11,30.91%,TET3;CTR9;TET2;OGT;SETD1A;PRDM9;KMT2A;BEND3
prerank,peptidyl-proline hydroxylation (GO:0019511),0.556915400193728,1.1685248352892088,0.3109090909090909,0.962412967846331,1.0,4/11,10.29%,P3H2;CRTAP;P4HTM;P4HA2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.33375511635946364,-1.1683702830226295,0.20080321285140562,0.827756340513943,1.0,19/43,24.02%,CDC14B;NAE1;MRE11;RINT1;INTS3;BRCC3;BLM;NBN;TAOK1;FOXN3;NOP53;HUS1;ATM;CHFR;HMGA2;TAOK2;TRIM39;CLSPN;CDKN1A
prerank,regulation of gene expression (GO:0010468),0.3800066047868377,1.1680865322292047,0.076,0.9624244804522711,1.0,120/903,11.82%,MYOM1;ACTA2;CCDC3;SOX6;MLF2;MYLK2;TMPRSS4;TTN;WTIP;ACTG2;MEF2C;NTRK3;CRIP1;ATP2B4;HEY2;ZFHX3;ACTA1;ANGPT1;PTP4A3;ROCK1;FGF1;CD36;LIMS1;LIMD1;MYD88;PDGFB;NAB1;ALPK2;CDK6;PLA2G3;RORA;SLC8A2;SLC8A1;MLF1;GABPA;HINFP;RBM38;SORT1;ACTG1;GCNT2;RBAK;PRDM1;CD276;MUSK;RBMS3;UBR5;ATXN1;OSR2;HAVCR2;BMPR1A;SLC38A2;EMILIN1;PRKCQ;TESC;ATP1B1;MYBBP1A;TAF1;MAPT;TERT;TP53;SLC2A10;VEGFA;FBXW7;PIN1;ZBTB38;GDNF;SFPQ;YTHDF2;AR;PPARGC1A;TRAF3;MED1;PPARGC1B;ZNF431;CELF1;REXO4;BTG1;YAP1;NAT8;C1QTNF1;SOX9;SNAI2;DICER1;TGFB2;RELA;KMT2D;ADNP2;DAPK3;CUX2;TRIM68;MBNL2;MAP2K1;MSL3;FUS;NSD3;PPIE;KAT7;RPL5;HIF1A;PTBP2;MBNL1;NR2C2;NUP107;TOB2;GPER1;ROCK2;SRSF10;RUNX1;ANKRA2;RB1;RHOH;TERF2;BAZ2A;AFF1;NFX1;ACVR1B;ESRRA;CNOT7;PSPC1;USP13
prerank,zinc ion transmembrane transport (GO:0071577),-0.3976505775005838,-1.1680482183539067,0.246684350132626,0.8269204166235924,1.0,7/22,15.28%,SLC39A10;SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,long-term synaptic potentiation (GO:0060291),0.5152542561514134,1.1675269220494473,0.3037974683544304,0.9629075454116135,1.0,3/21,2.87%,CRHR2;SLC8A2;GRIN2C
prerank,superoxide metabolic process (GO:0006801),0.4808015707102125,1.1675123630322128,0.3042212518195051,0.9615649487227458,1.0,1/29,0.36%,NCF2
prerank,peptide hormone secretion (GO:0030072),0.4886936010391927,1.1672285210369104,0.2869692532942899,0.9610705151855835,1.0,2/26,2.78%,CAMK2G;ANXA1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.48948280767134217,1.1671104930602352,0.2984218077474892,0.9600987327203299,1.0,4/28,6.97%,NOTCH3;TCIM;FBXW7;YTHDF2
prerank,glycoprotein metabolic process (GO:0009100),-0.33362504187392616,-1.1667608659863913,0.20098039215686275,0.8293638277900233,1.0,13/53,11.00%,MAN1C1;ST3GAL4;ST8SIA4;NGLY1;ST6GALNAC3;ST8SIA1;FUT8;MGAT4B;GANAB;GOLPH3;MAN2A1;ADAMTS9;ST8SIA2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4536606511439438,1.1659419292498487,0.266304347826087,0.9625367125379862,1.0,7/43,5.14%,RBPMS2;HTR1B;PDGFB;CDH13;IGFBP5;CCL5;BMPR1A
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.37126103537031896,-1.1657961748426766,0.22186495176848875,0.8305670040157372,1.0,7/29,13.87%,LEF1;TLE1;TCF7L2;BCL9L;CTNNB1;EP300;LEO1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5551815482718414,1.1654906761383608,0.29965156794425085,0.9625768033959524,1.0,2/12,6.73%,PRKCQ;IL12RB1
prerank,alcohol catabolic process (GO:0046164),-0.4994300039955041,-1.1654154364444038,0.30620985010706636,0.8299433532440085,1.0,3/10,10.72%,CYP27A1;APOE;SCARF1
prerank,regulation of phospholipase activity (GO:0010517),-0.503194057631088,-1.1648897506642102,0.26939655172413796,0.8297175975815044,1.0,4/10,14.15%,LRP1;PDPK1;FGFR2;SNCA
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5089725849175576,1.1645022661027795,0.3127035830618892,0.9644660216438199,1.0,3/20,5.82%,KCNMA1;SLC8A1;ATP1B1
prerank,regulation of pseudopodium assembly (GO:0031272),0.5797780249015234,1.1637671614069334,0.3036053130929791,0.9641838520403769,1.0,2/10,8.93%,CDC42EP3;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5797780249015234,1.1637671614069334,0.3036053130929791,0.9641838520403769,1.0,2/10,8.93%,CDC42EP3;WASHC1
prerank,protein neddylation (GO:0045116),0.5554914498338017,1.163467412696758,0.32976827094474154,0.9638092860261733,1.0,5/13,12.09%,DCUN1D2;RNF7;UBE2F;DCUN1D1;UBA3
prerank,myeloid cell development (GO:0061515),-0.40988519901749415,-1.1631255684031432,0.29110512129380056,0.8340479867350026,1.0,5/18,7.97%,FOXP1;KIT;ANXA2;APP;ALAS1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.32090621405804,-1.162907531646608,0.22727272727272727,0.832864747208512,1.0,29/52,29.70%,DCPS;RC3H2;SAMD4B;LSM1;DIS3;EXOSC1;DCP2;PAN2;EXOSC9;PAN3;EDC4;CNOT11;TUT4;TUT7;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;CNOT10;EXOSC5;LSM3;ZFP36;LSM6;PNLDC1;PDE12;POLR2D
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.3705809756223901,-1.1628564223089208,0.22988505747126436,0.8311215495053397,1.0,18/29,37.60%,MRE11;HSP90AB1;RAD50;ANKRD28;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;GAR1;TINF2;PPP6C;NOP10;PPIA;ACD;RPA1;RFC1;NHP2
prerank,response to copper ion (GO:0046688),-0.405301091840256,-1.1621073957686578,0.24383561643835616,0.8317264828782749,1.0,11/20,18.89%,SNCA;MT2A;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H;HSF1
prerank,digestive tract morphogenesis (GO:0048546),0.5416148496483678,1.1609061906270468,0.31833910034602075,0.9709314219960038,1.0,1/14,0.81%,RBPMS2
prerank,positive regulation of locomotion (GO:0040017),0.47814116453232297,1.1608214678016682,0.3086232980332829,0.9698682576858721,1.0,4/27,5.41%,CAVIN1;PDGFB;NTN1;RARRES2
prerank,ethanol metabolic process (GO:0006067),0.5549958552648485,1.1602862314753757,0.30998248686514884,0.9702248154587487,1.0,1/12,0.89%,ACSS1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4596971286001478,-1.1602248378085307,0.2829736211031175,0.8360502368338986,1.0,9/13,31.08%,ELOVL7;HACD4;ELOVL4;ELOVL6;HACD2;ELOVL1;HACD3;ELOVL5;TECRL
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4271107171543389,-1.1600899776447202,0.28342245989304815,0.8346878607780037,1.0,14/19,33.56%,PGM3;RENBP;UGDH;PMM2;SLC35D1;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1;PMM1;NANS;GNPNAT1;MPI
prerank,secretion (GO:0046903),-0.4496341490578607,-1.1597165411570494,0.2962962962962963,0.8341975423901637,1.0,4/14,15.79%,SLC22A6;NPR1;SLC22A4;FBLN5
prerank,intermediate filament organization (GO:0045109),0.5451622734290548,1.159491114414121,0.31433224755700323,0.9714958451602587,1.0,2/17,2.61%,DES;VIM
prerank,vesicle transport along microtubule (GO:0047496),0.5056236337807393,1.159324718244968,0.2874432677760968,0.9707290270739611,1.0,9/23,12.26%,KIF3B;KIF1A;KIF5B;TRAK1;FYCO1;KIF1C;KIFAP3;FBXW11;KIF5A
prerank,regulation of B cell proliferation (GO:0030888),0.4592491994613538,1.1583373307456464,0.27903871829105475,0.9726280725786852,1.0,6/44,10.86%,MEF2C;IL2;TNFSF13B;BCL2;CD300A;TNFRSF21
prerank,carboxylic acid catabolic process (GO:0046395),-0.47277867015653013,-1.1579048531295708,0.2863636363636364,0.8383069285119081,1.0,10/12,48.06%,RENBP;ACOT8;AMDHD2;NPL;GNPDA1;PON3;NAGK;IL4I1;BCKDK;GNPDA2
prerank,regulation of T cell migration (GO:2000404),0.502762630072398,1.1573282738209774,0.3066884176182708,0.9745140287353283,1.0,4/18,6.99%,DOCK8;CCL5;CD200R1;CD200
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5324697244676372,1.1571714704649403,0.3127147766323024,0.9736262858187,1.0,4/15,12.12%,CD36;MYD88;EIF2AK2;USP50
prerank,sodium ion transmembrane transport (GO:0035725),0.41359832816155867,1.1569779163867413,0.2628504672897196,0.9729251626281307,1.0,10/84,5.82%,SCN4A;ASIC3;SLC6A17;ANO6;SLC8A2;SLC8A1;SLC4A8;SLC6A2;SLC6A5;ATP1B1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.38520792602783116,-1.156770684035528,0.25072886297376096,0.8402709011864802,1.0,11/25,21.40%,SMAD3;PKD2;NOS1AP;HSP90AB1;DDAH1;PTGS2;KLF2;INSR;AKT1;DDAH2;ASS1
prerank,response to lipid (GO:0033993),-0.28532636009948,-1.1565436467497017,0.18181818181818182,0.8391775489922559,1.0,32/105,17.24%,FOXP1;SMAD6;LBP;RBP4;FOXO1;LGALS9;SOCS2;ACER2;CTSH;IRAK1;NOCT;RPS6KA3;CTNNB1;PAQR7;PTPN22;IRAK3;PELI1;SPP1;NOS3;TAB2;ESR1;TGFB1;PAQR8;VPS4B;PCK2;SNCA;GCH1;IFNAR1;RARA;SRR;PPARG;TRIM16
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.29142168920964223,-1.1563273501892322,0.1610738255033557,0.8380466424882769,1.0,35/87,25.38%,RPL27A;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;SEC63;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;RPL36A;RPS8;RPS21;RPL9;SEC61A1;RPS7;RPL27;RPL11;SRP9;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RPS4X;RPS27
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3910785643993767,1.1562007628994435,0.2733118971061093,0.9741367258511313,1.0,22/151,10.84%,RAP1A;NTRK3;ANGPT1;CD36;PDGFB;PDGFC;FERMT2;ROR1;THPO;CCL5;GCNT2;PDGFD;MFHAS1;TNFRSF11A;FBXW7;GAREM1;RASGRP1;MAP2K1;PDGFRB;CCL14;PDGFA;GPER1
prerank,pyroptosis (GO:0070269),-0.44100984150208766,-1.1555969941952813,0.3014354066985646,0.8386886277889404,1.0,4/15,18.82%,GSDME;CASP8;GSDMD;CASP4
prerank,Ras protein signal transduction (GO:0007265),0.3982247695885373,1.1554525064311114,0.24581005586592178,0.9751484453942918,1.0,27/137,11.36%,AGTR1;RAP1A;ROCK1;CDC42EP3;PLCE1;CCNA2;RASGRP2;CDH13;MYO9B;RERG;NTN1;KSR1;ARHGAP6;ARHGDIG;RAP2C;TP53;RRAS;CYFIP1;RAPGEF6;RASGRP1;GNA12;ARHGAP1;RAP2A;ROCK2;RB1;ARHGAP5;RHOH
prerank,positive regulation of B cell activation (GO:0050871),0.43794211782000936,1.155367788863542,0.2857142857142857,0.9740570555463137,1.0,11/50,17.14%,MEF2C;IL2;TNFSF13B;BCL2;PAXIP1;RIF1;IRS2;KMT5B;MAD2L2;VAV3;MIF
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.4639558841730395,1.1553177078683947,0.29022988505747127,0.9728739577608522,1.0,8/32,11.28%,DLC1;ITGA1;PPP2R5A;PIN1;CALM1;CD300A;PDGFRB;PRKCD
prerank,neuron projection morphogenesis (GO:0048812),0.3924112861647994,1.1548611760739755,0.2549019607843137,0.9730866082128262,1.0,33/137,15.42%,NTF3;SDC2;ROCK1;PLXNB1;DOCK10;MAP1B;SLITRK5;ACTB;KLF7;MEF2A;SLITRK4;DAB2IP;AFG3L2;RAB3A;DICER1;IMPACT;BRSK1;FLRT1;S100A6;ZDHHC17;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;EPHB1;LRRK2;ADGRB1;DVL1;ANKRD27;CNTNAP1;PTEN;DNM2
prerank,protein tetramerization (GO:0051262),0.42373469973903094,1.1546693989900838,0.27581863979848864,0.9723359039697644,1.0,11/67,12.68%,RYR1;KCNJ12;HSD17B10;CRYZ;ACACB;TRPM4;ALDOA;GLS;OSBPL2;TRPM2;HOMER1
prerank,diol biosynthetic process (GO:0034312),-0.43142177056527803,-1.1540830038639558,0.2777777777777778,0.8418980632458681,1.0,7/15,22.94%,SPTLC2;ACER2;ASAH2;GCH1;SPR;ABCA2;SPHK1
prerank,cellular response to interleukin-4 (GO:0071353),-0.4942656898689336,-1.1538418136233062,0.31965442764578833,0.8407422828923288,1.0,3/10,20.34%,LEF1;STAT6;SHPK
prerank,histone H3 acetylation (GO:0043966),-0.34176314048070217,-1.1535101795377705,0.216,0.8400418474465297,1.0,13/40,18.19%,LEF1;MBIP;TADA2A;YEATS2;TADA1;DR1;BRPF1;PER1;NAA60;TAF12;MEAF6;TRIM16;TAF6L
prerank,response to prostaglandin E (GO:0034695),-0.4902840412472498,-1.1531693018395721,0.2924731182795699,0.8392893865587513,1.0,1/10,0.16%,TGFBR3
prerank,fluid transport (GO:0042044),-0.47105009660525454,-1.1531049526641508,0.29767441860465116,0.8376308762319752,1.0,1/12,1.63%,PDPN
prerank,positive regulation of ossification (GO:0045778),0.45792317192192383,1.152673828399994,0.29499323410013534,0.9775509314796018,1.0,12/39,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;TGFB2;ATP2B1
prerank,external encapsulating structure organization (GO:0045229),0.38943899226481654,1.152575353573511,0.23157894736842105,0.9765096180199887,1.0,28/205,8.54%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;PDGFB;ITGA1;ITGA3;ADAMTS5;ADAMTS19;COL4A6;ITGB1;BGN;JAM3;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;ITGA4;COL27A1;COL4A5
prerank,protein localization to membrane (GO:0072657),0.38993194949205007,1.152422306298182,0.2457627118644068,0.9756453939929094,1.0,48/187,16.94%,CACNB2;FLNA;TSPAN32;FGF13;RAP1A;ROCK1;FERMT2;CLASP2;EHD2;KCNB1;FYB2;KCNIP3;TESC;ATP1B1;ZDHHC2;CAV1;TTC7A;RAB3A;RAMP1;RAPGEF6;SAV1;ITGA4;LIN7C;EPHA2;RAP2A;ACTN2;AGRN;ROCK2;DPP10;TMEM88;TNIK;PACSIN1;RAB40C;SLMAP;GAS6;DVL1;TSPAN17;RAB34;RAB8B;FLOT1;PRAM1;RFTN1;ANK1;LIN7A;SMURF1;RAB8A;TM9SF2;RAB38
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5126659963731898,1.152096052792375,0.3154471544715447,0.9754324335012383,1.0,4/18,8.26%,ROCK1;ITGB1;ADD2;ITGA4
prerank,cellular component assembly (GO:0022607),0.38160725034830156,1.1520600852958904,0.21560574948665298,0.9742144928515035,1.0,47/253,13.57%,FLNA;TCAP;PLS3;CALD1;LIMS1;FERMT2;LCP1;SH3BGR;ACTG1;MYO1B;SKAP2;FLNC;RSPH1;ACTB;CEP290;HAS2;CHAF1B;AFG3L2;LIMS2;TP53;ABCA3;LAMC1;RHOJ;YTHDF2;CYFIP1;PPARGC1A;MDN1;TOGARAM1;YAP1;SOX9;ADD2;MAGI1;PARVA;PAWR;SYCP2;TEAD1;DNM1L;PDGFA;TLCD2;RHOH;KIFAP3;SNX9;PDCD10;DMTN;KPNA3;FOXJ1;GAS6
prerank,cellular potassium ion homeostasis (GO:0030007),0.5401117415906974,1.151799630537055,0.3229357798165138,0.9737191744174488,1.0,2/13,5.82%,KCNMA1;ATP1B1
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2916254850306472,-1.1512752537042663,0.1870967741935484,0.8417404602702643,1.0,28/91,17.81%,BMP6;ABCG2;CP;FBXL5;APP;SLC39A10;SLC30A10;SCARA5;ABCB7;SLC39A8;ATOX1;FTL;ATP6AP1;ATP6V1G1;FTH1;SLC30A1;ACO1;SLC39A6;MT2A;SMAD4;MT1G;MT1A;MT1B;MT1F;MT1M;MT1E;MT1X;MT1H
prerank,negative regulation of leukocyte activation (GO:0002695),0.5251152737366156,1.151092823365767,0.336734693877551,0.9746870550723639,1.0,5/15,10.84%,MILR1;HAVCR2;CD200;CD300A;GPER1
prerank,synapse assembly (GO:0007416),0.42265010781075235,1.1507000278291515,0.29181929181929184,0.9745864501450539,1.0,17/67,15.34%,FGF13;IGFN1;FZD5;PLXND1;PLXNB1;KIRREL3;PCDHB14;DSCAM;PCDHB11;CDH2;GABRB2;CBLN4;GABRB3;SHANK2;PLXNB2;DVL1;PTEN
prerank,positive regulation of tissue remodeling (GO:0034105),0.5653439083700407,1.150699687151239,0.3176895306859206,0.9732477324937556,1.0,2/10,3.19%,ROCK1;IL2
prerank,extracellular structure organization (GO:0043062),0.38838513748978987,1.1506324276644113,0.2339304531085353,0.9720965539808486,1.0,28/204,8.54%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;PDGFB;ITGA1;ITGA3;ADAMTS5;ADAMTS19;COL4A6;ITGB1;BGN;JAM3;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;ITGA4;COL27A1;COL4A5
prerank,ERBB signaling pathway (GO:0038127),-0.30197293106703027,-1.1504355872068468,0.22110552763819097,0.8426408180358763,1.0,14/64,11.28%,PIK3CA;EFEMP1;GRB2;TGFA;PDPK1;PTPN11;EGFR;PTK2;SLC30A10;GAB1;PTK2B;NRG2;TGFB1;STUB1
prerank,nuclear membrane disassembly (GO:0051081),-0.45516213002031747,-1.1504124181086703,0.2789598108747045,0.8408817751730757,1.0,4/14,16.58%,PRKCB;AKAP8L;NEK9;NEK6
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4720379467822093,-1.1494514804875327,0.3274336283185841,0.8422865771901505,1.0,5/12,27.47%,PPHLN1;SETDB1;MPHOSPH8;RESF1;SETDB2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.2992035379221776,-1.1494179209427398,0.16201117318435754,0.8405360825096266,1.0,18/70,7.71%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5861225948579162,1.1490635158181213,0.3406193078324226,0.9759916403997269,1.0,4/10,14.92%,PMAIP1;IRS1;PTH1R;IRS2
prerank,limb morphogenesis (GO:0035108),-0.3984617536063218,-1.1489281047633297,0.28688524590163933,0.8404277387249527,1.0,4/20,5.56%,PCSK5;CYP26B1;PTCH1;MEGF8
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2970348237284701,-1.148860009190438,0.15819209039548024,0.8388283684328115,1.0,18/73,7.71%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,protein polyubiquitination (GO:0000209),-0.2447580842720876,-1.1487824258480122,0.0625,0.8372514616967491,1.0,72/297,14.53%,TTC3;SASH1;NEDD4L;FBXL7;TRIP12;FBXL5;RNF146;AREL1;ITCH;FBXO10;CUL3;TNKS2;ANAPC1;RNF20;PPIL2;UBE2D3;NPEPPS;RNF135;RC3H2;RNF144B;SHPRH;RNF217;UNKL;RNF6;UBR2;CTNNB1;BIRC2;FBXO9;PSMD7;PSMD9;PSMD13;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;WWP1;SMURF2;RNF144A;RNF31;PRKN;UBE3A;UBE4B;PSMB3;UBC;TRIM5;RNF34;STUB1;HECTD2;RMND5A;SKP2;DZIP3;LONRF1;TRIM14;RNF125;DTX3L;RNF166;PSMC5;FBXW8;SIAH1;PSMA5;PSMA1;PSMC2;UBE2H;RNF115;HECW1;CDC26
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5092923089806813,1.148689077444062,0.3250825082508251,0.9758948249726893,1.0,3/19,5.14%,MEF2C;TBX2;BMPR1A
prerank,regulation of microglial cell activation (GO:1903978),-0.4365570619698737,-1.1486339216711998,0.2975,0.8359255264321122,1.0,6/15,22.94%,LDLR;CX3CL1;SYT11;GRN;TTBK1;SPHK1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4431662664196468,-1.1485626272075522,0.28888888888888886,0.8343259541061702,1.0,4/14,24.60%,IL18;DENND1B;RARA;CD86
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4031543356658231,-1.1482973383366417,0.27692307692307694,0.8315968969244102,1.0,3/21,1.39%,EYA2;EYA1;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4031543356658231,-1.1482973383366417,0.27692307692307694,0.8315968969244102,1.0,3/21,1.39%,EYA2;EYA1;EYA4
prerank,negative regulation of immune system process (GO:0002683),0.5266308001493635,1.1482813883492353,0.32059800664451826,0.975864746536853,1.0,4/16,12.43%,CD200;SOX9;GPER1;COL3A1
prerank,bile acid and bile salt transport (GO:0015721),0.5005239695541562,1.148168420568419,0.31278890600924497,0.9748653256459797,1.0,3/24,2.91%,NR1H4;ATP8B1;SLC10A1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2984049486206823,-1.147367591881178,0.14857142857142858,0.8327677426553961,1.0,18/71,7.71%,ELMO1;PIK3CA;GRB2;CYFIP2;PTK2;ABI1;WIPF2;BAIAP2;ARPC5;VAV2;WASF2;PLCG2;ARPC3;NCK1;HSP90AB1;PIK3CB;ARPC4;PRKCE
prerank,stabilization of membrane potential (GO:0030322),-0.43475473055891367,-1.1472849543724557,0.2783018867924528,0.8312371402490957,1.0,2/16,6.55%,KCNK2;KCNK5
prerank,negative regulation of cytokine production (GO:0001818),-0.2619541182873055,-1.1471707642295044,0.1388888888888889,0.8298272635711303,1.0,43/163,21.01%,LGR4;LEF1;APPL2;ARRB1;HMGB1;FN1;ITCH;APOD;RNF135;OTUD7B;MAPKBP1;LGALS9;HDAC7;ADCY7;ILRUN;UFD1;SRGN;PCBP2;CD34;NAV3;PTPN22;IRAK3;TRIM25;HOMER3;PDCD4;RGCC;SIRPA;RNF125;CX3CL1;ANXA4;SYT11;C1QTNF3;SSC5D;RARA;NLRC5;UBA7;NCKAP1L;ZC3H12A;TWSG1;BCL3;CEACAM1;CD274;PPP1R11
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4231525230760059,1.1468529961539107,0.28588957055214725,0.9776709994185854,1.0,10/72,5.09%,ABRA;GPR20;DLC1;SYNPO2L;ITGA3;MYO9B;KANK1;NET1;TNFAIP1;ARHGEF2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.457893601548199,-1.1464708487473478,0.30536130536130535,0.8302251106371552,1.0,7/13,21.39%,NOS3;GCH1;PRKG2;AKT1;PTS;FPGS;SPR
prerank,glycine transport (GO:0015816),0.56401062532564,1.1463207889393545,0.34275618374558303,0.978099537095185,1.0,3/10,10.37%,SLC6A17;SLC6A5;SLC7A8
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2701468535740543,-1.145837182642781,0.16346153846153846,0.8305404477833256,1.0,35/128,17.45%,PTN;BMP6;SASH1;IL15;APP;IL18;WNT5A;STX3;NFKBIA;PUM1;POLR3F;GPR4;STX4;NAPEPLD;TNFRSF1A;THBD;OPTN;TGFB1;RIOK3;PDCD4;SCARF1;POLR3B;DDX60;IL33;NFKBIZ;PPM1F;CX3CL1;SNCA;ANKRD17;PLA2G7;TLR3;GRN;SERPINE1;PDE2A;CCN4
prerank,histone H2A ubiquitination (GO:0033522),-0.42306623686749933,-1.1457749773824069,0.2890625,0.8289622550913697,1.0,6/17,22.77%,RYBP;UBR2;DDB1;DTX3L;BCOR;UBE2B
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.32409520626685245,-1.1454100400633835,0.19911504424778761,0.8284216216846375,1.0,10/53,9.53%,EYA2;EYA1;EYA4;DDX5;SPRED2;ATR;EGFR;FBH1;SMCHD1;BRCC3
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.4471733732595288,1.1453110961623223,0.3165374677002584,0.9799776146283418,1.0,13/48,12.81%,POLR2L;PADI2;H1-0;ARID1A;ACTB;MYBBP1A;CHEK1;ERCC6;POLR1E;SERTAD2;POLR1H;SMARCA5;SF3B1
prerank,nitric oxide metabolic process (GO:0046209),-0.4403795514503259,-1.1451252144576387,0.3127962085308057,0.8274818946322052,1.0,6/14,21.39%,CYP1B1;NOS3;GCH1;AKT1;DDAH2;SPR
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5545327562157188,1.1450455834359416,0.3233743409490334,0.9794987353299225,1.0,5/13,15.37%,RNF152;KPTN;CASTOR1;CASTOR2;ITFG2
prerank,negative regulation of phagocytosis (GO:0050765),0.5131262353176508,1.1449792171139992,0.35333333333333333,0.9783966654132987,1.0,4/17,8.34%,FER1L5;DYSF;PIP4P2;CD300A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.45521358224312425,1.1449212159027118,0.30303030303030304,0.9772615508891409,1.0,11/40,7.87%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.31021892257410916,-1.1448769780872958,0.23414634146341465,0.8265086235534105,1.0,20/56,17.59%,KMT2E;DDX3X;CUL3;CCND3;EGFR;RAB11A;ADAMTS1;TFDP1;RDX;UBE2E2;CDC23;RGCC;VPS4B;RCC2;CDC25B;ANKRD17;AKT1;CDC25A;KLHL18;ANAPC4
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3764271667989765,-1.1445972773836948,0.25443786982248523,0.8257043686299784,1.0,10/26,18.18%,SMAD3;PKD2;NOS1AP;HSP90AB1;DDAH1;PTGS2;KLF2;INSR;AKT1;DDAH2
prerank,negative regulation of cyclase activity (GO:0031280),-0.438640653983395,-1.144347070340817,0.3140096618357488,0.8247689178274786,1.0,3/14,2.21%,ADGRV1;PALM;GRM3
prerank,actin filament bundle assembly (GO:0051017),0.46801174434278264,1.1440235350543109,0.3068017366136035,0.9788489840987326,1.0,6/33,10.16%,PLS3;CALD1;LCP1;MYO1B;ADD2;PAWR
prerank,positive regulation of cellular metabolic process (GO:0031325),0.403699178731653,1.1437422753037627,0.27963176064441886,0.978473330109451,1.0,14/98,10.44%,NTF3;AGTR1;ANGPT1;PDGFB;DHRS4;CCL5;TP53;VEGFA;ACACB;CBR1;PPARA;ATAD1;PDGFRB;SCYL2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3375377864555218,-1.143739952228852,0.23076923076923078,0.8250389002900261,1.0,13/40,12.16%,DAB2;SMAD3;LEF1;COL1A1;PDPN;TCF7L2;BCL9L;CTNNB1;SDCBP;TGFB1;TGFBR1;RGCC;WWTR1
prerank,eye development (GO:0001654),-0.32232736904651776,-1.1436731327676368,0.22115384615384615,0.8234956946939201,1.0,9/54,6.53%,SHROOM2;FBN1;SMOC1;EFEMP1;LAMA1;PBX3;FBN2;RBP4;COL5A1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.340409621767542,-1.1436208449156937,0.2563176895306859,0.8219342303275181,1.0,13/38,25.15%,BMP6;SASH1;PUM1;POLR3F;RIOK3;POLR3B;DDX60;ANKRD17;GRN;SLC15A4;GBP5;POLR3C;POLR3D
prerank,regulation of osteoclast differentiation (GO:0045670),-0.35630678866547616,-1.1432759003369817,0.22742474916387959,0.8212691899358222,1.0,11/33,33.70%,FBN1;TCTA;CEBPB;PRXL2A;TLR3;GPR137B;MAFB;GPR137;CAMK4;FSTL3;UBASH3B
prerank,regulation of cell growth (GO:0001558),0.37975108339427294,1.143187173019373,0.2358490566037736,0.9788979809641531,1.0,41/204,14.70%,SLIT3;AGTR1;AKAP6;PAPPA2;MYL2;PLCE1;RASGRP2;CAMK2D;IL2;RERG;FHL1;NET1;PABIR1;ATAD3A;FXN;BCL2;JADE1;PRKCQ;NDRG3;TP53;BTG1;TGFB2;ADNP2;ADAM17;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;HDGFL2;BCL6;CEP43;MUL1;SGK1;N6AMT1;HYAL1;NUBP1;VGLL4
prerank,positive regulation of chemotaxis (GO:0050921),0.44741385554737567,1.1431588330771285,0.3045822102425876,0.9776682167275038,1.0,9/43,10.07%,NTRK3;PDGFB;SEMA5A;CDH13;RARRES2;DSCAM;VEGFA;ADAM17;PDGFRB
prerank,acute-phase response (GO:0006953),0.5442158834450741,1.1429018319556867,0.32413793103448274,0.9771981810118388,1.0,3/12,7.82%,ITIH4;MBL2;IL22
prerank,cellular response to interleukin-6 (GO:0071354),-0.3688019725867298,-1.1427547213918479,0.28291316526610644,0.8213543269614679,1.0,6/26,8.49%,PID1;ST3GAL6;SBNO2;PTPN11;CTR9;IL6R
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4230558982224325,-1.1426416576946412,0.2795969773299748,0.820065623555472,1.0,8/17,26.78%,STX3;STX4;SNAP29;STX1A;SYP;STX2;TOR1A;SYNGR2
prerank,cochlea morphogenesis (GO:0090103),0.5559968168571101,1.1423444656125445,0.30129390018484287,0.9776881460185395,1.0,2/10,7.68%,TBX18;SOX9
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.480844268109711,-1.1421774177342632,0.3160377358490566,0.8197599158098368,1.0,2/10,2.40%,APOE;ABCA1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4538829976756207,1.1420032995723441,0.2959889349930844,0.9774445545711862,1.0,9/39,12.03%,ARHGEF7;ITGA1;PTPN18;DAB2IP;DUSP3;AREG;HBEGF;STAM2;TSG101
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3502963619101951,-1.14184036030878,0.2379182156133829,0.8191564426823181,1.0,8/36,8.60%,RBBP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,positive regulation of secretion (GO:0051047),-0.4792060191677388,-1.1416797095059137,0.31291028446389496,0.8180124596167078,1.0,2/11,9.95%,NPR1;ACSL3
prerank,regulation of multicellular organismal development (GO:2000026),-0.38647206292280045,-1.1413300598078742,0.27044025157232704,0.8174273335507369,1.0,11/25,30.54%,PTN;TRIP12;INSR;SOX17;OAS2;SPAAR;DUSP6;KAT2A;CD24;TDG;RACGAP1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4970082669496458,-1.1412742719929085,0.3141592920353982,0.8159019396599428,1.0,4/10,17.22%,BMP6;RGCC;PPM1F;NOTCH4
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3660875583403589,-1.140914700981767,0.2260061919504644,0.815403824561923,1.0,6/29,11.59%,ZBTB20;APOE;LDLR;LPGAT1;CREBL2;CREB1
prerank,maintenance of blood-brain barrier (GO:0035633),0.47333269474829964,1.1409047910072327,0.3157894736842105,0.9796793051624625,1.0,8/30,7.75%,DMD;VCL;ACTG1;ITGB1;ACTB;JAM3;LAMC1;MBP
prerank,purine nucleotide metabolic process (GO:0006163),-0.39227622057152667,-1.1408033762566308,0.2832369942196532,0.8140393168701132,1.0,10/24,23.52%,XDH;NT5E;GART;HPRT1;PRPSAP2;ITPA;GPX1;PNP;GUK1;PRPS2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5340024547908773,1.140802589272071,0.35604770017035775,0.9786911443477916,1.0,3/15,5.82%,KCNA5;KCNN2;ATP1B1
prerank,neuron maturation (GO:0042551),-0.4197655319141265,-1.1407900653535494,0.2576530612244898,0.8124020395490024,1.0,10/18,21.23%,APP;ADGRB3;B4GALT6;ANKS1A;SCARF1;CX3CL1;EPHA8;PICK1;LGI4;MTCH1
prerank,adherens junction organization (GO:0034332),0.44234915526948926,1.1407877349930309,0.29427792915531337,0.9774212525360861,1.0,13/48,12.73%,CDH6;VCL;FERMT2;CDH13;CDH4;ACTB;JAM3;CDHR3;CDH2;PAK2;TBCD;NECTIN2;CDH10
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5406044742129218,1.14068650179382,0.3333333333333333,0.9764411857473011,1.0,3/14,10.84%,ANO6;ITGA4;GPER1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.4245751424076764,1.1403960985790844,0.2936010037641154,0.9760554029291967,1.0,20/62,19.65%,WTIP;POLR2L;LIMD1;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;STAT3;DHX9;NUP54;NUP160;NUP133;AGO1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3703899887500436,-1.1401869267628146,0.28115015974440893,0.8126365421216636,1.0,12/29,26.98%,VTI1A;COPB2;COG6;COPE;GABARAPL2;COG2;NAPG;TRAPPC3;COPB1;GOLGA5;COPG2;GOSR1
prerank,nucleotide catabolic process (GO:0009166),-0.4328954953440121,-1.1397710399949363,0.29974811083123426,0.8123252189263378,1.0,7/16,19.77%,XDH;NT5E;SAMHD1;NUDT3;ITPA;GPX1;PNP
prerank,nitric oxide biosynthetic process (GO:0006809),-0.44787253700311214,-1.1396053059612692,0.3140877598152425,0.8112308297871609,1.0,6/13,21.39%,CYP1B1;NOS3;GCH1;AKT1;DDAH2;SPR
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4507597521879081,-1.1393617265915994,0.29010989010989013,0.8103618120319395,1.0,5/13,8.24%,PLXNA2;NRP2;NRP1;SEMA3A;PLXNA4
prerank,ventricular septum morphogenesis (GO:0060412),0.48475529997207106,1.1393302091664383,0.3359013867488444,0.978295454700494,1.0,5/27,7.86%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,ureteric bud morphogenesis (GO:0060675),-0.4245439150624906,-1.1392838543907728,0.2764423076923077,0.8089212685542863,1.0,5/16,16.03%,BMP4;PKD2;SALL1;SIX1;FGF2
prerank,regulation of axonogenesis (GO:0050770),-0.3219849824059054,-1.1392365813264695,0.2290748898678414,0.8073837688509942,1.0,9/51,8.24%,PLXNA2;ROBO1;SLIT2;KIF13B;EPHA4;SIPA1L1;RUFY3;TIAM2;PLXNA4
prerank,potassium ion transmembrane transport (GO:0071805),0.3878335467592905,1.1391825350950326,0.2855543113101904,0.9774571226690096,1.0,17/135,11.35%,KCNAB1;KCNJ12;KCNQ5;KCNA5;KCNQ4;KCNN2;KCNE4;KCNB1;CCDC51;KCNH1;ATP1B1;KCNT2;SLC9A8;ABCC8;KCNH8;KCNK3;KCNA2
prerank,response to interleukin-1 (GO:0070555),0.4137416089265617,1.1390744145459069,0.28518971848225216,0.9764870780119747,1.0,17/73,14.87%,MYD88;ANXA1;CCL5;PTGIS;UPF1;HAS2;TNFRSF11A;DAB2IP;SOX9;RELA;NR1D1;HIF1A;CCL14;YTHDC2;GBP2;HYAL1;PRKCA
prerank,regulation of protein import into nucleus (GO:0042306),0.45241132832808834,1.138915477204871,0.2986111111111111,0.9756898416336454,1.0,3/36,4.55%,FLNA;CABP1;UBR5
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.4604422625307186,-1.138781587348677,0.325,0.807081513085719,1.0,4/13,8.50%,AKT3;HMGB1;PDPK1;IGF2
prerank,actin filament bundle organization (GO:0061572),0.46833483921067887,1.1387252591891452,0.33827893175074186,0.9750185812815724,1.0,6/33,10.16%,PLS3;CALD1;LCP1;MYO1B;ADD2;PAWR
prerank,ganglioside metabolic process (GO:0001573),-0.4078207241638888,-1.1383901752853174,0.2988826815642458,0.8065661435206817,1.0,10/20,29.51%,ST8SIA4;ST3GAL5;ST6GALNAC3;ST8SIA2;HEXA;ST6GALNAC5;ABCA2;NEU1;ST6GALNAC4;ST8SIA3
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.48649407490472507,-1.138229766698286,0.31065759637188206,0.8054016352256149,1.0,6/11,22.99%,IP6K1;IP6K2;PPIP5K2;FGF2;ITPKB;IPPK
prerank,natural killer cell mediated immunity (GO:0002228),0.5166898128678952,1.1378727507729534,0.31314878892733566,0.9764581145043829,1.0,2/15,7.78%,LYST;KIF5B
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3407739125116109,-1.1375010369287748,0.272,0.8060682204187475,1.0,13/39,18.87%,TSPAN5;ROBO1;AAK1;BMP2K;ZMIZ1;NOS3;CCN3;SNW1;EP300;JAG2;MAML1;NOTCH4;ITGB1BP1
prerank,response to organic cyclic compound (GO:0014070),0.43340679186624564,1.1372731017890707,0.3054448871181939,0.9770423916721462,1.0,7/52,6.40%,PMAIP1;ABCB4;ANXA1;IGFBP5;CCL5;STRN3;ARL6IP5
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4549130628486596,1.1370536406305656,0.31657608695652173,0.9764772361229992,1.0,7/39,6.96%,ACTN4;JAG1;KANK1;FZD4;GCNT2;AJAP1;CORO1C
prerank,Rap protein signal transduction (GO:0032486),0.567933297311139,1.1369474615510227,0.375,0.975554794725211,1.0,3/10,9.85%,RAP1A;RAP2C;RAP2A
prerank,positive regulation of cell migration (GO:0030335),0.3795741374177173,1.1351344195611937,0.23735810113519093,0.9799767294958057,1.0,48/253,13.36%,NTF3;MYLK;ARHGEF7;NTRK3;ACTN4;FGF1;PDGFB;PPP3CA;CCN1;PDGFC;FERMT2;SEMA5A;CLASP2;CDH13;ACTG1;ITGB1;CCL5;GCNT2;PDGFD;SEMA6C;ARHGEF2;HAS2;SYNE2;CBLL1;CAV1;DAB2IP;VEGFA;SOX9;SNAI2;TGFB2;SUN2;ADAM17;WASHC1;HIF1A;PDGFRB;DOCK1;HBEGF;PDGFA;GPER1;ROCK2;ACVR1B;KIF20B;PDCD10;DMTN;CLASP1;CPNE3;FGF10;CEP43
prerank,magnesium ion transport (GO:0015693),-0.4638768768157832,-1.13492265531296,0.30238095238095236,0.8125671446616054,1.0,5/12,19.06%,TUSC3;SLC41A1;NIPAL2;NIPAL3;MMGT1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4674986199836346,1.1348342119528732,0.3255131964809384,0.9796750084562126,1.0,5/28,13.54%,FLNA;UBR5;BAG3;PRKCD;TRIM28
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5544508181708432,1.134821265054515,0.3291592128801431,0.9784271279436622,1.0,3/11,19.40%,PKD1L3;LPO;RTP4
prerank,protein insertion into ER membrane (GO:0045048),-0.34346204469360514,-1.134635668113976,0.254416961130742,0.8118062842650334,1.0,12/37,19.06%,APP;EMC2;ALDH3A2;CYB5A;STX5;SGTA;EMC3;EMC8;EMD;STX1A;TRAM2;MMGT1
prerank,cellular response to fluid shear stress (GO:0071498),0.5477432454851288,1.1342642649629884,0.3572679509632224,0.9788780644081831,1.0,3/12,11.08%,MEF2C;HAS2;SREBF2
prerank,organic hydroxy compound transport (GO:0015850),0.4619810992204796,1.1334338400067294,0.3173913043478261,0.9801954905484401,1.0,4/36,2.91%,NR1H4;ATP8B1;SLC5A3;SLC10A1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4927807909033492,1.1327682971561241,0.33796296296296297,0.9809905142355153,1.0,4/23,8.12%,MAP3K5;TNFRSF11A;DAB2IP;MAP3K10
prerank,anion transmembrane transport (GO:0098656),-0.3054024264425464,-1.1324980750170774,0.2222222222222222,0.8167799126788642,1.0,34/67,33.14%,SLC6A13;SLC13A4;SLC16A12;SLC1A3;SLC13A3;LRRC8B;SLC3A2;SLC7A5;SLC39A8;SLC6A9;SLC25A14;SFXN2;SLC35A2;SLC25A30;SLC38A5;SLC25A11;SLC25A38;LRRC8D;SLC1A1;SLC6A8;SLC25A22;LRRC8A;ABCC5;SLC25A19;SLC25A21;SLC1A2;SLC5A6;SLC35C2;SLC25A18;SFXN3;SLC13A5;SLC1A6;SLC35B1;PRAF2
prerank,positive regulation of apoptotic process (GO:0043065),0.37298616283349345,1.1320922029783795,0.24211597151576805,0.9819031614044162,1.0,45/293,12.53%,KCNMA1;OBSCN;ARHGEF7;MAP3K20;DLC1;MAP3K5;PMAIP1;KALRN;ABR;ARHGEF17;ANO6;ITSN1;TGFB3;ITGB1;NET1;PTGIS;ARHGEF16;ARHGEF2;ATG7;MYBBP1A;DAB2IP;RPS6KA2;ARL6IP5;TP53;PHLDA3;BTG1;FZD9;TGFB2;MAP3K10;DAPK3;TNFAIP8;ARHGEF4;HRK;SIRT2;PAWR;DNM1L;VAV1;GPER1;TRIM35;BOK;CLIP3;CSRNP3;DIABLO;CLU;ITGB3BP
prerank,negative regulation of receptor binding (GO:1900121),0.5645702510517716,1.1318921193369296,0.36666666666666664,0.9813012420274703,1.0,3/10,10.32%,ATP2A2;PTPRF;ATP2A3
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.4989002245742334,1.1314422322524444,0.34134615384615385,0.9814661475687487,1.0,5/22,13.14%,IL2;LAG3;CBFB;RUNX1;BCL6
prerank,hippo signaling (GO:0035329),-0.37778025474286636,-1.1313353105234405,0.2904191616766467,0.8186465763242826,1.0,9/26,13.00%,TJP1;TJP2;AMOTL1;TEAD4;LATS2;WWC1;TEAD2;WWTR1;MOB1B
prerank,positive regulation of protein processing (GO:0010954),0.49822458725650903,1.1312683158625494,0.3091216216216216,0.9807220906210089,1.0,4/19,13.17%,ANGPTL8;MYH9;LPCAT3;BAG2
prerank,negative regulation of chemotaxis (GO:0050922),-0.35807568530824874,-1.1311044213688384,0.27741935483870966,0.8177677561846265,1.0,8/31,7.79%,ROBO1;SEMA3D;SEMA3C;SEMA6A;SLIT2;SEMA7A;SEMA3A;SEMA4D
prerank,negative regulation of coagulation (GO:0050819),-0.4486990667475846,-1.1306183049844671,0.3392405063291139,0.817738457414957,1.0,5/14,8.27%,APOE;VTN;TFPI;CD34;THBD
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.44217482453990564,-1.130523107567779,0.3215130023640662,0.8164252422054048,1.0,3/13,2.21%,ADGRV1;PALM;GRM3
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4157830115930292,-1.130449403639073,0.3078817733990148,0.8150122091489591,1.0,6/18,19.38%,CAMK1D;MOSPD2;MCU;RIPOR2;NCKAP1L;TIRAP
prerank,transport along microtubule (GO:0010970),0.525675673578405,1.1300771757431887,0.3462214411247803,0.9832045299881386,1.0,5/13,11.84%,APBA1;ARHGAP21;BAG3;DYNC1I2;CLIP3
prerank,embryonic axis specification (GO:0000578),-0.4283664218874722,-1.1297835329343762,0.31565656565656564,0.8154870816198331,1.0,3/15,3.58%,COBL;SMAD6;PTCH1
prerank,membrane repolarization (GO:0086009),-0.42917514903073944,-1.129714880765071,0.2830188679245283,0.8141047521178645,1.0,4/15,9.85%,ATP1A2;ATP1B3;ATP1B2;KCND3
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4588612082448622,-1.1295191606824362,0.33031674208144796,0.8131501935690438,1.0,4/12,21.36%,HDAC4;CCN3;BHLHE41;TMEM119
prerank,phosphatidylserine metabolic process (GO:0006658),-0.35029995885157444,-1.1293447140367854,0.28052805280528054,0.8120928740791185,1.0,8/32,14.01%,OSBPL8;OSBPL10;PLA1A;SERINC1;PTDSS2;SERINC5;PLAAT3;ABHD12
prerank,cranial nerve development (GO:0021545),-0.46269017432583814,-1.128363450916447,0.3259423503325942,0.8136491003598028,1.0,3/11,21.56%,CHD7;SALL1;TMEM126A
prerank,alpha-amino acid catabolic process (GO:1901606),0.46391542146602766,1.1281552434630868,0.33382137628111275,0.9879840441058629,1.0,6/29,10.70%,HSD17B10;BLMH;HGD;KMO;GOT2;SARDH
prerank,epithelial to mesenchymal transition (GO:0001837),0.4321526494884141,1.128115249911353,0.3386454183266932,0.9868531992879237,1.0,12/47,10.88%,HEY2;ROCK1;LIMS1;FAM83D;LOXL2;HEYL;SOX9;SNAI2;TGFB2;AKNA;HIF1A;ROCK2
prerank,diterpenoid metabolic process (GO:0016101),0.4287635808853134,1.1277215213286353,0.324905183312263,0.9867809414018371,1.0,7/55,7.14%,TTR;SDC2;LPL;DHRS3;RARRES2;GPC4;AKR1B1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.40785135839099385,-1.127371527343607,0.29442970822281167,0.8150977173023009,1.0,4/18,11.42%,PTN;NF1;PTPRZ1;HES1
prerank,endocardial cushion development (GO:0003197),0.4897672838427256,1.1270852485955334,0.34065934065934067,0.9874871586130439,1.0,5/21,7.86%,TBX2;HEYL;BMPR1A;SOX9;TGFB2
prerank,telomere maintenance via telomerase (GO:0007004),-0.36275989777066875,-1.1269505224152137,0.27988338192419826,0.8148922994897688,1.0,17/28,37.60%,MRE11;HSP90AB1;RAD50;ANKRD28;PPP6R3;TERF2IP;WRAP53;TELO2;CDK2;GAR1;TINF2;PPP6C;NOP10;ACD;RPA1;RFC1;NHP2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3664759491568704,1.1267973699016203,0.23891129032258066,0.9871173161123069,1.0,55/390,10.88%,NTF3;ARHGEF7;NCF2;NTRK3;COL4A2;SDC2;ANGPT2;ANGPT1;ROCK1;FGF1;KALRN;MERTK;POLR2L;MST1R;PDGFB;POLR2I;PDGFC;PDK4;ROR1;FRK;ITSN1;COL4A6;BCAR3;SORT1;ACTG1;PDGFD;MUSK;ACTB;ACTR3;CHN1;RARRES2;POLR2G;ATP6V1H;IRS1;SORBS1;ATP6V0A2;MAPKAPK2;VEGFA;CYFIP1;LCP2;ITGB3;PLCB1;PAK2;SLA;EPHA2;ATP6V1C1;AXL;SIRT2;PDGFRB;DOCK1;FLRT1;SLC39A14;PDGFA;VAV1;ROCK2
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3960379209679201,-1.126484133864373,0.2988826815642458,0.8147129599761971,1.0,4/20,7.18%,B2M;IL18;CD55;DENND1B
prerank,peptidyl-lysine methylation (GO:0018022),0.4755983583667023,1.125959041165493,0.32262996941896027,0.9884498728384161,1.0,8/26,15.16%,SMYD1;SETD6;SUV39H2;SETD3;ATPSCKMT;VCPKMT;N6AMT1;EEF1AKMT2
prerank,primary miRNA processing (GO:0031053),-0.48750287308993817,-1.1258954694766299,0.3277511961722488,0.8149791974241317,1.0,4/10,16.33%,SMAD3;SRRT;METTL3;SMAD2
prerank,positive regulation of chromosome organization (GO:2001252),-0.42326845625947546,-1.1258453516176037,0.3058252427184466,0.8135576196488057,1.0,5/15,12.84%,MRE11;PML;RAD50;GNL3;NBN
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5517727362905909,1.1256089478851146,0.3421516754850088,0.9883074917497483,1.0,2/12,7.14%,CACNA1H;AKR1B1
prerank,regulation of osteoblast proliferation (GO:0033688),0.5086247050268016,1.1255283654433357,0.3684210526315789,0.9873110440913133,1.0,4/17,10.61%,CCN1;PLXNB1;MN1;EIF2AK2
prerank,regulation of cellular component movement (GO:0051270),0.4371796502793609,1.1254683626208237,0.33700137551581844,0.9862218131205578,1.0,10/49,10.88%,ACTN1;ACTN4;ROCK1;CDK6;VEGFA;DAPK3;ADAM17;PKN2;HBEGF;ROCK2
prerank,cellular response to lipid (GO:0071396),0.3741919867015232,1.1246036163964352,0.2848101265822785,0.9876756465619765,1.0,31/191,11.11%,MEF2C;ADCY5;NR1H4;MYD88;ADCY2;ABCB4;PDK4;RORA;VIM;FZD4;LPL;UPF1;CD14;TESC;IRS1;DAB2IP;CHMP5;AR;MED1;SOX9;NFKBIB;RELA;ADNP2;GSTP1;NR1D1;ADCY6;AXL;BRINP1;GPER1;ROCK2;CD180
prerank,genitalia development (GO:0048806),0.5492828903108116,1.124129144146556,0.36192109777015435,0.9879012736515531,1.0,1/12,0.60%,LHCGR
prerank,Golgi ribbon formation (GO:0090161),-0.4528476582888824,-1.1236701588170215,0.3031026252983294,0.8188024595300903,1.0,7/13,20.67%,VTI1A;TMED5;OPTN;GCC2;GOLPH3;TRIP11;STX6
prerank,negative regulation of DNA recombination (GO:0045910),0.43314022650049244,1.123291356011735,0.31215469613259667,0.9891733727196438,1.0,13/43,16.73%,POLR2L;POLR2I;CGAS;H1-0;POLR2G;FANCB;RIF1;TERF2;RMI2;POLR2J;ZRANB3;MAD2L2;MSH2
prerank,manganese ion transport (GO:0006828),0.5241433844582227,1.1223495356328757,0.351493848857645,0.9909000919157809,1.0,3/14,10.71%,TRPC6;TRPC5;SLC39A14
prerank,T cell homeostasis (GO:0043029),0.5643019001324991,1.122305039359347,0.36538461538461536,0.9897769715909737,1.0,1/10,1.50%,PMAIP1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4917552722373755,1.1221752445657427,0.34967320261437906,0.988916012020956,1.0,1/19,0.51%,RYR2
prerank,negative regulation of dephosphorylation (GO:0035305),0.49787098407886254,1.1221431326435625,0.36075949367088606,0.9877457723244512,1.0,5/18,15.29%,PPP1R26;MFHAS1;ENSA;ARPP19;URI1
prerank,toxin transport (GO:1901998),-0.47256129934039165,-1.1217448634123357,0.3377777777777778,0.8231127236461383,1.0,7/10,45.88%,ADAM10;RAB29;RAB40B;ANTXR2;SLC22A2;SLC22A3;SLC29A4
prerank,regulation of GTPase activity (GO:0043087),0.3825541135842343,1.1213873928317593,0.291220556745182,0.9888305767589981,1.0,33/177,11.20%,ARHGEF7;RAP1A;PRKG1;RGS6;LIMS1;RASGRP2;FERMT2;DOCK8;PLXND1;PLXNB1;BCAR3;DOCK10;ITGB1;CCL5;NET1;TBC1D20;RSU1;CHN1;LARS1;MAPRE2;RABGAP1;DAB2IP;PIN1;RAPGEF6;RASGRP1;EVI5;AGRN;ARHGAP12;CCL14;SNX18;VAV1;SH3BP4;ARHGAP15
prerank,peptide catabolic process (GO:0043171),-0.3837570369529949,-1.1208621301369992,0.32,0.8241683859228226,1.0,6/23,10.15%,ANPEP;XPNPEP1;NPEPPS;CTSH;ECE1;ACE
prerank,regulation of hippo signaling (GO:0035330),0.50788348775836,1.12074422391225,0.3343949044585987,0.9896845677151915,1.0,2/17,1.88%,WTIP;LIMD1
prerank,negative regulation of lyase activity (GO:0051350),-0.4225017012529842,-1.120433157345194,0.2963917525773196,0.8239118685875962,1.0,3/16,2.21%,ADGRV1;PALM;GRM3
prerank,regulation of organelle organization (GO:0033043),0.4031294224975601,1.1203649130750102,0.3013530135301353,0.9896252967927527,1.0,20/80,17.15%,NEXN;PDE4DIP;ZEB2;PLXNB1;MAPT;MIEF2;CAPN2;PAK2;STX18;DNM1L;PDCD10;MUL1;MAPK1;RHOT1;VPS35;CLIC4;PREB;S100A8;S100A9;MARK2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.4035117470243986,-1.1200278059805169,0.28465346534653463,0.8235566105845997,1.0,7/18,18.04%,NLGN1;PTK2B;SHANK3;NRXN1;NLGN2;NLGN3;RIMS2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.39157287587190415,1.1199374926208587,0.2894736842105263,0.9897391122877186,1.0,19/101,10.74%,ATP2B4;FGF1;MST1R;TCIM;PDGFB;PDGFC;FERMT2;CCND2;SLC8A2;PDGFD;DAB2IP;VEGFA;CALM1;RASGRP1;CCND1;ADAM17;MAP2K1;PDGFRB;PDGFA
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5423852400470054,1.1192881327208768,0.3482142857142857,0.9904113663587641,1.0,1/13,1.50%,PMAIP1
prerank,regulation of protein kinase activity (GO:0045859),0.38708213410981945,1.119120565870792,0.2958715596330275,0.9896868714181398,1.0,23/106,14.58%,TTN;RAP1A;PLCE1;CCN1;SMG8;PPM1E;MMD;CAMKK2;RAP2C;LCP2;ANKRD54;GSTP1;PAK2;CENPE;RB1;CEP85;SNX9;CEP43;GAS6;MAP2K3;GNAQ;DVL1;MAPRE3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.352755515287397,-1.1190150536062908,0.30201342281879195,0.825186713288769,1.0,8/32,8.41%,DAPK1;DLG1;APP;NLGN1;PTK2B;LRRC7;SLC6A9;NEFL
prerank,regulation of viral entry into host cell (GO:0046596),0.4596936934214399,1.118870566032061,0.32894736842105265,0.9892347668722866,1.0,1/30,0.21%,TMPRSS4
prerank,neurogenesis (GO:0022008),0.4342125551895513,1.118801399029154,0.32,0.9881821445846126,1.0,8/43,8.64%,CLN5;CDK6;ANXA1;BTBD2;MAPT;ERCC6;TGFB2;TRAK1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.529102248848393,1.1184387367883055,0.37254901960784315,0.9880894538113012,1.0,5/14,9.32%,RAD51AP1;PARP1;ERCC6;FUS;FANCB
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.28402004531614333,-1.1184227358430345,0.20512820512820512,0.8253542023168429,1.0,18/76,10.61%,NFAT5;SASH1;UACA;BMP7;DLG1;APP;DDX3X;EGFR;NOD1;PPM1B;NFKBIA;LGALS9;IRAK1;HDAC7;RASSF2;PTPN22;CCN3;PDCD4
prerank,P-body assembly (GO:0033962),0.5306667003502671,1.1183796539328266,0.36300174520069806,0.9870259351799694,1.0,2/12,5.76%,LIMD1;ATXN2
prerank,negative regulation of translation (GO:0017148),0.3991067344070049,1.11792037112387,0.3107947805456702,0.9871592666421514,1.0,20/87,14.33%,RBM24;ROCK1;IGFBP5;SAMD4A;MRPL13;BTG2;EIF4EBP1;CPEB1;YTHDF2;CELF1;FTO;DAPK3;EIF3E;EIF2AK2;ROCK2;CNOT7;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.449630157548216,1.117874426477024,0.336231884057971,0.9860605074059812,1.0,5/35,4.74%,FLNA;SEMA5A;PLXND1;PLXNB1;SEMA6C
prerank,cellular response to leucine starvation (GO:1990253),0.5522607424896525,1.1177918023948907,0.37478108581436076,0.9851022059548034,1.0,3/10,9.52%,LARS1;IMPACT;RRAGB
prerank,protein ubiquitination (GO:0016567),-0.23405796026468548,-1.1172647995394949,0.0,0.8275605237906596,1.0,112/471,15.38%,RNF220;SASH1;NEDD4L;ARRB1;SH3RF1;FBXL7;TRIP12;FBXL5;RNF146;AREL1;ITCH;RNF38;FBXO10;CUL3;RNF185;TNKS2;PRKDC;MYCBP2;RNF20;PPIL2;KLHL12;PEX14;UBE2D3;NPEPPS;RNF135;BIRC6;RC3H2;ATG3;RNF144B;SHPRH;RNF217;UNKL;TRIM24;RNF6;DERL1;UBR2;CTR9;CTNNB1;BIRC2;FBH1;PHC1;RNF25;RNF13;FBXO9;PSMD7;USP7;HERC2;PSMD9;PSMD13;COMMD1;RNF213;MDM2;PELI1;FBXO4;TOPORS;UBE2E2;CDC23;UBE2E3;FBXO7;RBCK1;TRIM25;WWP1;PEX5;SH3RF3;KLHL2;SMURF2;CUL7;RNF144A;RNF31;PRKN;UBE3A;MGRN1;FBXO25;MKRN2;RNF181;DDB1;UBE4B;PSMB3;UBC;TRIM5;KLHL22;RNF34;STUB1;HECTD2;RMND5A;SKP2;DZIP3;LONRF1;DTX1;TRIM33;VPS18;TRIM14;RNF125;DTX3L;RNF166;RTF1;PSMC5;FBXW8;SH3RF2;SIAH1;PSMA5;LEO1;OS9;PSMA1;PSMC2;UBE2H;RNF115;HECW1;RNF10;OBI1;NHLRC3;RNF43
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3110687519984597,-1.1169126960633864,0.2889908256880734,0.8271087791913555,1.0,13/58,9.47%,SGMS1;ST3GAL4;SGMS2;ELOVL7;CERS5;HACD4;SPTLC2;SPTSSA;ACER2;ALDH3A2;CERS6;SGPP1;CERT1
prerank,lipid transport (GO:0006869),-0.27956311088081676,-1.116842555067293,0.20149253731343283,0.8256867004262081,1.0,26/97,15.20%,OSBPL8;PITPNA;ATP8A1;ABCA9;PLTP;APOE;ABCA1;SLCO2B1;LBP;CHKA;ABCA4;LDLR;SLCO1C1;NCOA1;SLC25A17;SLCO2A1;PITPNC1;SLCO3A1;ABCC4;CERT1;SPNS2;PLEKHA3;ABCA6;ABCD3;CLN3;TNFAIP8L3
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5514984819709847,1.1166778385325884,0.36983842010771995,0.9872718702049724,1.0,2/10,6.50%,SMARCD3;VEGFA
prerank,response to interleukin-4 (GO:0070670),-0.48093512996859517,-1.1164840952254371,0.34623655913978496,0.8252335340560436,1.0,1/10,0.83%,LEF1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.36863745134726045,-1.1163553893656315,0.2953846153846154,0.8241089394507017,1.0,9/24,16.94%,HMGB1;SLIT2;NBL1;MOSPD2;CCN3;LYN;PLA2G7;DUSP1;SERPINE1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5500588667779265,1.1157625413274528,0.36095764272559855,0.9889072590684108,1.0,3/12,8.12%,DMD;ATP1B1;WNK2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2652416308960747,-1.1157533045628936,0.21495327102803738,0.8243546919365012,1.0,40/110,25.38%,UPF2;PPP2CA;RPL27A;SMG1;RPS19;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;PABPC1;RPLP0;RPS29;RPL28;RPS10;RPLP1;RPS20;RPL23A;RPL34;NCBP2;RPL36A;RPS8;RPS21;RPL9;SMG6;RPS7;RPL27;RPL11;PNRC2;RPL18A;RPL37A;RPL38;RPL29;RPL10A;RPL32;RNPS1;RPS4X;RPS27
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.44818238268342636,-1.1156149614479178,0.3333333333333333,0.823211525900773,1.0,2/13,2.35%,DKK3;APOE
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3729716358425736,-1.1155544120242016,0.33024691358024694,0.8218102949521339,1.0,12/27,30.50%,ENPP2;PLA2G6;GDPD1;ABHD12;PLA2G7;GDE1;GPCPD1;PNPLA6;INPP5F;ENPP6;PNPLA8;SMPD4
prerank,apical junction assembly (GO:0043297),-0.3092799948443024,-1.114272216993258,0.26548672566371684,0.8243162138546255,1.0,8/53,6.83%,AFDN;DLG1;CDH5;PECAM1;PARD6G;OCLN;CLDN5;CLDN11
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.2711075641717831,-1.1141139368316852,0.16666666666666666,0.8232526959351624,1.0,29/113,17.14%,PTN;BMP6;IGF1;NRP2;AKT3;NOTCH2;TCF7L2;TGFA;BMP4;TEK;NRP1;EGFR;WNT5A;F3;BMPR2;SRSF6;OSR1;LAMB1;FGFR2;TGFBR1;RTN4;KDR;ARNT;VEGFC;AKT1;FGF2;GRN;STAT5A;VEGFB
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3673301209989431,1.1137104751986717,0.28704663212435233,0.9940999646279086,1.0,37/214,11.75%,RAP1A;NTRK3;ANGPT1;CD36;PDGFB;CCN1;PDGFC;FERMT2;ROR1;FAM83D;THPO;CCL5;GCNT2;PDGFD;MFHAS1;EMILIN1;DAB2IP;DUSP3;RRAS;FBXW7;PIN1;PTPN1;GAREM1;RASGRP1;WNK2;TNIP1;MAP2K1;GSTP1;CNKSR3;EPHA2;PDGFRB;CCL14;PDGFA;GPER1;ZDHHC17;HTR2B;DUSP29
prerank,mitochondrion morphogenesis (GO:0070584),-0.4674572621750297,-1.1133616073395571,0.3295194508009153,0.8241080170961288,1.0,5/11,22.17%,PID1;FIS1;PNPT1;NUBPL;SLIRP
prerank,regulation of fibroblast migration (GO:0010762),0.4909846093420656,1.1133610312377287,0.35313001605136435,0.9939745724078537,1.0,4/20,8.67%,ARHGEF7;ITGB1;CORO1C;GNA12
prerank,regulation of inclusion body assembly (GO:0090083),-0.4743118643286435,-1.1130736153398049,0.35147392290249435,0.8235035240635765,1.0,6/11,35.65%,SNCAIP;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A
prerank,vitamin D metabolic process (GO:0042359),0.5417958344244028,1.1126851585924953,0.37043478260869567,0.9949032793775575,1.0,2/13,5.64%,PIAS4;GC
prerank,regulation of actin filament depolymerization (GO:0030834),0.5525065225129436,1.1126707182658782,0.35813148788927335,0.993725860456453,1.0,4/12,8.01%,SEMA5A;WDR1;PLEK;CFL2
prerank,extracellular matrix organization (GO:0030198),0.37105865305715935,1.11251012694045,0.2650103519668737,0.9929870742933803,1.0,45/276,10.79%,ITGA8;TTR;MMP17;COL18A1;COL4A2;COL4A1;ITGB6;ELN;ADAMTS14;ITGA7;LAMA5;P3H2;PDGFB;ITGA1;ITGA3;ADAMTS5;LOXL2;HTRA1;KLK2;CRTAP;ADAMTS19;LCP1;COL4A6;ITGB1;BGN;DST;JAM3;HAS2;PXDN;ITGB5;LAMC1;LAMB2;ITGB3;TGFB2;ITGA4;COL27A1;COL4A5;WASHC1;CAPN2;ITGA9;AGRN;P4HA2;COL19A1;PDGFA;THSD4
prerank,negative regulation of protein binding (GO:0032091),0.410800577879314,1.1122090475365818,0.32014833127317677,0.9926887009866862,1.0,17/71,14.51%,XIRP1;ROCK1;ATP2A2;PDGFB;ACTB;CAV1;PTPRF;PIN1;ITGA4;PPP1CA;PSME3IP1;ATP2A3;PRKCD;BAG2;CSNK1E;LRRK2;DVL1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.44540696435220417,1.112179402531956,0.3360544217687075,0.991543351820711,1.0,6/35,10.07%,PPP1R12A;ITGA1;CALM1;NUAK1;CD300A;PDGFRB
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4921456491586592,1.1120445331407074,0.3619344773790952,0.9907329235980451,1.0,6/18,14.08%,NAT8L;GOT1;GOT2;ADI1;SMS;SLC25A12
prerank,ephrin receptor signaling pathway (GO:0048013),0.4046436642435011,1.1117719755519289,0.3372502937720329,0.9903490034810513,1.0,9/82,4.73%,ARHGEF7;SDC2;ROCK1;KALRN;ITSN1;ACTG1;ACTB;ACTR3;CHN1
prerank,neuromuscular synaptic transmission (GO:0007274),0.49450734424919096,1.1114758760133236,0.3446054750402576,0.9900530875867714,1.0,4/18,9.76%,DTNA;STAC3;RIMBP2;FCHSD2
prerank,defense response to symbiont (GO:0140546),0.39558096685628064,1.1112029278644766,0.31271878646441076,0.9896833697755807,1.0,9/92,7.89%,FLNA;PMAIP1;MYD88;CGAS;BCL2;ATG7;LYST;ABCE1;RELA
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4159984814599226,1.111196259690976,0.3140604467805519,0.9884968667255652,1.0,8/55,10.07%,AGTR1;PDGFB;DHRS4;ALOX5;TP53;CBR1;SIRT2;PDGFRB
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3808617796953258,-1.1108753710905415,0.3240223463687151,0.8288599465368723,1.0,4/22,2.35%,AKAP13;AEBP1;PIK3CA;APOE
prerank,negative regulation of stem cell differentiation (GO:2000737),0.537324695258218,1.1107561736591618,0.3905109489051095,0.988639129849771,1.0,4/12,12.34%,JAG1;YTHDF2;HNRNPU;NELFB
prerank,B cell receptor signaling pathway (GO:0050853),0.4541074101140868,1.1105193257705848,0.3515850144092219,0.9881464941247127,1.0,3/32,4.50%,MEF2C;CD79A;BCL2
prerank,ventricular septum development (GO:0003281),0.44377356210384283,1.1102843210204407,0.3483606557377049,0.9876977654124636,1.0,5/37,7.86%,SLIT3;HEY2;HEYL;BMPR1A;TGFB2
prerank,male gonad development (GO:0008584),0.4560068399754818,1.1101037522263295,0.34985835694050993,0.987046990637333,1.0,5/34,7.86%,LHCGR;CSDE1;AR;SOX9;TGFB2
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4176844215103418,-1.1100255853301855,0.34328358208955223,0.8299550114775041,1.0,4/16,10.83%,POGZ;PDS5A;MAU2;NAA50
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.38245496122402567,-1.1099178909305085,0.31402439024390244,0.8287548284523149,1.0,3/22,1.84%,ALDH1A2;RBP1;VKORC1L1
prerank,regulation of protein neddylation (GO:2000434),0.5538510066823996,1.1095185433637376,0.3673469387755102,0.9876723453765696,1.0,4/10,9.57%,DCUN1D2;DCUN1D1;RPL5;HIF1A
prerank,regulation of lymphocyte activation (GO:0051249),0.533717450252475,1.109340684403194,0.3836589698046181,0.9870063948464342,1.0,2/12,9.74%,CCL5;PAG1
prerank,negative regulation of cellular process (GO:0048523),0.358334071721224,1.1092149647440703,0.24120603015075376,0.9862089964041404,1.0,74/521,11.80%,MYOCD;SLIT3;ACTN1;IGFBP7;COL18A1;DLC1;ANGPT1;MYL2;TMIGD3;FER1L5;P3H2;SPEG;CCN1;ITGA1;CDK6;FERMT2;DYSF;MYH9;SEMA5A;PLXND1;PLXNB1;CDH13;NR4A1;FRK;RERG;TGFB3;GMNN;BTG2;FHL1;NACC2;NUP62;ALOX5;PIP4P2;TGFB1I1;BCL2;JADE1;ARHGDIG;EMILIN1;TESC;CBLL1;DSCAM;DAB2IP;NDRG3;TMEM98;RPS6KA2;TP53;CD200;AR;BNIPL;CELF1;BTG1;TGFB2;ADNP2;WNK2;LPCAT3;DIS3L2;IMPACT;MAP2K1;SKI;NDUFS3;CRLF3;SIRT2;SERTAD2;BRINP1;EIF2AK2;SH3BP4;GPER1;TNFRSF21;RB1;COPS8;TCHP;HTR2B;ACVR1B;CNOT7
prerank,contractile actin filament bundle assembly (GO:0030038),0.5202549835798904,1.10907015471379,0.35294117647058826,0.9842340431139636,1.0,7/15,12.63%,PDLIM1;ITGB1;TNFAIP1;ITGB5;SORBS1;FHDC1;PDCD10
prerank,stress fiber assembly (GO:0043149),0.5202549835798904,1.10907015471379,0.35294117647058826,0.9842340431139636,1.0,7/15,12.63%,PDLIM1;ITGB1;TNFAIP1;ITGB5;SORBS1;FHDC1;PDCD10
prerank,regulation of mitochondrial translation (GO:0070129),0.48876668542782276,1.1086580888137285,0.3611556982343499,0.9843030482861291,1.0,11/21,20.37%,RPUSD3;TRMT10C;RCC1L;TSFM;RPUSD4;FASTKD2;TRUB2;RMND1;MALSU1;UQCC2;C1QBP
prerank,potassium ion export across plasma membrane (GO:0097623),0.5260228731743106,1.108591412650393,0.38204225352112675,0.9832980194590057,1.0,3/13,7.75%,KCNA5;KCNE4;KCNT2
prerank,response to alcohol (GO:0097305),0.4606190629340352,1.1082516459876592,0.3417910447761194,0.9831479200822613,1.0,1/27,0.19%,SLIT3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4493705816208992,1.1080712933100114,0.35694444444444445,0.9825363721030321,1.0,9/35,12.18%,DLC1;ITGA3;KANK1;TNFAIP1;DAB2IP;TGFB2;MFN2;ARHGAP35;SCAI
prerank,apical protein localization (GO:0045176),0.5463802552087811,1.1077267587071848,0.37545787545787546,0.9823897727157419,1.0,5/10,11.08%,ATP8B1;ACTB;JAM3;INSC;GOPC
prerank,canonical glycolysis (GO:0061621),0.481213552249364,1.1077228461899016,0.36268656716417913,0.9800391601172583,1.0,5/24,11.23%,PFKP;ENO3;HK2;ALDOA;PFKM
prerank,glucose catabolic process to pyruvate (GO:0061718),0.481213552249364,1.1077228461899016,0.36268656716417913,0.9800391601172583,1.0,5/24,11.23%,PFKP;ENO3;HK2;ALDOA;PFKM
prerank,cellular response to gamma radiation (GO:0071480),0.5040426524897357,1.1075896686584048,0.3629160063391442,0.9792973040177442,1.0,3/17,7.59%,MAP3K20;TP53;YAP1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3998719070500531,-1.1069684708759373,0.32978723404255317,0.8365314027907109,1.0,10/17,26.21%,CD44;MDM2;PRKN;RNF34;PTTG1IP;KDM1A;ARMC10;SNAI1;YJU2;TWIST1
prerank,organophosphate ester transport (GO:0015748),-0.37211018221173686,-1.1067352943158597,0.3303030303030303,0.8357016936138358,1.0,5/24,6.16%,OSBPL8;PITPNA;PLTP;LDLR;PITPNC1
prerank,cellular response to glucose stimulus (GO:0071333),-0.34660814570095494,-1.106703034043154,0.2996742671009772,0.8342509154120799,1.0,8/30,12.74%,ZBTB20;UNC13B;PTPRN2;TRA2B;RAB11FIP5;ERN1;SOX4;PCK2
prerank,sphingoid biosynthetic process (GO:0046520),-0.45952333300338866,-1.1061504978205816,0.36054421768707484,0.8328265894897081,1.0,5/11,22.94%,SPTLC2;ACER2;ASAH2;ABCA2;SPHK1
prerank,sphingosine biosynthetic process (GO:0046512),-0.45952333300338866,-1.1061504978205816,0.36054421768707484,0.8328265894897081,1.0,5/11,22.94%,SPTLC2;ACER2;ASAH2;ABCA2;SPHK1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3672742766281195,-1.105974154218579,0.3083832335329341,0.8318427535549803,1.0,10/25,18.55%,IL31RA;IFNAR2;GHR;PKD2;SOCS2;CTR9;STAT2;IFNAR1;STAT5A;STAT6
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4123751976299056,-1.105496271966921,0.33866666666666667,0.8317593750003449,1.0,7/17,19.66%,ARRB1;OTUD7B;MAPKBP1;PTPN22;ANXA4;SSC5D;BCL3
prerank,regulation of centrosome cycle (GO:0046605),0.4820071534807454,1.1048082530401593,0.359253499222395,0.9865042969911257,1.0,5/21,13.43%,CHMP4C;NAT10;CHMP5;CHMP2B;CHMP2A
prerank,regulation of endopeptidase activity (GO:0052548),0.4200059240385321,1.1046035481830256,0.3304130162703379,0.9858677757125468,1.0,3/59,3.37%,SERPINB8;SERPINI1;SERPINE2
prerank,autophagy of nucleus (GO:0044804),-0.41318546600731415,-1.1045470707788518,0.3333333333333333,0.833153126690384,1.0,10/16,28.28%,RB1CC1;ATG3;ATG5;ATG2B;WIPI2;ATG2A;WDR45B;ULK2;WIPI1;ATG12
prerank,autophagy of peroxisome (GO:0030242),-0.45935892124864663,-1.104492046228235,0.33890214797136037,0.8318201573921955,1.0,6/12,28.27%,RB1CC1;PEX5;ACBD5;ATM;SQSTM1;MAP1LC3B
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.46145778783428476,1.1040438267201935,0.363905325443787,0.9864326598944528,1.0,4/27,4.89%,ATP2B4;SNTA1;CAMK2D;UTRN
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.46893110514687925,1.1039435867972567,0.3561643835616438,0.9855624585532078,1.0,9/23,17.85%,MTMR7;PIP4P2;SYNJ2;SACM1L;INPP5B;TPTE;INPP5J;PTEN;MTMR3
prerank,carboxylic acid metabolic process (GO:0019752),0.4460800667210264,1.1038050692049521,0.34281650071123754,0.9848667521852164,1.0,10/33,14.48%,CSGALNACT1;PTGIS;GNE;TBXAS1;SLC23A2;SLC23A1;ST6GAL1;SIRT4;PLA2G4A;CYB5R3
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.4837532735277239,-1.1032431439710024,0.375,0.8342729191535545,1.0,4/10,14.56%,USP7;SIRT7;OGT;DGKQ
prerank,negative regulation of lymphocyte activation (GO:0051250),0.48785231013552594,1.103037670276796,0.3484375,0.9859781412513221,1.0,6/21,13.52%,LAX1;DUSP3;PIBF1;SAMSN1;PAG1;FOXJ1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.47632716062720915,-1.1029770947173008,0.34968017057569295,0.8335470380709639,1.0,4/10,14.02%,PRKCB;VTN;ITGA5;ARNT
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.38599010545193957,-1.1027897359958787,0.32463768115942027,0.8325533586363199,1.0,4/20,13.39%,IGF1;NIBAN2;TGFB1;EP300
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.545469527982114,1.1027016215093548,0.3398230088495575,0.9858434263130248,1.0,4/11,10.01%,PADI2;ARID1A;CHEK1;SERTAD2
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.34284012376762696,-1.1026618255569698,0.2894736842105263,0.8314133286189773,1.0,7/30,21.37%,HMGB1;LGALS9;PLCG2;CD34;CD46;CD274;HSPD1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.46450392337016416,1.1024586306593234,0.332312404287902,0.9853599679624094,1.0,6/27,9.06%,FBXL22;CRTC1;USP2;TP53;PPP1CB;PPP1CA
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3638682221602671,1.1023087743668094,0.2973523421588595,0.9845672647358021,1.0,44/308,11.73%,SOX6;PRDM16;SOX5;ROCK1;PRKAB2;CD36;PDGFB;PDGFC;PLA2G3;FERMT2;FST;EBF2;ADRA1D;LOXL2;IL2;TGFB3;GCNT2;TSHR;TGFB1I1;BMPR1A;TAPT1;CAV1;TERT;VEGFA;TRPV2;FABP4;GDNF;PPARGC1A;MED1;PPARGC1B;DIO2;SOX9;TGFB2;PLCB1;TRPM4;RBM19;PAXIP1;RIF1;NR2C2;EIF2AK2;MFN2;NKX6-1;HTR2B;ACVR1B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.44941458387338884,1.1018253552628947,0.3482810164424514,0.984931405974595,1.0,7/32,11.77%,CAVIN1;POLR2L;GTF2H4;TAF1;CDK7;POLR1E;POLR1H
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.33541284140291205,-1.1013083271356572,0.28113879003558717,0.8340692393518251,1.0,8/35,5.39%,FLT1;NF1;SULF1;SPARC;APOE;XDH;COL4A3;PTPRM
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.46347017651029054,-1.101105719177405,0.34186046511627904,0.8331910369939965,1.0,5/11,15.51%,RIN3;SLIT2;NBL1;CCN3;DUSP1
prerank,positive regulation of insulin secretion (GO:0032024),-0.33082841200841606,-1.1010076763386376,0.3041958041958042,0.8320475332640755,1.0,13/36,17.29%,TCF7L2;MYRIP;RBP4;MCU;PSMD9;STX4;NNAT;SOX4;PLA2G6;NLGN2;CAPN10;ACSL4;AACS
prerank,negative regulation of type I interferon production (GO:0032480),-0.3297055937363042,-1.1009800121182787,0.3053435114503817,0.830631661996829,1.0,17/40,27.46%,ITCH;PPM1B;RNF135;ILRUN;UFD1;PCBP2;TRIM25;SIRPA;RNF125;RELB;NLRC5;UBA7;NLRX1;CYLD;NLRC3;IKBKE;GPATCH3
prerank,protein localization to cell-cell junction (GO:0150105),-0.42752319551146695,-1.1005965633428114,0.32608695652173914,0.8302400276582234,1.0,5/15,6.56%,TJP1;CGNL1;TJP2;CDH5;LSR
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.4223957593652599,1.1005194380121393,0.36150845253576075,0.9876280258800421,1.0,13/48,16.73%,CRIP1;DYRK2;BCL2;TP53;PHLDA3;RPS27L;BCL2L2;EPHA2;BOK;FNIP2;MCL1;HIPK2;MSH2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3415225476233111,-1.100354717486579,0.26714801444043323,0.8294874023458486,1.0,13/33,16.03%,TJP1;GLUL;SEMA6A;PDPK1;EPN1;PIK3CB;ITGA5;BMPER;ADAMTS9;CEMIP2;KLF2;CREB3L1;FGF2
prerank,dephosphorylation (GO:0016311),0.37357052026865195,1.1000302189068791,0.32756756756756755,0.9879713365941467,1.0,29/147,13.12%,PPP1R12A;PPM1L;PPM1J;PPP3CA;MTMR7;DUSP5;PPP2R1B;ACP3;PPM1E;PTPN18;PTPRS;LHPP;SDHAF2;PTPRF;DUSP3;PPP2R5A;PPM1A;PTPN1;PLPPR1;PPP1CB;PPP1CA;CTDSP2;DUSP29;FBXW11;SBF1;CTDSP1;TPTE;DUSP16;PPP3CB
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.45934934289651863,-1.099987036309744,0.3773148148148148,0.8290844324766289,1.0,4/11,13.03%,NECAB1;ITM2A;BACE2;SOAT1
prerank,positive regulation of programmed cell death (GO:0043068),0.3618290179721753,1.0999257083905005,0.30275229357798167,0.9871477510683377,1.0,39/272,12.53%,KCNMA1;OBSCN;ARHGEF7;MAP3K20;MAP3K5;PMAIP1;KALRN;ABR;ARHGEF17;ANO6;ITSN1;TGFB3;ITGB1;NET1;ARHGEF16;ARHGEF2;ATG7;DAB2IP;RPS6KA2;ARL6IP5;TP53;PHLDA3;FZD9;MAP3K10;DAPK3;TNFAIP8;ARHGEF4;HRK;PAWR;DNM1L;VAV1;GPER1;TRIM35;BOK;CLIP3;CSRNP3;DIABLO;CLU;ITGB3BP
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4522989057019482,-1.0995521049943398,0.3697674418604651,0.828862406888696,1.0,5/12,22.47%,STX3;STX4;SNAP29;STX1A;STX2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3876284042621246,1.099070324790508,0.3298245614035088,0.9885414402884911,1.0,16/87,12.98%,NEB;DLC1;ROCK1;RHOBTB3;ARHGAP17;DAPK3;RHOF;PDGFRB;PDGFA;ROCK2;PRKCD;RHOH;ARHGAP35;RICTOR;TRPM2;DMTN
prerank,regulation of protein kinase A signaling (GO:0010738),0.4930786536536069,1.0989419355443457,0.3777429467084639,0.9877375761589069,1.0,2/20,2.08%,AKAP6;TCIM
prerank,telomere maintenance via recombination (GO:0000722),-0.45344654541163865,-1.0985915221909794,0.37906976744186044,0.8304118243697617,1.0,6/11,24.63%,RAD50;SMC5;TPRKB;NSMCE2;ERCC1;ERCC4
prerank,neuron projection regeneration (GO:0031102),-0.47383475500507344,-1.0984587618051898,0.3761261261261261,0.8293234166163015,1.0,2/10,10.39%,PTN;MAPK8IP3
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.47547329880565914,-1.0984151588825857,0.36086956521739133,0.8279952600669218,1.0,4/10,19.06%,EMC2;EMC3;EMC8;MMGT1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3808244337078913,-1.0979256666502066,0.337696335078534,0.8279549779708073,1.0,9/20,18.09%,MCU;LETM1;SPG7;MCUB;MICU2;MAIP1;STOML2;YME1L1;SLC8B1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.452198144101972,-1.0977762429106124,0.33860045146726864,0.8268893272773234,1.0,3/12,16.58%,PRKCB;NEK9;NEK6
prerank,positive regulation of protein import (GO:1904591),0.4485032368467869,1.0976619398707435,0.35526315789473684,0.9903369227521647,1.0,5/30,13.54%,FLNA;UBR5;BAG3;PRKCD;TRIM28
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.466464527033889,-1.0973645914295966,0.35891647855530473,0.8266652213182195,1.0,3/10,7.84%,ANXA2;EPHA4;FURIN
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.32279946699036216,-1.0969220125720662,0.3107142857142857,0.8265232439174409,1.0,16/39,26.33%,ABCA1;SEL1L;RAB12;CANX;STEAP3;GOLPH3;PDIA4;RCN3;ARFGAP3;MON1A;RAB13;MIA3;PPY;SVBP;RAB3D;COPG2
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.34940395990347106,-1.096605531323955,0.3219814241486068,0.8259987280376732,1.0,9/27,18.64%,ARRB1;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;C1QTNF3;NCKAP1L;ZC3H12A
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.4216891189164946,1.096472343993184,0.35809018567639256,0.9926464890282344,1.0,11/48,15.55%,PRDM16;NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210
prerank,signal transduction in response to DNA damage (GO:0042770),0.4226750726690978,1.0963719469300182,0.35638297872340424,0.9917757487960451,1.0,12/49,10.63%,MAP3K20;HINFP;BRIP1;NDRG1;TP53;CHEK1;RAD9A;ERCC6;PAXIP1;STK33;FBXO6;RHNO1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4426182813366238,-1.0963610683561311,0.34988179669030733,0.8253181358969923,1.0,2/12,1.03%,DAB2;FOXP1
prerank,regulation of cell differentiation (GO:0045595),0.372053089405193,1.0961686940916204,0.3230769230769231,0.9911900397359182,1.0,24/148,13.30%,NTF3;HEY2;ZFHX3;ROCK1;CDK6;PHLDB2;CLASP2;ALOX5;CBFB;TAF8;GDNF;PA2G4;AR;SNAI2;NR1D1;EIF2AK2;RUNX1;BMPR1B;MOSMO;CLASP1;BCL6;NSUN2;ZFP36L1;CASZ1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4912181584962228,1.096092343714656,0.36817472698907955,0.9902583283815151,1.0,4/19,6.80%,DYRK2;TP53;PHLDA3;RPS27L
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3696032849375879,-1.0954392083840778,0.3005464480874317,0.826668705709052,1.0,18/24,46.28%,XRCC1;LIG3;UBC;UBB;LIG1;RPA3;RFC3;RPA2;POLD3;LIG4;RPA1;RFC1;POLE;RFC4;RFC5;POLB;POLD2;RFC2
prerank,visual perception (GO:0007601),-0.2758048079784128,-1.0953270290625803,0.2654320987654321,0.8255586197160049,1.0,12/84,9.56%,PITPNA;COL1A1;EYA4;EFEMP1;ABLIM1;ADGRV1;COL11A1;SLC4A10;ZIC2;CEP250;EML2;MYO9A
prerank,embryonic eye morphogenesis (GO:0048048),-0.45404474822761987,-1.095320784013133,0.35,0.8241134397998237,1.0,4/11,3.63%,FBN1;EFEMP1;FBN2;MFAP5
prerank,urogenital system development (GO:0001655),0.5363878291505584,1.0948847004865205,0.3930530164533821,0.9928685558133329,1.0,3/11,7.68%,ANXA1;OSR2;SOX9
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.378446550839922,-1.0947316174099861,0.34269662921348315,0.8245428313229249,1.0,7/20,11.67%,LBP;IL18;IRAK1;PRKCE;PTPN22;TGFB1;LYN
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.42195852359693015,1.094604178559848,0.34710743801652894,0.992578528121206,1.0,7/46,5.98%,RBPMS2;ELN;PDGFB;CDH13;IGFBP5;CCL5;OGN
prerank,negative regulation of axonogenesis (GO:0050771),0.4624064527993708,1.0942780981270688,0.362962962962963,0.9923902321361547,1.0,2/27,4.99%,FGF13;PTPRS
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3934266231535788,1.094266833440468,0.34378769601930037,0.9912660499555251,1.0,14/79,10.68%,RBPMS2;ATP2B4;CRIM1;ACVR2A;BMPR1A;MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4;SKI;VWC2L;UBE2D1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.36247741783305576,-1.0942263890202406,0.3434650455927052,0.824630843179002,1.0,8/26,19.27%,POR;APOE;NPR3;NOS1AP;PIK3CB;GCH1;AKT1;PARK7
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.49739771007332434,1.0940427580531853,0.3890675241157556,0.990734377451299,1.0,3/17,4.10%,CACNA2D1;SNTA1;KCNE4
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.39151129260011797,1.0939771333362565,0.3340961098398169,0.9897636565397187,1.0,14/95,9.18%,ASPN;PRDM16;VASN;ZEB2;ITGA3;TGFB1I1;EMILIN1;CAV1;SLC2A10;PPM1A;PIN1;PPARA;ADAM17;SKI
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.44999525907384885,-1.0937679766449273,0.37585421412300685,0.8245746107235205,1.0,4/11,19.27%,SLC30A10;ABCB7;COA8;PARK7
prerank,sterol transport (GO:0015918),0.48855528512349444,1.093525278607779,0.36260162601626017,0.9900032449333885,1.0,5/19,13.96%,CD36;CAV1;OSBPL2;LDLRAP1;OSBPL5
prerank,protein polyglutamylation (GO:0018095),0.5405602543868675,1.093505509230081,0.38704028021015763,0.9889084517719814,1.0,2/11,3.99%,TTLL7;CEP41
prerank,protein K11-linked ubiquitination (GO:0070979),-0.3602224766785022,-1.093458357697727,0.2990353697749196,0.824130626998464,1.0,10/27,17.59%,ANAPC1;UBE2D3;UBE2E2;CDC23;UBE2E3;PRKN;UBE2H;CDC26;UBE2S;ANAPC4
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3811879321271824,1.0932461311288646,0.3444700460829493,0.9885773508610355,1.0,15/95,11.11%,MEF2C;MYD88;FZD5;VIM;UPF1;CD14;DAB2IP;CHMP5;NFKBIB;RELA;GSTP1;NR1D1;AXL;SIRT2;CD180
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3142825603660298,-1.0930650941292193,0.2786259541984733,0.8238664604841744,1.0,12/45,11.99%,DDX5;BMP4;POLR2A;EGFR;NMD3;SIRT7;RBM20;SETX;TGFB1;DIMT1;MAP2K2;ERN1
prerank,regulation of signal transduction (GO:0009966),0.36499962309593065,1.0929127951036806,0.3326293558606125,0.9883824374290661,1.0,40/190,14.47%,IGFBP7;LIFR;RGS6;CD36;PLCE1;SEMA5A;RORA;RGS4;ZFAND2B;SLC8A2;ITGA3;SOCS5;IGFBP5;NUP62;DHRS3;CBFB;CASTOR1;IFT81;RFNG;PTPN1;IGFBP4;GDNF;YJEFN3;ANKRD54;PLCB1;MGLL;AMFR;CDC42SE2;SREBF2;RUNX1;ZDHHC17;TSPAN12;CHRNA7;CLU;HOMER1;NCK2;USP20;RGS5;LRRK2;CASTOR2
prerank,regulation of telomerase activity (GO:0051972),0.41745468711258843,1.0920138106617447,0.3369713506139154,0.9899591533779739,1.0,7/45,9.59%,PARM1;PARN;PRKCQ;TP53;PKIB;NAF1;CERS1
prerank,cell projection organization (GO:0030030),0.4442639586405512,1.0919252472764585,0.3663220088626292,0.9890726743844188,1.0,8/30,11.36%,PACSIN2;ITGB1;RHOJ;CYFIP1;PLEK;PARVA;PDGFA;RHOH
prerank,triglyceride metabolic process (GO:0006641),-0.305029479600088,-1.0907891227189268,0.3025210084033613,0.8294655666378522,1.0,5/48,4.78%,AGMO;APOE;SEL1L;LPGAT1;LPIN2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.4379865163289183,-1.0906812910019321,0.35214446952595935,0.8283150130904295,1.0,4/12,19.46%,CDC14B;RAB1A;UBE2S;BTRC
prerank,regulation of lipase activity (GO:0060191),0.5219025654924103,1.0905452018092174,0.3954305799648506,0.9920124872555087,1.0,2/13,3.34%,ANGPTL8;LPL
prerank,negative regulation of macrophage activation (GO:0043031),-0.40385343627087145,-1.0900984106272458,0.35036496350364965,0.8286442415793357,1.0,6/16,18.64%,IL31RA;LDLR;CX3CL1;SYT11;GRN;ZC3H12A
prerank,positive regulation of signaling (GO:0023056),-0.32053385490900493,-1.0896244315378547,0.2857142857142857,0.828608091247145,1.0,13/37,26.31%,ANXA2;SYT1;ECE1;WLS;SNCA;RAB29;RIMS2;CD80;NMU;SCRIB;INPP5F;SOX11;EDN3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.4094814400330919,-1.0893936166085032,0.366412213740458,0.8278773522720031,1.0,6/16,17.72%,PRKDC;PARP3;SMCHD1;DTX3L;WRAP53;KDM4D
prerank,cation transmembrane transport (GO:0098655),-0.31007428344350474,-1.0887489233243497,0.276,0.8284226073693657,1.0,8/44,9.92%,TRPM3;ATP1A2;TRPM6;PKD2;SLC3A2;SLC7A5;SLC6A9;SFXN2
prerank,regulation of G0 to G1 transition (GO:0070316),-0.32764757781506815,-1.0887060090746805,0.277992277992278,0.8271076545679538,1.0,8/38,8.60%,RBBP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,peptidyl-asparagine modification (GO:0018196),-0.34499409267000125,-1.088644309182325,0.34843205574912894,0.8258618950956348,1.0,14/31,28.12%,TUSC3;MGAT1;FUT8;UGGT2;OSTC;MGAT5;MCFD2;LMAN1;HIF1AN;RPN2;MGAT2;DPM3;STT3B;ASGR1
prerank,protein localization to nucleus (GO:0034504),-0.26919696955520966,-1.0885806309849486,0.24031007751937986,0.8246647986288698,1.0,35/102,22.22%,APPL2;COL1A1;BMP7;BMP4;E2F3;FAM53A;NUP88;PML;ARL2BP;TOR1AIP2;MDM2;TOPORS;NUTF2;IPO8;TOR1AIP1;SIX1;PTTG1IP;APPL1;NUP50;CALR;AKT1;EIF4ENIF1;NOP53;XPA;TBRG1;ARL2;RPL11;NUP85;BCL3;TAF3;IPO11;RPF2;NXT2;NUP214;RAN
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4287724259879291,-1.088476253343517,0.35799522673031026,0.8235463233382455,1.0,4/13,9.75%,GLUL;ALDH4A1;NOS3;DDAH1
prerank,cytoplasmic translational initiation (GO:0002183),0.49325905650075486,1.0884355227385476,0.38006756756756754,0.99704274150353,1.0,4/17,8.82%,DENR;EIF3M;EIF2D;EIF4A1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.25636811735616344,-1.0882673966358687,0.23529411764705882,0.8227895397711573,1.0,29/129,14.23%,RNF220;LRRK1;LGR4;COL1A1;ADGRA2;WNK1;RNF146;DDX3X;PTK7;EGFR;LYPD6;TNKS2;PPM1B;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;SMURF2;SFRP4;TGFB1;FGFR2;PSMB3;SOX4;ZBED3;PSMC5;PSMA5;PSMA1;PSMC2
prerank,photoperiodism (GO:0009648),0.459199689147397,1.0881838288321608,0.35276073619631904,0.996710902430009,1.0,8/28,14.12%,FBXL22;CRTC1;USP2;TP53;PPP1CB;PPP1CA;CLOCK;MTA1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4748802445326653,1.0877376137646717,0.375,0.9968891632282443,1.0,5/19,13.43%,CHMP4C;CHMP5;HNRNPU;CHMP2B;CHMP2A
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.41404013386105076,1.0874876682835117,0.3602015113350126,0.9964694199608953,1.0,14/51,15.42%,NTF3;PLXNB1;DAB2IP;DICER1;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;LRRK2;ANKRD27;SNX1;CNTNAP1;DNM2
prerank,defense response to virus (GO:0051607),0.38730487793158896,1.087375395527378,0.3500583430571762,0.9956914428725535,1.0,10/100,7.89%,FLNA;PMAIP1;MYD88;CGAS;ATAD3A;BCL2;ATG7;LYST;ABCE1;RELA
prerank,regulation of cell population proliferation (GO:0042127),0.3537917201480793,1.0871103030807892,0.2602602602602603,0.9953426328518112,1.0,77/691,8.83%,MYOCD;NTF3;AGTR1;IGFBP7;COL18A1;NTRK3;DLC1;LIFR;ELN;TBX2;TMIGD3;FGF1;S1PR3;LIMS1;P3H2;MST1R;SPEG;PDGFB;ITGA1;PDGFC;CDK6;TRNP1;CCND2;CDH13;CRLF1;FRK;ADRA1D;THPO;JAG1;IL2;RERG;TGFB3;GCNT2;BTG2;PDGFD;NACC2;NUP62;IL12RB2;TSHR;TGFB1I1;FXN;BCL2;KSR1;OSR2;ARHGEF2;BMPR1A;HAS2;TESC;KCNH1;JUND;IRS1;TNFRSF11A;DAB2IP;RPS6KA2;TIPIN;TP53;VEGFA;GDNF;CD200;AREG;AR;BNIPL;GAREM1;CELF1;BTG1;YAP1;SOX9;TGFB2;RELA;NUAK1;KMT2D;WNK2;DIS3L2;MVD;ADAM17;TRPM4;MAP2K1
prerank,rRNA transcription (GO:0009303),0.5001766651050074,1.087023983072132,0.3852596314907873,0.994452845005877,1.0,6/17,19.12%,CAVIN1;GTF3C4;POLR1E;SPIN1;GTF3A;NIFK
prerank,muscle tissue development (GO:0060537),0.5147045261921406,1.0869927486086433,0.4090909090909091,0.9934082254642653,1.0,2/13,1.66%,CSRP1;CSRP3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4775662798211624,-1.0867950433453697,0.37142857142857144,0.8258727661673149,1.0,5/10,14.45%,ATP1A2;NEDD4L;PRKCE;OSR1;HECW1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.43640155834776456,-1.0866522138006407,0.33414634146341465,0.8248601388403896,1.0,3/13,1.18%,UST;DCN;DSE
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.4447841011701288,-1.0859152366701996,0.3443396226415094,0.8257111309474052,1.0,3/12,1.18%,UST;DCN;DSE
prerank,B cell activation (GO:0042113),0.40046345505965675,1.0856837161369417,0.35714285714285715,0.9961970854709249,1.0,10/68,9.73%,MEF2C;CD79A;ITGB1;LAX1;HDAC9;BCL2;RASGRP1;ITGA4;ADAM17;TPD52
prerank,catecholamine metabolic process (GO:0006584),-0.4309689191862236,-1.0855828157133938,0.37735849056603776,0.8253471828660071,1.0,4/14,21.44%,SNCAIP;PRKN;DDC;DRD2
prerank,carboxylic acid transport (GO:0046942),-0.29896380810021617,-1.0855662427200812,0.3034825870646766,0.8239977424496178,1.0,21/55,22.84%,SLC6A13;SLC16A12;SLC13A3;SLC16A9;SLC6A12;SLC6A6;SLC16A1;SLC3A2;SLC7A5;SLC16A11;SLC6A9;SLC6A11;CLN3;SLC66A1;SLC38A5;SLC38A6;SLC15A4;SLC1A4;PSAP;SLC36A1;SLC1A1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.40044842910607537,-1.0853896595187917,0.37209302325581395,0.8230807288968779,1.0,5/16,11.92%,DDX5;SRSF6;CELF4;HNRNPM;DDX17
prerank,bone development (GO:0060348),-0.32913519755548176,-1.0845975185755248,0.3161512027491409,0.8240481708370423,1.0,9/39,10.58%,RANBP3L;AKAP13;SULF1;GJA1;GNAS;CYP26B1;SLC10A7;SFRP4;FGFR2
prerank,iron ion transmembrane transport (GO:0034755),-0.4691964405173752,-1.0837584654486865,0.38562091503267976,0.8251769573432779,1.0,4/10,14.04%,SCARA5;ABCB7;SLC39A8;SLC25A28
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5266513001193114,1.083455061342712,0.4021543985637343,1.0,1.0,2/11,9.92%,MST1R;SIRT2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3758870641416751,1.0834134191674136,0.33554817275747506,1.0,1.0,39/128,20.35%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;FBXL22;CEP41;HAUS8;CEP290;ENSA;PLCB1;PPP1CB;BRSK1;CDK7;CEP192;DYNC1I2;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;DNM2;PLK4;CDK14;DCTN1;MASTL;MNAT1;HAUS4;BRSK2;CEP135;CKAP5;ACTR1A;KDM8;SFI1
prerank,positive regulation of rRNA processing (GO:2000234),-0.45852260427264946,-1.0833809536042778,0.36507936507936506,0.8249080561897869,1.0,6/10,35.68%,SIRT7;DIMT1;BUD23;HEATR1;RIOK2;TRMT112
prerank,protein heterooligomerization (GO:0051291),-0.39547573456200596,-1.0833685720398956,0.3569620253164557,0.8235469946400358,1.0,4/17,13.81%,PKD2;KCNC2;FARSB;TMEM120A
prerank,sensory perception of light stimulus (GO:0050953),-0.2669850728468874,-1.0829009525830384,0.28859060402684567,0.8234672259355338,1.0,12/87,9.56%,PITPNA;COL1A1;EYA4;EFEMP1;ABLIM1;ADGRV1;COL11A1;SLC4A10;ZIC2;EML2;WHRN;MYO9A
prerank,organophosphate catabolic process (GO:0046434),-0.4450586080262954,-1.0824224816279069,0.36027713625866054,0.8235788127680133,1.0,2/11,14.01%,ENPP2;ABHD12
prerank,epithelial cell morphogenesis (GO:0003382),0.500187680653146,1.0824024787837965,0.39553429027113235,1.0,1.0,1/17,0.72%,COL18A1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4692564704550678,1.082351802847657,0.36959761549925485,1.0,1.0,3/22,6.18%,RASL11A;PWP1;SMARCB1
prerank,sulfation (GO:0051923),-0.45196178576885737,-1.0816788542936606,0.36941176470588233,0.8244550635597796,1.0,1/11,0.11%,UST
prerank,purine nucleotide catabolic process (GO:0006195),-0.44224615028425607,-1.0815755413294865,0.3744075829383886,0.8233630310076122,1.0,6/13,19.77%,XDH;NT5E;HINT1;ITPA;GPX1;PNP
prerank,defense response to protozoan (GO:0042832),0.5233206783598906,1.0812896088798258,0.40344827586206894,1.0,1.0,3/12,12.29%,MYD88;LYST;GBP2
prerank,positive regulation of DNA recombination (GO:0045911),0.4501196513942737,1.0810721084958657,0.3643292682926829,1.0,1.0,10/27,16.16%,RAD51AP1;ZCWPW1;PARP1;ERCC6;FUS;FANCB;PAXIP1;RIF1;KMT5B;MAD2L2
prerank,regulation of Golgi organization (GO:1903358),0.4899089922443633,1.080750204742639,0.4016949152542373,1.0,1.0,5/17,14.04%,PDE4DIP;MAP2K1;STX18;PDCD10;MAPK1
prerank,organophosphate biosynthetic process (GO:0090407),-0.3276581822654688,-1.0798376417197526,0.32094594594594594,0.8272062853545241,1.0,17/37,30.30%,AGPAT4;IP6K1;GNPAT;IP6K2;TKT;PPIP5K2;GPAM;FGF2;AGPAT5;ITPKB;GK5;IPPK;FADS1;GK;NFS1;TPI1;PPIP5K1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3586758474276213,1.0791866026011316,0.355464759959142,1.0,1.0,33/259,10.52%,FLNA;MYLK;ARHGEF7;RAP1A;DYNLL1;VCL;PLA2G3;KIF27;ANO6;CDH13;EHD2;ITGB1;NTN1;CEP41;KIF3B;ACTR3;CEP290;IFT43;RAP2C;IFT81;STK26;CYFIP1;RAPGEF6;PIBF1;BBIP1;WHAMM;ARHGEF4;IQCB1;PARVA;RAP2A;ACTN2;EXOC6;RAB11FIP3
prerank,regulation of cilium assembly (GO:1902017),-0.28731581619467234,-1.0789392255719634,0.31,0.8286004571787533,1.0,31/62,26.17%,TBC1D16;LIMK2;TBC1D15;DCDC2;CEP97;ATG3;TBC1D2B;TBC1D13;TBC1D5;TBC1D8;IFT88;ATG5;TBC1D9B;RABEP2;TBC1D24;TBC1D30;TBC1D22A;SGSM3;DYNLT2B;ODF2L;TBC1D10A;TBC1D7;SDCCAG8;KCTD17;TBC1D14;CYLD;CCP110;CROCC;TBC1D2;CDKL1;BBS4
prerank,negative regulation of autophagy (GO:0010507),-0.297075911781728,-1.0787395974588712,0.301255230125523,0.8278156452312053,1.0,21/54,23.82%,LEPR;PIK3CA;NUPR1;FOXK2;SMG1;DAP;NRBP2;PTPN22;RASIP1;TAB2;KLHL22;EIF4G3;SNCA;DAPL1;AKT1;ZKSCAN3;QSOX1;TLK2;TBC1D14;LZTS1;SMCR8
prerank,cellular response to type I interferon (GO:0071357),-0.32147886205496434,-1.07739102701101,0.34328358208955223,0.8289291584137761,1.0,18/41,22.75%,IFNAR2;IRAK1;SAMHD1;IP6K2;SP100;STAT2;IRF9;IFIT1;IFIT3;IFNAR1;ADAR;BST2;IFITM1;OAS2;IFITM3;IFIT2;RNASEL;IFI27
prerank,type I interferon signaling pathway (GO:0060337),-0.32147886205496434,-1.07739102701101,0.34328358208955223,0.8289291584137761,1.0,18/41,22.75%,IFNAR2;IRAK1;SAMHD1;IP6K2;SP100;STAT2;IRF9;IFIT1;IFIT3;IFNAR1;ADAR;BST2;IFITM1;OAS2;IFITM3;IFIT2;RNASEL;IFI27
prerank,stress granule assembly (GO:0034063),0.4700580099060555,1.0773420841370756,0.38817891373801916,1.0,1.0,9/20,17.73%,CSDE1;ATXN2;MAPT;CIRBP;YTHDF2;RPS23;G3BP1;PRRC2C;BICD1
prerank,regulation of feeding behavior (GO:0060259),-0.4446591598713145,-1.0772734700259983,0.3648351648351648,0.8279222096155356,1.0,1/11,0.87%,LEPR
prerank,positive regulation of binding (GO:0051099),-0.27789712793632104,-1.0772328551849344,0.30357142857142855,0.8266546581206758,1.0,29/84,22.25%,IGF1;LRP1;TCF7L2;HMGB1;BMP4;APOE;APP;VTN;B2M;NVL;CLDN5;DERL1;NMD3;GPSM1;MED25;FKBP1A;PRKN;HES1;DTX3L;SPPL3;RARA;PPARG;KDM4D;RALB;RPL11;DACT1;NME1;RAN;STMN1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5078140882208705,1.076888609056349,0.4010152284263959,1.0,1.0,5/15,14.92%,PMAIP1;IRS1;PPARA;LDLRAP1;IRS2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5199219753987334,1.0767297402945413,0.3832752613240418,1.0,1.0,4/13,10.01%,PADI2;ARID1A;CHEK1;SERTAD2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3525910807390408,-1.0765107473215407,0.32507739938080493,0.8274353208336818,1.0,13/26,24.63%,USP45;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;RAD23B;ERCC4
prerank,bicarbonate transport (GO:0015701),0.4484305999821129,1.0764646376575462,0.38284839203675347,1.0,1.0,4/25,8.07%,CA3;SLC4A8;SLC4A3;SLC4A7
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4278897422862286,1.0764558295083893,0.376158940397351,1.0,1.0,9/40,13.26%,NTF3;ANGPT1;HIP1;VEGFA;DGKD;ATAD1;SCYL2;CLU;LDLRAP1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.32230052416794636,-1.0763917657808457,0.3333333333333333,0.8264609553513904,1.0,14/39,17.22%,BMP4;SLIT2;GLI2;NRP1;ENG;PKD2;TIE1;CTNNB1;RASIP1;SALL1;SIX1;KDR;FGF2;NOTCH4
prerank,monocyte chemotaxis (GO:0002548),0.4331090485681411,1.0763182558174547,0.37254901960784315,1.0,1.0,5/32,10.43%,PDGFB;ANXA1;CCL5;TNFRSF11A;CCL14
prerank,ion homeostasis (GO:0050801),0.44838896547249973,1.075534458708146,0.3850658857979502,1.0,1.0,7/30,8.12%,CAMK2D;SLC4A8;P2RY2;FHL1;SLC4A3;SLC4A7;WNK2
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3288978318472706,-1.0750062015288337,0.3223684210526316,0.8292438471239171,1.0,15/34,18.87%,FLT1;PIK3CA;SEMA6A;MAPK14;NRP1;GAS1;GAB1;SPRY2;ERN1;RAMP2;KDR;VEGFC;VEGFB;MT1G;ITGB1BP1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3934038911985508,1.0748905008053335,0.3774752475247525,1.0,1.0,10/72,7.13%,FGF13;TRIM54;CHADL;CLASP2;KANK1;ARHGEF2;EMILIN1;DYRK1A;HDGFL3;TPX2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.40871421396283275,-1.0747626401832164,0.37789203084832906,0.8285723962182789,1.0,14/15,59.17%,CD55;PNP;SYK;CCR2;HSPH1;NKAP;SHH;GLI3;IL12A;IL23A;EBI3;IHH;IL23R;IL12B
prerank,peptide cross-linking (GO:0018149),0.4581523273673174,1.0742985621025276,0.3755656108597285,1.0,1.0,2/25,2.78%,FCGR3A;ANXA1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4060427103993251,1.0740604182533993,0.38738738738738737,1.0,1.0,14/52,11.84%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;ZDHHC2;CNST;SORBS1;STAC3;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,artery morphogenesis (GO:0048844),0.44100606901411143,1.073997974463177,0.3953488372093023,1.0,1.0,7/30,10.07%,HEY2;TBX2;JAG1;BMPR1A;VEGFA;TGFB2;PDGFRB
prerank,regulation of biosynthetic process (GO:0009889),0.5328641595829121,1.0737996985058627,0.40148698884758366,1.0,1.0,6/11,22.88%,ALOX5;GSTP1;SLC25A33;THRSP;PIKFYVE;MID1IP1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4458328244132518,1.073472905793534,0.4011713030746706,1.0,1.0,10/28,13.74%,SORT1;BCL2;GABARAP;DAB2IP;BAG3;DEDD2;CASP8AP2;DIABLO;DEDD;TNFRSF10B
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4374398373263757,1.0734244666455928,0.3906911142454161,1.0,1.0,13/32,20.76%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,tRNA export from nucleus (GO:0006409),0.4374398373263757,1.0734244666455928,0.3906911142454161,1.0,1.0,13/32,20.76%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4118883235519882,-1.0731396947409462,0.37922705314009664,0.8319470786803189,1.0,6/16,15.80%,APOE;NPR3;NOS1AP;PIK3CB;GCH1;AKT1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3647279831928539,-1.072901152900946,0.35384615384615387,0.831354109210307,1.0,6/22,16.41%,ZBTB20;APOE;CREBL2;CREB1;AKT1;PPARG
prerank,photoreceptor cell development (GO:0042461),0.4915765200226794,1.0725094477585688,0.38528896672504376,1.0,1.0,3/14,6.50%,CDHR1;CEP290;VEGFA
prerank,ribosomal small subunit assembly (GO:0000028),-0.40235058464738926,-1.072453780835442,0.3598014888337469,0.831267636530427,1.0,10/16,29.79%,PRKDC;XRCC5;RPS19;RPSA;ERAL1;RRP7A;RPS27;MRPS11;RPS5;RPS15
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4566055489375632,1.0723400950584263,0.38571428571428573,1.0,1.0,3/22,6.81%,ROCK1;PACSIN3;TIMP4
prerank,establishment of protein localization to membrane (GO:0090150),-0.2880709615758808,-1.0711118288074446,0.35789473684210527,0.8339567817034871,1.0,13/66,13.38%,AFDN;EGFR;RAB11A;ZDHHC18;ATG3;SYNE3;ZDHHC15;SDCBP;SEC63;RAB3GAP2;FRMPD1;ZDHHC9;ZDHHC20
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.38008485744771414,-1.071019386405498,0.37346437346437344,0.8328777309146599,1.0,15/18,49.60%,OFD1;CCDC39;SPEF2;NEK10;CFAP53;ROPN1L;ADCY10;SPAG17;AQP4;SPA17;DNAAF2;ODAD4;NPHP3;CCDC40;DNAAF4
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4898633755329302,1.0708766034029127,0.3898858075040783,1.0,1.0,5/17,11.57%,FGF1;LPCAT3;MBTPS1;SREBF2;ABCG1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.45099871413760473,1.0708081026753806,0.4065620542082739,1.0,1.0,6/29,10.84%,PMAIP1;PPP2R1B;CAV1;PAK2;DEDD2;GPER1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.47711640267200744,1.070707377384194,0.4112,1.0,1.0,4/20,10.84%,ANO6;PIAS4;ITGA4;GPER1
prerank,negative regulation of protein polymerization (GO:0032272),-0.3492045975978667,-1.0706610331144943,0.3564954682779456,0.832613563873576,1.0,10/27,14.15%,CDH5;SLIT2;KANK3;CYRIB;EML2;SSH2;PFN2;PFN1;SSH1;SNCA
prerank,purine-containing compound catabolic process (GO:0072523),-0.43427724768835535,-1.0702496257685485,0.3855140186915888,0.8324989238891811,1.0,6/13,19.77%,XDH;NT5E;ITPA;DPYD;GPX1;PNP
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.36482201019337246,-1.0701226049234327,0.36312849162011174,0.8315112113673816,1.0,12/22,29.56%,URB1;ERI3;EXOSC9;RPS21;FTSJ3;NOP9;EXOSC2;UTP20;EXOSC7;EXOSC3;PES1;RRS1
prerank,methylguanosine-cap decapping (GO:0110156),-0.46928735022598045,-1.070075178020341,0.39029535864978904,0.8302892141710457,1.0,6/10,22.61%,DCPS;LSM1;DCP2;EDC4;PNRC2;EDC3
prerank,anterior/posterior axis specification (GO:0009948),0.4994540865734387,1.0698988232665767,0.3910149750415973,1.0,1.0,2/15,9.18%,FZD5;SKI
prerank,thymus development (GO:0048538),-0.41910335319632475,-1.069687913671636,0.3798449612403101,0.8300518005387694,1.0,6/13,27.22%,SIX1;HES1;TGFBR1;ZBTB1;FOXE1;EPHB3
prerank,regulation of macrophage cytokine production (GO:0010935),-0.41764146493363286,-1.0695979185850275,0.3469387755102041,0.8289686596059967,1.0,5/13,10.30%,WNT5A;SEMA7A;PLCG2;IRAK3;TGFB1
prerank,regulation of nervous system development (GO:0051960),0.42376880038178444,1.069234136022702,0.393646408839779,1.0,1.0,7/37,9.92%,HEY2;HEYL;PRUNE1;GBX1;YTHDF2;YAP1;SIRT2
prerank,inorganic anion transmembrane transport (GO:0098661),0.3940987885905192,1.06880205946482,0.37454100367197063,1.0,1.0,11/63,9.82%,ANO1;GABRE;ANO6;SLC4A8;SLC20A2;GABRA4;GABRA5;GABRB2;XPR1;GABRG1;ANO3
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3663858153059705,-1.068420031675591,0.35365853658536583,0.8310539906819051,1.0,7/22,13.52%,SLIT2;KANK3;CYRIB;SSH2;PFN2;PFN1;SSH1
prerank,cardiac ventricle development (GO:0003231),0.4707640730836944,1.068145232645132,0.396875,1.0,1.0,2/20,3.09%,HEY2;HEYL
prerank,response to molecule of bacterial origin (GO:0002237),-0.2829466697022599,-1.0681146628729463,0.3105263157894737,0.8306069654838995,1.0,17/69,16.15%,FOXP1;SMAD6;LBP;LGALS9;IRAK1;NOCT;RPS6KA3;CYRIB;PTPN22;IRAK3;PELI1;NOS3;TAB2;SNCA;GCH1;IFNAR1;SRR
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.41336767635253135,1.0679596278332517,0.37066666666666664,1.0,1.0,4/45,3.34%,CD36;MYD88;FZD5;LPL
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5305184132568345,1.0677730968560697,0.4180887372013652,1.0,1.0,5/11,18.30%,TP53;RPS27L;MAD2L2;HIPK2;RPS6KA6
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4366372707569898,1.0671627534206647,0.40955137481910275,1.0,1.0,8/34,10.84%,FERMT2;RORA;RUNX1T1;ASXL1;BBS12;YAP1;SIRT2;GPER1
prerank,leukotriene metabolic process (GO:0006691),0.4762939436336532,1.0671472501819426,0.40268456375838924,1.0,1.0,4/19,14.18%,ALOX5;MAPKAPK2;PTGR1;PLA2G4A
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.30112036323417857,-1.067127150880014,0.341991341991342,0.8322042835531157,1.0,17/50,20.79%,ZIC1;PTCH1;GAS1;DCDC2;IFT122;MEGF8;TULP3;INTU;HERC4;MGRN1;FGFR2;EVC;GLIS2;TXNDC15;BTRC;GPC3;PDCL
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3383076933994651,-1.0671035174768742,0.3673469387755102,0.8309515308450884,1.0,6/30,6.47%,DAB2;FOXP1;DDX5;SAFB2;RNF6;PRMT2
prerank,negative regulation of MAPK cascade (GO:0043409),-0.26064784142795416,-1.0669155774345271,0.34328358208955223,0.8301480082561398,1.0,24/87,22.01%,NF1;FBLN1;SEMA6A;BMP7;DLG1;BMP4;APOE;SPRED2;FOXO1;STK38;PIK3CB;IRAK3;LYN;SPRY2;SIRPA;IGBP1;DUSP1;LMO3;SMAD4;ITGB1BP1;QARS1;PTPN2;PEBP1;EPHB2
prerank,T cell proliferation (GO:0042098),0.5080233252421669,1.0668442023099556,0.39177101967799643,1.0,1.0,4/13,13.12%,DOCK8;RASGRP1;LMBR1L;PPP3CB
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.39520704273607526,1.0667396185924112,0.38558786346396967,1.0,1.0,10/66,11.28%,FLNA;FERMT2;MCRS1;UBR5;TERT;YAP1;KAT7;BAG3;CCT3;PRKCD
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.45051227773154756,-1.0664277658708465,0.394273127753304,0.8289400212333724,1.0,4/10,41.35%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.45051227773154756,-1.0664277658708465,0.394273127753304,0.8289400212333724,1.0,4/10,41.35%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.46903224135980914,1.0662075274207967,0.3957654723127036,1.0,1.0,5/19,13.03%,POLR2L;POLR2I;POLR2G;TERF2;POLR2J
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.46903224135980914,1.0662075274207967,0.3957654723127036,1.0,1.0,5/19,13.03%,POLR2L;POLR2I;POLR2G;TERF2;POLR2J
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.22836818559350683,-1.0660401346354273,0.21052631578947367,0.8287175064064853,1.0,83/314,19.50%,ECPAS;NEDD4L;ARRB1;FBXL7;FBXL5;ATXN3;AREL1;ITCH;CUL3;SEL1L;RNF185;ANAPC1;UBXN4;UBQLN1;UBE2D3;DNAJB12;PML;DERL1;UFD1;UBR2;HSPA5;DNAJC10;CTNNB1;USP19;BIRC2;PCBP2;FBXO9;PSMD7;PSMD9;PSMD13;LTN1;MDM2;PELI1;FBXO4;TOPORS;CDC23;RBCK1;TRIM25;WWP1;ARMC8;SMURF2;PRKN;KCTD2;RMND5B;DDB1;SGTA;UBE4B;PSMB3;UBC;KLHL22;RNF34;STUB1;RMND5A;SKP2;DNAJB2;HSP90B1;PSMC5;SGTB;SIAH1;NEMF;PSMA5;OS9;PSMA1;BUB3;PSMC2;HECW1;CDC26;NHLRC3;UBXN1;UBQLN2;AMN1;UBE2S;ANAPC4;SIAH2;SYVN1;UBXN8;FBXW5;DNAJB9;HERPUD1;SPOPL;SPSB4;BTRC;FBXO31
prerank,regulation of AMPA receptor activity (GO:2000311),0.453678262708569,1.0660372801787017,0.39644970414201186,1.0,1.0,4/25,7.44%,MEF2C;SHISA9;CNIH2;GSG1L
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5226754088069647,1.06600976698104,0.4096153846153846,1.0,1.0,4/10,15.38%,SOX9;PDGFA;LRP5;STAT1
prerank,long-chain fatty acid transport (GO:0015909),0.4473485526629396,1.0654082568113414,0.39705882352941174,1.0,1.0,6/30,8.96%,PRKAB2;CD36;ACACB;FABP4;CPT1B;ABCD4
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3356931256998147,-1.064955970041593,0.3344594594594595,0.8305228533417597,1.0,15/31,21.50%,IGF1;CHST11;EXTL3;BMPR2;CHST9;UGDH;HS3ST3B1;GLCE;CANT1;XYLT1;PXYLP1;FOXL1;CHST12;B4GALT7;B3GAT1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.37606158120806443,-1.0646318970539774,0.3685636856368564,0.8301289392702709,1.0,8/19,24.98%,TPST1;BPNT2;SLC26A2;ENPP1;PAPSS1;PAPSS2;SLC35B3;BPNT1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3646907783323716,-1.0645529993643295,0.3834808259587021,0.8290236225233008,1.0,13/21,42.50%,EPHA7;BIRC2;DELE1;BIRC3;TTBK1;PSMB9;PYCARD;NGF;GRIN1;AIM2;FYN;BEX3;GRIN2B
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4221822557955235,1.063789572425984,0.38722826086956524,1.0,1.0,6/40,7.22%,PMAIP1;BCL2;NDUFS1;MAPT;ARL6IP5;HEBP2
prerank,regulation of cellular component size (GO:0032535),0.4424433334121555,1.0629949503786476,0.3997113997113997,1.0,1.0,4/30,10.78%,NEB;LARS1;PPP1CA;VAV1
prerank,endoderm development (GO:0007492),0.5078976155425718,1.062832290597569,0.43781094527363185,1.0,1.0,2/13,6.91%,DUSP5;LAMC1
prerank,response to interferon-alpha (GO:0035455),-0.3978253449290653,-1.0627205029341376,0.39951573849878935,0.8329897837338699,1.0,10/16,30.01%,IFNAR2;IFNAR1;ADAR;BST2;IFITM1;IFITM3;RO60;IFITM2;PDE12;KLHL20
prerank,regulation of mitochondrial fusion (GO:0010635),-0.4431422979660849,-1.0626483592617832,0.40401785714285715,0.831864891506201,1.0,2/11,10.06%,PID1;PRKN
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3561698983978353,1.0624617554517504,0.37447698744769875,1.0,1.0,37/198,13.21%,ITPK1;PLCE1;LIMD1;PFKP;INPP4B;PPP3CA;PLA2G3;PLCB4;PIP4K2A;DUSP5;HK2;LPL;ACP3;PFKFB1;INPP5A;NUDT4;GFPT1;LHPP;COQ8A;DUSP3;PPM1A;CALM1;PLPPR1;PLCB1;PPP1CA;PAK2;INPPL1;PLCD1;ALDOA;INPP5B;PFKM;HTR2B;ITPKC;TPTE;DUSP16;PPP3CB;PLB1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5318986254275249,1.062458994898292,0.4251824817518248,1.0,1.0,4/10,12.84%,DGKD;GAP43;HTR2B;PRKD3
prerank,positive regulation of embryonic development (GO:0040019),-0.3784323209627779,-1.0623658972675158,0.35475578406169667,0.8314583825929185,1.0,4/19,12.54%,NIBAN2;WNT4;OSR1;ZBED3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4858230727687597,1.062321156599729,0.38198198198198197,1.0,1.0,3/13,5.14%,RBPMS;TGFB3;BMPR1A
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.4364424481362699,1.062311703293198,0.40953716690042075,1.0,1.0,6/32,6.80%,PMAIP1;DYRK2;MYBBP1A;TP53;PHLDA3;RPS27L
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.45471673069159224,1.0622743209584702,0.4120300751879699,1.0,1.0,4/23,9.45%,CHMP4C;PABIR1;CHEK1;ZWINT
prerank,regulation of neuron death (GO:1901214),0.38355299556414907,1.0622735629512563,0.3834319526627219,1.0,1.0,17/82,14.96%,MEF2C;MAP3K5;TRIM2;CCL5;INPP5A;CD200R1;MAPT;CD200;PPARGC1A;FAIM2;CHRNA7;CLU;SARM1;EPHB1;LRRK2;SNCG;DHCR24
prerank,phosphorylation (GO:0016310),0.34660105311499606,1.0622429564166662,0.3598790322580645,1.0,1.0,90/384,17.24%,DGKB;DGKG;MAP3K20;STK38L;TNNI3K;PRKG1;MAP3K5;ROCK1;DYRK2;MERTK;LIMD1;PDGFB;CDK6;PDK4;FRK;FAM20A;CAMK2D;ACVR2A;CAMKK2;PEAK1;MARK1;BMPR1A;DYRK1A;MAP4K3;MAP4K5;TAF1;COQ8A;MAPKAPK2;DYRK1B;STK26;CHEK1;FGGY;TGFB2;NUAK1;WNK2;DAPK3;PRKACB;PRKAR1B;MAP2K1;CCNT1;BRSK1;PKN2;PAK2;DGKD;CDK7;STK24;CDK18;EIF2AK2;ROCK2;PRKCD;COPS8;HTR2B;ACVR1B;CDK12;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;GAS6;CSNK1E;PDK2;DGKZ;SGK1;STK10;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;CSNK1A1;JAK2;STAT3;PLK4;HIPK2;STRADB;RYK;MAP3K13;EIF2AK3;NADK;CDK14;MARK2;POMK
prerank,regulation of inflammatory response (GO:0050727),0.354468633703635,1.0618875053792338,0.3953732912723449,1.0,1.0,30/190,11.28%,AGTR1;NR1H4;MYD88;RORA;ANXA1;IL2;LPL;FEM1A;CCL5;PTGIS;ALOX5;MFHAS1;SETD6;CD200R1;PIK3AP1;TNFAIP6;CD200;CELF1;RELA;TNIP1;LPCAT3;PPARA;NR1D1;MGLL;AKNA;AOAH;GPSM3;GPER1;RB1;PRKCD
prerank,inositol phosphate catabolic process (GO:0071545),0.49319215822783646,1.0616775733575268,0.39824561403508774,1.0,1.0,5/12,15.34%,INPP5A;SYNJ2;INPP5B;INPP5J;PTEN
prerank,receptor clustering (GO:0043113),0.44496507223132237,1.0615791065447409,0.4,1.0,1.0,5/27,10.06%,FLNA;MUSK;SAV1;ITGA4;AGRN
prerank,positive regulation of coagulation (GO:0050820),-0.4457084396624227,-1.0613890119021527,0.3758241758241758,0.8317716163495046,1.0,3/10,19.34%,ST3GAL4;SERPINE1;ENPP4
prerank,positive regulation of hemostasis (GO:1900048),-0.4457084396624227,-1.0613890119021527,0.3758241758241758,0.8317716163495046,1.0,3/10,19.34%,ST3GAL4;SERPINE1;ENPP4
prerank,chemical synaptic transmission (GO:0007268),0.3454706289900917,1.061294277778723,0.3520408163265306,1.0,1.0,44/284,12.68%,CACNB2;STXBP2;HCRTR1;APBA1;HTR1B;DTNA;GABRE;KCNMB1;GRIN2C;SLC6A2;SLC6A5;CACNB4;CAMKK2;SYT10;GABARAP;PCDHB14;STAC3;RPS6KA2;GABRA4;CALM1;RAB3A;GABRA5;MBP;PCDHB11;PRKACB;PRKAR1B;RAPSN;GRIK5;LIN7C;GABRB2;RIMBP2;BRSK1;GABRG1;HRH3;FCHSD2;CBLN2;KCNK3;CACNA1B;HTR2B;GABRB3;KIF5A;CHRNA7;CHRFAM7A;HOMER1
prerank,protein transport (GO:0015031),-0.22435278634834416,-1.0610410344288554,0.3333333333333333,0.8314961910784271,1.0,91/332,19.78%,SPTBN1;PRKCB;LRP1;VAMP5;CALCRL;APOE;TBC1D16;ABCA1;SNX27;SEL1L;RABGAP1L;RAB5A;STXBP1;STX3;TBC1D15;RAB12;USO1;SCAMP2;ERP29;TBC1D8B;ATP6V0A4;GOLGA4;TMED5;SEC23IP;TBC1D2B;SCG5;TBC1D13;SLC10A7;CANX;STEAP3;STX5;HERC2;TBC1D5;STX4;OPTN;ARL5B;GCC2;TMED7;TMED10;WLS;COPB2;GOLPH3;TBC1D8;PPT1;ATP6AP1;ATP6V1G1;RAB3GAP2;SNX6;PDIA4;ARF3;BLZF1;UNC93B1;SNX15;ARFIP2;RCN3;RAMP2;TBC1D25;HSP90B1;TOM1;TBC1D9B;SGSM1;GRTP1;MYO6;ARFGAP3;RAB1A;TBC1D30;RAB29;TBC1D22A;TBC1D9;MON1A;EHD1;STX1A;TCIRG1;SGSM3;PPARG;NDC1;COG7;PICK1;TMED3;RAB13;SCFD1;STX8;RAB1B;NAPG;ARRDC1;TBC1D10A;TMED4;MCOLN1;SCAMP3;MIA3;PPY
prerank,response to retinoic acid (GO:0032526),-0.2882667081224193,-1.0609983035694746,0.35960591133004927,0.8303290871825565,1.0,18/59,18.28%,PTK7;WNT5A;RBP4;EPHA3;ACER2;PTK2B;CTSH;WNT9A;SETX;ABL2;SNW1;CREB1;LYN;RARA;WNT6;TRIM16;ATM;RORB
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.43441083194014285,-1.060993596997446,0.38717339667458434,0.8290406921180885,1.0,7/12,29.15%,SETX;IRGM;INSR;UVRAG;SMCR8;JMJD4;ADRB2
prerank,regulation of glycolytic process (GO:0006110),-0.2835526520085735,-1.060856572170651,0.30939226519337015,0.8281269007568128,1.0,22/68,21.68%,IGF1;ZBTB20;PRKAG2;NUPR1;APP;NUP88;HDAC4;ENTPD5;OGT;PFKFB2;EP300;NUP50;ARNT;INSR;PRXL2C;NDC1;GIT1;NUP85;PFKFB3;PRKAA1;NUP214;CBFA2T3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3674645891703676,-1.0607924108937181,0.345821325648415,0.8270126440670705,1.0,9/22,22.71%,MAN1C1;SEL1L;RNF185;UGGT2;UBC;OS9;SYVN1;UBB;MAN1A2
prerank,regulation of intracellular signal transduction (GO:1902531),0.3422009912624138,1.060768581784242,0.3515151515151515,1.0,1.0,84/420,14.61%,OBSCN;ARHGEF7;NTRK3;AKAP6;DLC1;FGF1;KALRN;PRKAB2;DYRK2;LBH;ABR;PIP5K1B;ARHGEF17;PIP4K2A;FAM83D;MYO9B;DEPDC1B;ITSN1;BRIP1;NET1;PRDM1;ARHGAP21;ARHGAP10;ARHGEF16;USP2;CHN1;ARHGAP6;ARHGEF2;ARHGDIG;TAF1;MAPT;CASTOR1;DAB2IP;TP53;RRAS;VEGFA;PIN1;RHOJ;TPX2;TRAF3;CHEK1;RAD9A;ANKRD54;RELA;PEX5L;NUAK1;ARHGAP17;RHOF;ARHGAP39;GNA12;ARHGAP30;PRKAR1B;ARHGEF4;PAK2;ARHGAP1;RRAGB;RPL5;ARHGAP12;TRAF5;PRR5;RHNO1;VAV1;INPP5B;ARHGAP15;ARHGAP5;RHOH;ZFAND6;ARHGAP35;RICTOR;TNIK;BCR;ARHGAP32;TPTE;RMI2;TAOK3;CHD4;SGK1;TMSB4X;MAPK1;LRRK2;PRKAA2;CASTOR2;ARHGAP24;UFL1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3627778511316038,-1.0604445238575821,0.3551912568306011,0.826693740603674,1.0,8/23,19.38%,SLIT2;CAMK1D;MOSPD2;MCU;RIPOR2;DPP4;NCKAP1L;TIRAP
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.49281208253561054,1.0601425401246427,0.41430948419301167,1.0,1.0,4/15,11.73%,FST;ACVR2A;SKI;ACVR1B
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2302640926078678,-1.0600326567914908,0.26666666666666666,0.8266332926148252,1.0,120/341,26.04%,TTC3;NEDD4L;ARRB1;FBXL7;TRIP12;RNF146;ATXN3;AREL1;ITCH;FBXO10;CUL3;RNF185;ANAPC1;RNF20;UBQLN1;UBE2D3;OTUD7B;BIRC6;RC3H2;RNF144B;RNF217;UBL7;RNF6;PML;UFD1;CTNNB1;BIRC2;PCBP2;UBAP1;RNF13;PSMD7;WDR91;PSMD9;PSMD13;RNF213;MDM2;PELI1;TOPORS;CDC23;FBXO7;RBCK1;TRIM25;WWP1;ARMC8;SMURF2;RNF144A;PRKN;KCTD2;RMND5B;DDB1;UBE4B;PSMB3;KLHL22;RNF34;STUB1;RMND5A;SKP2;VPS4B;RNF125;DTX3L;RNF166;PSMC5;SIAH1;PSMA5;OS9;PSMA1;BUB3;PSMC2;UBE2H;RNF115;HECW1;CDC26;TOLLIP;NHLRC3;UBXN1;RNF43;KLHL3;UBQLN2;UBE2S;ANAPC4;MVB12B;SIAH2;SYVN1;FBXW5;RNF130;HERPUD1;CHFR;SPOPL;ARRDC1;ARIH1;SPSB4;BTRC;UBAP1L;PPP1R11;NUB1;ZFAND2A;WDR81;SHARPIN;KCTD17;PSME3;PSMC4;ZNRF3;KEAP1;IFI27;UBE2B;PSMB6;MVB12A;UBR4;FBXL19;RAD23B;TBL1XR1;VPS37C;SIAH3;UCHL1;PSMB10;ANAPC15;HECTD3;SPSB1;TRIM32;RNF19B
prerank,organelle assembly (GO:0070925),0.34885149812555594,1.0597591722668984,0.35931174089068824,1.0,1.0,89/384,18.90%,LMOD1;FLNA;DYNLL1;LMOD2;LMOD3;ATP2A2;CHMP4C;LIMD1;PLA2G3;KIF27;EHD2;CEP41;NUP62;HAUS8;KIF3B;ACTR3;CSDE1;CEP290;ATG16L2;ATG7;GABARAP;MAPRE2;ATXN2;IFT43;TUBGCP6;MAPT;IFT81;CHMP5;ABCA3;CIRBP;YTHDF2;PIBF1;AUP1;BBIP1;SYNPO;IQCB1;ANLN;PARVA;IST1;CENPE;EXOC6;NSFL1C;RPS23;RAB11FIP3;STX12;STAM2;FHDC1;WDR45;CHMP2B;TSG101;HPS4;STK36;VPS36;PIK3C3;CHMP2A;FOXJ1;TTC39C;G3BP1;HAUS7;HAUS2;MAPRE3;PLA2G4C;STAM;RAB8B;STX7;CCDC66;ATG13;CFAP43;RFX3;PLK4;PRRC2C;RAB8A;CENPW;INO80;RAB38;STARD9;DZIP1L;UBXN2B;VPS4A;GALNT11;BICD1;SH3PXD2B;DHX29;FARP2;RBM14;MRPL22;HAUS4;ULK1;HDAC6
prerank,vesicle coating (GO:0006901),-0.28493145203345693,-1.0597081005046474,0.3191489361702128,0.823746809800173,1.0,18/61,19.23%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.28493145203345693,-1.0597081005046474,0.3191489361702128,0.823746809800173,1.0,18/61,19.23%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,COPII vesicle coating (GO:0048208),-0.28493145203345693,-1.0597081005046474,0.3191489361702128,0.823746809800173,1.0,18/61,19.23%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG
prerank,cellular component maintenance (GO:0043954),0.5124387678198562,1.0596968511057716,0.42807625649913345,1.0,1.0,2/12,4.94%,ITGA3;LNPK
prerank,metal ion export (GO:0070839),0.43399832064272337,1.059545803374917,0.3954887218045113,1.0,1.0,5/31,7.75%,ATP2B4;KCNA5;KCNE4;ATP1B1;KCNT2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35533109190488893,1.0594957400106426,0.37731958762886597,1.0,1.0,24/234,8.37%,MYOCD;ABRA;CD36;MYD88;ROR1;CRTC1;ARID5B;FZD4;CRTC3;ARHGEF2;PRKCQ;MTDH;TNFRSF11A;CAV1;TAF1;SMARCB1;VEGFA;CD200;AR;PPARGC1A;PPARGC1B;NFKBIB;RELA;TRIM68
prerank,synaptic vesicle exocytosis (GO:0016079),-0.3247690949765961,-1.05948515542902,0.34191176470588236,0.8231232911537897,1.0,13/40,22.47%,UNC13C;UNC13B;STX3;SYT1;STX4;SNAP29;SNCA;PCLO;SNPH;STX1A;RIMS2;SYT2;STX2
prerank,positive regulation of DNA binding (GO:0043388),-0.3282849458510667,-1.0590916571209132,0.3734567901234568,0.8228749469588446,1.0,12/31,27.56%,IGF1;NIBAN2;HMGB1;PRKN;TGFB1;HES1;PPARG;PARK7;NME1;TWIST1;HMGB2;EGF
prerank,cell cycle G2/M phase transition (GO:0044839),0.3667907279531859,1.0589733480444354,0.3798449612403101,1.0,1.0,39/129,20.35%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;FBXL22;CEP41;HAUS8;CEP290;ENSA;PLCB1;PPP1CB;BRSK1;CDK7;CEP192;DYNC1I2;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;DNM2;PLK4;CDK14;DCTN1;MASTL;MNAT1;HAUS4;BRSK2;CEP135;CKAP5;ACTR1A;KDM8;SFI1
prerank,regulation of type I interferon production (GO:0032479),-0.27267860326086835,-1.0582755456011825,0.3313253012048193,0.8239642940376887,1.0,42/84,27.70%,ITCH;PRKDC;XRCC5;RNF135;MRE11;IRAK1;ILRUN;POLR3F;UFD1;CTNNB1;PCBP2;PTPN22;TRIM25;POLR3B;POLR3A;XRCC6;RNF125;EP300;NLRP4;TRIM56;POLR3H;NLRC5;POLR3E;UBA7;STAT6;POLR2K;TIRAP;POLR2F;POLR2H;POLR3GL;TRIM21;NLRX1;POLR3C;CYLD;DDX41;POLR3D;TRIM32;NFKB2;POLR2E;IKBKE;GPATCH3;PQBP1
prerank,negative regulation of cell activation (GO:0050866),0.501925982896834,1.058141138899977,0.43209876543209874,1.0,1.0,7/14,10.84%,PDGFB;EMILIN1;CD200;C1QTNF1;NR1D1;PDGFA;GPER1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.363822336835319,1.058070775122213,0.38478747203579416,1.0,1.0,15/121,7.48%,NTF3;ANGPT1;ANGPT4;PDGFB;CRLF1;CSPG4;IL2;CCL5;ARHGEF2;DOK7;TP53;VEGFA;PTPN1;PIBF1;ITGB3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5012495394825642,1.0579589043572895,0.4038800705467372,1.0,1.0,2/12,3.64%,DOCK8;CCL5
prerank,sphingolipid biosynthetic process (GO:0030148),-0.28247549243628733,-1.057922449486191,0.33157894736842103,0.823726258037349,1.0,16/71,9.94%,SGMS1;SGMS2;ELOVL7;CERS5;HACD4;ST3GAL5;SPTLC2;ST8SIA1;SPTSSA;B4GALT6;ACER2;ALDH3A2;CERS6;SGPP1;CERT1;ASAH2
prerank,regulation of protein autophosphorylation (GO:0031952),0.4212189678600869,1.0576410552689215,0.40581717451523547,1.0,1.0,10/36,10.74%,PDGFB;PDGFC;PDGFD;RAP2C;VEGFA;PPP2R5A;CALM1;IMPACT;RAP2A;PDGFA
prerank,cellular response to exogenous dsRNA (GO:0071360),0.504058155271639,1.0574943550022422,0.4078014184397163,1.0,1.0,5/12,16.80%,CGAS;CAV1;MUL1;FLOT1;DHX9
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3563452189724696,1.0573390610292546,0.391304347826087,1.0,1.0,32/182,12.63%,CCDC3;MEF2C;ATP2B4;HEY2;PDGFB;PLA2G3;HINFP;RBMS3;HAVCR2;BMPR1A;EMILIN1;ATXN2;TAF1;MAPT;TERT;SLC2A10;VEGFA;FBXW7;CELF1;YAP1;DICER1;TGFB2;MAP2K1;HIF1A;GPER1;ROCK2;RUNX1;RB1;TERF2;CNOT7;CITED2;PDCD10
prerank,macrophage activation involved in immune response (GO:0002281),0.49561814769743595,1.0573186819386176,0.4214046822742475,0.9999463697748653,1.0,2/13,2.43%,FER1L5;DYSF
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.43664290337161354,1.0570617718721123,0.3883211678832117,0.9996197690155773,1.0,12/26,20.45%,SOCS5;SOCS4;FBXW7;AREG;ADAM17;HBEGF;TSG101;NCK2;CBLB;ADRA2A;SHC1;ERRFI1
prerank,cellular amino acid catabolic process (GO:0009063),0.37564478202796797,1.0568206118070775,0.3783783783783784,0.9992899768304976,1.0,15/87,11.00%,BCAT2;MCCC2;HSD17B10;CARNS1;HIBADH;BLMH;DLD;HGD;KMO;DLST;GOT1;GOT2;SARDH;GLS2;GLS
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.24335727359883697,-1.056369014138333,0.3274336283185841,0.8266649934684154,1.0,31/132,14.51%,IGF1;ZBTB20;DAPK1;DCN;HMGB1;APOE;APP;NRDC;ITCH;TPCN1;FOXO1;ABHD5;PRR5L;PIK3CB;TFEB;FURIN;OPTN;RDX;STK11;ENTPD5;TRIM5;IRGM;GTPBP1;PTTG1IP;TRIM14;DTX3L;PFKFB2;ARNT;SNCA;INSR;TMEM59
prerank,histone mRNA metabolic process (GO:0008334),-0.35230778380075567,-1.0554977762786157,0.35451505016722407,0.8278281517946876,1.0,9/27,18.84%,SSB;SLBP;LSM1;DCP2;NCBP2;TUT4;ATM;CPSF2;TUT7
prerank,negative regulation of receptor internalization (GO:0002091),-0.42444426989065903,-1.0554966892503004,0.4038876889848812,0.8265658151464472,1.0,4/12,16.13%,RIN3;ANKRD13A;SDCBP;UBQLN2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4576410665945864,1.0549265912404993,0.4165316045380875,1.0,1.0,2/21,6.32%,ATP2A1;AFG3L2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.36935337481915503,-1.0546741831324882,0.3582474226804124,0.827590922783614,1.0,7/20,18.65%,APOE;NLGN1;SHANK3;CAMK1;LRP8;DBN1;FMR1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5001092548182539,1.0541381864755146,0.4489795918367347,1.0,1.0,5/16,15.82%,CHMP4C;CHMP5;VPS36;STAM;LEPROT
prerank,positive regulation of cellular process (GO:0048522),0.34198059712774326,1.0539562174382853,0.34804413239719156,1.0,1.0,114/565,17.54%,NTF3;TPM1;RYR2;NTRK3;AKAP6;LIFR;ACTN4;ZFHX3;TBX2;FGF1;MERTK;CD36;S1PR3;MST1R;PDGFB;PPP3CA;PDGFC;CCND2;CRLF1;ADRA1D;THPO;IL2;TGFB3;CCL5;GCNT2;PDGFD;PABIR1;IL12RB2;TSHR;FXN;BCL2;OSR2;HAS2;IRS1;TNFRSF11A;CAV1;MAPT;TPPP;TIPIN;VEGFA;ACACB;GDNF;PA2G4;AREG;AR;GAREM1;CHEK1;CELF1;SOX9;DICER1;TGFB2;RELA;KMT2D;ADNP2;CCND1;MVD;ADAM17;TRPM4;SIRT2;PDGFRB;RTKN2;IL13RA1;CCL14;HBEGF;PDGFA;GPER1;LRP5;PRKCD;HTR2B;CNOT7;BMPR1B;HDGFL2;CHRNA7;CITED2;KIF20B;PDCD10;POU3F3;NSMCE4A;SHANK2;ZFP36L1;FGF10;CEP43;GAS6;N6AMT1;S1PR2;HYAL1;PRKAA2;UFL1;PRKCA;MLXIPL;IRS2;FBXO5;SRPK2;RHOG;PTEN;CIAO1;FLOT1;NAMPT;TUB;ASH2L;MT3;INO80;DDX49;RPS6;MTLN;S100A8;S100A9;FGFR3;FAF1;EIF4G2;DNAJA2;ADRA2A;MAP1A;HDAC1
prerank,hexose biosynthetic process (GO:0019319),0.4185858097520813,1.0538439884446238,0.4098798397863818,1.0,1.0,12/42,15.43%,ENO3;PFKFB1;MDH1;AKR1B1;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;CRTC2;SLC25A12;GAPDHS
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.47928549702062617,1.0537300895333084,0.4176182707993475,1.0,1.0,4/16,14.87%,ACP3;SLC39A14;GPER1;PRKCA
prerank,negative regulation of catabolic process (GO:0009895),0.4019240187816117,1.0536424977019536,0.4005235602094241,1.0,1.0,6/47,9.92%,FLNA;PFKFB1;PIN1;SF3B3;PPARA;SIRT2
prerank,mitotic sister chromatid segregation (GO:0000070),0.37031099384488175,1.05348760912535,0.3837342497136312,1.0,1.0,24/98,17.60%,TTN;CHMP4C;NUP62;SET;NCAPD3;CHMP5;PIBF1;DIS3L2;TENT4A;ZWINT;CENPE;WRAP73;RB1;NCAPD2;CHMP2B;CHMP2A;KIF18A;KNSTRN;TEX14;RAD21;INO80;DSN1;CENPK;VPS4A
prerank,negative regulation of blood pressure (GO:0045776),-0.40936202415322204,-1.0534415216739423,0.41025641025641024,0.8296830404406076,1.0,4/13,21.44%,BMPR2;NOS3;SCPEP1;DRD2
prerank,post-translational protein modification (GO:0043687),0.3482132907146599,1.05274963103611,0.381243628950051,1.0,1.0,53/332,12.46%,IGFBP7;MFGE8;LTBP1;SPARCL1;SDC2;ASB15;HRC;ASB10;KCTD7;CCN1;ASB18;FBXL22;FBXO40;SOCS5;IGFBP5;FEM1C;FEM1A;LMO7;ASB2;ASB1;CUL2;SOCS6;RNF7;NUCB1;ASB8;PSMC6;ELOC;FBXW7;FBXO30;FBXL18;KTN1;IGFBP4;LAMC1;LAMB2;RAB3A;UBE2F;CUL9;DCUN1D1;CDH2;HIF1A;PSME4;FBXO6;SUMF1;PSMB1;MBTPS1;PSMD5;FBXO32;COPS8;FBXW11;UBA3;WSB1;PSMB2;DCAF11
prerank,regulation of leukocyte activation (GO:0002694),0.5089170431039126,1.0515028774484205,0.4424778761061947,1.0,1.0,4/14,10.84%,MFHAS1;MYO18A;CD200;GPER1
prerank,hemopoiesis (GO:0030097),-0.26521417547237275,-1.05121736947238,0.381294964028777,0.834845440731165,1.0,17/87,11.03%,TGFBR3;FLT1;MECOM;NOTCH2;BMP4;KIT;TEK;RUNX2;MFAP5;WNT5A;PGM3;CD34;TET2;FUT10;TGFB1;FGFR2;FLT3LG
prerank,myeloid dendritic cell activation (GO:0001773),-0.4329084601050138,-1.0511650000342763,0.39285714285714285,0.833740945289119,1.0,9/12,52.83%,HMGB1;DOCK2;CAMK4;BATF;PYCARD;BATF2;TGFBR2;IL4;BATF3
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3815758115144592,1.0508748745835534,0.40816326530612246,1.0,1.0,11/75,12.67%,ATP2B4;CACNA2D1;KCNJ12;SLC8A2;SLC8A1;ATP1B1;TRPV2;TRPM4;SLC39A14;TRPM2;HCN2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4391559712520287,-1.0504157853131193,0.3980815347721823,0.8345294409187841,1.0,6/11,14.79%,SEMA6A;EPN1;PIK3CB;ADAMTS9;KLF2;CREB3L1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.4262291335916953,-1.050357997342696,0.38349514563106796,0.8334323403240206,1.0,3/12,5.56%,CYP26B1;PTCH1;MEGF8
prerank,regulation of biomineral tissue development (GO:0070167),0.4391505660192755,1.0502922405272768,0.40381791483113066,1.0,1.0,7/26,16.46%,HEY2;ROCK1;SOX9;ROCK2;GAS6;FBXO5;ANKH
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.48865471793065873,1.0502664647399054,0.40308747855917665,1.0,1.0,4/13,15.39%,SOCS5;SOCS4;TSG101;CBLB
prerank,aerobic electron transport chain (GO:0019646),0.3872516398534281,1.0502287553188032,0.40632603406326034,1.0,1.0,24/68,18.70%,NDUFS1;COX7A2L;NDUFA11;NDUFA2;SDHC;SDHAF2;COX8A;NDUFC1;NDUFB6;NDUFS3;COX7B;NDUFV2;NDUFB8;NDUFS2;SDHA;NDUFAB1;NDUFA1;UQCRFS1;NDUFAF1;COX6C;UQCRH;COX5B;NDUFV3;UQCRQ
prerank,histone H4-K8 acetylation (GO:0043982),0.4987800939757522,1.0501345048735813,0.4372937293729373,1.0,1.0,6/15,12.59%,MCRS1;JADE1;KAT7;KANSL3;JADE3;KANSL1
prerank,histone H4-K5 acetylation (GO:0043981),0.4987800939757522,1.0501345048735813,0.4372937293729373,1.0,1.0,6/15,12.59%,MCRS1;JADE1;KAT7;KANSL3;JADE3;KANSL1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.44877829252700996,-1.0501202921304524,0.4216589861751152,0.8327921964613177,1.0,3/10,19.38%,LBP;PTPN22;TIRAP
prerank,fatty acid transport (GO:0015908),0.48021823876743064,1.049506321774395,0.42070116861435725,1.0,1.0,4/17,7.85%,CD36;FABP4;CPT1B;GOT2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5066410307352818,1.0492773551561134,0.4166666666666667,1.0,1.0,5/13,14.84%,SLC8A2;SHISA9;RAB3A;PPFIA3;SHISA6
prerank,release of cytochrome c from mitochondria (GO:0001836),0.47350483474608906,1.0492451748708147,0.4418604651162791,1.0,1.0,8/17,18.01%,BCL2;FZD9;DNM1L;GGCT;BOK;CLU;MFF;BBC3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5100061671019578,1.049036876732163,0.42441860465116277,1.0,1.0,3/10,8.97%,ACAD11;ETFA;ACADS
prerank,regulation of glucose metabolic process (GO:0010906),0.4261831855929574,1.048839976997759,0.4008438818565401,1.0,1.0,4/34,5.88%,PMAIP1;PDK4;RORA;IRS1
prerank,amyloid fibril formation (GO:1990000),0.4046021831734906,1.0485479279370407,0.4007731958762887,1.0,1.0,6/51,7.63%,TTR;MFGE8;CD36;MAPT;CALB1;NAT8
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.41671078640712345,1.0479940361836062,0.39620081411126185,1.0,1.0,13/38,18.23%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFA1;NDUFAF1;NDUFV3
prerank,spliceosomal complex assembly (GO:0000245),-0.3061174056804397,-1.0478857511648108,0.39325842696629215,0.8381293228982764,1.0,13/46,19.07%,CELF2;KHDC4;RBM5;SNRNP200;SRSF6;SRSF5;CELF4;SETX;CRNKL1;SNRPD1;SMN1;SRPK1;SCAF11
prerank,histone lysine methylation (GO:0034968),0.43582945778470045,1.047853358794128,0.4085545722713864,1.0,1.0,9/33,16.57%,SMYD1;SETD6;SUV39H2;KMT2D;SETD3;PAXIP1;N6AMT1;WDR5B;ASH2L
prerank,activation of phospholipase C activity (GO:0007202),0.4366173099780956,1.0475648635907795,0.3979135618479881,1.0,1.0,2/29,4.86%,EDNRA;ARHGAP6
prerank,transcription by RNA polymerase I (GO:0006360),0.4247191981226962,1.0475326663128035,0.4088888888888889,0.9992525089677041,1.0,7/34,11.77%,CAVIN1;POLR2L;GTF2H4;TAF1;CDK7;POLR1E;POLR1H
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5108510043320389,1.0472501072456712,0.45108695652173914,0.9989970880427427,1.0,8/12,20.19%,CDYL;LRIF1;HNRNPU;PCGF5;PCGF3;RBM15;RLIM;YTHDC1
prerank,regulation of protein metabolic process (GO:0051246),-0.30178909895234374,-1.0470556178247024,0.375,0.8392008387301484,1.0,17/44,18.85%,NEDD4L;APOE;APP;LDLR;LTBP4;HSP90AB1;FURIN;FKBP1A;MDM2;ACE;KLF2;SSH1;HGS;GSAP;CHEK2;ODC1;SPOPL
prerank,ESCRT complex disassembly (GO:1904896),0.5151256994634156,1.0468451484893027,0.4358047016274864,0.9980476349310076,1.0,5/10,17.60%,CHMP5;IST1;CHMP2B;CHMP2A;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),0.5151256994634156,1.0468451484893027,0.4358047016274864,0.9980476349310076,1.0,5/10,17.60%,CHMP5;IST1;CHMP2B;CHMP2A;VPS4A
prerank,anterograde trans-synaptic signaling (GO:0098916),0.34452832501353015,1.046582655624046,0.3970893970893971,0.9977697537493778,1.0,34/224,12.68%,CACNB2;HCRTR1;APBA1;HTR1B;DTNA;GABRE;KCNMB1;SLC6A2;SLC6A5;CACNB4;CAMKK2;SYT10;GABARAP;PCDHB14;RPS6KA2;GABRA4;CALM1;GABRA5;MBP;PCDHB11;PRKACB;PRKAR1B;RAPSN;GABRB2;GABRG1;HRH3;KCNK3;CACNA1B;HTR2B;GABRB3;KIF5A;CHRNA7;CHRFAM7A;HOMER1
prerank,negative regulation of cell growth (GO:0030308),0.3623584294878696,1.0462268760132047,0.4064587973273942,0.9977793396774447,1.0,23/121,14.70%,SLIT3;FGF13;MYL2;RERG;FHL1;JADE1;PTPRS;NDRG3;TP53;BTG1;TGFB2;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6;MUL1;HYAL1;VGLL4
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5052955101318314,1.0461847970816585,0.45276292335115864,0.9968755318296869,1.0,2/14,7.16%,ENTPD1;ENTPD7
prerank,response to progesterone (GO:0032570),0.4667559207093125,1.0461502384612347,0.4222972972972973,0.9959538590448428,1.0,4/18,7.86%,TGFB3;CAV1;YAP1;TGFB2
prerank,tRNA transport (GO:0051031),0.41930538217059116,1.0458105481921802,0.425,0.9958321077212785,1.0,13/35,20.76%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,ERBB2 signaling pathway (GO:0038128),-0.31704060843233295,-1.0457676769022748,0.3853503184713376,0.8416610497923445,1.0,6/31,11.28%,PIK3CA;GRB2;EGFR;GAB1;NRG2;STUB1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3937698410891856,1.0457675513986324,0.41624365482233505,0.9949368008386401,1.0,1/54,0.09%,CCDC3
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5181771833464063,1.0457587863536066,0.42401500938086306,0.9939469263087974,1.0,3/10,15.16%,SETD6;SETD3;EEF1AKMT2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.4019206080782991,-1.0457502313720153,0.3919239904988123,0.8404465349657562,1.0,10/14,28.88%,ADK;GMPS;ADSS2;PFAS;GART;ATIC;RFK;IMPDH1;IMPDH2;PAICS
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4435844867778592,1.045673770589054,0.42276422764227645,0.9931853138087526,1.0,4/21,6.45%,RBPMS;TGFB3;BMPR1A;SLC2A10
prerank,COPII-coated vesicle budding (GO:0090114),-0.27269489608534453,-1.0456027352283015,0.34285714285714286,0.8395923188001713,1.0,34/68,35.44%,TGFA;CUL3;KLHL12;USO1;SEC23IP;STX5;TMED10;SEC23B;SEC24B;MCFD2;ANKRD28;RAB1A;F8;PPP6R3;LMAN1;SCFD1;RAB1B;TRAPPC3;TFG;MIA3;F5;TRAPPC2;SAR1A;PEF1;SEC16B;PPP6C;CTSC;PPP6R1;TRAPPC6A;SAR1B;CSNK1D;SCAP;TRAPPC5;CNIH3
prerank,regulation of protein modification process (GO:0031399),-0.2921682306922847,-1.0454813673678571,0.35968379446640314,0.838717749847086,1.0,13/50,17.72%,CDH5;FN1;SPRED2;PTK2;PPP2CA;ASPSCR1;PML;IGF2;STAT2;LYN;GRM5;NOP53;KDM4D
prerank,positive regulation of axon extension (GO:0045773),0.45999983603826655,1.0453240255682092,0.4344262295081967,0.9931369205665528,1.0,5/22,6.50%,SEMA5A;NTN1;MAPT;DSCAM;VEGFA
prerank,positive regulation of MAPK cascade (GO:0043410),0.3465613723479159,1.0452513099950809,0.41649484536082476,0.9923216992006356,1.0,34/245,10.88%,RAP1A;NTRK3;ANGPT1;ROCK1;FGF1;CD36;MST1R;PDGFB;PDGFC;FERMT2;ROR1;ADRA1D;THPO;BCAR3;CCL5;GCNT2;PDGFD;MFHAS1;KSR1;DAB2IP;ARL6IP5;VEGFA;FBXW7;GAREM1;RASGRP1;TGFB2;MAP2K1;PDGFRB;CCL14;PELI2;EIF2AK2;PDGFA;GPER1;ROCK2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4168341721597454,1.0446736080513503,0.43646408839779005,0.9929034170164572,1.0,10/38,11.36%,NR1H4;RORA;CARD19;DAB2IP;PPM1A;TNIP1;OTUD7A;GSTP1;NR1D1;RHOH
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3704854118927034,-1.0446381206487323,0.4131578947368421,0.8399035707345501,1.0,9/18,27.91%,NGLY1;SAMHD1;ADAMTS9;FBXO17;BPGM;NAGA;STT3B;DERA;FBXO44
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4361115415651694,1.0440472814864856,0.4258720930232558,0.99366458984725,1.0,4/27,8.83%,WTIP;LIMD1;TP53;MAP2K1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3411475193267395,1.0439249954802414,0.39117352056168503,0.992981534799393,1.0,81/423,15.38%,NTF3;MEF2C;NTRK3;RBPMS2;LIFR;TBX2;FGF1;S1PR3;MST1R;PDGFB;CCN1;PDGFC;CDK6;CCND2;CDH13;CRLF1;ADRA1D;THPO;IL2;TGFB3;CCL5;GCNT2;PDGFD;IL12RB2;TSHR;FXN;BCL2;OSR2;BMPR1A;HAS2;IRS1;TNFRSF11A;TERT;TIPIN;VEGFA;GDNF;LAMC1;AREG;AR;GAREM1;YAP1;FZD9;SOX9;TGFB2;RELA;KMT2D;SAAL1;MVD;ADAM17;TRPM4;PDGFRB;RTKN2;HNRNPU;IL13RA1;CCL14;HBEGF;S100A6;PDGFA;GPER1;LRP5;HTR2B;CNOT7;CHRNA7;KIF20B;PDCD10;POU3F3;SHANK2;FGF10;CEP43;GAS6;S1PR2;HYAL1;UFL1;MLXIPL;IRS2;FBXO5;SRPK2;RHOG;PTEN;CIAO1;STAT1
prerank,regulation of neurotransmitter transport (GO:0051588),0.48307471677853475,1.0434576092947008,0.4188034188034188,0.9932588208567799,1.0,1/16,0.71%,MEF2C
prerank,monocarboxylic acid transport (GO:0015718),0.40182520288795287,1.0432464597354658,0.41687979539641945,0.9928569707891749,1.0,6/51,2.91%,NR1H4;CD36;ATP8B1;ABCB4;SLC16A7;SLC10A1
prerank,gluconeogenesis (GO:0006094),0.42020030063141034,1.0431544088696525,0.44021739130434784,0.9921146691972629,1.0,11/39,15.43%,ENO3;PFKFB1;MDH1;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;CRTC2;SLC25A12;GAPDHS
prerank,lipid translocation (GO:0034204),-0.36320603945928415,-1.042918929196871,0.39669421487603307,0.8435113913006979,1.0,7/21,8.34%,ATP8A1;ABCA1;ABCA4;ATP11C;ATP8A2;RFT1;TMEM30A
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.41372626369525484,-1.042657735042664,0.43028846153846156,0.8430297650552235,1.0,9/13,30.46%,SART3;PRPF19;LSM2;AAR2;PRPF31;PRPF8;SRSF12;PRPF3;DDX20
prerank,potassium ion import across plasma membrane (GO:1990573),-0.31267086217720724,-1.042614830341176,0.3602941176470588,0.8419292275175488,1.0,6/41,10.17%,ATP1A2;ATP1B3;SLC12A2;SLC12A7;ATP1B2;KCNJ13
prerank,T cell differentiation in thymus (GO:0033077),0.4764057005627823,1.0416069895243332,0.4256410256410256,0.9953703996038196,1.0,5/14,21.70%,ADAM17;ZFP36L1;MR1;PTPRC;ZFP36L2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.4766637269826129,1.040993897156417,0.40978077571669475,0.9960652512000858,1.0,6/17,12.48%,ROCK1;RTN2;PIN1;RTN1;CHRNA7;CLU
prerank,positive regulation of chemokine production (GO:0032722),-0.29650525751229656,-1.0409683194352848,0.3709677419354839,0.8453586682921529,1.0,7/44,8.49%,HMGB1;APP;DDX3X;IL18;WNT5A;LGALS9;IL6R
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.39284774878361306,-1.0406635766097676,0.42385786802030456,0.844900903798736,1.0,5/16,4.96%,ST8SIA4;ST3GAL5;ST6GALNAC3;ST8SIA1;B4GALT6
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.32514297958262084,-1.0401524104980515,0.38461538461538464,0.8450969750911692,1.0,3/33,1.02%,IGF1;NF1;PIK3CA
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3857956961469893,-1.040068455311094,0.39950372208436724,0.8440817757748357,1.0,4/17,11.42%,PTN;PTPRZ1;TGFB1;HES1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5055417671000867,1.0396195614306665,0.426056338028169,0.9988158145645821,1.0,5/13,16.02%,CRLF1;OASL;STAT1;JAK2;STAT3
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3953872690374672,1.039501481961228,0.4062111801242236,0.998130540216382,1.0,6/62,5.51%,MYL9;MEF2C;CDK6;CBFB;CNOT4;PRKCQ
prerank,cytoplasmic microtubule organization (GO:0031122),0.3981184961427308,1.0391038236882526,0.4295125164690382,0.9982004777737318,1.0,6/54,6.20%,TRDN;HOOK2;DST;TUBGCP6;MAPT;TPPP
prerank,epithelial cell differentiation (GO:0030855),0.3706667747296387,1.0389596995276964,0.4142857142857143,0.9976075297290089,1.0,9/88,8.75%,TAGLN;ANXA1;JAG1;TAGLN2;DMBT1;VEGFA;CNN3;CBR1;VDAC1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3821870133813874,1.038923116689418,0.4199029126213592,0.9966999247147511,1.0,24/69,18.70%,NDUFS1;COX7A2L;NDUFA11;NDUFA2;SDHC;SDHAF2;COX8A;NDUFC1;NDUFB6;NDUFS3;COX7B;NDUFV2;NDUFB8;NDUFS2;SDHA;NDUFAB1;NDUFA1;UQCRFS1;NDUFAF1;COX6C;UQCRH;COX5B;NDUFV3;UQCRQ
prerank,midbody abscission (GO:0061952),0.4646001811942118,1.0388302204923336,0.43023255813953487,0.9959330453212446,1.0,4/17,13.43%,CHMP4C;CHMP5;CHMP2B;CHMP2A
prerank,histone H4-K16 acetylation (GO:0043984),0.47515234105089427,1.038752240233273,0.41214057507987223,0.9951291035758404,1.0,8/19,15.23%,MCRS1;JADE1;MSL3;KAT7;KANSL3;JADE3;KANSL1;MSL1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.39958633874932403,-1.038678631943498,0.42757009345794394,0.846908478940307,1.0,4/14,16.30%,PUM1;DDX60;ANKRD17;TLR3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.37213797073880606,1.0380907003585937,0.4174757281553398,0.9959379870906797,1.0,13/76,10.68%,KLHL40;ANGPT1;UBA2;DCUN1D2;PIAS4;SAE1;CAV1;FBXW7;DCUN1D1;TNIP1;AMER1;PAXIP1;UBE2D1
prerank,protein localization to kinetochore (GO:0034501),-0.40151592139921977,-1.03747479467616,0.42168674698795183,0.8491449761963075,1.0,8/14,41.80%,IK;RCC2;BUB3;ZWILCH;KNL1;TTK;CENPT;SPDL1
prerank,positive regulation of neuron differentiation (GO:0045666),0.40810123237276147,1.03719061918053,0.435506241331484,0.9974780616383536,1.0,6/40,10.56%,MEF2C;HEYL;MMD;ARHGEF2;IMPACT;BRINP1
prerank,sensory perception of chemical stimulus (GO:0007606),0.4791649315345192,1.036624268402089,0.44197952218430037,0.9979861245535917,1.0,2/15,4.63%,CD36;SYT10
prerank,peptide metabolic process (GO:0006518),0.37966650017905007,1.0365583029951924,0.41595092024539876,0.9971815113651074,1.0,12/75,12.11%,DMD;CLN5;ETHE1;LNPEP;APEH;GSTT1;ENPEP;NAT8;GSTP1;MIPEP;OPLAH;GSTA4
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4222873623868481,-1.03618791783971,0.4166666666666667,0.8517321278285667,1.0,2/11,0.31%,DAB2;MLLT3
prerank,protein destabilization (GO:0031648),-0.3208073548104234,-1.0356918862565472,0.4084507042253521,0.8518560673811976,1.0,9/32,14.31%,CUL3;CTSH;DERL1;MDM2;PRKN;IRGM;EP300;SNCA;SOX17
prerank,regulation of interleukin-8 production (GO:0032677),-0.2658205412060473,-1.0356472598337267,0.32,0.8507277223610217,1.0,17/69,19.66%,ARRB1;HMGB1;LBP;F3;NOD1;OTUD7B;MAPKBP1;LGALS9;PTPN22;ANXA4;RAB1A;SSC5D;TLR3;SERPINE1;PARK7;TIRAP;BCL3
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.430036719520077,-1.0356461281917153,0.42757009345794394,0.8494783788087721,1.0,3/12,5.66%,NOTCH2;DOCK11;PTK2B
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.49715881340427676,1.035568096661503,0.4406196213425129,0.9989196600534954,1.0,4/13,11.96%,LARGE1;CHST5;CHST3;CHST1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.46738847287566165,1.035567602133159,0.4268502581755594,0.9979266236480484,1.0,4/15,17.16%,MYD88;HIF1A;STAT3;TICAM1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.40211107679756825,-1.0354614973577378,0.423728813559322,0.8487344152491809,1.0,2/15,2.55%,CPEB2;DDX3X
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4147411056671617,1.035424597485018,0.42090784044016505,0.9973361915518897,1.0,14/37,18.01%,PMAIP1;NACC2;BCL2;CAV1;TP53;SFPQ;EIF5A;DNM1L;BOK;S100A8;S100A9;BCAP31;DDIT3;BBC3
prerank,negative regulation of binding (GO:0051100),0.3736202706522415,1.0353112315752706,0.41113744075829384,0.996634794149805,1.0,15/81,14.51%,PLN;XIRP1;ROCK1;PDGFB;ACTB;CAV1;PIN1;PPP1CA;PSME3IP1;PEX19;PRKCD;BAG2;CSNK1E;LRRK2;DVL1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.49575700198815764,1.035251251175115,0.43133802816901406,0.9957899733892762,1.0,2/13,6.50%,COL4A1;VEGFA
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3567900777281003,1.034946254897394,0.41485714285714287,0.9956692747987391,1.0,12/110,9.65%,LHCGR;PTGER3;ADCY5;S1PR3;ADCY2;ADRA1D;ADCY9;TSHR;RAMP1;PTH1R;ADCY6;ADGRL2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.40314858292431344,-1.0348466276486716,0.42247191011235957,0.8493853788942917,1.0,4/13,9.82%,BMP7;BMP4;NR3C1;ESR1
prerank,regulation of autophagosome maturation (GO:1901096),-0.420564728960986,-1.03478135731767,0.44,0.848334302153745,1.0,7/13,29.15%,IRGM;TBC1D25;CLN3;UVRAG;SMCR8;PHF23;ADRB2
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.356553239875582,-1.0347606368332416,0.42441860465116277,0.8471489763005965,1.0,6/22,19.44%,APPL2;PTPRZ1;TAFA1;NES;KDM1A;NAP1L1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.34998580913093824,-1.0345710272468132,0.39002932551319647,0.8464624643539295,1.0,9/24,25.12%,NF1;EPHA7;NUPR1;CTNNB1;GRN;BAX;ATF4;FOXO3;CDK5R1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4077451473432554,-1.0343703370550659,0.43884892086330934,0.8445024011610812,1.0,4/13,16.94%,GRB2;IL15;IL15RA;STAT5A
prerank,cellular response to interleukin-15 (GO:0071350),-0.4077451473432554,-1.0343703370550659,0.43884892086330934,0.8445024011610812,1.0,4/13,16.94%,GRB2;IL15;IL15RA;STAT5A
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.3313567257333287,-1.0341890295192813,0.4119718309859155,0.8437374019606593,1.0,13/30,28.12%,TUSC3;MGAT1;FUT8;UGGT2;OSTC;MGAT5;MCFD2;LMAN1;RPN2;MGAT2;DPM3;STT3B;ASGR1
prerank,negative regulation of metabolic process (GO:0009892),0.39325494832307334,1.0340062365917282,0.41460234680573665,0.9972495219439819,1.0,7/54,9.23%,CCDC3;ADAMTS5;PLCL1;LNPEP;ADAM17;GSTP1;NR1D1
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4192741098637064,-1.033796354645147,0.4341801385681293,0.8435914980741941,1.0,3/12,15.17%,PTK2;LYN;BST2
prerank,histone H3-K4 methylation (GO:0051568),-0.34289486348581283,-1.033683010195537,0.4206128133704735,0.8427007145003115,1.0,13/26,30.91%,TET3;CTR9;TET2;OGT;KMT2C;DPY30;SETD1A;KDM6A;PRDM9;CXXC1;KMT2A;RBBP5;BEND3
prerank,fatty acid beta-oxidation (GO:0006635),0.3867456957521709,1.033420710795737,0.41073825503355704,0.9978549934668796,1.0,12/51,10.20%,HSD17B10;PEX2;HSD17B4;ACAD11;CRAT;MECR;ETFA;ABCD4;ACADS;ACAD10;HADHB;SCP2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4619281105992209,1.0333126852046064,0.4056291390728477,0.9971710637983572,1.0,6/19,12.48%,ROCK1;RTN2;PIN1;RTN1;CHRNA7;CLU
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3381144187354982,1.0332520978376791,0.43491422805247226,0.9963244458005904,1.0,58/348,14.04%,NTF3;RBPMS;RAP1A;NTRK3;ATP2B4;ANGPT1;FGF1;ANGPT4;PDGFB;CCN1;PDGFC;CCND2;CSPG4;THPO;FAM20A;BCAR3;TGFB3;MMD;PDGFD;ACVR2A;MUSK;CAMKK2;ARHGEF2;BMPR1A;RARRES2;CAV1;RAP2C;TP53;VEGFA;PIN1;CALM1;LCP2;RASGRP1;ITGB3;SOX9;TGFB2;CCND1;ADAM17;PAK2;GDF1;RAP2A;CENPE;PELI2;PDGFA;GPER1;ROCK2;CLIP3;TNIK;AKTIP;CHRNA7;SNX9;PDCD10;FNIP2;FGF10;GAS6;MAP2K3;S1PR2;MAPK1
prerank,positive regulation of dephosphorylation (GO:0035306),0.42591340330779504,1.03271792012885,0.4264705882352941,0.9968611335149317,1.0,4/27,7.02%,DLC1;PPP2R5A;PIN1;CALM1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4902910787692467,1.0321255317658569,0.4307178631051753,0.9975188718921134,1.0,2/14,3.06%,ANXA1;SOCS5
prerank,glutamate receptor signaling pathway (GO:0007215),-0.30996412576838944,-1.0320846892869622,0.3952702702702703,0.8460722571103808,1.0,13/37,19.56%,GRM3;APP;GRM7;PTK2B;HOMER3;GRIN3A;DAGLA;GRIK3;GRM5;CLN3;GRID2;FMR1;GRIK1
prerank,positive regulation of defense response (GO:0031349),0.364608960116211,1.0318259040359166,0.40946745562130177,0.9973683875428083,1.0,6/89,3.64%,AGTR1;MEF2C;IL2;LPL;FEM1A;CCL5
prerank,protein sumoylation (GO:0016925),0.3907475036422211,1.0314946704854018,0.45789473684210524,0.9973229153743323,1.0,20/49,19.61%,UBA2;NUP62;PIAS4;SAE1;TRPM4;NUP153;NUP107;AAAS;PIAS2;TRIM28;NUP98;NUP37;NUP210;PIAS1;BCL11A;NUP54;SUMO1;UBE2I;NUP160;NUP133
prerank,mitotic cytokinetic process (GO:1902410),0.4502012361050847,1.0314135408775926,0.44193548387096776,0.9965786069537378,1.0,6/20,17.60%,CHMP4C;CHMP5;CHMP2B;CHMP2A;CNTROB;VPS4A
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3504367945856694,1.031383402526308,0.44468546637744033,0.9956681818668853,1.0,35/172,15.72%,DGKB;DGKG;PIP5K1B;INPP4B;PIP4K2A;MTMR7;SLC44A5;PITPNM3;STARD7;SYNJ2;SACM1L;SLC44A1;LPCAT3;AGPAT3;INPPL1;DGKD;MTMR14;PCYT2;TAMM41;GPD1L;CDIPT;SBF1;CPNE3;PNPLA3;PIK3C3;DGKZ;RAB14;PLA2G4A;CHKB;PLEKHA1;PLA2G4C;INPP5J;PITPNM2;PTEN;VAC14
prerank,adipose tissue development (GO:0060612),0.5140266895022846,1.0311899048675492,0.4633699633699634,0.9952149779323098,1.0,5/11,17.89%,ARID5B;DYRK1B;LRP5;NAMPT;SH3PXD2B
prerank,regulation of spindle assembly (GO:0090169),0.4237105111134384,1.030491512855989,0.4371345029239766,0.9961168412968182,1.0,6/25,13.43%,CHMP4C;CHMP5;HNRNPU;CHMP2B;SENP6;CHMP2A
prerank,polyamine metabolic process (GO:0006595),0.4907822100313623,1.030459812507985,0.46324786324786327,0.995211337135676,1.0,4/13,14.98%,OAZ2;SAT2;SMS;PAOX
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4263718445351624,-1.0295422434819084,0.42761692650334077,0.8523336920461715,1.0,5/11,12.06%,LGALS9;CD34;ATP6AP2;PTGS2;CD46
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3668266009810199,1.0292465807362423,0.4206730769230769,0.9974064347583113,1.0,17/86,13.32%,NTF3;ANGPT1;ANGPT4;PDGFB;CSPG4;ARHGEF2;RAP2C;TP53;VEGFA;ITGB3;PAK2;SAMSN1;PDGFA;PRKCD;CNOT7;DMTN;FGF10
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.37804711822272413,-1.0291493179554903,0.44505494505494503,0.8521660604316729,1.0,7/18,17.31%,APOE;ADAM10;APH1A;NCSTN;CLN3;APH1B;PSEN2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.24858202265445567,-1.0291229998936087,0.4365079365079365,0.851036279647496,1.0,47/108,28.23%,TLE1;LRP1;SULF1;NXN;APP;PTK7;APCDD1;WWOX;PPP2CA;DCDC2;CTNNB1;WLS;ATP6AP2;KREMEN1;ESR1;SALL1;PRKN;SFRP4;RSPO2;FGFR2;CCNY;NOTUM;TMEM237;EMD;RNF43;FOXL1;SNX3;DISC1;CTNND2;DACT3;BTRC;MDFI;GPC3;DACT1;RSPO3;NFATC1;AXIN1;CBY1;SULF2;CSNK2A1;SOX7;HHEX;MDFIC;TIAM1;HMGXB4;RACK1;TAX1BP3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.336993513959629,1.0283955882769986,0.4242728184553661,0.9987240002642195,1.0,46/476,9.80%,ACTA2;MYOCD;PRDM16;TNNI2;MEF2C;HEY2;MAP3K5;ZFHX3;SMARCD3;LBH;NR1H4;PDGFB;RORA;ETS2;FZD4;HINFP;TGFB3;NUP62;ARID1A;NR2F2;TGFB1I1;CAMKK2;OSR2;CEP290;DYRK1A;TESC;TP53;DYRK1B;PPM1A;AR;PPARGC1A;MED1;YAP1;MED12;SOX9;RELA;PLCB1;SETD3;ZXDC;PPARA;MAP2K1;NSD3;NR1D1;HIF1A;CRLF3;SFR1
prerank,regulation of protein localization to centrosome (GO:1904779),0.5028587905203193,1.028276426552105,0.42397137745974955,0.9980577495003472,1.0,5/10,17.73%,NUP62;NSFL1C;CEP72;UBXN2B;BICD1
prerank,plasma membrane organization (GO:0007009),0.3784280905774247,1.027654014995334,0.43773119605425403,0.9987323244214735,1.0,16/61,12.66%,FER1L5;DYSF;MYH9;ANO6;PACSIN3;PACSIN2;EHD2;FA2H;RAB3A;WHAMM;TLCD2;OSBPL2;NSF;PACSIN1;SNX9;A4GALT
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.49556490844934464,1.0274670681834783,0.4475043029259897,0.9982291654922967,1.0,2/12,4.48%,CCDC68;BICD2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3850786975537369,-1.0274225212496562,0.3929471032745592,0.8547142965462906,1.0,4/15,17.24%,BMP4;PRKCH;SFRP4;TRIM16
prerank,regulation of epithelial cell differentiation (GO:0030856),0.45478918718314715,1.026593214316458,0.4375,0.9995515207629856,1.0,4/17,7.68%,KLF7;CAV1;AJAP1;SOX9
prerank,development of primary male sexual characteristics (GO:0046546),0.4208953319163689,1.0264338563641853,0.42775393419170243,0.9990101791327445,1.0,5/34,7.86%,LHCGR;CSDE1;AR;SOX9;TGFB2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.47228671926917554,1.026244451010614,0.42833607907743,0.9985358472637964,1.0,4/18,6.99%,CRTC1;CRTC3;VEGFA;CD200
prerank,T cell activation involved in immune response (GO:0002286),0.49352737303677735,1.0256588569708032,0.45585585585585586,0.9990455122826623,1.0,1/12,3.35%,LCP1
prerank,organic anion transport (GO:0015711),-0.26249456307775537,-1.0254936999331803,0.34946236559139787,0.858889511896825,1.0,15/76,9.39%,ABCG2;SLC4A10;SLCO2B1;SLC26A7;SLCO1C1;SLC25A17;SLCO2A1;SLC52A1;CYB5R4;CA2;SLC39A8;SLC22A6;SLC4A2;SLCO3A1;ABCC4
prerank,regulation of programmed cell death (GO:0043067),0.3430875888480851,1.0250411301499665,0.4398699891657638,0.9997579091722959,1.0,29/161,15.91%,NTF3;ACTN1;ACTN4;PMAIP1;HIP1;ALPK2;NUP62;NDRG1;TP53;STK26;SOX9;DAPK3;ACTN2;GLS2;ZBTB7A;TNFRSF25;CLU;TMEM219;PERP;BCL6;RBM25;SGK1;TNFRSF10B;LRRK2;USP42;STAT1;RAF1;MAGED1;JAK2
prerank,regulation of dendrite development (GO:0050773),-0.3106503368554051,-1.0248085809633818,0.39552238805970147,0.8594849443215278,1.0,9/37,10.02%,PTN;COBL;NEDD4L;BMP7;ADGRB3;CAMK1D;ZDHHC15;SEMA4D;ALK
prerank,mitochondrial gene expression (GO:0140053),0.39812133194901933,1.0245991775781453,0.43337819650067294,0.9999783400816991,1.0,17/42,20.50%,FASTKD5;GATB;IARS2;MRPS28;MRPL51;MRPL23;GFM2;MRPL16;TFB2M;MRPL47;LARS2;FASTKD2;MRPS21;TEFM;GATC;MRPS14;SLC25A33
prerank,translesion synthesis (GO:0019985),-0.30771465731157477,-1.0245873465285313,0.38866396761133604,0.8588793322827115,1.0,22/42,37.19%,UFD1;PARP10;TRIM25;POLDIP2;UBC;REV1;POLN;USP10;PRIMPOL;UBB;POLE2;ZBTB1;POLI;RPA3;RFC3;USP43;RPA2;POLD3;PCLAF;RPA1;RFC1;RFC4
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4557135268389608,1.0244303593717574,0.423861852433281,0.9994374276039469,1.0,3/19,4.05%,PLCE1;PPP3CA;INPP5A
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.47370004547319006,1.024152277253549,0.432937181663837,0.999200923480873,1.0,5/14,17.10%,IRS1;PPARA;LONP2;IRS2;MTLN
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3327290224066571,1.0241518463292534,0.4164164164164164,0.9982364438250033,1.0,70/509,11.23%,NTF3;FLNA;NTRK3;ACTN4;ANGPT1;PTP4A3;ROCK1;FGF1;PMAIP1;LIMS1;HIP1;MYD88;MST1R;TCIM;PDGFB;PDGFC;FERMT2;SEMA5A;ROR1;PLXNB1;CDH13;ADRA1D;THPO;CGAS;BCAR3;ITGB1;CCL5;GCNT2;PDGFD;NUP62;MFHAS1;BCL2;KSR1;CD14;LARS1;MTDH;PIK3AP1;IRS1;CAV1;DAB2IP;TP53;VEGFA;PPM1A;HEXIM1;NEDD4;AREG;SOX9;GOLT1B;TIFA;TGFB2;RELA;TRIM68;SEC13;RRAGB;THEM4;EDAR;AXL;PDGFRB;RTKN2;TRAF5;HBEGF;PELI2;EIF2AK2;DNM1L;PDGFA;VAV1;GPER1;ROCK2;DDX1;ZDHHC17
prerank,cellular response to retinoic acid (GO:0071300),-0.29986106806038726,-1.0235268507433473,0.417910447761194,0.8606992529786343,1.0,13/42,18.28%,PTK7;WNT5A;EPHA3;PTK2B;WNT9A;SETX;ABL2;SNW1;CREB1;LYN;WNT6;ATM;RORB
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3129680757609682,-1.0234721418466304,0.40878378378378377,0.8596206392098263,1.0,11/32,16.03%,JCAD;STARD13;AKT3;MEOX2;HDAC7;FOXC2;MAP3K3;CARD10;PTGS2;KDR;FGF2
prerank,chemical homeostasis (GO:0048878),-0.2715889435132433,-1.0231715380333266,0.44554455445544555,0.8592736854968456,1.0,10/61,8.18%,ZBTB20;RBP1;NEDD4L;WNK1;DDX3X;SLC4A10;WNK4;ABHD5;WNK3;SLC4A2
prerank,negative regulation of anoikis (GO:2000811),0.4913993892245594,1.0230006779927012,0.4571917808219178,1.0,1.0,5/14,7.71%,PDK4;ITGB1;BCL2;CAV1;SNAI2
prerank,mitotic spindle organization (GO:0007052),0.34857626579814455,1.0229734819707463,0.4345945945945946,0.9993954130459772,1.0,29/153,14.15%,FLNA;DYNLL1;CLASP2;KIF2A;CENPP;TOGARAM2;KIF3B;DCTN6;EFHC1;EML1;TPX2;PIBF1;TOGARAM1;SUN2;CENPO;SEC13;ZWINT;CEP192;CENPE;WRAP73;NUP107;AAAS;DYNC1I2;ITGB3BP;CLASP1;MAP4;NUP98;KIF18A;NUP37
prerank,neuron development (GO:0048666),-0.23841062964685383,-1.0228163128364347,0.36904761904761907,0.8590815918065168,1.0,42/141,18.50%,PLP1;PBX3;HMGB1;APOE;WNK1;THOC2;APP;FRYL;GLI2;RASGRF1;RAB11A;STX3;NLGN1;B4GALT6;PTPRM;TDP2;ATP8A2;UHMK1;TMEM108;DTNBP1;TENM3;UGDH;PPT1;LAMB1;ALK;UNK;MANF;LYN;OPHN1;EPHA8;TBC1D24;STMN4;EHD1;VSX1;CNTN4;RAB13;SH3GL2;ATXN10;LGI4;RP1;CDK16;RAB35
prerank,regulation of vacuole organization (GO:0044088),-0.36204516873041614,-1.0226934800121188,0.4199475065616798,0.8581869166246107,1.0,10/20,24.08%,ANXA2;RAB5A;NPRL3;SCARB2;IFT88;UBQLN2;RAB1B;ENO2;TBC1D14;ENO1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.4222735251415194,-1.0224105483947532,0.4543269230769231,0.8577784350953019,1.0,3/12,7.19%,MYCBP2;B4GALT6;HSP90AB1
prerank,negative regulation of chemokine production (GO:0032682),-0.3976853586507507,-1.0222014580454657,0.4475,0.8571779260066069,1.0,4/14,15.25%,APOD;LGALS9;SIRPA;C1QTNF3
prerank,endochondral bone morphogenesis (GO:0060350),0.5086604583358725,1.0219398133170687,0.4540337711069418,1.0,1.0,3/11,12.19%,MEF2C;INPPL1;BMPR1B
prerank,potassium ion homeostasis (GO:0055075),0.4421001717883849,1.0219280204950063,0.4345146379044684,1.0,1.0,2/23,5.82%,KCNMA1;ATP1B1
prerank,cellular protein modification process (GO:0006464),0.3316868055664687,1.0217326907595294,0.417,0.9997960314475425,1.0,181/982,14.87%,ART1;PPP1R12A;MAP3K20;IGFBP7;MFGE8;LTBP1;SPARCL1;STK38L;SDC2;TNNI3K;PRKG1;MAP3K5;ASB15;PPM1L;ROCK1;HRC;DYRK2;MERTK;PPM1J;ASB10;FCGR3A;KCTD7;PDGFB;PPP3CA;CCN1;ASB18;CDK6;LARGE1;FBXL22;FBXO40;PDK4;ANXA1;FRK;MTMR7;LOXL2;FAM20A;DUSP5;SOCS5;CAMK2D;PPP2R1B;IGFBP5;FEM1C;FEM1A;PPM1E;GCNT2;ACVR2A;SIRT3;MCRS1;LMO7;ASB2;CAMKK2;PTPN18;ASB1;PEAK1;MARK1;SEPHS1;CUL2;PTPRS;SOCS6;RNF7;BMPR1A;LHPP;NUCB1;DYRK1A;ATG7;PHKA2;MAP4K3;CHST5;MAP4K5;SDHAF2;ASB8;PTPRF;TAF1;PSMC6;ELOC;COQ8A;MAPKAPK2;DYRK1B;FBXW7;FBXO30;PPP2R5A;FBXL18;PPM1A;PARP1;ART4;KTN1;PTPN1;IGFBP4;LAMC1;LAMB2;RAB3A;STK26;UBE2F;CUL9;CHEK1;TGFB2;NUAK1;DCUN1D1;SETD3;WNK2;DAPK3;PRKACB;DDOST;CDH2;PRKAR1B;MAP2K1;UBE2E1;CCNT1;PPP1CB;PPP1CA;BRSK1;PKN2;PAK2;CDK7;HIF1A;PSME4;SIRT2;STK24;FBXO6;CTDSP2;SUMF1;CDK18;PSMB1;MBTPS1;PSMD5;EIF2AK2;ROCK2;PHEX;FBXO32;ST8SIA5;PRKCD;COPS8;ACVR1B;DUSP29;WDR45;FBXW11;CDK12;UBA3;MAN2A2;DMPK;BMPR1B;TNIK;WSB1;BCR;PSMB2;SBF1;COL3A1;DCAF11;CDC42BPB;CTDSP1;STK36;MACROD1;TPTE;DUSP16;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;ST3GAL2;PRSS23;PIK3C3;GAS6;CSNK1E;DNAJC3;PDK2;SIRT4;SGK1;STK10;MAPK1;LRRK2;PRKAA2;UFL1;PIGH;PSMB7;FEM1B;PSMD3;TNC;KCTD6;PRKCA;PRKACA
prerank,microtubule nucleation (GO:0007020),0.4654745760805119,1.0216019261460054,0.44867549668874174,0.9992312526414958,1.0,4/19,7.13%,CLASP2;TUBGCP6;TPPP;TPX2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.47476186485910904,1.0213267179884462,0.45107794361525705,0.9990187657978378,1.0,4/15,13.20%,ANXA1;HNRNPU;GPER1;ZFP36L1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3355022334023109,-1.0211720535498894,0.40782122905027934,0.8587876363089707,1.0,8/26,19.45%,HMGB1;DDX3X;LBP;PTPN22;RTN4;TLR3;TIRAP;SLC15A4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3701740556815809,1.0210432563472993,0.4221954161640531,0.9988058066372332,1.0,11/74,7.86%,VASN;FERMT2;PHLDB2;CLASP2;LOXL2;TGFB3;GCNT2;TGFB1I1;SDHAF2;DAB2IP;TGFB2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.44448579237549046,-1.02102209920042,0.4588235294117647,0.8579847945237414,1.0,4/11,9.08%,RNF185;DERL1;UFD1;UGGT2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4747081441656201,1.020933962126563,0.4446280991735537,0.9981566214923093,1.0,6/15,20.58%,SEMA5A;VEGFA;TMSB4X;P2RX4;PRKD1;HSPB1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.32313311104050274,-1.0207538366299271,0.40625,0.8575938313697145,1.0,19/31,40.31%,PEX14;PEX5;TIMM44;DNAJC19;AIFM1;TIMM17B;HSPD1;TOMM70;TIMM21;TIMM23;GRPEL1;PEX6;PEX16;DNLZ;TOMM40L;TOMM40;TIMM50;PEX12;GRPEL2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3749385276010125,1.0207495103038209,0.424968474148802,0.9976956273891546,1.0,12/65,9.92%,PMAIP1;ANGPT4;RORA;PTGIS;SUV39H2;NDRG1;TERT;TP53;CPEB1;VEGFA;HIF1A;SIRT2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4824041636508979,1.0206795133751263,0.454242928452579,0.9969461500357824,1.0,4/15,11.96%,LARGE1;CHST5;CHST3;CHST1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.22788913883205,-1.0206512058384718,0.3875,0.8566955778477212,1.0,40/186,14.82%,BICC1;MCC;DAB2;MLLT3;TLE1;LRP1;IGFBP2;TCF7L2;NXN;DKK3;APOE;FZD6;CUL3;WNT5A;APCDD1;WWOX;KLHL12;SOX13;CTNND1;TMEM64;LATS2;PSMD7;PSMD9;PSMD13;RNF213;STK11;KREMEN1;PRKN;SFRP4;IGFBP6;PSMB3;WWTR1;PSMC5;PSMA5;NOTUM;PSMA1;PSMC2;SOX17;HECW1;EMD
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4191538555786762,-1.0205450104017917,0.4411764705882353,0.8557634738422858,1.0,6/11,21.39%,NOS3;GCH1;PRKG2;AKT1;PTS;SPR
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.3758664276045578,-1.0204783712849503,0.44776119402985076,0.8547761946876481,1.0,7/17,34.99%,PDE3B;ALK;AKT1;PRKAA1;MFSD2A;BSCL2;GPLD1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.49359358610386295,1.0201673953067587,0.4542372881355932,0.9973491978006993,1.0,3/12,13.12%,ANO1;TRPM4;PPP3CB
prerank,positive regulation of protein localization to membrane (GO:1905477),0.36147063761394677,1.0200846873575438,0.44533029612756264,0.9966312360354996,1.0,19/98,11.84%,ATP2B4;STAC;PMAIP1;ITGA3;SLC5A3;ITGB1;BCL2;ARHGEF16;KCNB1;SORBS1;STAC3;TP53;KIF5B;MIEF2;MIEF1;EPHA2;GPER1;DPP10;CLIP3
prerank,rRNA pseudouridine synthesis (GO:0031118),0.507971208740513,1.0199700109728396,0.44964028776978415,0.9959968311712415,1.0,3/10,13.50%,RPUSD3;NAF1;RPUSD4
prerank,negative regulation of cell adhesion (GO:0007162),0.36981306868182295,1.0197742576296795,0.4444444444444444,0.9955724055231511,1.0,13/72,7.71%,ANGPT1;SEMA5A;PLXND1;PLXNB1;CDH13;JAG1;FZD4;GCNT2;JAM3;ARHGDIG;CBLL1;DSCAM;SNAI2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.30950089105563233,-1.0196472787112523,0.4206896551724138,0.8560409608646742,1.0,7/35,9.60%,VTN;B2M;HNRNPK;AAK1;BMP2K;PIK3CB;PPT1
prerank,mitotic cell cycle phase transition (GO:0044772),0.342776605990684,1.0194114818189908,0.4383561643835616,0.9955048453348225,1.0,40/203,14.87%,PPP1R12A;PPP1R12B;DYNLL1;CCNA2;CDK6;FBXL22;CLASP2;CCND2;HINFP;CEP41;EIF4EBP1;HAUS8;CUL2;CEP290;ENSA;PLCB1;CCND1;PPP1CB;BRSK1;CDK7;CEP192;CRLF3;DYNC1I2;RB1;GSPT1;ACVR1B;NEDD1;FBXW11;ARPP19;CLASP1;CEP72;CEP43;CHMP2A;CSNK1E;DCTN3;HAUS7;HAUS2;CCNJL;EIF4E;PRKACA
prerank,neural crest cell development (GO:0014032),-0.2994702603137467,-1.0192307096268407,0.42857142857142855,0.8559732813962878,1.0,9/44,7.79%,SEMA3D;SEMA3C;SEMA6A;KLHL12;RADIL;ANXA6;SEMA7A;SEMA3A;SEMA4D
prerank,gene silencing by miRNA (GO:0035195),0.42246380040932063,1.0191423675913085,0.4488078541374474,0.995296171530656,1.0,2/32,1.88%,WTIP;LIMD1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.2717397480567236,-1.0188204113993473,0.4166666666666667,0.855940324060105,1.0,27/72,25.45%,CARM1;TFDP1;ACER2;PML;ARID3A;MDM2;SP100;RGCC;SOX4;NBN;EP300;MYO6;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;USP10;BCL3;PCBP4;PLAGL1;CDKN1A;SESN2;TFAP4;CNOT10
prerank,atrial septum morphogenesis (GO:0060413),0.5099988598492513,1.0184890291552435,0.417910447761194,0.9960852306021625,1.0,2/10,7.86%,HEY2;TGFB2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.28722195322973715,-1.0183709535808803,0.4230769230769231,0.8560027011447408,1.0,19/54,25.45%,CARM1;TFDP1;PML;ARID3A;MDM2;RGCC;SOX4;EP300;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;PCBP4;PLAGL1;CDKN1A;CNOT10
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.4399920868395023,-1.01824726940763,0.4503171247357294,0.8551449683320232,1.0,3/10,24.62%,LGALS9;CD274;SCRIB
prerank,positive regulation of biosynthetic process (GO:0009891),0.4062571308238475,1.018225121150918,0.43741765480895917,0.9958659597282223,1.0,12/40,14.89%,CD36;VIM;SLC5A3;TGFB3;CCL5;SORBS1;PPARA;SUCO;RUNX1;SIRT4;ADGRB1;MLXIPL
prerank,peptidyl-serine modification (GO:0018209),0.34062588896743806,1.018186357345714,0.4444444444444444,0.9950159292417278,1.0,44/166,17.52%,STK38L;ROCK1;MAST4;DYRK2;PDGFB;CAMK2D;GALNT16;MARK1;DYRK1A;PRKCQ;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;PARP1;MAP3K10;BRSK1;PKN2;PAK2;ROCK2;PRKCD;GALNT3;RICTOR;GALNT2;DMPK;HPF1;MAST1;GAS6;CSNK1E;SGK1;MAPK1;GALNT1;LRRK2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;HIPK2;MAST3;MAP3K13;EIF2AK3;MARK2;MASTL
prerank,cellular response to lipopolysaccharide (GO:0071222),0.35352354055638274,1.0177774306301213,0.44394110985277463,0.9951307450669341,1.0,15/101,11.11%,MEF2C;MYD88;VIM;CCL5;UPF1;CD14;MTDH;DAB2IP;CHMP5;NFKBIB;RELA;GSTP1;NR1D1;AXL;CD180
prerank,regulation of small molecule metabolic process (GO:0062012),0.43020012659132506,1.017017737167074,0.45652173913043476,0.9962232907269915,1.0,3/28,2.57%,NR1H4;PDK4;RORA
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4548035612953115,1.0168604357098276,0.4533106960950764,0.9957056289026232,1.0,4/18,8.08%,SUV39H2;ASH1L;KMT2D;SETD3
prerank,endothelial cell migration (GO:0043542),0.407638049775195,1.0166190009314093,0.46175637393767704,0.9953708261021335,1.0,6/37,2.95%,PTP4A3;MYH9;PLXND1;CDH13;NR4A1;LOXL2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4421689846276087,1.0161123636893978,0.4647887323943662,0.9957288863262223,1.0,2/20,2.65%,ENTPD1;ANO6
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4399787410326632,-1.01607219055493,0.45322245322245325,0.860106123846018,1.0,4/10,15.42%,NT5E;UPP2;UPB1;DPYD
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.42002552200947363,-1.0159666183897114,0.46208530805687204,0.859205819276997,1.0,3/10,5.71%,WNK1;WNT5A;ADAM10
prerank,negative regulation of innate immune response (GO:0045824),-0.31200906004644124,-1.0159606444600853,0.4154929577464789,0.8580385786606609,1.0,20/34,37.75%,RPS19;IRAK3;METTL3;SAMHD1;STAT2;GRN;SERPING1;NLRC5;YTHDF3;PTPN2;TRIM21;A2M;NLRC3;USP18;TNFAIP3;NMI;TYRO3;LYAR;DHX58;TTLL12
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3903873623013983,-1.0157287035167233,0.43735763097949887,0.8574534802753375,1.0,5/16,26.91%,LDLR;ABHD5;MFSD2A;DAGLB;PNPLA2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4268270052296966,1.01570529830993,0.46005917159763315,0.9958018599222008,1.0,4/27,8.19%,CD36;MYD88;CD14;TNIP1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4548628404725036,1.0156274804479908,0.44427001569858715,0.9950568084195599,1.0,2/20,7.14%,HSD17B10;AKR1B1
prerank,establishment of protein localization to organelle (GO:0072594),0.3688560217416501,1.0155448536038778,0.45454545454545453,0.9943312772432079,1.0,20/72,16.02%,RYR2;HK2;NUP62;RANBP17;IL10RA;SPRN;NEURL1B;SEC13;NUP153;PPP1R10;NUP107;PEX19;RANBP6;TNPO3;FAM53B;IPO4;TSPAN17;IPO7;FAM53C;STAT3
prerank,response to amino acid starvation (GO:1990928),0.3707532632986284,1.0154527268001978,0.4443099273607748,0.9936536587256704,1.0,23/72,20.84%,MAP3K5;RNF152;LARS1;KPTN;ATP6V1H;CASTOR1;IMPACT;SEC13;RRAGB;ATP6V1C1;NPRL2;EIF2AK2;ATP6V0D2;MAPK1;CASTOR2;ITFG2;EIF2AK3;EIF2AK4;PRKD1;ATP6V0C;LAMTOR3;EIF2S1;LARP1
prerank,negative regulation of cell population proliferation (GO:0008285),0.33253855770520774,1.0151460957157306,0.4444444444444444,0.9935173035705016,1.0,39/351,9.18%,MYOCD;IGFBP7;COL18A1;DLC1;TMIGD3;P3H2;SPEG;ITGA1;CDK6;PLXNB1;CDH13;FRK;RERG;IGFBP5;TGFB3;BTG2;NACC2;NUP62;TGFB1I1;PEX2;TESC;MN1;OGN;DAB2IP;RPS6KA2;TP53;CD200;AR;BNIPL;CELF1;BTG1;SOX9;TGFB2;WNK2;CD300A;DIS3L2;MAP2K1;GSTP1;SKI
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.236679155935906,-1.0150658046976815,0.4117647058823529,0.8581646164636905,1.0,32/152,14.23%,RNF220;LRRK1;LGR4;SULF1;COL1A1;ADGRA2;WNK1;RNF146;DDX3X;PTK7;EGFR;LYPD6;TNKS2;PPM1B;PSMD7;PSMD9;PSMD13;WLS;ATP6AP2;SMURF2;SALL1;SFRP4;RSPO2;TGFB1;FGFR2;PSMB3;SOX4;ZBED3;PSMC5;PSMA5;PSMA1;PSMC2
prerank,regulation of macroautophagy (GO:0016241),-0.24572618731528212,-1.0149825271916795,0.3902439024390244,0.8572118198903782,1.0,35/105,25.16%,PRKAG2;DCN;PIK3CA;RB1CC1;PAFAH1B2;CAPNS1;LAMTOR1;UBQLN1;SMG1;NRBP2;GPSM1;IKBKG;ATP6V1G1;SNX6;RHEB;ERN1;TBC1D25;KDR;CLN3;AKT1;UBQLN2;EXOC1;EXOC7;BNIP3L;QSOX1;PRKAG3;PRKAA1;LZTS1;SMCR8;ATP6V0D1;RRAGD;SESN2;UCHL1;CDK5R1;LAMTOR2
prerank,base conversion or substitution editing (GO:0016553),-0.42357664880956347,-1.014807600927825,0.45351473922902497,0.8564987538710224,1.0,4/11,33.92%,METTL3;ADAR;ADARB2;NUDT16
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3471094531160913,-1.014726511472413,0.43010752688172044,0.8555444034695532,1.0,9/21,22.01%,CGNL1;SLIT2;CYRIB;CD2AP;SPRY2;ARHGAP25;SYNGAP1;MAPKAP1;EPHB2
prerank,regulation of protein localization to nucleus (GO:1900180),-0.2940596358001448,-1.0146055442767712,0.44649446494464945,0.8547222423747094,1.0,11/43,12.75%,GLUL;BMP4;LIMK2;OTUD7B;NVL;ILRUN;LATS2;CARD10;TGFB1;WWTR1;DTX3L
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.4394899783854942,1.0145634973540227,0.4394409937888199,0.9940962164788256,1.0,3/21,7.62%,SMARCD3;VEGFA;FZD9
prerank,cellular response to amino acid starvation (GO:0034198),0.3719338961393631,1.0142676724700928,0.4531059683313033,0.9939115636533513,1.0,22/71,20.44%,MAP3K5;RNF152;LARS1;KPTN;ATP6V1H;CASTOR1;IMPACT;SEC13;RRAGB;ATP6V1C1;NPRL2;EIF2AK2;ATP6V0D2;MAPK1;CASTOR2;ITFG2;EIF2AK3;EIF2AK4;PRKD1;ATP6V0C;LAMTOR3;EIF2S1
prerank,nervous system development (GO:0007399),0.32894102591936747,1.0142545797213844,0.45875251509054327,0.9930075698401869,1.0,47/429,10.76%,SOX6;NTF3;FGF13;MEF2C;SERPINI1;IGFN1;KALRN;MERTK;CRIM1;APBA1;MST1R;ZEB2;PDGFC;NAB1;CLN5;EDNRB;FZD5;SEMA5A;PLXND1;DPYSL4;JAG1;KIRREL3;ATXN1;DYRK1A;BTBD2;MBD5;PCDHB14;DSCAM;VEGFA;GDNF;YAP1;FZD9;ERCC6;MBP;PCDHB11;TRAK1;CDH2;TRPC5;GSTP1;AXL;MBNL1;COX7B;HAPLN2;NR2C2;TEAD1;GFRA1;NDUFV2
prerank,regulation of anoikis (GO:2000209),0.45338773775317964,1.0141229010701034,0.45865834633385333,0.9924124339438747,1.0,6/19,7.71%,PDK4;ITGB1;BCL2;MYBBP1A;CAV1;SNAI2
prerank,mesonephros development (GO:0001823),0.4902386797429349,1.014039282036507,0.44181818181818183,0.9916863989762026,1.0,2/11,4.90%,FGF1;OSR2
prerank,phospholipid translocation (GO:0045332),-0.3349575549944454,-1.0136970979035964,0.4634920634920635,0.8560500236959814,1.0,8/28,8.34%,PLSCR4;ATP8A1;ABCA1;PLSCR2;ABCA4;ATP11C;ATP8A2;TMEM30A
prerank,secretory granule organization (GO:0033363),-0.44014123980415265,-1.0136702423719808,0.47404063205417607,0.8549419584553324,1.0,3/10,8.94%,ABCA1;SRGN;DTNBP1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.4368193984241413,-1.0131294966783402,0.46004319654427644,0.8552497362293301,1.0,6/10,30.65%,PTPN22;PDCD4;AIDA;HIPK3;MAPK8IP1;DUSP19
prerank,chloride transport (GO:0006821),0.3678979628966499,1.0128822166241775,0.45145631067961167,0.9938204184299784,1.0,12/74,9.82%,ANO1;GABRE;ANO6;SLC4A8;CLCN6;GABRA4;TTYH1;GABRA5;ANO10;GABRB2;GABRG1;ANO3
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3209751511998021,-1.0127683080815082,0.45180722891566266,0.8550187386436737,1.0,11/31,18.89%,ATXN3;DNAJB12;HSPA5;OPTN;PRKN;STUB1;ERN1;HSPA13;BAX;HSPA9;HSF1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.38672375241518353,-1.0124179523970398,0.4358974358974359,0.8548527085490057,1.0,3/15,6.40%,AEBP1;LRP1;TIE1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.2566876105995753,-1.012208089587779,0.3987341772151899,0.8542695297321247,1.0,28/77,25.49%,IGF1;SH3RF1;TCF7L2;BMP4;DDX3X;ITGA6;BIRC6;ITGAV;GHITM;BCL2L1;ASAH2;PRKN;TGFBR1;MAZ;CX3CL1;NOC2L;AKT1;GPX1;SIAH2;HERPUD1;PARK7;QARS1;PSME3;TMBIM6;SLC35F6;PELI3;CSNK2A2;CSNK2A1
prerank,nucleic acid metabolic process (GO:0090304),0.367314428650228,1.0120189926073628,0.45197044334975367,0.9951487509818394,1.0,14/69,13.68%,LSM8;POLR2L;POLR2I;HNRNPR;POLR2G;ATXN2;HNRNPU;DDX1;HNRNPC;POLG;KPNA2;POLR2J;DXO;DNASE1L1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3898232530839688,-1.0117572275564466,0.43488372093023253,0.8543295327323707,1.0,9/14,35.21%,NT5E;UPP2;UPB1;DPYD;DHODH;NT5C1A;UMPS;CAD;ERH
prerank,regulation of apoptotic process (GO:0042981),0.32947373854817336,1.0117217082369385,0.47847847847847846,0.9950103097967138,1.0,100/676,13.74%,NTF3;FLNA;KCNMA1;OBSCN;ARHGEF7;MAP3K20;ACTN1;MEF2C;NAA38;ACTN4;MAP3K5;ANGPT1;PMAIP1;KALRN;NR1H4;ABR;HIP1;ANGPT4;MYD88;TCIM;TRIM2;ARHGEF17;ALPK2;ANO6;CCND2;ANXA1;IL2;ITSN1;TGFB3;ITGB1;NET1;NUP62;ARHGAP10;ATAD3A;FXN;BCL2;ARHGEF16;ARHGEF2;MYO18A;ATG7;MTDH;NDRG1;DAB2IP;RPS6KA2;ARL6IP5;TP53;VEGFA;PHLDA3;GDNF;STK26;PA2G4;MED1;BCL2L2;FZD9;NAT8;OPA1;SOX9;RELA;MAP3K10;DAPK3;API5;CBX4;VDAC1;TNFAIP8;GSTP1;ARHGEF4;PAK2;HRK;BAG3;AXL;ACTN2;FAIM2;PAWR;DNM1L;VAV1;GPER1;GLS2;TRIM35;ZFAND6;BOK;HTR2B;ZBTB7A;CLIP3;TNFRSF25;CSRNP3;DIABLO;CLU;CITED2;ITGB3BP;PDCD10;POU3F3;TMEM219;PERP;BCL6;RBM25;GAS6;DNAJC3;SON;SGK1;TNFRSF10B
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4485146772025937,1.0112867987927048,0.46467817896389324,0.995270953985472,1.0,6/21,13.20%,ROCK1;CBFB;KLF7;ROCK2;RUNX1;ZFP36L1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.4435415491655952,1.0112497088992494,0.4717607973421927,0.9944492214837205,1.0,5/19,12.91%,AMPD1;TERT;AMPD2;POLD1;GMPR
prerank,epithelium development (GO:0060429),0.35440288730078534,1.0112146255156937,0.4671201814058957,0.9936162284214428,1.0,11/107,8.75%,TAGLN;TBX2;VCL;TAGLN2;DMBT1;VEGFA;CNN3;SOX9;SNAI2;CBR1;VDAC1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3826018619861314,1.0109437018974168,0.44696969696969696,0.9933826351150329,1.0,7/47,7.71%,ATP2B4;PTGIS;CAV1;FBXW7;PLEK;GLA;SNAI2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3848685979314665,-1.0107887490171916,0.4621212121212121,0.8558822336326598,1.0,6/15,16.77%,IGF1;GHITM;BCL2L1;PRKN;AKT1;GPX1
prerank,regulation of interleukin-4 production (GO:0032673),-0.3481710898601551,-1.0103832942204818,0.4438202247191011,0.8558870891733245,1.0,8/21,26.07%,LEF1;LGALS9;SLC7A5;CEBPB;RARA;CD86;SYK;ZFPM1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5008846738066519,1.0103049925375824,0.44642857142857145,0.9940445742832151,1.0,4/10,10.48%,FBXW7;AREG;ADAM17;HBEGF
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4601528845251139,1.0102494421369048,0.4557377049180328,0.9932797249385272,1.0,6/16,12.88%,AMPD1;LHPP;AMPD2;NUDT2;PPAT;ADSS1
prerank,T cell receptor signaling pathway (GO:0050852),-0.23420511164778607,-1.0101265367124115,0.46808510638297873,0.8554462501330339,1.0,29/138,15.98%,PIK3CA;WNK1;PDPK1;KHDRBS1;RC3H2;FYB1;PLCG2;NCK1;DENND1B;PIK3CB;PSMD7;PSMD9;PSMD13;PTPN22;IKBKG;RBCK1;TAB2;RNF31;PSMB3;CHUK;EIF2B3;NFKBIZ;PSMC5;PSMA5;PSMA1;PSMC2;STOML2;SPPL3;THEMIS
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4056582880124024,1.00970805091892,0.4542897327707454,0.9938428673307754,1.0,5/37,6.30%,DYNLL1;DYNLRB1;KIF3B;IFT43;IFT81
prerank,regulation of cell development (GO:0060284),0.4028891467318169,1.0095865758842313,0.4527503526093089,0.9932272564652446,1.0,6/36,7.59%,HEY2;HEYL;HDAC9;PRUNE1;YTHDF2;YAP1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.41980589799394086,1.0095125333640718,0.45648854961832064,0.9924779961829227,1.0,6/30,11.77%,CAVIN1;POLR2L;GTF2H4;CDK7;POLR1E;POLR1H
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.37388205288677445,-1.009179232252315,0.4424083769633508,0.8570341766642231,1.0,5/17,13.13%,BMP6;SASH1;CD55;TRIM5;CX3CL1
prerank,establishment of endothelial barrier (GO:0061028),-0.32874452692799777,-1.0091346050868146,0.4440993788819876,0.8560130929889417,1.0,7/29,8.64%,AFDN;TJP1;TJP2;PECAM1;RAPGEF1;RAP1B;RDX
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.33802599924516974,-1.008860807516452,0.4553072625698324,0.8555500112804078,1.0,3/26,1.39%,EYA2;EYA1;EYA4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4818331945685161,1.008483485570787,0.4426807760141093,0.9941684309896245,1.0,2/13,7.16%,ENTPD1;ENTPD7
prerank,negative regulation of nuclear division (GO:0051784),-0.4225858014594856,-1.008434107895193,0.4523809523809524,0.855628367306711,1.0,2/11,2.12%,BMP7;BMP4
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4431227690599257,1.0082965682493834,0.43661971830985913,0.9937412213305208,1.0,4/21,5.14%,HTR1B;PDGFB;IGFBP5;BMPR1A
prerank,sphingolipid metabolic process (GO:0006665),-0.24713094973632502,-1.008243674991101,0.43846153846153846,0.8549925276760971,1.0,23/108,11.74%,SGMS1;SGMS2;ELOVL7;CERS5;CERK;HACD4;SPTLC2;ST6GALNAC3;PPP2CA;SPTSSA;ACER2;ALDH3A2;ENPP2;SERINC1;SUMF2;CERS6;SGPP1;CERT1;PPT1;ASAH2;HEXA;B3GALNT1;SPNS2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.28931173688970124,-1.0079320679788764,0.4312267657992565,0.854726005810818,1.0,10/43,12.79%,PRKCB;PID1;GKAP1;PTPN11;PIP4K2B;NCK1;IGF2;OGT;GRB14;ENPP1
prerank,regulation of bone mineralization (GO:0030500),0.3846686431014598,1.0074947174651065,0.4619289340101523,0.9948846518179765,1.0,12/55,8.74%,MEF2C;CCN1;ANO6;SLC8A1;TGFB3;ACVR2A;ALOX5;OSR2;BMPR1A;FZD9;ATP2B1;TRPM4
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3834748526276347,1.007459194828192,0.4595635430038511,0.9940732794862761,1.0,8/50,10.61%,ACTN4;PTP4A3;LIMS1;TCIM;CD14;RELA;RTKN2;EIF2AK2
prerank,protein complex oligomerization (GO:0051259),-0.2631476102529032,-1.007453648768096,0.41875,0.8549016791607027,1.0,28/85,24.43%,SPAST;PKD2;RNF135;MCU;LETM1;WDCP;JMJD6;RNF213;UGDH;KCNC2;BLM;GSDMD;UPB1;TMEM120A;SNCA;STOML2;EHD1;G3BP2;YME1L1;PNPT1;ZC3H12A;EHD3;LRRC8D;CLDN1;RBMX;CPSF6;ALS2;ZBTB1
prerank,regulation of sodium ion transport (GO:0002028),0.41165031882625275,1.006901351800581,0.45767575322812054,0.9946109739320379,1.0,11/34,15.59%,ATP2B4;SNTA1;NEDD4;PRSS8;WNK2;CNKSR3;AHCYL1;GPD1L;SLMAP;YWHAH;NOS1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.43304572202317493,1.0066641870949364,0.47791798107255523,0.9942953655618123,1.0,9/25,12.81%,DDX23;TXNL4A;SF3B3;SRSF4;PRPF4;SRSF10;SF3A3;SRRM1;SF3B1
prerank,cellular glucan metabolic process (GO:0006073),0.4942339272305781,1.006243611257172,0.4692737430167598,0.9944688519739363,1.0,1/11,1.09%,PYGM
prerank,regulation of protein sumoylation (GO:0033233),0.44657284229187344,1.0061748748102897,0.44745762711864406,0.9937247892712011,1.0,3/17,6.07%,UBA2;PIAS4;SAE1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.27314161840048934,-1.0059409603065679,0.41363636363636364,0.8579291849247465,1.0,29/57,35.86%,GLUL;RPS19;SDAD1;NVL;RPS24;NOC2L;RRP36;PAK1IP1;LTO1;RPS7;RPL11;DDX31;RPF2;RPL38;EMG1;SURF6;EBNA1BP2;BYSL;RBIS;PES1;NIP7;RRS1;RPS15;RPL35A;RIOK2;WDR74;URB2;RPL14;MRTO4
prerank,negative regulation of growth (GO:0045926),0.3458232069986157,1.0058878840883352,0.4844789356984479,0.9935848897230417,1.0,22/121,14.70%,SLIT3;TMPRSS4;MYL2;RERG;FHL1;JADE1;NDRG3;TP53;BTG1;TGFB2;NDUFS3;CRLF3;SERTAD2;SH3BP4;RB1;TCHP;ACVR1B;DCBLD2;BCL6;MUL1;HYAL1;VGLL4
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4832632462648087,1.0056057116061545,0.4672413793103448,0.9934066081624817,1.0,6/13,18.65%,GLRX5;ISCA1;ISCA2;GLRX3;CIAO1;NFU1
prerank,response to organonitrogen compound (GO:0010243),-0.2992964574449945,-1.00552569442948,0.44964028776978415,0.8579343801253089,1.0,13/38,22.57%,SEL1L;RNF185;DNAJB12;DERL1;GLRB;IRAK3;PRKN;GLRA2;RCN3;SYVN1;GLRA1;DRD2;CCDC47
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3432884297532823,1.005457289315675,0.46483516483516485,0.992862766198381,1.0,16/138,10.07%,NTF3;NTRK3;LIFR;MERTK;MST1R;ROR1;FRK;ACVR2A;MUSK;PTPRF;LCP2;SLA;EPHA2;AXL;NPR2;PDGFRB
prerank,regulation of intracellular protein transport (GO:0033157),-0.30718109429447993,-1.0052170811687835,0.4462025316455696,0.857662188490029,1.0,10/32,10.30%,PTPN14;BMP4;PCM1;RUFY3;PRR5L;UHMK1;SIRT7;GCC2;ICE1;TGFB1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.38891907064393927,1.0051816589288411,0.46082337317397076,0.9926804392050993,1.0,9/48,9.57%,ANGPT1;ANGPT4;PDGFB;ANXA1;HDAC9;VEGFA;RHOJ;ADAM17;HIF1A
prerank,endocrine system development (GO:0035270),0.4472496754387914,1.005102258863881,0.4556765163297045,0.99198579855801,1.0,1/21,0.40%,TG
prerank,response to unfolded protein (GO:0006986),-0.28446711447265405,-1.0047121251844777,0.4235294117647059,0.8578990865193157,1.0,19/48,21.37%,HSPA4L;HSPA4;SERPINH1;DERL1;HSPA5;HSP90AB1;OPTN;PRKN;ERN1;DNAJB2;HSPA13;BAX;HSPA9;HSPE1;HERPUD1;DNAJB4;HSF1;DNAJC4;HSPD1
prerank,axon development (GO:0061564),0.3588396625858592,1.0042117792161929,0.4538922155688623,0.9932633094201768,1.0,24/78,19.86%,SEMA5A;MAP1B;SLITRK5;ACTB;KLF7;SLITRK4;MAPT;AFG3L2;RAB3A;BRSK1;GAP43;S100A6;ZDHHC17;ARHGAP35;ADGRB1;RTN4RL1;RAB8A;RYK;MARK2;MAP1A;MAP1S;BRSK2;NREP;PARD3
prerank,error-prone translesion synthesis (GO:0042276),-0.3556165599969485,-1.0041868780454357,0.4454022988505747,0.8581793596426007,1.0,12/21,37.19%,UBC;REV1;PRIMPOL;UBB;POLE2;POLI;RPA3;RFC3;RPA2;RPA1;RFC1;RFC4
prerank,negative regulation of cell division (GO:0051782),0.49109087944885527,1.0036727760516315,0.48613678373382624,0.9937073784193253,1.0,1/11,1.79%,CHMP4C
prerank,embryonic digestive tract development (GO:0048566),0.4456434895096903,1.0033840813116313,0.4864433811802233,0.9935023914952974,1.0,3/18,7.86%,RBPMS2;RARRES2;TGFB2
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.34286283788054767,-1.002969240690448,0.43699731903485256,0.8604068333425492,1.0,7/21,18.53%,CYP26B1;LPIN2;ACOT8;ACBD5;HOGA1;ACOX1;LPIN3
prerank,regulation of mitotic spindle organization (GO:0060236),0.3945542737197026,1.0026368689934275,0.4794908062234795,0.9944637294505371,1.0,9/35,17.37%,CHMP4C;NUP62;CHMP5;TPX2;HNRNPU;CHMP2B;CHMP2A;MAP9;DCTN1
prerank,regulation of defense response to virus (GO:0050688),-0.38914404847360484,-1.0025057327347175,0.4569377990430622,0.8605638749408069,1.0,4/14,7.42%,ITCH;PPM1B;ILRUN;PCBP2
prerank,glycolytic process (GO:0006096),0.4237938346776748,1.0024644815719075,0.4570596797671033,0.9940066042012178,1.0,8/28,19.37%,ENO3;HK2;PFKFB1;ALDOA;PFKM;GAPDHS;LDHA;PKM
prerank,bile acid biosynthetic process (GO:0006699),0.43106623648615844,1.0022438119810677,0.4485407066052227,0.9936602773466104,1.0,5/24,11.78%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.32656970644101657,-1.0021977465356129,0.4482758620689655,0.8602398966985412,1.0,11/26,15.80%,KMT2E;DDX3X;CCND3;EGFR;ADAMTS1;TFDP1;RDX;UBE2E2;RGCC;ANKRD17;AKT1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.501930711534111,1.0015249400613033,0.4748700173310225,0.994598048924515,1.0,4/10,18.30%,TP53;RPS27L;HIPK2;RPS6KA6
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.5079532610509323,1.0014369613581875,0.47947761194029853,0.9939033785900524,1.0,2/10,5.71%,SET;KLF15
prerank,cellular response to hexose stimulus (GO:0071331),-0.3416460344791589,-1.0013109654662185,0.4447513812154696,0.8614348341548584,1.0,6/23,12.74%,ZBTB20;UNC13B;TRA2B;ERN1;SOX4;PCK2
prerank,cardiac atrium morphogenesis (GO:0003209),0.4593870788548983,1.0008961671288155,0.4521452145214521,0.9944096911924627,1.0,2/16,7.86%,HEY2;TGFB2
prerank,regulation of phagocytosis (GO:0050764),0.37858294520702473,1.000592866237682,0.45817245817245816,0.9942626424272684,1.0,4/53,4.33%,MERTK;FER1L5;DYSF;PIP4P2
prerank,NAD biosynthetic process (GO:0009435),0.4446841618796,1.0005370159720464,0.4740061162079511,0.9935046402804592,1.0,6/20,15.71%,NMNAT2;PTGIS;NAXE;NMNAT1;NNMT;NAMPT
prerank,regulation of protein ubiquitination (GO:0031396),-0.24662860196339703,-1.0004402651008208,0.4444444444444444,0.8627030978875305,1.0,29/108,15.80%,SASH1;ARRB1;NXN;CUL3;MYCBP2;UBQLN1;CRY1;DERL1;HSP90AB1;BIRC2;PRMT3;COMMD1;FKBP1A;SIRT7;FBXO4;PRKN;UBE3A;OGT;STUB1;TGFBR1;SPRY2;SOX4;DNAJB2;PTTG1IP;SH3RF2;FANCI;BIRC3;UBXN1;AKT1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3323541431895087,1.0001821254200682,0.5,0.9934887616807881,1.0,45/327,11.82%,SOX6;MLF2;WTIP;MEF2C;ACTN4;ZFHX3;PTP4A3;LIMD1;NAB1;RORA;MLF1;HINFP;RBAK;ATXN1;PRKCQ;MYBBP1A;TP53;ZBTB38;SFPQ;PPARGC1A;PPARGC1B;ZNF431;REXO4;BTG1;SNAI2;RELA;KMT2D;DAPK3;MSL3;FUS;NSD3;PPIE;KAT7;HIF1A;NR2C2;NUP107;SRSF10;RB1;RHOH;BAZ2A;NFX1;ACVR1B;ESRRA;PSPC1;USP13
prerank,regulation of developmental growth (GO:0048638),-0.322091260323805,-1.0001672936469188,0.45980707395498394,0.8622933705654404,1.0,11/29,24.02%,IGF1;APOE;GHR;APP;LATS2;SIX1;INSR;STAT5A;SPAAR;MFSD2A;OLFM1
prerank,regulation of mRNA stability (GO:0043488),0.3422099539334539,0.9999364384181891,0.4692982456140351,0.9932154540324448,1.0,29/145,14.87%,RBM24;TENT5B;ROCK1;VIM;SAMD4A;PARN;SET;PSMC6;MAPKAPK2;CIRBP;GDNF;YTHDF2;CELF1;FTO;FASTKD1;FUS;PSME4;HNRNPU;PSMB1;PSMD5;ROCK2;PRKCD;DCP1A;PSMB2;ZFP36L1;GIGYF2;PSMB7;PSMD3;PRKCA
prerank,ncRNA export from nucleus (GO:0097064),0.40030786269406193,0.999892787847897,0.457182320441989,0.9924116455006392,1.0,13/36,20.76%,NOL6;NUP62;SEC13;NUP153;NUP107;AAAS;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,intestinal absorption (GO:0050892),0.466863989009409,0.9998429273129608,0.47584973166368516,0.991639032495314,1.0,1/13,1.72%,CD36
prerank,retinoid metabolic process (GO:0001523),0.3700977254850566,0.9997972724088715,0.47889022919179736,0.9908612042430249,1.0,7/71,7.14%,TTR;SDC2;LPL;DHRS3;RARRES2;GPC4;AKR1B1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3062060499099535,-0.9997384011059328,0.45149253731343286,0.8623985964382564,1.0,13/38,18.20%,DDX3X;TNFSF10;CASP8;BCL2L1;STX4;MADD;NOS3;RNF34;SP100;FAIM;GPX1;SERPINE1;TMBIM1
prerank,keratinocyte differentiation (GO:0030216),0.4144790695661309,0.9994596767022594,0.4607703281027104,0.9907867321646153,1.0,5/29,12.31%,ANXA1;JAG1;MED1;EPHA2;BCR
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.45996380587662095,0.9989168931381343,0.4763572679509632,0.9912307669053849,1.0,5/16,16.16%,CGAS;FANCB;RIF1;RMI2;MAD2L2
prerank,collagen fibril organization (GO:0030199),0.35729878345251687,0.998113416768597,0.4865497076023392,0.9923928189486545,1.0,19/88,13.25%,COL18A1;COL4A2;COL4A1;ADAMTS14;P3H2;LOXL2;CRTAP;COL4A6;DST;PXDN;TGFB2;COL27A1;COL4A5;P4HA2;COL19A1;COL6A3;COL3A1;COL14A1;COL8A1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.47196525401782197,0.9980513625756311,0.466893039049236,0.9916500090025746,1.0,5/14,18.40%,NMNAT2;AK7;NMNAT1;CMPK1;CMPK2
prerank,plasma membrane invagination (GO:0099024),0.4171581384556241,0.9978534395995033,0.47763347763347763,0.9912619500224849,1.0,7/29,12.59%,CD36;MYH9;SPIRE1;ARHGAP12;DOCK1;SNX18;SNX9
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3651576455611761,-0.9976975527336637,0.5013123359580053,0.8668920594316861,1.0,8/18,24.28%,RAB11A;VPS4B;RCC2;CDC25B;CDC25A;MECP2;CDC7;RAD51C
prerank,protein import (GO:0017038),-0.2476733255485407,-0.9974719244965055,0.5174418604651163,0.8663790217699421,1.0,28/84,22.22%,APPL2;APOE;HSPA4;E2F3;PEX14;FAM53A;SLC25A17;NUP88;ALDH3A2;NUTF2;IPO8;PEX5;ACBD5;PTTG1IP;ABCD3;APPL1;NUP50;FIS1;AKT1;EIF4ENIF1;SAMM50;NUP85;IPO11;NXT2;PXMP2;PEX13;NUP214;RAN
prerank,regulation of chemokine production (GO:0032642),-0.29791225336053034,-0.9972726154719492,0.4416058394160584,0.8657603205731473,1.0,6/36,8.49%,FOXP1;APP;IL18;WNT5A;LGALS9;IL6R
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.429680727239459,0.997254315665027,0.47648902821316613,0.9918690270097908,1.0,4/26,8.61%,CD36;SLC5A3;ALOX5;PPARA
prerank,signal release from synapse (GO:0099643),0.3916228684212764,0.9972351004547747,0.4718019257221458,0.9910359668584483,1.0,6/43,9.42%,STXBP2;SYT10;RAB3A;LIN7C;BRSK1;HRH3
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.40199040410406883,-0.9971473832544676,0.48214285714285715,0.8649449857721211,1.0,2/13,3.17%,BMP4;GLI2
prerank,cellular response to organic substance (GO:0071310),0.34302441799364924,0.9971082451630126,0.4710467706013363,0.9904707993040612,1.0,12/116,7.15%,SLIT3;AKAP6;NR1H4;CACNA1H;PDGFB;IGFBP5;CCL5;ACVR2A;PTPN18;BMPR1A;ARL6IP5;RAMP1
prerank,regulation of membrane depolarization (GO:0003254),0.44748224115052204,0.9968343392575597,0.4780564263322884,0.990290740023378,1.0,5/18,16.09%,CAMK2D;FHL1;GPD1L;LRRK2;GJA5
prerank,regulation of interleukin-1 production (GO:0032652),-0.38757137504912287,-0.9964133030407708,0.48184019370460046,0.8658040121755637,1.0,4/15,12.16%,FOXP1;HMGB1;TMED10;SIRPA
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.30316509629760285,-0.9962745564186002,0.4528301886792453,0.8650618298643238,1.0,20/36,33.93%,SGMS1;DEPTOR;MADD;ASAH2;TGFBR1;MAZ;CX3CL1;CRADD;BCL2L12;QARS1;TRIM39;TMBIM6;CYLD;CSNK2A2;CSNK2A1;STYXL1;PPIA;TRAF1;TPD52L1;ING5
prerank,regulation of T cell chemotaxis (GO:0010819),-0.40465632090702053,-0.9961977666809801,0.47494033412887826,0.8641364564162527,1.0,3/11,5.71%,WNK1;WNT5A;ADAM10
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.36260032352722604,-0.9961468360892792,0.46835443037974683,0.8631164399452511,1.0,10/18,33.92%,PTBP3;RPS13;ESR1;TGFB1;NRDE2;ZC3H12A;TMBIM6;ZC3H10;NCOR1;NUDT16
prerank,hexose metabolic process (GO:0019318),-0.2976756482617958,-0.9959361860688026,0.4620938628158845,0.8625099576248234,1.0,15/39,27.96%,APOD;BRAT1;SORD;PMM2;HECTD4;SLC35A2;FPGT;GALK2;FUCA2;PGM1;ALDOC;GALM;GALK1;PMM1;GDPGP1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4025090424183415,0.9959254701855306,0.4480796586059744,0.9916607605856921,1.0,9/35,10.84%,PADI2;ARID1A;UBR5;NEDD4;AR;MED1;PPARGC1B;YAP1;GPER1
prerank,cellular response to starvation (GO:0009267),0.33956711752034147,0.9957424522172663,0.47844827586206895,0.9912118164886724,1.0,32/147,14.47%,MAP3K5;PMAIP1;RNF152;PDK4;LARS1;KPTN;ATG7;GABARAP;ATP6V1H;MYBBP1A;CASTOR1;TP53;STK26;NUAK1;PPARA;IMPACT;SEC13;XPR1;BRSK1;RRAGB;ATP6V1C1;STK24;NPRL2;EIF2AK2;SREBF2;WDR45;ATP6V0D2;PIK3C3;MAPK1;LRRK2;PRKAA2;CASTOR2
prerank,positive regulation of growth (GO:0045927),0.36594450614398355,0.9946927070503353,0.45807259073842305,0.9929975933816043,1.0,25/64,21.28%,AKAP6;IL2;PABIR1;FXN;BCL2;TGFB2;PLCB1;ADNP2;ADAM17;HDGFL2;CEP43;N6AMT1;HYAL1;RFTN1;INO80;DDX49;S100A8;S100A9;EIF4G2;WFS1;SLC25A33;ERBB2;TAF9B;H3-3A;LGI1
prerank,negative regulation of defense response (GO:0031348),0.3586920059190325,0.9946674327853312,0.4708680142687277,0.9921932710475915,1.0,15/77,11.28%,NR1H4;RORA;FEM1A;PTGIS;ALOX5;MFHAS1;TNFAIP6;LPCAT3;PPARA;NR1D1;SIRT2;AOAH;GPER1;RB1;PRKCD
prerank,regulation of interferon-gamma production (GO:0032649),0.3632164724556564,0.9946150829039552,0.4705159705159705,0.9914270676396344,1.0,10/71,11.18%,NR1H4;FZD5;IL12RB2;CD276;HAVCR2;CD14;IL12RB1;RASGRP1;AXL;PDE4D
prerank,positive regulation of translation (GO:0045727),0.35555234892782434,0.9944722868597841,0.4908675799086758,0.9909074234625548,1.0,35/94,20.84%,VIM;SAMD4A;CCL5;NAT10;RPUSD3;POLR2G;TRMT10C;RCC1L;RPS27L;CIRBP;YTHDF2;PYM1;RPL5;EIF3E;EIF5AL1;EIF5A;RBM3;ZCCHC4;CPEB3;PLXNB2;RPUSD4;FASTKD2;PIWIL2;DHX9;EEF2;TRUB2;RMND1;UPF3A;HABP4;PKM;NSUN5;UQCC2;C1QBP;ERBB2;LARP1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3329441411862025,-0.9944039818119845,0.4339622641509434,0.8656148717118521,1.0,10/24,26.56%,B2M;CANX;SEC24B;ACE;CALR;ABCB9;TAP1;TAPBP;HFE;TAPBPL
prerank,regulation of cytoplasmic translation (GO:2000765),0.4640616718148368,0.994383642129894,0.4761092150170648,0.9902356885438415,1.0,2/14,6.43%,RBM24;CPEB1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3039507690864836,-0.9941744122642078,0.44485294117647056,0.8651264218956236,1.0,13/35,24.17%,SASH1;DLG1;XDH;LGALS9;RELL1;PTPN22;MAP3K4;PER1;DUSP1;ZC3H12A;GADD45B;SPHK1;CYLD
prerank,negative regulation of cellular component movement (GO:0051271),0.4566866934366938,0.9938465515420771,0.44574290484140233,0.990649103508304,1.0,2/15,6.74%,ACTN1;PIN1
prerank,negative regulation of viral transcription (GO:0032897),-0.3883325431421275,-0.9936701142395672,0.4838709677419355,0.8653320624023205,1.0,8/13,31.20%,TRIM14;LARP7;MID2;IFITM3;TRIM21;TRIM32;ZFP36;TRIM13
prerank,carboxylic acid transmembrane transport (GO:1905039),0.39464241511363246,0.9935840707670196,0.470976253298153,0.9904191359593227,1.0,6/40,10.37%,SLC38A11;SLC16A7;SLC38A2;SLC23A2;SLC23A1;SLC7A8
prerank,positive regulation of immune effector process (GO:0002699),-0.32395780197877133,-0.9934703659566052,0.48427672955974843,0.8647074849382806,1.0,7/27,15.16%,APPL2;LBP;LGALS9;RPS19;DDX60;CD46;ANKRD17
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4297657115741784,0.9933154284132869,0.475,0.9902244796888646,1.0,6/24,13.20%,ROCK1;CBFB;MED1;ROCK2;RUNX1;ZFP36L1
prerank,ribosomal large subunit assembly (GO:0000027),0.4294845067053022,0.9930042723779414,0.46967340590979784,0.9901201903520184,1.0,7/24,17.33%,RPL3L;NLE1;MDN1;RPL5;DHX30;FASTKD2;BOP1
prerank,negative regulation of wound healing (GO:0061045),0.4182609598934738,0.9926404340773686,0.5060240963855421,0.9901117007883727,1.0,5/28,6.76%,PHLDB2;CLASP2;SERPINE2;ALOX5;AJAP1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.3255897602865964,-0.9925906657241417,0.4561933534743202,0.865963410665053,1.0,11/26,33.56%,PDE8A;FBXO7;PRKN;AKT1;PARK7;ATF4;MAPK7;BAG5;HTRA2;PPIA;GPR37
prerank,regulation of telomere capping (GO:1904353),-0.3418838430820744,-0.9925811471374971,0.4583333333333333,0.8648525883733073,1.0,8/23,18.12%,TNKS2;RAD50;USP7;NBN;MAP3K4;HNRNPD;SMG6;ATM
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4395694117149698,0.9924632472892647,0.46534653465346537,0.9896830501228282,1.0,5/20,7.86%,HEY2;HEYL;HAS2;SNAI2;TGFB2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.40683919848898636,-0.9924532563713119,0.48089887640449436,0.8640755359867126,1.0,2/11,7.11%,WNT5A;CTNNB1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.49999573373388556,0.9924388332413431,0.4797047970479705,0.9888814547609606,1.0,4/11,16.02%,IL12RB2;STAT1;JAK2;STAT3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.29516653466737564,-0.9922101960413826,0.4474708171206226,0.8636126807534009,1.0,20/39,32.77%,RPS19;RPSA;RPS24;RIOK3;WDR3;RRP36;DDX52;RPS7;ERAL1;RRP7A;EMG1;SURF6;NOL11;RPS27;LSM6;MRPS11;RPS5;RPS15;RIOK2;TSR3
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.28550321188414346,-0.9919349561313267,0.4533898305084746,0.86324988077203,1.0,11/41,16.14%,IGF1;LBP;LGALS9;ILRUN;CD34;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;RARA
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4803560925782844,0.9917957432504311,0.4778156996587031,0.9895852610371976,1.0,3/12,6.28%,DYRK2;IRS1;SORBS1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3915885373107808,-0.9917608540930734,0.4892086330935252,0.8626404393759989,1.0,5/14,19.38%,IRAK1;CARD10;CARD14;TLR3;TIRAP
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.364899527161816,0.9915647821608465,0.472258064516129,0.989276092331488,1.0,9/60,10.91%,PARM1;PDGFB;PARN;PRKCQ;PKIB;CHTF18;NAF1;PDGFRB;CCT3
prerank,regulation of transposition (GO:0010528),-0.3869986207174332,-0.991236599476124,0.4815668202764977,0.8630701555450484,1.0,3/13,18.07%,UBR2;SIRT7;TEX15
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4138400982669071,-0.9909220392264356,0.4784688995215311,0.8628548977326495,1.0,4/10,13.75%,WNK1;PODXL;PIEZO1;DPP4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.32954677752866934,-0.9908387522052292,0.4581005586592179,0.8619411774970336,1.0,9/26,18.06%,LGR4;APPL2;BIRC2;IRAK3;APPL1;BIRC3;GPR108;TLR3;LRRC14
prerank,melanocyte differentiation (GO:0030318),0.47374877687319294,0.9908277707652413,0.4621212121212121,0.9902050094554167,1.0,3/11,11.82%,MEF2C;MREG;USP13
prerank,positive regulation of viral transcription (GO:0050434),0.4216977777870593,0.9908038800795954,0.47530864197530864,0.9894001286800806,1.0,9/25,18.18%,POLR2L;POLR2I;POLR2G;CCNT1;NELFB;POLR2J;NELFCD;DHX9;RSF1
prerank,regulation of fatty acid oxidation (GO:0046320),0.4564403890521558,0.9904525119642534,0.47906197654941374,0.9893923228783803,1.0,6/16,13.71%,PDK4;PPARGC1A;SOX9;PPARA;LONP2;SIRT4
prerank,regulation of fibrinolysis (GO:0051917),-0.3996861268047709,-0.9903733025739795,0.4838709677419355,0.8621268510837656,1.0,11/13,60.06%,THBD;SERPINE1;USF1;HRG;FAP;KLKB1;APOH;PLG;THBS1;F11;F2
prerank,miRNA metabolic process (GO:0010586),0.442688651340122,0.9903043136781667,0.48200312989045385,0.9888921026972263,1.0,6/20,13.82%,PARN;DICER1;DIS3L2;XPO5;DROSHA;DGCR8
prerank,positive regulation of protein modification process (GO:0031401),0.33220932705614264,0.9902946237587222,0.4936842105263158,0.988040643155835,1.0,34/203,12.38%,NTRK3;DLC1;ANGPT1;FGF1;CCN1;CCND2;THPO;FAM20A;ACVR2A;MUSK;CAMKK2;RARRES2;DYRK1A;ATG7;VEGFA;PPP2R5A;PIN1;TRABD2B;CALM1;RAMP1;RASGRP1;ITGB3;SOX9;CCND1;ADAM17;RAP2A;PELI2;GPER1;ROCK2;PRKCD;CLIP3;TNIK;AKTIP;CHRNA7
prerank,regulation of integrin activation (GO:0033623),0.4595480661293548,0.9900627548537277,0.4735945485519591,0.9877786254754793,1.0,3/15,7.51%,FERMT2;JAM3;PLEK
prerank,regulation of neuron migration (GO:2001222),-0.3257516248365354,-0.9899849371980862,0.4590643274853801,0.8620494579149549,1.0,4/26,7.32%,PHACTR1;SEMA6A;SRGAP2;SEMA3A
prerank,anterior/posterior pattern specification (GO:0009952),-0.2752949934693579,-0.9897938050777441,0.45714285714285713,0.8614281651572526,1.0,12/53,12.17%,HOXB6;HOXB3;PCSK5;HOXA3;HOXB4;HOXA5;BMPR2;WLS;ATP6AP2;HES1;TGFBR1;BHLHE41
prerank,negative regulation of ossification (GO:0030279),0.42549915387579945,0.9897023188604058,0.47723935389133626,0.9878172049804702,1.0,3/23,8.74%,MEF2C;SOX9;TRPM4
prerank,neutrophil activation (GO:0042119),-0.40387106502968606,-0.9890972518207667,0.5048780487804878,0.8622911516486584,1.0,2/12,2.05%,KMT2E;IL15
prerank,sulfur compound catabolic process (GO:0044273),0.3934710302914183,0.9889962951795834,0.4871099050203528,0.9886928068556158,1.0,5/38,5.98%,CSPG4;NUDT7;BGN;TXN2;OGN
prerank,long-term memory (GO:0007616),0.438764611372259,0.9889598241488715,0.46859903381642515,0.9879029742184997,1.0,4/19,13.73%,SLC2A4;CALB1;CPEB3;SGK1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.339274653132796,-0.9889250034317569,0.4783861671469741,0.8616305503216065,1.0,10/23,23.13%,NUPR1;CRY1;HDAC4;SIK1;EP300;C1QTNF3;GIT1;CBFA2T3;CLK2;PGP
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.41049307605900165,-0.9888544749151925,0.4683257918552036,0.8607284092196059,1.0,5/10,36.60%,IRAK3;MAPK7;SIGIRR;TLE5;KLF4
prerank,cellular lipid catabolic process (GO:0044242),-0.32471292787788675,-0.9887619847520579,0.5044510385756676,0.8598960498412462,1.0,8/27,18.53%,LPIN2;ENPP2;CYP1B1;ACOT8;ACBD5;ABHD12;ACOX1;LPIN3
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3427132263919621,0.9885548931580675,0.4630484988452656,0.9880205851952404,1.0,7/107,4.35%,NTF3;MEF2C;ABR;SLC8A2;SLC4A8;ITGB1;RIMS3
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.3471736974631075,-0.9880495541368657,0.4781491002570694,0.8606412735052841,1.0,6/20,4.20%,IGF1;LRP1;SLIT2;VTN;NRP1;IGFBP3
prerank,myelination (GO:0042552),-0.2807017329008299,-0.9877678374883347,0.5018867924528302,0.860256857681301,1.0,14/46,20.42%,NF1;PLP1;ADGRG6;B4GALT6;SBF2;PLLP;MAL;ARHGEF10;CMTM8;LGI4;MYOC;EIF2B5;PMP22;BCAS1
prerank,histone deubiquitination (GO:0016578),-0.3623953742963316,-0.987101599539951,0.43640897755610975,0.860963875468598,1.0,4/18,14.70%,USP7;BRCC3;USP3;ATXN7
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3739382545625456,0.9870905477624426,0.46064516129032257,0.9906714877307049,1.0,4/51,3.34%,CD36;MYD88;FZD5;LPL
prerank,actin cytoskeleton reorganization (GO:0031532),0.3643906116399571,0.9870542589675726,0.4861111111111111,0.989915554019062,1.0,15/63,13.99%,FLNA;MYH9;ANXA1;PTPN1;PLEK;WHAMM;PARVA;RAP2A;RICTOR;TNIK;CDC42BPB;DMTN;FGF10;MKLN1;S1PR2
prerank,regulation of centrosome duplication (GO:0010824),0.41631348244953825,0.9868172948356034,0.47947214076246336,0.9896279545042371,1.0,9/29,19.54%,CHMP4C;NAT10;CHMP5;CHMP2B;CEP120;CHMP2A;CCNF;CEP295;CENATAC
prerank,multivesicular body assembly (GO:0036258),0.4023447911573225,0.9865300751590808,0.4892086330935252,0.9894692732207799,1.0,9/30,15.01%,CHMP4C;CHMP5;IST1;STAM2;CHMP2B;TSG101;VPS36;CHMP2A;STAM
prerank,phosphatidylinositol metabolic process (GO:0046488),0.34507853166546837,0.9864188073929121,0.4886104783599089,0.9888853025321113,1.0,28/109,15.72%,PIP5K1B;INPP4B;PLA2G3;PIP4K2A;MTMR7;PITPNM3;PIP4P2;SYNJ2;SACM1L;PLEK;PLCB1;INPPL1;PLCD1;MTMR14;PDGFRB;INPP5B;CDIPT;SBF1;TPTE;PIK3C3;RAB14;PLA2G4A;PLEKHA1;PLA2G4C;INPP5J;PITPNM2;PTEN;VAC14
prerank,mucosal immune response (GO:0002385),-0.37955579993316313,-0.986095007043077,0.48418491484184917,0.8624269697930035,1.0,2/15,9.13%,OTUD7B;DEFA6
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4185070951013896,0.9859660072057153,0.4783950617283951,0.9891551251425379,1.0,4/24,4.86%,DLC1;PHLDB2;CLASP2;ARHGAP6
prerank,establishment of melanosome localization (GO:0032401),-0.35087311564962764,-0.9858088000238251,0.4770408163265306,0.8620968807506711,1.0,2/19,3.89%,SHROOM2;RAB11A
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4667415884802218,0.9857644307011596,0.466893039049236,0.9887872391036776,1.0,2/13,5.63%,MYD88;PIK3AP1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3510232445621523,0.98542687223455,0.4880546075085324,0.9887498603310565,1.0,8/107,6.42%,ATP2A1;MAP3K5;ATP2A2;ITPR1;TMEM259;BCL2;DAB2IP;TP53
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.22145168220315445,-0.985043030592046,0.47368421052631576,0.8630072114403063,1.0,49/168,20.30%,DDX5;UPF2;PPP2CA;RPL27A;DCPS;SMG1;RC3H2;RPS19;SAMD4B;RPSA;RPL21;RPS24;RPS18;RPL36;RPL18;RPS13;PABPC1;LSM1;RPLP0;RPS29;RPL28;RPS10;DCP2;RPLP1;RPS20;RPL23A;RPL34;NCBP2;PAN2;EXOSC9;RPL36A;RPS8;PAN3;RPS21;CNOT11;TUT4;RPL9;SMG6;ATM;ZC3H12A;RPS7;RPL27;TUT7;RPL11;PNRC2;NBDY;RPL18A;RPL37A;RPL38
prerank,regulation of catabolic process (GO:0009894),0.42966371662683067,0.9847583644306036,0.4723618090452261,0.9895686727332454,1.0,4/18,5.87%,FAM83D;ITGB1;RARRES2;ZDHHC2
prerank,melanosome localization (GO:0032400),-0.333520696170609,-0.984636234805981,0.4681933842239186,0.8629566312849537,1.0,2/21,3.89%,SHROOM2;RAB11A
prerank,response to peptide hormone (GO:0043434),0.3846411507048759,0.9846170091882037,0.46308724832214765,0.9890752176109019,1.0,11/43,16.02%,ROCK1;ANXA1;IGFBP5;SORT1;IRS1;CAV1;GPER1;ROCK2;ZFP36L1;STAT1;STAT3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3740250729779395,0.9841864817720136,0.4793814432989691,0.9892747368167223,1.0,12/52,11.84%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;SORBS1;STAC3;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,regulation of water loss via skin (GO:0033561),0.45922444642707727,0.9841611686181264,0.47471451876019577,0.9876244916502748,1.0,2/15,4.19%,TMEM79;FA2H
prerank,establishment of skin barrier (GO:0061436),0.45922444642707727,0.9841611686181264,0.47471451876019577,0.9876244916502748,1.0,2/15,4.19%,TMEM79;FA2H
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.39761860444544983,-0.982942044380558,0.4965197215777262,0.8663928755378624,1.0,3/12,8.50%,GKAP1;PTPN11;IGF2
prerank,sphingolipid catabolic process (GO:0030149),-0.37409222448136586,-0.982478760756247,0.47146401985111663,0.8665916486203358,1.0,4/15,9.94%,ACER2;ENPP2;PPT1;ASAH2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4746754573095483,0.9817390049588417,0.4982758620689655,0.9926381021212306,1.0,3/13,6.28%,DYRK2;IRS1;SORBS1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.35482996730077476,-0.9817215129221257,0.472,0.8675509429702762,1.0,8/18,29.45%,DAB2;RDX;MAP2K2;DNAJC13;SNX3;MTMR2;SNX12;SRC
prerank,pore complex assembly (GO:0046931),-0.34927722014451434,-0.9816651445964564,0.5,0.8666120968336017,1.0,8/19,22.88%,AFDN;ADAM10;AHCTF1;GSDMD;RTN4;NDC1;PDZD11;PLEKHA7
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.3859185358546235,0.9814937664000962,0.47009735744089015,0.9923914237317262,1.0,3/39,2.65%,ANGPT1;SEMA5A;ANO6
prerank,regulation of filopodium assembly (GO:0051489),-0.29451573325557,-0.981402927754463,0.5243055555555556,0.8661851306328484,1.0,15/38,24.74%,PALM;DOCK11;NRP1;RAB5A;NLGN1;FNBP1L;RIPOR2;DPYSL3;RHOQ;CDC42;FMR1;GPM6A;FSCN1;FXR1;ABITRAM
prerank,cellular response to oxidative stress (GO:0034599),0.34127847967913894,0.9813741854105649,0.5061728395061729,0.9918033592114583,1.0,28/118,17.31%,TPM1;NCF2;ANKRD2;CAMKK2;MAPT;TP53;PARP1;PPARGC1A;ADNP2;SRXN1;NUDT2;GSTP1;LONP1;PYROXD1;HIF1A;SIRT2;PRKCD;TXNRD2;PDK2;MAPK1;LRRK2;PRKAA2;ZFAND1;RAD52;MT3;SOD3;PRDX5;PRDX6
prerank,regulation of stem cell proliferation (GO:0072091),-0.3646167987342456,-0.9809902809599644,0.4717948717948718,0.8661928897345967,1.0,3/17,1.74%,AGO3;FBLN1;GJA1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.25620393835397065,-0.9803928044104442,0.4691358024691358,0.8667781072549766,1.0,23/76,18.64%,ARRB1;BMP7;ITCH;NFKBIA;IRAK1;PRMT2;PARP10;DAP;USP7;COMMD1;CYP1B1;IRAK3;PYDC1;RBCK1;IRAK2;CHUK;ANXA4;G3BP2;MTURN;NLRC5;LRRC14;NWD1;ZC3H12A
prerank,regulation of protein processing (GO:0070613),0.4332793956090077,0.9803867386486865,0.4738562091503268,0.9934042203476738,1.0,5/21,14.40%,ANGPTL8;SERPINE2;RUNX1;BAG2;LRRK2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.35708296399668815,-0.9803687751453742,0.47745358090185674,0.8657581281824849,1.0,4/18,10.05%,HDAC7;CD34;NAV3;HOMER3
prerank,secondary alcohol metabolic process (GO:1902652),-0.2975379025493503,-0.9799462683966,0.484375,0.8657766788649139,1.0,20/42,37.27%,CYP27A1;APOE;ABCA1;SOAT1;PIP4P1;SQLE;GBA2;IDH3G;CLN8;RXRA;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;SCAP;CH25H;LCAT;IDH1
prerank,ncRNA 3'-end processing (GO:0043628),-0.38651940866844053,-0.9797095226440211,0.48,0.8653182022704384,1.0,8/14,28.48%,INTS6;TRNT1;SSB;INTS2;PTCD1;ELAC2;INTS14;TOE1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3233093377725457,0.9796972436793392,0.5454545454545454,0.9942229565883992,1.0,51/366,11.82%,SOX6;MLF2;WTIP;MEF2C;ZFHX3;PTP4A3;LIMD1;CCNA2;NAB1;RORA;MLF1;HINFP;GMNN;RBAK;ATXN1;PRKCQ;ATXN2;MYBBP1A;TP53;ZBTB38;SFPQ;CYFIP1;PPARGC1A;PPARGC1B;ZNF431;REXO4;BTG1;SNAI2;RELA;KMT2D;DAPK3;MSL3;FUS;NSD3;PPIE;KAT7;HIF1A;NR2C2;NUP107;PDGFA;SRSF10;RB1;DDX25;RHOH;RBM3;BAZ2A;NFX1;ACVR1B;ESRRA;PSPC1;USP13
prerank,Fc receptor signaling pathway (GO:0038093),-0.2352860909360813,-0.9792606323653853,0.5108695652173914,0.8654691779707955,1.0,22/110,14.23%,NFATC3;GAB2;PIK3CA;GRB2;KIT;PDPK1;VAV2;PLCG2;PIK3CB;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;PSMA5;PSMA1;PSMC2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.27609597130207575,-0.979089939986908,0.4936708860759494,0.8648409432152552,1.0,13/43,20.40%,IGF1;LBP;LGALS9;ILRUN;CD34;PTPN22;IRAK3;SIRPA;CX3CL1;SYT11;RARA;ZC3H12A;CD274
prerank,nucleus organization (GO:0006997),0.37783054001975336,0.9790504027543167,0.48456375838926175,0.9949103725477582,1.0,14/47,19.61%,CHMP4C;SYNE1;PITPNB;CHMP5;SUN2;CHMP2B;DMPK;CHMP2A;NUP98;SUN1;USP36;VPS4A;NUP54;NUP133
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.4293000202778315,0.9787869498303087,0.48335974643423135,0.9947375399307977,1.0,6/20,12.88%,AMPD1;NT5C2;LHPP;AMPD2;PPAT;ADSS1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4063458621704001,0.9787673812985288,0.4921090387374462,0.9939361864249308,1.0,3/29,6.25%,VASN;SDHAF2;DAB2IP
prerank,mitochondrial fusion (GO:0008053),0.43525621939663145,0.9786549927480361,0.4755700325732899,0.9933458920171793,1.0,9/18,21.72%,AFG3L2;OPA1;MIEF2;MIEF1;MFN2;USP30;MFF;MFN1;GDAP1
prerank,positive regulation of neurogenesis (GO:0050769),-0.2606607143486198,-0.9786471586879901,0.4666666666666667,0.8649921372314956,1.0,21/68,19.44%,PLXNA2;ROBO1;SLIT2;CUX1;TIAM2;SHANK3;CTNNB1;PLXNA4;CDKL3;SPEN;CUL7;PTPRD;SNW1;CX3CL1;FBXW8;FAIM;NUMB;OBSL1;KDM1A;DISC1;NAP1L1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.3962855295099327,-0.9783737275792652,0.518348623853211,0.8646902522605194,1.0,2/11,2.36%,IGF1;GHR
prerank,negative regulation of lymphocyte migration (GO:2000402),0.49273374526033764,0.9782655205479167,0.487758945386064,0.9934541848845169,1.0,3/10,6.99%,PADI2;CD200R1;CD200
prerank,positive regulation of cellular component organization (GO:0051130),-0.2330245931343996,-0.9778860303169818,0.5050505050505051,0.8649652318464236,1.0,29/107,20.52%,DAB2;FRMPD4;LRP1;NEDD4L;BMP7;CDH5;APOE;ABCB7;SHANK3;SLF2;CAMK1;TMEM30A;SURF4;ICE1;TGFB1;SLF1;NRXN1;TGFBR1;SNCA;INSR;MMP1;GPX1;LMAN1;BAX;PARK7;TIRAP;AJUBA;BID;GPC3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3719558957909822,-0.9774639080871749,0.48641975308641977,0.8650079124926976,1.0,3/15,1.18%,UST;DCN;DSE
prerank,regulation of interleukin-2 production (GO:0032663),-0.2816391725087265,-0.9772981690834988,0.5120967741935484,0.8644132397890543,1.0,6/43,10.05%,SPTBN1;HDAC7;PLCG2;CD34;NAV3;HOMER3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.424881160569365,-0.977209472879756,0.5097613882863341,0.8635294185447622,1.0,2/10,1.71%,SH3RF1;HMGB1
prerank,neurotransmitter secretion (GO:0007269),0.3824272697900712,0.9768983368856595,0.5,0.9958312099968525,1.0,6/44,9.42%,STXBP2;SYT10;RAB3A;LIN7C;BRSK1;HRH3
prerank,regulation of axon regeneration (GO:0048679),-0.3968666477426964,-0.9768938355628118,0.4707259953161593,0.8633226397220068,1.0,2/12,2.92%,PTN;EPHA4
prerank,regulation of chromatin organization (GO:1902275),-0.37870380566925116,-0.976809984162697,0.5098522167487685,0.8624713374643577,1.0,5/14,22.36%,MLLT3;IGF2;SETD5;SETD1A;TLK2
prerank,tRNA 5'-end processing (GO:0099116),0.44948698054945524,0.976809698694813,0.4777397260273973,0.9951992927332531,1.0,2/15,5.56%,HSD17B10;TRMT10C
prerank,regulation of JUN kinase activity (GO:0043506),0.4013100512999273,0.9767296669506204,0.487698986975398,0.994558278190025,1.0,5/33,8.98%,MAP3K5;TNFRSF11A;DAB2IP;MAP3K10;GSTP1
prerank,carbohydrate catabolic process (GO:0016052),0.3904193610806316,0.975826427659869,0.5082191780821917,0.9959656418766217,1.0,7/38,11.56%,ENO3;HK2;PFKFB1;NEU3;ALDOA;PFKM;MAN2C1
prerank,defense response to fungus (GO:0050832),0.44023888024014535,0.9757387334880965,0.4918300653594771,0.995317252826287,1.0,4/17,17.13%,RARRES2;FAM3A;S100A8;S100A9
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3729290020151853,0.9755379959546202,0.4973474801061008,0.9949931654986988,1.0,6/48,7.37%,FZD5;IL12RB2;CD276;CD14;IL12RB1;RASGRP1
prerank,amino acid transport (GO:0006865),0.37682176114292887,0.9754811444274128,0.5102564102564102,0.9942726034317458,1.0,8/49,11.03%,SLC38A11;SLC6A17;SLC38A2;SLC25A29;SLC1A5;SLC7A8;SH3BP4;SLC6A15
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.2859491584605074,-0.9752469420878642,0.4753521126760563,0.8655324460029382,1.0,23/39,38.29%,ERCC5;FAN1;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;OGG1;RPA3;RFC3;RPA2;ERCC3;POLD3;RPA1;RFC1;RFC4;NTHL1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.3936190750255972,0.9751481710411518,0.5171428571428571,0.9942913077966902,1.0,8/32,12.90%,SDC2;SS18L2;NEDD4;CUX2;RAP2A;IL1RAPL1;TNIK;SARM1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.27872460104892643,-0.9750284140360558,0.48945147679324896,0.8650347754840726,1.0,12/51,17.14%,PTN;HMGB1;PTK2;LGALS9;MOSPD2;IL6R;AKIRIN1;VEGFC;CALR;PLA2G7;SERPINE1;VEGFB
prerank,inflammatory response (GO:0006954),0.3250047640895219,0.9745071868902953,0.5447761194029851,0.9949189140686053,1.0,13/195,7.89%,AGTR1;AOC3;TMIGD3;PTGER3;ANXA1;CCL5;HDAC9;MFHAS1;CD14;TNFAIP6;MAPKAPK2;IL22;RELA
prerank,regulation of fat cell differentiation (GO:0045598),0.35518429561211484,0.9744880905601115,0.5012376237623762,0.9941208880478711,1.0,16/74,11.24%,FERMT2;RORA;RUNX1T1;LPL;ALOX5;RARRES2;ASXL1;BBS12;TAF8;YAP1;FTO;TRPM4;NR1D1;SIRT2;GPER1;LRP5
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.33083478951574175,-0.9744517756260053,0.5,0.8654091612509222,1.0,5/25,9.37%,RIN3;APP;ANKRD13A;ITGAV;SDCBP
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.38045972075422574,-0.9743528504092279,0.4707379134860051,0.8646027507530266,1.0,3/14,3.93%,ATR;TNKS2;XRCC5
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.45283614623828955,0.9738650563875616,0.488245931283906,0.9947942179116284,1.0,4/13,8.61%,PDGFB;SOX9;RELA;PPARA
prerank,positive regulation of type I interferon production (GO:0032481),-0.2569344119454466,-0.9738221402820781,0.5086705202312138,0.8649738666297345,1.0,33/73,26.59%,DDX3X;PTPN11;PRKDC;XRCC5;RNF135;MRE11;IRAK1;POLR3F;CTNNB1;PTPN22;RIOK3;POLR3B;CHUK;POLR3A;XRCC6;EP300;TRIM56;TLR3;POLR3H;OAS2;POLR3E;STAT6;POLR2K;HSPD1;POLR2F;POLR2H;POLR3GL;POLR3C;DDX41;TOMM70;POLR3D;NFKB2;POLR2E
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4332229588464823,0.973769768298265,0.4873015873015873,0.994174737826841,1.0,2/18,2.43%,FER1L5;DYSF
prerank,regulation of ruffle assembly (GO:1900027),-0.3251077592513433,-0.9735442560906462,0.49709302325581395,0.8646577384007278,1.0,8/23,16.15%,EPS8;NLGN1;RDX;PLEKHM1;PFN2;PFN1;EPS8L2;EVL
prerank,multivesicular body organization (GO:0036257),0.39838763762952256,0.9734207831346207,0.5115606936416185,0.994215175392125,1.0,9/31,15.01%,CHMP4C;CHMP5;IST1;STAM2;CHMP2B;TSG101;VPS36;CHMP2A;STAM
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.29844537557910117,-0.9734191238443605,0.5136054421768708,0.8639313748017313,1.0,5/34,8.32%,WNT5A;RBP4;SLC7A5;STX4;PTPN22
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.47545593720853657,0.9734161799291269,0.508637236084453,0.9933894238136082,1.0,1/11,2.68%,CDH13
prerank,mitochondrial membrane organization (GO:0007006),0.4025071785019749,0.9732794308344104,0.5071022727272727,0.992867991122586,1.0,7/32,11.30%,PMAIP1;BCL2;RCC1L;OPA1;MTX1;DNAJC11;MFN2
prerank,inner ear morphogenesis (GO:0042472),-0.33145646755631986,-0.9731554289449438,0.47107438016528924,0.863567057097409,1.0,5/22,13.54%,ZIC1;CHD7;FGFR2;SIX1;MYO6
prerank,intracellular protein transport (GO:0006886),-0.20486851743585244,-0.9728724458566774,0.6666666666666666,0.8632810426950362,1.0,86/304,20.77%,RANBP3L;APPL2;TBC1D16;KIF13B;SNX27;E2F3;RABGAP1L;RAB5A;STXBP1;STX3;NLGN1;FAM53A;TBC1D15;USO1;ERP29;TBC1D8B;NUP88;TMED5;SEC23IP;RASSF9;TBC1D2B;SCG5;TBC1D13;STX5;HERC2;TBC1D5;STX4;ARL5B;TMED7;SURF4;TMED10;WLS;COPB2;NUTF2;IPO8;TBC1D8;FUT10;HOMER3;RANBP3;RAB3GAP2;TGFB1;SNX6;ARF3;UNC93B1;SNX15;ARFIP2;PTTG1IP;TBC1D25;TBC1D9B;SGSM1;GRTP1;MYO6;ARFGAP3;APPL1;NUP50;RAB1A;CALR;TBC1D30;MAIP1;GIPC1;RAB29;CCHCR1;TBC1D22A;TBC1D9;EHD1;AKT1;EIF4ENIF1;STX1A;SGSM3;LMAN1;COG7;PICK1;TMED3;SCFD1;STX8;RAB1B;NAPG;RPL11;TBC1D10A;SRPRA;TMED4;NUP85;IPO11;ARL4A;STX6;NXT2
prerank,regulation of cellular component biogenesis (GO:0044087),0.37945589307945427,0.9726440777154798,0.4771505376344086,0.9935449573739168,1.0,3/39,1.72%,RAP1A;ROCK1;CD36
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3369811807818091,-0.9721277131080686,0.5057471264367817,0.8641641053696281,1.0,12/20,37.29%,FAR2;PPT1;ACSL3;ACLY;ACSL4;HSD17B8;DGAT2;FITM2;GCDH;SLC25A1;SCD;ACACA
prerank,protein export from nucleus (GO:0006611),-0.3244218672440402,-0.9720867498022947,0.4774011299435028,0.8632016262283365,1.0,8/27,22.22%,RANBP3L;NUTF2;RANBP3;TGFB1;CALR;CCHCR1;NUP214;RAN
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3717059943885751,0.9720617879952268,0.4871099050203528,0.9940521731999739,1.0,6/47,11.38%,AGTR1;EDNRB;ATXN2;CYFIP1;DDX25;RBM3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4207766835395933,0.9720009360985697,0.5052631578947369,0.9933645771011639,1.0,5/25,10.84%,PMAIP1;TP53;HRK;DNM1L;GPER1
prerank,positive regulation of viral process (GO:0048524),0.3674281082879532,0.9719420744995034,0.5,0.9926673276601223,1.0,19/60,18.18%,POLR2L;POLR2I;CCL5;TBC1D20;POLR2G;PPARA;CCNT1;PPIE;PKN2;AXL;CNOT7;KPNA2;NELFB;POLR2J;SRPK2;NELFCD;DHX9;VPS4A;RSF1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.372365193911539,0.971887929205664,0.49206349206349204,0.991969707087756,1.0,8/46,13.57%,FLNA;UBR5;TP53;NEDD4;BAG3;PRKCD;TRIM28;GAS6
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3232783516243187,-0.9715137857619691,0.47678018575851394,0.86368698294047,1.0,3/25,0.71%,IGF1;NSD1;NIBAN2
prerank,regulation of MAPK cascade (GO:0043408),0.3295210344974552,0.9708285308737509,0.526775956284153,0.9936435965259977,1.0,30/157,14.04%,NTRK3;ROCK1;LBH;PDGFB;CCN1;ROR1;ADRA1D;FAM83D;THPO;BCAR3;KSR1;CAV1;DAB2IP;DUSP3;RRAS;RASGRP1;MAP2K1;GSTP1;PAK2;EPHA2;PELI2;PDGFA;GPER1;ROCK2;ZDHHC17;TNIK;TAOK3;FGF10;EPHB1;MAPK1
prerank,protein O-linked glycosylation (GO:0006493),-0.2366750705780466,-0.9700792414978968,0.5039370078740157,0.8663496062600228,1.0,15/96,13.02%,GXYLT2;TMTC1;ST3GAL4;TMTC2;ST3GAL1;GALNT10;TET3;RXYLT1;PGM3;TMTC4;TET2;ST3GAL3;OGT;PLOD2;GALNT12
prerank,regulation of Notch signaling pathway (GO:0008593),0.3559797703474428,0.9698846189523468,0.5035971223021583,0.9950481899144654,1.0,16/76,12.63%,NOTCH3;TCIM;JAG1;EPN2;FBXW7;RFNG;MAML2;YTHDF2;YJEFN3;YAP1;TGFB2;MAML3;SREBF2;ZBTB7A;TM2D3;PDCD10
prerank,response to chemokine (GO:1990868),-0.38733865080290375,-0.9698699250241369,0.4939467312348668,0.8658795649746988,1.0,6/13,18.64%,WNK1;SLC12A2;RIPOR2;DUSP1;LRCH1;ZC3H12A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.31680782542770575,-0.9698088637608074,0.4831081081081081,0.86498086892517,1.0,17/31,28.65%,DCPS;LSM1;DIS3;EXOSC1;DCP2;EXOSC9;EDC4;LSM7;EXOSC2;EDC3;LSM2;LSM5;EXOSC7;EXOSC3;EXOSC5;LSM3;LSM6
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3123187991060781,-0.9695799772840925,0.5014492753623189,0.8645662159844731,1.0,9/28,20.06%,PRKDC;PARP3;SIRT7;SMCHD1;DTX3L;WRAP53;KDM4D;HSF1;HMGA2
prerank,retrograde axonal transport (GO:0008090),0.4524558709988266,0.9694378236702123,0.5070643642072213,0.99530072159269,1.0,6/16,12.26%,DST;KIF1A;KIF5B;KIF1C;FBXW11;KIF5A
prerank,regulation of protein catabolic process (GO:0042176),0.3379019794115929,0.9691311897767959,0.5184331797235023,0.9951929827261153,1.0,10/99,7.94%,FLNA;NKD1;OAZ2;FAM83D;ATG7;ZDHHC2;DAB2IP;PIN1;NEDD4;SF3B3
prerank,protein heterotetramerization (GO:0051290),-0.3864036947384311,-0.968615281962659,0.4988344988344988,0.8659981993031673,1.0,6/13,42.50%,PKD2;FARSB;CPSF6;HSD17B8;GRIN1;GRIN2B
prerank,negative regulation of transport (GO:0051051),0.362996990374872,0.9683464704240697,0.5132275132275133,0.9961994034560135,1.0,6/51,7.48%,FER1L5;DYSF;PACSIN3;PIP4P2;ARL6IP5;ITGB3
prerank,regulation of ERAD pathway (GO:1904292),-0.4090749127357875,-0.9682118415855071,0.5090497737556561,0.8659449101516906,1.0,7/11,23.53%,ATXN3;RNF185;USP19;UBXN1;HERPUD1;RNFT1;USP25
prerank,regulation of protein dephosphorylation (GO:0035304),0.3805336378701014,0.9681275107529456,0.49796472184531887,0.9959122380717821,1.0,8/37,12.78%,DLC1;MFHAS1;PPP2R5A;PIN1;CALM1;ENSA;PRKCD;ARPP19
prerank,nucleosome organization (GO:0034728),0.36804548979986396,0.9680508593501351,0.5158831003811944,0.995255102157011,1.0,15/55,19.30%,SMARCD3;H1-0;ARID1A;SET;CHAF1B;SMARCB1;SOX9;MCM3AP;SMARCA5;INO80;RSF1;NAP1L4;VPS72;NAP1L2;BRD2
prerank,regulation of defense response (GO:0031347),0.3554078783565768,0.9679456576625705,0.5030229746070133,0.9946879584718173,1.0,12/76,9.50%,AGTR1;MYD88;ANXA1;ALOX5;ELMOD2;SETD6;PIK3AP1;TRAF3;CELF1;RELA;MGLL;AKNA
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3180929861376627,0.9677771013216618,0.606,0.9942465696805386,1.0,106/834,11.37%,MYOCD;NOTCH3;PPP1R12A;FHL5;HJV;ABRA;MEF2C;HEY2;ZFHX3;SMARCD3;FGF1;MICAL2;NR1H4;CSRP3;PDGFB;PPP3CA;CCN1;ZEB2;MLIP;FZD5;PLXND1;RORA;SS18L2;CDH13;NR4A1;CRTC1;GABPA;HEYL;JAG1;HINFP;MRTFA;TGFB3;CRTC3;FOSL2;ACVR2A;MCRS1;NR2F2;LMO7;VEZF1;ACTR3;ELL;OSR2;SP7;ARHGEF2;BMPR1A;KLF7;MEF2A;NCOA7;DBP;FOXJ3;ASXL1;KLF15;JUND;SMARCB1;DAB2IP;TERT;TP53;RXRG;VEGFA;PARP1;GRHL1;PIN1;ZBTB38;GDNF;MAML2;SFPQ;HOXC4;AR;PPARGC1A;MED1;PPARGC1B;YAP1;MED12;SOX9;TGFB2;RELA;KMT2D;SETD3;TNIP1;MAML3;PPARA;CCNT1;NR4A2;SKI;NR1D1;KAT7;PAXIP1;AKNA;CDK7;HIF1A;CRLF3;KANSL3;SIRT2;AGRN;HNRNPU;MED14;NR2C2;TEAD1;EIF5A;GPER1;PCGF5;SREBF2;RUNX1;PFKM;LRP5;ATF3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4609143815581626,0.9677519152704712,0.4937833037300178,0.9934815308925428,1.0,2/13,3.01%,LTBP1;GREM2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.37652880695908153,0.967690055305912,0.5013774104683195,0.992797266147701,1.0,11/42,16.51%,CGAS;RAD51AP1;PARP1;CHEK1;ERCC6;FUS;FANCB;RIF1;RMI2;MAD2L2;SIRT6
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.24961617296526134,-0.9675845838181645,0.5165562913907285,0.8664511852663774,1.0,19/80,17.93%,UACA;DAPK1;EPHA7;SH3RF1;HMGB1;DDX3X;NOD1;TNFSF10;RPS6KA3;CD44;DELE1;PDCD5;PPM1F;IGBP1;SNCA;FIS1;AKT1;GPX1;SIAH2
prerank,steroid metabolic process (GO:0008202),0.3588396967981673,0.9672766271652102,0.5006060606060606,0.9929382666629294,1.0,7/72,5.64%,HSD17B10;CYP7B1;DHRS4;HSD17B7;PIAS4;HSD17B4;GC
prerank,positive regulation of signal transduction (GO:0009967),0.3212222994453816,0.9671881462045717,0.5415384615384615,0.9923196959250573,1.0,48/238,15.41%,NTF3;FLNA;NTRK3;SLC2A4;FGF1;LIMS1;JAG1;DEPDC1B;KANK1;PTGIS;MN1;ASXL1;IRS1;MBD5;EPN2;SMARCB1;DAB2IP;SORBS1;LIMS2;TERT;MAML2;ITGB3;YAP1;TGFB2;TTC23;CUX2;MAML3;SKI;HIF1A;AXL;SLC39A14;GPER1;CD180;TM2D3;CHRNA7;CITED2;PDCD10;HOMER1;STK36;DMTN;SPIN1;GAS6;TUBD1;LRRK2;RAB34;PRKCA;PTEN;CAV2
prerank,fibrinolysis (GO:0042730),-0.3831072447766031,-0.9671641981078758,0.5110565110565111,0.8665361082375549,1.0,9/13,57.02%,PLAT;SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA
prerank,cholesterol metabolic process (GO:0008203),-0.2543561639103694,-0.9669338441834872,0.5578947368421052,0.8661079498300452,1.0,32/68,36.88%,CYP27A1;APOE;ABCA1;LBR;GGPS1;CYP51A1;SCARF1;HMGCR;ACLY;SOAT1;ARV1;INSIG1;PIP4P1;SQLE;GBA2;PMVK;LSS;MVK;CLN8;RXRA;INSIG2;EBP;TSKU;PPARD;ANGPTL3;ABCA5;CLN6;TM7SF2;SCAP;DHCR7;CH25H;LCAT
prerank,negative regulation of neuron differentiation (GO:0045665),-0.33440019134042914,-0.9668870290337556,0.4947916666666667,0.8651854943300399,1.0,6/22,16.85%,BMP7;B2M;HES1;DTX1;CALR;CNTN4
prerank,receptor catabolic process (GO:0032801),-0.3284523519589528,-0.9666443771996054,0.5085714285714286,0.8647529378391766,1.0,11/24,30.63%,GPRASP1;TGFB1;AP2S1;RNF43;AP2A2;CLTA;UVRAG;ZNRF3;MVB12A;AP2M1;SNX25
prerank,protein dephosphorylation (GO:0006470),0.3288862149804418,0.9664456483589017,0.5377049180327869,0.9932554034144307,1.0,27/135,13.12%,PPP1R12A;PPM1L;PPM1J;PPP3CA;MTMR7;DUSP5;PPP2R1B;PPM1E;PTPN18;PTPRS;LHPP;SDHAF2;PTPRF;DUSP3;PPP2R5A;PPM1A;PTPN1;PPP1CB;PPP1CA;CTDSP2;DUSP29;FBXW11;SBF1;CTDSP1;TPTE;DUSP16;PPP3CB
prerank,female gamete generation (GO:0007292),-0.2967639673693332,-0.9663818871912998,0.5032679738562091,0.8644551598398614,1.0,2/29,1.34%,PTN;MARF1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3338307819852457,-0.9661663564827234,0.5012987012987012,0.8639471776864264,1.0,6/21,13.83%,IGF1;LGALS9;CTSH;ITGAV;MAP2K2;KDR
prerank,histone mRNA catabolic process (GO:0071044),-0.37953657870192853,-0.9660067576862166,0.5164556962025316,0.8633392915526759,1.0,6/15,18.84%,SSB;LSM1;DCP2;TUT4;ATM;TUT7
prerank,positive regulation of autophagy (GO:0010508),-0.2474873401108696,-0.9659586135951045,0.5414364640883977,0.8624298626431978,1.0,24/81,19.66%,DAPK1;DCN;HMGB1;PAFAH1B2;TPCN1;FOXO1;GPSM1;PIK3CB;TFEB;OPTN;STK11;FBXO7;IKBKG;PRKN;TRIM5;IRGM;TRIM14;KDR;TMEM59;PLK2;MID2;ZC3H12A;PARK7;BNIP3L
prerank,nucleotide metabolic process (GO:0009117),0.41679332513597933,0.9659248788266601,0.49770992366412214,0.9935876679555365,1.0,12/23,22.83%,NMNAT2;DCTD;AK7;NMNAT1;CMPK1;REXO2;CMPK2;DCK;FHIT;CTPS2;NMNAT3;NUDT5
prerank,regulation of fibroblast proliferation (GO:0048145),0.371940571663394,0.965620622161475,0.49343832020997375,0.9934808990515469,1.0,11/45,10.74%,PDGFB;PDGFC;CDK6;PEX2;DAB2IP;TP53;CD300A;GSTP1;SKI;S100A6;PDGFA
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.45292778555003294,0.9655000128150198,0.5025466893039049,0.9929574853789794,1.0,5/14,16.16%,PAXIP1;RIF1;NECTIN2;KMT5B;MAD2L2
prerank,protein homotrimerization (GO:0070207),-0.3812102646749549,-0.9652257973023689,0.5093023255813953,0.8623233919526798,1.0,2/14,3.83%,CLYBL;SCARA5
prerank,protein trimerization (GO:0070206),-0.3812102646749549,-0.9652257973023689,0.5093023255813953,0.8623233919526798,1.0,2/14,3.83%,CLYBL;SCARA5
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.39660658554098005,-0.965114497082073,0.5153508771929824,0.8615749679853795,1.0,5/11,28.11%,FBXO7;PRKN;PARK7;ATF4;RACK1
prerank,endoderm formation (GO:0001706),0.3931804786776066,0.9640964011489808,0.5021645021645021,0.9954718737382097,1.0,5/35,8.26%,COL4A2;ITGA7;DUSP5;ITGB5;ITGA4
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.4501032137775656,0.9636596829252628,0.5075125208681135,0.9956994507242117,1.0,2/16,5.17%,RYR2;TAPT1
prerank,DNA packaging (GO:0006323),0.4325438388763204,0.9633038953422605,0.5090016366612111,0.9956884079218778,1.0,4/16,10.54%,H1-0;CHAF1B;TP53;HAT1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3202039749747733,0.9632986468067652,0.540169133192389,0.9948775761140897,1.0,37/193,15.44%,NTRK3;ANGPT1;FGF1;HIP1;MST1R;PDGFB;FERMT2;SEMA5A;THPO;ITGB1;GCNT2;MFHAS1;MTDH;PIK3AP1;IRS1;RRAS;PHLDA3;AREG;PPARA;EPHA2;THEM4;AXL;PDGFRB;HBEGF;PDGFA;VAV1;GPER1;RICTOR;TPTE;FGF10;MUL1;GAS6;PLEKHA1;IRS2;RHOG;PTEN;MYDGF
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3265130745614746,0.9632977646832936,0.52453653217012,0.9940574775138135,1.0,28/144,16.22%,FLNA;PMAIP1;OAZ2;FZD5;BCL2;UBR5;KCNB1;CEP290;ZDHHC2;SAE1;TP53;FBXW7;MIEF2;MIEF1;BAG3;SREBF2;PRKCD;KIF20B;PDCD10;HPS4;TRIM28;GAS6;MTCL1;ZFAND1;YWHAH;ATG13;LEPROT;SLC51B
prerank,nucleoside catabolic process (GO:0009164),-0.4011680218432677,-0.9632928917407287,0.5159235668789809,0.8651547888670706,1.0,6/11,29.44%,NT5E;UPP2;UPB1;DPYD;DERA;NT5C1A
prerank,stem cell differentiation (GO:0048863),0.38302983832701815,0.9631981732821647,0.5203804347826086,0.9934582208304463,1.0,8/39,12.34%,MEF2C;SP7;SETD6;TP53;TGFB2;LMBR1L;HTR2B;NELFB
prerank,response to reactive oxygen species (GO:0000302),0.36386514898204786,0.9630275945927443,0.5208596713021492,0.9930414484406623,1.0,12/54,14.35%,TPM1;CAMKK2;MAPT;STK26;GSTP1;HIF1A;STK24;TXNRD2;PDCD10;PDK2;MAPK1;HYAL1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.35901394834148437,0.9627509500096901,0.5245283018867924,0.9928535579140406,1.0,15/61,16.90%,NR1H4;OAZ2;PDK4;CAV1;PSMC6;PPARA;PSME4;PSMB1;PSMD5;PSMB2;PDK2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.40908143937250585,-0.9622654092252191,0.5192743764172335,0.8656078239936407,1.0,2/10,0.85%,NFAT5;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),-0.40908143937250585,-0.9622654092252191,0.5192743764172335,0.8656078239936407,1.0,2/10,0.85%,NFAT5;NFATC3
prerank,protein import into peroxisome membrane (GO:0045046),-0.3257699045610868,-0.9622638975740023,0.5053191489361702,0.864589177915634,1.0,9/22,21.53%,PEX14;SLC25A17;ALDH3A2;PEX5;ACBD5;ABCD3;FIS1;PXMP2;PEX13
prerank,regulation of DNA replication (GO:0006275),-0.26678869023616286,-0.9622281737361748,0.5345622119815668,0.8636451955623397,1.0,14/49,16.10%,ATR;GLI2;EGFR;ACVRL1;PPP2CA;STN1;PDS5A;ORC5;BLM;CTC1;TSPYL2;ANKRD17;OBI1;USP37
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.42231100405361177,0.9620423113605873,0.5132192846034215,0.9936965430879622,1.0,12/25,20.32%,ELL;HEXIM1;HNRNPU;CDK12;NELFB;NELFCD;ZMYND11;BRD4;CDK13;EAPP;WDR43;NELFA
prerank,Golgi to endosome transport (GO:0006895),-0.3559106267392136,-0.9619840180353506,0.5,0.8632280457704186,1.0,4/16,10.59%,VPS13A;MON2;GBF1;EPS15
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3662798101949117,-0.9616629377326985,0.5,0.8630697131806198,1.0,4/15,11.77%,PDGFRA;FGFR2;SIX1;TGFBR1
prerank,cellular respiration (GO:0045333),0.3795880062369196,0.9616361039762922,0.5035360678925035,0.993859961113831,1.0,17/41,22.10%,SIRT3;ME3;NDUFS1;SDHC;PPARGC1A;ETFA;SDHA;LYRM7;UQCRFS1;UQCRH;MTLN;MDH2;ATP5F1D;NDUFS4;OXA1L;COQ10A;ETFRF1
prerank,mRNA catabolic process (GO:0006402),-0.27557878413576203,-0.9612803099194202,0.5165289256198347,0.86303221073174,1.0,20/44,29.77%,AGO3;DDX5;METTL3;ERN1;DCP2;EXOSC9;TUT4;PNPT1;TUT7;NBDY;METTL16;LSM2;LSM5;CNOT10;NUDT12;AGO4;ZFP36;LSM6;PDE12;THRAP3
prerank,lipid oxidation (GO:0034440),0.45993765012138815,0.9612464279788332,0.5036101083032491,0.9939243690050974,1.0,2/12,7.18%,ALOX5;PPARGC1A
prerank,negative regulation of cellular protein localization (GO:1903828),-0.2950650809222751,-0.9605276958983954,0.5,0.8639794421683173,1.0,7/34,8.79%,NEDD4L;ANKRD13A;OTUD7B;ILRUN;LATS2;COMMD1;RIPOR2
prerank,positive regulation of innate immune response (GO:0045089),-0.30321523763684416,-0.9599325919778909,0.5085324232081911,0.8644672338119306,1.0,17/30,37.04%,LBP;WNT5A;RPS19;POLR3F;RIOK3;POLR3B;NLRC5;SLC15A4;GBP5;POLR3C;POLR3D;NMI;TRIM6;SPI1;PLSCR1;ADAM8;ZBP1
prerank,response to gamma radiation (GO:0010332),0.41677475391247554,0.9598171246180446,0.49001536098310294,0.9964273250474218,1.0,3/24,7.59%,MAP3K20;TP53;YAP1
prerank,protein processing (GO:0016485),0.33710434118613586,0.9596370869511122,0.5292740046838408,0.9960109211844421,1.0,6/102,6.32%,TMPRSS4;HJV;CLN5;KLK2;FXN;AFG3L2
prerank,positive regulation of TOR signaling (GO:0032008),-0.28521101246617636,-0.959580885719147,0.5335968379446641,0.8643440609400291,1.0,19/40,30.26%,PIK3CA;LAMTOR1;GOLPH3;RHEB;KLHL22;PIP4P1;NCKAP1L;GPR137B;MIOS;TELO2;SMCR8;RRAGD;LAMTOR2;GPR137;SIK3;PIH1D1;RRAGA;RPTOR;SLC38A9
prerank,establishment of spindle localization (GO:0051293),0.4444769813514536,0.9592880640737373,0.5142378559463987,0.9960282950556385,1.0,4/14,18.58%,CLASP2;CLASP1;MAP4;CFL1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4515852584755323,0.9591705028146839,0.5040387722132472,0.9955039626441421,1.0,5/14,14.06%,TBC1D20;SEC31B;SEC13;SEC24A;SEC24C
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3952819697815103,0.9590220271456914,0.5167883211678832,0.9950503002364904,1.0,7/31,11.24%,CRIM1;LIMD1;CDK6;SOX9;TRPM4;SKI;LRP5
prerank,Wnt signaling pathway (GO:0016055),-0.2369022798334784,-0.9585209897027461,0.5496688741721855,0.8660774235698269,1.0,16/92,10.92%,LEF1;WNT4;TCF7L2;NXN;FZD6;DDX3X;WNT5A;KLHL12;BCL9L;DIXDC1;PLCG2;WNT9A;CTNNB1;WLS;SFRP4;UBC
prerank,protein O-linked mannosylation (GO:0035269),-0.3507135079039477,-0.9583202780870074,0.5292620865139949,0.8655700003543101,1.0,4/18,7.12%,TMTC1;TMTC2;RXYLT1;TMTC4
prerank,detection of visible light (GO:0009584),-0.35300862861808635,-0.958260243856188,0.5189873417721519,0.8646939355800378,1.0,7/16,41.40%,ABCA4;CEP250;RP1;CACNA2D4;TULP1;CNGB1;GNA11
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.25841027317140886,-0.9580780961891714,0.5052083333333334,0.864148120703098,1.0,22/63,25.45%,CARM1;PRKDC;TFDP1;PML;ARID3A;MDM2;RGCC;SOX4;EP300;PLK2;BAX;CNOT11;CRADD;CHEK2;ATM;E2F4;FBXO31;PCBP4;PLAGL1;CDK2;CDKN1A;CNOT10
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.35377243366271044,-0.9572929509309113,0.5026041666666666,0.8651631131823423,1.0,7/16,17.60%,IRAK3;OGFOD1;GLE1;TBC1D25;INSR;CLN3;SHFL
prerank,positive regulation of histone modification (GO:0031058),-0.2914916508562489,-0.957267142279374,0.5121107266435986,0.8642166088661876,1.0,16/33,35.76%,ARRB1;TADA2A;AKAP8;AKAP8L;SART3;CHTOP;KDM1A;FMR1;RPS6KA4;ZBTB7B;TADA2B;RUVBL2;SAP30BP;APLNR;PAF1;BRCA1
prerank,apoptotic process (GO:0006915),0.3168795688671095,0.9570992065623667,0.5621052631578948,0.9987009535203563,1.0,31/203,12.39%,ATP2A1;DLC1;PMAIP1;RNF152;HIP1;MYD88;HK2;TNFAIP1;BCL2;JADE1;NDUFS1;CD14;PARP1;BNIPL;CHEK1;MAP3K10;DAPK3;NUDT2;VDAC1;TRPC5;ATCAY;AHCYL1;PAWR;TNFRSF21;PRKCD;RELT;TCHP;BOK;TNFRSF25;DMPK;DIABLO
prerank,mitochondrial genome maintenance (GO:0000002),0.4686035572473032,0.9562111303337574,0.5017421602787456,0.9998934559583542,1.0,4/11,9.01%,MEF2A;PARP1;OPA1;LONP1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.29090755817257274,-0.956117517308477,0.5185185185185185,0.8662472621954719,1.0,12/33,18.87%,PTPN11;PTK2;ACER2;FOXC2;CYP1B1;PDE3B;LYN;EPHA8;DPP4;SERPINE1;NCKAP1L;ITGB1BP1
prerank,histone acetylation (GO:0016573),-0.2529721242011342,-0.9551793618758251,0.5833333333333334,0.8675692702107206,1.0,18/69,18.19%,LEF1;PHF20;MBIP;TADA2A;YEATS2;TADA1;ATF2;NAA50;DR1;BRPF1;EP300;PER1;NAA60;TAF12;MORF4L2;MEAF6;TRIM16;TAF6L
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3007090157722569,-0.9549420573598328,0.5197368421052632,0.8671420611873547,1.0,11/29,22.65%,IFNAR2;PTPN11;WNT5A;HSP90AB1;METTL3;SAMHD1;STAT2;NLRC5;YTHDF3;PTPN2;RNASEL
prerank,response to glucose (GO:0009749),-0.2712181725237745,-0.9549231403736803,0.5581395348837209,0.866179928160925,1.0,9/46,12.74%,ZBTB20;UNC13B;TCF7L2;TRA2B;EIF2B3;ERN1;SOX4;ZBED3;PCK2
prerank,phospholipid catabolic process (GO:0009395),-0.32879724002209004,-0.9542737878003656,0.5565476190476191,0.8668327217635695,1.0,10/24,32.73%,ENPP2;GDPD1;ABHD12;GDE1;GPCPD1;PNPLA6;ENPP6;SMPDL3A;SMPD4;ANGPTL3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35773833241080133,0.9542668537041268,0.5215123859191656,1.0,1.0,14/52,18.33%,PMAIP1;FZD5;BCL2;SAE1;TP53;FBXW7;SREBF2;HPS4;YWHAH;ATG13;LEPROT;USP36;BBC3;TOMM7
prerank,positive regulation of developmental growth (GO:0048639),-0.2722742691540637,-0.9542350290184184,0.5098039215686274,0.8659425621483461,1.0,7/49,7.79%,NEDD4L;GHR;SEMA7A;RUFY3;GOLGA4;SYT1;SEMA4D
prerank,placenta development (GO:0001890),-0.38764783592609076,-0.9537184149202307,0.5398230088495575,0.8662231342392707,1.0,3/12,16.41%,PTK2;CUL7;PPARG
prerank,proteasome assembly (GO:0043248),0.4620651578792604,0.9535734088941396,0.5160714285714286,1.0,1.0,3/11,10.53%,ADRM1;OTUD6B;PSMD5
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3454974983176703,0.9533097552069517,0.5249695493300852,1.0,1.0,10/75,9.57%,AGTR1;PDGFB;SEMA5A;CDH13;NR4A1;VEGFA;ITGB3;ITGA4;ADAM17;HIF1A
prerank,"phagocytosis, engulfment (GO:0006911)",0.38119343279116463,0.9527208742287657,0.5274725274725275,1.0,1.0,8/36,15.30%,CD36;MYH9;XKR4;ARHGAP12;DOCK1;RHOH;ADGRB1;RHOG
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.3005372593536787,-0.9527175273348725,0.5465116279069767,0.866794536537674,1.0,9/29,30.57%,ACSF2;ACOT8;DBI;ACOT9;ACLY;CROT;ACOT7;ACOT11;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.3005372593536787,-0.9527175273348725,0.5465116279069767,0.866794536537674,1.0,9/29,30.57%,ACSF2;ACOT8;DBI;ACOT9;ACLY;CROT;ACOT7;ACOT11;OXSM
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.31196848954299666,0.9517950507915034,0.676,1.0,1.0,128/1082,11.24%,ACTA2;MYOCD;PRDM16;PPP1R12A;FHL5;TNNI2;HJV;ABRA;MEF2C;HEY2;MAP3K5;ZFHX3;SMARCD3;FGF1;LBH;NR1H4;CSRP3;RASL11A;PDGFB;PPP3CA;CCN1;ZEB2;MLIP;FZD5;RORA;SS18L2;CDH13;NR4A1;CRTC1;GABPA;ETS2;HEYL;JAG1;FZD4;PADI2;HINFP;MRTFA;TGFB3;H1-0;CRTC3;FOSL2;NUP62;ACVR2A;MCRS1;ARID1A;NR2F2;LMO7;TGFB1I1;VEZF1;CAMKK2;ACTR3;ELL;OSR2;SP7;ARHGEF2;BMPR1A;KLF7;CEP290;MEF2A;DYRK1A;NCOA7;TESC;DBP;FOXJ3;ASXL1;KLF15;JUND;SMARCB1;DAB2IP;TP53;RXRG;VEGFA;DYRK1B;PPM1A;PARP1;GRHL1;PIN1;ZBTB38;GDNF;MAML2;SFPQ;HOXC4;AR;PPARGC1A;MED1;PPARGC1B;CHEK1;YAP1;ERCC6;MED12;SOX9;RELA;PLCB1;KMT2D;SETD3;TNIP1;ZXDC;MAML3;PPARA;MAP2K1;CCNT1;NSD3;NR4A2;SKI;NR1D1;KAT7;AKNA;CDK7;HIF1A;CRLF3;SFR1;KANSL3;SIRT2;SERTAD2;AGRN;HNRNPU;NAT14;MED14;NR2C2;TEAD1;EIF5A;RAI1;GPER1;PCGF5;SREBF2;RUNX1;PFKM;LRP5
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3631528946511978,-0.9517686170049571,0.5538847117794486,0.8682215318145784,1.0,8/15,21.44%,PTN;NF1;CTNNB1;TAFA1;CX3CL1;KDM1A;DISC1;DRD2
prerank,engulfment of apoptotic cell (GO:0043652),0.43678936173444877,0.9512326011993997,0.5148861646234676,1.0,1.0,4/15,15.30%,XKR4;RHOH;ADGRB1;RHOG
prerank,regulation of sensory perception of pain (GO:0051930),0.4642643410806348,0.9509019363010992,0.532608695652174,1.0,1.0,3/11,11.92%,ACP3;MGLL;ATPSCKMT
prerank,carbohydrate derivative transport (GO:1901264),-0.34779460490547853,-0.9505695090763192,0.5277777777777778,0.8702322924995609,1.0,6/18,22.48%,PLTP;LBP;SLC10A7;CLN3;SLC15A4;MFSD2A
prerank,selective autophagy (GO:0061912),-0.26179208297688905,-0.9502594042182231,0.5990566037735849,0.8700145130630017,1.0,23/56,22.15%,RB1CC1;DYNC1I1;DYNC1LI2;UBQLN1;RETREG1;TEX264;IFT88;PEX5;ATG5;PRKN;ATG2B;AMBRA1;UBC;ACBD5;ATG2A;LGALS8;KLHL3;ATM;PARK7;PCNT;DYNLL2;WDR81;UBB
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.40426531259855436,0.9495215577370352,0.5030120481927711,1.0,1.0,4/23,15.00%,PLA2G3;LPCAT3;PLA2G4A;PLA2G4C
prerank,RNA modification (GO:0009451),0.35826974163813724,0.9494911713835117,0.5313315926892951,1.0,1.0,7/54,5.49%,WDR4;TRDMT1;NAT10;PARN;CDKAL1;TYW5;FTSJ1
prerank,lytic vacuole organization (GO:0080171),0.3854151728904861,0.9494777043838428,0.5270655270655271,1.0,1.0,9/32,14.40%,CLN5;HOOK2;ACP3;CLVS1;HOOK1;MBTPS1;AKTIP;HPS4;LRRK2
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4313908231621109,0.9493969175193524,0.5293159609120521,1.0,1.0,5/19,14.04%,CCL5;JAM3;RARRES2;MPP1;MAPK1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3116902718201293,-0.9492557612867609,0.5146198830409356,0.8716015800543326,1.0,5/27,4.90%,LRP1;PLTP;APOE;PTCH1;NFKBIA
prerank,positive regulation of T cell proliferation (GO:0042102),-0.266525227156029,-0.9491705565695605,0.5714285714285714,0.8707896091890304,1.0,8/55,8.50%,IGF1;IGFBP2;HMGB1;IL15;IL18;VCAM1;NCK1;IGF2
prerank,regulation of mast cell activation (GO:0033003),0.47470194009148514,0.94914911178372,0.5326278659611993,1.0,1.0,2/10,11.85%,MILR1;NECTIN2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.44357500158350566,0.9489501369189391,0.5480607082630692,1.0,1.0,2/16,2.57%,PDK4;RORA
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3485081593647481,0.9488446624853057,0.5254237288135594,1.0,1.0,14/70,16.90%,NCF2;CD36;LNPEP;PSMC6;ITGB5;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;MFSD6;PSMA2;PSMD14
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4093825929600484,-0.9486548549385578,0.5325842696629214,0.8711239855121451,1.0,5/10,24.73%,NF2;PPP2CA;PARP14;PTPN2;INPP5F
prerank,regulation of protein localization (GO:0032880),-0.2564299638641867,-0.9486053519143426,0.5323383084577115,0.8702391069191481,1.0,25/58,29.68%,AFDN;DLG1;AAK1;RABGAP1L;HSP90AB1;CAMK1;FKBP1A;TRIM25;RSL1D1;TRIM5;TRIM14;PPM1F;TMEM231;KDM1A;RAB9A;STX6;TRIM21;TRIM17;MAPK8;ADCYAP1;WDPCP;RACK1;TESK1;CTSD;TRIM46
prerank,cellular response to interferon-beta (GO:0035458),-0.3631313400596202,-0.948590284946088,0.5195121951219512,0.8692863978936114,1.0,9/14,40.53%,IRGM;PNPT1;IFITM2;HTRA2;CDC34;NDUFA13;TRIM6;IRF1;AIM2
prerank,proteasomal protein catabolic process (GO:0010498),-0.20894263231463048,-0.9483809151016548,0.5957446808510638,0.8688256367668865,1.0,70/201,25.75%,NEDD4L;ARRB1;ATXN3;AREL1;ITCH;CUL3;SEL1L;RNF185;UBE2D3;DNAJB12;PML;DERL1;CTNNB1;BIRC2;PCBP2;PSMD7;PSMD9;PSMD13;MDM2;PELI1;TOPORS;RBCK1;WWP1;ARMC8;SMURF2;PRKN;KCTD2;RMND5B;DDB1;UBE4B;PSMB3;KLHL22;RNF34;STUB1;RMND5A;SKP2;RCN3;PSMC5;SIAH1;PSMA5;PSMA1;PSMC2;HECW1;NHLRC3;UBXN1;SIAH2;SYVN1;FBXW5;SPOPL;SPSB4;RNF41;BTRC;ZFAND2A;SHARPIN;KCTD17;PSME3;PSMC4;PRPF19;CCDC47;IFI27;UBE2B;PSMB6;FBXL19;RAD23B;TBL1XR1;SIAH3;UCHL1;PSMB10;HECTD3;SPSB1
prerank,positive regulation of protein maturation (GO:1903319),0.4633248506357672,0.9480653919394219,0.5255474452554745,1.0,1.0,1/11,1.92%,ANGPTL8
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.37819923701225167,0.9480152853293472,0.5280112044817927,1.0,1.0,7/38,12.48%,ATP2B4;CD36;PTGIS;CAV1;GLA;ROCK2;CLU
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4156275716307267,0.9475845524311564,0.5205254515599343,1.0,1.0,4/21,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,cyclooxygenase pathway (GO:0019371),0.45968396446554227,0.9475622580037292,0.5050505050505051,1.0,1.0,3/10,8.49%,PTGIS;TBXAS1;CBR1
prerank,linoleic acid metabolic process (GO:0043651),0.42276144654707026,0.9475253498211442,0.5264847512038523,1.0,1.0,3/17,8.98%,ALOX5;FADS2;GSTP1
prerank,respiratory tube development (GO:0030323),0.39239820244804435,0.946638967586543,0.5413533834586466,1.0,1.0,5/28,7.58%,FGF1;ITGA3;VEGFA;ABCA3;HECA
prerank,copper ion homeostasis (GO:0055070),-0.3477420169209369,-0.9462957226342104,0.5357142857142857,0.8730074024425575,1.0,5/17,22.59%,APP;COMMD1;ATOX1;MT2A;SLC31A1
prerank,regulation of JNK cascade (GO:0046328),-0.23207553746215331,-0.9460479973897787,0.6036036036036037,0.8726023553617616,1.0,31/101,24.17%,TGFBR3;MECOM;SH3RF1;HMGB1;APP;ITCH;EGFR;PTK2B;MBIP;SEMA3A;RASSF2;SDCBP;SH3RF3;PRKN;MAPK8IP3;SIRPA;SH3RF2;TAOK1;PER1;AIDA;MTURN;TIRAP;GADD45B;DACT1;TAOK2;FLT4;MAP3K11;AXIN1;WNT16;MAPK8IP1;CYLD
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3179047467148709,0.9457820368610892,0.5674217907227616,1.0,1.0,38/153,17.52%,STK38L;ROCK1;MAST4;DYRK2;PDGFB;CAMK2D;MARK1;DYRK1A;PRKCQ;TAF1;RPS6KA2;MAPKAPK2;DYRK1B;MAP3K10;BRSK1;PKN2;PAK2;ROCK2;PRKCD;RICTOR;DMPK;MAST1;GAS6;CSNK1E;SGK1;MAPK1;LRRK2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1;HIPK2;MAST3;MAP3K13;EIF2AK3;MARK2;MASTL
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3711612623098527,-0.9453532311190241,0.5161290322580645,0.8733482672434295,1.0,5/14,16.89%,IGF1;LDLR;CX3CL1;SYT11;GRN
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.24622626518045554,-0.9451413219871029,0.5656565656565656,0.8728716245545256,1.0,24/73,21.37%,ROBO1;SMAD3;XDH;F3;NOD1;COL4A3;SENP1;ACER2;TNFSF10;DAP;CASP8;EGLN3;SNCA;CASP9;PPARG;APAF1;BAX;HSPE1;CRADD;AIFM1;CASP4;BID;MTCH1;HSPD1
prerank,regulation of peptidase activity (GO:0052547),-0.33520951341927513,-0.9450821330095376,0.5472222222222223,0.8720211514858422,1.0,4/19,12.24%,NRDC;CTSH;FURIN;RCN3
prerank,positive regulation of cell division (GO:0051781),-0.2802473229346676,-0.94421004602373,0.5392491467576792,0.8731490000708395,1.0,14/38,23.48%,PKP4;CDC14B;CUL3;SPAST;PRKCE;FGFR2;CDC25B;GIPC1;CIT;CDC42;SVIL;CSPP1;DRD2;TAL1
prerank,positive regulation of transferase activity (GO:0051347),0.3174286206195826,0.9437853181976913,0.5653631284916201,1.0,1.0,19/142,10.07%,PARM1;NTRK3;MERTK;MST1R;ROR1;DCUN1D2;MUSK;PARN;PRKCQ;FBXW7;PKIB;PIN1;CD200;CHTF18;DCUN1D1;NAF1;EPHA2;AXL;PDGFRB
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.30706687210663725,0.9435498716548165,0.6663326653306614,1.0,1.0,89/572,13.14%,PRDM16;MYOZ2;HJV;MEF2C;HEY2;ZFHX3;TBX2;NR1H4;PDGFB;ZEB2;EDNRB;MLIP;ID4;FST;FRK;LOXL2;ETS2;ARID5B;ZNF436;H1-0;NACC2;PRDM1;HDAC9;NR2F2;ANKRD2;NR2C1;USP2;ATXN1;OSR2;CBFB;KLF7;KCNIP3;MEF2A;PEX2;MTDH;SUV39H2;CAV1;TAF1;DAB2IP;ARID5A;TP53;VEGFA;PPM1A;PARP1;HEXIM1;SFPQ;NEDD4;AR;MED1;ZNF431;YAP1;SOX9;SNAI2;HSF4;DICER1;RELA;CUX2;LIN37;CCND1;PPARA;CBX4;IMPACT;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;BAG3;SIRT2;RIF1;HNRNPU;ZNF3;NR2C2;UBE2D1;SREBF2;RUNX1;RB1;ATF3;NKX6-1;ZBTB7A;NFX1;ORC2;CITED2;CPEB3;NR6A1;FNIP2;ZFP69;MXD4;BCL6
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.39528724878520677,-0.9430666636147444,0.5373134328358209,0.8749478717391095,1.0,5/11,27.47%,PPHLN1;SETDB1;MPHOSPH8;RESF1;SETDB2
prerank,positive regulation of sodium ion transport (GO:0010765),0.45653426186852286,0.942537307421422,0.5428051001821493,1.0,1.0,5/12,15.59%,PRSS8;CNKSR3;AHCYL1;GPD1L;NOS1
prerank,intracellular lipid transport (GO:0032365),0.4196052217964733,0.9420762321619389,0.543859649122807,1.0,1.0,6/21,14.41%,PRKAB2;ACACB;CPT1B;ABCD4;CPT1A;PRKAA2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3604222570372172,0.9418920942342867,0.5348525469168901,1.0,1.0,9/51,12.19%,RBPMS2;CRIM1;GREM2;ACVR2A;BMPR1A;SKI;VWC2L;UBE2D1;BMPR1B
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.3892783404109916,-0.9414976739515711,0.5555555555555556,0.8778808744427359,1.0,3/11,7.48%,MECOM;WNT5A;CD34
prerank,regulation of cell morphogenesis (GO:0022604),0.39021299865284437,0.9411056308562151,0.5364806866952789,1.0,1.0,2/30,2.33%,WTIP;FERMT2
prerank,endothelial cell proliferation (GO:0001935),0.42582664448187935,0.9410330575755508,0.5383333333333333,1.0,1.0,3/17,2.95%,ANGPT4;SEMA5A;LOXL2
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.4019203601505954,0.9409280557451292,0.5447530864197531,1.0,1.0,2/24,2.51%,ANGPT1;SEMA5A
prerank,cellular response to peptide (GO:1901653),0.35012572062435987,0.940684710446802,0.5149625935162094,1.0,1.0,8/56,8.26%,CACNA2D1;CD36;VIM;ARHGEF2;CAV1;CHMP5;TP53;ITGA4
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3706426658011832,-0.9405763509116624,0.5247747747747747,0.8791350688817011,1.0,6/13,31.20%,PML;TRIM5;MID2;TRIM21;TRIM32;TRIM13
prerank,autonomic nervous system development (GO:0048483),-0.35467774595937884,-0.9402039331364114,0.5518207282913166,0.8790703679924341,1.0,5/17,12.08%,NF1;FN1;NRP1;SEMA3A;SOX4
prerank,positive regulation of transmembrane transport (GO:0034764),0.4479577124396998,0.9401345325940957,0.5335689045936396,1.0,1.0,4/13,15.64%,ANO6;ACSL5;CLIP3;AZIN2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3409313046226487,0.9399778051459837,0.5751789976133651,1.0,1.0,9/75,7.86%,COL4A2;ATP2B4;ROCK1;ANGPT4;ALOX5;EMILIN1;DAB2IP;YJEFN3;TGFB2
prerank,negative regulation by host of viral process (GO:0044793),-0.3982384729027463,-0.9398455380314238,0.5460526315789473,0.8789726837295745,1.0,3/10,21.39%,PRKN;ZC3H12A;CCNK
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.43468104524808615,0.9395348963583273,0.5360281195079086,1.0,1.0,4/16,7.43%,PADI2;ARID1A;AR;PPARGC1B
prerank,regulation of dephosphorylation (GO:0035303),-0.35590056710795304,-0.9394304245560776,0.528169014084507,0.8789612591201056,1.0,6/15,34.73%,MTMR4;IGBP1;SMG6;MTMR2;SRC;MTMR1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4179089683789525,0.9389776173302424,0.5393442622950819,1.0,1.0,6/19,11.11%,ROCK1;CBFB;SNAI2;EPHA2;ROCK2;RUNX1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.4469499343582027,0.9386740502980817,0.5281306715063521,1.0,1.0,2/12,4.95%,SEPHS2;SEPHS1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.36831056828014275,-0.938643824193788,0.5350467289719626,0.8798542398279783,1.0,3/13,7.95%,STX3;HSP90AB1;STX4
prerank,zymogen activation (GO:0031638),-0.2769009732329675,-0.9385664012698935,0.5905511811023622,0.8790533883510849,1.0,6/39,7.84%,CYFIP2;PLAT;CTSL;CTSH;CASP8;FURIN
prerank,phospholipid dephosphorylation (GO:0046839),0.380071406049283,0.9384964005066053,0.5352112676056338,1.0,1.0,9/37,15.34%,MTMR7;PIP4P2;SYNJ2;SACM1L;PLPPR1;INPP5B;TPTE;INPP5J;PTEN
prerank,positive regulation of myelination (GO:0031643),0.46595318045144085,0.938425628800731,0.5427509293680297,1.0,1.0,2/11,7.81%,TPPP;DICER1
prerank,central nervous system myelination (GO:0022010),-0.3975021049877471,-0.9384254327520264,0.5673913043478261,0.8784152815217953,1.0,2/11,4.96%,PLP1;B4GALT6
prerank,regulation of mitochondrion organization (GO:0010821),0.362022358391283,0.9382812003434768,0.5255376344086021,1.0,1.0,16/47,18.90%,INF2;FZD5;MAPT;FBXW7;PPARGC1A;MIEF2;VDAC1;DNM1L;SREBF2;MUL1;LRRK2;RHOT1;VPS35;USP36;MFF;HDAC6
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.38234632730443363,-0.9379045314672516,0.5388235294117647,0.8787234270063894,1.0,5/12,26.58%,WNK1;AKT1;MIA3;ASS1;SKAP1
prerank,regulation of dendritic spine development (GO:0060998),0.4168383401628138,0.9378469244208052,0.5447409733124019,1.0,1.0,3/19,6.12%,MEF2C;PTPRS;KIF1A
prerank,glucose metabolic process (GO:0006006),0.3607427116666997,0.9378187423460614,0.5484276729559748,1.0,1.0,14/58,15.43%,ENO3;PFKFB1;MDH1;ADPGK;PPARGC1A;GOT1;GOT2;SLC39A14;ALDOA;LRP5;CRTC2;SLC25A12;IRS2;GAPDHS
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.46956727120113906,0.9375503981772362,0.5164233576642335,1.0,1.0,1/10,5.12%,SAG
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.261361392149623,-0.9374616612823956,0.5742971887550201,0.8788558185677472,1.0,12/50,19.27%,SH3RF1;DDX3X;RPS6KA3;CD44;RNF34;IGBP1;SNCA;AKT1;GPX1;SIAH2;BCL2L12;PARK7
prerank,muscle cell migration (GO:0014812),0.4675608448065852,0.9372635713638684,0.5302752293577981,1.0,1.0,2/10,7.48%,ROCK1;ITGB3
prerank,regulation of actomyosin structure organization (GO:0110020),0.4450226034810725,0.9368610952626505,0.551304347826087,1.0,1.0,2/13,3.59%,ROCK1;ACTG1
prerank,protein palmitoylation (GO:0018345),0.3902578517705853,0.9365408360790441,0.5342066957787481,1.0,1.0,12/30,18.76%,GOLGA7B;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;CLIP3;ZDHHC13;ZDHHC4;ZDHHC5;ZDHHC8;ZDHHC3
prerank,regulation of cytokinesis (GO:0032465),-0.2371355404744929,-0.9365322037923505,0.6055555555555555,0.8801633352399918,1.0,26/78,26.50%,PKP4;CDC14B;CUL3;SPAST;RAB11A;BIRC6;AHCTF1;BCL2L1;PRKCE;CDC25B;GIPC1;CIT;PLK2;CDC42;GIT1;SVIL;UVRAG;CSPP1;DRD2;ZFYVE26;PLK5;CCP110;PRPF40A;CALM3;BBS4;KIF23
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3290062271355434,0.9363666514404533,0.5754824063564131,1.0,1.0,19/101,13.37%,AGTR1;VIM;ASPH;SAMD4A;NAT10;ATG7;RPS27L;CIRBP;PYM1;AMER1;RPL5;IST1;EIF3E;RBM3;ZCCHC4;FBXW11;CPEB3;PERP;PLXNB2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.32708370367534734,-0.936348453812853,0.5755813953488372,0.8796345340489475,1.0,8/20,28.97%,WNT4;PRMT3;SIK1;WDTC1;CEACAM1;ABCA2;ASXL3;ACADVL
prerank,homeostasis of number of cells (GO:0048872),-0.38796319957663217,-0.9361383915734214,0.5677570093457944,0.8791921848650694,1.0,3/12,9.36%,NAPEPLD;NOS3;CCN3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.36764840031365487,-0.9360931278684056,0.5441860465116279,0.8783314991994565,1.0,3/13,8.50%,GKAP1;PTPN11;IGF2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.41057997965471793,0.9359627996125488,0.5310457516339869,1.0,1.0,5/20,9.57%,CHD6;VEGFA;RELA;CARF;HIF1A
prerank,protein hydroxylation (GO:0018126),0.429437528721465,0.9358499566817349,0.5113043478260869,1.0,1.0,2/15,2.85%,P3H2;ASPH
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.30962728021673414,-0.9358333241893951,0.5202492211838006,0.8779819048701761,1.0,7/26,15.91%,DAB2;FOXP1;CRY1;VPS18;PER1;CALR;CRY2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4248804536972209,0.9357931361734179,0.5484949832775919,1.0,1.0,2/16,7.78%,LYST;KIF5B
prerank,eye photoreceptor cell development (GO:0042462),0.42612218980557304,0.9349838605447444,0.5135593220338983,1.0,1.0,3/15,6.50%,CEP290;RPGRIP1L;VEGFA
prerank,cholesterol efflux (GO:0033344),-0.32725280754308583,-0.9346759806315845,0.5519125683060109,0.879862323164451,1.0,2/20,2.40%,APOE;ABCA1
prerank,regulation of neuron projection development (GO:0010975),0.320623333109543,0.934531971653064,0.5889967637540453,1.0,1.0,19/163,9.46%,RAP1A;NTRK3;PDLIM5;CAMK2G;SERPINI1;PLA2G3;ROR1;KANK1;CHN1;MARK1;PTPRS;ITM2C;KIF1A;DAB2IP;NCS1;CDH2;BRSK1;PAK2;ADCY6
prerank,purine-containing compound salvage (GO:0043101),0.44692795352594256,0.9339519133477713,0.541970802919708,1.0,1.0,2/12,6.85%,AMPD1;AMPD2
prerank,negative regulation of cellular component organization (GO:0051129),-0.2524517875955332,-0.933636305827255,0.6025641025641025,0.8814708251773066,1.0,18/74,16.78%,BMP6;DDX3X;XRCC5;EPHA3;MCTP1;HSPA5;IAPP;RDX;IRAK3;PEX5;RIOK3;SPRY2;DNAJB2;EP300;SYT11;AIDA;NOP53;CDC42
prerank,regulation of MAP kinase activity (GO:0043405),0.33017763805029826,0.9334596370998499,0.5692488262910798,1.0,1.0,21/92,14.41%,FGF1;MST1R;PDGFB;PDGFC;PDGFD;KSR1;DAB2IP;VEGFA;PTPN1;RASGRP1;CD300A;GSTP1;PDGFRB;PDGFA;PRKCD;HTR2B;CDK12;TSG101;PDCD10;LRRK2;DIRAS2
prerank,positive regulation of lipid transport (GO:0032370),-0.37465535773622666,-0.9334306589759435,0.5304740406320542,0.8810041064656476,1.0,4/12,10.54%,LRP1;APOE;SPP1;DBI
prerank,negative regulation of apoptotic process (GO:0043066),0.30486237565801744,0.9333030086997188,0.6696878147029205,1.0,1.0,51/444,9.79%,NTF3;FLNA;MEF2C;NAA38;ANGPT1;NR1H4;MERTK;ANGPT4;MYD88;TCIM;PLA2G3;PDK4;CCND2;CRLF1;ANXA1;IL2;TGFB3;ITGB1;NUP62;ARHGAP10;SET;ATAD3A;FXN;BCL2;MYO18A;MTDH;CAV1;TP53;VEGFA;GDNF;SFPQ;PA2G4;PPARGC1A;MED1;BCL2L2;YAP1;FZD9;NAT8;OPA1;SOX9;SNAI2;RELA;API5;CBX4;VDAC1;TNFAIP8;GSTP1;NR4A2;PAK2;BAG3;AXL
prerank,regulation of osteoblast differentiation (GO:0045667),0.33112877387760775,0.9332429522783047,0.5616921269095182,1.0,1.0,14/82,9.18%,MEF2C;CRIM1;LIMD1;CCN1;CDK6;FERMT2;ACVR2A;BMPR1A;YAP1;SOX9;SNAI2;TRPM4;SUCO;SKI
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3782879010065104,-0.9332270915704745,0.5749440715883669,0.8805188770269681,1.0,2/12,1.71%,FOXP1;HMGB1
prerank,establishment of mitotic spindle localization (GO:0040001),0.3853022170808103,0.9329563072212343,0.5451936872309899,1.0,1.0,8/28,17.51%,CLASP2;ITGB1;INSC;NSFL1C;FBXW11;CLASP1;DCTN1;UBXN2B
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3054749579977081,-0.9327634250804611,0.5533707865168539,0.880703782144989,1.0,3/24,3.54%,PID1;LEPR;COQ10B
prerank,negative regulation of RNA splicing (GO:0033119),-0.339725819944263,-0.9325229788627444,0.5670103092783505,0.8803486826725251,1.0,10/19,26.26%,PTBP3;SRSF7;SRSF6;RPS13;SFSWAP;RBMX;PCBP4;TMBIM6;RNPS1;SRSF12
prerank,ncRNA metabolic process (GO:0034660),0.37804521021311227,0.932374769840727,0.5552523874488404,1.0,1.0,10/37,19.44%,PARN;DTD1;MAPT;DICER1;XPO5;DROSHA;DGCR8;PIWIL2;NIFK;PRKRA
prerank,icosanoid metabolic process (GO:0006690),0.3673840225427637,0.9319750796062198,0.538787023977433,1.0,1.0,12/40,19.49%,PTGIS;ALOX5;TBXAS1;MAPKAPK2;MGLL;PTGR1;PLA2G4A;PLA2G4C;EPHX1;PON2;FAAH;ABCC10
prerank,membrane repolarization during action potential (GO:0086011),0.44641240170939234,0.9316468795845544,0.5269565217391304,1.0,1.0,2/13,5.82%,KCNE4;ATP1B1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3904082506355595,0.93132268915866,0.5302593659942363,1.0,1.0,2/26,2.53%,PRKAB2;PDK4
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.43295266700264595,0.9312589111538423,0.5268630849220104,1.0,1.0,5/13,18.84%,EDEM2;UBE2J1;SVIP;BCAP31;BRSK2
prerank,response to interferon-gamma (GO:0034341),-0.24103468777241638,-0.930585063951451,0.6,0.8842271278483059,1.0,15/67,17.93%,DAPK1;WNT5A;LGALS9;GBP7;CXCL16;SP100;SIRPA;CX3CL1;GBP4;SNCA;GCH1;BST2;IFITM1;SHFL;IFITM3
prerank,defense response to Gram-positive bacterium (GO:0050830),0.36903933330331534,0.9303442034572001,0.5513157894736842,1.0,1.0,10/40,16.53%,MYD88;DMBT1;RARRES2;MBL2;ADAM17;GBP2;DROSHA;RNASE3;MR1;MPEG1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3414098730790073,-0.9302440611570292,0.5634517766497462,0.8841322831161589,1.0,7/18,15.32%,DCN;MCU;PRKN;DDHD1;RALBP1;KDR;FIS1
prerank,proteolysis (GO:0006508),0.3090360426607265,0.9301881703188344,0.6251276813074566,1.0,1.0,34/252,14.95%,TMPRSS4;TINAGL1;MMP17;PAPPA2;PGPEP1L;HTRA1;LNPEP;RNPEP;APEH;AFG3L2;TRABD2B;CPA4;CPA3;ENPEP;ADAM17;LONP1;CAPN2;MIPEP;FBXO6;MBTPS1;ATG4D;LONP2;PHEX;RSPRY1;UBA3;DDI2;ATG4A;DPP8;SENP6;HM13;SPPL2B;ADAM19;PCSK4;CTSA
prerank,regulation of nuclear division (GO:0051783),0.4115877138482632,0.9301603713928025,0.5609756097560976,1.0,1.0,6/20,15.41%,PIN1;CUL9;DAPK3;KIF20B;FBXO5;CAV2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4344197158968915,0.929905435267133,0.5573770491803278,1.0,1.0,5/15,12.51%,BTG2;POLR2G;TENT4A;CNOT7;CPEB3
prerank,positive regulation of immune system process (GO:0002684),0.4199438102210479,0.9298475370311658,0.5457570715474209,1.0,1.0,3/16,7.86%,ANXA1;VEGFA;TGFB2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.41440021904538593,0.9297819241132047,0.5441640378548895,1.0,1.0,5/19,11.11%,VIM;TGFB3;EMILIN1;SUCO;RUNX1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.346675345442877,0.9296663128202741,0.5655430711610487,1.0,1.0,7/61,7.60%,ABRA;GPR20;SYNPO2L;NET1;MAPRE2;RASGRP1;GPR17
prerank,regulation of trophoblast cell migration (GO:1901163),-0.3683355731210338,-0.929216361051722,0.5567567567567567,0.8856018276056369,1.0,5/14,19.47%,GJA1;SMURF2;ARHGDIB;CALR;YTHDF3
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3132659135670927,0.9292063502753258,0.5928338762214984,1.0,1.0,21/150,10.78%,ANGPT1;FGF1;HIP1;MST1R;PDGFB;FERMT2;SEMA5A;THPO;ITGB1;GCNT2;MFHAS1;MTDH;PIK3AP1;IRS1;AREG;THEM4;AXL;PDGFRB;HBEGF;PDGFA;VAV1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.32825176663118855,0.929187619954852,0.5831460674157304,1.0,1.0,18/117,10.96%,CKM;CD36;CKMT2;MCCC2;LPL;FA2H;ME3;DLD;CPT1B;MECR;GOT2;PPARA;VDAC1;AASDHPPT;THEM4;SCP2;AOAH;PTGR1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.32315367017634883,-0.9289298720731061,0.5388739946380697,0.8853386865212017,1.0,13/20,31.69%,HOXA5;PTK2B;CTR9;MEIS2;LEO1;HSPA9;HOXB8;HOXA9;MAFB;ZFP36;CIB1;LDB1;MEIS1
prerank,negative regulation of bone mineralization (GO:0030502),-0.36409753230655817,-0.9285976908149974,0.553921568627451,0.8852157765160009,1.0,7/13,34.94%,PTK2B;SRGN;ENPP1;BCOR;RFLNA;RFLNB;GREM1
prerank,positive regulation of kinase activity (GO:0033674),0.31952611635979783,0.9285301413058912,0.5785797438882422,1.0,1.0,14/107,10.07%,RAP1A;NTRK3;MERTK;MST1R;CCN1;ROR1;MMD;MUSK;MAPT;LCP2;EPHA2;AXL;CENPE;PDGFRB
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4544923055427717,0.9282744513709531,0.5256410256410257,1.0,1.0,3/10,12.36%,TERT;DICER1;DROSHA
prerank,cellular response to ionizing radiation (GO:0071479),0.3612688321797006,0.9282145862086252,0.5723771580345286,1.0,1.0,6/47,7.61%,MAP3K20;NET1;RAD51AP1;TP53;YAP1;RAD9A
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4081500627085683,0.9274431337610212,0.5463108320251178,1.0,1.0,8/22,18.76%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;CLIP3;ZDHHC4;ZDHHC8;ZDHHC3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4081500627085683,0.9274431337610212,0.5463108320251178,1.0,1.0,8/22,18.76%,GOLGA7B;ZDHHC2;ZDHHC1;ZDHHC14;CLIP3;ZDHHC4;ZDHHC8;ZDHHC3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.32083727754438335,-0.927334661956042,0.5929919137466307,0.8873793515617753,1.0,8/21,24.28%,RAB11A;VPS4B;RCC2;CDC25B;CDC25A;MECP2;CDC7;RAD51C
prerank,bile acid metabolic process (GO:0008206),0.391713116811997,0.9267988443497529,0.5465465465465466,1.0,1.0,5/27,11.78%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.45304511526501495,0.9267574993858495,0.5573192239858906,1.0,1.0,3/12,12.38%,ROCK1;ROCK2;CHRNA7
prerank,UV-damage excision repair (GO:0070914),-0.38299650556410714,-0.9265957353665628,0.5800970873786407,0.8882040764827013,1.0,7/12,41.62%,DDB1;XPA;ACTR5;ERCC1;POLD3;XPC;POLA1
prerank,regulation of gene silencing by RNA (GO:0060966),0.3511828154680062,0.9264414756872047,0.564875491480996,1.0,1.0,18/50,21.18%,POLR2L;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;AGO1;TPR;H3-3A
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3511828154680062,0.9264414756872047,0.564875491480996,1.0,1.0,18/50,21.18%,POLR2L;POLR2I;NUP62;POLR2G;SEC13;NUP153;NUP107;AAAS;POLR2J;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;AGO1;TPR;H3-3A
prerank,alanine transport (GO:0032328),0.462722399027355,0.9264166096721879,0.5632582322357019,1.0,1.0,1/10,2.28%,SLC6A17
prerank,in utero embryonic development (GO:0001701),-0.30718935834283784,-0.9262206519321179,0.5714285714285714,0.8881170902370962,1.0,7/25,11.77%,CHD7;ARNT2;ADAM10;FUT8;IGF2;FGFR2;TGFBR1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.3363141604281293,-0.9259681363566707,0.550251256281407,0.8877586538062894,1.0,4/16,10.15%,BMPR2;PLCB3;DDAH1;ACE
prerank,mitochondrial protein processing (GO:0034982),0.45161447235701635,0.9253857836488508,0.514336917562724,1.0,1.0,6/11,18.38%,AFG3L2;MIPEP;PMPCB;PMPCA;ATP23;IMMP1L
prerank,synaptic vesicle transport (GO:0048489),0.45837001167624447,0.9251996519919293,0.547576301615799,1.0,1.0,6/11,21.95%,KIF5B;KIF5C;KIF5A;DNM2;SNAPIN;SYNJ1
prerank,regulation of platelet activation (GO:0010543),0.4005249732124502,0.92508085797857,0.5536,1.0,1.0,7/21,14.87%,PDGFB;PRKCQ;PLEK;C1QTNF1;PDGFA;PLA2G4A;PRKCA
prerank,positive regulation of ERAD pathway (GO:1904294),-0.36684082801601425,-0.9245528550440647,0.5298329355608592,0.8902083138546686,1.0,7/13,19.17%,ATXN3;RNF185;UBQLN1;SGTA;UBQLN2;HERPUD1;RNFT1
prerank,7-methylguanosine RNA capping (GO:0009452),0.3783680490132299,0.9243341985328702,0.5652173913043478,1.0,1.0,5/31,9.52%,POLR2L;POLR2I;GTF2H4;POLR2G;CDK7
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3783680490132299,0.9243341985328702,0.5652173913043478,1.0,1.0,5/31,9.52%,POLR2L;POLR2I;GTF2H4;POLR2G;CDK7
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.29661043089594125,-0.9240098135079018,0.617737003058104,0.8905715927359428,1.0,5/30,5.55%,NIBAN2;DACH1;ACVRL1;STN1;BMPR2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.40036783395102404,-0.9234290460975978,0.5429184549356223,0.890958457925448,1.0,3/10,15.23%,ENPP2;PLA2G6;PLA2G7
prerank,double-strand break repair (GO:0006302),-0.2074839545916207,-0.9231926850430812,0.7384615384615385,0.8905702857170723,1.0,55/158,28.16%,EYA1;HMGB1;KDM2A;PRKDC;XRCC5;TDP2;MRE11;RAD50;PARP3;ACTR8;FBH1;HERC2;ERCC5;XRCC1;FAN1;SAMHD1;BRCC3;SETX;LIG3;MDC1;POLM;BLM;XRCC6;DTX3L;NBN;RMI1;SMC5;UBXN1;MMS22L;ZSWIM7;HUS1;POLN;KDM4D;CHEK2;ATM;DCLRE1A;IFFO1;ACTR5;NSMCE2;PRPF19;ZFYVE26;SMARCAL1;NSMCE1;NUCKS1;RAD51C;ERCC1;ERCC4;AP5Z1;DCLRE1B;MAPK8;HMGB2;RPA3;DNA2;CYREN;XRCC2
prerank,positive regulation of cell projection organization (GO:0031346),0.3259375724678632,0.9229179373265461,0.5781071835803877,1.0,1.0,9/115,3.34%,RAP1A;NTRK3;SERPINI1;PLA2G3;PLXND1;ROR1;SS18L2;PLXNB1;FZD4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.4008497512541785,0.9226858436033196,0.5370370370370371,1.0,1.0,5/19,17.10%,IRS1;PPARA;PRKCD;IRS2;MTLN
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.38573475593386997,0.9225803260789031,0.540785498489426,1.0,1.0,4/27,4.86%,DLC1;PHLDB2;CLASP2;ARHGAP6
prerank,mitochondrion organization (GO:0007005),0.310931285861322,0.9223862308637196,0.6125265392781316,1.0,1.0,54/165,21.24%,ATP2A1;HSD17B10;GABPA;HK2;SIRT3;ATAD3A;NDUFS1;COX7A2L;MEF2A;AFG3L2;TERT;PARP1;PPARGC1A;OPA1;MTX1;MIEF2;MIEF1;TRAK1;ATCAY;LONP1;DNM1L;TFB2M;MFN2;ESRRA;MUL1;SIRT4;ADCK1;USP30;LRRK2;CAV2;DNM2;RHOT1;MGME1;TOMM5;ATP23;RAB38;BCAP31;MFF;TOMM7;ATP5F1D;GABPB1;AGTPBP1;VPS13C;PPRC1;HIGD2A;MTX3;PHB2;MFN1;SLC25A33;CLUH;BIK;TIMM9;TIMM22;OXA1L
prerank,neurotransmitter transport (GO:0006836),0.3331912739647821,0.9222282321202028,0.5721212121212121,1.0,1.0,15/73,14.51%,STXBP2;APBA1;SLC6A2;SLC38A2;RAB3A;LIN7C;BRSK1;HRH3;GLS2;GLS;SLC6A15;SLC29A1;PPFIA3;SLC38A1;DVL1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.2935851930107528,-0.9220162408738001,0.5773809523809523,0.8925516598361162,1.0,13/29,30.92%,RPS19;RRP36;RPS8;RPS21;TSR2;NOP9;DCAF13;UTP20;HEATR1;UTP6;MRPS11;RRS1;TBL3
prerank,DNA recombination (GO:0006310),-0.27860324393431807,-0.9218475794126202,0.6040268456375839,0.8919566814650759,1.0,17/37,37.93%,HMGB1;MRE11;RAD50;FBH1;BLM;RAD51C;IGHMBP2;ERCC1;TSN;XRCC2;RAD54L;RPAIN;RAD51;LIG4;RPA1;HDAC10;GEN1
prerank,negative regulation of response to external stimulus (GO:0032102),0.3231804561604225,0.9213908800527616,0.5764840182648402,1.0,1.0,18/105,11.28%,NR1H4;RORA;FEM1A;PTGIS;ALOX5;MFHAS1;PTPRS;TNFAIP6;DUSP3;AJAP1;LPCAT3;PPARA;NR1D1;SIRT2;AOAH;GPER1;RB1;PRKCD
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.39651723764772384,0.9213446156705494,0.5678233438485805,1.0,1.0,8/24,9.57%,MMRN2;EMILIN1;EPN2;DAB2IP;PTPN1;NEDD4;ITGB3;HIF1A
prerank,regulation of lipid storage (GO:0010883),0.4008308716827334,0.9212171006286443,0.531055900621118,1.0,1.0,4/22,8.00%,LPL;FBXW7;ITGB3;FTO
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.21617297626656598,-0.9211054130317482,0.7068965517241379,0.8928117869932608,1.0,30/110,21.02%,CDH5;APOE;ABCA1;DDX3X;HJURP;PTPN11;STXBP1;HSPA5;IAPP;SLF2;PEX5;HCFC1;ICE1;TGFB1;RIOK3;SLF1;IRGM;EP300;AIDA;NOP53;MMP1;CDC42;BAX;RALB;HSF1;PARK7;TIRAP;AJUBA;BID;KIF9
prerank,cellular response to alcohol (GO:0097306),-0.2675903949713023,-0.9204110053340597,0.6007751937984496,0.8935335846794069,1.0,14/42,18.13%,PTCH1;GRAMD1C;CDH1;ADCY7;CTNNB1;ADAM15;ADCY1;GOLPH3;AHR;GLRA2;BLM;GRAMD1A;ADCY3;PTGFR
prerank,response to zinc ion (GO:0010043),0.3887482339745878,0.9201402416749503,0.5560675883256528,1.0,1.0,2/25,3.50%,CRIP1;D2HGDH
prerank,regulation of steroid biosynthetic process (GO:0050810),0.45058792327561586,0.9199501542463684,0.545,1.0,1.0,1/11,1.64%,NR1H4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3956975268445,-0.9196221041938003,0.5868131868131868,0.8944692590855425,1.0,4/10,9.36%,WNK1;ACER2;CYP1B1;PDE3B
prerank,negative regulation of neuron projection development (GO:0010977),-0.25488156709310444,-0.9193825210404503,0.6135265700483091,0.8940912660458995,1.0,19/56,27.09%,EFNB2;LPAR1;APOE;EPHA4;NLGN1;RUFY3;SEMA3A;DPYSL3;RTN4;RAB29;CBFA2T2;HDAC2;PRAG1;PTPRO;EFNB3;PTPN9;BAG5;THY1;DENND5A
prerank,pulmonary valve morphogenesis (GO:0003184),0.42187272352738076,0.9193702690639305,0.5669291338582677,1.0,1.0,4/17,7.86%,HEY2;HEYL;JAG1;TGFB2
prerank,regulation of tissue remodeling (GO:0034103),-0.32920682200419005,-0.9193237798595537,0.57,0.8932637845640183,1.0,3/18,3.27%,LEPR;IL15;IL18
prerank,neutrophil degranulation (GO:0043312),0.29988006912510307,0.9188791363732614,0.683,1.0,1.0,67/425,14.95%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,negative regulation of gene expression (GO:0010629),0.30135217437695516,0.9184854169301722,0.6298568507157464,1.0,1.0,44/302,12.63%,CCDC3;MEF2C;ATP2B4;HEY2;PDGFB;PLA2G3;HINFP;IGFBP5;SAMD4A;MRPL13;BTG2;HDAC9;RBMS3;ASB1;HAVCR2;BMPR1A;EMILIN1;TAF1;MAPT;TERT;SLC2A10;VEGFA;FBXW7;YTHDF2;CELF1;YAP1;DICER1;TGFB2;ATP2B1;DAPK3;DIS3L2;MAP2K1;HIF1A;PTBP2;EIF2AK2;GPER1;ROCK2;RUNX1;RB1;TERF2;CNOT7;CITED2;CPEB3;PDCD10
prerank,regulation of amyloid-beta formation (GO:1902003),0.3711985489020041,0.9169408923332126,0.5426008968609866,1.0,1.0,9/34,12.48%,ROCK1;RTN2;PIN1;RTN1;RELA;ROCK2;ABCG1;CHRNA7;CLU
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24878647894115777,-0.9168913586591991,0.6435643564356436,0.8981472521685059,1.0,19/59,16.93%,NFKBIA;BIRC2;TNFRSF1A;NKIRAS1;IKBKG;RBCK1;TAB2;RNF31;IRAK1BP1;IRAK2;UBC;CHUK;TAB1;FAIM;BIRC3;RELB;AKT1;TLR3;PRDX4
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3253313051845773,0.9168743558570496,0.5764294049008168,1.0,1.0,13/85,7.86%,ANGPT1;FGF1;LIMS1;CDK6;NR4A1;OSR2;PEX2;DAB2IP;VEGFA;LAMC1;YAP1;SOX9;TGFB2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.3902498841162486,0.9167452761584264,0.555886736214605,1.0,1.0,11/27,20.45%,PDGFB;PDGFC;CDK6;S100A6;PDGFA;GAS6;DHX9;MIF;AGT;NDUFS4;DDR2
prerank,neutrophil activation involved in immune response (GO:0002283),0.29894272701404045,0.9163999799623359,0.687,1.0,1.0,67/428,14.95%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3058919517300979,-0.9162784290793478,0.5694050991501416,0.8986309053322384,1.0,13/25,29.00%,EPHA4;PML;HSP90AB1;SGTA;OPHN1;GABARAPL2;RPS7;RPL11;TRIM39;CSNK2A2;CSNK2A1;HFE;PSMF1
prerank,regulation of response to external stimulus (GO:0032101),0.31938658801126013,0.916096607095326,0.58,1.0,1.0,17/121,9.93%,AGTR1;CD36;MYD88;ANXA1;ALOX5;ELMOD2;SAG;SETD6;PIK3AP1;CAV1;CALM1;TRAF3;CELF1;RELA;MGLL;AKNA;STK24
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3102985734334313,0.9160059171948234,0.6290491118077325,1.0,1.0,38/175,17.39%,ACTN4;LIMS1;TNFSF13B;CCL5;ARHGEF2;HAS2;TNFRSF11A;PSMC6;DAB2IP;TP53;TRAF3;RELA;ADAM17;NR1D1;PSME4;EDAR;TRAF5;PSMB1;CCL14;PSMD5;EIF5A;GPER1;TNFRSF21;ZFAND6;TNFRSF25;GBP2;PSMB2;ZFP36L1;TMSB4X;HYAL1;PSMB7;PSMD3;STAT1;JAK2;PSMA2;DHX9;PSMD14;TNFSF12
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.22006707394047137,-0.915914929806671,0.7448979591836735,0.8985353360106786,1.0,21/109,14.23%,NFATC3;GAB2;PIK3CA;GRB2;PDPK1;VAV2;PLCG2;PIK3CB;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;PSMA5;PSMA1;PSMC2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.20930615752275553,-0.9157537933939559,0.7228915662650602,0.8979650105692929,1.0,28/149,13.39%,PRKCB;EDA;APP;PRKCH;IL18;WNT5A;NOD1;NFKBIA;LGALS9;IRAK1;RNF25;IRAK3;SLCO3A1;IKBKG;RBCK1;TRIM25;TAB2;RNF31;ALK;IRAK2;UBC;TRIM5;CHUK;CARD14;TRIM14;CX3CL1;TAB1;EP300
prerank,mRNA 3'-end processing (GO:0031124),-0.23358413697686045,-0.9157371108778272,0.6405228758169934,0.8970391275034115,1.0,35/78,32.19%,THOC2;APP;PABPN1;SRSF7;SRSF6;SRSF11;SRSF5;POLDIP3;SLBP;PABPC1;THOC5;SRSF2;LEO1;NCBP2;CHTOP;PAPOLG;SRSF3;CPSF2;SARNP;SCAF8;CPSF6;CSTF2T;SSU72;CPSF4;RNPS1;DHX38;ALYREF;CSTF2;CPSF1;LSM11;CLP1;POLR2D;PAPOLB;SLU7;DDX39A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.43460006128244943,0.9156091473328075,0.5407801418439716,1.0,1.0,2/12,6.25%,ATP2B4;DAB2IP
prerank,synaptic membrane adhesion (GO:0099560),0.43176842657503156,0.9155823804428006,0.5652920962199313,1.0,1.0,3/14,6.09%,PTPRS;GPC4;PTPRF
prerank,natural killer cell activation (GO:0030101),0.3942849033437164,0.9155773227545305,0.5598159509202454,1.0,1.0,4/23,9.79%,IL2;RASGRP1;KAT7;AXL
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.3899470877022952,-0.9154892603780626,0.6031390134529148,0.8966056074263999,1.0,5/10,18.55%,GHR;LYN;PRLR;STAT5A;STAT6
prerank,chromatin organization (GO:0006325),0.31763456119016226,0.9151812778166696,0.6050884955752213,1.0,1.0,18/132,12.71%,PRDM16;PADI3;SMARCD3;LOXL2;PADI2;CHRAC1;ARID1A;SUV39H2;SMARCB1;HMGN3;INO80C;SOX9;MCM3AP;RB1;BAZ2A;ZBTB7A;RUVBL1;SMARCA5
prerank,positive regulation of phospholipid transport (GO:2001140),0.45116609989995177,0.9149984772837453,0.55765595463138,1.0,1.0,2/10,6.65%,ABCB4;ABCA3
prerank,clathrin-dependent endocytosis (GO:0072583),-0.300751078997206,-0.9143174662523136,0.5789473684210527,0.8984442220048576,1.0,9/26,19.15%,FCHO2;DNAJC6;FNBP1L;CANX;AP2S1;LMBRD1;CLTB;AP2A2;CLTA
prerank,positive regulation of establishment of protein localization (GO:1904951),0.4062137489949984,0.9142264259437191,0.567741935483871,1.0,1.0,3/18,12.24%,PTP4A3;CCT3;CEP120
prerank,cellular senescence (GO:0090398),0.3869699240745796,0.91421846133623,0.5588673621460507,1.0,1.0,5/27,11.53%,TBX2;OPA1;MAP2K1;PRKCD;TERF2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.41978062140803796,0.9139622768592126,0.5718701700154559,1.0,1.0,3/19,5.63%,NR1H4;CD14;PIK3AP1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.33548384908684314,-0.9139232416345442,0.5756097560975609,0.8984111615604908,1.0,6/17,12.59%,FSTL1;SULF1;SLIT2;TMEM204;SFRP4;CASK
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.45355761991371857,0.913714614231556,0.5586690017513135,1.0,1.0,2/11,5.51%,CCL5;PRKCQ
prerank,zinc ion transport (GO:0006829),-0.3211755094649269,-0.9134969880153213,0.6011080332409973,0.8985079285029355,1.0,6/21,15.28%,SLC30A10;SLC39A11;SLC39A8;SLC30A1;SLC39A1;SLC39A6
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3553974156290411,-0.9134738402721368,0.5756097560975609,0.8975977511807597,1.0,7/14,23.72%,BCL2L1;PRKN;CREB3L1;SYVN1;HERPUD1;PARK7;TMBIM6
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.38365633814737493,-0.9132381432436765,0.5677570093457944,0.8971961235455657,1.0,6/11,37.30%,STX4;CAMK4;TYROBP;ITGB2;SPI1;ITGAM
prerank,establishment of vesicle localization (GO:0051650),-0.32951272152672817,-0.9130731134380047,0.5846994535519126,0.896667270625326,1.0,6/18,14.71%,LIMK2;RAB11A;TMEM230;CCDC186;IKBKG;SYT11
prerank,negative regulation of transferase activity (GO:0051348),0.37321338021313083,0.9123330220966309,0.5522388059701493,1.0,1.0,9/28,19.07%,MAPT;TP53;CERS1;NPRL2;HNRNPU;IRS2;FBXO5;MEN1;ABL1
prerank,monocyte differentiation (GO:0030224),-0.3948670679204613,-0.9122782839626963,0.576017130620985,0.8976485760638933,1.0,6/10,17.76%,IL31RA;PIR;BMP4;THOC5;PPARG;MT1G
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.32806699005498174,-0.9117480778520849,0.5858585858585859,0.8979624179610786,1.0,4/18,12.58%,ATP1A2;NEDD4L;COMMD1;SLC43A2
prerank,brain development (GO:0007420),0.31137088744309455,0.9116644965011853,0.6026058631921825,1.0,1.0,13/136,10.44%,SOX6;COL4A1;ZFHX3;CLN5;SLC6A17;GRIN2C;ATXN1;SYNJ2;EML1;SLC23A1;CDH2;ADGRL2;SCYL2
prerank,negative regulation of angiogenesis (GO:0016525),0.32545133928322684,0.9111960244352221,0.6144018583042973,1.0,1.0,10/84,7.86%,COL4A2;ATP2B4;ROCK1;ANGPT4;ALOX5;EMILIN1;EPN2;DAB2IP;YJEFN3;TGFB2
prerank,ATP transport (GO:0015867),-0.3949546586619844,-0.9111336918285461,0.6099137931034483,0.8985034024590044,1.0,4/10,35.76%,SLC25A17;SLC25A24;SLC17A9;SLC25A4
prerank,ncRNA processing (GO:0034470),-0.20073200562575272,-0.9107924494994605,0.782608695652174,0.8983630279737566,1.0,77/200,30.28%,SMAD3;AGO3;INTS6;RPL27A;SRRT;RPS19;SENP3;NVL;RPL21;RPS24;RPL36;RPL18;METTL3;INTS3;SSB;POP1;RPLP0;DIS3;C1D;EXOSC1;RPL28;WDR3;RPLP1;INTS2;RPL23A;RPL34;RRP36;MPHOSPH10;FCF1;ADAR;EXOSC9;RPL36A;NOP53;SMAD2;AARS1;TUT4;RPL9;DDX52;RPS7;RPL27;TUT7;RPL11;RPL18A;RPL37A;RPL38;RRP7A;EMG1;DCAF13;RPL29;EXOSC2;EBNA1BP2;UTP20;RPL10A;INTS11;RPL32;BYSL;NOL11;NOP56;EXOSC7;EXOSC3;UTP18;RPS27;HEATR1;NOLC1;IMP3;WDR18;EXOSC5;PIH1D1;AGO4;PES1;RPL4;UTP6;FBL;RPS15;RPL35A;NOL8;POP4
prerank,negative regulation of telomere maintenance (GO:0032205),-0.34555555900362833,-0.9106187092295708,0.5781990521327014,0.8978032714179426,1.0,8/15,24.63%,TNKS2;RAD50;NBN;TERF2IP;SMG6;ATM;ERCC1;ERCC4
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.2876243155430463,-0.9105295319894181,0.5808580858085809,0.8970675279791033,1.0,7/30,10.30%,MLLT3;FLT1;BMP4;KIT;HOXB4;ACE;TGFB1
prerank,tRNA 5'-leader removal (GO:0001682),-0.36162558727989225,-0.9102015831596397,0.5967741935483871,0.8969066896668628,1.0,7/13,43.56%,SSB;POP1;POP4;RPP38;RPP21;RPP25L;POP7
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.32755272759971177,0.910158986812931,0.5921052631578947,1.0,1.0,32/82,23.06%,DYNLL1;CEP41;HAUS8;CEP290;TP53;TPX2;CEP192;DYNC1I2;NEDD1;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;PLK4;DCTN1;HAUS4;CEP135;CKAP5;ACTR1A;SFI1;MAPRE1;ODF2;PPP2R1A;NINL;TUBA4A;CEP63;YWHAG;NDE1
prerank,cellular response to hypoxia (GO:0071456),0.31164179379890455,0.9100303474431045,0.6291759465478842,1.0,1.0,19/126,10.53%,PMAIP1;LIMD1;ANGPT4;RORA;PTGIS;CUL2;SUV39H2;PSMC6;NDRG1;ELOC;TERT;TP53;CPEB1;VEGFA;HIF1A;PSME4;SIRT2;PSMB1;PSMD5
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.24184733272454403,-0.9100221135445332,0.6234567901234568,0.896391345765774,1.0,13/66,8.81%,APPL2;KMT2E;DLG1;DDX3X;CCND3;EGFR;DCUN1D3;ADAMTS1;PKD2;TFDP1;PRMT2;RDX;UBE2E2
prerank,long-chain fatty acid import into cell (GO:0044539),0.4527766200346709,0.9096787311805975,0.5850091407678245,1.0,1.0,1/10,1.72%,CD36
prerank,regulation of organelle assembly (GO:1902115),-0.23878262030788153,-0.9091627635112774,0.6467391304347826,0.8974740779866525,1.0,30/72,25.61%,TBC1D16;RAB5A;TBC1D15;DCDC2;NPRL3;ATG3;TBC1D2B;TBC1D13;TBC1D5;RDX;TBC1D8;IFT88;ATG5;TBC1D9B;RABEP2;TBC1D24;TBC1D22A;PLK2;UBQLN2;SGSM3;DYNLT2B;RAB1B;TBC1D10A;SDCCAG8;KIF9;TBC1D14;CYLD;TBC1D2;CEP76;CDKL1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.43979654198310114,0.9090859691306368,0.5454545454545454,1.0,1.0,3/12,7.68%,VEGFA;GDNF;SOX9
prerank,response to iron ion (GO:0010039),-0.3642489284388642,-0.9088788406489561,0.5784543325526932,0.8971331661023453,1.0,4/12,14.15%,BMP6;B2M;ACO1;SNCA
prerank,lysosome organization (GO:0007040),0.3609144021873901,0.9088766048169044,0.5734072022160664,1.0,1.0,9/36,14.40%,CLN5;HOOK2;ACP3;CLVS1;HOOK1;MBTPS1;AKTIP;HPS4;LRRK2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.36937102475437233,-0.908817727612129,0.5932642487046632,0.8944712439278334,1.0,6/12,29.25%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.36937102475437233,-0.908817727612129,0.5932642487046632,0.8944712439278334,1.0,6/12,29.25%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.36937102475437233,-0.908817727612129,0.5932642487046632,0.8944712439278334,1.0,6/12,29.25%,CUL3;CDC23;ANAPC4;NSMCE2;CDC16;CDC27
prerank,carbohydrate transport (GO:0008643),0.4359830442483306,0.9084278377591678,0.5688729874776386,1.0,1.0,2/11,8.03%,SLC23A2;SLC23A1
prerank,cell cycle G1/S phase transition (GO:0044843),0.33916076175370724,0.9084043843442234,0.5813953488372093,1.0,1.0,11/61,11.73%,CCNA2;CDK6;HINFP;EIF4EBP1;CUL2;CCND1;CDK7;CRLF3;RB1;GSPT1;ACVR1B
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4021910837824232,-0.908391849654922,0.6119733924611973,0.8945382617680634,1.0,5/10,14.45%,NEDD4L;PRKCE;COMMD1;OSR1;HECW1
prerank,negative regulation of synaptic transmission (GO:0050805),-0.31172576071258384,-0.9083193594831303,0.5797101449275363,0.8937968586574274,1.0,10/23,27.32%,STXBP1;GRIK3;SLC30A1;PRRT1;SYT11;PLK2;PICK1;DRD2;MTMR2;SLC24A2
prerank,regulation of angiogenesis (GO:0045765),0.30163838287863015,0.9082898864500695,0.6460084033613446,1.0,1.0,22/192,7.86%,COL4A2;ATP2B4;ROCK1;FGF1;ANGPT4;HSPB6;SEMA5A;PLXND1;HK2;STIM1;ITGB1;PTGIS;ALOX5;EMILIN1;MTDH;DAB2IP;RRAS;VEGFA;RHOJ;YJEFN3;BTG1;TGFB2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.36627504198817284,-0.9082428308078854,0.5649202733485194,0.8930471379354046,1.0,4/12,17.42%,GNL3;CCT8;CCT4;WRAP53
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.2969315499681346,-0.9081525053145446,0.5867052023121387,0.8923248916723107,1.0,12/27,26.05%,NIBAN2;DACH1;ACVRL1;BMPR2;RGCC;FGF2;SMG6;ATM;FGFR4;CDKN1A;PARP4;PRKD2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.3620889249439204,0.9081495646663177,0.5822784810126582,1.0,1.0,8/34,12.90%,MFHAS1;PTPRS;CD14;DAB2IP;CD300A;NR1D1;OTUD4;SARM1
prerank,neutrophil mediated immunity (GO:0002446),0.2967193802261403,0.9076801175686723,0.7187187187187187,1.0,1.0,68/432,14.95%,TTR;STXBP2;RAP1A;DYNLL1;VCL;ROCK1;CD36;FCGR3B;CNN2;ANO6;FRK;AGL;PADI2;ACP3;UNC13D;HMOX2;ALOX5;PLEKHO2;PYGB;CRISPLD2;CD14;CEP290;BRI3;ATG7;APEH;TNFAIP6;RAP2C;RAB3A;CYFIP1;PA2G4;HEBP2;CAP1;IGF2R;GLA;PRG2;STOM;STBD1;CD300A;DDOST;RHOF;ADAM17;GSTP1;GCA;PPIE;IST1;PSMB1;ALDOA;DGAT1;PRKCD;YPEL5;VPS35L;TRPM2;GM2A;CPNE3;DNAJC3;DNASE1L1;CFP;STK10;MAPK1;CD53;RAB14;GDI2;CYB5R3;PSMB7;PSMD3;CPPED1;GLB1;CTSA
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2676408367700746,-0.9076086156225833,0.6401515151515151,0.8926562988472234,1.0,17/41,25.60%,ITCH;RNF135;PELI1;UBE2E2;UBE2E3;PRKN;TRIM5;STUB1;RNF115;TRIM56;UBE2S;PRPF19;UBE2B;HECTD1;TRIM21;PELI3;UBE2O
prerank,fatty acid oxidation (GO:0019395),0.3378746204287981,0.907514960861518,0.5788113695090439,1.0,1.0,11/57,10.20%,HSD17B10;PEX2;HSD17B4;PPARGC1A;ACAD11;MECR;ABCD4;ACADS;ACAD10;HADHB;SCP2
prerank,negative regulation of immune effector process (GO:0002698),-0.3595332004796087,-0.9067843381206603,0.5829493087557603,0.8936380621011566,1.0,5/13,16.89%,RPS19;CD55;ENPP3;APPL1;GRN
prerank,RNA metabolic process (GO:0016070),0.31179134898056404,0.9063445353969452,0.6150442477876106,1.0,1.0,23/127,13.07%,RBPMS;LSM8;POLR2L;POLR2I;HNRNPR;PARN;ATXN1;POLR2G;ATXN2;DICER1;FTO;FASTKD1;PAPOLA;DEDD2;DHX8;HNRNPU;PRPF4;RBM3;HNRNPC;RBM6;DROSHA;POLR2J;PCBP3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.34362958697158885,0.9062483203876159,0.5889724310776943,1.0,1.0,19/56,21.64%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;NDUFA1;NDUFAF2;NDUFAF1;NDUFV3;NDUFS4;OXA1L;NDUFA3;NDUFAF6
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.34362958697158885,0.9062483203876159,0.5889724310776943,1.0,1.0,19/56,21.64%,NDUFS1;NDUFA11;NDUFA2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;NDUFA1;NDUFAF2;NDUFAF1;NDUFV3;NDUFS4;OXA1L;NDUFA3;NDUFAF6
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.4126615272687633,0.9060011299045723,0.583732057416268,1.0,1.0,6/16,17.30%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4048715630168804,0.9059451695518113,0.5668789808917197,1.0,1.0,4/21,9.35%,NDST3;EXT2;HS2ST1;HS6ST1
prerank,regulation of T cell differentiation (GO:0045580),0.36913927618293246,0.9059231398560251,0.5726256983240223,1.0,1.0,5/33,11.36%,IL2;PRDM1;CBFB;RUNX1;RHOH
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3729582366526082,0.9057402951315358,0.5631349782293179,1.0,1.0,5/29,7.96%,DCUN1D2;FEM1A;FBXW7;PIN1;DCUN1D1
prerank,neuropeptide signaling pathway (GO:0007218),0.34229226108502075,0.9052775852600926,0.5643939393939394,1.0,1.0,3/58,5.49%,HCRTR1;SORT1;CYSLTR2
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.3241378184595203,-0.904921593055685,0.6065989847715736,0.8971503976544435,1.0,14/18,47.13%,LIG3;GINS3;LIG1;RFC3;GINS4;POLD3;GINS1;POLE;RFC4;MCM3;POLE3;POLA1;POLD2;GINS2
prerank,transport across blood-brain barrier (GO:0150104),0.32128283352945036,0.9045575232074249,0.5978391356542617,1.0,1.0,12/83,6.97%,ATP2B4;SLC2A4;CD36;SLC6A17;SLC16A7;SLC8A2;SLC5A3;SLC4A8;SLC38A2;SLC4A3;SLC2A10;SLC44A1
prerank,protein localization to condensed chromosome (GO:1903083),-0.3707492503806874,-0.9038006822316926,0.6051401869158879,0.8988487836053387,1.0,10/12,55.30%,IK;BUB3;ZWILCH;KNL1;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,small GTPase mediated signal transduction (GO:0007264),0.32326939469529226,0.9037127355926255,0.6147635524798154,1.0,1.0,22/103,14.16%,ABR;PLCE1;CCNA2;RASGRP2;RRAD;RERG;NTN1;KSR1;NUCB1;TP53;RRAS;RAPGEF6;RASGRP1;RIN2;ARHGAP30;ARHGAP1;RB1;USP50;BCR;ARHGAP32;TRIM28;G3BP1
prerank,protein maturation (GO:0051604),0.32054731907389156,0.9033224737824591,0.6105990783410138,1.0,1.0,17/95,15.35%,TMPRSS4;TSPAN32;TESC;AFG3L2;ISCA1;ADAM17;LONP2;PHEX;NDUFAB1;GALNT2;DDI2;TSPAN17;ADAM19;PCSK4;NAA35;GLRX3;CIAO1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2934436609862622,0.9023768530448979,0.785,1.0,1.0,124/807,13.60%,FLNA;PRDM16;MYOZ2;HJV;MEF2C;HEY2;ZFHX3;TBX2;LBH;NR1H4;LIMS1;LIMD1;PDGFB;ZEB2;NAB1;EDNRB;ATP8B1;MLIP;ID4;FST;FRK;LOXL2;ETS2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;GMNN;ZNF436;H1-0;RBAK;NACC2;PRDM1;HDAC9;SET;NR2F2;ANKRD2;NR2C1;USP2;MTERF3;ATXN1;OSR2;PIAS4;CBFB;KLF7;KCNIP3;MEF2A;PEX2;MTDH;SUV39H2;MYBBP1A;CAV1;TAF1;DAB2IP;ARID5A;TP53;VEGFA;PPM1A;PARP1;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;AR;L3MBTL2;MED1;ZNF431;YAP1;SOX9;SNAI2;HSF4;DICER1;RELA;PLCB1;MAP3K10;CUX2;LIN37;CCND1;PPARA;CBX4;IMPACT;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;RIF1;PCGF6;SPINDOC;HNRNPU;ZNF3;NR2C2;UBE2D1;SREBF2;RUNX1;RB1;ATF3;NKX6-1;ZBTB7A;NFX1;CNOT7;PSPC1;FBXW11;ORC2;CITED2;CPEB3;NR6A1;POU3F3;FNIP2;ZFP69;MXD4;BCL6;IKZF1;FOXJ1;TRIM28;GAS6;ZBTB5
prerank,transcription by RNA polymerase II (GO:0006366),0.29696281635905397,0.9019446105644174,0.6930091185410334,1.0,1.0,44/305,12.61%,NOTCH3;SOX5;NR1H4;POLR2L;POLR2I;RORA;NR4A1;ADRM1;PRRX1;TEAD3;HDAC9;GTF2H4;NR2C1;WDR33;ELL;PCF11;CBFB;POLR2G;TAF1;ELOC;RXRG;PARP1;TAF8;MAML2;AR;PPARGC1A;MED1;YAP1;ERCC6;PAPOLA;MAML3;PPARA;CCNT1;NR4A2;NR1D1;CDK7;NR2C2;TEAD1;NFX1;ESRRA;CDK12;NELFB;INTS5;NR6A1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3225708804015591,0.9012806642353495,0.6133960047003525,1.0,1.0,25/80,18.43%,VIM;SAMD4A;NAT10;SIRT3;RPS27L;CIRBP;RELA;PYM1;RPL5;EIF3E;ROCK2;PRKCD;RBM3;ZCCHC4;ABCG1;CHRNA7;CLU;CPEB3;PLXNB2;SP1;PIWIL2;LRRTM3;SMPD2;EEF2;UPF3A
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.44578660424043903,0.9011078470413643,0.5693430656934306,1.0,1.0,4/10,12.51%,IMPACT;BAG3;SIRT2;CITED2
prerank,tRNA methylation (GO:0030488),0.35947683539501124,0.9011067961392508,0.5627586206896552,1.0,1.0,8/34,16.95%,HSD17B10;TRDMT1;FTSJ1;TRMT10C;METTL6;NSUN2;TRMT44;WDR6
prerank,regulation of presynapse organization (GO:0099174),-0.33379056193151635,-0.9010526613744946,0.6020151133501259,0.903274211328842,1.0,5/18,17.30%,GPC6;APP;PTPRD;SNCA;LRRC4B
prerank,regulation of presynapse assembly (GO:1905606),-0.33379056193151635,-0.9010526613744946,0.6020151133501259,0.903274211328842,1.0,5/18,17.30%,GPC6;APP;PTPRD;SNCA;LRRC4B
prerank,positive regulation of vasculature development (GO:1904018),0.3162268594543045,0.9007755092926469,0.6129032258064516,1.0,1.0,12/94,7.58%,FGF1;ANGPT4;HSPB6;SEMA5A;HK2;STIM1;ITGB1;PTGIS;MTDH;RRAS;VEGFA;BTG1
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.34473999976698677,-0.9002742426987707,0.5717821782178217,0.9041651015426729,1.0,6/14,15.51%,PPP2R2B;PPP2CA;PPP2CB;NCK1;PPM1F;DUSP1
prerank,DNA dealkylation (GO:0035510),0.45013091872211775,0.9001064703007022,0.5716753022452504,1.0,1.0,5/10,26.25%,FTO;MPG;ASCC1;ALKBH1;ALKBH5
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.45013091872211775,0.9001064703007022,0.5716753022452504,1.0,1.0,5/10,26.25%,FTO;MPG;ASCC1;ALKBH1;ALKBH5
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3896056573367314,-0.9000341037996109,0.6,0.9038127623667601,1.0,8/10,44.52%,DLGAP1;DLGAP2;NPTXR;DLGAP3;AKAP9;BEGAIN;NPTX2;CACNG5
prerank,AMP metabolic process (GO:0046033),0.4362516000239712,0.8998613556225862,0.5567010309278351,1.0,1.0,4/13,12.88%,AMPD1;AMPD2;NUDT2;ADSS1
prerank,positive regulation of macroautophagy (GO:0016239),-0.2608182675722668,-0.8997355314850908,0.6282051282051282,0.9035344617842157,1.0,16/48,24.90%,DCN;PAFAH1B2;SPTLC2;PIP4K2B;GPSM1;OPTN;IKBKG;RAB3GAP2;IRGM;KDR;RALB;BNIP3L;UVRAG;SMCR8;LRSAM1;SESN2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3124207487690227,-0.8995823126043038,0.6124260355029586,0.9020383583655076,1.0,14/21,36.07%,ERCC5;DDB1;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;ERCC2;ERCC1;ERCC4;RPA3;RPA2;ERCC3;RPA1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3124207487690227,-0.8995823126043038,0.6124260355029586,0.9020383583655076,1.0,14/21,36.07%,ERCC5;DDB1;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;ERCC2;ERCC1;ERCC4;RPA3;RPA2;ERCC3;RPA1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4085533101510381,0.8994402532531206,0.5669421487603306,1.0,1.0,4/17,8.65%,PDGFB;CCND2;CCND1;ADAM17
prerank,transition metal ion homeostasis (GO:0055076),0.3692707329881939,0.8986149815393446,0.5844544095665172,1.0,1.0,4/28,10.71%,HJV;HMOX2;NEO1;SLC39A14
prerank,negative regulation of cell cycle process (GO:0010948),-0.24938890120792856,-0.8982584399498839,0.6509433962264151,0.9040707857404136,1.0,10/61,8.60%,BMP7;RBBP4;BMP4;CBX5;MGA;TFDP1;RYBP;PHC3;PHC1;MAX
prerank,negative regulation of cell motility (GO:2000146),0.3132857446753855,0.8981627852041331,0.6204954954954955,1.0,1.0,11/108,7.06%,TPM1;DLC1;VCL;TMIGD3;JAG1;KANK1;IGFBP5;RAP2C;DUSP3;PIN1;STK26
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.25535628411478684,-0.8980266518658022,0.6387832699619772,0.9036923859992807,1.0,9/44,17.93%,SH3RF1;DDX3X;RPS6KA3;CD44;IGBP1;SNCA;AKT1;GPX1;SIAH2
prerank,vitamin transport (GO:0051180),-0.2887379458689619,-0.897638012561256,0.6024096385542169,0.9036149812755424,1.0,5/29,9.84%,ABCG2;PDPN;SLC25A32;SLC52A1;SLC35F3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.39639608560235545,0.8974285781124514,0.5878489326765188,1.0,1.0,4/19,7.85%,DLD;DLST;GOT1;GOT2
prerank,negative regulation of cell migration (GO:0030336),0.3079816156792141,0.8971541683966113,0.6440306681270537,1.0,1.0,15/137,7.06%,TPM1;DLC1;VCL;TMIGD3;PHLDB2;CLASP2;JAG1;KANK1;IGFBP5;BMPR1A;RAP2C;DAB2IP;DUSP3;CORO1C;STK26
prerank,actin filament polymerization (GO:0030041),-0.29546348611172524,-0.8971017365971018,0.639871382636656,0.9038558503876227,1.0,2/29,0.74%,GAS7;COBL
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3214024370889187,0.8970842329548292,0.6198347107438017,1.0,1.0,17/84,14.33%,ROCK1;IGFBP5;SAMD4A;RTN2;MRPL13;BTG2;PIN1;RTN1;DAPK3;EIF2AK2;CNOT7;CHRNA7;CLU;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,retina homeostasis (GO:0001895),0.3988838114411338,0.8970503051176986,0.5647590361445783,1.0,1.0,3/23,4.69%,ACTG1;ACTB;POTEF
prerank,chromatin assembly or disassembly (GO:0006333),0.4321875653871451,0.8970382858204454,0.5633802816901409,1.0,1.0,3/11,6.42%,CHAF1B;SUV39H2;TP53
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3205553796604581,-0.8966060828005028,0.5989445910290238,0.9040489179453198,1.0,1/18,0.13%,PTN
prerank,transcription by RNA polymerase III (GO:0006383),0.37635789188559393,0.8964546032214665,0.5841874084919473,1.0,1.0,3/27,4.85%,POLR2L;GTF3C4;ELL
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.27236567619463536,-0.8964322512476979,0.6176470588235294,0.9035242792293122,1.0,7/37,10.06%,RIN3;APOE;ANKRD13A;ITGAV;OPTN;SDCBP;PRKN
prerank,positive regulation of integrin activation (GO:0033625),0.4321222524224688,0.8963826173564993,0.5833333333333334,1.0,1.0,2/11,7.51%,FERMT2;PLEK
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3009295617705451,-0.8963467155466645,0.5942857142857143,0.9027937405228785,1.0,6/23,12.68%,KIT;GHR;PTK2B;CYP1B1;HES1;PRLR
prerank,cellular response to ATP (GO:0071318),0.4272688123761209,0.8959399669298201,0.5771230502599654,1.0,1.0,2/14,6.15%,P2RY2;TAF1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3116088560736105,-0.8955263930716666,0.5969696969696969,0.903763594376002,1.0,8/23,16.29%,IGF1;ZBTB20;APP;ENTPD5;PFKFB2;ARNT;INSR;PRXL2C
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.35278938415479366,-0.8950238244397837,0.5939675174013921,0.9039934081245941,1.0,4/14,18.53%,CHKA;LPIN2;SELENOI;LPIN3
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.37528143837902195,-0.8949868465162182,0.6192560175054704,0.9031343174648697,1.0,3/11,18.89%,CASP8;TGFB1;HSF1
prerank,histone methylation (GO:0016571),0.3774587376736085,0.8949350084719246,0.5786350148367952,1.0,1.0,5/26,9.03%,SMYD1;SETD6;SUV39H2;PRMT7;NSD3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3894918064652956,0.8942525731178967,0.5957120980091883,1.0,1.0,3/23,6.42%,PMAIP1;BCL2;TP53
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3894918064652956,0.8942525731178967,0.5957120980091883,1.0,1.0,3/23,6.42%,PMAIP1;BCL2;TP53
prerank,intracellular sterol transport (GO:0032366),-0.3573515173856643,-0.8941301340643991,0.60431654676259,0.9042985279728444,1.0,6/13,23.59%,ABCA1;ARV1;STARD4;OSBP;RELCH;NPC1
prerank,autophagosome maturation (GO:0097352),0.35930074363090164,0.89366278664815,0.585195530726257,1.0,1.0,5/32,7.51%,ATP2A2;LIX1L;GABARAP;CALM1;LIX1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3987500686136244,0.893615818892699,0.5615763546798029,1.0,1.0,2/19,5.01%,LIFR;CBFB
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.23077252145513255,-0.8936145159319938,0.7070063694267515,0.9046655703478487,1.0,29/80,24.05%,GBF1;RINT1;KDELR1;ERGIC3;TMED7;SURF4;TMED10;COPB2;GOLPH3;ARFGAP2;ARF3;ARFGAP1;COPE;ARFGAP3;RAB1A;RER1;KLC2;COG7;PICK1;TMED3;SCFD1;RAB1B;UVRAG;KIF26A;ARF5;ATP9A;USE1;COPB1;TAPBP
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3188011059719421,0.8935797936238862,0.6157461809635723,1.0,1.0,13/95,5.98%,SDC2;ANGPT1;CSPG4;CHSY3;CSGALNACT1;BGN;EXT2;GCNT2;HS2ST1;HAS2;GPC4;CHST5;OGN
prerank,cellular protein localization (GO:0034613),0.29357703153673975,0.8935101185796319,0.7202868852459017,1.0,1.0,50/285,16.94%,FLNA;DMD;STXBP2;HEY2;TBC1D1;ANGPT1;VCL;CSRP3;FERMT2;ITSN1;BICD2;JAM3;ARHGEF2;RABGAP1;SEC31B;VPS26A;EVI5;EIF2D;SEC13;VPS26B;RRAGB;RAP2A;STX12;MFN2;WDR45;SNX13;NSF;PACSIN1;SNX9;FGF10;FOXJ1;RAB14;LRRK2;SNX17;CTSA;SNX1;CNTNAP1;USP4;STX7;YWHAH;GGA2;ATG13;RUNDC1;TBC1D22B;VPS35;SMURF1;TM9SF2;TBC1D12;ARL4D;RAB38
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3028398128016663,-0.8932157691208856,0.6094674556213018,0.9047010415513917,1.0,5/22,11.85%,KIT;GHR;CYP1B1;HES1;MGAT5
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3593599203574468,0.8931046802569645,0.613960113960114,1.0,1.0,8/36,11.68%,ATP2B4;CAV1;TERT;CALM1;GLA;HIF1A;TERF2;HTR2B
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.40108315973081315,0.8929482780710549,0.5709459459459459,1.0,1.0,6/18,9.18%,PEX2;DAB2IP;TP53;CD300A;GSTP1;SKI
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.24941403312266316,-0.8928054921125301,0.6130434782608696,0.9047388436364658,1.0,14/52,15.44%,CELF2;DDX5;KHDRBS1;RBM5;RBFOX3;SRSF6;TRA2B;NOVA1;CELF4;DDX17;SMU1;RBFOX1;NOVA2;KHDRBS2
prerank,cellular protein-containing complex assembly (GO:0034622),0.3058832568992953,0.8925879776602789,0.6452665941240479,1.0,1.0,24/159,14.20%,DMD;ANGPT1;PDE4DIP;CASQ1;HIP1;ADRM1;COX7A2L;MAPT;BBS12;OTUD6B;LONP1;ANLN;NUP153;CENPE;NUP107;TBCD;CLU;SNX9;CHMP2A;NCK2;HOPX;NUP98;PTGES3L;SRP19
prerank,regulation of nervous system process (GO:0031644),-0.3227477044583188,-0.8923604557215652,0.6112531969309463,0.9048654067658577,1.0,6/18,12.38%,APP;DLGAP1;TMEM108;NOS3;DLGAP2;HTR2C
prerank,negative regulation of cartilage development (GO:0061037),0.4172317234216715,0.8922451613754206,0.5856164383561644,1.0,1.0,3/13,7.71%,CHADL;SOX9;SNAI2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3005925222702395,0.8920863916669702,0.6461038961038961,1.0,1.0,30/150,15.34%,NTF3;DMD;NTRK3;PPM1E;EMILIN1;CAV1;DAB2IP;CORO1C;CALM1;IMPACT;GSTP1;PAK2;CNKSR3;SAMSN1;SIRT2;GPD1L;PDE4D;RB1;PRKCD;CEP85;DMTN;CEP43;NCK2;DNAJC3;GNAQ;LRRK2;DVL1;MLXIPL;INPP5J;PTEN
prerank,protein phosphorylation (GO:0006468),0.2891941735457023,0.8919334772495363,0.7386934673366834,1.0,1.0,86/478,15.26%,MYLK2;MAP3K20;STK38L;TNNI3K;PRKG1;MAP3K5;ROCK1;MAST4;DYRK2;MERTK;PDGFB;CCNA2;CDK6;PDK4;FRK;FAM20A;CAMK2D;ACVR2A;MUSK;GTF2H4;CAMKK2;PEAK1;MARK1;BMPR1A;DYRK1A;PRKCQ;MAP4K3;MAP4K5;TAF1;DAB2IP;RPS6KA2;COQ8A;MAPKAPK2;DYRK1B;STK26;CHEK1;TGFB2;NUAK1;MAP3K10;WNK2;DAPK3;PRKACB;PRKAR1B;MAP2K1;CCNT1;BRSK1;PKN2;PAK2;CDK7;STK33;STK24;PDGFRB;CDK18;EIF2AK2;ROCK2;PRKCD;COPS8;ACVR1B;CDK12;RICTOR;DMPK;BMPR1B;TNIK;BCR;CDC42BPB;STK36;TAOK3;FNIP2;CDK15;MAST1;PPP3CB;EEF2K;GAS6;CSNK1E;PDK2;SGK1;STK10;EPHB1;MAPK1;LRRK2;PRKAA2;PRKCA;PRKACA;SRPK2;MAPK12;CSNK1A1
prerank,brain morphogenesis (GO:0048854),-0.35896821799321005,-0.891825183997711,0.5964912280701754,0.9051632100899494,1.0,6/12,30.52%,PAFAH1B1;SHANK3;SPEF2;MKKS;BBS4;CTNNA2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3654289171659459,0.891630872359802,0.5879043600562588,1.0,1.0,7/33,10.69%,PDGFB;TERT;TP53;TGFB2;RELA;HIF1A;TEAD1
prerank,regulation of RNA metabolic process (GO:0051252),-0.25000830196164703,-0.8915757427525888,0.671875,0.9048541831454036,1.0,11/59,10.17%,PTBP3;RASA1;RC3H2;AHNAK2;TRA2B;PCBP2;NOVA1;BRDT;AHNAK;RBM20;CLK3
prerank,cellular protein metabolic process (GO:0044267),0.29123983994267477,0.8914982145346106,0.7419354838709677,1.0,1.0,32/396,6.92%,IGFBP7;MFGE8;LTBP1;SPARCL1;PAPPA2;SDC2;LMCD1;MSRB3;RPL3L;HRC;CCN1;CLN5;LOXL2;IGFBP5;D2HGDH;MRPL36;MRPL13;MCRS1;HARS2;SEPHS1;DMBT1;NUCB1;PHKA2;ZDHHC2;DAB2IP;AFG3L2;ABCA3;KTN1;IGFBP4;LAMC1;LAMB2;RPL8
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.34250909703109444,0.8908943492901624,0.5875486381322957,1.0,1.0,6/45,9.58%,RBPMS;TGFB3;ACVR2A;BMPR1A;TGFB2;GDF1
prerank,axonal transport of mitochondrion (GO:0019896),0.4295055858130066,0.8906599350241546,0.5791304347826087,1.0,1.0,4/11,9.57%,MAPT;OPA1;TRAK1;HIF1A
prerank,tyrosine metabolic process (GO:0006570),0.4354369752098155,0.8905843793853838,0.5763016157989228,1.0,1.0,2/11,10.78%,HGD;THAP4
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3119167905243494,0.8905761704876258,0.6330376940133038,1.0,1.0,25/114,17.39%,ACTN4;LIMS1;TNFSF13B;TNFRSF11A;PSMC6;TP53;TRAF3;RELA;ADAM17;PSME4;EDAR;TRAF5;PSMB1;PSMD5;EIF5A;TNFRSF25;PSMB2;TMSB4X;PSMB7;PSMD3;STAT1;JAK2;PSMA2;PSMD14;TNFSF12
prerank,positive regulation of dendrite extension (GO:1903861),-0.3277255394095136,-0.8904943257130697,0.6123456790123457,0.9063877336393847,1.0,8/17,36.94%,NEDD4L;SYT1;RIMS2;SYT2;SYT3;PLAA;CPNE5;CPNE9
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4122528998907735,0.8903697473939306,0.5927099841521395,1.0,1.0,2/17,3.64%,ANO6;CCL5
prerank,hyaluronan metabolic process (GO:0030212),-0.29787533143235284,-0.8901071251549008,0.5958083832335329,0.9063530835803063,1.0,6/23,16.03%,CEMIP;CD44;TGFB1;HEXA;CEMIP2;FGF2
prerank,regulation of stem cell differentiation (GO:2000736),0.31568748419602277,0.8900093016139204,0.6274738067520372,1.0,1.0,20/89,14.71%,RBM24;JAG1;CBFB;SP7;BMPR1A;PSMC6;GDNF;YTHDF2;YAP1;PSME4;HNRNPU;PSMB1;PSMD5;EIF2AK2;RUNX1;PSMB2;NELFB;NSUN2;PSMB7;PSMD3
prerank,glutathione biosynthetic process (GO:0006750),0.43756966029100197,0.8899314855246616,0.5716845878136201,1.0,1.0,5/11,20.63%,OPLAH;GGCT;CHAC2;CNDP2;HAGH
prerank,myelin assembly (GO:0032288),0.43023916240466936,0.8898659712600341,0.5489130434782609,1.0,1.0,3/10,15.12%,TPPP;DICER1;CNTNAP1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.21880403159859085,-0.8898648113418056,0.7611940298507462,0.9059900407659098,1.0,34/94,27.99%,NOD1;NFKBIA;IRAK1;PSMD7;PSMD9;PSMD13;IRAK3;PELI1;MAP3K3;IKBKG;TAB2;PSMB3;IRAK2;UBC;CHUK;PSMC5;TAB1;PSMA5;PSMA1;PSMC2;TOLLIP;BTRC;IL1RAP;PSME3;UBB;PSMC4;PSMB6;IRAK4;PSMB10;PELI3;RPS6KA4;PSMA4;SQSTM1;PSME1
prerank,peptidyl-lysine modification (GO:0018205),0.31233210671024847,0.889545052496981,0.6359447004608295,1.0,1.0,33/99,19.61%,UBA2;LOXL2;NUP62;HDAC9;SIRT3;PIAS4;SAE1;TRPM4;NUP153;SIRT2;NUP107;AAAS;PIAS2;ATPSCKMT;NDUFAB1;SENP6;TRIM28;VCPKMT;SIRT4;NUP98;NUP37;EEF1AKMT2;NUP210;PIAS1;BCL11A;ESCO1;HDAC6;NUP54;SUMO1;SENP2;UBE2I;NUP160;NUP133
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.29455325485380435,-0.8893460850607463,0.6226993865030674,0.9062589375850134,1.0,11/26,26.59%,FBN1;TCTA;RARA;TLR3;GPR137B;PTPN2;CEACAM1;C1QC;ZFPM1;MAFB;GPR137
prerank,cellular response to glucose starvation (GO:0042149),0.34578140418720527,0.8892216012205234,0.6045576407506702,1.0,1.0,13/41,18.84%,PMAIP1;KPTN;MYBBP1A;TP53;NUAK1;IMPACT;BRSK1;PIK3C3;PRKAA2;ITFG2;EIF2AK3;MTMR3;BRSK2
prerank,regulation of steroid metabolic process (GO:0019218),0.3870445995864085,0.8891825384447526,0.5916795069337443,1.0,1.0,2/23,2.57%,NR1H4;RORA
prerank,protein targeting to membrane (GO:0006612),-0.22780862695530962,-0.889040329827126,0.6967741935483871,0.9060612216481171,1.0,29/83,25.23%,SEC62;ZDHHC18;PEX14;SLC25A17;ATG3;ALDH3A2;ZDHHC15;SDCBP;PEX5;SEC63;SGTA;ACBD5;ZDHHC9;ZDHHC20;ABCD3;SGTB;FIS1;SSR1;SEC61A1;SRPRA;SSR2;CHM;PXMP2;PEX13;TAOK2;CHMP4B;CHMP4A;VPS37C;ZDHHC24
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.41660440028357326,0.8889061623301092,0.5652920962199313,1.0,1.0,5/13,19.14%,KPNA4;KPNA2;KPNA3;CBLB;NUP54
prerank,embryonic organ morphogenesis (GO:0048562),0.34524509337487197,0.8880951284878336,0.5784447476125512,1.0,1.0,4/42,6.96%,RYR2;RBPMS2;OSR2;HOXC4
prerank,aminoglycan biosynthetic process (GO:0006023),0.3447121401273789,0.8880422525682133,0.5769230769230769,1.0,1.0,7/49,10.06%,SDC2;EXT2;GCNT2;HS2ST1;GPC4;HS6ST1;AGRN
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.3753618308467739,-0.8878026822555599,0.6395604395604395,0.9060991215145315,1.0,5/11,27.03%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,coenzyme A biosynthetic process (GO:0015937),-0.3753618308467739,-0.8878026822555599,0.6395604395604395,0.9060991215145315,1.0,5/11,27.03%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.3753618308467739,-0.8878026822555599,0.6395604395604395,0.9060991215145315,1.0,5/11,27.03%,PPCDC;PANK1;DCAKD;ACOT7;PPCS
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4356467639279529,0.8874576444798769,0.5954063604240283,1.0,1.0,3/12,11.59%,DAB2IP;PTPN1;BOK
prerank,protein oxidation (GO:0018158),0.4321977787020645,0.8867732416965799,0.5646853146853147,1.0,1.0,2/11,10.21%,LOXL2;SUMF1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.4111088362041021,0.8862905183711746,0.5902777777777778,1.0,1.0,2/15,4.60%,CDH13;PTPN18
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.31660917689019413,0.8862217488020334,0.6334519572953736,1.0,1.0,21/86,16.90%,LIMD1;ANKRD2;CUL2;PSMC6;ELOC;TP53;VEGFA;CHEK1;IMPACT;HIF1A;PSME4;BAG3;PSMB1;PSMD5;ATF3;PSMB2;PSMB7;PSMD3;PSMA2;INO80;PSMD14
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3271409522295706,0.8861201775928055,0.6126674786845311,1.0,1.0,13/67,17.84%,NCF2;CD36;PSMC6;ITGB5;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14;SNAP23
prerank,icosanoid biosynthetic process (GO:0046456),0.43795657257007403,0.8860902107889937,0.575812274368231,1.0,1.0,2/10,14.18%,ALOX5;PLA2G4A
prerank,regulation of dendrite extension (GO:1903859),-0.3209988889348031,-0.8859356480626179,0.5994962216624685,0.9094306231532833,1.0,8/18,36.94%,NEDD4L;SYT1;RIMS2;SYT2;SYT3;PLAA;CPNE5;CPNE9
prerank,positive regulation of synapse assembly (GO:0051965),-0.288148999532659,-0.8857990033841971,0.6352941176470588,0.9087918944553272,1.0,13/27,28.55%,NLGN1;SEMA4D;PTPRD;NRXN1;NLGN2;NLGN3;LRRC4B;GRID2;IL1RAP;EPHB2;SRPX2;EPHB3;SYNDIG1
prerank,eosinophil migration (GO:0072677),0.4151374179334567,0.8857940672869931,0.5836177474402731,1.0,1.0,1/14,3.64%,CCL5
prerank,eosinophil chemotaxis (GO:0048245),0.4151374179334567,0.8857940672869931,0.5836177474402731,1.0,1.0,1/14,3.64%,CCL5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4460395549305165,0.885611869736661,0.5711422845691383,1.0,1.0,2/10,8.34%,ANO6;CD300A
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3314626340231891,0.885565389504019,0.6192307692307693,1.0,1.0,13/57,13.95%,PMAIP1;CAMKK2;TP53;PPARGC1A;MIEF2;MIEF1;SPIRE1;HRK;DNM1L;GPER1;BOK;MUL1;ADCK1
prerank,MAPK cascade (GO:0000165),0.2906789281172602,0.8854037228258625,0.7035532994923858,1.0,1.0,59/295,16.90%,MAP3K20;FGF13;MEF2C;MAP3K5;ANGPT1;FGF1;PDGFB;RASAL2;DUSP5;IL2;CCL5;KSR1;CAMKK2;MEF2A;PRKCQ;IRS1;PSMC6;DAB2IP;MAPKAPK2;GDNF;CALM1;AREG;RASGRP1;SOX9;MBP;MAP2K1;PPP1CB;PSME4;ACTN2;PDGFRB;PSMB1;HBEGF;PSMD5;PDGFA;GFRA1;ABHD17B;HTR2B;FBXW11;TNIK;PSMB2;SPTB;TAOK3;ZFP36L1;FGF10;MAPK1;LRRK2;PSMB7;PSMD3;CSF2RA;IRS2;KARS1;MAPK12;RAF1;JAK2;PSMA2;RASGRP3;MT3;SHOC2;PSMD14
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3425610132589308,0.8849757447399584,0.5997392438070405,1.0,1.0,19/49,18.01%,PMAIP1;BCL2;CAV1;TP53;BCL2L2;NDUFS3;RTKN2;DNM1L;BOK;MCL1;URI1;PTPMT1;EIF2AK3;S100A8;S100A9;BCAP31;DAPK2;DDIT3;BBC3
prerank,negative regulation of T cell proliferation (GO:0042130),-0.2875950260382765,-0.8849732448056968,0.611764705882353,0.9097301985958863,1.0,7/28,24.62%,LGALS9;CEBPB;SDC4;CD80;CD274;CD86;SCRIB
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.2933449009411752,-0.8849077278857848,0.625,0.9089681802453812,1.0,8/26,14.47%,APP;NLGN1;PTK2B;SHANK3;TMEM108;NRXN1;NLGN2;NLGN3
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.34511785205989204,0.8847813350562036,0.6002710027100271,1.0,1.0,11/41,16.23%,ALOX5;FADS3;HSD17B4;FADS2;GSTP1;MGLL;SCP2;PTGR1;PLA2G4A;PLA2G4C;EPHX1
prerank,cellular response to unfolded protein (GO:0034620),-0.2945868299077331,-0.8846130754944478,0.6160458452722063,0.9086700086297428,1.0,12/26,29.36%,HSPA5;OPTN;PRKN;ERN1;HSPA13;BAX;HSPA9;HSF1;HSPD1;TMBIM6;PACRG;HSPA8
prerank,lipid homeostasis (GO:0055088),-0.24071098992039644,-0.8844874657423231,0.6973684210526315,0.908026347116391,1.0,5/57,2.55%,ZBTB20;RBP1;APOE;ABCA1;DDX3X
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2721953584737195,-0.8843027830202975,0.6461538461538462,0.9075196801845681,1.0,11/33,19.27%,DDX5;CARM1;SAFB2;RNF6;PRMT2;ESR1;EP300;GPAM;CALR;KDM1A;PARK7
prerank,cardiac conduction system development (GO:0003161),0.37776846163962075,0.8841564181005622,0.5966514459665144,1.0,1.0,3/24,5.24%,HEY2;BMPR1A;TBX18
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.33910365031946654,-0.8840037951567972,0.6235294117647059,0.906385743296157,1.0,7/15,31.36%,DTNBP1;AP3M2;AP3S1;AP3M1;BLOC1S6;BLOC1S2;AP3S2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.33910365031946654,-0.8840037951567972,0.6235294117647059,0.906385743296157,1.0,7/15,31.36%,DTNBP1;AP3M2;AP3S1;AP3M1;BLOC1S6;BLOC1S2;AP3S2
prerank,erythrocyte differentiation (GO:0030218),-0.2536363301453374,-0.8837301795933965,0.6546184738955824,0.9061269469309847,1.0,13/44,26.07%,TGFBR3;KMT2E;KIT;RPS19;ALAS1;LYN;HSPA9;SLC25A38;NCKAP1L;PTPN2;TAL1;UBA5;ZFPM1
prerank,visual system development (GO:0150063),-0.27336622429121193,-0.8834088829776416,0.6551724137931034,0.9059004012937147,1.0,16/37,34.99%,SMOC1;PBX3;RBP4;MEIS2;MEIS3;PBX4;C1QA;SIPA1L3;PBX1;SMG9;ZDHHC16;MEIS1;ATF6;SALL2;C3;ADAMTS18
prerank,lung epithelium development (GO:0060428),-0.37342381690894516,-0.8833365022225327,0.6004273504273504,0.9051471347804844,1.0,2/10,12.24%,BMP4;RCN3
prerank,regulation of T cell cytokine production (GO:0002724),0.41173582347928084,0.8828830307087453,0.5970149253731343,1.0,1.0,2/15,8.74%,FZD5;TRPM4
prerank,RNA splicing (GO:0008380),0.31543222689686773,0.8827680333722501,0.641946697566628,1.0,1.0,26/95,15.21%,DDX23;TXNL4A;SFPQ;PPARGC1A;SF3B3;SRSF4;SNRPN;PRPF18;FUS;ZMAT5;RBM8A;MBNL1;U2AF1;DHX8;PRPF4;SRSF10;SF3A3;HNRNPC;CDK12;SRRM1;SF3B2;SF3B1;ZCRB1;SYNCRIP;PDCD7;SRPK2
prerank,regulation of primary metabolic process (GO:0080090),0.3029497435606831,0.8823848547781336,0.6626637554585153,1.0,1.0,27/126,16.90%,SMARCD3;PRKAB2;ANGPTL8;OAZ2;PSMC6;ACACB;IDI1;MED1;MVD;PPARA;NR1D1;PSME4;PSMB1;PSMD5;ROCK2;SREBF2;TGS1;PSMB2;ZFP69;EDF1;PSMB7;PSMD3;IRS2;SIN3A;SP1;PSMA2;PSMD14
prerank,DNA biosynthetic process (GO:0071897),0.40909284157028514,0.8823230454764454,0.6062176165803109,1.0,1.0,3/16,11.21%,TERT;WRNIP1;POLD1
prerank,regulation of mitochondrial fission (GO:0090140),0.37479450894440386,0.8821942736635583,0.5905631659056316,1.0,1.0,10/24,17.98%,INF2;MAPT;MIEF2;MIEF1;SPIRE1;DNM1L;MUL1;LRRK2;VPS35;MFF
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.3529336728386561,-0.8821816555396198,0.5766423357664233,0.9068749555542723,1.0,7/13,27.00%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1
prerank,megakaryocyte differentiation (GO:0030219),0.4359151810381722,0.8807891704068118,0.5826235093696763,1.0,1.0,2/11,7.29%,THPO;MED1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.43295931241339236,0.8803591395771846,0.5947467166979362,1.0,1.0,6/12,20.32%,HEXIM1;HNRNPU;NELFB;NELFCD;EAPP;NELFA
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3706359965815894,-0.8800640406719228,0.6209302325581395,0.9107975555435213,1.0,8/11,32.18%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1;GNPNAT1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3186961574040308,0.879944991710894,0.6356033452807647,1.0,1.0,16/78,11.84%,ATP2B4;STAC;ITGA3;ITGB1;ARHGEF16;ACTB;ZDHHC2;SORBS1;STAC3;PPP2R5A;AR;KIF5B;EPHA2;GPER1;DPP10;CLIP3
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3205850516527842,-0.8797465060427885,0.6134020618556701,0.9106164217316243,1.0,7/17,23.41%,RNF20;CTR9;VIRMA;NCBP2;ZC3H3;HSF1;CPSF6
prerank,cell projection assembly (GO:0030031),0.3782104604877028,0.8789879893328753,0.5945945945945946,1.0,1.0,6/22,15.30%,RHOJ;CYFIP1;PARVA;PDGFA;RHOH;RHOG
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.32786046888110865,-0.8789398713385307,0.6225490196078431,0.9115068458132094,1.0,5/15,24.18%,ZC3H12B;POP1;ZC3H12C;ZC3H12A;KHNYN
prerank,negative regulation of cilium assembly (GO:1902018),-0.3504887248892369,-0.8788208116828321,0.625,0.910817171211021,1.0,7/12,29.20%,LIMK2;CEP97;TBC1D30;ODF2L;TBC1D7;CCP110;TESK1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3526449216082306,-0.8787543673535466,0.6377171215880894,0.9100646769999711,1.0,7/13,40.39%,DUSP1;ANAPC15;DYNC1LI1;MAD2L1;GEN1;NDC80;XRCC3
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2709931442679205,-0.8786545550772185,0.6604938271604939,0.909375472412038,1.0,14/30,31.42%,ELOVL7;HACD4;ABCD3;ACOX1;ELOVL4;ELOVL6;HACD2;SLC27A4;ELOVL1;HACD3;ACSL1;ELOVL5;TECRL;SLC27A2
prerank,cellular response to acid chemical (GO:0071229),0.3627555073998304,0.8785081982789482,0.5905743740795287,1.0,1.0,7/27,12.51%,LARS1;CPEB1;VEGFA;CAPN2;RRAGB;SH3BP4;CPEB3
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3682883579387445,0.8783777997953464,0.613251155624037,1.0,1.0,4/27,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,chondroitin sulfate catabolic process (GO:0030207),0.41399421368922007,0.8783017848211254,0.5813953488372093,1.0,1.0,2/13,3.64%,CSPG4;BGN
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35859423868598456,0.878007294593643,0.5950540958268934,1.0,1.0,9/30,18.33%,FZD5;SAE1;FBXW7;SREBF2;HPS4;ATG13;LEPROT;USP36;TOMM7
prerank,regulation of cell cycle phase transition (GO:1901987),0.31178191077128103,0.8776167221391488,0.6313993174061433,1.0,1.0,21/91,17.86%,ATP2B4;TCIM;ANAPC10;MN1;TAF1;PSMC6;TP53;FBXW7;UBE2E1;PSME4;PSMB1;PSMD5;UBE2D1;PSMB2;PSMB7;PSMD3;FBXO5;PSMA2;PSMD14;ANAPC16;ANAPC5
prerank,positive regulation of leukocyte activation (GO:0002696),-0.32016774207202875,-0.8773615236248979,0.6601123595505618,0.911324716509763,1.0,3/18,12.31%,LBP;WNT5A;IL33
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3933553945209949,0.8770692542052518,0.6097972972972973,1.0,1.0,2/17,3.81%,ADRA1D;ADCY9
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.26012730356704344,-0.8767800416282614,0.6666666666666666,0.9117143180687495,1.0,21/37,38.29%,ERCC5;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;ERCC1;ERCC4;RPA3;RFC3;RPA2;ERCC3;POLD3;RPA1;RFC1;RFC4;NTHL1
prerank,histone H4 deacetylation (GO:0070933),0.43648317668585074,0.8767659127504682,0.5969868173258004,1.0,1.0,4/10,19.59%,HDAC9;SIRT2;HDAC1;SMARCAD1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.36990845099528147,0.8766100289016099,0.6144927536231884,1.0,1.0,7/29,14.86%,STRN3;CBFB;YAP1;KMT2D;RUNX1;UFL1;KCTD6
prerank,regulation of BMP signaling pathway (GO:0030510),0.3210401812564706,0.876433459995356,0.6314496314496314,1.0,1.0,7/73,5.14%,RBPMS2;CRIM1;CCN1;ITGA3;FST;ACVR2A;BMPR1A
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.3648076441565265,-0.8756275362663761,0.6135371179039302,0.9133830408337726,1.0,4/12,12.96%,ELF1;PTPN22;LYN;ELF2
prerank,skeletal system development (GO:0001501),0.29734367288545227,0.8750852844760927,0.6656017039403621,1.0,1.0,6/148,3.03%,SOX6;SOX5;PLS3;SNORC;ALX4;ETS2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3433350734468956,0.8742347565992571,0.6024423337856174,1.0,1.0,7/39,12.68%,TRPC6;FHL1;UTRN;NEDD4;AHCYL1;GPD1L;HOMER1
prerank,RNA processing (GO:0006396),0.2952970480801568,0.8740072421712143,0.671306209850107,1.0,1.0,43/176,16.52%,RBPMS;HNRNPR;FASTKD5;DDX23;ATXN1;U2AF2;SFPQ;PPARGC1A;CELF1;DICER1;SF3B3;SRSF4;SNRPN;TENT4A;PRPF18;FUS;ZMAT5;DEDD2;RBM8A;MBNL1;U2AF1;DHX8;HNRNPU;PRPF4;RBM3;SF3A3;HNRNPC;RBM6;CDK12;SRRM1;DROSHA;SF3B2;SF3B1;ZCRB1;SON;SYNCRIP;PDCD7;PRKACA;FASTKD2;SRPK2;SF3A1;WBP4;PIWIL2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3443873205070862,0.8738670913810024,0.6253369272237197,1.0,1.0,6/42,6.96%,LIMS1;PDGFB;FZD4;GCNT2;RSU1;CORO1C
prerank,regulation of endocytosis (GO:0030100),0.3263357234533776,0.873765217954883,0.6190476190476191,1.0,1.0,7/61,6.82%,ROCK1;HIP1;CDH13;PACSIN3;PACSIN2;CBLL1;PTPN1
prerank,cellular response to increased oxygen levels (GO:0036295),0.4369216986245935,0.8735657348471557,0.5752688172043011,1.0,1.0,3/11,6.32%,ATG7;CAV1;ATP6V0A2
prerank,microtubule anchoring at centrosome (GO:0034454),0.4383556382433359,0.8733509316317263,0.5851449275362319,1.0,1.0,1/10,2.05%,CCDC68
prerank,protein-containing complex subunit organization (GO:0043933),0.3098956877778941,0.8729152620650945,0.6670467502850627,1.0,1.0,20/109,14.33%,TCAP;SH3BGR;SKAP2;AFG3L2;TP53;LAMC1;PPARGC1A;MDN1;YAP1;SOX9;ADD2;MAGI1;TEAD1;DNM1L;KIFAP3;SNX9;DMTN;KPNA3;NUP98;EPRS1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.311031789228396,0.872660466139573,0.643598615916955,1.0,1.0,14/86,12.51%,RBPMS;CCN1;ZEB2;TGFB3;ACVR2A;TGFB1I1;BMPR1A;SLC2A10;TGFB2;ADAM17;GDF1;ACVR1B;BMPR1B;CITED2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3428433647910258,0.8724479608825647,0.6329639889196675,1.0,1.0,9/43,12.19%,MEF2C;CCN1;FERMT2;ACVR2A;BMPR1A;YAP1;SUCO;LRP5;BMPR1B
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2894746647416879,-0.8719502477086548,0.6705539358600583,0.9206077595984993,1.0,5/27,12.16%,NFAT5;IRAK1;CYRIB;CD44;SIRPA
prerank,regulation of cellular response to heat (GO:1900034),0.3169285838566699,0.8718594225004769,0.6411483253588517,1.0,1.0,24/77,20.93%,CAMK2G;CAMK2D;NUP62;MAPT;MAPKAPK2;SEC13;NUP153;BAG3;NUP107;AAAS;BAG2;NUP98;MAPK1;NUP37;NUP210;FKBP4;HSPB8;DNAJB6;NUP54;NUP160;NUP133;HIKESHI;TPR;PTGES3
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.23794624918062582,-0.8718349315438658,0.7368421052631579,0.9199846337365646,1.0,22/57,24.02%,CDC14B;PRKDC;MRE11;RINT1;BRCC3;ATF2;MDC1;BLM;NBN;TAOK1;FOXN3;NOP53;HUS1;CHEK2;ATM;FBXO31;HMGA2;TAOK2;TRIM39;CLSPN;CDK2;CDKN1A
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.4015722525853002,0.8717327234619079,0.6159052453468697,1.0,1.0,3/14,7.71%,CHADL;SOX9;SNAI2
prerank,glucose homeostasis (GO:0042593),0.3139863491177913,0.8716015882086545,0.6422569027611045,1.0,1.0,19/83,17.43%,SLC2A4;PDK4;HK2;ALOX5;KCNB1;KLF7;IRS1;MBD5;PPARGC1A;NR1D1;HIF1A;CRTC2;PDK2;PRKAA2;MLXIPL;STAT3;SELENOT;RPS6;ADRA2A
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2979422398804573,-0.8714803196812774,0.6474164133738601,0.9198391032935547,1.0,10/22,24.55%,DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;RAD23B
prerank,regulation of ion transport (GO:0043269),-0.22502328850916622,-0.8713548589223741,0.7261146496815286,0.919209859246423,1.0,16/76,14.72%,NEDD4L;WNK1;B2M;NKAIN3;SYT1;CA2;NKAIN4;DTNBP1;SIK1;PRKN;KCNJ13;SNX6;PER1;SNCA;SYT11;SYT12
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.40028946705604107,0.8713108449080872,0.5982905982905983,1.0,1.0,2/15,7.86%,TGFB3;TGFB2
prerank,positive regulation of protein kinase activity (GO:0045860),0.2953622051946934,0.8712939554890553,0.6948968512486428,1.0,1.0,26/148,13.61%,RAP1A;PDGFB;CCN1;SLC8A2;CCL5;MMD;DOK7;DAB2IP;VEGFA;PTPN1;CALM1;TPX2;LCP2;ITGB3;TGFB2;MAP2K1;PAK2;CENPE;PRKCD;TNIK;CLU;SNX9;PDCD10;TAOK3;GAS6;MAP2K3
prerank,pulmonary valve development (GO:0003177),0.39300535447600293,0.8709738198489723,0.6025039123630673,1.0,1.0,4/18,7.86%,HEY2;HEYL;JAG1;TGFB2
prerank,translational termination (GO:0006415),0.3104647607291631,0.8709336297134151,0.6697782963827305,1.0,1.0,33/95,22.04%,MRPL36;MRPS31;MRPL13;APEH;MRPL30;ABCE1;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;GSPT1;MRPL47;MRPL9;MRPL42;N6AMT1;ETF1;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3200363045410876,0.8709146048746359,0.6268844221105527,1.0,1.0,13/64,13.03%,POLR2L;POLR2I;ADRM1;GTF2H4;ELL;POLR2G;ELOC;CCNT1;CDK7;POLR1E;CDK12;NELFB;POLR2J
prerank,positive regulation of actin nucleation (GO:0051127),0.43155087966912986,0.8707270207592642,0.5975820379965457,1.0,1.0,3/11,9.76%,CYFIP1;WHAMM;FCHSD2
prerank,regulation of protein phosphorylation (GO:0001932),0.2881904200673932,0.8707093199875563,0.7100409836065574,1.0,1.0,41/256,13.57%,TTN;NTRK3;ANGPT1;FGF1;HRC;PLCE1;CCN1;CCND2;THPO;FAM20A;SMG8;ACVR2A;MUSK;CAMKK2;RARRES2;DAB2IP;VEGFA;PPP2R5A;PIN1;CORO1C;RASGRP1;ITGB3;SOX9;ANKRD54;CCND1;ADAM17;IMPACT;RAP2A;PELI2;PDGFA;GPER1;ROCK2;ATF3;CLIP3;TNIK;AKTIP;CHRNA7;FNIP2;FGF10;PLXNB2;GAS6
prerank,microtubule anchoring (GO:0034453),0.41756904567692954,0.8705065815304439,0.6151142355008787,1.0,1.0,2/12,4.48%,CLASP2;BICD2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.22467402397211456,-0.8702650256288835,0.7150259067357513,0.9206408798768603,1.0,29/72,30.19%,MRE11;RAD50;FBH1;ERCC5;FAN1;DDB1;UBC;RNASE4;ENPP1;CHD1L;XPA;EDC4;GTF2H5;GTF2H2;ZC3H12A;PNRC2;GTF2H3;UBB;ERCC2;EDC3;ERCC1;ERCC4;SPO11;MUS81;OGG1;RPA3;DNA2;PDE12;RFC3
prerank,regulation of microtubule-based movement (GO:0060632),-0.35362860815653613,-0.8699735267744351,0.6264775413711584,0.9203564592029821,1.0,7/11,46.43%,IGBP1;DYNLT2B;LAMP1;DRC1;HAP1;CCDC65;CFAP298
prerank,lipoprotein transport (GO:0042953),-0.36508192379967336,-0.8698514334735752,0.6275720164609053,0.9197147088571845,1.0,2/10,1.11%,PRKCB;LRP1
prerank,response to histamine (GO:0034776),0.4259809821394729,0.869593622751328,0.6159420289855072,1.0,1.0,2/10,11.98%,GABRB2;GABRB3
prerank,Rac protein signal transduction (GO:0016601),-0.3203531161917742,-0.8695619280873703,0.6382428940568475,0.9194236833351221,1.0,2/18,1.21%,ELMO1;EPS8
prerank,tRNA aminoacylation (GO:0043039),0.35421930134629015,0.8692387900479484,0.6401673640167364,1.0,1.0,14/37,19.50%,HARS2;LARS1;GATB;IARS2;AIMP1;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2;GARS1;GATC
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3985977452786035,0.8680834117726732,0.6347687400318979,1.0,1.0,4/18,11.82%,PMAIP1;TMEM259;BOK;USP13
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.3597154643261888,0.8674445633685175,0.603030303030303,1.0,1.0,5/27,6.82%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1
prerank,regulation of interleukin-6 production (GO:0032675),-0.21217562043185761,-0.8674037303720429,0.8028169014084507,0.9232051559413315,1.0,20/96,19.38%,ARRB1;HMGB1;APP;PTPN11;LBP;WNT5A;LGALS9;PLCG2;PTPN22;IL6R;IRAK3;SIRPA;IL33;CX3CL1;SYT11;C1QTNF3;TLR3;NCKAP1L;ZC3H12A;TIRAP
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.30641878152484525,0.8672470099372734,0.6617480136208853,1.0,1.0,17/104,12.63%,CCNA2;CCND2;SLC8A2;SLC8A1;KSR1;ACTB;DAB2IP;CALM1;CCND1;MAP2K1;CCNT1;CDK7;RB1;LRP5;CDK12;TSG101;PDCD10
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.35169653380777,-0.866836241244442,0.6564705882352941,0.9235017857216176,1.0,3/12,6.39%,ABCA1;NFKBIA;ITGAV
prerank,regulation of defense response to virus by host (GO:0050691),0.3614610905014186,0.8667476176555152,0.6233576642335766,1.0,1.0,8/30,17.63%,CGAS;IL12RB1;ZDHHC1;MUL1;STAT1;SIN3A;DHX9;EIF2AK4
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2773717075015907,-0.8667383954354804,0.6728971962616822,0.9227766719899374,1.0,15/29,37.29%,ELOVL7;PPT1;ACSL3;ACLY;ACSL4;ELOVL6;HACD2;ELOVL1;ACSL1;HSD17B8;ELOVL5;GCDH;SLC25A1;SCD;ACACA
prerank,gland development (GO:0048732),0.326708804742851,0.8667230091051054,0.6292559899117276,1.0,1.0,10/59,13.32%,TG;ANXA1;ARID5B;TGFB3;CAV1;SOX9;ARHGAP35;GFER;CITED2;FGF10
prerank,neuron fate commitment (GO:0048663),-0.34241549580465636,-0.8667050001797265,0.6610169491525424,0.9219277545232829,1.0,10/14,54.73%,TGFBR1;POU3F2;DLL4;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1;MYT1L
prerank,positive regulation of inflammatory response (GO:0050729),0.30866332161293975,0.8665627143388787,0.6583034647550776,1.0,1.0,5/86,3.61%,AGTR1;PLA2G3;IL2;LPL;FEM1A
prerank,regulation of TORC1 signaling (GO:1903432),0.35387692518465436,0.8660916547025506,0.6313559322033898,1.0,1.0,5/33,9.52%,RNF152;LARS1;KPTN;CASTOR1;RRAGB
prerank,dendritic cell migration (GO:0036336),0.39648240854176603,0.8659638264238603,0.6071428571428571,1.0,1.0,4/16,12.48%,CCL5;ALOX5;TRPM4;TRPM2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.23467902033613547,-0.8657386566196026,0.735632183908046,0.9232531108264271,1.0,15/72,11.25%,ELF1;IFNAR2;PTPN11;IRAK1;CASP8;HSP90AB1;BIRC2;MADD;TNFRSF1A;IRAK3;IKBKG;RBCK1;RNF31;IRAK2;CHUK
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3153715228659277,-0.8655105818622962,0.6684636118598383,0.9228399432476081,1.0,7/18,22.15%,SEL1L;RNF185;UGGT2;UBC;OS9;SYVN1;UBB
prerank,regulation of pH (GO:0006885),0.42350215368814065,0.8652303236246561,0.589041095890411,1.0,1.0,1/11,2.53%,PDK4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.35706581314828556,-0.8647098005946782,0.6336405529953917,0.9235730519287065,1.0,4/11,20.40%,HMGB1;LGALS9;TWSG1;CD274
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4257578211965856,0.8646678002098718,0.5961199294532628,1.0,1.0,1/10,2.16%,ZEB2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.30974991150366415,-0.8646172414434696,0.6470588235294118,0.9228960322212666,1.0,6/18,26.59%,FBN1;TCTA;TLR3;GPR137B;MAFB;GPR137
prerank,regulation of vasculature development (GO:1901342),-0.2899909156715367,-0.8646137139687116,0.667590027700831,0.9220019722359731,1.0,5/26,11.43%,NF1;ADGRA2;CTNNB1;BMPER;SP100
prerank,cellular copper ion homeostasis (GO:0006878),-0.333409290966472,-0.8645040262144419,0.6378504672897196,0.9213529247750267,1.0,4/14,22.59%,APP;ATOX1;MT2A;SLC31A1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.28086540143758393,0.8644250822127062,0.944,1.0,1.0,261/1646,15.59%,ACTA2;MYOCD;SOX6;MLF2;PRDM16;SOX5;TNNI2;WTIP;MEF2C;ATP2B4;HEY2;MAP3K5;ZFHX3;TBX2;SMARCD3;PTP4A3;LBH;NR1H4;POLR2L;LIMS1;EBF1;LIMD1;TCIM;PDGFB;ZEB2;NAB1;ATP8B1;ALX4;RORA;MLF1;ID4;NR4A1;EBF2;SIM2;LOXL2;GABPA;PRRX1;ETS2;ARID5B;IFRD1;RUNX1T1;HEYL;TEAD3;PBXIP1;CAMK2D;IRX5;FZD4;HINFP;BRIP1;TGFB3;GMNN;ZNF436;FOSL2;RBAK;NACC2;NUP62;PRDM1;HDAC9;ARID1A;SET;NR2F2;TGFB1I1;ANKRD2;NR2C1;VEZF1;MTERF3;CAMKK2;ATXN1;OSR2;PIAS4;CBFB;SP7;KLF7;CCNQ;CEP290;TBX18;MEF2A;GBX1;DYRK1A;NCOA7;KLF16;PRKCQ;MTDH;TESC;DBP;FOXJ3;KLF15;SUV39H2;MYBBP1A;JUND;SMARCB1;CHD2;DAB2IP;ELOC;ARID5A;TP53;RXRG;VEGFA;DYRK1B;PPM1A;GRHL1;ZNF418;HEXIM1;ZBTB38;HDGFL3;SFPQ;HOXC4;BCL7A;PA2G4;AR;PPARGC1A;ZFP28;L3MBTL2;MED1;PPARGC1B;ZNF431;MED29;REXO4;BTG1;YAP1;ERCC6;MED12;SOX9;SNAI2;HSF4;RELA;ZFP62;PLCB1;KMT2D;SETD3;MAP3K10;DAPK3;CUX2;EPC2;ZXDC;ZKSCAN4;PPARA;TRAK1;CBX4;BBX;MAP2K1;MED13L;MSL3;CARF;CCNT1;FUS;NSD3;MTA3;NR4A2;PPIE;NR1D1;LRRFIP1;KAT7;ZBTB33;HIF1A;CRLF3;SFR1;ZBTB41;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC;CDK18;ZNF3;NAT14;MED14;NR2C2;NUP107;TEAD1;RAI1;SRSF10;PCGF5;SREBF2;RUNX1;RB1;LRP5;RHOH;ATF3;PIAS2;HOXC8;NKX6-1;ZKSCAN1;BAZ2A;ZBTB7A;NFX1;ACVR1B;ESRRA;CNOT7;PSPC1;LCORL;USP13;FBXW11;RUVBL1;LIN9;TSFM;CSRNP3;HDGFL2;TOX4;CITED2;CTDSP1;NR6A1;POU3F3;ZXDB;SMARCA5;MED8;ZBTB10;ZNF83;CDK15;ZFP69;MXD4;PPP3CB;BCL6;CHD4;IKZF1;CASZ1;MEF2B;HMG20A;FOXJ1;TRIM28;SPIN1;GAS6;ZBTB5;MAP2K3;RFX7;ZKSCAN7;CLOCK;ETV3;HOPX;ZNF276;ZBTB4;SP4;RFX1;EDF1;DVL1;MAPRE3;EBF3;VGLL4;UXT;IRF2BPL;PCGF3;MLXIPL;ZNF711;KLF6;KARS1;FBXO5;HOXB2;POFUT1;ZSCAN22;KDM2B;URI1;RHOG;RBM15;CIAO1;STAT1;DNM2;YWHAH;HOXC5;NR5A1;MAGED1;NOS1
prerank,cellular response to UV (GO:0034644),0.31681197315205734,0.8643835512275565,0.654524089306698,1.0,1.0,11/76,11.28%,CRIP1;TAF1;TP53;PARP1;NEDD4;CHEK1;IMPACT;CERS1;RHNO1;POLD1;PRKCD
prerank,error-free translesion synthesis (GO:0070987),-0.2997204534961167,-0.8642665364980034,0.6530054644808743,0.9209652907761293,1.0,11/22,37.19%,UFD1;POLDIP2;UBC;REV1;UBB;RPA3;RFC3;RPA2;RPA1;RFC1;RFC4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3696499045417606,0.8638590195740262,0.642965204236006,1.0,1.0,14/26,23.23%,DAB2IP;DUSP3;MED1;GAREM1;SOX9;SNAI2;ZFP36L1;KNSTRN;PTPN12;ERBB2;ZFP36L2;DUSP22;ZPR1;PLCG1
prerank,sterol biosynthetic process (GO:0016126),-0.2710974362628655,-0.8636731078521963,0.7095709570957096,0.9213353094024289,1.0,12/33,25.00%,PRKAG2;LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK
prerank,cellular response to metal ion (GO:0071248),0.29866724838162695,0.8635588739753153,0.6751101321585903,1.0,1.0,8/123,5.58%,RYR1;MEF2C;CACNA1H;RASGRP2;CAMK2D;SYT10;MEF2A;KCNH1
prerank,carbohydrate homeostasis (GO:0033500),0.31863423540526087,0.863379572779768,0.6425855513307985,1.0,1.0,7/67,5.92%,SLC2A4;PDK4;ALOX5;KCNB1;KLF7;IRS1;MBD5
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.396883223855456,0.8627692596336116,0.6063651591289783,1.0,1.0,1/17,2.32%,PLA2G3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.29251322319198253,-0.8624269266356651,0.6898550724637681,0.9231736672867983,1.0,6/23,20.22%,HSP90AB1;IRGM;PARP14;PPARG;NLRC5;PTPN2
prerank,DNA double-strand break processing (GO:0000729),-0.3119302918046869,-0.8623760727017661,0.6855036855036855,0.9223803744967741,1.0,5/18,18.12%,MRE11;RAD50;BLM;NBN;ATM
prerank,gas transport (GO:0015669),0.42734399963111025,0.8623014356108982,0.6007194244604317,1.0,1.0,1/10,2.97%,MB
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3576675861902495,0.8620961817617745,0.6382393397524071,1.0,1.0,4/33,4.59%,CDK6;FHL1;NACC2;JADE1
prerank,regulation of establishment of cell polarity (GO:2000114),0.3926303723571536,0.8620747112716531,0.5834710743801653,1.0,1.0,4/16,12.58%,ROCK1;KANK1;ROCK2;KIF20B
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.38753866482233723,0.8615462723897107,0.5979899497487438,1.0,1.0,6/17,15.87%,VEZF1;BTG1;SOX9;NKX6-1;FOXJ1;RFX3
prerank,stress-activated MAPK cascade (GO:0051403),0.3258048379058231,0.8613717597132331,0.6394052044609665,1.0,1.0,8/61,14.04%,MAP3K20;MAP3K5;MAP4K3;MAP3K10;FBXW11;ZFP36L1;MAP2K3;MAPK1
prerank,lipoprotein localization (GO:0044872),-0.3520308568165187,-0.861256212109307,0.6617021276595745,0.9238163517695236,1.0,2/11,1.11%,PRKCB;LRP1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.32241257493381836,-0.8599490412707321,0.6610169491525424,0.9257378164531969,1.0,3/16,5.23%,HMGB1;CECR2;KPNA1
prerank,regulation of myelination (GO:0031641),-0.2905523586973343,-0.8597119028545241,0.7029411764705882,0.9253640746358966,1.0,3/25,5.83%,PTN;JAM2;PTPRZ1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3376575052141617,-0.8595540721748776,0.645933014354067,0.9248199248573168,1.0,5/12,17.24%,CYP26B1;SNW1;KLF2;CALR;TRIM16
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2249609701679786,-0.8594859890748334,0.7616580310880829,0.9240707614396515,1.0,8/68,8.49%,HMGB1;APP;PTPN11;LBP;WNT5A;LGALS9;PLCG2;IL6R
prerank,regulation of axon extension (GO:0030516),-0.26714149320697056,-0.8594572522132682,0.6724137931034483,0.9232325515675882,1.0,8/37,12.47%,APOE;SEMA7A;RUFY3;GOLGA4;RNF6;SEMA3A;CDKL3;RTN4
prerank,positive regulation of T cell differentiation (GO:0045582),-0.26134897599853735,-0.8589395359199469,0.7009966777408638,0.9234898295034185,1.0,7/36,19.77%,LEF1;GLI2;ZMIZ1;CD46;SOX4;NCKAP1L;PNP
prerank,endomembrane system organization (GO:0010256),0.28988848565177405,0.8589153212510849,0.7056323060573858,1.0,1.0,36/178,17.67%,ARHGEF7;FER1L5;SYNE1;ATP8B1;DYSF;CLASP2;HOOK2;TBC1D20;ARHGAP21;LNPK;MYO18A;SEC31B;SUN2;HOOK1;NSFL1C;DNM1L;TLCD2;OSBPL2;CHMP2B;USP50;DMPK;AKTIP;PLEKHJ1;A4GALT;CLASP1;BNIP1;LRRK2;CSNK1A1;CAV2;SUN1;EIF2AK3;TRAPPC12;VPS51;UBXN2B;VPS4A;ARFGEF2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4071155278815243,0.8587153955347343,0.6226086956521739,1.0,1.0,4/13,15.76%,IL12RB1;NECTIN2;STX7;MR1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2964807664630726,-0.8586315094993275,0.684971098265896,0.9232656804527225,1.0,7/22,22.94%,SASH1;XDH;RELL1;MAP3K4;ZC3H12A;GADD45B;SPHK1
prerank,cell-cell junction organization (GO:0045216),0.3113467853455934,0.8583594499732531,0.6595238095238095,1.0,1.0,11/79,8.70%,CDH6;LIMS1;GJC1;CDH13;TGFB3;CDH4;CDHR3;LIMS2;TLN1;TGFB2;CDH2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.31224682772652385,-0.8583550833401842,0.6373333333333333,0.9229303034690839,1.0,8/19,17.74%,CUX1;CDKL3;CUL7;PTPRD;FBXW8;LRP8;OBSL1;DBN1
prerank,cortical cytoskeleton organization (GO:0030865),0.3400920827061458,0.8580154875296346,0.6244604316546762,1.0,1.0,7/41,11.36%,ROCK1;LCP1;RHOBTB3;PLEK;RHOF;ROCK2;RHOH
prerank,snRNA 3'-end processing (GO:0034472),-0.3142349933805857,-0.8578822938850766,0.6892655367231638,0.9230688186381282,1.0,9/19,28.48%,INTS6;INTS2;EXOSC9;EXOSC2;EXOSC7;EXOSC3;EXOSC5;INTS14;TOE1
prerank,negative regulation of protein secretion (GO:0050709),-0.261981275678692,-0.857460779879191,0.6928104575163399,0.9230697325955218,1.0,9/38,13.40%,APOE;ERP29;PSMD9;CCN3;RAB11FIP5;PRKN;CYP51A1;HMGCR;RAB11FIP1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3189152073617012,0.8569471135808742,0.629582806573957,1.0,1.0,8/56,9.58%,RBPMS;TGFB3;ACVR2A;BMPR1A;EMILIN1;PIN1;TGFB2;GDF1
prerank,endocytic recycling (GO:0032456),0.32898549441133923,0.8567415599988799,0.6418918918918919,1.0,1.0,15/50,17.39%,EHD2;ANKRD50;VPS26A;WASHC1;RAB11FIP3;RAB11FIP4;DENND1A;VPS35L;VPS50;RAB14;ANKRD27;SNX17;VPS35;SNX4;VPS51
prerank,regulation of spindle organization (GO:0090224),0.37945768644884886,0.856722161672513,0.6386138613861386,1.0,1.0,6/18,19.27%,NUP62;TPX2;SENP6;MAP9;DCTN1;CLTC
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.32316051680229707,0.8564338945975143,0.6388888888888888,1.0,1.0,16/55,18.01%,PMAIP1;BCL2;CAV1;DAB2IP;TP53;PAK2;DEDD2;DNM1L;GPER1;BOK;S100A8;S100A9;TNFSF12;BCAP31;DDIT3;BBC3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.2862952762667351,-0.8558443461798121,0.6885245901639344,0.9255234484409025,1.0,9/24,24.51%,SULF1;CCBE1;CYP1B1;TGFB1;PTGS2;ARNT;ATF4;FLT4;SULF2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.34768709432966993,0.8557210478323337,0.6547788873038516,1.0,1.0,3/31,4.75%,CACNA1H;SYT10;KCNB1
prerank,protein deacylation (GO:0035601),-0.2872784381331998,-0.8556626886660409,0.6809815950920245,0.9250276509499985,1.0,7/23,15.14%,LYPLA1;HDAC7;HDAC4;SIRT7;PPT1;NOTUM;ABHD17C
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.28221419299980954,-0.8556090434097672,0.7100591715976331,0.9242544281252801,1.0,8/27,18.53%,CHKA;LPIN2;NAAA;NAPEPLD;PLA2G6;PLAAT3;SELENOI;LPIN3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.379335891633057,0.8554493560734164,0.6325581395348837,1.0,1.0,3/21,5.29%,SAMD4A;PARN;CNOT4
prerank,macrophage activation (GO:0042116),0.3413075274184059,0.8553216513342053,0.6375176304654443,1.0,1.0,4/34,6.17%,FER1L5;DYSF;CRTC3;MAPT
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3926761698073704,0.8552512723285108,0.6285714285714286,1.0,1.0,3/15,14.06%,HGD;KMO;QDPR
prerank,glycosphingolipid metabolic process (GO:0006687),0.34287537393992795,0.8551527856927149,0.6234817813765182,1.0,1.0,11/42,14.95%,ESYT2;LARGE1;NEU3;GLA;SUMF1;ST8SIA5;A4GALT;GM2A;GLTP;GLB1;CTSA
prerank,cortical actin cytoskeleton organization (GO:0030866),0.38489735854682794,0.8550263149104697,0.6356073211314476,1.0,1.0,4/20,10.88%,ROCK1;LCP1;PLEK;ROCK2
prerank,negative regulation of insulin secretion (GO:0046676),0.3889641664198802,0.8547993475002194,0.6178451178451179,1.0,1.0,3/17,5.88%,KCNB1;KLF7;IRS1
prerank,positive regulation of neuron death (GO:1901216),-0.24709088480420877,-0.8545205826452584,0.7349397590361446,0.9255729737619884,1.0,5/46,3.76%,NF1;EPHA7;EFNB2;NUPR1;WNT5A
prerank,steroid hormone biosynthetic process (GO:0120178),0.3574448828971832,0.8535192903359187,0.6304347826086957,1.0,1.0,4/29,11.04%,HSD17B7;AKR1B1;MED1;SRD5A3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.35991551048431997,0.852770019618304,0.6272189349112426,1.0,1.0,6/24,17.63%,CGAS;IL12RB1;ZDHHC1;STAT1;SIN3A;EIF2AK4
prerank,transition metal ion transport (GO:0000041),0.3460741256516531,0.8526964246123019,0.6436781609195402,1.0,1.0,8/35,16.64%,TRPC6;TTYH1;TRPC5;SLC30A5;ATP7B;SLC31A2;IREB2;MT3
prerank,cellular response to dsRNA (GO:0071359),0.4006003642840768,0.8524646383371475,0.6328671328671329,1.0,1.0,5/15,16.80%,CGAS;CAV1;MUL1;FLOT1;DHX9
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.40251961612829956,0.8524537819884815,0.6273830155979203,1.0,1.0,1/12,2.54%,DPYSL4
prerank,positive regulation of superoxide anion generation (GO:0032930),0.4072919184164875,0.8519504958153034,0.6125827814569537,1.0,1.0,3/13,11.28%,MAPT;GSTP1;PRKCD
prerank,amino sugar biosynthetic process (GO:0046349),-0.3486232946693361,-0.8516967384651536,0.6348837209302326,0.9307070909537087,1.0,7/12,27.00%,PGM3;RENBP;UAP1;AMDHD2;GFPT2;UAP1L1;GNPDA1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2972798328551365,0.8516223027206943,0.6954087346024636,1.0,1.0,35/119,19.44%,PIP5K1B;INPP4B;PIP4K2A;MTMR7;SOCS5;PITPNM3;PIGN;SOCS6;SOCS4;SYNJ2;PIGA;SACM1L;TTC7A;INPPL1;MTMR14;ITPKC;CDIPT;SBF1;PIK3C3;RAB14;PLEKHA1;PIGH;INPP5J;PIGB;PITPNM2;PTEN;VAC14;PIGP;DPM2;PLEKHA2;MTMR3;INPP4A;MBOAT7;PIK3R2;PGAP4
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.22285875414804707,-0.8512491911402528,0.8333333333333334,0.9308059289207099,1.0,27/72,29.00%,IRAK1;BIRC2;PSMD7;PSMD9;PSMD13;CARD10;PSMB3;CHUK;CARD14;PSMC5;PSMA5;PSMA1;PSMC2;BIRC3;RELB;AKT1;TLR3;TIRAP;BTRC;PSME3;PSMC4;PSMB6;PSMB10;NFKB2;PSMA4;PSME1;PSMF1
prerank,positive regulation of phosphorylation (GO:0042327),0.2834618103732473,0.8510840864118965,0.739085239085239,1.0,1.0,47/240,15.72%,NTRK3;ANGPT1;FGF1;MERTK;MST1R;CCN1;ROR1;CCND2;THPO;FAM20A;CCL5;PFKFB1;ACVR2A;MUSK;CAMKK2;RARRES2;DSCAM;VEGFA;PIN1;AR;RASGRP1;ITGB3;SOX9;CCND1;ADAM17;EPHA2;HIF1A;AXL;RAP2A;PDGFRB;PELI2;GPER1;ROCK2;CLIP3;TNIK;AKTIP;CHRNA7;FGF10;GAS6;EPHB1;LRRK2;PRKAA2;MLXIPL;GAPDHS;MYDGF;FLOT1;VAC14
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3616367499295312,-0.8510751279499523,0.6376146788990825,0.9302906884817165,1.0,3/10,10.15%,MLLT3;HOXB4;ACE
prerank,snRNA metabolic process (GO:0016073),-0.3201517590317697,-0.8510149825605641,0.6675257731958762,0.9295295421161481,1.0,5/17,23.70%,INTS6;INTS3;INTS2;RBM7;INTS11
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.30628704359686243,-0.8508865517020484,0.6919060052219321,0.9289004231193904,1.0,8/19,25.87%,PRKDC;ZMIZ1;XRCC6;NCKAP1L;PPP2R3C;ZBTB1;MMP14;SYK
prerank,fatty acid metabolic process (GO:0006631),0.29515818826931733,0.8505382777878644,0.7085201793721974,1.0,1.0,18/115,14.01%,CD36;LPL;FA2H;ALOX5;PEX2;ACSL5;PPARGC1A;CPT1B;CRAT;MECR;PPARA;THEM4;NUDT19;AOAH;NDUFAB1;PNPLA3;CPT1A;ACOT6
prerank,intracellular cholesterol transport (GO:0032367),-0.33078791027098897,-0.8505273589473699,0.6917098445595855,0.9287497238394147,1.0,6/15,23.59%,ABCA1;LDLR;STARD4;OSBP;RELCH;NPC1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.406536538108609,0.8502064092270994,0.6144781144781145,1.0,1.0,2/14,5.41%,CCL5;RARRES2
prerank,protein homooligomerization (GO:0051260),0.2963922721228103,0.8500883922073911,0.689419795221843,1.0,1.0,16/114,13.72%,RYR1;KCNJ12;HSD17B10;CRYZ;NACC2;ACACB;TIFA;TRPM4;FUS;SLC1A5;ALDOA;GLS;OSBPL2;TRPM2;CHMP2A;VSTM5
prerank,acylglycerol catabolic process (GO:0046464),0.35459283935784575,0.8499435058845011,0.6546762589928058,1.0,1.0,4/30,13.34%,LPL;FABP4;MGLL;PNPLA3
prerank,cellular amide metabolic process (GO:0043603),-0.21095243282604303,-0.8496272016077738,0.8076923076923077,0.9297533661872786,1.0,24/102,22.28%,AEBP1;CERK;ST3GAL1;PPP2CA;SLC25A32;PCCA;NAAA;NAPEPLD;ACSF2;ASAH2;ACOT8;DBI;ACOT9;PLAAT3;CPD;CPXM1;MTHFS;ALDH1L1;FPGS;ABCB9;MCCC1;ATF4;ABCA2;PDZD11
prerank,cognition (GO:0050890),0.336441715230517,0.8489542442779708,0.6451612903225806,1.0,1.0,7/42,12.38%,LHCGR;SLC8A2;CYFIP1;CUX2;HRH3;CHMP2B;CHRNA7
prerank,response to exogenous dsRNA (GO:0043330),0.37797735320003956,0.8489065522013386,0.6155115511551155,1.0,1.0,7/18,17.16%,CGAS;CAV1;MUL1;FLOT1;RFTN1;DHX9;TICAM1
prerank,mitochondrial fission (GO:0000266),-0.32153156550417206,-0.8487831798007166,0.6842105263157895,0.9306460419435225,1.0,5/16,15.32%,DNM3;DNM1;MTFR1;PRKN;FIS1
prerank,regulation of cholesterol storage (GO:0010885),0.39554168138446466,0.848592111784516,0.6354515050167224,1.0,1.0,4/15,11.57%,LPL;PPARA;SREBF2;ABCG1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3319762399667662,-0.8485645435161134,0.665948275862069,0.9302383937126251,1.0,5/13,30.92%,RPS21;NOP9;UTP20;RRS1;TBL3
prerank,aerobic respiration (GO:0009060),0.36970369921900437,0.8479751934290147,0.6130573248407644,1.0,1.0,3/20,5.59%,SIRT3;ME3;SDHC
prerank,regulation of keratinocyte migration (GO:0051547),0.41191747814384516,0.8474795027313918,0.6205128205128205,1.0,1.0,5/12,24.11%,MAPRE2;FGF10;PTEN;ADAM9;IQSEC1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.341263970180432,-0.8470790083439398,0.667447306791569,0.9324596499842985,1.0,8/12,28.88%,GMPS;ADSS2;PFAS;GART;ATIC;IMPDH1;IMPDH2;PAICS
prerank,phosphate ion homeostasis (GO:0055062),-0.36602630144581383,-0.8470494400742561,0.6575963718820862,0.9316382342176668,1.0,3/10,21.26%,SFRP4;ENPP1;FGFR4
prerank,negative regulation of interferon-gamma production (GO:0032689),0.36735981515349697,0.8469106680705132,0.6434108527131783,1.0,1.0,4/23,13.57%,NR1H4;HAVCR2;AXL;GAS6
prerank,protein modification process (GO:0036211),-0.21764950301444888,-0.8458697075254126,0.7987804878048781,0.9332519528477714,1.0,25/76,27.41%,ST3GAL6;PLAT;ST8SIA4;ST3GAL1;PRKDC;UBE2D3;STK38;ATG3;CDKL3;ABL2;ST8SIA2;PLOD2;PPP4R2;NTAQ1;UBE2S;UBA7;CHRM3;B4GALT7;RPN2;FBXW2;USP25;SERP1;PARP4;LOX;QPCT
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2928837410724849,0.8457206407973804,0.7059483726150393,1.0,1.0,16/124,11.49%,TPM1;ROCK1;FRY;ARMC2;BTG2;MAPT;GDNF;HDGFL3;NEDD4;CYFIP1;PLEK;ERCC6;ATCAY;SAMD14;RB1;KIFAP3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.36864514767285333,0.8455572268320626,0.6235864297253635,1.0,1.0,4/20,12.11%,GSTT1;GSTP1;ESD;GSTA4
prerank,glutathione derivative metabolic process (GO:1901685),0.36864514767285333,0.8455572268320626,0.6235864297253635,1.0,1.0,4/20,12.11%,GSTT1;GSTP1;ESD;GSTA4
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3155123045597172,-0.8455514774213831,0.6945812807881774,0.9330161775863979,1.0,4/16,10.78%,AUTS2;RASGRF1;PIK3CB;OGT
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.28301550832300176,0.8453692975566394,0.7258771929824561,1.0,1.0,25/151,15.00%,DMD;PPM1L;LARGE1;SLC44A5;FA2H;STARD7;TYW5;HACD1;GSTT1;SLC44A1;TNIP1;LPCAT3;GSTP1;CERS1;MOCS1;SAMD8;ESD;GSTA4;SLC25A2;PRKD3;ST3GAL2;PLA2G4A;CHKB;SPTLC1;PLA2G4C
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.32470758119834653,-0.845191299154059,0.6674528301886793,0.9328970401834645,1.0,5/16,14.87%,DCPS;SNRNP200;CWC15;SFSWAP;NCBP2
prerank,positive regulation of cell junction assembly (GO:1901890),0.3178198517637487,0.8451601788186279,0.648171500630517,1.0,1.0,8/56,11.33%,ROCK1;LIMS1;FERMT2;CAV1;VEGFA;CUX2;EPHA2;IL1RAPL1
prerank,regulation of plasminogen activation (GO:0010755),0.410838911504685,0.8451087974514236,0.6169064748201439,1.0,1.0,2/12,11.11%,SERPINE2;RUNX1
prerank,retinal metabolic process (GO:0042574),-0.3439164382551043,-0.8450928061428568,0.672093023255814,0.9322341906466582,1.0,2/12,8.42%,ABCA4;CYP1B1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3399719676201779,-0.8449511687580868,0.6777251184834123,0.9316245007713222,1.0,5/13,21.19%,GLUL;ASPA;ACOT8;MTHFS;GAD1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2889683572497081,-0.844593485371148,0.6957671957671958,0.9314606609267637,1.0,4/21,10.06%,SLC30A10;ABCB7;COA8;PRKN
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.324425574101981,-0.8444241323789858,0.6899766899766899,0.9309267063257607,1.0,10/14,59.17%,ATP6AP1;TYROBP;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3499901909181832,-0.8442055989051966,0.6705069124423964,0.9304697510498599,1.0,5/11,23.41%,KHDRBS1;AKAP8L;NCBP2;NRDE2;CPSF6
prerank,regulation of embryonic development (GO:0045995),0.3394820004929899,0.8441754969117309,0.6536856745479833,1.0,1.0,7/34,14.14%,PHLDB2;CLASP2;PLCB1;RBM19;NR2C2;CLASP1;RAB14
prerank,positive regulation of blood coagulation (GO:0030194),-0.3101963207533335,-0.8441112703246489,0.675392670157068,0.9297748695585597,1.0,6/17,21.91%,ST3GAL4;F3;THBD;SERPINE1;ENPP4;USF1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.32233001503854125,0.8439325557460784,0.676923076923077,1.0,1.0,11/46,11.75%,EMILIN1;DAB2IP;DUSP3;PIN1;PTPN1;WNK2;TNIP1;GSTP1;CNKSR3;GPER1;DUSP29
prerank,dendritic cell chemotaxis (GO:0002407),0.39496096577667694,0.8437894102962575,0.6444833625218914,1.0,1.0,3/14,12.48%,CCL5;TRPM4;TRPM2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.28511362040115323,-0.8437501430685737,0.6876640419947506,0.9296463557397772,1.0,12/23,34.13%,ATXN3;OTUD7B;MINDY1;VCPIP1;USP37;OTUD3;USP25;TNFAIP3;YOD1;USP34;MINDY2;BAP1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.34305935326905124,-0.8429657990765298,0.6940133037694013,0.9303220544823776,1.0,7/12,34.15%,ESR1;TGFB1;PPARG;ZC3H12A;ZC3H10;NCOR1;ELAVL1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.33490779207346283,0.8429588458558884,0.6603260869565217,1.0,1.0,7/41,10.48%,PDGFB;DOK7;FBXW7;PTPN1;AREG;ADAM17;HBEGF
prerank,camera-type eye morphogenesis (GO:0048593),0.4242242758914331,0.8427062053584297,0.6416510318949343,1.0,1.0,3/10,9.18%,TBX2;VEGFA;SKI
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3112442418424618,0.84270110972619,0.6759142496847415,1.0,1.0,12/62,13.03%,POLR2L;POLR2I;ADRM1;GTF2H4;ELL;POLR2G;ELOC;CCNT1;CDK7;CDK12;NELFB;POLR2J
prerank,ribosome assembly (GO:0042255),0.32966741551359696,0.842274858293291,0.6501340482573726,1.0,1.0,7/47,9.57%,RPL3L;MTERF3;RPS27L;NLE1;MDN1;PWP2;RPL5
prerank,endodermal cell differentiation (GO:0035987),0.3454243653284539,0.8420108718386782,0.6138763197586727,1.0,1.0,4/31,8.26%,COL4A2;ITGA7;ITGB5;ITGA4
prerank,intraciliary retrograde transport (GO:0035721),-0.3439827487967729,-0.8419837323697426,0.6847058823529412,0.9313937114263144,1.0,5/12,28.51%,IFT122;DYNC2H1;DYNLT2B;DYNC2I2;DYNC2I1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4098595280797802,0.8416555060600004,0.6349480968858131,1.0,1.0,2/11,6.18%,PWP1;SMARCB1
prerank,myoblast differentiation (GO:0045445),0.3956803283431408,0.8412923290400364,0.6214876033057851,1.0,1.0,5/14,11.19%,JAG1;HINFP;PLEKHM3;MBNL1;RB1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.32749343705553785,-0.8409916496299066,0.6682692307692307,0.9326179414321741,1.0,3/14,10.27%,STARD13;MEOX2;CARD10
prerank,positive regulation of neuron projection development (GO:0010976),0.3084884444973262,0.8407057955187743,0.6960193003618818,1.0,1.0,5/85,2.57%,RAP1A;NTRK3;SERPINI1;PLA2G3;ROR1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3797278729521227,0.8402414905501085,0.6495016611295681,1.0,1.0,5/20,13.26%,NR1H4;LPCAT3;MBTPS1;SREBF2;LDLRAP1
prerank,Golgi organization (GO:0007030),0.29359497262197354,0.8401622978621976,0.7123745819397993,1.0,1.0,7/112,5.29%,ARHGEF7;SYNE1;ATP8B1;CLASP2;TBC1D20;ARHGAP21;MYO18A
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3622048059983351,-0.83986435285646,0.6688888888888889,0.9340392227284045,1.0,5/10,21.50%,DSE;DSEL;XYLT1;PXYLP1;B3GAT1
prerank,negative regulation of TOR signaling (GO:0032007),0.34236503578383715,0.8394218089414368,0.6619115549215406,1.0,1.0,9/36,15.37%,RNF152;KPTN;CASTOR1;EPM2A;NPRL2;SH3BP4;PRKAA2;CASTOR2;ITFG2
prerank,lung development (GO:0030324),0.338820874527702,0.8392241939771226,0.6704545454545454,1.0,1.0,4/33,6.65%,FGF1;ITGA3;VEGFA;ABCA3
prerank,regulation of catecholamine secretion (GO:0050433),-0.2625699674871212,-0.8391517578815898,0.7337461300309598,0.9345463627822954,1.0,16/29,31.38%,SYT1;DTNBP1;PRKN;GRK2;SNCA;SYT11;SYT12;STX1A;SYT6;SYT2;DRD2;SYT7;SYT9;CHGA;SYT13;SYT3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.36714614635347836,0.8391229786802579,0.6438569206842923,1.0,1.0,7/21,18.00%,PMAIP1;OPA1;BOK;LRRK2;EIF2AK3;CREB3;DDIT3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27537079714247276,0.8385587744499944,0.8361809045226131,1.0,1.0,50/417,10.27%,PRDM16;HEY2;TBX2;LBH;LIMS1;LIMD1;PDGFB;NAB1;ATP8B1;ID4;LOXL2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;GMNN;RBAK;NACC2;HDAC9;SET;NR2F2;MTERF3;ATXN1;PIAS4;SUV39H2;MYBBP1A;DAB2IP;ARID5A;TP53;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;L3MBTL2;SOX9;RELA;PLCB1;MAP3K10;CBX4;MTA3;NR1D1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3400317424797043,0.8384498647441645,0.6619915848527349,1.0,1.0,6/36,8.04%,PPP3CA;FZD5;FZD4;GNAO1;CALM1;PLCB1
prerank,cellular response to nutrient levels (GO:0031669),0.31677308142637506,0.8383631076511439,0.6931818181818182,1.0,1.0,13/62,14.41%,PDK4;LPL;KCNB1;ATG7;STK26;PPARA;RRAGB;STK24;SREBF2;WDR45;PDK2;LRRK2;PRKAA2
prerank,nuclear membrane organization (GO:0071763),-0.2981812155524428,-0.8377227550383277,0.6726342710997443,0.9364737305834183,1.0,9/19,26.55%,SPAST;TOR1AIP1;AKAP8L;TARDBP;EMD;TMEM43;CHMP4B;TOR1A;CHMP7
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.34117853743469423,0.8377169218113191,0.641399416909621,1.0,1.0,8/29,20.62%,PLA2G3;LPCAT3;PLB1;PLA2G4A;PLA2G4C;NR1H3;MBOAT7;LPCAT1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.30288089365327797,-0.8376827094703365,0.6886075949367089,0.9356768613126668,1.0,3/18,8.06%,THOC2;PABPN1;POLDIP3
prerank,fat cell differentiation (GO:0045444),0.3154995605192831,0.8373587663001194,0.649367088607595,1.0,1.0,7/57,11.84%,PRDM16;NR4A1;PPARGC1A;MED1;NR4A2;ZBTB7A;CLIP3
prerank,membrane fusion (GO:0061025),0.3461557517855224,0.837209309640091,0.6666666666666666,1.0,1.0,10/33,17.84%,FER1L5;DYSF;OPA1;GCA;NSFL1C;DNM1L;NSF;DNM2;UBXN2B;SNAP23
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.30933837966211847,0.836660913613221,0.7012835472578763,1.0,1.0,18/79,15.69%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;MFSD6;DNM2;AP1S3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.27005658804485666,-0.8366570134708038,0.719626168224299,0.9367604806125168,1.0,8/29,16.30%,UBE2D3;CASP8;BIRC2;IKBKG;UBC;CHUK;BIRC3;TLR3
prerank,calcium import into the mitochondrion (GO:0036444),-0.3597285377822144,-0.8361316178346582,0.6817204301075269,0.9368980054328228,1.0,4/10,14.63%,MCU;MCUB;MICU2;MAIP1
prerank,response to X-ray (GO:0010165),-0.32976891657865814,-0.8360710490295401,0.6797235023041475,0.936145437181906,1.0,7/14,23.64%,XRCC5;BRCC3;BLM;XRCC6;ATM;IKBIP;NUCKS1
prerank,kinetochore organization (GO:0051383),-0.33789457871083517,-0.8360485697253631,0.6761487964989059,0.935314829392361,1.0,2/13,5.53%,POGZ;CENPC
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.3604665124791798,-0.8358324630735225,0.6824324324324325,0.9348456017664505,1.0,5/10,22.15%,UBC;TUT4;CHFR;TUT7;UBB
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3652924075893724,0.8358056714508149,0.6593567251461988,1.0,1.0,6/22,10.58%,PSMC6;TP53;MED1;MED12;PAXIP1;MED14
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.3353894077358785,-0.8357096085369357,0.6658823529411765,0.9342034614321687,1.0,7/13,29.79%,SDAD1;NUP88;NMD3;NOP9;RAN;RRS1;RPS15
prerank,myelination in peripheral nervous system (GO:0022011),-0.32869455315850654,-0.8356234373754904,0.6861826697892272,0.9335006558402962,1.0,5/13,19.29%,NF1;ADGRG6;ARHGEF10;LGI4;MYOC
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.22961582344986886,-0.8355396733466459,0.8018018018018018,0.932812157628995,1.0,21/52,30.33%,EXTL3;HSPA5;SRPRB;CUL7;ERN1;ARFGAP1;TSPYL2;ZBTB17;SYVN1;DNAJB9;SSR1;SRPRA;TPP1;ATP6V0D1;CXXC1;SERP1;WIPI1;PPP2R5B;ACADVL;KLHDC3;PARP16
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.2480703022218291,-0.835269766550122,0.7677902621722846,0.9324812776316298,1.0,24/42,42.96%,PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;ZBTB1;POLI;RPA3;RFC3;USP43;RPA2;POLD3;PCLAF;RPA1;RFC1;POLE;RFC4;CDKN2D;DTL;POLA1;RFC5
prerank,embryonic organ development (GO:0048568),0.3110805897478163,0.8351608325348602,0.6809583858764187,1.0,1.0,9/61,10.74%,HEY2;TBX2;TEAD3;BMPR1A;RARRES2;GDNF;TGFB2;TEAD1;PDGFA
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2111238670121755,-0.8351601770558249,0.8243243243243243,0.9318166305827771,1.0,34/85,31.53%,FZD6;PRICKLE2;VANGL1;WNT5A;MAGI2;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2;CDC42;AP2A2;PSME3;PSMC4;CELSR1;VANGL2;PSMB6;PSMB10;DVL2;TIAM1;PSMA4;PSME1;WNT11;PSMF1;AP2M1;ARHGEF19;PSMB9;PSME2
prerank,arachidonate transport (GO:1903963),0.4238541073592576,0.8348159713332127,0.6505190311418685,1.0,1.0,1/10,2.78%,ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.4238541073592576,0.8348159713332127,0.6505190311418685,1.0,1.0,1/10,2.78%,ANXA1
prerank,O-glycan processing (GO:0016266),-0.2310295555877806,-0.8345729787986372,0.8168316831683168,0.9320927092525805,1.0,4/54,3.34%,GXYLT2;ST3GAL4;ST3GAL1;GALNT10
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.38557868233659665,0.8345304968312657,0.6441515650741351,1.0,1.0,3/16,6.84%,ZFAND2B;IGFBP5;IGFBP4
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2833989228288614,0.8344301760045477,0.7364505844845909,1.0,1.0,42/166,18.77%,DYRK2;CD36;PDGFB;ZEB2;VIM;BCAR3;SAMD4A;CCL5;NAT10;IRS1;SORBS1;RPS27L;CIRBP;PPARGC1A;PYM1;NR1D1;KAT7;PTH1R;RPL5;HIF1A;PDGFRB;EIF3E;RBM3;ZCCHC4;CLU;CPEB3;ARPP19;PLXNB2;NNMT;MLXIPL;IRS2;PAOX;SP1;PIWIL2;DHX9;FAF1;NR1H3;P2RX4;EEF2;UPF3A;EGR1;CCL19
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3857900228817511,0.834391618389272,0.6282467532467533,1.0,1.0,4/18,9.74%,LAX1;DUSP3;PPARA;PAG1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.28294268617948454,-0.8343649877418907,0.7074626865671642,0.9316316278338307,1.0,4/25,3.38%,APP;ITGA6;NRP1;EGFR
prerank,cellular response to mechanical stimulus (GO:0071260),0.31875932723904915,0.8342973449955725,0.6636363636363637,1.0,1.0,8/46,17.09%,MYD88;CNN2;CHEK1;SOX9;CASP8AP2;TNFRSF10B;MAP2K4;MAP3K2
prerank,aminoglycan catabolic process (GO:0006026),0.34452860670361257,0.8340306227387165,0.6783004552352049,1.0,1.0,3/28,10.06%,SDC2;GPC4;AGRN
prerank,sulfur amino acid metabolic process (GO:0000096),0.36443452224653067,0.8338273751269495,0.6641452344931922,1.0,1.0,4/24,10.81%,TXN2;ADI1;AHCY;SMS
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.21812846749429649,-0.8330327778536528,0.8376623376623377,0.9334127725652276,1.0,32/80,28.66%,DENND2A;GBF1;VTI1A;TMEM87B;STX5;TBC1D5;GCC2;HEATR5A;SURF4;SNX6;RBSN;RAB29;YKT6;LMAN1;SNX3;VPS53;RAB9A;TBC1D10A;EHD3;VPS52;STX6;TBC1D14;BET1L;UBE2O;ARL1;ERC1;BAIAP3;GOSR1;PHETA1;DENND5A;RIC1;SNX12
prerank,negative regulation of translational initiation (GO:0045947),0.40088968357356236,0.8328447064143208,0.644808743169399,1.0,1.0,5/13,20.84%,EIF4EBP1;EIF3E;EIF2AK4;TPR;LARP1
prerank,isotype switching (GO:0045190),-0.3583368164261602,-0.832363626203846,0.6567164179104478,0.933885004842891,1.0,5/10,35.66%,MSH6;HSPD1;EXOSC3;BATF;LIG4
prerank,regulation of T cell activation (GO:0050863),0.3297104125083199,0.8323632889429076,0.6716216216216216,1.0,1.0,5/42,9.74%,CCL5;LAX1;PRKCQ;DUSP3;PAG1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.23835855351326787,-0.8321219578929935,0.8042553191489362,0.9334903322059798,1.0,7/42,11.95%,LBP;RPS19;OPTN;IL6R;DEFA6;IRGM;GSDMD
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3183236440711034,0.831863795681937,0.6728232189973615,1.0,1.0,7/54,10.06%,SDC2;EXT2;GCNT2;HS2ST1;GPC4;HS6ST1;AGRN
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.19595833896718742,-0.831766690763131,0.8793103448275862,0.9333611221041401,1.0,23/124,14.23%,LEF1;AGO3;WNT4;TCF7L2;FZD6;PRICKLE2;VANGL1;WNT5A;PLCB3;CTNNB1;PSMD7;PSMD9;PSMD13;SMURF2;SFRP4;PSMB3;TNRC6A;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2
prerank,ncRNA transcription (GO:0098781),0.3993723194263107,0.8315523118004908,0.6758620689655173,1.0,1.0,1/13,1.68%,CAVIN1
prerank,body fluid secretion (GO:0007589),-0.31548317584789926,-0.831385815323633,0.7142857142857143,0.9332622539542041,1.0,3/15,12.68%,NPR1;SLC22A4;PRLR
prerank,iron-sulfur cluster assembly (GO:0016226),0.3638564603383881,0.8311142708413436,0.6687402799377916,1.0,1.0,8/24,15.35%,FXN;GLRX5;ISCA1;ISCA2;NUBP2;NUBP1;GLRX3;CIAO1
prerank,regulation of myoblast fusion (GO:1901739),0.3980624505834561,0.8311124566020953,0.6479400749063671,1.0,1.0,4/11,15.51%,EHD2;CD53;ADGRB1;FLOT1
prerank,phagosome maturation (GO:0090382),0.33936322502353466,0.8309803950962228,0.6676176890156919,1.0,1.0,16/35,25.65%,ATP6V1H;ATP6V0A2;MREG;ATP6V1C1;ATP6V0D2;RAB14;RAB34;RAB38;ATP6V0C;PIKFYVE;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,endoplasmic reticulum organization (GO:0007029),0.30111097972116635,0.8305307714461576,0.6958637469586375,1.0,1.0,13/72,17.01%,TRDN;LNPK;SEC31B;LPCAT3;STX18;DNM1L;GET4;TRAM1;BNIP1;LRRK2;CAV2;SEC61B;EIF2AK3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3433391640474506,-0.8300033734757146,0.7031578947368421,0.935085320714991,1.0,4/11,19.27%,UBQLN1;PRKN;P4HB;PARK7
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.2662382628621891,-0.8298688252399532,0.7272727272727273,0.9344956672109742,1.0,8/30,16.30%,UBE2D3;CASP8;BIRC2;IKBKG;UBC;CHUK;BIRC3;TLR3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3408384604892346,0.8298123345316124,0.6447552447552447,1.0,1.0,9/33,16.02%,THPO;ACVR2A;TESC;MED1;ANKRD54;HIF1A;ACVR1B;STAT1;STAT3
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2640286061189058,-0.829698944820472,0.7170418006430869,0.9339649918584605,1.0,8/31,13.57%,TNKS2;MRE11;PML;RAD50;GNL3;NBN;MAP3K4;HNRNPD
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.25096607896284134,-0.8294482738311233,0.762589928057554,0.9335541953462523,1.0,19/37,26.44%,RYBP;PML;HSP90AB1;USP7;SDCBP;SGTA;OGT;GIPC1;UBXN1;NOP53;RPS7;RPL11;PARK7;TRIM39;TLK2;BAG5;CSNK2A2;CSNK2A1;HFE
prerank,protein deubiquitination (GO:0016579),-0.187705161053641,-0.8291489365615194,0.8695652173913043,0.9333079019682344,1.0,59/242,19.25%,SMAD3;ATXN3;USP46;FOXK2;USP11;ASXL2;NFKBIA;OTUD7B;WDR48;USP45;UFD1;USP19;BIRC2;ACTR8;PSMD7;USP7;USP12;PSMD9;PSMD13;MDM2;IKBKG;BRCC3;SMURF2;HCFC1;ESR1;SENP8;PRKN;OGT;PSMB3;UBC;TGFBR1;SKP2;USP3;IL33;SUDS3;PSMC5;TAB1;EP300;PSMA5;USP29;PSMA1;PSMC2;BIRC3;ATXN7;MINDY1;HGS;VCPIP1;USP37;OTUD3;SMAD2;CDC25A;EIF3F;USP24;SMAD4;SNX3;SIAH2;ZC3H12A;USP10;USP32
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.277414783290588,-0.8290727787133746,0.7093023255813954,0.9325969055985578,1.0,12/22,44.88%,WNT5A;SLC7A5;TRIL;LAPTM5;NOD2;TRIM6;BTK;SPHK2;CCR2;LACC1;TNFRSF14;LILRB1
prerank,cellular response to ketone (GO:1901655),0.33219300411596403,0.8287739319092501,0.6872309899569584,1.0,1.0,5/35,10.88%,ADCY5;ADCY2;AR;ADCY6;ROCK2
prerank,steroid biosynthetic process (GO:0006694),-0.22608813918843093,-0.828706923937823,0.7860262008733624,0.9324203053176321,1.0,27/56,36.69%,PRKAG2;CYP27A1;LBR;CYP51A1;ACOT8;HMGCR;PRLR;INSIG1;SQLE;OSBP;AMACR;DHRS11;PMVK;LSS;FDXR;OSBPL7;OSBPL9;INSIG2;EBP;SLC27A2;SC5D;STAR;TM7SF2;HSD11B1;SRD5A1;DHCR7;CH25H
prerank,organonitrogen compound catabolic process (GO:1901565),-0.22869845527947705,-0.8286153386305234,0.7889447236180904,0.9317530359986911,1.0,21/57,27.86%,GGACT;ANPEP;NPEPPS;TRIM24;RENBP;ENPP2;PPT1;ACE;PLA2G6;SIAH1;PLA2G7;CLPX;AMDHD2;USE1;TPP1;NPL;LRSAM1;GNPDA1;PNPLA8;CPQ;CLN8
prerank,response to ethanol (GO:0045471),-0.3186296112324293,-0.8285199141186366,0.7019230769230769,0.9310635179861534,1.0,10/14,45.69%,ADCY7;GRIN3A;GLRA2;GLRA1;SDF4;GRIN2A;GRIN1;SOD1;GRIN2B;CHRNB2
prerank,protein-containing complex disassembly (GO:0032984),0.31004118228423544,0.8282439205830028,0.698992443324937,1.0,1.0,11/54,15.26%,FZD5;LIX1L;GABARAP;CAV1;LIX1;PYM1;AMER1;PPP1CA;TSG101;DVL1;CSNK1A1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.3533927067999323,-0.8274448956332674,0.7032710280373832,0.9322589363744224,1.0,1/10,1.71%,HMGB1
prerank,protein localization to chromatin (GO:0071168),-0.2962235509315648,-0.827287799863823,0.6976744186046512,0.9317043327738412,1.0,7/18,33.88%,PPHLN1;ESR1;LEMD2;CHMP7;PIH1D1;RUVBL2;MCM8
prerank,integrin-mediated signaling pathway (GO:0007229),0.30322890603933617,0.8271908665483614,0.69377990430622,1.0,1.0,10/73,7.51%,ITGB6;LAMA5;FERMT2;MYH9;ITGB1;DST;FYB2;ITGB5;ITGB3;PLEK
prerank,negative regulation of proteolysis (GO:0045861),0.3359691006049314,0.8270990987339525,0.6689944134078212,1.0,1.0,3/34,6.81%,ROCK1;SERPINE2;TIMP4
prerank,protein secretion (GO:0009306),-0.22925087988506357,-0.8266369474246671,0.8,0.932058965080049,1.0,18/56,19.78%,PCSK5;ABCA1;SEL1L;RAB12;CYB5R4;CANX;STEAP3;WLS;GOLPH3;PDIA4;RCN3;ARFGAP3;MON1A;RAB13;RIMS2;PARK7;MIA3;PPY
prerank,negative regulation of viral genome replication (GO:0045071),-0.24790395396338144,-0.8264790322653466,0.7553191489361702,0.9315331722994753,1.0,15/40,25.32%,PARP10;SETDB1;IFIT1;BST2;MPHOSPH8;IFITM1;OAS2;SHFL;IFITM3;SRPK1;HMGA2;RNASEL;RESF1;ZC3HAV1;IFITM2
prerank,organelle transport along microtubule (GO:0072384),0.3340796899296734,0.8261134239854795,0.6756756756756757,1.0,1.0,10/31,18.33%,ARHGAP21;BICD2;MAPT;KIF5B;TRAK1;FBXW11;UXT;RHOT1;BICD1;MAP1S
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3530374614411808,0.8258723644928007,0.6606334841628959,1.0,1.0,5/24,11.37%,CHD6;TP53;VEGFA;HIF1A;ATF3
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2933771689434994,-0.8256499328066472,0.6852367688022284,0.9323321198481416,1.0,12/18,52.69%,EGFR;ESR1;CCDC62;RUVBL2;FAM210B;SFRP1;NCOA3;SSTR2;POU4F1;RAMP3;CRHBP;SSTR1
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.30730522526527054,-0.8255147736091615,0.6876574307304786,0.9317433930304563,1.0,6/15,23.18%,LRP1;PDPN;TGFB1;DPP4;FGFR4;FSCN1
prerank,N-terminal protein amino acid modification (GO:0031365),-0.3203775577404736,-0.8250107047467163,0.6847058823529412,0.9318307343582102,1.0,6/14,35.64%,METAP1D;NAA50;NAA60;NAA40;NAA10;NTMT1
prerank,positive regulation of nuclear division (GO:0051785),0.34830074875915074,0.8247332719882406,0.6529680365296804,1.0,1.0,5/25,11.24%,PDGFB;NUP62;SIRT2;PDGFRB;LRP5
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.39418778680913724,0.8244319533638513,0.659468438538206,1.0,1.0,4/13,12.51%,BTG2;POLR2G;CNOT7;CPEB3
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.26837975788828666,-0.8243093712017127,0.7441077441077442,0.9323339902955481,1.0,12/29,24.55%,CCNH;ERCC5;DDB1;UBC;CHD1L;XPA;GTF2H5;GTF2H2;GTF2H3;UBB;ERCC2;RAD23B
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.37060849247402405,0.8234823904241428,0.6488673139158576,1.0,1.0,4/17,12.17%,DHDDS;MVD;SRD5A3;ALG13
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3517453462463723,0.8233456340062797,0.680379746835443,1.0,1.0,6/24,11.70%,NAT10;PARP1;SLX4;HNRNPU;TERF2;HNRNPC
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3301307305322658,-0.8228769288377014,0.7211981566820277,0.9342230548309979,1.0,7/13,27.91%,APP;SHANK3;ADCY1;EPHB2;SHISA7;SQSTM1;RELN
prerank,heterocycle biosynthetic process (GO:0018130),0.38324467771857335,0.8228405494063862,0.6520979020979021,1.0,1.0,2/14,9.62%,ALOX5;MOCS1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.29302140485743494,0.8227513090552412,0.7273781902552204,1.0,1.0,10/88,7.48%,ANGPT1;PDGFB;SEMA5A;CDH13;NR4A1;ALOX5;NR2F2;CAV1;VEGFA;ITGB3
prerank,fatty acid catabolic process (GO:0009062),0.3054438010817035,0.8226969091675554,0.7055837563451777,1.0,1.0,12/67,10.20%,HSD17B10;NUDT7;PEX2;HSD17B4;ACAD11;MECR;ABCD4;ACADS;ACAD10;NUDT19;HADHB;SCP2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.28819365724881474,0.8226542386045376,0.7389830508474576,1.0,1.0,14/113,7.51%,CD36;MYD88;FERMT2;LCP1;GTF2H4;MPP7;PSMC6;TPPP;DAB2IP;TP53;VEGFA;PARP1;TRABD2B;PLEK
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3583305518202079,-0.8226092142141962,0.7052401746724891,0.9338936620780706,1.0,5/10,44.88%,LGALS9;CEACAM1;ARRB2;FCGR2B;LILRB1
prerank,covalent chromatin modification (GO:0016569),-0.3209688437239173,-0.8223962242051714,0.7086092715231788,0.933413874998377,1.0,4/14,19.27%,SIRT7;CHD1;SETD5;PARK7
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.30986130488955693,-0.8222600100056716,0.6700507614213198,0.9328368441081286,1.0,5/15,17.73%,CD44;MDM2;PRKN;PTTG1IP;KDM1A
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.37213893977119916,0.8221865921999,0.6586921850079744,1.0,1.0,2/18,4.47%,CABP1;MFHAS1
prerank,postreplication repair (GO:0006301),-0.23943303830603818,-0.8221706674841093,0.803030303030303,0.9321744247992243,1.0,23/45,37.19%,PARP10;TRIM25;UBC;REV1;POLN;USP10;PRIMPOL;UBB;UBE2B;NSMCE1;ZBTB1;POLI;RPA3;RFC3;USP43;RAD18;RPA2;POLD3;BRCA1;PCLAF;RPA1;RFC1;RFC4
prerank,regulation of lipid biosynthetic process (GO:0046890),0.34345135613587585,0.821696131507401,0.675,1.0,1.0,9/32,15.54%,PRKAB2;PDK4;SORBS1;PPARA;GPER1;SIRT4;PRKAA2;MLXIPL;NR5A1
prerank,heme biosynthetic process (GO:0006783),-0.2759675470940238,-0.8213817239703893,0.7237569060773481,0.932777859430193,1.0,6/22,20.86%,ABCG2;ALAS1;COX10;PPOX;SLC25A38;UROS
prerank,ameboidal-type cell migration (GO:0001667),0.3067389171007513,0.8212490721121855,0.7098930481283422,1.0,1.0,7/51,9.21%,PDLIM1;SEMA5A;SEMA6C;GDNF;CORO1C;ITGA4;PKN2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.30279991003668194,-0.8211385176333208,0.6989247311827957,0.9323702282661174,1.0,4/17,12.26%,IL18;CD55;CD46;GNL1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.28771908813221214,0.8206425264992246,0.7208480565371025,1.0,1.0,22/85,16.72%,DLC1;PLCE1;MYO9B;KANK1;NUP62;ARHGEF2;GABARAP;DAB2IP;RASGRP1;TGFB2;ARHGAP17;VAV1;DENND1A;MFN2;BCR;PDCD10;FGF10;IRS2;RAF1;JAK2;RALGPS1;SHOC2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3191420151456877,-0.8205246995624662,0.7146401985111662,0.9326413027139392,1.0,2/15,6.71%,GRB2;FRS2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.35155322070722317,-0.8202874617914289,0.6915887850467289,0.9322775804936257,1.0,4/10,14.23%,HMGB1;ESR1;PSMC5;PSMC2
prerank,extracellular matrix disassembly (GO:0022617),0.3134839294577991,0.8202056690752845,0.6742138364779874,1.0,1.0,7/53,9.08%,ADAMTS5;HTRA1;KLK2;LCP1;LAMC1;WASHC1;CAPN2
prerank,mitochondrion transport along microtubule (GO:0047497),0.38185172871684925,0.820123775504855,0.6394557823129252,1.0,1.0,6/13,18.33%,MAPT;OPA1;HIF1A;UXT;RHOT1;MAP1S
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.30304896420518196,0.8199516827984534,0.7174418604651163,1.0,1.0,17/78,15.69%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;DNM2;AP1S3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.30304896420518196,0.8199516827984534,0.7174418604651163,1.0,1.0,17/78,15.69%,DYNLL1;KIF2A;LAG3;KIF3B;DCTN6;SEC13;CENPE;DYNC1I2;KIFAP3;KIF5A;SEC24A;CAPZB;DCTN3;SEC24C;KIF18A;DNM2;AP1S3
prerank,organelle fission (GO:0048285),-0.2748212747420005,-0.8198714656526292,0.7262247838616714,0.9322481687440721,1.0,7/24,15.32%,DNM3;DNM1;MTFR1;PRKN;ACOT8;TMCC1;FIS1
prerank,regulation of viral transcription (GO:0046782),0.3265058188181895,0.8197533036727764,0.6760168302945302,1.0,1.0,10/39,18.18%,POLR2L;POLR2I;POLR2G;HEXIM1;CCNT1;NELFB;POLR2J;NELFCD;DHX9;RSF1
prerank,apoptotic cell clearance (GO:0043277),0.3339579849294579,0.819578368689054,0.660436137071651,1.0,1.0,8/30,17.46%,XKR4;ANXA1;ITGB3;RHOH;GAS6;ADGRB1;RHOG;NR1H3
prerank,axonal fasciculation (GO:0007413),-0.33557485390470754,-0.8195634922844217,0.7052154195011338,0.9319189929496612,1.0,8/12,27.22%,EPHA4;EPHA3;MEGF8;RTN4;CNTN4;EPHB2;CDK5R1;EPHB3
prerank,regulation of translation (GO:0006417),0.27674627069439245,0.8195156961901072,0.7634635691657867,1.0,1.0,44/173,18.43%,VIM;IGFBP5;SAMD4A;MRPL13;BTG2;NAT10;UPF1;CSDE1;ATXN2;EIF1;RPS27L;CIRBP;CYFIP1;DAPK3;PYM1;IMPACT;RPL5;EIF3E;EIF2AK2;DDX1;GSPT1;DDX25;RBM3;ZCCHC4;CNOT7;EIF3H;TSFM;CPEB3;PLXNB2;SYNCRIP;GIGYF2;EPRS1;EIF4E;CTIF;NANOS1;ETF1;PIWIL2;DHX9;EIF2AK3;EIF4G2;METAP1;EIF2AK4;EEF2;UPF3A
prerank,positive regulation of organelle assembly (GO:1902117),0.32354084262463884,0.8190767470182762,0.7085561497326203,1.0,1.0,9/44,16.21%,PIP4K2A;LCP1;NUP62;TAPT1;STX18;ARHGAP35;CEP120;G3BP1;PLK4
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3265421165802345,-0.819030196957967,0.7223529411764706,0.9320449649842909,1.0,8/13,40.51%,TMEM30A;GCC2;INSIG1;SAR1A;SEC16B;SAR1B;TM9SF4;CD81
prerank,cellular component disassembly (GO:0022411),0.31383260771326316,0.8188754487323999,0.6796973518284993,1.0,1.0,7/53,9.08%,ADAMTS5;HTRA1;KLK2;LCP1;LAMC1;WASHC1;CAPN2
prerank,negative regulation of signal transduction (GO:0009968),0.27018921098640614,0.8188633722089703,0.8037190082644629,1.0,1.0,27/249,7.71%,NOTCH3;NKD1;TCIM;PIP4K2A;SOCS5;KANK1;IGFBP5;CCL5;NTN1;BCL2;PTPN18;MMRN2;EMILIN1;PRKCQ;ASXL1;RPGRIP1L;IRS1;EPN2;DAB2IP;SLC2A10;FBXW7;PTPN1;YTHDF2;TRABD2B;NEDD4;PLEK;SNAI2
prerank,organelle fusion (GO:0048284),0.3508940597032543,0.8187357326219167,0.6687898089171974,1.0,1.0,9/22,21.72%,AFG3L2;OPA1;MIEF2;MIEF1;MFN2;USP30;MFF;MFN1;GDAP1
prerank,spermatid development (GO:0007286),0.34135629328782896,0.8184823991098089,0.6814159292035398,1.0,1.0,6/32,12.06%,RSPH1;ACRBP;CDYL;DDX25;NECTIN2;YTHDC2
prerank,positive regulation of cilium assembly (GO:0045724),0.37086179824571447,0.8179477531928101,0.6629392971246006,1.0,1.0,4/18,12.24%,TAPT1;WRAP73;ARHGAP35;CEP120
prerank,aggrephagy (GO:0035973),0.34543440085536636,0.8177247859851903,0.6721804511278195,1.0,1.0,2/27,2.61%,DYNLL1;VIM
prerank,positive regulation of protein ubiquitination (GO:0031398),0.29469828292769656,0.8175056200818366,0.7260765550239234,1.0,1.0,10/80,10.68%,KLHL40;ANGPT1;DCUN1D2;CAV1;FBXW7;PIN1;DCUN1D1;AMER1;PAXIP1;UBE2D1
prerank,aorta development (GO:0035904),0.3894617253970242,0.817356908994877,0.6695205479452054,1.0,1.0,2/14,3.14%,TBX2;JAG1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2659058567763718,0.8173252660061217,0.983,1.0,1.0,224/1668,13.63%,MYOCD;SOX6;PRDM16;PPP1R12A;FHL5;MYOZ2;SOX5;HJV;ABRA;MEF2C;ATP2B4;HEY2;ZFHX3;TBX2;SMARCD3;FGF1;NR1H4;CSRP3;EBF1;PPP3CA;CCN1;ZEB2;EDNRB;ALX4;MLIP;FZD5;RORA;SS18L2;CDH13;ID4;NR4A1;FST;FRK;EBF2;SIM2;CRTC1;LOXL2;GABPA;PRRX1;ETS2;ARID5B;IFRD1;HEYL;TEAD3;JAG1;CAMK2D;IRX5;HINFP;MRTFA;BRIP1;TGFB3;ZNF436;H1-0;CRTC3;FOSL2;RBAK;NACC2;ACVR2A;PRDM1;HDAC9;GTF2H4;MCRS1;ARID1A;NR2F2;LMO7;ANKRD2;NR2C1;VEZF1;USP2;ACTR3;ATXN1;OSR2;PIAS4;CBFB;SP7;ARHGEF2;BMPR1A;KLF7;CCNQ;TBX18;KCNIP3;MEF2A;PEX2;GBX1;NCOA7;KLF16;MTDH;DBP;FOXJ3;ASXL1;KLF15;SUV39H2;JUND;CAV1;TAF1;SMARCB1;CHD2;DAB2IP;ELOC;ARID5A;TP53;RXRG;VEGFA;PPM1A;PARP1;GRHL1;ZNF418;HEXIM1;PIN1;ZBTB38;GDNF;MAML2;HDGFL3;SFPQ;HOXC4;AR;PPARGC1A;ZFP28;MED1;PPARGC1B;ZNF431;MED29;YAP1;MED12;SOX9;SNAI2;HSF4;DICER1;RELA;ZFP62;KMT2D;SETD3;TNIP1;CUX2;EPC2;LIN37;ZXDC;ZKSCAN4;CCND1;MAML3;PPARA;TRAK1;CBX4;BBX;IMPACT;MED13L;CARF;CCNT1;FUS;MTA3;NR4A2;SKI;NR1D1;LRRFIP1;KAT7;ZBTB33;AKNA;CDK7;HIF1A;CRLF3;KANSL3;ZBTB41;SIRT2;MIDEAS;RIF1;AGRN;PCGF6;HNRNPU;ZNF3;MED14;NR2C2;UBE2D1;TEAD1;EIF5A;RAI1;GPER1;PCGF5;SREBF2;RUNX1;RB1;PFKM;LRP5;ATF3;PIAS2;HOXC8;NKX6-1;ZKSCAN1;ZBTB7A;NFX1;ESRRA;LCORL;CDK12;RUVBL1;LIN9;BMPR1B;CSRNP3;HDGFL2;TOX4;ORC2;CITED2;CPEB3;CTDSP1;NR6A1;POU3F3;ZXDB;SMARCA5;MED8;ZBTB10;FNIP2;CRTC2;ZNF83;ZFP69;MXD4;PPP3CB;BCL6;CHD4;IKZF1;CASZ1;MEF2B;NCK2;FOXJ1;TRIM28;ZBTB5;RFX7
prerank,protein prenylation (GO:0018342),-0.3441357020044883,-0.8172370639003993,0.6834381551362684,0.9344781149323375,1.0,6/10,39.18%,CHM;RCE1;CHML;RABGGTA;FNTA;FNTB
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.36776187328377186,0.8169713395417311,0.6712538226299695,1.0,1.0,4/18,11.97%,PARN;NAF1;CCT3;RUVBL1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.35631330687318924,0.8167288064126292,0.6636771300448431,1.0,1.0,5/22,12.81%,DUSP5;PPM1E;PPM1A;PPP1CA;DUSP16
prerank,negative regulation of double-strand break repair (GO:2000780),0.3353548220364976,0.8166581430659597,0.6770833333333334,1.0,1.0,6/30,12.82%,CGAS;UBR5;ERCC6;FANCB;RIF1;RMI2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3690909524875862,0.8164803334765951,0.7021630615640599,1.0,1.0,6/17,16.87%,ARL6IP5;TGFB2;EIF2AK2;PDCD10;TAOK3;SEMA4C
prerank,regulation of transport (GO:0051049),-0.24799508745108836,-0.8163955617219802,0.7661016949152543,0.935105519225751,1.0,8/36,14.46%,LEPR;NRP1;RAB11A;PRKN;WWC1;MYO6;SNCA;ICA1
prerank,amide biosynthetic process (GO:0043604),0.31315379639535595,0.8159373442876956,0.686382393397524,1.0,1.0,2/47,4.19%,DMD;FA2H
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2851975489322289,0.8159077912858743,0.7527964205816555,1.0,1.0,30/122,18.77%,DYRK2;PDGFB;VIM;BCAR3;SAMD4A;NAT10;IRS1;SORBS1;RPS27L;CIRBP;AR;TGFB2;PYM1;KAT7;RPL5;PDGFRB;EIF3E;RBM3;ZCCHC4;CPEB3;PLXNB2;IRS2;NAMPT;JAK2;PIWIL2;DHX9;FAF1;EEF2;UPF3A;CCL19
prerank,positive regulation of T cell migration (GO:2000406),0.3599145335579516,0.8157999995496271,0.6525157232704403,1.0,1.0,3/20,8.65%,DOCK8;CCL5;ADAM17
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3435123731913545,-0.8157094147330834,0.7196467991169978,0.9355072226496741,1.0,3/11,26.44%,AHR;CEACAM1;HFE
prerank,rRNA processing (GO:0006364),-0.1827150736385405,-0.8154022671440008,0.9523809523809523,0.9352047914859389,1.0,69/172,30.37%,NSA2;PRKDC;RPL27A;RPS19;SENP3;NVL;RPL21;RPS24;RPL36;RPL18;RSL1D1;RIOK3;RPLP0;DIS3;C1D;EXOSC1;RPL28;WDR3;RPLP1;RPL23A;MRPL1;RPL34;RRP36;MPHOSPH10;FCF1;EXOSC9;RPL36A;NOP53;RPL9;DDX52;RPS7;RPL27;RPL11;RPL18A;RPL37A;RPL38;RRP7A;EMG1;DCAF13;RPL29;EXOSC2;EBNA1BP2;UTP20;RPL10A;RPL32;BYSL;NOL11;THUMPD1;NOP56;EXOSC7;EXOSC3;UTP18;RPS27;HEATR1;NOLC1;IMP3;WDR18;EXOSC5;PIH1D1;PES1;RPL4;LSM6;UTP6;FBL;RPS15;RPL35A;NOL8;POP4;SART1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.2710629171672768,-0.8150304431919416,0.744408945686901,0.935032195232864,1.0,7/25,26.05%,SPTBN1;PLCG2;STOML2;PNP;CD80;CD86;PRKD2
prerank,signal transduction by p53 class mediator (GO:0072331),0.33430564179986866,0.8149733656839161,0.688953488372093,1.0,1.0,7/30,13.65%,PMAIP1;MYBBP1A;NDRG1;TP53;PAXIP1;BOK;PDK2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2901905605409294,0.8146650677529833,0.7415865384615384,1.0,1.0,19/85,15.53%,KLHL40;SOCS5;TMEM259;PABIR1;GABARAP;TAF1;PSMC6;DAB2IP;FBXW7;RNF180;SIRT2;USP13;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;HSPBP1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.29699316804628334,0.814482625797468,0.7057356608478803,1.0,1.0,4/66,3.34%,CD36;MYD88;FZD5;LPL
prerank,limb development (GO:0060173),0.3344787843508415,0.8144655975022406,0.6642011834319527,1.0,1.0,2/28,4.94%,MAP3K20;LNPK
prerank,ion transport (GO:0006811),0.2855500316617974,0.8144456646271071,0.7494252873563219,1.0,1.0,13/111,10.90%,TRPC6;ANO1;ANO6;SLC8A2;SLC8A1;SLC20A2;KCNN2;PKD1L3;SLC9A8;ANO10;VDAC1;SLC25A26;PANX1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24325044877491556,-0.8140818715918623,0.7553191489361702,0.9358433629915135,1.0,16/40,26.69%,PTK2;PTK2B;PML;COMMD1;UBE3A;SGTA;RPS7;RPL11;NUB1;TRIM39;AXIN1;RAD23B;CSNK2A2;CSNK2A1;HFE;LAPTM5
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3515978496056825,-0.8140724661054174,0.717391304347826,0.9350282868679728,1.0,7/10,33.14%,SLC1A3;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.35751564079989545,0.8134765353923489,0.6645865834633385,1.0,1.0,7/22,15.35%,FXN;GLRX5;ISCA1;ISCA2;NUBP2;NUBP1;CIAO1
prerank,protein targeting to lysosome (GO:0006622),-0.28574164687681275,-0.8134041374164385,0.7030456852791879,0.935333643962041,1.0,10/20,30.77%,SCARB2;GCC2;GNPTAB;AP3M1;HGS;M6PR;NCOA4;LAPTM5;HSPA8;GGA3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.30073983792817965,-0.813214852370649,0.7066974595842956,0.934851912927392,1.0,6/16,15.42%,NT5E;TET2;UPP2;DPYSL3;UPB1;DPYD
prerank,dicarboxylic acid metabolic process (GO:0043648),0.30566851146264895,0.8131090397526314,0.7014157014157014,1.0,1.0,8/52,8.66%,D2HGDH;MDH1;ME3;MTHFD2L;DLST;GOT1;GOT2;ALDH1L2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2254788166203815,-0.8128777945664185,0.8493723849372385,0.934651324515651,1.0,17/54,20.42%,ARRB1;NXN;DCUN1D3;CRY1;CTNNB1;PRMT3;SIRT7;OGT;SPRY2;SOX4;SH3RF2;UBXN1;AKT1;SPOPL;RPL11;PARK7;PIAS3
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.304654985002506,-0.8125223017672312,0.7215189873417721,0.9345081363270044,1.0,6/15,20.22%,METTL3;SAMHD1;STAT2;NLRC5;YTHDF3;PTPN2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2791592966596895,0.8121838073752351,0.7745856353591161,1.0,1.0,21/125,14.15%,DYNLL1;CLASP2;KIF2A;CENPP;KIF3B;DCTN6;EFHC1;EML1;SUN2;CENPO;SEC13;ZWINT;CENPE;NUP107;DYNC1I2;ITGB3BP;CLASP1;MAP4;NUP98;KIF18A;NUP37
prerank,mononuclear cell differentiation (GO:1903131),-0.2769362326554228,-0.8121530013105599,0.7611111111111111,0.9344315229076232,1.0,8/24,17.76%,IL31RA;PIR;BMP4;LYN;THOC5;RELB;PPARG;MT1G
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3505660071148884,0.8117100469723383,0.6747720364741642,1.0,1.0,7/24,22.24%,PLA2G3;ABCA3;PLA2G4A;LPCAT1;PLA2G15;CRLS1;SERAC1
prerank,neural tube closure (GO:0001843),0.32293602365979673,0.8116602019167192,0.683599419448476,1.0,1.0,7/34,16.87%,DLC1;TGFB2;SKI;PLXNB2;DVL1;KDM2B;SEMA4C
prerank,respiratory system development (GO:0060541),0.3304331405704148,0.8115393999959107,0.7098214285714286,1.0,1.0,4/32,6.65%,FGF1;ITGA3;VEGFA;ABCA3
prerank,regulation of monocyte differentiation (GO:0045655),0.3842621695646708,0.8114279487286403,0.6537162162162162,1.0,1.0,4/14,20.75%,CDK6;ZFP36L1;ACIN1;CTNNBIP1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.20318545840419702,-0.8111888685778852,0.900709219858156,0.9353324316007162,1.0,34/88,31.53%,FZD6;PRICKLE2;VANGL1;WNT5A;PSMD7;PSMD9;PSMD13;SMURF2;PSMB3;PSMC5;AP2S1;PFN1;PSMA5;PSMA1;PSMC2;CDC42;AP2A2;DACT1;PSME3;PSMC4;CELSR1;VANGL2;PSMB6;PSMB10;DVL2;TIAM1;PSMA4;PSME1;WNT11;PSMF1;AP2M1;ARHGEF19;PSMB9;PSME2
prerank,iron ion transport (GO:0006826),-0.22862042396142623,-0.8109043834035616,0.8156862745098039,0.9350431635832356,1.0,8/47,10.80%,CP;SCARA5;ABCB7;ATP6V0A4;STEAP3;ATP6AP1;ATP6V1G1;FTH1
prerank,gene expression (GO:0010467),0.26551546145488397,0.8107396077273424,0.8435923309788093,1.0,1.0,67/348,16.41%,TSPAN32;RBPMS;ANGPT2;RPL3L;POLR2L;POLR2I;MLF1;MRPL36;MRPL13;NUP62;PWP1;HARS2;WDR33;UPF1;ATXN1;MEF2A;POLR2G;TESC;U2AF2;RPL8;NFKBIB;MRPL43;SRSF4;TNIP1;SEC13;NR4A2;ZC3H11A;MRPL51;NUP153;RPL5;MCM3AP;MRPL23;DEDD2;RBM8A;U2AF1;DHX8;HNRNPU;RPS23;NUP107;AAAS;PRPF4;GSPT1;DDX25;THOC7;RBM3;BAZ2A;RBM6;MRPL9;GALNT2;SRRM1;DROSHA;POLR2J;MRPL42;SYNCRIP;RPL15;NUP98;NUP37;TSPAN17;EIF4E;FASTKD2;NUP210;RPL22;SARS1;FIP1L1;XAB2;RPL31;DNAJB11
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.277601175230748,-0.8107067780993821,0.735632183908046,0.9346086750312723,1.0,8/22,19.27%,APOD;BAG4;RANGAP1;SP100;INSIG1;LMAN1;ITGB1BP1;PARK7
prerank,respiratory electron transport chain (GO:0022904),0.3816414702096729,0.8104392083591404,0.66723259762309,1.0,1.0,5/14,16.06%,PPARGC1A;ETFA;SDHA;SLC25A12;UQCRFS1
prerank,membrane protein proteolysis (GO:0033619),0.32264343882473834,0.8101551816360275,0.6916666666666667,1.0,1.0,9/37,14.56%,MYH9;PRKCQ;AFG3L2;RELA;ADAM17;MBTPS1;HM13;SPPL2B;ADAM19
prerank,regulation of humoral immune response (GO:0002920),-0.23608594800003696,-0.8100949251921622,0.7634854771784232,0.9348688819654206,1.0,19/44,40.51%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;GATA6;CR1L;C1QC;C1QA;CFHR2;C2;CR2;C3;C3AR1;C6;FCGR2B;C7;CD81
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.35769564775345264,0.810067783711719,0.6872037914691943,1.0,1.0,4/20,8.65%,PDGFB;CCND2;CCND1;ADAM17
prerank,negative regulation of endocytosis (GO:0045806),0.3414715994687537,0.8099326477469926,0.6876971608832808,1.0,1.0,3/24,8.34%,PACSIN3;CAV1;CD300A
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3095537026881694,-0.8098674305434218,0.6944444444444444,0.9344445957159205,1.0,3/15,7.84%,APOE;NRDC;FURIN
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.20605771120695762,-0.8098182415363471,0.9025974025974026,0.933714900198304,1.0,33/84,31.53%,CUL3;ANAPC1;PSMD7;PSMD9;PSMD13;CDC23;PSMB3;UBC;SKP2;PSMC5;PSMA5;PSMA1;BUB3;PSMC2;CDC26;UBE2S;ANAPC4;FBXO31;PSME3;UBB;PSMC4;CDK2;PSMB6;PSMB10;ANAPC15;PSMA4;PSME1;CDC16;PSMF1;CDC27;FZR1;PSMB9;PSME2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.36113515035308896,0.80978949477325,0.6699029126213593,1.0,1.0,2/18,3.29%,ROCK1;KANK1
prerank,protein localization to mitochondrion (GO:0070585),0.39702262150223316,0.8093342787682813,0.6744604316546763,1.0,1.0,3/11,17.91%,HK2;LRRK2;ISG15
prerank,regulation of acute inflammatory response (GO:0002673),0.359497645211931,0.8091321698813112,0.6919275123558485,1.0,1.0,18/18,64.09%,GSTP1;OSMR;DNASE1L3;C2CD4A;F12;C2CD4B;PLA2G2D;DNASE1;FFAR2;OSM;IL6;CREB3L3;IL4;IL6ST;NLRP3;KLKB1;ADAM8;PTGES
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.31290276352416785,-0.808655548591135,0.7241379310344828,0.9348918336533732,1.0,7/13,26.21%,CD44;MDM2;PTTG1IP;KDM1A;SNAI1;YJU2;TWIST1
prerank,positive regulation of angiogenesis (GO:0045766),0.27941034677280074,0.8084717143093163,0.7541899441340782,1.0,1.0,12/108,7.58%,FGF1;ANGPT4;HSPB6;SEMA5A;HK2;STIM1;ITGB1;PTGIS;MTDH;RRAS;VEGFA;BTG1
prerank,fatty acid biosynthetic process (GO:0006633),-0.21440333844856824,-0.8082743497259323,0.8465346534653465,0.9347248677439639,1.0,24/63,31.98%,ELOVL7;HACD4;ASAH2;PTGS2;ACLY;ABCD3;EPHX2;ABHD3;ELOVL4;ELOVL6;HACD2;DECR2;ELOVL1;HACD3;FADS1;ACOT7;HPGD;ALOX12;HSD17B8;DEGS1;OXSM;ELOVL5;TECRL;GPX4
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29797126267003526,0.8081128921911136,0.7354085603112841,1.0,1.0,11/68,14.40%,AMPD1;NT5C2;SULT4A1;AMPD2;ENTPD7;OPA1;EPHA2;THEM4;ADSS1;ACOT6;LRRK2
prerank,lymphocyte differentiation (GO:0030098),0.29508914515375867,0.8080531694473497,0.7210718635809987,1.0,1.0,13/68,13.27%,CD79A;IL2;ITGB1;HDAC9;ITGA4;ADAM17;KAT7;TPD52;AXL;LMBR1L;RHOH;ZBTB7A;IKZF1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.30456778877785873,-0.8080271377135192,0.7216494845360825,0.934367993049998,1.0,7/16,24.73%,NF2;PPP2CA;PARP14;HGS;BCL3;PTPN2;INPP5F
prerank,mitochondrial RNA metabolic process (GO:0000959),0.38718184331851163,0.8076468650716281,0.696551724137931,1.0,1.0,3/14,10.74%,FASTKD5;FASTKD1;TFB2M
prerank,negative regulation of phosphorylation (GO:0042326),0.2891930901240971,0.8074487027634958,0.7275902211874272,1.0,1.0,11/85,10.29%,NTRK3;DYNLL1;ROCK1;PFKFB1;MAPT;DAB2IP;CORO1C;PPARA;IMPACT;NPRL2;HNRNPU
prerank,cardiolipin metabolic process (GO:0032048),0.38654563732655345,0.8073922807526579,0.696763202725724,1.0,1.0,5/13,16.83%,HADHB;TAMM41;PLA2G4A;HADHA;PTPMT1
prerank,protein methylation (GO:0006479),-0.2420156381769942,-0.8069167158165568,0.8071428571428572,0.9355135312490209,1.0,6/40,9.40%,NSD1;CARM1;CAMKMT;PRMT2;PRMT3;EEF1AKMT1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3244683503105134,0.8068597351096356,0.682825484764543,1.0,1.0,6/34,6.82%,DUSP5;PTPN18;PTPRS;PTPRF;DUSP3;PTPN1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3775371134479627,0.806836012368683,0.6771004942339374,1.0,1.0,4/16,11.11%,VIM;TGFB3;SUCO;RUNX1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3709427232717345,0.8065491600899541,0.6736,1.0,1.0,4/17,11.11%,VIM;TGFB3;SUCO;RUNX1
prerank,response to estrogen (GO:0043627),0.3368177156543509,0.8065048665905619,0.690406976744186,1.0,1.0,9/31,18.10%,CAV1;ARID5A;AR;KMT2D;SFR1;CITED2;PELP1;ASH2L;SERPINB9
prerank,positive regulation of organelle organization (GO:0010638),0.3255834455588323,0.8061350972754006,0.7037552155771906,1.0,1.0,5/32,10.32%,ANXA1;LNPK;PPARGC1A;FYCO1;STX18
prerank,pancreas development (GO:0031016),-0.3187025083368418,-0.806074136967419,0.7348837209302326,0.9361798292793966,1.0,3/12,21.63%,TCF7L2;CCDC39;ZIC3
prerank,regulation of dopamine secretion (GO:0014059),-0.26774294744985166,-0.8060357171558296,0.7631578947368421,0.9354309081688418,1.0,13/25,31.38%,SYT1;DTNBP1;PRKN;SNCA;SYT11;SYT12;SYT6;SYT2;DRD2;SYT7;SYT9;SYT13;SYT3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.29901610834593406,0.8056652332016812,0.7518610421836228,1.0,1.0,8/59,11.97%,HSD17B10;CYP7B1;LPL;ALOX5;HSD17B4;SCP2;OSBPL2;NDUFAB1
prerank,leukotriene biosynthetic process (GO:0019370),0.38173047230163326,0.8056429170210015,0.6888888888888889,1.0,1.0,2/14,14.18%,ALOX5;PLA2G4A
prerank,cellular response to estrogen stimulus (GO:0071391),0.38802697479490483,0.8056364522438944,0.6643478260869565,1.0,1.0,5/14,18.10%,ARID5A;AR;SFR1;PELP1;SERPINB9
prerank,establishment of spindle orientation (GO:0051294),0.33637449240427203,0.8054993667438473,0.7070707070707071,1.0,1.0,8/28,17.51%,ITGB1;INSC;NSFL1C;FBXW11;CLASP1;MAP4;DCTN1;UBXN2B
prerank,positive regulation of double-strand break repair (GO:2000781),0.3217455638789197,0.8054947454805014,0.6933701657458563,1.0,1.0,8/39,10.04%,RAD51AP1;ZCWPW1;PARP1;ERCC6;SPIRE1;FUS;FANCB;RIF1
prerank,positive regulation of vacuole organization (GO:0044090),-0.3392160277214011,-0.805490789438027,0.7080610021786492,0.9355428714157447,1.0,5/10,18.54%,ANXA2;PIP4K2B;RAB3GAP2;GRN;RALB
prerank,protein lipidation (GO:0006497),0.3046116597946088,0.8043818660215843,0.7380352644836272,1.0,1.0,20/59,19.53%,PIGN;ATG7;ZDHHC2;PIGA;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;WDR45;PIK3C3;PIGH;PIGB;ZDHHC13;PIGP;DPM2;ZDHHC5;ZDHHC8;ZDHHC3;PGAP4;ATG10
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.27496733060246226,-0.8041200756599202,0.7922077922077922,0.9370621345462442,1.0,4/23,15.69%,CADM1;LGALS9;PIK3R6;PVR
prerank,regulation of interleukin-10 production (GO:0032653),-0.22574069313080355,-0.8040090625709981,0.8178294573643411,0.936456563006778,1.0,17/44,40.34%,HMGB1;LGALS9;PLCG2;CD34;CD46;CD274;HSPD1;SYK;TYROBP;NOD2;TRIB2;JAK3;PYCARD;FCGR2B;DLL1;AGER;TLR4
prerank,positive regulation of endothelial cell migration (GO:0010595),0.28702646353214667,0.803740506087441,0.7282479141835518,1.0,1.0,11/84,9.57%,ANGPT1;FGF1;ANGPT4;PDGFB;SEMA5A;RRAS;VEGFA;ITGB3;RIN2;ADAM17;HIF1A
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3627445949849035,0.8034217565999177,0.6895475819032761,1.0,1.0,9/22,20.16%,ELL;ERCC6;CCNT1;KAT7;CDK12;BRD4;HMGN1;CDK13;EAPP
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.2502821650833225,-0.8029625830843307,0.8063492063492064,0.9374032154124189,1.0,9/32,18.12%,ATR;TNKS2;XRCC5;CTNNB1;FBXO4;MAP3K4;CCT8;CCT4;ATM
prerank,vasculogenesis (GO:0001570),0.32602132420411145,0.8027676215860816,0.697841726618705,1.0,1.0,5/32,10.07%,HEY2;HAS2;CAV1;VEGFA;PDGFRB
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3863982073261235,0.8021980541555056,0.6826568265682657,1.0,1.0,3/12,10.20%,HSD17B4;FADS2;SCP2
prerank,meiosis I (GO:0007127),0.3497180755952305,0.8020867710425366,0.685099846390169,1.0,1.0,2/23,5.67%,ZCWPW1;FOXJ3
prerank,acyl-CoA metabolic process (GO:0006637),-0.24388296906266937,-0.8014308885104954,0.779874213836478,0.9393130309926053,1.0,6/35,11.39%,SUCLG2;ACSF2;HMGCS2;ACOT8;DBI;ACOT9
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3513143992626358,0.8013826898024525,0.6802507836990596,1.0,1.0,6/21,14.56%,MYH9;PRKCQ;ADAM17;HM13;SPPL2B;ADAM19
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.26209964941724245,-0.8011984540017196,0.7810650887573964,0.9388539730950793,1.0,15/27,33.17%,SLC1A3;SLC47A1;SLC3A2;SLC7A5;SLC6A9;SLC38A5;SLC25A38;SLC1A4;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2;SLC22A2
prerank,positive regulation of DNA replication (GO:0045740),-0.2980055218883485,-0.8010609402799337,0.7257281553398058,0.938254044768951,1.0,3/16,4.80%,GLI2;EGFR;STN1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2861801756488973,0.8003976067270258,0.7511904761904762,1.0,1.0,15/88,14.33%,EDNRB;SERPINE2;IGFBP5;SAMD4A;MRPL13;BTG2;DAB2IP;DAPK3;EIF2AK2;CNOT7;DNAJC1;CPEB3;SYNCRIP;GIGYF2;EPRS1
prerank,tRNA processing (GO:0008033),0.29279311549765735,0.7994898506495863,0.7531645569620253,1.0,1.0,16/61,19.48%,WDR4;TRDMT1;CDKAL1;TYW5;FTSJ1;TRMT10C;RTCB;DDX1;NSUN2;KARS1;SARS1;FARS2;TRUB1;FAM98B;TRMT6;AARS2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3914590164357035,0.7992937764010153,0.687037037037037,1.0,1.0,4/11,15.12%,GMNN;TIPIN;ZRANB3;FBXO5
prerank,negative regulation of locomotion (GO:0040013),-0.32158683641088703,-0.7991449319101994,0.7266355140186916,0.9406734160998046,1.0,4/12,20.22%,FBLN1;FRMD5;CCDC125;PTPN2
prerank,regulation of exosomal secretion (GO:1903541),-0.28986033042227755,-0.7988640376118196,0.7557840616966581,0.9403476552416895,1.0,7/19,26.35%,SDCBP;PRKN;VPS4B;SDC4;HGS;ATP9A;SDC1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.2794095010587837,-0.7987051882370688,0.7676470588235295,0.9398242326429864,1.0,5/22,13.67%,APPL2;LBP;PTPN22;LYN;APPL1
prerank,organelle disassembly (GO:1903008),-0.24442298385223366,-0.7985972720762156,0.8,0.939192023978039,1.0,12/33,25.87%,RB1CC1;GBF1;STX5;RETREG1;TEX264;ATG2B;ATG2A;KIF9;MTIF3;PLK5;ULK2;UBA5
prerank,regulation of superoxide anion generation (GO:0032928),0.37585506135370705,0.7978069903313497,0.6993464052287581,1.0,1.0,3/14,11.28%,MAPT;GSTP1;PRKCD
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.2601620842929128,-0.7977677206037754,0.8074712643678161,0.9397157340609753,1.0,6/26,14.02%,SULF1;CCBE1;CYP1B1;TGFB1;PTGS2;ARNT
prerank,regulation of translational initiation (GO:0006446),0.2971614203169167,0.7971209980893974,0.7354037267080745,1.0,1.0,21/63,20.84%,CCL5;EIF4EBP1;CSDE1;POLR2G;EIF1;YTHDF2;IMPACT;EIF3E;DDX1;ATF3;EIF3H;NCK2;DNAJC3;CTIF;EIF2AK3;EIF4G2;EIF2AK4;HABP4;HSPB1;TPR;LARP1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.35259517713359306,0.7966525641797041,0.670906200317965,1.0,1.0,3/18,13.20%,ANXA1;HNRNPU;ZFP36L1
prerank,vacuolar acidification (GO:0007035),0.34694975416100055,0.7963687395713334,0.6830427892234548,1.0,1.0,3/21,6.32%,CLN5;ATP6V1H;ATP6V0A2
prerank,mitochondrial translation (GO:0032543),0.27836975895258514,0.7961116411595254,0.7760180995475113,1.0,1.0,34/104,22.04%,MRPL36;MRPS31;MRPL13;MRPL30;GATB;MRPL43;IARS2;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42;LARS2;FASTKD2;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;GATC;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3402814048991686,-0.79600783078895,0.7505938242280285,0.9418455856874152,1.0,4/10,29.29%,STOML2;CDC7;DBF4;ATRX
prerank,negative regulation of cell projection organization (GO:0031345),-0.2229231778037458,-0.7959204699706962,0.8739495798319328,0.9412000999596069,1.0,11/48,17.55%,EFNB2;LPAR1;APOE;EPHA4;SEMA3A;SPRY2;DPYSL3;RAB29;CBFA2T2;HDAC2;PRAG1
prerank,regulation of macrophage activation (GO:0043030),-0.24943818138083754,-0.7951042914001442,0.7612903225806451,0.9417227488420533,1.0,9/30,22.94%,IL31RA;LBP;WNT5A;IL33;ZC3H12A;GPR137B;SHPK;HSPD1;SPHK1
prerank,positive regulation of T cell activation (GO:0050870),0.2956478706304876,0.7947971183456668,0.753731343283582,1.0,1.0,5/62,5.51%,DOCK8;ANXA1;CCL5;CD276;PRKCQ
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.36068283410608504,0.7947264381101028,0.6789297658862876,1.0,1.0,3/16,10.46%,SLX4;HFM1;TOP2B
prerank,regulation of autophagy (GO:0010506),0.2646477929218091,0.7942107636473095,0.8245798319327731,1.0,1.0,63/216,19.81%,ROCK1;PRKAB2;RNF152;ITPR1;FZD5;PIP4K2A;BCL2;MTDH;ATP6V1H;MAPT;ATP6V0A2;FBXW7;IL10RA;VPS26A;NEDD4;DAPK3;TRIM68;VDAC1;WASHC1;VPS26B;RRAGB;ATP6V1C1;SIRT2;NPRL2;DNM1L;SH3BP4;SREBF2;BOK;HTR2B;USP13;ATP6V0D2;MCL1;LRRK2;PRKAA2;UFL1;TRIM65;EIF4E;PRKACA;CTSA;ATG13;STAT3;VPS35;RAB8A;MT3;SVIP;WDR6;TICAM1;WDR41;EIF4G2;USP36;DAPK2;MTMR3;DDIT3;PRKD1;ULK1;HDAC6;KAT8;ABL1;PIK3R2;ATP6V0C;KDM4A;PRKAB1;DCAF12
prerank,response to ATP (GO:0033198),0.36375032907723803,0.7939625241707661,0.7040650406504065,1.0,1.0,2/18,6.15%,P2RY2;TAF1
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.26318700696608166,-0.7931458643803807,0.7844311377245509,0.9441841501832314,1.0,3/23,5.86%,SLC12A2;SLC12A7;ATP6V0A4
prerank,mitochondrial translational elongation (GO:0070125),0.28306792972930556,0.792827325531508,0.7653301886792453,1.0,1.0,17/88,13.16%,MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42
prerank,nucleotide biosynthetic process (GO:0009165),0.3527297142865116,0.7922930779094809,0.700164744645799,1.0,1.0,3/18,12.20%,NMNAT2;NMNAT1;PPAT
prerank,regulation of neurogenesis (GO:0050767),0.29628903994740574,0.7922536919136383,0.7255154639175257,1.0,1.0,5/55,7.59%,HEY2;HEYL;PRUNE1;YTHDF2;YAP1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.28173285029273765,0.792145874947531,0.7304878048780488,1.0,1.0,19/76,17.98%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;FBXW7;RNF180;SIRT2;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;PTEN;HSPBP1;SMURF1;RCHY1;PIAS1
prerank,regulation of transmembrane transport (GO:0034762),0.3261770218472552,0.791945724938669,0.7034277198211625,1.0,1.0,4/31,7.03%,KCNJ12;BCL2;ACTB;NEDD4
prerank,regulation of DNA recombination (GO:0000018),0.3205766172745445,0.7918359800267005,0.7105643994211288,1.0,1.0,8/32,16.73%,H1-0;RAD51AP1;ZCWPW1;CHEK1;KPNA2;ZRANB3;SIRT6;MSH2
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.31230617804301275,-0.7918048047912484,0.7411764705882353,0.945507624960422,1.0,3/13,12.79%,TPST1;BPNT2;ENPP1
prerank,oligodendrocyte development (GO:0014003),-0.30785920941863226,-0.7917220033126121,0.7493975903614458,0.9448400099636385,1.0,3/15,11.81%,PLP1;B4GALT6;EIF2B3
prerank,early endosome to late endosome transport (GO:0045022),0.3497528131702073,0.7913356528538761,0.6841269841269841,1.0,1.0,5/20,14.57%,HOOK2;HOOK1;AKTIP;PIK3C3;ANKRD27
prerank,pre-miRNA processing (GO:0031054),-0.31120624760960847,-0.7909871159605928,0.7488038277511961,0.9453042755405949,1.0,4/14,18.84%,AGO3;ADAR;TUT4;TUT7
prerank,positive regulation of cell growth (GO:0030307),0.27705697639801646,0.7908895401593586,0.7582159624413145,1.0,1.0,23/96,17.44%,AKAP6;IL2;NTN1;PABIR1;FXN;BCL2;MAPT;TGFB2;ADNP2;ADAM17;ITSN2;HDGFL2;CEP43;N6AMT1;HYAL1;SMURF1;INO80;MAP3K13;DDX49;S100A8;S100A9;EIF4G2;RASAL1
prerank,cellular response to chemical stress (GO:0062197),0.2800722004936658,0.7908648503401314,0.7592165898617511,1.0,1.0,21/96,17.31%,NCF2;ATG7;CAV1;PARP1;PPARGC1A;ADNP2;SRXN1;NUDT2;GSTP1;LONP1;PYROXD1;SIRT2;TXNRD2;LRRK2;PRKAA2;ZFAND1;RAD52;MT3;SOD3;PRDX5;PRDX6
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.325802130347357,0.7904498568857767,0.7054380664652568,1.0,1.0,5/28,6.82%,PIP4K2A;KANK1;PRKCQ;IRS1;PTPN1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.362634939795729,0.790359582075729,0.7126050420168067,1.0,1.0,4/16,11.53%,PARP1;NAF1;SLX4;TERF2
prerank,DNA conformation change (GO:0071103),-0.28764644595305316,-0.7903182934794091,0.7679012345679013,0.9456367278821716,1.0,9/17,34.34%,HMGB1;TOP1;HHEX;HMGB2;TOP3B;TOP1MT;NAA10;TOP2A;ERCC3
prerank,pyruvate metabolic process (GO:0006090),0.30458487271267715,0.790159258194503,0.7183462532299741,1.0,1.0,8/52,11.23%,ENO3;HK2;PFKFB1;ME3;DLD;VDAC1;ALDOA;PFKM
prerank,synaptic vesicle cycle (GO:0099504),-0.254345906284434,-0.7900852679278957,0.7865853658536586,0.9451811729795574,1.0,7/30,16.01%,RAB5A;NLGN1;SNCA;SLC17A6;PLD2;PCLO;STX1A
prerank,regulation of hormone secretion (GO:0046883),0.3610918608001555,0.790023899139394,0.6789727126805778,1.0,1.0,1/15,2.78%,ANXA1
prerank,primary neural tube formation (GO:0014020),0.31548087954101395,0.7892242863031457,0.7092511013215859,1.0,1.0,3/30,9.18%,DLC1;TGFB2;SKI
prerank,cell-cell junction maintenance (GO:0045217),0.38655379923743416,0.7888351997859889,0.7142857142857143,1.0,1.0,1/11,2.33%,FERMT2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3785202462781596,0.7887236117958732,0.7055837563451777,1.0,1.0,3/15,8.93%,ACTR3;WHAMM;WASHC1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.290909423985038,0.7883695200200209,0.7466007416563659,1.0,1.0,14/65,17.60%,CHMP4C;FHL1;PABIR1;PSMC6;CHEK1;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14;VPS4A
prerank,sterol homeostasis (GO:0055092),0.2946628369277245,0.7879522942114519,0.7307221542227662,1.0,1.0,10/65,14.30%,RORA;CYP7B1;LPL;HDAC9;CAV1;NR1D1;LRP5;ABCG1;LDLRAP1;MTTP
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.38571173799764713,0.7878753871033837,0.6767485822306238,1.0,1.0,4/11,15.38%,SOX9;PDGFA;LRP5;STAT1
prerank,cholesterol homeostasis (GO:0042632),0.2964630808527574,0.7874039772817598,0.7323420074349443,1.0,1.0,10/64,14.30%,RORA;CYP7B1;LPL;HDAC9;CAV1;NR1D1;LRP5;ABCG1;LDLRAP1;MTTP
prerank,regulation of macromolecule metabolic process (GO:0060255),0.262859379174803,0.7873471488284792,0.810752688172043,1.0,1.0,23/170,13.47%,TMPRSS4;CRIP1;ALPK2;CDK6;SLC8A2;SLC8A1;HINFP;SORT1;PRDM1;ATP1B1;PIN1;GDNF;ADNP2;TRIM68;HIF1A;TOB2;ROCK2;ANKRA2;AFF1;PCBP3;ZFP36L1;HMG20A;MKLN1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.26681864833786995,-0.7872860307206293,0.7863501483679525,0.9489338664729369,1.0,3/22,8.22%,BMP7;WNK1;CD44
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2686309781959209,-0.7868587416216962,0.7851458885941645,0.9488713235188662,1.0,4/23,7.40%,HMGB1;CECR2;KPNA1;FBH1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2973568177726673,-0.7868267977467843,0.7553444180522565,0.9481098470586814,1.0,7/15,35.62%,ANAPC1;CDC23;NEK6;CDC16;CDC27;RIOK2;TACC3
prerank,modulation by symbiont of entry into host (GO:0052372),-0.29877122085396796,-0.7866719540283568,0.7622549019607843,0.9475764655530133,1.0,7/16,23.25%,TRIM25;TRIM5;EXOC2;TRIM14;EXOC7;FUCA2;TRIM21
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.23532892327435073,-0.7861991558864128,0.8242677824267782,0.9475242658878097,1.0,18/40,37.93%,ATR;FBH1;BLM;MMS22L;PRIMPOL;SMARCAL1;NUCKS1;DONSON;ALYREF;ATRX;BOD1L1;TIMELESS;RFWD3;TRAIP;RAD51;POLE;CENPX;GEN1
prerank,tube closure (GO:0060606),0.3129497157950268,0.7860684946387962,0.7120115774240231,1.0,1.0,3/31,9.18%,DLC1;TGFB2;SKI
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3071321762501497,-0.785685846718733,0.7544303797468355,0.9475172361942247,1.0,5/15,18.43%,OSBPL8;ABHD5;PLIN2;PPARG;PLIN3
prerank,positive regulation of leukocyte migration (GO:0002687),-0.2524025558607758,-0.7853100129578982,0.804093567251462,0.9473530703428217,1.0,1/27,0.13%,PTN
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3086123109153556,0.7850506845112886,0.7161981258366801,1.0,1.0,12/42,16.15%,NARS2;HARS2;LARS1;IARS2;AIMP1;IARS1;SARS2;EPRS1;KARS1;LARS2;SARS1;FARS2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.38907294104342305,0.7850076886652139,0.6764705882352942,1.0,1.0,2/10,13.32%,MAPRE2;FGF10
prerank,heterochromatin assembly (GO:0031507),-0.2817877980693417,-0.7849684254196879,0.7929155313351499,0.9471211779728306,1.0,6/20,20.70%,EZH1;SMCHD1;NRDE2;RRP8;HMGA2;SUV39H1
prerank,DNA replication checkpoint signaling (GO:0000076),0.361531061942277,0.7849548578038594,0.712171052631579,1.0,1.0,3/16,7.80%,TIPIN;RAD9A;HUS1B
prerank,cell part morphogenesis (GO:0032990),-0.3129514677694165,-0.7847186729455035,0.7435897435897436,0.9467048209398243,1.0,6/13,22.17%,PID1;FIS1;PNPT1;CSPG5;NUBPL;SLIRP
prerank,dendrite morphogenesis (GO:0048813),0.31627458061949487,0.784623592616562,0.7105263157894737,1.0,1.0,4/35,5.32%,SDC2;DOCK10;KLF7;MEF2A
prerank,nucleotide-sugar metabolic process (GO:0009225),0.37159381849783546,0.7842883847307981,0.6759581881533101,1.0,1.0,3/12,11.20%,CSGALNACT1;GFPT1;PARG
prerank,regulation of neurotransmitter secretion (GO:0046928),0.31760678181275104,0.7842343711709479,0.6942857142857143,1.0,1.0,2/32,4.35%,MEF2C;RIMS3
prerank,acylglycerol biosynthetic process (GO:0046463),-0.26787510766567707,-0.7842272498842897,0.77088948787062,0.9466845345014133,1.0,3/23,4.78%,AGMO;LPGAT1;LPIN2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.25708290956675073,0.7842005243022037,0.9158316633266533,1.0,1.0,55/497,10.27%,PRDM16;HEY2;TBX2;LBH;LIMS1;LIMD1;PDGFB;NAB1;ATP8B1;ID4;LOXL2;ARID5B;RUNX1T1;HEYL;PBXIP1;HINFP;IGFBP5;SAMD4A;GMNN;MRPL13;RBAK;BTG2;NACC2;HDAC9;SET;NR2F2;MTERF3;ATXN1;PIAS4;SUV39H2;MYBBP1A;DAB2IP;ARID5A;TP53;HEXIM1;ZBTB38;SFPQ;BCL7A;PA2G4;L3MBTL2;SOX9;RELA;PLCB1;MAP3K10;DAPK3;CBX4;MTA3;NR1D1;KAT7;ZBTB33;SIRT2;DEDD2;MIDEAS;PCGF6;SPINDOC
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.28467976651262517,0.7841151489559369,0.7531328320802005,1.0,1.0,17/69,15.34%,PLCE1;PLCB4;PLCL1;KCNH1;IRS1;PLCB1;PLCD1;SIRT2;PDGFRB;HTR2B;TPTE;ZFP36L1;PIK3C3;PLEKHA1;IRS2;PITPNM2;PTEN
prerank,negative regulation of cell communication (GO:0010648),0.34529494866475396,0.784029801468566,0.715927750410509,1.0,1.0,2/21,6.82%,SOCS5;PTPN1
prerank,B cell differentiation (GO:0030183),0.3031325601052036,0.7830936850784825,0.733957219251337,1.0,1.0,7/46,11.69%,CD79A;ITGB1;HDAC9;ITGA4;ADAM17;TPD52;ZBTB7A
prerank,L-amino acid transport (GO:0015807),-0.25419237565921904,-0.7830730267936167,0.8092307692307692,0.9477516032192876,1.0,13/28,33.14%,SLC1A3;SLC3A2;SLC7A5;CTNS;SLC38A5;SLC1A4;SLC36A1;SLC1A1;SLC25A22;SLC1A2;SLC25A18;SLC1A6;PRAF2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2615533522730254,0.7829962298629302,0.8566978193146417,1.0,1.0,27/208,11.68%,FLNA;NR1H4;MYD88;RORA;ROR1;NUP62;CARD19;MTDH;DAB2IP;PPM1A;TRAF3;GOLT1B;TIFA;RELA;TNIP1;TRIM68;OTUD7A;GSTP1;NR1D1;EDAR;TRAF5;PELI2;DDX1;ZDHHC17;RHOH;ZFAND6;HTR2B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.35403622183150996,0.7825184233591103,0.7142857142857143,1.0,1.0,4/18,6.95%,ANXA1;HDAC9;VEGFA;RHOJ
prerank,response to lipopolysaccharide (GO:0032496),0.2639655365672449,0.7821989244322146,0.8004362050163577,1.0,1.0,15/138,9.79%,MEF2C;MYD88;VIM;UPF1;CD14;TNFRSF11A;DAB2IP;CHMP5;MAPKAPK2;NFKBIB;RELA;ADAM17;GSTP1;NR1D1;AXL
prerank,positive regulation of cell cycle (GO:0045787),0.288971782920708,0.7819893486738223,0.7571964956195244,1.0,1.0,15/62,15.21%,PDGFB;CCND2;EIF4EBP1;USP2;DUSP3;CHEK1;TGFB2;CCND1;ADAM17;PKN2;CITED2;MAPRE3;EIF4E;PRKCA;SRPK2
prerank,central nervous system development (GO:0007417),0.25963645328856993,0.7818597062922338,0.86414708886619,1.0,1.0,22/250,10.44%,SOX6;COL4A1;SERPINI1;ZFHX3;PDGFC;CLN5;SLC6A17;GRIN2C;ATXN1;SYNJ2;TPPP;EML1;SOX9;MBP;SLC23A1;CDH2;GSTP1;NR4A2;ADGRL2;COX7B;HAPLN2;SCYL2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.32106770953578523,0.781812810191697,0.7420289855072464,1.0,1.0,4/33,8.61%,ANGPT1;SEMA5A;YAP1;PPARA
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.378111630059648,0.7815793586942378,0.7037037037037037,1.0,1.0,6/13,20.32%,HEXIM1;HNRNPU;NELFB;NELFCD;EAPP;NELFA
prerank,positive regulation of cellular senescence (GO:2000774),0.39067625831306113,0.7812109629557202,0.706959706959707,1.0,1.0,1/10,3.13%,CGAS
prerank,negative regulation of response to wounding (GO:1903035),0.3568837680385651,0.7810463114840013,0.7044728434504792,1.0,1.0,3/19,6.76%,ALOX5;PTPRS;AJAP1
prerank,monoacylglycerol metabolic process (GO:0046462),0.37459392934629665,0.7808991547815135,0.689119170984456,1.0,1.0,4/13,18.67%,MGLL;DGAT1;PLA2G4A;FAAH
prerank,regulation of cell size (GO:0008361),-0.2656244767195681,-0.7806074172941283,0.7943661971830986,0.9508840059189891,1.0,4/23,8.64%,DEPTOR;PRR16;VAV2;RDX
prerank,organic cation transport (GO:0015695),-0.2782391737762331,-0.7800996003836933,0.7881136950904393,0.950907031351151,1.0,5/20,13.70%,SLC47A1;SEC14L1;SLC22A4;RALBP1;SLC22A18
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3637078092653935,0.780043956957184,0.7238421955403087,1.0,1.0,2/15,6.50%,FGF1;VEGFA
prerank,energy reserve metabolic process (GO:0006112),0.34084391035640754,0.7796822210581258,0.6832797427652733,1.0,1.0,2/19,4.84%,PYGM;GFPT1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2917771150191652,-0.7796404680664847,0.7525773195876289,0.9508713124155935,1.0,9/16,27.74%,KLHL22;PIP4P1;GPR137B;TELO2;RRAGD;GPR137;SIK3;PIH1D1;RRAGA
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3433321411397014,0.7795001396832902,0.7437185929648241,1.0,1.0,7/18,17.90%,RELA;ROCK2;ABCG1;CHRNA7;CLU;SP1;LRRTM3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.266219339769183,0.7793685616554508,0.802660753880266,1.0,1.0,14/136,9.68%,FLNA;TMIGD3;HEYL;PTGIS;HAVCR2;SETD6;TAF1;DAB2IP;CD200;TRAF3;ZNF431;MAP3K10;PAXIP1;NFKBIE
prerank,response to peptide (GO:1901652),0.322045375292971,0.7793660038473282,0.716374269005848,1.0,1.0,7/33,16.02%,ANXA1;IRS1;KAT7;CACNA1B;CHRNA7;STAT1;STAT3
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2958534404097187,-0.7793119984368074,0.7836538461538461,0.9505622590679068,1.0,4/15,16.42%,GGACT;ALDH4A1;ABHD12;HOGA1
prerank,glycogen biosynthetic process (GO:0005978),0.3770085253747043,0.7791176323873751,0.6989247311827957,1.0,1.0,3/12,10.14%,NR1D1;NHLRC1;GYS1
prerank,glucan biosynthetic process (GO:0009250),0.3770085253747043,0.7791176323873751,0.6989247311827957,1.0,1.0,3/12,10.14%,NR1D1;NHLRC1;GYS1
prerank,nuclear export (GO:0051168),-0.2038219661896902,-0.778970065187517,0.9431818181818182,0.9502994214739706,1.0,16/80,14.97%,RANBP3L;THOC2;SRSF7;SRSF6;SRSF11;SRSF5;POLDIP3;NUTF2;RANBP3;TGFB1;THOC5;SRSF2;NEMF;CALR;NCBP2;CCHCR1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.1900465380773021,-0.7786202673856653,0.9745762711864406,0.9500390132028159,1.0,35/105,33.35%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3349173588922279,0.7786151044405271,0.7190839694656489,1.0,1.0,11/25,22.61%,ELL;ERCC6;CCNT1;KAT7;TSFM;ZMYND11;HMGN1;WDR43;HTATSF1;CCAR2;THOC1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.22642693408244488,-0.7784377795128573,0.8333333333333334,0.9495331170282748,1.0,14/42,23.80%,SMARCA2;RBBP4;CECR2;SMARCA1;ACTR8;CHD3;ACTR6;MTA2;HDAC2;ZNHIT1;SRCAP;ACTR5;SMARCD2;GATAD2B
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.31905194256944475,0.7784293742519108,0.7346041055718475,1.0,1.0,3/31,6.42%,PMAIP1;BCL2;TP53
prerank,protein-DNA complex assembly (GO:0065004),-0.19640442996445828,-0.7780661451793724,0.963302752293578,0.9492926202767673,1.0,53/116,36.07%,TCF4;CCNH;PSMD7;PSMD9;PSMD13;ERCC5;DDB1;PSMB3;ORC6;UBC;ORC5;PSMC5;PSMA5;NAA60;CHD1L;PSMA1;PSMC2;SART3;ASF1A;XPA;GTF2H5;GTF2H2;NAP1L1;GTF2H3;PSME3;UBB;PSMC4;ERCC2;PSMB6;ORC4;RAD23B;PSMB10;HMGB2;PSMA4;RPA3;PSME1;ORC1;SPTY2D1;PSMF1;ATRX;PSMB9;NAP1L3;PSME2;PSMA8;KAT6B;CETN2;MCM8;RPA2;ERCC3;RAD51;CHAF1A;PSMD8;RPA1
prerank,stem cell development (GO:0048864),0.35727249496856406,0.7778994292601205,0.6993243243243243,1.0,1.0,3/16,8.70%,TAPT1;SNAI2;CDH2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3123269021846854,0.7777835276091662,0.7658402203856749,1.0,1.0,8/40,12.48%,PMAIP1;FXN;TP53;OPA1;HRK;DNM1L;GPER1;CLU
prerank,atrial septum development (GO:0003283),0.3671877101232177,0.7775513895586742,0.6879310344827586,1.0,1.0,2/13,7.86%,HEY2;TGFB2
prerank,immunoglobulin mediated immune response (GO:0016064),0.38605410155024156,0.7774842385836324,0.7001897533206831,1.0,1.0,10/10,61.42%,CD27;ZP3;CD74;GAPT;CD19;FCER1G;CARD9;TLR8;CD81;FCGR2B
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.2757726828247008,0.777323526002707,0.7978971962616822,1.0,1.0,14/87,14.35%,FGF1;POLR2L;POLR2I;NR4A1;CCL5;POLR2G;FLRT1;GALNT3;POLR2J;ZFP36L1;FGF10;MAPK1;RAB14;HYAL1
prerank,cellular response to lectin (GO:1990858),-0.1911798887288157,-0.7773174922447832,0.9745762711864406,0.9488336143255344,1.0,35/104,33.35%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.1911798887288157,-0.7773174922447832,0.9745762711864406,0.9488336143255344,1.0,35/104,33.35%,PDPK1;PLCG2;PSMD7;PSMD9;PSMD13;IKBKG;TAB2;PSMB3;CHUK;LYN;PSMC5;TAB1;EP300;PSMA5;PSMA1;PSMC2;KRAS;RELB;BTRC;PSME3;PSMC4;PSMB6;PSMB10;SYK;PSMA4;PSME1;PSMF1;ICAM2;SRC;NFKB1;PSMB9;PSME2;TYROBP;PSMA8;HRAS
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2726467350213393,-0.7770420076725171,0.7728531855955678,0.9484767053518361,1.0,6/21,19.46%,CDC14B;RAB1A;UBE2S;RPS7;RPL11;BTRC
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3610803374642942,0.7766498493286333,0.7197346600331676,1.0,1.0,5/16,13.90%,PARP1;PPARGC1A;PPARA;ATPSCKMT;TMSB4X
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.33607196373600384,0.7763122861954665,0.7254601226993865,1.0,1.0,2/22,6.73%,FZD5;IL12RB1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.36387073974063994,0.7754527946768492,0.7065972222222222,1.0,1.0,2/13,9.24%,CABP1;NUP153
prerank,glycosaminoglycan catabolic process (GO:0006027),0.2908329105609938,0.7752752881597762,0.7645569620253164,1.0,1.0,5/55,5.98%,SDC2;CSPG4;BGN;GPC4;OGN
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.2883854177872852,-0.7746019731510085,0.7745098039215687,0.9515331075865266,1.0,3/15,13.83%,EGFR;PTK2B;KDR
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3056227444619156,0.7745818941312356,0.7320441988950276,1.0,1.0,9/43,10.69%,PDGFB;TERT;TP53;SOX9;TGFB2;RELA;PPARA;HIF1A;TEAD1
prerank,cellular response to amino acid stimulus (GO:0071230),0.31372436277405924,0.7743903704223091,0.7381974248927039,1.0,1.0,8/33,14.47%,LARS1;CASTOR1;CPEB1;CAPN2;RRAGB;SH3BP4;CPEB3;CASTOR2
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3167634691692726,-0.774298725123776,0.745575221238938,0.9512041293099917,1.0,3/12,16.91%,CENPC;RMDN1;MAD1L1
prerank,regulation of postsynapse organization (GO:0099175),0.3242591259752849,0.7737638761491429,0.7206537890044576,1.0,1.0,8/28,16.45%,PDLIM5;KIF1A;ABHD17B;IL1RAPL1;HOMER1;LRRK2;LZTS3;VPS35
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2311560006678665,-0.7734859489073592,0.862876254180602,0.9516830867608731,1.0,14/33,28.61%,PABPN1;SLBP;SETX;MAZ;NCBP2;CPSF2;SCAF8;CSTF2T;SSU72;CPSF4;CSTF2;CPSF1;LSM11;CLP1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.3265539459142333,-0.7734719447038879,0.7391304347826086,0.9509103046223261,1.0,3/10,20.56%,HSPA5;HERPUD1;ATF4
prerank,positive regulation of mRNA processing (GO:0050685),-0.2716270737761901,-0.7731873862066269,0.8096590909090909,0.9505423249691878,1.0,6/21,14.87%,TRA2B;CELF4;DAZAP1;SNW1;LEO1;NCBP2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.27433613453145195,-0.7730851263267088,0.7949438202247191,0.9499084768135665,1.0,4/20,8.43%,FKBP5;CWC27;PPIL2;FKBP1A
prerank,regulation of cellular catabolic process (GO:0031329),0.2876448481599345,0.7726435431511961,0.7644110275689223,1.0,1.0,20/62,19.81%,ROCK1;ITPR1;PIP4K2A;MAPT;DAPK3;RRAGB;LONP2;BOK;USP13;LRRK2;RAB8A;WDR41;DAPK2;MTMR3;DDIT3;HDAC6;KAT8;ABL1;PIK3R2;DCAF12
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3215383405987118,0.7725104837000859,0.7458646616541353,1.0,1.0,4/25,12.91%,AMPD1;AMPD2;PPAT;GMPR
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.21685774457739498,-0.7721932641123456,0.8722466960352423,0.9504920445185381,1.0,5/49,5.31%,HMGB1;LBP;F3;NOD1;LGALS9
prerank,dendritic spine organization (GO:0097061),0.33516537767158855,0.7720704162121195,0.7511045655375552,1.0,1.0,5/26,15.34%,ITGA3;DOCK10;CHRNA7;EPHB1;PTEN
prerank,response to UV-A (GO:0070141),-0.3050203389267502,-0.7719059347532264,0.7518987341772152,0.9501361362485161,1.0,4/14,16.36%,EGFR;MMP2;AKT1;MMP1
prerank,translational elongation (GO:0006414),0.27121550197325456,0.7717678954274179,0.7958236658932715,1.0,1.0,27/101,19.18%,EEFSEC;MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;TSFM;MRPL42;EEF2K;GTPBP2;MRPL14;MRPL4;EEF2;MRPS21;MRPL40;MRPL22;MRPL50
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.32694104635529764,0.7713186876037095,0.7285067873303167,1.0,1.0,5/23,15.39%,SOCS5;SOCS4;CAV1;TSG101;CBLB
prerank,DNA methylation or demethylation (GO:0044728),-0.2794712882699849,-0.7712839905180436,0.7818181818181819,0.9494839255120315,1.0,11/19,45.32%,KMT2E;PPM1D;TEX15;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,DNA alkylation (GO:0006305),-0.2794712882699849,-0.7712839905180436,0.7818181818181819,0.9494839255120315,1.0,11/19,45.32%,KMT2E;PPM1D;TEX15;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.23767376096411563,-0.7709259559154836,0.8445229681978799,0.9492560703071043,1.0,9/35,18.12%,ATR;TNKS2;XRCC5;CTNNB1;FBXO4;MAP3K4;CCT8;CCT4;ATM
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25573130818243905,0.7698785808576316,0.8724066390041494,1.0,1.0,53/241,16.32%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;SF3B3;SRSF4;PAPOLA;SNRPN;GPKOW;FUS;PPIL1;PPIE;ZMAT5;RBM19;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;SF3A3;HNRNPC;PSPC1;RBM6;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;PPWD1;SYNCRIP;PDCD7;CWC22;PPIL3;SNRPB2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3457438020214508,0.7697926303904874,0.7041800643086816,1.0,1.0,3/18,8.65%,MEF2C;ITGA4;ADAM17
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.37978101252395546,0.769588990849114,0.7206703910614525,1.0,1.0,3/12,8.49%,TP53;RPS27L;CCND1
prerank,B cell mediated immunity (GO:0019724),0.38605410155024167,0.7693698539984022,0.7237354085603113,1.0,1.0,10/10,61.42%,MSH2;CD27;CD70;CD74;CD19;SLA2;FCER1G;CARD9;TLR8;FCGR2B
prerank,positive regulation of signaling receptor activity (GO:2000273),0.31003982302163957,0.7693111104899749,0.7565337001375516,1.0,1.0,7/36,10.48%,ITGB1;TAF1;FBXW7;AREG;ADAM17;HIF1A;HBEGF
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.31833555076956255,-0.7691027438151673,0.7828810020876826,0.9512750525979918,1.0,2/11,8.20%,NEDD4L;COMMD1
prerank,macroautophagy (GO:0016236),0.26733753156403633,0.7687344425421762,0.8081264108352144,1.0,1.0,32/118,20.60%,DYNLL1;PRKAB2;CHMP4C;PIP4K2A;MTERF3;LIX1L;ATG7;GABARAP;LIX1;VDAC1;MTMR14;STAM2;MFN2;CHMP2B;TSG101;VPS36;PIK3C3;CHMP2A;PRKAA2;STAM;ATG13;TOMM5;VPS4A;MTMR3;FUNDC1;TOMM7;ULK1;ATG10;VPS37A;PRKAB1;MFN1;LAMP2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.266695158905933,-0.7682669074328358,0.803680981595092,0.9517929777447756,1.0,11/23,31.76%,ELOVL7;FAR2;ACSL3;ACSL4;ELOVL6;HACD2;ELOVL1;ACOT7;ACSL1;ELOVL5;DGAT2
prerank,prostaglandin biosynthetic process (GO:0001516),0.34239745369436736,0.7682144161340354,0.7269681742043551,1.0,1.0,5/18,17.14%,PTGIS;TBXAS1;CBR1;PLA2G4A;MIF
prerank,glutathione metabolic process (GO:0006749),0.31327037158853827,0.7680297754634862,0.7601683029453016,1.0,1.0,7/38,12.11%,ETHE1;GSTT1;NAT8;GSTP1;OPLAH;GGCT;GSTA4
prerank,protein localization to microtubule organizing center (GO:1905508),0.3576545173891503,0.7678771600308555,0.7094594594594594,1.0,1.0,4/15,11.87%,PIBF1;CEP192;C2CD3;NEDD1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3668211853514006,0.7676161305501327,0.7051724137931035,1.0,1.0,1/13,1.50%,PMAIP1
prerank,cholesterol transport (GO:0030301),0.30078130195121566,0.7666346055395394,0.7576158940397351,1.0,1.0,10/45,17.72%,CD36;CAV1;STX12;ABCG1;OSBPL2;CLU;LDLRAP1;OSBPL5;VPS4A;LIMA1
prerank,membrane organization (GO:0061024),0.25729242722852463,0.7665675932832761,0.8657648283038502,1.0,1.0,38/227,13.43%,TRDN;CHMP4C;FER1L5;HIP1;DYSF;PACSIN2;ITSN1;FZD4;ACTG1;ACTB;ACTR3;TTPA;SYNJ2;EPN2;CHMP5;CORO1C;AREG;IGF2R;OPA1;SUN2;LPCAT3;GCA;STX18;NSFL1C;HBEGF;DNM1L;STAM2;TLCD2;MFN2;OSBPL2;CHMP2B;DMPK;SNX9;A4GALT;FNBP1;GLTP;LDLRAP1;CHMP2A
prerank,erythrocyte development (GO:0048821),0.3839867064772342,0.7663839099439795,0.7127659574468085,1.0,1.0,3/10,12.98%,MED1;ZBTB7A;DMTN
prerank,import into nucleus (GO:0051170),-0.2021720078962559,-0.7656651624496981,0.9171597633136095,0.9548995229908693,1.0,22/73,23.86%,APPL2;E2F3;FAM53A;NUP88;NUTF2;IPO8;PTTG1IP;GEMIN8;APPL1;NUP50;SNRPD1;AKT1;EIF4ENIF1;GEMIN7;SMN1;NUP85;IPO11;NXT2;NUP214;RAN;HTATIP2;IPO13
prerank,epidermal cell differentiation (GO:0009913),0.30313040822710213,0.7651369904325382,0.7376171352074966,1.0,1.0,5/41,12.31%,ANXA1;JAG1;MED1;EPHA2;BCR
prerank,positive regulation of epithelial cell migration (GO:0010634),0.27291412138111615,0.7640333784764438,0.795774647887324,1.0,1.0,14/92,10.88%,ANGPT1;FGF1;ANGPT4;CLASP2;MAPRE2;RRAS;VEGFA;ITGB3;SOX9;TGFB2;RIN2;HIF1A;DOCK1;ROCK2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.2760035533675432,0.7637934557697221,0.8045563549160671,1.0,1.0,16/74,16.90%,LIMD1;CUL2;PSMC6;ELOC;VEGFA;HIF1A;PSME4;SIRT2;PSMB1;PSMD5;PSMB2;CITED2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3508913284315186,0.763288629235261,0.6968174204355109,1.0,1.0,3/15,7.68%,VEGFA;GDNF;SOX9
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.2759069665484174,-0.762908089078788,0.8062015503875969,0.9582146437195507,1.0,3/17,6.97%,PID1;NUPR1;HDAC4
prerank,peroxisomal membrane transport (GO:0015919),-0.24933946106637622,-0.7628877935718555,0.827893175074184,0.9574529153934498,1.0,9/27,21.53%,PEX14;SLC25A17;ALDH3A2;PEX5;ACBD5;ABCD3;FIS1;PXMP2;PEX13
prerank,chondroitin sulfate metabolic process (GO:0030204),0.31863426324407407,0.7626352588574266,0.7414561664190193,1.0,1.0,4/30,3.64%,CSPG4;CHSY3;CSGALNACT1;BGN
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.35420568567113647,0.7626025134773545,0.7313974591651543,1.0,1.0,6/13,19.61%,ALOX5;LPCAT3;CLU;EIF2AK3;NR1H3;WFS1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3176965079958126,0.7620851625194068,0.7550432276657061,1.0,1.0,12/30,23.14%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2;PGAP4;PIGK;PIGZ;GPAA1;PIGS;PIGM
prerank,regulation of complement activation (GO:0030449),-0.22759606929625265,-0.7612504115024844,0.842741935483871,0.9591059472977865,1.0,11/40,27.54%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;CR1L;C1QC;C1QA;CFHR2;C2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3427441244779853,0.7606967035116351,0.7099358974358975,1.0,1.0,5/18,16.35%,PLCB1;HRH3;AGRN;GNAQ;RGS10
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2510831465524152,0.7606165016582744,0.8853305785123967,1.0,1.0,58/264,16.32%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;CLNS1A;SF3B3;SRSF4;PAPOLA;SNRPN;GPKOW;PRMT7;FUS;PPIL1;PPIE;ZMAT5;RBM19;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;DDX1;SF3A3;HNRNPC;PSPC1;RBM6;TGS1;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;PPWD1;SYNCRIP;PDCD7;CWC22;PPIL3;SNRPB2;SRPK2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,regulation of protein polymerization (GO:0032271),-0.2273061953003192,-0.7599048665090965,0.8686868686868687,0.9602928258725318,1.0,9/35,20.24%,ARHGAP28;RASA1;PFN2;PFN1;DBN1;TTBK1;TPPP3;ARL2;GBA2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3449860309113859,0.7595447814548245,0.7441860465116279,1.0,1.0,2/16,6.86%,FGF1;GDNF
prerank,mitochondrial translational termination (GO:0070126),0.2717047457085655,0.759441432025028,0.8161328588374852,1.0,1.0,28/88,22.04%,MRPL36;MRPS31;MRPL13;MRPL30;MRPL43;MRPS35;MRPS28;MRPL51;MRPL45;MRPL21;MRPL23;GFM2;MRPL16;MRPL47;MRPL9;MRPL42;MRPL14;MRPL4;MRPS21;MRPL40;MRPL22;MRPL50;MRPS14;MRRF;OXA1L;MRPL24;MRPS12;MRPS10
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.31867465980975107,-0.7589719485722447,0.7801418439716312,0.9608561518190062,1.0,6/11,35.72%,UQCRC1;UQCRC2;UQCR11;CYC1;UQCC3;CYCS
prerank,negative regulation of T cell activation (GO:0050868),0.3068862250551829,0.7587889259547647,0.7524613220815752,1.0,1.0,5/35,10.86%,LAX1;HAVCR2;DUSP3;PAG1;TNFRSF21
prerank,glycerolipid catabolic process (GO:0046503),-0.2756406735332602,-0.7587345519915651,0.7795698924731183,0.9604009210566893,1.0,9/19,30.50%,GDPD1;ABHD12;GDE1;GPCPD1;PNPLA6;ABHD6;LYPLA2;ENPP6;SMPD4
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.25133882847428557,-0.7587150921294458,0.8442622950819673,0.9596288809707192,1.0,14/26,31.22%,TET3;CTR9;TET2;OGT;SETD5;ETFBKMT;SETD1A;SUV39H1;PRDM9;EEF2KMT;KMT2A;BEND3;SMYD5;ANTKMT
prerank,"DNA-templated transcription, termination (GO:0006353)",0.27898681012303905,0.7586623768727188,0.7952559300873908,1.0,1.0,8/68,9.60%,CAVIN1;POLR2L;GTF2H4;WDR33;PCF11;PAPOLA;CDK7;POLR1E
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3018145658429948,0.7585990819665422,0.7800546448087432,1.0,1.0,5/38,6.82%,PDGFB;DOK7;CAV1;RAP2C;PTPN1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2957936102136496,0.7584142623331595,0.7831168831168831,1.0,1.0,6/50,9.52%,CCNA2;CCND2;ACTB;CCND1;CCNT1;CDK7
prerank,positive regulation of neuron migration (GO:2001224),0.3732981503421602,0.758256937155855,0.7212543554006968,1.0,1.0,3/11,12.58%,ARHGEF2;DAB2IP;KIF20B
prerank,inositol lipid-mediated signaling (GO:0048017),0.2873562217073942,0.7581271413126162,0.7810026385224275,1.0,1.0,8/50,10.07%,PLCE1;PLCB4;PLCL1;KCNH1;IRS1;PLCB1;PLCD1;PDGFRB
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.32064015635732923,0.7580665484335285,0.7449567723342939,1.0,1.0,6/27,12.55%,CPA4;NAT8;MSL3;KAT7;RUVBL1;MORF4L1
prerank,maintenance of protein localization in organelle (GO:0072595),0.33324859742426705,0.758040306753073,0.7491909385113269,1.0,1.0,4/19,10.29%,HK2;TAPT1;TAF8;HNRNPU
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3006083616585381,0.757861164459267,0.7412790697674418,1.0,1.0,10/38,18.33%,FZD5;SAE1;FBXW7;SREBF2;HPS4;LRRK2;ATG13;LEPROT;USP36;TOMM7
prerank,regulation of microtubule polymerization (GO:0031113),0.29875916505470657,0.7574920608344707,0.7640603566529492,1.0,1.0,13/40,20.86%,PRUNE1;DYRK1A;MAPT;TOGARAM1;TBCD;CLIP3;CLASP1;STMN2;MAPRE3;DCTN1;ABL1;CAMSAP1;MAPRE1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.32740161344809426,-0.7573619448051325,0.7690631808278867,0.9607958784237521,1.0,2/10,5.68%,LGALS9;CD55
prerank,regulation of chromatin binding (GO:0035561),-0.32433977717251655,-0.7571947688810783,0.78,0.9602448716767584,1.0,4/10,17.72%,BTAF1;MED25;DTX3L;KDM4D
prerank,histone H3 deacetylation (GO:0070932),0.3497619901577142,0.7568259087359575,0.75,1.0,1.0,6/15,19.59%,HDAC9;SFPQ;SIRT2;SIRT6;HDAC1;SMARCAD1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3251622469938789,0.7568244391384125,0.7465007776049767,1.0,1.0,1/23,1.50%,PMAIP1
prerank,positive regulation of phagocytosis (GO:0050766),0.2896334892381607,0.7567425016041961,0.774365821094793,1.0,1.0,3/47,5.29%,MERTK;ANO6;MYO18A
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.35534558335131194,0.7566332633699554,0.7455429497568882,1.0,1.0,2/15,11.57%,PLA2G3;ABCG1
prerank,regulation of immune effector process (GO:0002697),-0.226322593420665,-0.7565381620514758,0.8653061224489796,0.9603690137482872,1.0,18/41,40.51%,VTN;PROS1;CD55;CD46;SERPING1;C1QB;CR1L;C1QC;C1QA;CFHR2;C2;CR2;C3;C3AR1;C6;FCGR2B;C7;CD81
prerank,neuron projection development (GO:0031175),0.2562396225663023,0.7563501054551643,0.8514225500526871,1.0,1.0,30/168,15.42%,NTF3;ROCK1;FRY;PLXNB1;DOCK10;BTG2;MAPT;DAB2IP;GDNF;HDGFL3;NEDD4;ERCC6;DICER1;ATCAY;SAMD14;RB1;TNIK;PACSIN1;KIF20B;TAOK3;SGK1;MAP4;EPHB1;STMN2;LRRK2;ANKRD27;PPP1R9A;CNTNAP1;PTEN;DNM2
prerank,anterograde axonal transport (GO:0008089),0.3030172545356106,0.7563284787537624,0.7725437415881561,1.0,1.0,10/37,17.50%,KIF3B;KIF1A;KIF5B;TRAK1;KIF1C;KIF5C;KIF5A;AP3B2;BLOC1S5;MAP1A
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.27662479841120124,-0.7563037900799555,0.8075949367088607,0.9598967023225384,1.0,5/17,19.06%,EMC2;SGTA;EMC3;EMC8;MMGT1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.31176702574962656,-0.7557602323272119,0.7575757575757576,0.9590993633337925,1.0,3/11,16.60%,CCT8;CCT4;LARP7
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.31176702574962656,-0.7557602323272119,0.7575757575757576,0.9590993633337925,1.0,3/11,16.60%,CCT8;CCT4;LARP7
prerank,negative regulation of kinase activity (GO:0033673),-0.2046800569518904,-0.7554251033439975,0.9296482412060302,0.9588214053982673,1.0,16/62,20.37%,PRKAG2;NF1;DEPTOR;PDPK1;DTNBP1;PYDC1;WWTR1;PPM1F;TAB1;SNCA;AKT1;ITGB1BP1;TRIB1;PARK7;QARS1;CEACAM1
prerank,signal peptide processing (GO:0006465),0.35790606132698155,0.7548466251654813,0.75,1.0,1.0,1/11,2.22%,CLN5
prerank,DNA methylation (GO:0006306),-0.26085776311887005,-0.7548285910595237,0.8268156424581006,0.9589259472335305,1.0,13/23,45.32%,KMT2E;PPM1D;PICK1;TEX15;ZFP57;ATRX;BEND3;DNMT3B;EHMT2;EHMT1;ATF7IP;DMAP1;FOS
prerank,DNA geometric change (GO:0032392),-0.25890367917584955,-0.7544139338166137,0.8224852071005917,0.9587122096451599,1.0,5/24,12.84%,HMGB1;MRE11;RAD50;BLM;NBN
prerank,regulation of mitotic nuclear division (GO:0007088),0.2860700828029652,0.7542210853626413,0.787012987012987,1.0,1.0,12/55,15.41%,PDGFB;NUP62;PIN1;CUL9;CHEK1;DAPK3;TOM1L2;PDGFRB;LRP5;KIF20B;FBXO5;CAV2
prerank,protein targeting (GO:0006605),0.26177079675951126,0.754185584230923,0.8338907469342252,1.0,1.0,37/118,22.34%,AKAP6;ZFAND2B;GOLGA7B;NACA;GABARAP;ZDHHC2;TRAK1;ZDHHC1;ZDHHC14;PEX19;LONP2;MFN2;ZFAND6;HPS4;AP1S3;TOMM5;AP4E1;ZDHHC4;BCAP31;MFF;TOMM7;ZDHHC3;RTP4;VPS37A;SPCS3;PARD3;SRP14;PEX1;MYO1C;LAMP2;TIMM9;CACNG3;TIMM22;SEC61G;GDAP1;PIKFYVE;TOMM22
prerank,phospholipid metabolic process (GO:0006644),0.2763356794868319,0.7534642268042092,0.8023952095808383,1.0,1.0,11/71,15.00%,PLA2G3;PIP4K2A;LPL;PLPPR1;AGPAT3;PLCD1;PCYT2;PLB1;PNPLA3;PLA2G4A;PLA2G4C
prerank,regulation of cellular response to stress (GO:0080135),0.26247223642977324,0.7534617547323452,0.8226711560044894,1.0,1.0,21/115,14.19%,CAMK2G;CAMK2D;NUP62;ALOX5;SLC38A2;MAPT;MAPKAPK2;NUAK1;SEC13;NUP153;BAG3;AMFR;NUP107;AAAS;ROCK2;ATF3;BAG2;NUP98;MAPK1;NUP37;MCL1
prerank,sensory perception (GO:0007600),0.2928584545262855,0.7528043549283101,0.7680965147453083,1.0,1.0,5/45,12.38%,ASIC3;TRPV2;NTSR2;KCNA2;CHRNA7
prerank,positive regulation of cell death (GO:0010942),0.2765419695411979,0.7525346665757485,0.7804878048780488,1.0,1.0,5/59,7.56%,MAP3K5;CD36;MAPT;HEBP2;CELF1
prerank,maintenance of protein location in nucleus (GO:0051457),0.327877510148608,0.7523678107062265,0.7551342812006319,1.0,1.0,4/20,10.29%,SYNE1;TAF8;SUN2;HNRNPU
prerank,mRNA processing (GO:0006397),0.24737451642839162,0.7519789668857517,0.9151329243353783,1.0,1.0,62/287,16.32%,LSM8;POLR2L;POLR2I;HNRNPR;CWC25;RAVER2;GTF2H4;DDX23;WDR33;PCF11;SF3B5;POLR2G;U2AF2;TXNL4A;SFPQ;PPARGC1A;CELF1;SF3B3;SRSF4;PAPOLA;SNRPN;PRPF18;GPKOW;FUS;PPIL1;PPIE;ZC3H11A;ZMAT5;RBM19;CDK7;RBM8A;U2AF1;DHX8;HNRNPU;PRPF4;SRSF10;THOC7;SF3A3;HNRNPC;PSPC1;RBM6;SRRM1;SF3B2;SF3B1;ZCRB1;POLR2J;PPWD1;SON;SYNCRIP;PDCD7;CWC22;PRKACA;PPIL3;SNRPB2;RBM15;SF1;RBM41;SF3A1;PUF60;FIP1L1;XAB2;WBP4
prerank,cellular response to amyloid-beta (GO:1904646),0.2980234501673107,0.7517549297830325,0.7755960729312763,1.0,1.0,2/35,1.72%,CACNA2D1;CD36
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2665732232313008,0.7517062902518299,0.8070388349514563,1.0,1.0,19/78,17.98%,KLHL40;SOCS5;PABIR1;GABARAP;CAV1;TAF1;RNF180;SIRT2;CLU;BAG2;CSNK1E;LRRK2;DVL1;CSNK1A1;HSPBP1;SIRT6;BCAP31;RCHY1;PIAS1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2842943301330476,0.7514899963995939,0.8012903225806451,1.0,1.0,6/56,7.82%,CD36;MYD88;CD14;MAPKAPK2;TRAF3;TIFA
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.19581707157347675,-0.7513659820864353,0.9378531073446328,0.9622619362609737,1.0,29/70,32.65%,ITCH;PRKDC;PUS7;PSMD7;PSMD9;PSMD13;METTL3;PSMB3;PSMC5;PSMA5;PSMA1;PSMC2;N4BP2L2;SETD1A;LMO2;PSME3;PSMC4;TAL1;PSMB6;PSMB10;PSMA4;KMT2A;PSME1;PSMF1;PSMB9;LDB1;PSME2;TCF3;PSMA8
prerank,inorganic anion transport (GO:0015698),0.28001275969727923,0.7512631226458604,0.7865168539325843,1.0,1.0,6/53,9.10%,ANO1;ANO6;CLCN6;TTYH1;ANO10;XPR1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.31851126260227725,-0.7506317722660484,0.7855579868708972,0.9609036349760974,1.0,5/10,27.82%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,t-circle formation (GO:0090656),-0.31851126260227725,-0.7506317722660484,0.7855579868708972,0.9609036349760974,1.0,5/10,27.82%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.31851126260227725,-0.7506317722660484,0.7855579868708972,0.9609036349760974,1.0,5/10,27.82%,BLM;NBN;SMARCAL1;ERCC1;DNA2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.375245296554741,0.7505011378827486,0.7425373134328358,1.0,1.0,3/10,18.45%,RB1;CLU;EGR1
prerank,mammary gland development (GO:0030879),0.3322095101117363,0.7503794915507359,0.7360890302066773,1.0,1.0,4/21,11.60%,TGFB3;CAV1;VEGFA;ARHGAP35
prerank,snRNA processing (GO:0016180),-0.2881787157324756,-0.7502253134426534,0.7857142857142857,0.9606757138264529,1.0,6/16,28.48%,INTS6;INTS3;INTS2;INTS11;INTS14;TOE1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.3726115753180931,0.7497206239650178,0.7422867513611615,1.0,1.0,3/10,13.99%,SLC44A1;SARDH;COMT
prerank,lymphocyte chemotaxis (GO:0048247),0.29917229181711624,0.7493756436444713,0.7482710926694329,1.0,1.0,6/34,18.77%,CYP7B1;CCL5;CCL14;GAS6;CCL25;CCL19
prerank,neuron differentiation (GO:0030182),0.25454681584505473,0.7491816566839831,0.8517722878625135,1.0,1.0,17/165,11.33%,MEF2C;FZD5;IRX5;FZD4;FZD8;ITM2C;VEGFA;PIN1;ERCC6;TGFB2;ADNP2;MAP2K1;NR4A2;BRSK1;HS6ST1;RUNX1;IL1RAPL1
prerank,response to steroid hormone (GO:0048545),0.30660871703699,0.7489562418662454,0.7717231222385862,1.0,1.0,6/31,7.86%,TGFB3;CAV1;AR;MED1;YAP1;TGFB2
prerank,regulation of mRNA catabolic process (GO:0061013),0.2605905598717813,0.7488373934948139,0.8445190156599552,1.0,1.0,23/121,16.90%,RBM24;VIM;SAMD4A;PARN;SET;UPF1;PSMC6;MAPKAPK2;YTHDF2;PSME4;PSMB1;PSMD5;PRKCD;DCP1A;CNOT7;PSMB2;ZFP36L1;PSMB7;PSMD3;PRKCA;PSMA2;XPO1;PSMD14
prerank,protein stabilization (GO:0050821),0.25196651372859513,0.7487836754768864,0.8565310492505354,1.0,1.0,30/168,15.51%,FLNA;HIP1;CRTAP;TSPAN1;USP2;TESC;ATP1B1;TAF1;FBXW7;PIN1;PPARGC1A;CDK7;RPL5;BAG3;PARVA;STX12;PEX19;CCT3;PRKCD;USP13;TMEM88;CLU;PDCD10;HPS4;BAG2;MUL1;GNAQ;DVL1;PTEN;FLOT1
prerank,axonal transport (GO:0098930),0.3032181415621169,0.7487338978404304,0.7675378266850069,1.0,1.0,10/36,17.37%,DST;KIF3B;KIF1A;MAPT;OPA1;HIF1A;FBXW11;AP3B2;BLOC1S5;DCTN1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27160948887209563,-0.7486729651192701,0.8083989501312336,0.9619532089027417,1.0,7/18,30.45%,PRKN;AKT1;PARK7;MAPK7;BAG5;HTRA2;PPIA
prerank,peptidyl-methionine modification (GO:0018206),0.3597132798415153,0.7481131826351265,0.7271157167530224,1.0,1.0,2/12,8.20%,NAA25;NAA20
prerank,DNA replication initiation (GO:0006270),-0.2230752320215192,-0.7480278355704869,0.8379310344827586,0.9620650544416433,1.0,23/37,41.95%,ORC6;ORC5;POLE4;POLE2;CDC7;CDK2;ORC4;DBF4;POLA2;RPA3;ORC1;CDC34;PRIM1;MCM8;RPA2;CDC45;RPA1;POLE;MCM3;POLE3;POLA1;MCM5;MCM10
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3250713006112076,0.7478830230950319,0.7586206896551724,1.0,1.0,2/20,3.81%,ADRA1D;ADCY9
prerank,negative regulation of potassium ion transport (GO:0043267),-0.29502757954970343,-0.7477578843448907,0.8022988505747126,0.9616461668030616,1.0,2/13,5.66%,NEDD4L;PTK2B
prerank,electron transport chain (GO:0022900),0.34470114921981193,0.7471843573979683,0.738898756660746,1.0,1.0,5/15,16.06%,PPARGC1A;ETFA;SDHA;ENOX2;UQCRFS1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.31160274022459034,0.7470146963292847,0.7689075630252101,1.0,1.0,3/31,4.59%,CDK6;FHL1;JADE1
prerank,response to growth factor (GO:0070848),0.2957079759739882,0.7461677539724542,0.7738896366083445,1.0,1.0,13/41,20.77%,PDGFB;ACVR2A;BMPR1A;EPHA2;ACVR1B;BMPR1B;CPNE3;URI1;NOS1;HDAC6;SHC1;ACVR1;ERBB2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.23297912515903604,-0.7460598272476267,0.8526315789473684,0.9632307374962642,1.0,10/30,26.21%,BCL2L1;CD44;MDM2;THOC5;PTTG1IP;KDM1A;TRIM32;SNAI1;YJU2;TWIST1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.373469710797741,0.745967126421007,0.7486437613019892,1.0,1.0,3/11,13.20%,PAPOLA;AHCYL1;ZFP36L1
prerank,sister chromatid segregation (GO:0000819),0.3097361522714268,0.745589313836502,0.7652050919377652,1.0,1.0,9/31,17.20%,ZWINT;WRAP73;TOP2B;RB1;KIF18A;KNSTRN;INO80;DSN1;CENPK
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.2624639537090168,0.7451737957559774,0.8357142857142857,1.0,1.0,34/94,23.06%,DYNLL1;CEP41;HAUS8;CEP290;RPGRIP1L;IQCB1;CEP192;DYNC1I2;C2CD3;NEDD1;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PRKACA;PLK4;DCTN1;HAUS4;CEP135;CKAP5;ACTR1A;SFI1;MAPRE1;NPHP4;ODF2;PPP2R1A;NINL;TUBA4A;CEP63;YWHAG;NDE1
prerank,protein-containing complex assembly (GO:0065003),0.24989029950859934,0.7450160480601502,0.9022633744855967,1.0,1.0,37/259,14.40%,DMD;TCAP;PDE4DIP;FERMT2;ANO6;SH3BGR;TBC1D20;SKAP2;CNIH2;AFG3L2;TERT;TP53;LAMC1;AREG;PPARGC1A;MDN1;YAP1;OPA1;SOX9;ADD2;KMT2D;AMER1;SEC13;MAGI1;TEAD1;DNM1L;KIFAP3;BOK;RUVBL1;NSF;SNX9;SEC24A;DMTN;KPNA3;SEC24C;EPRS1;LRRK2
prerank,negative regulation of secretion by cell (GO:1903531),0.28915141766491675,0.7447063749745048,0.776824034334764,1.0,1.0,5/38,11.33%,HTR1B;ANXA1;DPH3;HRH3;IL1RAPL1
prerank,arachidonic acid metabolic process (GO:0019369),0.3007672685191279,0.7443396826127276,0.7651403249630724,1.0,1.0,8/35,16.23%,PTGIS;ALOX5;TBXAS1;CBR1;MGLL;PLA2G4A;PLA2G4C;EPHX1
prerank,histone deacetylation (GO:0016575),0.2968993675892382,0.7441135499723815,0.7997237569060773,1.0,1.0,15/43,19.59%,HDAC9;SFPQ;MSL3;MTA3;SIRT2;MIDEAS;BAZ2A;MORF4L1;MTA1;SIN3A;SIRT6;HDAC1;RBM14;HDAC6;SMARCAD1
prerank,rRNA 3'-end processing (GO:0031125),-0.31803463770335944,-0.7440868343583832,0.7819905213270142,0.96511963974602,1.0,6/10,25.11%,ERI3;EXOSC9;RPS21;EXOSC2;EXOSC7;EXOSC3
prerank,regulation of viral genome replication (GO:0045069),-0.20483164974895332,-0.7437872854440865,0.911504424778761,0.9647623413088007,1.0,14/56,18.27%,DDX3X;STAU1;PARP10;PABPC1;DDB1;IFIT1;ADAR;BST2;PPIH;IFITM1;OAS2;SHFL;IFITM3;SRPK1
prerank,protein import into nucleus (GO:0006606),0.27121158252906696,0.7437087521496105,0.831055900621118,1.0,1.0,24/66,20.76%,NUP62;KPNA4;RANBP17;SPRN;SEC13;NUP153;PPP1R10;NUP107;RANBP6;KPNA2;TNPO3;KPNA3;FAM53B;IPO4;IPO7;CBLB;FAM53C;STAT3;NUP54;NUP133;PHB2;IPO9;HIKESHI;TPR
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.28785560866580373,-0.7436599430818897,0.8032407407407407,0.964133574700822,1.0,6/13,26.49%,PRR5L;GTPBP1;PNPT1;ZC3H12A;ZC3HAV1;MOV10
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.24115043097839312,-0.7435445726388303,0.8443708609271523,0.9635039220811076,1.0,16/26,42.50%,EPHA4;APH1A;LYN;NCSTN;APH1B;TTBK1;PSME3;PSENEN;PSME1;PSME2;PYCARD;GRIN1;AGER;AIM2;FYN;GRIN2B
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2890304231236416,0.7435223900830916,0.7776315789473685,1.0,1.0,6/46,9.22%,CNN2;LCP1;IL12RB2;IL12RB1;PLCB1;PAK2
prerank,regulation of viral life cycle (GO:1903900),0.3278856557139592,0.7435195911710744,0.7619808306709265,1.0,1.0,5/21,12.04%,TRIM68;AXL;NECTIN2;TSG101;KPNA2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3256335105523593,0.743229942886996,0.7552870090634441,1.0,1.0,1/22,1.43%,ROCK1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.24645029549772163,-0.7429974147558022,0.8414634146341463,0.9634156476095772,1.0,10/26,32.16%,CUL3;CDC23;DUSP1;NEK6;ANAPC4;NSMCE2;ANAPC15;CDC16;CDC27;RIOK2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3214508688457901,-0.7425884080380839,0.7830802603036876,0.9631742063490042,1.0,3/10,16.78%,MYO9A;OPHN1;CDC42
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3111275302785989,-0.7422425147792924,0.7891156462585034,0.9628608451235572,1.0,5/11,29.15%,ARRB1;GRK2;GTF2H2;ADM;ADRB2
prerank,maturation of 5.8S rRNA (GO:0000460),-0.2818059961390181,-0.7418410767941115,0.8269720101781171,0.9626240468689213,1.0,4/17,13.09%,NSA2;PRKDC;C1D;URB1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2796849407523916,0.7415734898071662,0.7992227979274611,1.0,1.0,3/57,2.85%,MAP3K5;PMAIP1;ASPH
prerank,negative regulation of DNA replication (GO:0008156),-0.29170366665326236,-0.7412918925731775,0.7976470588235294,0.962549118968511,1.0,2/13,5.09%,ATR;PDS5A
prerank,negative regulation of response to stimulus (GO:0048585),0.2719759929119574,0.7410848181673407,0.7708066581306018,1.0,1.0,17/60,19.68%,CDK6;SOCS5;ALOX5;KLF7;TERT;PTPN1;LPCAT3;TERF2;COL3A1;CLU;FBXO5;ADRA2A;NR1H3;HHIP;ACVR1;WFS1;VPS13C
prerank,response to insulin (GO:0032868),0.2670138991530934,0.7407060368775136,0.8270142180094787,1.0,1.0,8/80,7.78%,SLC2A4;SORT1;HDAC9;IRS1;SORBS1;CPEB1;PARP1;GOT1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3184847652234503,0.7406186814069721,0.7577160493827161,1.0,1.0,3/24,7.09%,PLCE1;ACTR3;CYFIP1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2621048623978338,0.7396643810410378,0.8208778173190985,1.0,1.0,22/84,15.98%,RBM24;KHDRBS3;U2AF2;CIRBP;CELF1;RBMXL1;SRSF4;MBNL2;RBM8A;MBNL1;HNRNPU;SRSF10;RBM3;ZBTB7A;RBM25;SON;NUP98;CWC22;SRPK2;RBM15;SF1;PUF60
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2638796313856144,-0.7394016338266015,0.8434065934065934,0.9642587267985497,1.0,11/20,38.61%,GATM;PLOD2;PTDSS2;MTHFS;FPGS;GCLC;GCLM;PTDSS1;GAMT;PLSCR1;GGT1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.28810000182226586,-0.7378202658895,0.7872860635696821,0.9655805263982568,1.0,5/13,33.56%,PDE8A;PARK7;RACK1;HGF;GPR37
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.26604942855552266,0.7377155935190416,0.816884661117717,1.0,1.0,18/70,17.39%,SORT1;BCL2;GABARAP;DAB2IP;BCL2L2;TGFB2;BAG3;DEDD2;CASP8AP2;BOK;ACVR1B;DIABLO;DEDD;TNFRSF10B;MCL1;JAK2;FGFR3;TNFSF12
prerank,regulation of response to oxidative stress (GO:1902882),0.35287457805483047,0.737512261029155,0.7567084078711985,1.0,1.0,2/11,7.22%,ALOX5;HEBP2
prerank,positive regulation of protein metabolic process (GO:0051247),0.2573151548318736,0.7374264334711268,0.8409610983981693,1.0,1.0,7/110,7.37%,AGTR1;NKD1;OAZ2;ATG7;DAB2IP;NEDD4;RASGRP1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3188084853727332,-0.7372835278708364,0.8039647577092511,0.9655223462305317,1.0,1/10,4.15%,LPGAT1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.34327768051389973,0.7366428068358907,0.7647058823529411,1.0,1.0,3/16,11.59%,ATP5MF;ATP5MC1;ATP5MG
prerank,canonical Wnt signaling pathway (GO:0060070),0.27313508826781635,0.7366410398079711,0.8077388149939541,1.0,1.0,18/68,18.16%,FZD5;FZD4;FZD8;CAV1;FZD9;AMER1;PPP1CA;NR4A2;SCYL2;LRP5;CSNK1E;LRRK2;DVL1;CSNK1A1;PTEN;RYK;WNT5B;TCF7
prerank,clathrin coat assembly (GO:0048268),0.34031573404605236,0.7365928237368516,0.7607655502392344,1.0,1.0,1/15,1.87%,HIP1
prerank,regulation of protein targeting to membrane (GO:0090313),0.3118972668220719,0.7363231833440753,0.7807017543859649,1.0,1.0,10/28,22.49%,KCNB1;MIEF2;MIEF1;DMTN;MTCL1;SLC51B;MFF;MYO1C;ERBB2;PDZK1
prerank,alpha-amino acid metabolic process (GO:1901605),0.28889779921174624,0.7361987397316937,0.7866492146596858,1.0,1.0,8/45,11.00%,RIMKLA;KMO;NAT8L;GOT1;GOT2;THAP4;GLS2;GLS
prerank,mammary gland epithelium development (GO:0061180),-0.2904024951873092,-0.735958776282846,0.8345679012345679,0.9664395260600092,1.0,1/14,1.10%,WNT4
prerank,melanosome organization (GO:0032438),-0.2414902391044476,-0.7358539312663063,0.8600583090379009,0.9657875444236905,1.0,9/26,31.66%,SHROOM2;DTNBP1;AP1M1;RAB29;AP1G1;BLOC1S6;RAB32;BLOC1S2;TRAPPC6A
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3173102005917059,0.7351100258472153,0.7754172989377845,1.0,1.0,3/24,6.59%,TTLL7;CEP41;PARP1
prerank,cilium organization (GO:0044782),0.24644425245304347,0.7346140776800084,0.8742138364779874,1.0,1.0,20/209,11.49%,FLNA;DYNLL1;PLA2G3;KIF27;ARMC2;EHD2;CEP41;KIF3B;ACTR3;CEP290;IFT43;IFT81;PIBF1;BBIP1;IQCB1;PARVA;EXOC6;RAB11FIP3;FHDC1;KIFAP3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3365826272954793,0.734577890071496,0.7619047619047619,1.0,1.0,3/16,12.48%,NACC2;SNAI2;CLU
prerank,GPI anchor metabolic process (GO:0006505),0.3135114501658763,0.7340565269067896,0.767616191904048,1.0,1.0,8/26,20.84%,PIGN;PIGA;PIGH;PIGB;PIGP;DPM2;PGAP4;PIGZ
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.24929938795860662,0.7340496420244156,0.8698030634573304,1.0,1.0,21/161,10.85%,TMEM131L;NKD1;LIMD1;FZD4;RBMS3;JADE1;TBX18;SDHAF2;CAV1;PSMC6;DAB2IP;IGFBP4;SOX9;SNAI2;AMER1;PSME4;AMFR;PSMB1;SCYL2;PSMD5;LMBR1L
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.32454546213280105,-0.7334459418069201,0.7962529274004684,0.9673771280484517,1.0,1/10,2.41%,WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.32454546213280105,-0.7334459418069201,0.7962529274004684,0.9673771280484517,1.0,1/10,2.41%,WNK1
prerank,ceramide transport (GO:0035627),-0.3098605339533135,-0.7331270760790551,0.84,0.9669798514607896,1.0,6/12,22.22%,PLTP;SGPP1;CERT1;PLEKHA3;PSAP;ABCA2
prerank,phagosome acidification (GO:0090383),0.3135881372877864,0.7328828854381843,0.7442922374429224,1.0,1.0,12/26,25.65%,ATP6V1H;ATP6V0A2;ATP6V1C1;ATP6V0D2;RAB38;ATP6V0C;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.30296900223382683,0.7326811836649529,0.751412429378531,1.0,1.0,6/33,8.65%,CCND2;ANXA1;FAM83D;PLCB1;CCND1;ADAM17
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.29547838565262596,-0.7326550411245275,0.8058968058968059,0.9667878565884354,1.0,10/13,49.88%,HES1;MGAT5;EGF;CRLF2;JAK3;PTPRT;PIGU;TSLP;IL7R;DOT1L
prerank,negative regulation of histone modification (GO:0031057),-0.28489430675007615,-0.7324808058880171,0.8108108108108109,0.9662428070836758,1.0,10/14,39.21%,NOC2L;SNCA;TAF7;TWIST1;JARID2;PRMT6;BRCA1;AASS;THAP7;SPHK2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.3506702019182337,0.731938874356897,0.750445632798574,1.0,1.0,2/13,11.11%,CBFB;RUNX1
prerank,regulation of exit from mitosis (GO:0007096),-0.212949968001399,-0.7319241537884948,0.9097744360902256,0.9661543396200858,1.0,9/38,17.59%,CDC14B;ANAPC1;CDC23;UBC;RGCC;BUB3;CDC26;UBE2S;ANAPC4
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.34507995569932126,0.7317813842952144,0.7571189279731994,1.0,1.0,3/14,11.70%,MYD88;MAPKAPK2;HNRNPC
prerank,positive regulation of cell aging (GO:0090343),0.3617955832935189,0.7316961825699385,0.7671480144404332,1.0,1.0,1/11,3.13%,CGAS
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2672039728455166,0.731562189291187,0.8249118683901293,1.0,1.0,14/69,16.47%,POLR2L;POLR2I;ELL;POLR2G;TAF8;CCNT1;CDK7;INTS5;POLR2J;INTS12;INTS7;TAF11;SP1;INTS1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.269863426245732,-0.7313025441145707,0.830423940149626,0.9661883167261996,1.0,5/18,22.22%,APOE;RDX;PTTG1IP;DACT1;ABCA2
prerank,regulation of ATP metabolic process (GO:1903578),0.2725318541989233,0.7312145447147895,0.7959697732997482,1.0,1.0,17/54,20.76%,NUP62;COX7A2L;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;UQCC2;SLC25A33;TPR
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.309274875731709,-0.7308706297280274,0.8,0.9659627890767978,1.0,3/10,17.42%,CCT8;CCT4;WRAP53
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.28551715255667115,-0.7303810847374109,0.8242894056847545,0.9657911615431404,1.0,6/14,17.31%,ADAM10;APH1A;NCSTN;CLN3;APH1B;PSEN2
prerank,replicative senescence (GO:0090399),0.3586906906066988,0.7303089377944426,0.7879858657243817,1.0,1.0,3/12,7.52%,TERT;TP53;CHEK1
prerank,glycoprotein catabolic process (GO:0006516),-0.26834823926616924,-0.7301248125631074,0.8245614035087719,0.9653110304983584,1.0,6/17,27.91%,NGLY1;CTSL;ADAMTS9;FBXO17;STT3B;FBXO44
prerank,negative regulation of programmed cell death (GO:0043069),0.24041590200334845,0.7301243532647108,0.934409687184662,1.0,1.0,36/355,10.09%,FLNA;NAA38;ANGPT1;NR1H4;ANGPT4;MYD88;TCIM;CCND2;ANXA1;IL2;NUP62;ARHGAP10;ATAD3A;FXN;BCL2;MYO18A;MTDH;TP53;VEGFA;GDNF;PA2G4;MED1;BCL2L2;NAT8;OPA1;SOX9;RELA;API5;CBX4;VDAC1;TNFAIP8;GSTP1;PAK2;BAG3;AXL;FAIM2
prerank,cellular response to insulin stimulus (GO:0032869),0.25105577742372986,0.7300975212176665,0.8734873487348734,1.0,1.0,22/124,15.71%,SLC2A4;PDK4;BCAR3;HDAC9;RARRES2;ATP6V1H;IRS1;SORBS1;ATP6V0A2;CPEB1;PARP1;GOT1;ATP6V1C1;SLC39A14;ATP6V0D2;ZFP36L1;PDK2;EPRS1;IRS2;RAB8B;CAV2;NAMPT
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.34918975639608324,0.729178589081678,0.7576853526220615,1.0,1.0,1/11,3.19%,IL2
prerank,cellular response to interleukin-2 (GO:0071352),0.34918975639608324,0.729178589081678,0.7576853526220615,1.0,1.0,1/11,3.19%,IL2
prerank,icosanoid secretion (GO:0032309),0.35575156138763564,0.7291261268105708,0.75,1.0,1.0,1/12,2.78%,ANXA1
prerank,regulation of lamellipodium organization (GO:1902743),-0.2846101485810558,-0.7290936360168913,0.8668341708542714,0.9657722648000951,1.0,4/14,22.71%,PDPN;CD44;CDC42;CARMIL1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3504586830480837,0.728485193721693,0.7737881508078994,1.0,1.0,2/13,7.68%,ANKRD2;SOX9
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.3518652094833165,0.7284811377011831,0.7676056338028169,1.0,1.0,5/12,20.63%,OPLAH;GGCT;CHAC2;CNDP2;HAGH
prerank,ATP synthesis coupled proton transport (GO:0015986),0.33892868894666117,0.7284488891063773,0.7806451612903226,1.0,1.0,3/17,11.59%,ATP5MF;ATP5MC1;ATP5MG
prerank,quinone biosynthetic process (GO:1901663),-0.28535440866254513,-0.7284085311832728,0.8228155339805825,0.9658410816045699,1.0,3/14,6.23%,COQ10B;COQ8B;COQ5
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.2614586947221019,-0.7281288211634438,0.8493506493506493,0.9654004472528936,1.0,4/19,21.37%,DDX3X;CHUK;TLR3;HSPD1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3001681726629991,0.7279749272227894,0.795774647887324,1.0,1.0,9/35,16.02%,CDK6;ACVR2A;MED1;ANKRD54;HIF1A;ACVR1B;ZFP36L1;STAT1;STAT3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.26686329228744904,-0.7279476887130566,0.868632707774799,0.9648585408885453,1.0,3/18,8.49%,PTPN11;CTR9;IL6R
prerank,cytokine-mediated signaling pathway (GO:0019221),0.23785140580335107,0.7278133548039322,0.9579579579579579,1.0,1.0,54/532,10.78%,CAMK2G;LIFR;ACTN4;CD36;LAMA5;LIMS1;MYD88;PDGFB;CNN2;RORA;VIM;CRLF1;ANXA1;GREM2;SOCS5;CAMK2D;IL2;TNFSF13B;LCP1;ITGB1;CCL5;IL12RB2;ALOX5;BCL2;SOCS6;IRS1;TNFRSF11A;PSMC6;TP53;VEGFA;IL10RA;IL12RB1;TRAF3;YAP1;IL22;RELA;PLCB1;TRIM68;CCND1;ADAM17;PAK2;SLA;INPPL1;HIF1A;PSME4;EDAR;TRAF5;PSMB1;IL13RA1;CCL14;PELI2;PSMD5;EIF5A;VAV1
prerank,positive regulation of translational initiation (GO:0045948),0.3275934948775424,0.727809410057693,0.7622047244094489,1.0,1.0,3/18,6.97%,CCL5;POLR2G;YTHDF2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2609247927519424,0.7265775602345496,0.8502304147465438,1.0,1.0,18/91,16.59%,HIP1;PLA2G3;CDH13;PACSIN3;PACSIN2;PTPN1;RAB3A;DENND10;MAP2K1;MBTPS1;NSF;PACSIN1;MAPK1;LRRK2;SNX17;RAB8B;STON1;RAB8A
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.23477393391453766,-0.726350394896068,0.907051282051282,0.9660057434015695,1.0,11/30,25.00%,LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK
prerank,epidermis development (GO:0008544),-0.19726911514029916,-0.7262197715562315,0.943127962085308,0.965417514980751,1.0,14/56,26.36%,SVEP1;EMP1;ALDH3A2;LAMA3;FGFR2;CRABP2;SCEL;HDAC2;GATA6;PTHLH;FGF7;YBX1;EDA2R;LAMC2
prerank,cytosolic transport (GO:0016482),0.25704455002731535,0.7261982698995904,0.8533034714445689,1.0,1.0,24/108,17.39%,MYO1D;CLN5;HOOK2;SORT1;RHOBTB3;VPS26A;EVI5;WASHC1;VPS26B;ANKFY1;HOOK1;AKTIP;PLEKHJ1;TMEM87A;PIK3C3;VPS50;RAB14;ANKRD27;SNX1;SPAG9;VPS35;CORO7;DCTN1;VPS51
prerank,oxoacid metabolic process (GO:0043436),-0.2396273466612056,-0.726092983453831,0.8892307692307693,0.9648087555581223,1.0,5/27,12.79%,TPST1;BPNT2;PPA1;PPA2;ENPP1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28893926748959214,0.725521387142284,0.7902777777777777,1.0,1.0,6/35,11.83%,MUTYH;PARP1;MBD4;PARG;POLD1;POLG
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.28838122178362907,-0.7252279657769871,0.8305882352941176,0.965081310168498,1.0,1/12,3.27%,IL18
prerank,indolalkylamine catabolic process (GO:0046218),0.3680269850375325,0.7250832851579087,0.7675675675675676,1.0,1.0,1/10,6.78%,KMO
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.28624520416877164,0.7246346484696018,0.79702300405954,1.0,1.0,8/45,15.91%,CAMK2G;CAMK2D;TRIM68;PRKCD;GBP2;OASL;STAT1;JAK2
prerank,negative regulation of cell aging (GO:0090344),0.3324741443463722,0.7239093534904395,0.7562189054726368,1.0,1.0,5/16,17.14%,CDK6;TERT;TERF2;FBXO5;MIF
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2906842426892451,0.7237865874892471,0.8071428571428572,1.0,1.0,4/32,8.24%,SLC44A5;STARD7;SLC44A1;LPCAT3
prerank,regulation of histone deacetylation (GO:0031063),0.3357820440895122,0.7237724401551633,0.7671232876712328,1.0,1.0,1/13,3.15%,CAMK2D
prerank,positive regulation of catalytic activity (GO:0043085),-0.21772614902845128,-0.7233614304508036,0.9145907473309609,0.9666067446033344,1.0,11/37,21.26%,MAPK14;XRCC5;STX4;IGF2;ABL2;APH1A;NCSTN;CHTOP;PSEN2;MSH6;FGFR4
prerank,membrane raft organization (GO:0031579),0.338947311751255,0.7232522915264582,0.7557377049180328,1.0,1.0,5/15,15.79%,FA2H;YJEFN3;NAXE;FLOT1;RFTN1
prerank,cilium assembly (GO:0060271),0.23973104382067978,0.7232133078120264,0.9282051282051282,1.0,1.0,45/296,15.87%,FLNA;DYNLL1;PLA2G3;KIF27;EHD2;CEP41;HAUS8;DYNLRB1;RSPH1;KIF3B;ACTR3;TBC1D32;CEP290;RPGRIP1L;IFT43;IFT81;PIBF1;TOGARAM1;BBIP1;IQCB1;PARVA;CEP192;EXOC6;RAB11FIP3;DYNC1I2;FHDC1;KIFAP3;C2CD3;NEDD1;STK36;CLASP1;CEP72;SPATA6;CEP43;FOXJ1;CSNK1E;DCTN3;TTC39C;HAUS7;HAUS2;PRKACA;RAB8B;CCDC66;CFAP43;RFX3
prerank,positive regulation of interleukin-4 production (GO:0032753),0.33088633285030333,0.7231571325805636,0.7794361525704809,1.0,1.0,2/17,5.51%,HAVCR2;PRKCQ
prerank,amino acid transmembrane transport (GO:0003333),0.2821296612575957,0.7230089761552059,0.8020434227330779,1.0,1.0,1/45,0.33%,SLC38A11
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.2907035440390703,-0.7229188202286212,0.8363228699551569,0.9663746514840154,1.0,2/13,9.33%,PID1;NOS3
prerank,negative regulation of cellular senescence (GO:2000773),0.341815538262021,0.7226308176338381,0.7717770034843205,1.0,1.0,4/13,15.12%,CDK6;TERT;TERF2;FBXO5
prerank,ubiquinone biosynthetic process (GO:0006744),-0.2774844361420522,-0.7224338858548632,0.8333333333333334,0.966208050967253,1.0,3/15,6.23%,COQ10B;COQ8B;COQ5
prerank,lysosome localization (GO:0032418),0.28888788586687564,0.7218317216554215,0.8263305322128851,1.0,1.0,4/37,7.78%,MYH9;MILR1;RAB3A;KIF5B
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.2751844316936119,-0.7206360415333717,0.8308823529411765,0.9675848792239833,1.0,1/15,1.06%,MOXD1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.18946195388887632,-0.7202399157325197,0.9588235294117647,0.9672903280247931,1.0,29/73,32.65%,ITCH;PRKDC;PUS7;PSMD7;PSMD9;PSMD13;METTL3;METTL14;PSMB3;PSMC5;PSMA5;PSMA1;PSMC2;SETD1A;LMO2;PSME3;PSMC4;TAL1;PSMB6;PSMB10;PSMA4;KMT2A;PSME1;PSMF1;PSMB9;LDB1;PSME2;TCF3;PSMA8
prerank,regulation of secretion (GO:0051046),-0.285799041392337,-0.719878445275875,0.8090692124105012,0.9669758232699593,1.0,4/13,18.58%,ACSL3;MYO6;OAS2;KCNQ1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3229641224478131,0.719765592093802,0.802547770700637,1.0,1.0,3/20,7.51%,CCL5;RPGRIP1L;PLEK
prerank,regulation of cellular protein localization (GO:1903827),0.2812584709401718,0.7194953100794177,0.8090787716955942,1.0,1.0,11/45,15.58%,LCP1;GPC4;MAPT;PARP1;PIN1;PTPN1;CEP72;CSNK1E;PRKAA2;DVL1;CCDC66
prerank,carnitine metabolic process (GO:0009437),0.34370263207624047,0.7192393430615724,0.7644927536231884,1.0,1.0,5/12,20.85%,CPT1B;CRAT;CPT1A;TMLHE;ACADM
prerank,glycolipid biosynthetic process (GO:0009247),0.2907538023113191,0.7191949267174539,0.8123209169054442,1.0,1.0,10/38,17.30%,LARGE1;PIGN;PIGA;ST8SIA5;A4GALT;ST3GAL2;PIGH;PIGB;PIGP;DPM2
prerank,proton transmembrane transport (GO:1902600),0.28414552617447764,0.7188617343904934,0.8027586206896552,1.0,1.0,3/36,5.57%,ATP5MF;UCP3;ATP6V1H
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2615722277102238,0.7185666767273925,0.852112676056338,1.0,1.0,27/87,21.64%,NDUFS1;NDUFA11;NDUFA2;SDHAF2;NDUFC1;NDUFB6;NDUFS3;NDUFV2;NDUFB8;NDUFS2;NDUFAB1;NDUFAF5;SDHAF3;NDUFA1;LYRM7;NDUFAF2;UQCRFS1;NDUFAF1;SCO1;NDUFV3;UQCC2;NDUFS4;SLC25A33;COA5;OXA1L;NDUFA3;NDUFAF6
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2594559633584642,0.7181033869338506,0.851037851037851,1.0,1.0,16/70,20.64%,PLA2G3;SLC44A5;STARD7;ABCA3;SLC44A1;LPCAT3;PLB1;PLA2G4A;CHKB;PLA2G4C;NR1H3;SLC44A2;MBOAT7;CHPT1;LPCAT1;PLA2G15
prerank,snRNA transcription (GO:0009301),0.26266474864734535,0.7177116495519281,0.8414201183431953,1.0,1.0,14/70,16.47%,POLR2L;POLR2I;ELL;POLR2G;TAF8;CCNT1;CDK7;INTS5;POLR2J;INTS12;INTS7;TAF11;SP1;INTS1
prerank,phospholipid homeostasis (GO:0055091),-0.2918678326155713,-0.7174673649747594,0.8222748815165877,0.9691055527251362,1.0,2/11,12.24%,ABCA1;RCN3
prerank,regulation of protein localization to membrane (GO:1905475),0.3021693536436498,0.7174003838138637,0.7947214076246334,1.0,1.0,5/28,7.14%,SLC5A3;ACTB;GPC4;ZDHHC2;AR
prerank,RNA biosynthetic process (GO:0032774),-0.22406505727123305,-0.7172644427460153,0.8921568627450981,0.9685741946894234,1.0,11/31,30.67%,POLR2A;SETX;TTF1;TAF12;TAF13;SMN1;TAF7;TAF5;POLA2;NCOA6;PRIM1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.2955167572383863,0.7172079314430605,0.793859649122807,1.0,1.0,4/29,7.05%,SLC8A2;SHISA9;ZDHHC2;RAB3A
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.27797786821356285,-0.7168355151793002,0.8650602409638555,0.9683112748164115,1.0,11/15,38.16%,ZBTB8OS;ERN1;TSEN34;CPSF4;CSTF2;CPSF1;CLP1;TRPT1;TSEN54;TSEN15;RTRAF
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.35723625440882323,0.7168051665741195,0.7669724770642202,1.0,1.0,4/10,19.47%,PRMT7;PCGF5;PCGF3;DNMT3A
prerank,lymphocyte mediated immunity (GO:0002449),0.34806152486982955,0.7167462330231054,0.7586206896551724,1.0,1.0,1/12,3.14%,JAG1
prerank,regulation of cell aging (GO:0090342),-0.2991980367514861,-0.7165594407741938,0.8218527315914489,0.9678544726779795,1.0,4/11,19.70%,RSL1D1;NEK6;PNPT1;NEK4
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2569326484302708,-0.7165594003535471,0.8328840970350404,0.9670923825420127,1.0,5/19,19.27%,CAT;GPX1;ACOX1;PRDX4;PARK7
prerank,ubiquinone metabolic process (GO:0006743),-0.272833022714394,-0.7165334014341233,0.8533653846153846,0.9663573570571451,1.0,9/15,33.71%,COQ10B;COQ8B;COQ5;AIFM2;COQ3;FDXR;UBIAD1;COQ6;COQ7
prerank,regulation of cellular senescence (GO:2000772),0.30207528179452575,0.716002346539491,0.8,1.0,1.0,5/28,11.53%,CDK6;CGAS;TERT;NUAK1;TERF2
prerank,prostaglandin metabolic process (GO:0006693),0.30380248129919385,0.7157778169861241,0.803076923076923,1.0,1.0,6/26,17.14%,PTGIS;TBXAS1;GSTP1;PTGR1;PLA2G4A;MIF
prerank,positive regulation of macrophage migration (GO:1905523),0.32133708391414945,0.7157251131307267,0.7632,1.0,1.0,2/19,5.41%,CCL5;RARRES2
prerank,response to cytokine (GO:0034097),0.2424486306174509,0.7154000128973673,0.901657458563536,1.0,1.0,13/141,8.40%,AKAP6;LIFR;ITIH4;MYD88;ANXA1;BCL2;PTPN18;MAP4K3;TNFRSF11A;MAPKAPK2;TIMP4;RELA;DDOST
prerank,microtubule-based transport (GO:0099111),-0.28728588413694456,-0.7152863233131029,0.8402777777777778,0.9670071241752843,1.0,9/12,49.60%,DYNC1I1;SPEF2;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.28275881772708017,-0.715169487527562,0.8513853904282116,0.9663646296296399,1.0,2/12,8.22%,BMP7;CD44
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.265843061349848,-0.714939575299247,0.83,0.9658908732569782,1.0,3/17,18.92%,LPGAT1;PLAAT3;PLA2G12A
prerank,myelin maintenance (GO:0043217),0.3539312368329096,0.7146987907468408,0.7752613240418118,1.0,1.0,2/10,15.34%,CLU;PTEN
prerank,"transcription, DNA-templated (GO:0006351)",0.23531480601237004,0.7140102659208549,0.9081419624217119,1.0,1.0,27/207,13.03%,SOX5;POLR2L;POLR2I;MLF1;PWP1;GTF2H4;GTF3C4;ELL;CBFB;MEF2A;POLR2G;TAF1;ELOC;TP53;PARP1;ERCC6;NFKBIB;CCNT1;NR4A2;CDK7;NAT14;TFB2M;BAZ2A;NFX1;NELFB;SMARCA5;POLR2J
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.23355467869684465,0.7139873559962219,0.9271255060728745,1.0,1.0,43/306,13.20%,RPL3L;POLR2L;POLR2I;LARGE1;MLF1;EEFSEC;MRPL36;BRIP1;EXT2;MRPL13;PWP1;SET;HARS2;UPF1;MEF2A;POLR2G;TERT;TIPIN;RPL8;CHEK1;RAD9A;NFKBIB;MRPL43;TNIP1;NR4A2;MRPL51;KAT7;RPL5;MRPL23;RPS23;RHNO1;POLD1;GSPT1;PTMS;BAZ2A;MRPL9;TSFM;ORC2;RMI2;POLR2J;ST3GAL2;MRPL42;EEF2K
prerank,mitotic recombination (GO:0006312),-0.2646686478351281,-0.7137828241813347,0.8434343434343434,0.9664096349784418,1.0,5/15,24.52%,RAD50;SMC5;TPRKB;NSMCE2;ERCC1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3219076237800734,0.7136404130801652,0.7823240589198036,1.0,1.0,6/17,20.67%,COX7A2L;COX8A;COX7B;COX6C;COX5B;COX6A1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2637259860362288,0.7136107394114097,0.8622908622908623,1.0,1.0,14/63,17.26%,ROCK1;BCL2;DAB2IP;IL10RA;TIMP4;WASHC1;SIRT2;HTR2B;MCL1;EIF4E;STAT3;MT3;WDR6;EIF4G2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2656669603299482,-0.7134218913658517,0.8516624040920716,0.9660865697663533,1.0,7/17,30.45%,UBQLN1;AKT1;P4HB;MAPK7;BAG5;HTRA2;PPIA
prerank,DNA strand elongation (GO:0022616),-0.25151890546510247,-0.7134155762211336,0.8538283062645011,0.9653355580758453,1.0,11/18,38.15%,MRE11;RAD50;NBN;GINS3;DCLRE1B;RFC3;GINS4;POLD3;GINS1;RFC4;MCM3
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2605445729568667,0.7127311632703351,0.821969696969697,1.0,1.0,12/67,13.33%,TBC1D1;ATP8B1;TBC1D20;CAV1;RABGAP1;EVI5;EPHA2;GAP43;MYO10;TRPM2;DMTN;CAPZB
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.308764699722473,0.7123772512285654,0.7843426883308715,1.0,1.0,4/23,8.65%,ZEB2;TGFB1I1;SLC2A10;ADAM17
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.308764699722473,0.7123772512285654,0.7843426883308715,1.0,1.0,4/23,8.65%,ZEB2;TGFB1I1;SLC2A10;ADAM17
prerank,glycerol metabolic process (GO:0006071),-0.3061585777066489,-0.7119116315208894,0.8173719376391982,0.9662210191420035,1.0,6/10,32.73%,GK5;COQ3;PGP;GK;TPI1;ANGPTL3
prerank,rRNA catabolic process (GO:0016075),-0.26534369787774026,-0.711591255059377,0.8430379746835444,0.9658318460431216,1.0,7/16,27.20%,TRIR;DIS3;EXOSC9;EXOSC2;EXOSC7;EXOSC3;EXOSC5
prerank,DNA modification (GO:0006304),0.30589188202797724,0.7113832289614581,0.7932618683001531,1.0,1.0,4/22,11.53%,MUTYH;PARP1;MBD4;TERF2
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.30045296036931873,-0.7111036053340437,0.8150406504065041,0.9656459979097908,1.0,2/10,12.03%,CRY1;THOC5
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3189762319515502,0.7110752363753878,0.8165869218500797,1.0,1.0,5/18,13.00%,CLASP2;EMILIN1;RUNX1;RB1;CLASP1
prerank,regulation of secretion by cell (GO:1903530),0.26819450918412346,0.710991581131411,0.8419721871049305,1.0,1.0,2/54,2.78%,MEF2C;ANXA1
prerank,response to acidic pH (GO:0010447),0.33498616130136327,0.7107842719674432,0.755700325732899,1.0,1.0,2/13,8.81%,PKD1L3;IMPACT
prerank,hemidesmosome assembly (GO:0031581),0.35237303036285006,0.7101534337552148,0.7880910683012259,1.0,1.0,2/11,6.91%,DST;LAMC1
prerank,cellular response to interleukin-1 (GO:0071347),0.24401737903400753,0.7092906289305543,0.8934065934065935,1.0,1.0,31/143,19.24%,MYD88;CCL5;PTGIS;UPF1;HAS2;PSMC6;DAB2IP;SOX9;RELA;PLCB1;NR1D1;HIF1A;PSME4;PSMB1;CCL14;PELI2;PSMD5;FBXW11;GBP2;PSMB2;HYAL1;PSMB7;PSMD3;PSMA2;PSMD14;IL1R1;CCL25;EGR1;CD47;CCL19;RPS27A
prerank,bone morphogenesis (GO:0060349),0.33608132231588944,0.7092538312262839,0.7975778546712803,1.0,1.0,5/14,17.15%,OSR2;SKI;LRP5;BMPR1B;FGFR3
prerank,regulation of macrophage differentiation (GO:0045649),-0.2712966769817019,-0.7089645150274686,0.8383084577114428,0.9672669696520849,1.0,5/15,32.52%,CASP8;HSF1;PTPN2;C1QC;INHA
prerank,glycerophospholipid metabolic process (GO:0006650),0.25577185054687746,0.7088763823533973,0.8307322929171669,1.0,1.0,17/75,17.31%,PLA2G3;PIGN;PIGA;ABCA3;PLEK;PLCB1;PLCD1;PDGFRB;CPNE3;PNPLA3;PLA2G4A;PIGH;PLA2G4C;PIGB;PIGP;DPM2;PRDX6
prerank,RNA interference (GO:0016246),0.3188989294315485,0.7083337303512237,0.782608695652174,1.0,1.0,7/17,19.65%,TERT;CELF1;DICER1;DROSHA;DHX9;PRKRA;AGO1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.26974600793243386,-0.7081442457244028,0.8610421836228288,0.967431058717685,1.0,1/14,3.27%,IL18
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.33766487434523085,0.7081106618861989,0.7736757624398074,1.0,1.0,3/14,14.61%,DAB2IP;PTPN1;UFL1
prerank,cellular response to interleukin-12 (GO:0071349),0.2740689336642843,0.707968053501255,0.8141361256544503,1.0,1.0,6/48,9.22%,CNN2;LCP1;IL12RB2;IL12RB1;PLCB1;PAK2
prerank,copper ion transport (GO:0006825),-0.29599953205435503,-0.7079349685831737,0.8428246013667426,0.9669286801673174,1.0,4/11,22.59%,STEAP3;ATOX1;STEAP2;SLC31A1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.30599068945813457,0.7078313993300817,0.7627906976744186,1.0,1.0,4/20,14.19%,BCL2;BCL2L2;BOK;MCL1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.30154670221812196,-0.7071309997875587,0.8472505091649695,0.9670616870515238,1.0,1/11,3.97%,LDLR
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.32652852060859494,0.7070559412199096,0.797962648556876,1.0,1.0,5/15,16.48%,OSR2;CELF1;TGFB2;RICTOR;UBR3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.33875737682100837,0.706602712321343,0.7661431064572426,1.0,1.0,4/11,20.82%,DCTD;NT5C3A;DCK;CTPS2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3415136940118913,0.7062684381861988,0.7727272727272727,1.0,1.0,2/12,10.81%,OAZ2;SMS
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.27685256503938815,-0.7062667833294322,0.8325242718446602,0.9672895119098025,1.0,5/14,22.42%,PKD2;NFKBIA;G3BP2;MDFI;KEAP1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2783193559925679,0.7062328590043471,0.8164642375168691,1.0,1.0,14/41,20.76%,NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,response to sterol (GO:0036314),0.35035021788123244,0.7057455022536373,0.7867383512544803,1.0,1.0,1/11,2.57%,RORA
prerank,polarized epithelial cell differentiation (GO:0030859),-0.2858619111509255,-0.7057348234659877,0.841726618705036,0.9671143532826213,1.0,11/13,52.42%,MYO9A;OPHN1;CDC42;SCRIB;SH3BP1;CAMSAP3;MSN;EZR;RHOA;SYNE4;ZDHHC7
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.25999164194202284,-0.7056448814513204,0.88,0.9664504837430082,1.0,5/18,17.84%,SPTBN1;APPL1;CLN3;VAMP8;STX8
prerank,cellular response to pH (GO:0071467),0.3225425101007839,0.7055410680613209,0.7931034482758621,1.0,1.0,3/17,14.35%,PKD1L3;IMPACT;HYAL1
prerank,regulation of cholesterol transport (GO:0032374),0.307117028706287,0.7054102427359018,0.8303425774877651,1.0,1.0,3/20,10.77%,ABCB4;YJEFN3;NAXE
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2704496749299974,-0.7051904137702049,0.8746928746928747,0.9661568323755527,1.0,4/15,15.59%,SDCBP;VPS4B;SDC4;HGS
prerank,non-motile cilium assembly (GO:1905515),0.29303056126345567,0.7051455366296254,0.7996987951807228,1.0,1.0,5/30,7.53%,TBC1D32;CEP290;RPGRIP1L;PIBF1;TOGARAM1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.33094432007773045,0.7047523193314498,0.779896013864818,1.0,1.0,4/15,17.46%,PPARGC1A;PPARA;MLXIPL;NR1H3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.2792952294759333,-0.7044349938649003,0.8444444444444444,0.9661633116909665,1.0,4/13,20.58%,MPDU1;ALG14;ALG1;ALG12
prerank,negative regulation of biosynthetic process (GO:0009890),0.3251340748879047,0.7043733469205536,0.8076923076923077,1.0,1.0,4/16,10.84%,EMILIN1;PPARA;GSTP1;GPER1
prerank,regulation of protein binding (GO:0043393),0.24477554923944136,0.7040879348874486,0.8850056369785795,1.0,1.0,22/114,15.51%,XIRP1;ROCK1;PDGFB;ACTB;CAV1;TAF1;TERT;PIN1;ADD2;PRMT7;PPP1CA;AMFR;PSME3IP1;PRKCD;AKTIP;BAG2;LDLRAP1;CSNK1E;LRRK2;DVL1;PRKACA;FLOT1
prerank,protein localization to centrosome (GO:0071539),0.32374389942120485,0.7037428311196526,0.7932203389830509,1.0,1.0,4/17,11.87%,PIBF1;CEP192;C2CD3;NEDD1
prerank,positive regulation of RNA splicing (GO:0033120),0.29823424591423137,0.7037225686976636,0.8177777777777778,1.0,1.0,7/29,14.02%,SLC38A2;DYRK1A;U2AF2;CIRBP;RBMXL1;RBM3;NUP98
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.2951961048576812,0.7035596475493971,0.8027777777777778,1.0,1.0,8/31,17.15%,WDR1;LIN7C;RAP2A;MTCL1;PARD3B;ANK1;LIN7A;MARK2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.29873188196143974,-0.7022703536353779,0.8554216867469879,0.9669128990262295,1.0,4/10,29.64%,AP2S1;AP2A2;CLTA;AP2M1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.29873188196143974,-0.7022703536353779,0.8554216867469879,0.9669128990262295,1.0,4/10,29.64%,AP2S1;AP2A2;CLTA;AP2M1
prerank,rRNA methylation (GO:0031167),-0.23623014826497524,-0.7021086737650122,0.9116809116809117,0.9663317246902583,1.0,11/22,35.68%,DIMT1;BUD23;NSUN3;METTL16;FTSJ3;EMG1;METTL15;FBL;MRM2;MRM3;TRMT112
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.2614735984953165,-0.7020101157652435,0.8511749347258486,0.9656842537132652,1.0,2/16,9.41%,PTPN22;AHR
prerank,positive regulation of proteolysis (GO:0045862),0.2597112369891822,0.7009228234059073,0.8452535760728218,1.0,1.0,9/55,13.17%,ANGPTL8;PACSIN3;ASPH;TNIP1;IST1;FBXW11;SNX9;PERP;BAG2
prerank,regulation of exocytosis (GO:0017157),0.2726234409899305,0.7002296155357145,0.8388814913448736,1.0,1.0,9/46,16.59%,CLASP2;ANXA1;UNC13D;RAB3A;IL1RAPL1;NSF;CLASP1;RAB8B;RAB8A
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.28555515223332006,-0.7001083493285997,0.8186046511627907,0.9669377677800185,1.0,3/11,17.42%,CCT8;CCT4;WRAP53
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.31327796852049006,0.7000459318505466,0.7766666666666666,1.0,1.0,4/19,11.70%,NAT10;HNRNPU;TERF2;HNRNPC
prerank,toll-like receptor signaling pathway (GO:0002224),0.25220376104519715,0.7000299376340811,0.8680555555555556,1.0,1.0,8/84,8.19%,NR1H4;CD36;MYD88;CD14;PIK3AP1;MAPKAPK2;TRAF3;TNIP1
prerank,cholesterol biosynthetic process (GO:0006695),-0.22540775895608103,-0.6997109216167131,0.9250814332247557,0.9666471407285455,1.0,16/31,35.80%,LBR;GGPS1;CYP51A1;HMGCR;ACLY;ARV1;INSIG1;SQLE;PMVK;LSS;MVK;INSIG2;EBP;SC5D;TM7SF2;DHCR7
prerank,cellular response to cytokine stimulus (GO:0071345),0.22792546196061458,0.6997061429851622,0.9698189134808853,1.0,1.0,47/416,11.46%,AKAP6;LIFR;CD36;LAMA5;DOCK8;RORA;VIM;CRLF1;ANXA1;GREM2;SOCS5;IL2;ITGB1;CCL5;IL12RB2;PTGIS;ALOX5;BCL2;PTPN18;UPF1;SOCS6;ARHGEF2;HAS2;DAB2IP;TP53;VEGFA;IL10RA;IL12RB1;SOX9;IL22;RELA;DAPK3;CCND1;NR1D1;SLA;INPPL1;HIF1A;AXL;NPR2;HNRNPU;IL13RA1;CCL14;VAV1;GPER1;TNFRSF21;IL1RAPL1;ZFAND6
prerank,regulation of regulated secretory pathway (GO:1903305),0.28498078530045584,0.699521019334835,0.8337988826815642,1.0,1.0,4/34,7.05%,UNC13D;RIMS3;SYT10;RAB3A
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.27207683292985874,-0.6983068774171883,0.8764845605700713,0.96741238999846,1.0,7/15,27.02%,RNF213;SFRP4;GPC3;DACT1;RSPO3;ZNRF3;TIAM1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2396439730382457,0.6982663358984116,0.9045005488474204,1.0,1.0,31/145,17.51%,DYNLL1;FHL1;CEP41;HAUS8;CEP290;PSMC6;TPX2;CCND1;PSME4;CEP192;PSMB1;PSMD5;DYNC1I2;NEDD1;PSMB2;CLASP1;CEP72;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PSMB7;PSMD3;PRKACA;FBXO5;PLK4;PSMA2;PSMD14;DCTN1;BRD4
prerank,regulation of double-strand break repair (GO:2000779),0.27725881655694196,0.6982277579409671,0.8457223001402524,1.0,1.0,5/39,8.53%,UBR5;RAD51AP1;ZCWPW1;CHEK1;SPIRE1
prerank,regulation of chromosome organization (GO:0033044),0.3035565687082589,0.6982139079440158,0.8006088280060882,1.0,1.0,5/22,12.82%,UPF1;MAPT;RB1;TERF2;RMI2
prerank,negative regulation of signaling (GO:0023057),0.2968452677531439,0.6980438721409783,0.8136645962732919,1.0,1.0,2/25,6.82%,SOCS5;PTPN1
prerank,regulation of cellular metabolic process (GO:0031323),0.2658393412764679,0.6973586050036756,0.8529801324503311,1.0,1.0,9/45,16.45%,ANGPTL8;PDK4;ACACB;PPARA;ABCG1;MKLN1;PDK2;FLOT1;VPS35
prerank,positive regulation of catabolic process (GO:0009896),0.2553129239272726,0.6973529387433893,0.8602673147023087,1.0,1.0,5/65,7.03%,NKD1;OAZ2;ATG7;DAB2IP;NEDD4
prerank,positive regulation of JNK cascade (GO:0046330),0.2589698185085001,0.6973261076812665,0.8547619047619047,1.0,1.0,9/70,10.27%,MAP3K5;MFHAS1;DAB2IP;TRAF3;RASGRP1;PLCB1;MAP3K10;EDAR;TRAF5
prerank,cristae formation (GO:0042407),0.296457355807389,0.6972992870749216,0.8255813953488372,1.0,1.0,8/27,18.78%,ATP5MF;AFG3L2;DNAJC11;ATP5MC1;ATP5MG;IMMT;APOOL;ATP5F1D
prerank,peptide biosynthetic process (GO:0043043),0.23786002877589857,0.6971783471575571,0.9137554585152838,1.0,1.0,15/153,11.92%,DMD;RPL3L;CARNS1;MRPL36;MRPL13;HARS2;RPL8;MRPL43;TNIP1;MRPL51;RPL5;MRPL23;RPS23;GSPT1;MRPL9
prerank,positive regulation of cell cycle process (GO:0090068),0.24963859848911943,0.6968006268275203,0.8833718244803695,1.0,1.0,11/91,12.58%,MAP3K20;PDGFB;NUP62;PKN2;SIRT2;PDGFRB;NSFL1C;RHNO1;LRP5;CEP120;KIF20B
prerank,cellular response to radiation (GO:0071478),0.27468642095876866,0.69679995930389,0.8362652232746955,1.0,1.0,10/40,19.76%,NET1;RAD51AP1;TP53;RAD9A;RHNO1;CLOCK;INTS7;INO80;SWI5;RAD9B
prerank,regulation of lysosomal lumen pH (GO:0035751),0.33425618201592255,0.6965088524152484,0.7982456140350878,1.0,1.0,1/12,2.22%,CLN5
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.31854618130303547,0.6964355562469383,0.804920913884007,1.0,1.0,3/14,10.20%,HSD17B4;CRAT;SCP2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.26512866909500654,-0.6963044866456978,0.8563829787234043,0.968761249533951,1.0,6/15,25.15%,LEF1;SNW1;EP300;CHD1;NUCKS1;TFAP4
prerank,protein kinase B signaling (GO:0043491),0.29910406434492354,0.6961839481184716,0.8194662480376766,1.0,1.0,8/23,16.64%,CCL5;EPHA2;THEM4;SIRT2;ZFP36L1;GAS6;PTEN;MT3
prerank,mitotic metaphase plate congression (GO:0007080),0.26227769027673514,0.6954156935460918,0.8363874345549738,1.0,1.0,8/51,14.11%,CHMP4C;NUP62;CHMP5;PIBF1;CENPE;CHMP2B;CHMP2A;KIF18A
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.2875008988810615,0.6952576834518727,0.8116147308781869,1.0,1.0,6/31,15.34%,PDLIM5;KIF1A;CUX2;LRRK2;LZTS3;PTEN
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2483044475725904,0.6943591244331462,0.8857466063348416,1.0,1.0,15/93,12.85%,MAP3K5;MFHAS1;DAB2IP;ARL6IP5;VEGFA;TRAF3;RASGRP1;TGFB2;PLCB1;MAP3K10;EDAR;TRAF5;EIF2AK2;PDCD10;TAOK3
prerank,amyloid-beta metabolic process (GO:0050435),0.32575889501385613,0.694314123337012,0.8131313131313131,1.0,1.0,3/16,7.63%,DYRK1A;APEH;NAT8
prerank,histone H4 acetylation (GO:0043967),0.26937952468006404,0.694299804368085,0.8534704370179949,1.0,1.0,15/47,19.06%,MCRS1;JADE1;MSL3;KAT7;KANSL3;HAT1;RUVBL1;JADE3;MORF4L1;KANSL1;MSL1;ZZZ3;TADA3;ACTL6A;KAT8
prerank,positive regulation of hormone secretion (GO:0046887),0.31375334354831175,0.6933341819691465,0.7955271565495208,1.0,1.0,1/17,2.32%,PLA2G3
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3319147730520408,0.6931877117304247,0.7958115183246073,1.0,1.0,4/13,15.71%,PTGIS;NAXE;NNMT;NAMPT
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.30037718904601635,0.6929988761474413,0.823088455772114,1.0,1.0,7/25,16.02%,ACVR2A;MED1;ANKRD54;HIF1A;ACVR1B;STAT1;STAT3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.24460701562918752,-0.6929564609184309,0.8910081743869209,0.9714241519973378,1.0,3/20,8.05%,AGO3;PUM1;TSNAX
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2530237967000414,0.692852571469084,0.865222623345367,1.0,1.0,20/83,19.57%,CDK6;HINFP;EIF4EBP1;CUL2;CCND1;CDK7;CRLF3;CDK18;RB1;GSPT1;ACVR1B;CDK15;EIF4E;FBXO5;CDK14;BRD4;CUL5;MNAT1;CACUL1;ACVR1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.22423926150755086,-0.6927789566711074,0.8848314606741573,0.9708580021290434,1.0,11/28,36.26%,PRKDC;CYRIB;XRCC6;SIRPA;NCKAP1L;HSPD1;THY1;TYROBP;SH3KBP1;NOD2;PYCARD
prerank,positive regulation of bone resorption (GO:0045780),-0.28814826303331487,-0.6922614141361209,0.864367816091954,0.9706160542186926,1.0,3/11,11.31%,SPP1;ATP6AP1;PLEKHM1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3198615897998221,0.6922032528435417,0.8149405772495756,1.0,1.0,3/15,11.28%,SIRT3;SAMD8;PRKCD
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.24875363487169372,0.6919964087859475,0.8810679611650486,1.0,1.0,10/72,14.14%,FGF1;POLR2L;POLR2I;POLR2G;FLRT1;GALNT3;POLR2J;FGF10;MAPK1;RAB14
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.261549277175136,0.6919192474968595,0.857707509881423,1.0,1.0,9/51,11.70%,NAT10;PARN;PRKCQ;PKIB;NAF1;HNRNPU;CCT3;TERF2;HNRNPC
prerank,mRNA metabolic process (GO:0016071),0.2455958886967077,0.6918712547045401,0.8732394366197183,1.0,1.0,20/90,15.96%,HNRNPR;PCF11;U2AF2;TP53;SFPQ;YTHDF2;PPARGC1A;CELF1;SRSF4;DIS3L2;PRPF18;U2AF1;SF3A3;SF3B2;PCBP3;DXO;SON;PRKACA;LSM10;SF3A1
prerank,prostanoid biosynthetic process (GO:0046457),0.3207688377774358,0.6907847746130393,0.7969543147208121,1.0,1.0,2/15,4.83%,PTGIS;TBXAS1
prerank,negative regulation of mRNA processing (GO:0050686),-0.26109950666292303,-0.6905766332647084,0.828978622327791,0.9715269259235122,1.0,7/15,26.26%,SRSF7;SRSF6;SFSWAP;RBMX;PCBP4;RNPS1;SRSF12
prerank,nucleoside salvage (GO:0043174),-0.3028864207253856,-0.6901894057155376,0.835820895522388,0.97116219494325,1.0,2/10,11.75%,UPP2;HPRT1
prerank,receptor internalization (GO:0031623),0.267702455441776,0.6898149142162892,0.8812415654520918,1.0,1.0,6/44,7.15%,CD36;ITGB1;SAG;CAV1;NEDD4;RAMP1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.2949182573803525,0.689607657127945,0.823088455772114,1.0,1.0,6/23,17.51%,ITGB1;INSC;NSFL1C;FBXW11;DCTN1;UBXN2B
prerank,translation (GO:0006412),0.23122946931016458,0.6895748062010991,0.9357894736842105,1.0,1.0,43/208,16.54%,RPL3L;EEFSEC;MRPL36;MRPL13;HARS2;LARS1;FTSJ1;APEH;GATB;RPL8;ABCE1;MRPL43;TNIP1;IARS2;MRPS28;MRPL51;RPL5;MRPL23;GFM2;RPS23;MRPL16;GSPT1;MRPL47;MRPL9;DRG2;AIMP1;TSFM;MRPL42;EEF2K;IARS1;N6AMT1;RPL15;SARS2;EPRS1;KARS1;LARS2;FASTKD2;RPL22;SARS1;FARS2;ETF1;RPL31;GTPBP2
prerank,exit from mitosis (GO:0010458),-0.27917810506692087,-0.6893301936439048,0.8775981524249422,0.9712341463638235,1.0,3/12,8.54%,EPS8;SPAST;SIRT7
prerank,response to tumor necrosis factor (GO:0034612),0.2449648937334855,0.6884582835159857,0.8938869665513264,1.0,1.0,16/91,14.35%,CCL5;ARHGEF2;HAS2;MAP4K3;TNFRSF11A;DAB2IP;RELA;NR1D1;CCL14;GPER1;TNFRSF21;ZFAND6;YTHDC2;GBP2;ZFP36L1;HYAL1
prerank,response to amyloid-beta (GO:1904645),0.263779696061501,0.6883327253637868,0.8473895582329317,1.0,1.0,2/44,1.72%,CACNA2D1;CD36
prerank,regulation of immune response (GO:0050776),0.2355626264670643,0.688152541763246,0.9203539823008849,1.0,1.0,12/135,8.34%,FCGR3B;FCGR3A;ITGB1;LAG3;CD276;ELMOD2;CD200R1;CD200;TRAF3;TGFB2;ITGA4;CD300A
prerank,regulation of phosphorylation (GO:0042325),0.23724703865129526,0.6881048924421707,0.903010033444816,1.0,1.0,19/120,14.15%,DYNLL1;ROCK1;CCL5;NUP62;DSCAM;PIN1;CORO1C;AR;SEC13;NUP153;HIF1A;SIRT2;NUP107;AAAS;ZBTB7A;FNIP2;PLXNB2;NUP98;NUP37
prerank,response to amino acid (GO:0043200),0.2772616485156836,0.6876094572555682,0.8465909090909091,1.0,1.0,6/31,12.51%,LARS1;CPEB1;CAPN2;RRAGB;SH3BP4;CPEB3
prerank,nucleotide-excision repair (GO:0006289),0.24446112173036547,0.6874186326044656,0.884393063583815,1.0,1.0,14/101,11.45%,POLR2L;POLR2I;BRIP1;GTF2H4;POLR2G;TP53;PARP1;ERCC6;HUS1B;SLX4;PPIE;CDK7;POLD1;COPS8
prerank,cellular iron ion homeostasis (GO:0006879),0.2600296406530808,0.6870455056739341,0.8709677419354839,1.0,1.0,4/55,6.32%,HJV;HMOX2;FXN;ATP6V0A2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.25335250490098715,0.686516141509693,0.8613496932515338,1.0,1.0,10/71,12.63%,PMAIP1;CHMP4C;SOCS6;UBE2W;OTUD7A;LONP1;CAPN2;NR1D1;RSPRY1;DDI2
prerank,neutral amino acid transport (GO:0015804),0.29247060230129823,0.6862630183947843,0.8408759124087591,1.0,1.0,6/28,14.11%,SLC6A17;SLC38A2;SLC1A5;SLC7A8;SLC6A15;SLC38A1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2745464872281695,0.686059220898438,0.8179310344827586,1.0,1.0,2/37,7.16%,ENTPD1;ENTPD7
prerank,lipid droplet formation (GO:0140042),-0.29127118417881653,-0.6859980010638915,0.8785714285714286,0.9737136267444753,1.0,6/10,33.13%,ZFYVE1;CDS1;SQLE;BSCL2;CDS2;FITM2
prerank,cellular response to hydroxyurea (GO:0072711),-0.29430897240186943,-0.685831760230766,0.8255813953488372,0.9731249333105486,1.0,6/10,41.33%,BLM;FMR1;ATRX;TIMELESS;NSMCE3;DDX11
prerank,positive regulation of telomere capping (GO:1904355),0.31048112202568384,0.685270049473847,0.8226600985221675,1.0,1.0,3/17,14.04%,PRKCQ;PKIB;MAPK1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.19430754911866874,-0.6850650117418273,0.9549180327868853,0.9731295888725381,1.0,10/49,18.42%,CPEB2;WNK1;GMIP;GPSM1;RDX;RCC2;SH3RF2;ZCCHC9;LRCH1;ARL2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.3352673195713525,0.6849430110618275,0.792910447761194,1.0,1.0,1/11,4.47%,MFHAS1
prerank,lysine catabolic process (GO:0006554),0.327293106919024,0.6841139358536903,0.8140794223826715,1.0,1.0,2/12,7.08%,DLD;DLST
prerank,lysine metabolic process (GO:0006553),0.327293106919024,0.6841139358536903,0.8140794223826715,1.0,1.0,2/12,7.08%,DLD;DLST
prerank,neuron projection fasciculation (GO:0106030),0.33958145659738986,0.6838939591891199,0.793040293040293,1.0,1.0,2/10,11.60%,SEMA5A;ARHGAP35
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.2968453846810321,0.6838370855283439,0.8170542635658915,1.0,1.0,3/22,10.72%,PMAIP1;HEXIM1;EIF5A
prerank,negative regulation by host of viral transcription (GO:0043922),0.3360231113326566,0.6838040723771104,0.7953020134228188,1.0,1.0,1/12,3.64%,CCL5
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.266215518809685,-0.683508132650041,0.8329466357308585,0.9738627764383732,1.0,7/14,26.26%,SRSF7;SRSF6;SFSWAP;RBMX;PCBP4;RNPS1;SRSF12
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2845971489121433,0.6834256533596328,0.8472834067547724,1.0,1.0,6/27,16.20%,DCTD;AK7;NUDT13;AK2;CMPK1;GLRX
prerank,regulation of RNA splicing (GO:0043484),0.2480131104964673,0.6828454260822919,0.8875154511742892,1.0,1.0,15/69,15.54%,KHDRBS3;RBM38;SLC38A2;DYRK1A;U2AF2;CELF1;MBNL2;FUS;PTBP2;MBNL1;SRSF10;SON;CWC22;SRPK2;SF1
prerank,negative regulation of DNA binding (GO:0043392),0.28871311002390615,0.6819549692923386,0.8216939078751857,1.0,1.0,1/28,1.06%,HEY2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.23072011928055927,0.6805253810764007,0.9363057324840764,1.0,1.0,16/158,11.68%,FLNA;MYD88;ROR1;NUP62;MTDH;PPM1A;GOLT1B;TIFA;RELA;TRIM68;EDAR;TRAF5;PELI2;DDX1;ZDHHC17;HTR2B
prerank,transcription preinitiation complex assembly (GO:0070897),0.326831194915364,0.6804228042943755,0.7843478260869565,1.0,1.0,3/12,15.89%,TAF1;POLR1E;TAF11
prerank,regulation of lamellipodium assembly (GO:0010591),0.27399161836707603,0.6797689783883226,0.8252840909090909,1.0,1.0,6/34,13.33%,PLCE1;ACTR3;CYFIP1;EPHA2;DMTN;CAPZB
prerank,regulation of urine volume (GO:0035809),0.3375729318191065,0.6793780592845545,0.816247582205029,1.0,1.0,2/10,9.46%,HAS2;ADCY6
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.263015473799104,0.6792454330343772,0.8688741721854305,1.0,1.0,12/47,14.04%,DAB2IP;ARL6IP5;RASGRP1;TGFB2;MAP2K1;GSTP1;RAP2A;EIF2AK2;PDCD10;TAOK3;EPHB1;MAPK1
prerank,regulation of actin nucleation (GO:0051125),-0.27008787048069244,-0.6792051606434073,0.8804071246819338,0.9771979849793729,1.0,10/12,48.42%,ARFIP2;PICK1;ARPIN;GSN;ARFIP1;WASHC5;CORO1B;CORO1A;SCIN;ARF1
prerank,regulation of astrocyte differentiation (GO:0048710),0.3278490555786395,0.6789378342104485,0.837037037037037,1.0,1.0,1/12,3.37%,SERPINE2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.31794222979550074,0.6786361207895942,0.8174342105263158,1.0,1.0,3/15,7.80%,TIPIN;RAD9A;HUS1B
prerank,myeloid cell differentiation (GO:0030099),-0.1940594352173346,-0.6777633959382429,0.9568965517241379,0.9777628025518094,1.0,12/47,26.07%,KMT2E;KIT;RPS19;TET2;LYN;HSPA9;SLC25A38;TIRAP;PTPN2;TAL1;UBA5;ZFPM1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.2997108141387728,0.6772184337176258,0.8088235294117647,1.0,1.0,3/21,4.84%,NUDT7;NUDT4;NT5C2
prerank,regulation of cytoplasmic transport (GO:1903649),0.3312365781135182,0.6759576967776111,0.8321554770318021,1.0,1.0,4/11,14.40%,DENND10;MAP2K1;MAPK1;LRRK2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.25274396409452143,-0.6759305797459791,0.8919597989949749,0.9786745085329353,1.0,1/16,0.84%,APPL2
prerank,regulation of mRNA processing (GO:0050684),0.272283960525658,0.6757606570894681,0.8522727272727273,1.0,1.0,10/32,16.80%,KHDRBS3;PAPOLA;AHCYL1;SRSF10;ZFP36L1;SON;CWC22;SRPK2;SF1;DHX9
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.2983804460916009,0.6755321842809607,0.8384146341463414,1.0,1.0,9/24,22.49%,KCNB1;MIEF2;MIEF1;MTCL1;SLC51B;MFF;MYO1C;ERBB2;PDZK1
prerank,protein import into peroxisome matrix (GO:0016558),0.3244586124253476,0.6752547409345007,0.8198529411764706,1.0,1.0,5/12,20.10%,PEX2;PEX5L;PEX10;PEX26;PEX1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2202759980773459,0.6745605545234649,0.9696048632218845,1.0,1.0,53/336,15.30%,CRIP1;RBM24;DYRK2;CGAS;HINFP;BTG2;MUTYH;GTF2H4;BCL2;UBR5;RAD51AP1;UPF1;TAF1;MAPKAPK2;TP53;PARP1;ZBTB38;MBD4;TDP1;CHEK1;BCL2L2;REXO4;YAP1;RAD9A;CCND1;SLX4;BRSK1;EPHA2;PSME4;STK33;RIF1;FBXO6;POLD1;BOK;AKTIP;NSMCE4A;MACROD1;RMI2;TAOK3;FNIP2;HPF1;BCL6;TRIM28;CSNK1E;SIRT4;ZRANB3;MCL1;ZBTB4;UFL1;UBA1;KMT5B;MAPK12;CHRNA4
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2513235077227106,0.6745380129849647,0.882202304737516,1.0,1.0,12/60,13.54%,HEY2;CBFB;TP53;MED1;MED12;SOX9;RELA;CCND1;PAXIP1;MED14;MED8;TRIM28
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.28330665201339555,0.6737034689069138,0.851528384279476,1.0,1.0,7/32,17.51%,HINFP;CDK18;RB1;CDK15;FBXO5;CDK14;BRD4
prerank,regulation of macrophage chemotaxis (GO:0010758),0.30264078472843325,0.6732863359063551,0.8359621451104101,1.0,1.0,2/21,5.41%,CCL5;RARRES2
prerank,protein autophosphorylation (GO:0046777),0.22653131747161764,0.6723250658824653,0.9291084854994629,1.0,1.0,25/157,14.40%,MYLK2;CAMK2D;MUSK;CAMKK2;PEAK1;DYRK1A;TAF1;MAPKAPK2;STK26;MAP3K10;WNK2;DAPK3;PAK2;STK33;STK24;PDGFRB;EIF2AK2;ACVR1B;CDK12;TNIK;TAOK3;EEF2K;STK10;EPHB1;LRRK2
prerank,protein modification by small protein conjugation (GO:0032446),0.21936456000030796,0.6715549558371428,0.9707070707070707,1.0,1.0,80/361,19.61%,TRIM54;UBA2;RNF152;TRIM55;TRIM63;DCUN1D2;NUP62;PDZRN3;LMO7;TNFAIP1;ASB2;ASB1;PIAS4;CUL2;RNF7;CNOT4;PEX2;ATG7;CBLL1;PCNP;SAE1;ELOC;FBXW7;UBE2W;NEDD4;UBE2F;CUL9;DCUN1D1;TRIM68;TRPM4;UBE2E1;NUP153;UHRF2;HIF1A;AMFR;TRIM7;NUP107;UBE2D1;AAAS;FBXO32;PIAS2;TRIM35;NFX1;FBXW11;UBA3;MUL1;TRIM28;NUP98;NUP37;TSPAN17;UFL1;UBA1;UBE2K;NUP210;GAN;UBR3;SMURF1;CCNF;RLIM;ANAPC16;PEX10;UBE2A;MIB2;CUL5;ISG15;RCHY1;PIAS1;BCL11A;RNF103;UBR1;ANAPC11;NUP54;RPS27A;SUMO1;TRIM23;UBE2I;NUP160;ATG10;MIB1;NUP133
prerank,tRNA modification (GO:0006400),0.2478012677720555,0.6715218928642968,0.8863636363636364,1.0,1.0,5/62,5.49%,WDR4;TRDMT1;CDKAL1;TYW5;FTSJ1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3353571801948356,0.671477080159511,0.8108614232209738,1.0,1.0,3/10,18.06%,SIRT3;PRKCD;SMPD2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3353571801948356,0.671477080159511,0.8108614232209738,1.0,1.0,3/10,18.06%,SIRT3;PRKCD;SMPD2
prerank,T cell activation (GO:0042110),0.24576795557573747,0.6712844681285183,0.8849449204406364,1.0,1.0,10/69,13.44%,PPP3CA;IL2;LCP1;CD276;RASGRP1;DDOST;LMBR1L;RHOH;PPP3CB;NCK2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2245539857694173,0.6712402779760794,0.9317180616740088,1.0,1.0,28/148,17.54%,PRKAB2;DYRK2;PIP4K2A;BRIP1;PRDM1;USP2;TAF1;TP53;HEXIM1;PIN1;TPX2;CHEK1;RAD9A;NUAK1;RPL5;PRR5;RHNO1;RICTOR;RMI2;CHD4;SGK1;PRKAA2;PPP2R5C;TAF11;HIPK2;BOP1;BRD7;HDAC1
prerank,insulin receptor signaling pathway (GO:0008286),0.24500955806876995,0.6708502421008083,0.8831942789034565,1.0,1.0,14/69,15.71%,PDK4;BCAR3;RARRES2;ATP6V1H;IRS1;SORBS1;ATP6V0A2;ATP6V1C1;SLC39A14;ATP6V0D2;PDK2;IRS2;CAV2;NAMPT
prerank,chromosome organization (GO:0051276),0.23998358185937133,0.6704547318843913,0.8937142857142857,1.0,1.0,23/99,21.51%,PADI3;PADI2;GEM;HMGN3;PARP1;TOP2B;COPS8;ZBTB7A;HMG20A;COPS4;CDAN1;CENPW;MSH2;HDAC1;COPS6;HMGN1;ABL1;RPS27A;NUP133;TCF7L1;H3-3A;CENPV;EZH2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.26850480065020793,-0.6700897365879073,0.8847926267281107,0.9832164050470799,1.0,1/12,3.27%,IL18
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.23100876561165062,-0.6698324309931054,0.9523809523809523,0.9826934116196874,1.0,10/23,31.98%,ASAH2;PTGS2;EPHX2;ELOVL6;FADS1;GSTM2;ACOT7;HPGD;ALOX12;GPX4
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2741162639049897,-0.6689501210993567,0.8727678571428571,0.9827175813764177,1.0,3/12,12.81%,GART;HPRT1;PRPSAP2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.2596458988613077,-0.6689399877621945,0.8689655172413793,0.9819777407220074,1.0,6/14,31.91%,RPL7L1;URB1;RPF2;FTSJ3;PES1;RPL35
prerank,neuron cell-cell adhesion (GO:0007158),0.3096684927261457,0.6688212243569416,0.8474870017331022,1.0,1.0,2/14,8.14%,ASTN2;ASTN1
prerank,regulation of response to stress (GO:0080134),0.3278887301818745,0.6687468545745731,0.8239564428312159,1.0,1.0,1/10,5.19%,SLC38A2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.26516055387527826,0.6683729315289382,0.8713692946058091,1.0,1.0,11/38,18.18%,CENPP;CENPO;HAT1;RUVBL1;ITGB3BP;SMARCA5;CABIN1;IPO4;CENPW;CENPK;RSF1
prerank,negative regulation of B cell proliferation (GO:0030889),0.3312793705686257,0.6682983862456561,0.825187969924812,1.0,1.0,2/11,10.86%,CD300A;TNFRSF21
prerank,ether lipid biosynthetic process (GO:0008611),0.3342571115651888,0.6680078965350605,0.829981718464351,1.0,1.0,4/10,20.00%,PEDS1;PLA2G4A;PLA2G4C;CHPT1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.288041940750396,-0.6673039803856898,0.8468085106382979,0.982619382077052,1.0,3/10,17.58%,CORO2B;PPM1F;SNX3
prerank,positive regulation of histone deacetylation (GO:0031065),-0.2687312665933326,-0.6672839124529266,0.8904761904761904,0.9818905543829396,1.0,6/12,32.42%,AKAP8;AKAP8L;PRKD2;ZBTB7B;SAP30BP;APLNR
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2434271764088513,-0.6669112032037982,0.8972222222222223,0.9814704013374015,1.0,6/18,21.98%,ELOVL7;ACSL3;ACSL4;ELOVL6;HACD2;ELOVL1
prerank,negative regulation of glycolytic process (GO:0045820),0.32925176571350273,0.6665861522457,0.8120437956204379,1.0,1.0,2/10,8.61%,PFKFB1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.32925176571350273,0.6665861522457,0.8120437956204379,1.0,1.0,2/10,8.61%,PFKFB1;PPARA
prerank,keratan sulfate catabolic process (GO:0042340),-0.2775285531211581,-0.6664165414773191,0.8758782201405152,0.9811435316124564,1.0,4/11,19.22%,HEXA;FMOD;GALNS;OMD
prerank,regulation of cell death (GO:0010941),0.23551711360895816,0.6662868946838083,0.9128386336866903,1.0,1.0,20/94,17.66%,CD36;CCN1;FERMT2;CCL5;CELF1;ADNP2;IMPACT;HTR2B;CHRNA7;CLU;SARM1;CHMP2A;EPHB1;LRRK2;SNCG;DHCR24;VPS35;MT3;FAF1;SNCB
prerank,tryptophan metabolic process (GO:0006568),0.3282812781024145,0.6662154620437398,0.8295652173913044,1.0,1.0,1/11,6.78%,KMO
prerank,nuclear pore organization (GO:0006999),0.3191572879657219,0.6661990575482599,0.8333333333333334,1.0,1.0,6/14,20.76%,NUP153;NUP107;NUP98;NUP54;NUP133;TPR
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.23361474492763618,-0.6655802680636098,0.9098360655737705,0.9796574972515651,1.0,5/20,18.12%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.23361474492763618,-0.6655802680636098,0.9098360655737705,0.9796574972515651,1.0,5/20,18.12%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.23361474492763618,-0.6655802680636098,0.9098360655737705,0.9796574972515651,1.0,5/20,18.12%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,regulation of cell killing (GO:0031341),0.30448075272397046,0.6655371356767443,0.8282828282828283,1.0,1.0,2/16,7.86%,CFH;TGFB2
prerank,regulation of B cell apoptotic process (GO:0002902),0.312529261824377,0.6654480066531436,0.8111510791366906,1.0,1.0,3/12,14.92%,IL2;BCL6;IRS2
prerank,mRNA transport (GO:0051028),0.23735199788090738,0.6648232654374785,0.9064327485380117,1.0,1.0,23/101,16.20%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;KIF5C;DDX25;THOC7;SRRM1;ZFP36L1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2622434014739836,0.6645873250485156,0.8854024556616644,1.0,1.0,14/41,20.76%,NUP62;SEC13;NUP153;HIF1A;NUP107;AAAS;ZBTB7A;NUP98;NUP37;NUP210;NUP54;NUP160;NUP133;TPR
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.28393936278512505,0.6635321050874959,0.8536231884057971,1.0,1.0,3/27,7.71%,PMAIP1;DYRK1A;SNAI2
prerank,cellular response to interferon-gamma (GO:0071346),0.23917220001173475,0.6631165768549934,0.9048723897911833,1.0,1.0,18/88,18.77%,CAMK2G;CAMK2D;CCL5;IL12RB1;DAPK3;TRIM68;CCL14;PRKCD;GBP2;OASL;SYNCRIP;EPRS1;STAT1;JAK2;IRF3;CCL25;CD47;CCL19
prerank,regulation of viral release from host cell (GO:1902186),-0.23157377453398034,-0.6630442813815506,0.9369627507163324,0.9811074700620501,1.0,7/21,25.85%,PML;TRIM25;DDB1;TRIM5;MID2;TRIM21;TRIM32
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.295226306460709,0.6628498500247643,0.8276972624798712,1.0,1.0,5/20,16.35%,PLCB1;AGRN;CHRNA7;GNAQ;RGS10
prerank,response to estradiol (GO:0032355),0.2736678673540075,0.6620422448590496,0.8634423897581792,1.0,1.0,2/31,3.69%,ANXA1;STRN3
prerank,cellular glucose homeostasis (GO:0001678),0.2647593224626784,0.6620066192795474,0.8835616438356164,1.0,1.0,10/41,14.87%,HK2;KCNB1;PPARGC1A;NR1D1;HIF1A;SLC39A14;GPER1;GAS6;PRKAA2;PRKACA
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.2726775920443967,0.6608517744905268,0.8618233618233618,1.0,1.0,2/29,3.64%,ANO6;CCL5
prerank,nuclear membrane reassembly (GO:0031468),0.24717905358484424,0.6602058793860607,0.8786346396965866,1.0,1.0,17/54,19.61%,CHMP4C;SEC13;IST1;SIRT2;NSFL1C;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;UBXN2B;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.28239052437460904,0.6598245813386378,0.864516129032258,1.0,1.0,7/22,17.90%,RELA;ROCK2;ABCG1;CHRNA7;CLU;SP1;LRRTM3
prerank,regulation of cellular pH (GO:0030641),0.2736498382322783,0.6594758417078004,0.8489208633093526,1.0,1.0,4/29,8.16%,SLC4A8;SLC4A3;SLC4A7;SLC9A8
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.31005804560525185,0.6594458708663353,0.8195876288659794,1.0,1.0,3/13,14.40%,ENTPD7;OPA1;LRRK2
prerank,sulfur compound biosynthetic process (GO:0044272),0.23197024904537142,0.6593715307702827,0.9212962962962963,1.0,1.0,17/104,13.27%,ANGPT1;CSPG4;CHSY3;CSGALNACT1;BGN;CHST5;OGN;GSTT1;GSTP1;CHST3;OPLAH;GGCT;ESD;CHST1;GSTA4;ST3GAL2;MAT2A
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.24335307885524787,0.6593311635465167,0.8907766990291263,1.0,1.0,6/69,7.37%,FZD5;LPL;HAVCR2;CD14;ARHGEF2;RASGRP1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.24812787930474714,0.6591368760582653,0.8934531450577664,1.0,1.0,5/57,9.97%,MEF2C;SHISA9;CNIH2;GSG1L;ACTN2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.28199914331625736,-0.6582565964299615,0.8923766816143498,0.9842724820054622,1.0,3/10,15.76%,PPM1B;SIRPA;RELB
prerank,mRNA polyadenylation (GO:0006378),0.2812403638055232,0.6582228025812549,0.8592375366568915,1.0,1.0,4/26,9.41%,WDR33;PCF11;PAPOLA;AHCYL1
prerank,RNA polyadenylation (GO:0043631),0.2812403638055232,0.6582228025812549,0.8592375366568915,1.0,1.0,4/26,9.41%,WDR33;PCF11;PAPOLA;AHCYL1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.3301525271628488,0.6578088708064603,0.8228782287822878,1.0,1.0,2/10,7.52%,SMARCB1;CHEK1
prerank,peroxisome organization (GO:0007031),0.27785863291495017,0.6560777345758927,0.8547140649149922,1.0,1.0,9/25,20.34%,PEX2;ABCD4;DNM1L;PEX19;LONP2;PEX10;MFF;PEX1;PEX3
prerank,cellular response to light stimulus (GO:0071482),0.24506641322610934,0.6554857920134929,0.9151061173533084,1.0,1.0,15/66,20.99%,SAG;TAF1;TP53;PARP1;NEDD4;RHNO1;POLD1;PRKCD;INO80;EIF2AK4;USP28;N4BP1;EIF2S1;YY1;GNB1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.22027070706835022,-0.6549935211850937,0.9461077844311377,0.9861450973152845,1.0,7/23,24.55%,COPS2;DDB1;UBC;XPA;COPS7B;UBB;RAD23B
prerank,regulation of adaptive immune response (GO:0002819),-0.24003449587883327,-0.6543099117230754,0.9072164948453608,0.9859316217640453,1.0,11/18,48.85%,ADCY7;AHR;SKAP1;PYCARD;IRF1;FCGR2B;IRF7;FADD;IL4I1;SASH3;IL6ST
prerank,synaptic vesicle localization (GO:0097479),0.3107445146290224,0.6542072094575194,0.8249566724436742,1.0,1.0,6/13,21.95%,KIF5B;KIF5C;KIF5A;DNM2;SNAPIN;SYNJ1
prerank,glycolipid metabolic process (GO:0006664),0.25033621942255374,0.6536297085793379,0.8847682119205298,1.0,1.0,9/47,14.95%,ESYT2;NEU3;GLA;SUMF1;GM2A;ST3GAL2;GLTP;GLB1;CTSA
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2608139268585935,0.6536080209477771,0.8714859437751004,1.0,1.0,2/42,3.64%,THPO;CCL5
prerank,regulation of cell projection organization (GO:0031344),-0.2641373578171834,-0.6533811109445212,0.883054892601432,0.9859433725221891,1.0,6/13,28.19%,SEMA4D;MYO9A;SPRY2;MFSD2A;MOV10;NTNG1
prerank,RNA export from nucleus (GO:0006405),0.23128613522266758,0.6532184177779664,0.9262672811059908,1.0,1.0,22/100,16.20%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;XPO5;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2501254500022342,0.6528866163071086,0.8959156785243741,1.0,1.0,13/50,19.26%,KLHL40;U2AF2;CAV1;TAF1;BAG2;ADGRB1;UFL1;FBXO5;USP4;ISG15;N4BP1;ABL1;SENP2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.29104567903536704,0.6528835891008915,0.8552845528455284,1.0,1.0,1/18,3.83%,LAX1
prerank,granulocyte chemotaxis (GO:0071621),0.2443180616044615,0.6522699888295131,0.8969465648854962,1.0,1.0,9/55,18.77%,ANXA1;CCL5;TGFB2;CCL14;S100A8;S100A9;CCL25;SCG2;CCL19
prerank,Golgi localization (GO:0051645),0.3208645771791847,0.6521888656646696,0.8511796733212341,1.0,1.0,2/11,12.63%,ARHGAP21;PDCD10
prerank,iron ion homeostasis (GO:0055072),0.2432723861037116,0.6518980344938755,0.8993630573248408,1.0,1.0,4/58,6.32%,HJV;HMOX2;FXN;ATP6V0A2
prerank,regulation of T cell proliferation (GO:0042129),0.244846334141802,0.6518505930140883,0.9085213032581454,1.0,1.0,3/61,4.16%,ANXA1;CCL5;CD276
prerank,histone modification (GO:0016570),0.23037433924153816,0.6513940579484423,0.9300225733634312,1.0,1.0,28/109,19.73%,PADI3;CCNA2;PADI2;HDAC9;CPA4;MSL3;PRMT7;NSD3;MTA3;SIRT2;MIDEAS;PRKCD;BAZ2A;RUVBL1;MORF4L1;MTA1;UFL1;SIN3A;MT3;USP36;HDAC1;UBE2A;ATXN7L3;RBM14;HDAC6;KAT8;KDM4A;PRMT1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3188303129781921,0.6513508467046873,0.8485915492957746,1.0,1.0,3/12,11.08%,LPCAT3;MBTPS1;SREBF2
prerank,negative regulation of protein processing (GO:0010955),0.3192246106253003,0.651294213344157,0.823943661971831,1.0,1.0,1/12,3.37%,SERPINE2
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.23713071520642312,-0.650982570844771,0.9193154034229829,0.9870743558651293,1.0,4/18,18.40%,PRKDC;METTL3;XRCC6;NCKAP1L
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.30176690640810144,0.6509733448135469,0.8256410256410256,1.0,1.0,3/13,8.04%,SLC2A10;RAMP1;PLCB1
prerank,negative regulation of T cell differentiation (GO:0045581),0.334535954494002,0.6509280984822239,0.8093457943925234,1.0,1.0,2/10,13.52%,LAG3;FOXJ1
prerank,regulation of lipid kinase activity (GO:0043550),-0.2691295183719922,-0.6507508577417197,0.9105882352941177,0.9864849132693263,1.0,2/11,7.75%,PIK3R3;WDR91
prerank,regulation of cell cycle (GO:0051726),0.21537878892116163,0.6505722869668763,0.9764585465711362,1.0,1.0,49/271,17.52%,MAP3K20;CDK6;FBXL22;TRNP1;MLF1;NR4A1;GMNN;MYBBP1A;JUND;DAB2IP;RPS6KA2;TP53;CHEK1;FZD9;SOX9;TGFB2;DAPK3;LIN37;WHAMM;CCND1;MAP2K1;UHRF2;CDK7;CRLF3;SIRT2;HNRNPU;BRINP1;GPER1;RB1;MFN2;LIN9;CITED2;KIF20B;FGF10;SON;PRKACA;MLXIPL;DHCR24;FBXO5;SRPK2;MAPK12;STAT3;HIPK2;TTC28;WDR6;MIF;EIF4G2;BOP1;MASTL
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.2406017684154548,-0.65039623523535,0.9234567901234568,0.9859970711731133,1.0,6/17,27.66%,PTPN22;PTPN2;CEACAM1;THY1;LAPTM5;PTPRJ
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.2741249276658158,0.6502714220547342,0.8784,1.0,1.0,8/24,19.61%,ALOX5;OPA1;LPCAT3;CLU;LRRK2;NR1H3;CREB3;WFS1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.274580821083044,0.6502255008589282,0.8586156111929307,1.0,1.0,7/26,14.87%,EIF4EBP1;USP2;DUSP3;PKN2;PPP1R10;EIF4E;PRKCA
prerank,positive regulation of exocytosis (GO:0045921),0.2594557503656871,0.6500445120062818,0.8845618915159944,1.0,1.0,7/35,15.01%,CLASP2;UNC13D;RAB3A;TSG101;CLASP1;CHMP2A;STAM
prerank,positive regulation of cytokine production (GO:0001819),0.2141565445083806,0.6499420986442636,0.9775967413441955,1.0,1.0,29/292,11.18%,NR1H4;POLR2L;MYD88;FZD5;RORA;ANXA1;CGAS;IL2;LPL;IL12RB2;CD276;HAVCR2;CD14;ARHGEF2;PRKCQ;IL12RB1;CD200;PIBF1;RASGRP1;MBP;RELA;PLCB1;ADAM17;LRRFIP1;HIF1A;EIF2AK2;ROCK2;RUNX1;PDE4D
prerank,inner mitochondrial membrane organization (GO:0007007),0.24934555780803508,0.6493238837410695,0.8845177664974619,1.0,1.0,8/47,11.59%,ATP5MF;AFG3L2;OPA1;MTX1;DNAJC11;TIMM29;ATP5MC1;ATP5MG
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2376182735946646,0.649303427759803,0.9248484848484848,1.0,1.0,11/80,12.24%,CDC42EP3;PLCE1;TGFB3;ACTR3;TAPT1;CYFIP1;WASHC1;ANLN;AGRN;ARHGAP35;CEP120
prerank,inner dynein arm assembly (GO:0036159),-0.2781763961435299,-0.6490061981809242,0.8876889848812095,0.9863194784366414,1.0,2/10,13.45%,DNAAF5;CCDC39
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.31212869974143825,0.6464040372778166,0.8475499092558983,1.0,1.0,4/11,20.67%,CAV1;ACTN2;KCNH2;CAB39
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.22807362336229225,0.6461402019352902,0.9343493552168816,1.0,1.0,14/108,13.74%,DLC1;MAP3K5;PMAIP1;HIP1;MAPT;ARL6IP5;RPS27L;ATP2A3;GPER1;CASP8AP2;BOK;DIABLO;MUL1;TNFRSF10B
prerank,cellular response to leucine (GO:0071233),-0.2748130287485195,-0.64601477730583,0.9142212189616253,0.9871232666872019,1.0,5/10,29.69%,UBR2;KLHL22;RRAGD;SESN2;RPTOR
prerank,response to leucine (GO:0043201),-0.2748130287485195,-0.64601477730583,0.9142212189616253,0.9871232666872019,1.0,5/10,29.69%,UBR2;KLHL22;RRAGD;SESN2;RPTOR
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3011117861200178,0.6454730900271448,0.8548387096774194,1.0,1.0,3/15,11.97%,NAF1;CCT3;RUVBL1
prerank,glycine metabolic process (GO:0006544),0.3041397802998534,0.6450040359495547,0.8249158249158249,1.0,1.0,1/12,6.00%,DLD
prerank,androgen receptor signaling pathway (GO:0030521),0.31542487368148275,0.6449290958462873,0.8375912408759124,1.0,1.0,2/11,7.14%,ARID1A;AR
prerank,protein localization to vacuole (GO:0072665),0.3105051976725976,0.644791102386796,0.8392857142857143,1.0,1.0,2/13,10.83%,KPTN;SH3BP4
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.24646530887250387,-0.6447774214918168,0.9230769230769231,0.9872758706333445,1.0,3/15,14.82%,TCF7L2;CAMK1;EMD
prerank,RNA methylation (GO:0001510),0.24020767506796073,0.6445072492406273,0.929368029739777,1.0,1.0,11/60,15.34%,TRDMT1;FTSJ1;TRMT10C;CBLL1;TFB2M;ZCCHC4;TGS1;METTL6;NSUN2;TRMT44;RBM15
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3251105648909369,0.6443616441539732,0.8434622467771639,1.0,1.0,3/10,14.04%,MAP2K1;GSTP1;MAPK1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.22872014817687703,0.6438475136733821,0.930715935334873,1.0,1.0,21/96,16.20%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3080493406373763,0.6437537927971325,0.856637168141593,1.0,1.0,1/13,2.85%,ASPH
prerank,DNA repair (GO:0006281),0.21145669642871356,0.6437318757183745,0.9766022380467956,1.0,1.0,53/284,16.88%,HINFP;BRIP1;BTG2;MUTYH;RAD51AP2;GTF2H4;WDR33;RAD51AP1;UPF1;PIAS4;FAAP24;MLH3;TP53;PARP1;WRNIP1;MBD4;TDP1;CHEK1;REXO4;RAD9A;ERCC6;HUS1B;FTO;TENT4A;SLX4;USP1;FANCB;PSME4;FAAP100;FBXO6;RHNO1;DDX1;POLD1;KPNA2;FANCE;NSMCE4A;SMARCA5;RMI2;HPF1;TRIM28;CSNK1E;ZRANB3;MTA1;EXD2;KMT5B;CHRNA4;BABAM1;MAD2L2;RAD52;MGME1;RAD21;MSH2;INO80
prerank,extracellular transport (GO:0006858),-0.2627367521525068,-0.6434608266726373,0.897025171624714,0.9875409037148009,1.0,9/12,49.60%,SPEF2;ARRDC1;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.20987735434932625,-0.6418277240683774,0.9419354838709677,0.9879691231666327,1.0,6/28,19.27%,OCLN;SLAIN2;NAV3;GIT1;ARL2;MECP2
prerank,positive regulation of synaptic transmission (GO:0050806),0.23549897098058886,0.6415138831015356,0.9226993865030675,1.0,1.0,5/72,5.87%,CRHR2;SLC8A2;GRIN2C;RIMS3;ZDHHC2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.2649012188306745,-0.6408673806500436,0.8959810874704491,0.9879221374329983,1.0,2/11,18.27%,SAFB2;SRPK1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.25341800582065355,-0.640703912897181,0.8962962962962963,0.9872886076516354,1.0,5/14,24.62%,MYO9A;OPHN1;CDC42;FSCN1;SCRIB
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.23493119663520634,0.6401983793522016,0.9197604790419162,1.0,1.0,6/73,7.37%,FZD5;LPL;HAVCR2;CD14;ARHGEF2;RASGRP1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.25951248396057325,-0.6399231305426931,0.9081885856079405,0.9870781066037536,1.0,6/12,34.94%,PLK2;CHFR;ZWILCH;WEE1;NABP1;BUB1B
prerank,positive regulation of lipid localization (GO:1905954),0.3090948977953099,0.6396413937749222,0.8467153284671532,1.0,1.0,1/11,3.34%,LPL
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2666060548870322,0.6396216754968832,0.8839941262848752,1.0,1.0,4/31,7.96%,DCUN1D2;FBXW7;PIN1;DCUN1D1
prerank,positive regulation of viral genome replication (GO:0045070),0.26836292941843587,0.6395757986152825,0.8744588744588745,1.0,1.0,6/29,11.80%,CCL5;PPARA;PPIE;PKN2;TOP2B;CNOT7
prerank,cellular response to superoxide (GO:0071451),-0.27536703454697276,-0.6384191520164181,0.9041095890410958,0.9874729488834774,1.0,6/10,42.24%,NOS3;ADPRS;PRDX1;PRDX2;ATP7A;SOD1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.20593851979330707,-0.6382686107244248,0.9585987261146497,0.9868411726677067,1.0,8/31,26.30%,LYN;CEBPB;SDC4;ATM;CD80;CD274;CD86;SOX11
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21645738099376977,0.6376359834020106,0.9720730397422127,1.0,1.0,27/163,16.90%,MEF2C;CD79A;LAX1;CD276;BCL2;FYB2;PRKCQ;PSMC6;LCP2;RELA;PAK2;PSME4;PAG1;PSMB1;PSMD5;TNFRSF21;PDE4D;FBXW11;PSMB2;PLEKHA1;PSMB7;PSMD3;PRAM1;RFTN1;PSMA2;VAV3;PSMD14
prerank,regulation of mononuclear cell migration (GO:0071675),0.2812450371835118,0.6375559439885419,0.8875,1.0,1.0,4/23,14.04%,CCL5;RARRES2;STK10;MAPK1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.23675319983887597,0.6374396936858386,0.9222222222222223,1.0,1.0,14/64,18.67%,ALOX5;HSD17B4;ACSL5;FADS2;GSTP1;MGLL;SCP2;PNPLA3;CPT1A;PLA2G4A;PLA2G4C;EPHX1;ACSBG1;FAAH
prerank,integrated stress response signaling (GO:0140467),0.30119499513400266,0.6371100533061794,0.8528428093645485,1.0,1.0,6/14,22.56%,IMPACT;EIF2AK3;EIF2AK4;DDIT3;EIF2S1;QRICH1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.24580165411424798,0.6365846955191286,0.8936170212765957,1.0,1.0,10/45,13.20%,BTG2;CHEK1;HECA;BTG1;TOM1L2;ZWINT;BRINP1;TRIM35;BCL6;ZFP36L1
prerank,autophagosome assembly (GO:0000045),0.24455369176285838,0.6358364354552462,0.9068241469816273,1.0,1.0,12/52,17.51%,ATP2A2;ATG16L2;ATG7;GABARAP;NSFL1C;STX12;MFN2;WDR45;PIK3C3;ATG13;SMURF1;UBXN2B
prerank,mismatch repair (GO:0006298),0.26320661528620776,0.6355278794910784,0.89209726443769,1.0,1.0,6/27,19.07%,MUTYH;MLH3;POLD1;MSH5;MSH2;ABL1
prerank,neuron apoptotic process (GO:0051402),0.2802205199262138,0.6354944508621886,0.880064829821718,1.0,1.0,4/19,12.39%,BCL2;TRPC5;TNFRSF21;DIABLO
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3016554932073131,0.6349001067269024,0.8538732394366197,1.0,1.0,4/12,15.81%,ACO2;IDH3A;SIRT4;IREB2
prerank,coenzyme A metabolic process (GO:0015936),-0.25266058276314524,-0.634572360143389,0.9203980099502488,0.9886461069344048,1.0,7/14,27.03%,PPCDC;PANK1;ACLY;CROT;DCAKD;ACOT7;PPCS
prerank,protein catabolic process (GO:0030163),0.23698041643612328,0.6345257634604604,0.9189526184538653,1.0,1.0,6/59,10.10%,PMAIP1;CLN5;SOCS6;DAB2IP;NR1D1;FBXO6
prerank,protein targeting to mitochondrion (GO:0006626),-0.179021439254727,-0.634307040404644,0.9829787234042553,0.9880931384751125,1.0,17/52,30.43%,HSPA4;FBXO7;TIMM44;DNAJC19;FIS1;SAMM50;TOMM34;AIFM1;TIMM17B;HSPD1;IMMP2L;TOMM70;TIMM21;TIMM23;TIMM10B;TIMM8B;GRPEL1
prerank,protein localization to lysosome (GO:0061462),-0.20783531040832112,-0.6340818910249847,0.9670658682634731,0.9874911617116777,1.0,10/28,26.69%,SCARB2;GCC2;RTN4;AP3M1;HGS;LMBRD1;M6PR;GLMP;NCOA4;LAPTM5
prerank,regulation of tumor necrosis factor production (GO:0032680),0.22126247216997053,0.633327295789269,0.9394618834080718,1.0,1.0,10/112,8.98%,NR1H4;FZD5;LPL;HAVCR2;CD14;ARHGEF2;MAPKAPK2;RASGRP1;DICER1;GSTP1
prerank,phospholipid biosynthetic process (GO:0008654),0.2477363602778011,0.6329666685728346,0.9029126213592233,1.0,1.0,8/36,13.23%,IDI1;DHDDS;AGPAT3;MVD;PCYT2;SAMD8;SRD5A3;CPNE3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.2876043702186774,0.6329066467218616,0.8914100486223663,1.0,1.0,3/17,11.53%,MUTYH;MBD4;TERF2
prerank,maturation of LSU-rRNA (GO:0000470),-0.21307614746921033,-0.6320487993804041,0.9538904899135446,0.9880912689114174,1.0,8/26,23.46%,NSA2;RSL1D1;RPL7L1;URB1;MRPL1;RPF2;FTSJ3;RPL10A
prerank,tryptophan catabolic process (GO:0006569),0.31570040422134427,0.6319929480103393,0.8617021276595744,1.0,1.0,1/11,6.78%,KMO
prerank,regulation of cellular amine metabolic process (GO:0033238),0.23968265425026172,0.6318670351565802,0.916445623342175,1.0,1.0,10/50,16.90%,OAZ2;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2164990370865955,0.631737664293706,0.9508928571428571,1.0,1.0,20/132,12.81%,RPL3L;DENR;DDX23;TXNL4A;RPS27L;NLE1;CLNS1A;MDN1;CELF1;DICER1;NAF1;EIF2D;PRPF18;PWP2;PRMT7;RPL5;SRSF10;DDX1;TGS1;SF3B1
prerank,lipid biosynthetic process (GO:0008610),0.23032711600505995,0.6313584912316524,0.950354609929078,1.0,1.0,10/77,12.02%,LPL;ALOX5;ACSL5;PDSS2;AGPAT3;MVD;PCYT2;SCP2;NDUFAB1;PDSS1
prerank,vesicle organization (GO:0016050),0.24808362792077543,0.6303303115036538,0.9131578947368421,1.0,1.0,8/46,12.41%,HOOK2;SORT1;CAV1;HOOK1;CHMP2B;USP50;AKTIP;PLEKHJ1
prerank,protein acylation (GO:0043543),0.2543187118821536,0.6299154466319931,0.8922237380627558,1.0,1.0,11/38,18.76%,NAT10;ZDHHC2;HHAT;ZDHHC1;ZDHHC14;ZDHHC17;CLOCK;ZDHHC13;ZDHHC5;ZDHHC8;ZDHHC3
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3173655335552318,0.629837035761095,0.8581687612208259,1.0,1.0,2/10,12.51%,CPEB1;CPEB3
prerank,sodium ion import across plasma membrane (GO:0098719),0.2890490475200239,0.6295883504471386,0.8811410459587956,1.0,1.0,3/17,12.67%,SLC8A1;TRPM4;HCN2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.2839363630370004,0.6293256981522243,0.8622448979591837,1.0,1.0,4/18,17.43%,KCNB1;IRS1;SIRT4;ADRA2A
prerank,positive regulation of protein catabolic process (GO:0045732),0.22393133699162102,0.6290190710667838,0.9601449275362319,1.0,1.0,15/84,17.43%,NKD1;OAZ2;PACSIN3;ATG7;DAB2IP;NEDD4;AMER1;NSF;SNX9;VGLL4;VPS35;SMURF1;FAF1;TNFSF12;ADRA2A
prerank,smoothened signaling pathway (GO:0007224),0.2583172247684215,0.6289737626823712,0.9016152716593245,1.0,1.0,6/32,17.79%,DYRK2;MAP3K10;DISP2;STK36;HIPK2;IFT27
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.2627730826167591,0.6286533953174018,0.887905604719764,1.0,1.0,7/28,16.55%,PSMC6;DAB2IP;FBXW7;CLU;BAG2;PTEN;SMURF1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.25475622454304403,-0.6284633276394144,0.9239904988123515,0.9897022233996539,1.0,1/12,4.19%,RBP4
prerank,JNK cascade (GO:0007254),0.2573406375818096,0.6281616219691867,0.9150943396226415,1.0,1.0,3/40,8.12%,MAP3K5;MAP4K3;MAP3K10
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.2736432727542091,0.6275481096523691,0.8869426751592356,1.0,1.0,1/19,2.09%,PDGFB
prerank,lipid catabolic process (GO:0016042),0.2897439234218417,0.6273485672647102,0.8778501628664495,1.0,1.0,2/18,9.92%,LPL;SIRT2
prerank,regulation of DNA metabolic process (GO:0051052),0.24238955972890877,0.6266124990230337,0.9152086137281292,1.0,1.0,8/44,12.04%,UPF1;WRNIP1;USP1;KAT7;PDGFA;PARG;TERF2;KPNA2
prerank,piRNA metabolic process (GO:0034587),-0.2245571625903758,-0.6265059480590366,0.9264305177111717,0.9902474586187374,1.0,17/19,64.24%,TEX15;TDRKH;EXD1;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,base-excision repair (GO:0006284),0.24211938230012348,0.6263605818186663,0.9353099730458221,1.0,1.0,7/48,11.83%,MUTYH;PARP1;MBD4;ERCC6;PARG;POLD1;POLG
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3123696353115009,0.6261793550152333,0.8476190476190476,1.0,1.0,1/10,5.78%,MTHFD2L
prerank,negative regulation of histone acetylation (GO:0035067),0.310134931973447,0.626073946114914,0.8178506375227687,1.0,1.0,1/11,4.30%,SET
prerank,regulation of proteolysis (GO:0030162),0.23976609385126074,0.6250591298924516,0.922077922077922,1.0,1.0,8/48,13.11%,ASPH;SERPINE2;CAV1;TRAF3;IST1;FBXW11;DNAJC1;PERP
prerank,establishment of epithelial cell polarity (GO:0090162),-0.22723658583110276,-0.6244779012643072,0.94579945799458,0.9908328516333897,1.0,5/19,16.78%,GOLPH3;MYO9A;OPHN1;CYTH1;CDC42
prerank,lymphocyte migration (GO:0072676),0.2530111515338799,0.6230208857719731,0.9067431850789096,1.0,1.0,5/32,19.66%,CCL5;CCL14;CCL25;CCL19;RET
prerank,mRNA methylation (GO:0080009),0.2878282838546825,0.6228278947926645,0.8689075630252101,1.0,1.0,3/15,13.19%,TRMT10C;CBLL1;NSUN2
prerank,lipoprotein biosynthetic process (GO:0042158),0.30540652253820705,0.6219536473950843,0.9009174311926605,1.0,1.0,3/11,13.34%,ATG7;WDR45;PIK3C3
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.30875234525257755,0.621567083572348,0.8620102214650767,1.0,1.0,3/12,14.30%,LPCAT3;DGAT1;MTTP
prerank,maturation of SSU-rRNA (GO:0030490),0.2486662531708161,0.62130853055899,0.8892005610098177,1.0,1.0,4/34,8.69%,NAT10;NOB1;WDR46;PWP2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.26282660048811074,0.6212516189674593,0.8936484490398818,1.0,1.0,3/27,7.97%,RIMS3;SYT10;ARHGAP17
prerank,nucleosome assembly (GO:0006334),0.25732819656288114,0.6212364668309809,0.8954802259887006,1.0,1.0,10/31,19.30%,CHAF1B;SOX9;HAT1;SMARCA5;CABIN1;IPO4;RSF1;NAP1L4;NAP1L2;BRD2
prerank,sensory perception of smell (GO:0007608),0.30637289693768843,0.6212262842887568,0.8720292504570384,1.0,1.0,1/11,4.63%,SYT10
prerank,regulation of oxidoreductase activity (GO:0051341),0.29382336137262466,0.6210227215428352,0.8783783783783784,1.0,1.0,5/13,21.24%,SIRT4;MT3;HDAC6;ABL1;OXA1L
prerank,RNA transport (GO:0050658),0.22874125888335106,0.6209659680340915,0.9416058394160584,1.0,1.0,16/71,15.79%,NUP62;ATXN2;U2AF2;SRSF4;ZC3H11A;NUP153;RBM8A;U2AF1;KIF5C;THOC7;SRRM1;XPO5;ZFP36L1;EIF4E;FLOT1;RFTN1
prerank,cellular response to sterol (GO:0036315),0.2985297758498379,0.6207087343542362,0.8726003490401396,1.0,1.0,1/13,2.57%,RORA
prerank,dendritic spine morphogenesis (GO:0060997),0.2964296250384698,0.6206816449446583,0.8776859504132232,1.0,1.0,3/15,15.34%,DOCK10;EPHB1;PTEN
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.3103726035726611,0.6205758785814018,0.8831858407079646,1.0,1.0,2/10,8.81%,CAV1;IMPACT
prerank,retinol metabolic process (GO:0042572),-0.24009364959482898,-0.6187798072183396,0.9219858156028369,0.9935504529890812,1.0,2/14,8.42%,RBP4;CYP1B1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.3113738314071126,0.618265292990954,0.8783068783068783,1.0,1.0,2/10,10.07%,LIN7C;ARHGAP12
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3089123200195492,0.6180480617600599,0.8869257950530035,1.0,1.0,1/11,4.25%,PARN
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.28204126093784987,0.6176710706072669,0.8729096989966555,1.0,1.0,5/16,17.31%,CIRBP;RBMXL1;RBM3;NUP98;PRDX6
prerank,peptidyl-proline modification (GO:0018208),0.26865242478834633,0.6174412425640817,0.8893939393939394,1.0,1.0,7/25,17.34%,P3H2;PIN1;PPIL1;PPIE;PPWD1;PPIL3;FKBP4
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.22781843089520426,-0.6173826243488963,0.924812030075188,0.993614669321007,1.0,8/17,41.90%,IK;BUB3;ZWILCH;BOD1;KNL1;TTK;SPDL1;CENPA
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.26390807612163203,-0.6170873775758782,0.9379310344827586,0.9930734732179556,1.0,2/10,13.83%,IL33;KDR
prerank,DNA catabolic process (GO:0006308),0.294013515267612,0.6165436421435962,0.8606403013182674,1.0,1.0,2/11,13.68%,REXO4;DNASE1L1
prerank,response to ionizing radiation (GO:0010212),0.22347455043160974,0.6164423194609597,0.9423312883435583,1.0,1.0,18/70,19.76%,ANXA1;NET1;RAD51AP1;TP53;RAD9A;BRSK1;PAXIP1;RHNO1;CLOCK;MTA1;INTS7;BABAM1;MSH2;INO80;USP28;MEN1;SWI5;RAD9B
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2419866849945042,-0.6162103930791923,0.9535962877030162,0.9928641920630281,1.0,10/14,38.16%,ZBTB8OS;TSEN34;CPSF4;CSTF2;CPSF1;CLP1;TRPT1;TSEN54;TSEN15;RTRAF
prerank,protein acetylation (GO:0006473),0.25986335060483073,0.6159907165382833,0.9048295454545454,1.0,1.0,5/30,14.98%,NAT10;MAPT;HAT1;CLOCK;NAA35
prerank,cell proliferation in forebrain (GO:0021846),0.3090947953788877,0.6158079821662514,0.8501805054151624,1.0,1.0,3/10,13.55%,AKNA;CEP120;NUMBL
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.18823966984144969,-0.6157746553147723,0.9516728624535316,0.9923877464541675,1.0,21/36,44.97%,WNT5A;PRKN;IRGM;PARP14;NLRC5;CASP4;AGPAT1;LAPTM5;AGPAT2;EDN1;TRIM6;HSPA1A;ZBP1;TXK;CASP1;IL7;CXCR4;CD300LF;PARP9;FADD;C1QTNF4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2157671320067341,0.6154271355882954,0.9612220916568742,1.0,1.0,27/100,20.15%,KLHL40;SOCS5;PABIR1;GABARAP;TAF1;RNF180;GNA12;SIRT2;EIF3H;CLU;BAG2;CSNK1E;LRRK2;DVL1;UFL1;CSNK1A1;HSPBP1;XPO1;MAP1A;RCHY1;PIAS1;N4BP1;DESI1;UCHL5;SUMO1;FHIT;FOXF2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.23884721661299024,0.6151789013417855,0.9106382978723404,1.0,1.0,4/37,9.57%,MYD88;ALOX5;PPARA;HIF1A
prerank,regulation of keratinocyte proliferation (GO:0010837),0.26979996146746427,0.6150743184783383,0.8975903614457831,1.0,1.0,5/22,13.32%,AREG;MED1;SNAI2;ZFP36L1;FGF10
prerank,I-kappaB phosphorylation (GO:0007252),-0.2595456100315389,-0.614631790644926,0.9235807860262009,0.9923268041391421,1.0,4/10,26.16%,CHUK;TLR3;PRDX4;ERC1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.19650985673621185,-0.6146197477282159,0.9746031746031746,0.9915973873172705,1.0,6/28,20.24%,ARHGAP28;RASA1;PFN2;PFN1;DBN1;GBA2
prerank,regulation of chromosome segregation (GO:0051983),-0.23434675971779373,-0.6144009279187747,0.9318181818181818,0.9909929565548184,1.0,4/16,25.49%,PUM1;SMC5;CSNK2A2;CSNK2A1
prerank,nuclear migration (GO:0007097),0.2960370486148277,0.6143319737333445,0.8629173989455184,1.0,1.0,4/13,12.24%,SYNE2;SUN2;FBXW11;CEP120
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.24618901388724135,0.6135529442095323,0.9159663865546218,1.0,1.0,5/33,13.67%,DUSP3;RELA;CD300A;NECTIN2;DGKZ
prerank,microglial cell activation (GO:0001774),-0.20889104691566013,-0.613529919532302,0.955026455026455,0.990740956644148,1.0,4/21,16.89%,APP;CX3CL1;SNCA;GRN
prerank,TOR signaling (GO:0031929),-0.20152932765599874,-0.6135271404519541,0.9603399433427762,0.9900134558068965,1.0,7/26,21.15%,SMG1;NPRL3;PRR5L;AKT1;RPS6KB2;MAPKAP1;SYAP1
prerank,serine family amino acid metabolic process (GO:0009069),0.28494292011223826,0.6132574311913753,0.8703703703703703,1.0,1.0,2/16,9.29%,SEPHS2;SEPSECS
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.2649485063588093,-0.6130772387083895,0.9359823399558499,0.9895394853057286,1.0,5/10,32.45%,GNB5;FMR1;DRD2;CALM3;CBARP
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2500263755590218,0.6123483734546172,0.9310829817158931,1.0,1.0,7/33,13.95%,FXN;MAPT;FZD9;OPA1;CLU;MUL1;ADCK1
prerank,Golgi to lysosome transport (GO:0090160),0.3104933240699108,0.6119276360658232,0.8804347826086957,1.0,1.0,2/11,9.53%,SORT1;ANKFY1
prerank,positive regulation of lipid storage (GO:0010884),0.27090316350262783,0.6102852436997908,0.897239263803681,1.0,1.0,3/21,13.42%,LPL;SREBF2;OSBPL11
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.2631433356651758,-0.610224559923637,0.9188034188034188,0.99046667382919,1.0,4/10,35.65%,DNAJB2;DNAJA4;DNAJB1;HSPA1A
prerank,interstrand cross-link repair (GO:0036297),0.2306740314409685,0.6097848045694451,0.9374185136897001,1.0,1.0,8/53,12.17%,RAD51AP2;RAD51AP1;FAAP24;SLX4;USP1;FANCB;FAAP100;FANCE
prerank,glutamine family amino acid metabolic process (GO:0009064),0.24997626533965647,0.6097227613405702,0.9142053445850914,1.0,1.0,7/33,13.71%,RIMKLA;ART4;GOT1;GOT2;GLS2;GLS;SIRT4
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.25605877918310094,0.6096019841742143,0.9160419790104948,1.0,1.0,8/29,18.18%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,CENP-A containing chromatin organization (GO:0061641),0.25605877918310094,0.6096019841742143,0.9160419790104948,1.0,1.0,8/29,18.18%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,phosphate ion transport (GO:0006817),0.2830939675489571,0.6095523872593606,0.8945686900958466,1.0,1.0,2/16,9.10%,SLC20A2;XPR1
prerank,regulation of protein transport (GO:0051223),0.25001728965623693,0.609198295180075,0.9107692307692308,1.0,1.0,3/27,12.06%,LCP1;PTPN1;DNAJC1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3063456013357037,0.6086086456789799,0.8747763864042933,1.0,1.0,1/11,4.50%,BCL2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2243429676160166,0.6085850761279362,0.9501216545012166,1.0,1.0,9/72,11.45%,POLR2L;POLR2I;GTF2H4;POLR2G;ERCC6;PPIE;CDK7;POLD1;COPS8
prerank,RNA 3'-end processing (GO:0031123),0.2218505136066853,0.6083361974953677,0.9441069258809235,1.0,1.0,11/69,12.22%,WDR33;PCF11;U2AF2;SRSF4;PAPOLA;TENT4A;ZC3H11A;RBM8A;U2AF1;THOC7;SRRM1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2674190520939891,0.608312642494763,0.896551724137931,1.0,1.0,1/21,3.22%,HK2
prerank,mRNA export from nucleus (GO:0006406),0.21499310300050553,0.6081914390134517,0.9598623853211009,1.0,1.0,21/102,16.20%,NUP62;WDR33;UPF1;U2AF2;SRSF4;SEC13;ZC3H11A;NUP153;MCM3AP;RBM8A;U2AF1;NUP107;AAAS;DDX25;THOC7;SRRM1;NUP98;NUP37;EIF4E;NUP210;FIP1L1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2239981071746205,0.6080494989128196,0.943558282208589,1.0,1.0,20/73,22.84%,POLR2L;ACTB;MYBBP1A;ERCC6;PRMT7;POLR1E;POLR1H;SMARCA5;SF3B1;MTA1;TFAP2C;TAF1A;HDAC6;DNMT3A;MYO1C;H3-3A;EZH2;CTCF;RBBP7;KAT2B
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.28606520547782716,0.6077179670358211,0.8896434634974533,1.0,1.0,1/15,2.95%,FAM83D
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.25608620421044326,0.6072872237355443,0.9121212121212121,1.0,1.0,3/27,7.81%,PARN;PCF11;DICER1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2396662910489458,0.6067677355088085,0.914804469273743,1.0,1.0,10/38,18.00%,PHLDA3;PPARA;EPHA2;THEM4;GPER1;MUL1;PLEKHA1;PTEN;PPP2R5C;DDIT3
prerank,modulation by host of symbiont process (GO:0051851),-0.188803519542143,-0.6066331621189587,0.9787985865724381,0.9917248746710243,1.0,6/31,15.29%,LEF1;NAPEPLD;SNW1;TARDBP;EP300;CHD1
prerank,negative regulation of cell death (GO:0060548),0.21572664960076168,0.6061126739860688,0.9681603773584906,1.0,1.0,9/88,8.81%,CCN1;FERMT2;NUP62;INPP5A;CD200R1;CD200;PPARGC1A;ADNP2;IMPACT
prerank,defense response to bacterium (GO:0042742),0.2095822430614978,0.6057386287068184,0.9695945945945946,1.0,1.0,18/105,17.91%,MYD88;DMBT1;RARRES2;LYST;MBL2;ADAM17;LPO;PRKCD;GBP2;DROSHA;CFP;ADGRB1;RNASE3;MR1;MPEG1;S100A8;S100A9;ISG15
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2311855128748825,0.6057063008558973,0.944516129032258,1.0,1.0,6/54,9.57%,RPL3L;RRP15;RPF1;NLE1;MDN1;RPL5
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.17378629114632232,-0.6050891243541601,0.9802371541501976,0.9918260986952703,1.0,22/46,40.56%,FBXO7;TIMM44;DNAJC19;FIS1;AKT1;TOMM34;AIFM1;TIMM17B;HSPD1;TOMM70;TIMM21;TIMM23;TIMM10B;TIMM8B;GRPEL1;DNLZ;TOMM40L;TOMM40;RALA;TIMM50;GRPEL2;TIMM10
prerank,spliceosomal snRNP assembly (GO:0000387),-0.17983514036429255,-0.6050698059195888,0.9934426229508196,0.9911142645771341,1.0,14/38,30.46%,GEMIN8;SART3;SNRPD1;GEMIN7;SMN1;PRPF19;LSM2;AAR2;PRPF31;PRPF8;SRSF12;PRPF3;SART1;DDX20
prerank,regulation of interferon-alpha production (GO:0032647),0.26169911708402016,0.6044728899878293,0.9062980030721967,1.0,1.0,9/23,25.10%,PTPRS;HAVCR2;STAT1;DHX9;IRF3;TLR7;TBK1;SETD2;IFIH1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.20449346662109852,0.6037367556637456,0.9872476089266737,1.0,1.0,57/184,23.06%,DYNLL1;CEP41;HAUS8;CEP290;ANAPC10;PSMC6;TPX2;UBE2E1;ANLN;PSME4;CEP192;SIRT2;CENPE;PSMB1;PSMD5;UBE2D1;DYNC1I2;NEDD1;PSMB2;CLASP1;CEP72;ZFP36L1;CEP43;CSNK1E;DCTN3;HAUS7;HAUS2;PSMB7;PSMD3;PRKACA;FBXO5;PLK4;PSMA2;INO80;PSMD14;ANAPC16;DCTN1;ANAPC5;HAUS4;ANAPC11;CEP135;RPS27A;CKAP5;ACTR1A;SFI1;MAPRE1;ODF2;ZFP36L2;PPP2R1A;ZW10;NINL;TUBA4A;CEP63;YWHAG;PSMA7;CDC14A;NDE1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2256103363932913,0.6032843641642414,0.9386422976501305,1.0,1.0,10/53,16.90%,OAZ2;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,pre-replicative complex assembly (GO:0036388),-0.16740762061984713,-0.6030568099907002,0.9949494949494949,0.9914156360312388,1.0,24/64,32.65%,PSMD7;PSMD9;PSMD13;PSMB3;ORC6;UBC;ORC5;PSMC5;PSMA5;PSMA1;PSMC2;PSME3;UBB;PSMC4;PSMB6;ORC4;PSMB10;PSMA4;PSME1;ORC1;PSMF1;PSMB9;PSME2;PSMA8
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.23053001709312732,-0.6025640878974153,0.9455782312925171,0.9909504694921413,1.0,2/15,8.95%,LDLR;SIK1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2482623220969345,0.602094093778824,0.9170243204577968,1.0,1.0,1/30,1.15%,KLHL40
prerank,phosphate ion transmembrane transport (GO:0035435),0.296707447087156,0.6019068847447687,0.8926746166950597,1.0,1.0,2/12,9.10%,SLC20A2;XPR1
prerank,positive regulation of chromatin organization (GO:1905269),-0.24815205835740517,-0.6006782877634684,0.9380733944954128,0.9911827072507705,1.0,6/12,33.67%,TERF2IP;MIER1;TAL1;TINF2;ATRX;ACD
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.20887605572898657,-0.6003879545728438,0.9555555555555556,0.990616109195523,1.0,5/21,18.12%,IK;KLHL22;BUB3;MAD1L1;ATM
prerank,dopaminergic neuron differentiation (GO:0071542),0.27311333667089577,0.5994694769848384,0.9033816425120773,1.0,1.0,2/19,9.09%,VEGFA;NR4A2
prerank,response to light stimulus (GO:0009416),0.22125586328309052,0.5987365832441792,0.9512195121951219,1.0,1.0,12/55,18.63%,MAP4K3;CIRBP;CPT1B;ERCC6;BRSK1;USP1;POLD1;ZRANB3;CLOCK;SPRTN;UBE2A;MEN1
prerank,negative regulation of B cell activation (GO:0050869),0.26186671640797526,0.5985246398920084,0.9059011164274322,1.0,1.0,4/21,13.52%,CD300A;SAMSN1;TNFRSF21;FOXJ1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2152981698611831,0.5980824479440738,0.9656804733727811,1.0,1.0,18/87,17.48%,CDK6;FHL1;JADE1;PSMC6;PSME4;PSMB1;PSMD5;RB1;PSMB2;ZFP36L1;PSMB7;PSMD3;FBXO5;PTEN;PSMA2;CDK2AP2;PSMD14;BRD7
prerank,regulation of intracellular pH (GO:0051453),0.24320169059253388,0.5979341801976074,0.9345403899721448,1.0,1.0,4/34,8.16%,SLC4A8;SLC4A3;SLC4A7;SLC9A8
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2636026764569308,0.5976385170948815,0.9089456869009584,1.0,1.0,6/20,16.69%,BBS12;LONP1;CLU;HOPX;PTGES3L;NDUFAF1
prerank,receptor metabolic process (GO:0043112),0.2259872644395896,0.597317096259611,0.9514687100893997,1.0,1.0,5/53,7.15%,CD36;ITGB1;CAV1;NEDD4;RAMP1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.2627215275274364,-0.5970885615616351,0.9359267734553776,0.991488127110748,1.0,5/10,36.82%,KDM1A;ATRX;JARID2;BRCA1;DNMT3B
prerank,innate immune response in mucosa (GO:0002227),-0.25387454613037097,-0.5967097535129294,0.9353348729792148,0.9909418742553319,1.0,1/10,9.13%,DEFA6
prerank,regulation of isotype switching (GO:0045191),0.2782669967996356,0.5964920037144852,0.9044368600682594,1.0,1.0,4/14,16.16%,PAXIP1;RIF1;KMT5B;MAD2L2
prerank,chromatin remodeling (GO:0006338),0.21176770338074974,0.5963891606770614,0.9628339140534262,1.0,1.0,16/100,13.22%,SMARCD3;CHRAC1;ARID1A;ACTB;SUV39H2;SMARCB1;INO80C;ERCC6;SOX9;RB1;BAZ2A;ZBTB7A;HNRNPC;RUVBL1;SMARCA5;CHD4
prerank,regulation of cell division (GO:0051302),0.21638135939918496,0.5963169151150653,0.9658952496954933,1.0,1.0,10/72,13.34%,FGF1;EFHC1;PIN1;CALM1;INSC;SIRT2;RAB11FIP3;RAB11FIP4;HTR2B;PIK3C3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.2495903502941193,-0.5960253209576504,0.9577464788732394,0.9905276380915837,1.0,3/11,19.66%,NF2;HGS;BCL3
prerank,endosome organization (GO:0007032),0.23827634573552647,0.5960058989484184,0.9275956284153005,1.0,1.0,7/41,12.41%,HOOK2;CORO1C;HOOK1;CHMP2B;USP50;AKTIP;PLEKHJ1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.23201142049153065,-0.5959206221147549,0.9451073985680191,0.9898500468682006,1.0,9/14,36.79%,ENPP3;ENPP1;ITPA;AK4;SMPDL3A;AK1;NME2;AK3;AK5
prerank,nuclear pore complex assembly (GO:0051292),0.2986625112338648,0.5957344539158727,0.8930581613508443,1.0,1.0,3/10,14.02%,NUP153;NUP107;NUP98
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.22532467850830404,0.5956231820335315,0.9511568123393316,1.0,1.0,15/51,19.61%,CHMP4C;SEC13;IST1;SIRT2;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,mitotic nuclear membrane organization (GO:0101024),0.22532467850830404,0.5956231820335315,0.9511568123393316,1.0,1.0,15/51,19.61%,CHMP4C;SEC13;IST1;SIRT2;NUP107;CHMP2B;CHMP2A;NUP98;NUP37;VPS4A;LMNA;SUMO1;UBE2I;NUP160;NUP133
prerank,transferrin transport (GO:0033572),0.24629092159920934,0.5954798764802679,0.9103840682788051,1.0,1.0,8/33,19.27%,ATP6V1H;ATP6V0A2;ARHGAP1;ATP6V1C1;ATP6V0D2;DNM2;ATP6V0C;CLTC
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24395212195446278,0.5952737392062689,0.9245283018867925,1.0,1.0,5/31,16.16%,IL2;PAXIP1;RIF1;KMT5B;MAD2L2
prerank,positive regulation of histone acetylation (GO:0035066),0.25816084974154213,0.5952221547844018,0.9122257053291536,1.0,1.0,4/23,9.41%,SMARCB1;PPARGC1A;KAT7;PAXIP1
prerank,T cell differentiation (GO:0030217),0.23416130048804035,0.593686789115206,0.93234100135318,1.0,1.0,6/40,13.20%,ANXA1;IL2;ADAM17;LMBR1L;RHOH;ZFP36L1
prerank,positive regulation of transport (GO:0051050),0.21099141359419693,0.5931214469572852,0.969047619047619,1.0,1.0,5/85,5.85%,MERTK;KCTD7;ANXA1;ACTB;CBLL1
prerank,autophagosome organization (GO:1905037),0.2292116775474122,0.592764332376353,0.9384816753926701,1.0,1.0,8/50,13.34%,ATP2A2;ATG16L2;ATG7;GABARAP;NSFL1C;STX12;WDR45;PIK3C3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2320581032973573,0.5927008838335606,0.9424157303370787,1.0,1.0,9/40,15.12%,MAPT;WRNIP1;USP1;PARG;PRKCD;NSMCE4A;MCL1;FEM1B;FBXO5
prerank,determination of bilateral symmetry (GO:0009855),0.256944769281787,0.5926429429359215,0.9257575757575758,1.0,1.0,5/24,17.66%,KIF3B;DNAH11;CITED2;FOXJ1;GALNT11
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.28558420149150937,0.5926388702750609,0.8984238178633975,1.0,1.0,2/12,8.98%,AR;GSTP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.29332046322495753,0.5924255784884662,0.8894736842105263,1.0,1.0,1/12,4.50%,BCL2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.2723329739749389,0.5922595957118022,0.9014336917562724,1.0,1.0,4/15,15.51%,EHD2;CD53;ADGRB1;FLOT1
prerank,chromatin remodeling at centromere (GO:0031055),0.24354065794825153,0.5922518214936227,0.9253294289897511,1.0,1.0,8/31,18.18%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,microtubule depolymerization (GO:0007019),0.264483366184043,0.5913091910369797,0.9,1.0,1.0,5/17,20.55%,KIF2A;KIF18A;STMN2;CKAP5;STMN3
prerank,nuclear body organization (GO:0030575),0.2816615421709976,0.5907459662218517,0.9142367066895368,1.0,1.0,7/12,23.05%,USP50;SRPK2;HIPK2;HABP4;SERBP1;ETS1;ZPR1
prerank,intracellular protein transmembrane transport (GO:0065002),0.22788897473290956,0.5905371155870958,0.9364864864864865,1.0,1.0,3/42,5.39%,ZFAND2B;RTN2;PEX2
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.22278240737746768,0.5905342612537469,0.9450980392156862,1.0,1.0,10/56,13.92%,ROCK1;EFHC1;SPIRE1;ANLN;IST1;SNX18;ROCK2;SNX9;SON;DCTN3
prerank,chromatin assembly (GO:0031497),0.23581380216283454,0.5903155029563457,0.9235924932975871,1.0,1.0,10/38,19.30%,H1-0;CHAF1B;TP53;SOX9;SMARCA5;CDAN1;RSF1;NAP1L4;NAP1L2;BRD2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.23342625045423737,-0.5896855042834823,0.9394618834080718,0.992067176407229,1.0,6/12,35.54%,ESR1;TGFB1;ZC3H12A;ZC3H10;NCOR1;BCDIN3D
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.23884187191059766,0.5894200210378191,0.9432918395573997,1.0,1.0,5/34,11.24%,PDGFB;NUP62;PDGFRB;RB1;LRP5
prerank,positive regulation of protein deacetylation (GO:0090312),-0.22622809029514576,-0.5893156553868376,0.9595238095238096,0.9915066903442056,1.0,8/14,38.79%,AKAP8;AKAP8L;ZBTB7B;SAP30BP;APLNR;BRMS1;ING2;FNTA
prerank,response to UV (GO:0009411),0.20592291410986152,0.5892178859779432,0.9745958429561201,1.0,1.0,23/95,18.98%,MAP4K3;TAF1;TP53;PARP1;CIRBP;NEDD4;ERCC6;RELA;CCND1;BRSK1;USP1;RHNO1;POLD1;PRKCD;ZRANB3;MSH2;INO80;SPRTN;EIF2AK4;UBE2A;USP28;MEN1;N4BP1
prerank,synaptonemal complex assembly (GO:0007130),0.2732295328980412,0.5882876452628655,0.8961474036850922,1.0,1.0,15/15,72.70%,SYCP2;RAD21;SYCE3;SYCE1;SYCP1;HORMAD1;RAD21L1;STAG3;TEX12;SYCE2;TRIP13;REC8;BAG6;TEX11;P3H4
prerank,synaptonemal complex organization (GO:0070193),0.2732295328980412,0.5882876452628655,0.8961474036850922,1.0,1.0,15/15,72.70%,SYCP2;RAD21;SYCE3;SYCE1;SYCP1;HORMAD1;RAD21L1;STAG3;TEX12;SYCE2;TRIP13;REC8;BAG6;TEX11;P3H4
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.25705734261541646,0.5879519311879605,0.9102990033222591,1.0,1.0,4/19,15.30%,RAPSN;CHRNA7;CHRFAM7A;CHRNA4
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.24102272293105048,-0.5873690962717114,0.9463087248322147,0.9917440109373059,1.0,5/12,32.49%,UPP2;DHODH;UMPS;CDA;CAD
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.21631339926656223,-0.5872680591257018,0.9391891891891891,0.9910615254229687,1.0,1/17,1.61%,CADM1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.253401752684732,-0.5872039032072598,0.9247058823529412,0.9903757631354477,1.0,1/10,2.80%,PRKCH
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.24859740673991226,-0.5869633984485104,0.9281183932346723,0.9897780316774057,1.0,2/10,11.67%,LGALS9;LYN
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2288411232187988,-0.5863168629141051,0.9494252873563218,0.989355110136933,1.0,6/13,31.93%,HSPA5;NCK1;DNAJB9;RACK1;PPP1R15B;ATF6B
prerank,regulation of cellular protein catabolic process (GO:1903362),0.2595687155154634,0.585717523907298,0.9107142857142857,1.0,1.0,5/18,17.25%,DAB2IP;AMER1;VGLL4;VPS35;FAF1
prerank,centromere complex assembly (GO:0034508),0.23358071193739763,0.5853835306989613,0.9261363636363636,1.0,1.0,9/36,18.18%,CENPP;CENPO;CENPE;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.260245519156166,0.584876971155541,0.9183359013867488,1.0,1.0,4/21,10.58%,MED1;MED12;PAXIP1;MED14
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.21984436049921663,-0.5834277383933315,0.9547511312217195,0.9899620629761701,1.0,1/16,1.61%,CADM1
prerank,positive regulation of isotype switching (GO:0045830),0.26780356132645355,0.5833987082912792,0.9271186440677966,1.0,1.0,4/15,16.16%,PAXIP1;RIF1;KMT5B;MAD2L2
prerank,rRNA modification (GO:0000154),0.25755076228709334,0.5828901615210289,0.9158878504672897,1.0,1.0,3/21,11.53%,NAT10;TFB2M;ZCCHC4
prerank,innate immune response (GO:0045087),0.19191570974755265,0.5818781421970989,0.9927536231884058,1.0,1.0,14/217,10.10%,NCF2;MYD88;FRK;ATAD3A;MFHAS1;DMBT1;RARRES2;MBL2;TIFA;RELA;TRIM68;SLA;MASP2;ZDHHC1
prerank,protein alkylation (GO:0008213),0.2555482689068506,0.5806890783287394,0.9396825396825397,1.0,1.0,9/22,19.73%,METTL22;GSPT1;VCPKMT;EEF1AKMT2;ETF1;FAM98B;PCMT1;SNRPD3;PRMT1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.28615097567725045,0.5804503455720292,0.926056338028169,1.0,1.0,3/10,14.40%,BCL2;FZD9;LRRK2
prerank,regulation of phosphatase activity (GO:0010921),0.24525379752610585,0.5795841962699563,0.9213313161875946,1.0,1.0,1/24,2.47%,PPP1R26
prerank,cellular response to chemokine (GO:1990869),0.22917769120031362,0.579517967786244,0.9519890260631001,1.0,1.0,2/46,3.64%,DOCK8;CCL5
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.20027307365772404,-0.5794400892899638,0.9708994708994709,0.9909836280184349,1.0,3/20,12.08%,ARRB1;TADA2A;SOX4
prerank,apoptotic nuclear changes (GO:0030262),0.24838654392121476,0.5792688968742259,0.9188361408882083,1.0,1.0,4/24,10.84%,H1-0;DICER1;DEDD2;GPER1
prerank,intracellular pH reduction (GO:0051452),0.2383443338404687,0.5782871526626813,0.9224011713030746,1.0,1.0,13/33,25.65%,ATP6V1H;ATP6V0A2;ATP6V1C1;ATP6V0D2;RAB38;ATP6V0C;DMXL1;ATP6V1F;ATP6V0E1;ATP6V1B2;ATP6V1G2;ATP6V0A1;RAB7A
prerank,lipoxygenase pathway (GO:0019372),0.27135607294772585,0.5782785160162911,0.9105263157894737,1.0,1.0,1/14,4.29%,ALOX5
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2889800627321297,0.5744746073997244,0.9137931034482759,1.0,1.0,3/10,18.78%,ATP5MC1;ATP5MG;ATP5F1D
prerank,protein modification by small protein removal (GO:0070646),0.18935907863180756,0.5738971039163605,0.9969325153374233,1.0,1.0,61/252,19.33%,CCNA2;ADRM1;MCRS1;USP2;ACTB;ASXL1;MBD5;PSMC6;TP53;AR;TRAF3;INO80C;OTUD6B;TNIP1;OTUD7A;USP1;HIF1A;PSME4;PSMB1;PSMD5;UBE2D1;STAM2;NFRKB;OTUD4;COPS8;USP13;RUVBL1;USP50;PSMB2;WDR20;SENP6;USP35;USP20;JOSD1;USP30;PSMB7;PSMD3;USP42;COPS4;STAM;USP4;PTEN;BABAM1;ABRAXAS2;RHOT1;PSMA2;INO80;PSMD14;USP36;MBD6;TADA3;USP28;COPS6;INO80D;ACTL6A;DESI2;DESI1;UCHL5;RPS27A;SENP2;SMAD1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.24695867207672847,-0.5731881584439036,0.9445628997867804,0.9927992124499327,1.0,4/10,24.69%,MTMR4;DNAJC19;MFSD2A;MTMR2
prerank,rRNA metabolic process (GO:0016072),0.19473787947939503,0.5715722133412533,0.9913700107874865,1.0,1.0,36/160,20.30%,NOL6;UTP14A;NOB1;MAPT;WDR46;RPL8;RPF1;WDR36;MDN1;HELQ;PWP2;RPL5;DEDD2;DIS3L;NOP58;TEX10;RPL15;IMP4;LAS1L;PELP1;RPL22;RPL31;DDX49;RPS6;BOP1;RCL1;PDCD11;RPS17;MPHOSPH6;EXOSC10;NIFK;RPS14;EXOSC8;DDX10;WDR43;DHX37
prerank,ceramide catabolic process (GO:0046514),0.2637510835349142,0.5714743890331797,0.9074380165289256,1.0,1.0,3/14,12.90%,NEU3;GLA;GM2A
prerank,regulation of cell cycle process (GO:0010564),0.1981957366252694,0.5714677362553716,0.9885321100917431,1.0,1.0,20/104,16.68%,TIPIN;PIN1;YTHDF2;CALM1;CUL9;CHEK1;SOX9;DAPK3;RAB11FIP3;RAB11FIP4;GPER1;CEP85;KIF20B;RMI2;PIK3C3;KNSTRN;FBXO5;CAV2;PLK4;MAP9
prerank,cellular response to oxygen levels (GO:0071453),-0.24776309438676997,-0.5710821840117773,0.9605263157894737,0.9929279490888278,1.0,5/10,27.12%,ATP6AP1;ATP6V1G1;PICK1;ATP6V0D1;TMEM199
prerank,regulation of aerobic respiration (GO:1903715),0.2648689575899201,0.5709920306378521,0.9089376053962901,1.0,1.0,1/15,4.78%,COX7A2L
prerank,glutamate metabolic process (GO:0006536),0.2589244653494591,0.5708433521617192,0.92776886035313,1.0,1.0,4/19,11.00%,GOT1;GOT2;GLS2;GLS
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.2469403005481629,0.5699777760822841,0.937592867756315,1.0,1.0,6/25,14.55%,KANK1;YAP1;PRKCD;TCHP;CAPZB;ARHGAP24
prerank,serine family amino acid catabolic process (GO:0009071),0.282730416188624,0.5690045811460586,0.9009174311926605,1.0,1.0,1/10,6.00%,DLD
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.20285699484569636,0.5684338103512528,0.9873125720876585,1.0,1.0,17/88,17.82%,FBXL22;CUL2;PSMC6;FBXW7;FBXL18;PSME4;FBXO6;PSMB1;PSMD5;FBXW11;PSMB2;PSMB7;PSMD3;PSMA2;CCNF;PSMD14;CUL5
prerank,positive regulation of nervous system process (GO:0031646),0.2558105979986681,0.5671338127905472,0.9083469721767594,1.0,1.0,3/18,11.92%,TPPP;DICER1;ATPSCKMT
prerank,regulation of mitotic cell cycle (GO:0007346),0.19261709933668394,0.5666103412464746,0.9968354430379747,1.0,1.0,35/171,17.95%,BTG2;EIF4EBP1;USP2;ANAPC10;PSMC6;DUSP3;PIN1;CUL9;HECA;BTG1;DAPK3;UBE2E1;PKN2;PSME4;HNRNPU;PSMB1;PSMD5;BRINP1;UBE2D1;RB1;TRIM35;PSMB2;KIF20B;PSMB7;PSMD3;EIF4E;PRKCA;FBXO5;CAV2;PSMA2;TTC28;PSMD14;ANAPC16;ANAPC5;BRINP2
prerank,response to axon injury (GO:0048678),-0.20458892220916383,-0.5665068449092444,0.9763157894736842,0.9939680888801552,1.0,11/18,42.80%,APOD;MAPK8IP3;DPYSL3;FLRT3;MORN4;MTR;TYROBP;P2RY12;SOD1;TREM2;DHFR
prerank,macromolecule catabolic process (GO:0009057),0.24087662801120666,0.5660874413021032,0.9516380655226209,1.0,1.0,2/26,7.03%,CLN5;NEDD4
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2289873239259532,0.56578901705707,0.9569444444444445,1.0,1.0,4/36,11.90%,KLHL40;F8A1;PSME3IP1;EIF3H
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.24410433430180392,0.5657791600295546,0.9469578783151326,1.0,1.0,2/23,7.02%,SAG;CALM1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.234947359935241,0.5646911385657379,0.9441860465116279,1.0,1.0,3/26,13.15%,LARGE1;TNIP1;ST3GAL2
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.21177160929044703,-0.5646894217156596,0.9639423076923077,0.9939022320937176,1.0,14/16,59.17%,CD274;TYROBP;TRIB2;JAK3;FCGR2B;DLL1;AGER;LILRB1;VSIR;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,regulation of sister chromatid cohesion (GO:0007063),0.2730023066615645,0.5646290802205122,0.9035532994923858,1.0,1.0,4/12,22.00%,RB1;RAD21;WAPL;CTCF
prerank,microtubule bundle formation (GO:0001578),0.21825961451914141,0.563961210417775,0.9682320441988951,1.0,1.0,8/42,15.58%,RSPH1;TPPP;TOGARAM1;AAAS;CLASP1;FOXJ1;MTCL1;CCDC66
prerank,regulation of synapse maturation (GO:0090128),-0.24409690469889764,-0.5636114708430316,0.9543568464730291,0.9935972377257472,1.0,4/10,27.91%,NRXN1;ARHGEF15;YWHAZ;RELN
prerank,ncRNA catabolic process (GO:0034661),0.23641200514948024,0.563047958068706,0.9416909620991254,1.0,1.0,4/28,10.66%,PARN;DIS3L2;DEDD2;DIS3L
prerank,cilium-dependent cell motility (GO:0060285),0.24581747345598498,0.5621374100745999,0.9338461538461539,1.0,1.0,2/22,6.37%,DNAH17;EFHC1
prerank,regulation of immunoglobulin production (GO:0002637),0.24124031043261143,0.5612080415382673,0.9407176287051482,1.0,1.0,1/23,3.19%,IL2
prerank,motile cilium assembly (GO:0044458),-0.22810308239857457,-0.5609201740921133,0.9494252873563218,0.993864901913614,1.0,2/12,18.73%,CCDC39;E2F4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.20593005640472956,-0.559889163584622,0.958005249343832,0.9935087003322303,1.0,7/17,32.02%,WASF2;ARFIP2;PICK1;ABI2;CTNNA2;ARFIP1;GMFB
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.2740051952622695,0.5596041510941229,0.9138840070298769,1.0,1.0,2/10,14.40%,STK26;LRRK2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.24559603843376265,0.5587716136247393,0.9333333333333333,1.0,1.0,7/21,19.21%,TTC23;STK36;TUBD1;RAB34;KIF7;DLG5;UCHL5
prerank,negative regulation of protein kinase activity (GO:0006469),0.1981329494725106,0.5587538561427117,0.982373678025852,1.0,1.0,15/88,14.51%,SLC8A1;PPM1E;CAV1;DAB2IP;DUSP3;PTPN1;CORO1C;GSTP1;PAK2;RB1;LRP5;CEP85;CEP43;GNAQ;DVL1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.23102393568253116,-0.5583864519193544,0.9662162162162162,0.9933367046524657,1.0,3/11,16.93%,CAT;GPX1;PRDX4
prerank,response to nitric oxide (GO:0071731),0.26937661620742476,0.5582539373187807,0.9200710479573713,1.0,1.0,1/13,3.85%,GUCY1B1
prerank,histone H2A monoubiquitination (GO:0035518),0.25856190300289644,0.5578449909520342,0.939443535188216,1.0,1.0,5/17,19.55%,PCGF6;PCGF5;PCGF3;KDM2B;PCGF2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.25810937818741186,0.5576598608023571,0.9431818181818182,1.0,1.0,5/15,19.07%,RPL5;BAG2;FBXO5;MAD2L2;ABL1
prerank,response to organophosphorus (GO:0046683),-0.2102260413722291,-0.5576584283526161,0.9719387755102041,0.9928638170126375,1.0,5/16,32.28%,DGKQ;TRIM16;TYMS;RFC3;VGF
prerank,DNA metabolic process (GO:0006259),0.18282800180966993,0.5572054633647209,0.9958634953464323,1.0,1.0,41/270,15.30%,HINFP;GMNN;BTG2;MUTYH;GTF2H4;DDX23;RAD51AP1;UPF1;SMARCB1;TERT;PARP1;PRIM2;MBD4;TDP1;CHEK1;REXO4;RAD9A;HUS1B;SLX4;LONP1;UHRF2;PSME4;RIF1;FBXO6;TOP2B;PARG;POLD1;TERF2;POLG;KPNA2;ORC2;NSMCE4A;RMI2;TRIM28;CSNK1E;DNASE1L1;ZRANB3;EXD2;KMT5B;SRPK2;CHRNA4
prerank,positive regulation of cell communication (GO:0010647),-0.17617236767731437,-0.5569544529776141,0.9906542056074766,0.9924059801945595,1.0,7/28,26.31%,SYT1;WLS;RIMS2;CD80;NMU;SOX11;EDN3
prerank,negative regulation of viral process (GO:0048525),0.20871235236848426,0.556652769875268,0.974025974025974,1.0,1.0,13/57,19.46%,CCL5;HEXIM1;MBL2;TNIP1;EIF2AK2;TRIM35;OASL;TRIM28;SRPK2;STAT1;ISG15;N4BP1;ILF3
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.27750473525851826,0.5551467070799129,0.916058394160584,1.0,1.0,3/10,19.53%,NAF1;RUVBL1;ZNHIT6
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.23234078110527864,-0.5537343916218308,0.9533333333333334,0.9927791237281093,1.0,4/11,20.56%,HSPA5;CEBPB;CREB3L1;ATF4
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.22745363582780748,-0.5522824633092123,0.960093896713615,0.9925583467803927,1.0,3/11,20.12%,RBBP4;ASF1A;HIRA
prerank,mitochondrial transport (GO:0006839),0.20704991712162657,0.5516423993818625,0.9694656488549618,1.0,1.0,14/53,22.50%,PMAIP1;BCL2;MFN2;TOMM5;BCAP31;MFF;TOMM7;SLC25A16;TIMM9;TIMM22;OXA1L;GDAP1;TOMM22;STARD3
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.27618120455412676,0.5516316744997534,0.9272727272727272,1.0,1.0,2/10,10.21%,GNE;ST6GAL1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2571562782759918,0.5515725280536727,0.9317803660565723,1.0,1.0,3/16,14.98%,NAA25;NAA20;NAA35
prerank,positive regulation of cellular protein localization (GO:1903829),0.20119597862861044,0.5496981876965232,0.9853836784409257,1.0,1.0,7/69,11.09%,FERMT2;SLC5A3;NUP62;MAPT;YAP1;KAT7;GPD1L
prerank,glial cell development (GO:0021782),0.23492356991335722,0.5493844465738867,0.9486404833836858,1.0,1.0,6/25,17.13%,CDK6;TPPP;NRROS;SOX10;MT3;S100A9
prerank,DNA duplex unwinding (GO:0032508),0.2151485176533503,0.5486998649798966,0.9568062827225131,1.0,1.0,5/50,11.06%,ANXA1;GTF2H4;PARP1;MCMDC2;DDX1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.227397510948894,0.547555144378255,0.9502196193265008,1.0,1.0,3/31,10.20%,ALOX5;MOCS1;SCP2
prerank,GTP metabolic process (GO:0046039),0.25382925866196904,0.5470660670759191,0.9368600682593856,1.0,1.0,3/15,14.40%,ENTPD7;OPA1;LRRK2
prerank,protein targeting to peroxisome (GO:0006625),0.22325449332657524,0.546225210176292,0.9584569732937686,1.0,1.0,11/29,21.72%,PEX2;ATAD1;PEX19;LONP2;ZFAND6;RAB8B;PEX10;PEX26;PEX1;PEX3;GDAP1
prerank,pseudouridine synthesis (GO:0001522),-0.21525674964651142,-0.5458962534633285,0.9681372549019608,0.9938780587894089,1.0,6/13,37.60%,PUS7;PUS3;GAR1;NOP10;PUS1;NHP2
prerank,regulation of rRNA processing (GO:2000232),-0.2009883470559486,-0.5458029019284562,0.9775561097256857,0.993194921522457,1.0,7/16,35.68%,SIRT7;DIMT1;BUD23;HEATR1;RIOK2;NUDT16;TRMT112
prerank,steroid catabolic process (GO:0006706),-0.22919652194187878,-0.5439941868271895,0.9660297239915074,0.9930038004371097,1.0,3/10,34.39%,SPP1;HSD17B11;HSD11B1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.24725061492142558,0.5434661401518758,0.9475357710651828,1.0,1.0,2/17,7.86%,CCL5;TGFB2
prerank,DNA replication (GO:0006260),0.19059883128854746,0.5415480550681198,0.9898190045248869,1.0,1.0,15/105,13.93%,BRIP1;SET;UPF1;TIPIN;WRNIP1;CHEK1;RAD9A;KAT7;RHNO1;POLD1;PTMS;POLG;ORC2;RMI2;NT5M
prerank,regulation of B cell differentiation (GO:0045577),-0.20491377157509455,-0.5411935415210867,0.9875621890547264,0.9930561912631634,1.0,10/17,48.06%,NCKAP1L;PPP2R3C;MMP14;SYK;INHA;BTK;XBP1;SFRP1;IL4I1;IKZF3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.19875957687389167,0.5405503553680927,0.9841269841269841,1.0,1.0,11/62,15.29%,BCL2;ARHGEF2;BCL2L2;OPA1;SNAI2;NDUFS3;RTKN2;CLU;MCL1;LRRK2;URI1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.2501880368845763,0.5389215265611113,0.9409780775716695,1.0,1.0,1/15,4.94%,LNPK
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2438216881497398,0.5382182508546303,0.9383333333333334,1.0,1.0,2/19,8.66%,MTHFD2L;ALDH1L2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.21330603605974902,-0.5376748690799478,0.9682926829268292,0.9933482064912632,1.0,5/13,32.47%,IL18;LAMP1;ZBTB1;AP1G1;TYROBP
prerank,protein deneddylation (GO:0000338),-0.2297553814400088,-0.5376464065419114,0.9635535307517085,0.9926421910542527,1.0,4/10,30.04%,COPS2;COPS7B;TOR1A;GPS1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.22607121226440063,0.5376102411382132,0.96274217585693,1.0,1.0,5/26,17.37%,MAPT;TOGARAM1;CLASP1;STMN2;DCTN1
prerank,mitotic cytokinesis (GO:0000281),0.2073602736986725,0.5368612255443617,0.9742547425474255,1.0,1.0,7/47,13.64%,ROCK1;EFHC1;ANLN;SNX18;ROCK2;SNX9;SON
prerank,central nervous system neuron differentiation (GO:0021953),0.21708415914422502,0.5353306528319005,0.9614285714285714,1.0,1.0,8/33,19.41%,MAPT;NR4A2;FAIM2;SIN3A;RYK;NPY;MDGA1;AGTPBP1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2619125260523373,0.5345783623181605,0.9559082892416225,1.0,1.0,2/12,9.70%,HUS1B;STK33
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.21591356484252255,0.5331804682021006,0.9633802816901409,1.0,1.0,4/35,9.78%,CCL5;CAV1;IL10RA;CRLF3
prerank,mRNA modification (GO:0016556),0.23117954665895452,0.532696128834298,0.9648854961832061,1.0,1.0,6/22,19.04%,TRMT10C;CBLL1;NSUN2;TRUB1;TRUB2;TRMT6
prerank,ribosome biogenesis (GO:0042254),0.1794155815337198,0.5324360258877534,1.0,1.0,1.0,42/187,20.44%,NOL6;MRPL36;UTP14A;NOB1;WDR46;RPL8;RPF1;ABCE1;WDR36;MDN1;NAF1;HELQ;PWP2;RPL5;NOP58;LSG1;TEX10;RPL15;IMP4;LAS1L;PELP1;RPL22;RPL31;GTF3A;XPO1;DDX49;RPS6;BOP1;RCL1;PDCD11;RPS17;DHX29;MPHOSPH6;MRPL22;EXOSC10;RPS14;MALSU1;EXOSC8;DDX10;WDR43;DHX37;EIF2A
prerank,peptidyl-lysine acetylation (GO:0018394),0.2677982488900844,0.5323893975595129,0.9342327150084317,1.0,1.0,3/10,22.84%,KAT7;ESCO1;KAT2B
prerank,regulation of phosphate metabolic process (GO:0019220),-0.1956328770073132,-0.5318248838879726,0.9699074074074074,0.9934892238683424,1.0,7/16,40.26%,IGBP1;SMG6;SRPX2;CD24;PSEN1;TIGAR;IKBKB
prerank,negative regulation of interleukin-12 production (GO:0032695),0.24836472380004943,0.5316658139930271,0.9459459459459459,1.0,1.0,1/14,7.27%,PIBF1
prerank,"phototransduction, visible light (GO:0007603)",0.24914703388024678,0.5298711135915283,0.9483333333333334,1.0,1.0,2/14,13.94%,SAG;GNAQ
prerank,recombinational repair (GO:0000725),0.18999933510654812,0.5290472496574536,0.9905100830367735,1.0,1.0,15/77,17.42%,RAD51AP2;RAD51AP1;PARP1;SFPQ;HUS1B;SLX4;HELQ;SFR1;RHNO1;MORF4L1;EXD2;RAD52;INO80;PSMD14;REV3L
prerank,regulation of centriole replication (GO:0046599),0.2396928294910207,0.5288728891690626,0.9477977161500816,1.0,1.0,4/17,18.49%,NUP62;PLK4;RBM14;CEP295
prerank,regulation of TOR signaling (GO:0032006),0.194333389162564,0.5285789354868129,0.9863692688971499,1.0,1.0,12/67,15.37%,FAM83D;LARS1;GNA12;SEC13;RRAGB;EPM2A;NPRL2;SH3BP4;RICTOR;GAS6;PRKAA2;ITFG2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.20640018004872462,0.5274087690717152,0.9837837837837838,1.0,1.0,5/44,11.78%,HSD17B10;CYP7B1;HSD17B4;SCP2;OSBPL2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2254150287478259,0.5271816691090171,0.9594813614262561,1.0,1.0,5/22,16.29%,PSME4;PSMB1;PSMB2;PSMB7;PSMA2
prerank,prostanoid metabolic process (GO:0006692),0.2530311326783084,0.5270104759769587,0.9369369369369369,1.0,1.0,2/13,10.96%,GSTP1;PTGR1
prerank,protein localization to phagophore assembly site (GO:0034497),0.2567668780537208,0.5266460642439634,0.9276672694394213,1.0,1.0,3/11,15.65%,MFN2;WDR45;ATG13
prerank,protein K63-linked deubiquitination (GO:0070536),0.21111009484410578,0.5262977850320484,0.9781659388646288,1.0,1.0,8/31,16.90%,OTUD7A;OTUD4;USP13;USP50;USP20;BABAM1;ABRAXAS2;PSMD14
prerank,male meiosis I (GO:0007141),0.24696406894564826,0.524315524973739,0.9540034071550255,1.0,1.0,1/16,5.67%,FOXJ3
prerank,homocysteine metabolic process (GO:0050667),0.2543474513402682,0.5240217710409347,0.9453924914675768,1.0,1.0,1/11,5.94%,BLMH
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.23574400929745065,0.5227785511546058,0.9516129032258065,1.0,1.0,5/20,14.38%,RELA;ADAM17;MBTPS1;HM13;SPPL2B
prerank,nuclear envelope organization (GO:0006998),-0.18413752334338587,-0.5226517349227354,0.9918032786885246,0.9950332994401005,1.0,8/20,31.67%,TOR1AIP1;EMD;LEMD2;TMEM43;TOR1A;REEP3;NUP155;NEMP1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.2312351787016818,0.5220468912685132,0.9548494983277592,1.0,1.0,3/18,13.52%,FZD9;BOK;MUL1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.22469451496732223,0.5210922744332872,0.960960960960961,1.0,1.0,3/24,12.48%,BCL2;SNAI2;CLU
prerank,water-soluble vitamin metabolic process (GO:0006767),0.19001430955034765,0.5205838791347245,0.989937106918239,1.0,1.0,7/68,9.19%,MCCC2;MTHFD2L;SLC23A2;SLC23A1;ALDH1L2;ABCD4;AASDHPPT
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.2483663899375083,0.5202946317240369,0.9650582362728786,1.0,1.0,4/15,15.59%,CNOT7;CPEB3;ZFP36L1;NANOS1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.2483663899375083,0.5202946317240369,0.9650582362728786,1.0,1.0,4/15,15.59%,CNOT7;CPEB3;ZFP36L1;NANOS1
prerank,neuron projection organization (GO:0106027),0.2401329675940923,0.5200317314801175,0.9626485568760611,1.0,1.0,5/15,17.50%,CHRNA7;ATP1A3;PLS1;DCTN1;MAP1A
prerank,response to nutrient levels (GO:0031667),0.23506707495918452,0.5164979623174902,0.9484193011647255,1.0,1.0,3/17,18.87%,KCNB1;PRKAA2;ULK1
prerank,folic acid metabolic process (GO:0046655),0.23687112874284982,0.5164621527359708,0.9546979865771812,1.0,1.0,2/18,8.66%,MTHFD2L;ALDH1L2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.250559395458373,0.5160324566120646,0.9540816326530612,1.0,1.0,3/13,15.91%,GSTP1;NAMPT;JAK2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22824064009904882,0.5160204968433135,0.9627228525121556,1.0,1.0,2/19,7.14%,ELL;AR
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.19761947609548533,0.5116936378492046,0.9837092731829574,1.0,1.0,14/53,20.15%,PSMC6;DAB2IP;FBXW7;F8A1;GNA12;PSME3IP1;BAG2;UFL1;PRKACA;XPO1;PSMD14;DESI1;UCHL5;FOXF2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.2364004767087169,0.509857600227203,0.9634920634920635,1.0,1.0,8/19,22.49%,FOXJ1;MTCL1;PARD3B;CLIC4;MARK2;PARD3;PATJ;ERBIN
prerank,antibacterial humoral response (GO:0019731),0.23358698095149288,0.5095107733937466,0.9507389162561576,1.0,1.0,1/16,5.11%,DMBT1
prerank,homologous chromosome segregation (GO:0045143),-0.17833209087038088,-0.5069885047154739,0.9975186104218362,0.9975899329509147,1.0,2/20,8.54%,CENPC;SIRT7
prerank,regulation of cytokine production (GO:0001817),0.1735779930438846,0.5069751122785617,0.9977924944812362,1.0,1.0,9/126,7.87%,ANXA1;HDAC9;CD276;ALOX5;ASB1;MAPKAPK2;TRAF3;SNAI2;ATP2B1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17888594076579853,0.5068840770480681,0.9965116279069768,1.0,1.0,22/95,20.91%,RAD51AP2;RAD51AP1;PARP1;SFPQ;HUS1B;SLX4;HELQ;FANCB;SFR1;MCMDC2;MORF4L1;EXD2;RAD52;RAD21;INO80;PSMD14;REV3L;RAD54B;SWI5;YY1;MCM4;RAD51D
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.21389262090581945,0.5060265083555103,0.9662058371735791,1.0,1.0,2/24,4.89%,FXN;SUCLA2
prerank,tRNA metabolic process (GO:0006399),0.22748797993190717,0.5055555227240276,0.9601910828025477,1.0,1.0,4/17,16.15%,DTD1;KARS1;SARS1;FARS2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.25742966011453927,0.5049897674481248,0.9607476635514018,1.0,1.0,2/10,14.06%,THAP4;QDPR
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.19827645816283868,0.5045686946842258,0.9769647696476965,1.0,1.0,12/45,21.34%,GCNT2;ATXN2;CYFIP1;DDX25;RBM3;EIF4E;NANOS1;METAP1;YTHDC1;EIF2A;LARP1;RPL10
prerank,neutrophil migration (GO:1990266),-0.1378061630370119,-0.5042227009064889,1.0,0.9973916014410005,1.0,4/58,8.21%,PECAM1;CXADR;GBF1;BSG
prerank,regulation of transferase activity (GO:0051338),0.2241809314972622,0.5023935229457195,0.9557377049180328,1.0,1.0,5/17,21.43%,FEM1A;FEM1B;PPP1R3F;HMBOX1;EMP2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.2126499275273646,-0.5018463858954603,0.9730337078651685,0.9971123200740161,1.0,2/10,15.44%,OS9;INSIG1
prerank,cellular response to UV-A (GO:0071492),-0.2142716623684051,-0.5012452640863192,0.9833729216152018,0.9965171058349851,1.0,6/11,45.27%,MMP2;MMP1;MME;OPN3;TIMP1;MMP3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.21153772988148917,0.4987007399874398,0.9625,1.0,1.0,3/22,13.67%,DUSP3;CD300A;DGKZ
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.24428822495606348,0.49827491756089276,0.9536541889483066,1.0,1.0,11/11,75.59%,TIMM29;TIMM9;TIMM22;ROMO1;TIMM13;AGK;TIMM10;NDUFA13;TIMM8B;TIMM10B;TOMM70
prerank,renal absorption (GO:0070293),0.24773775389546038,0.4980343053327747,0.9596491228070175,1.0,1.0,3/10,18.12%,HAS2;SGK1;SLC15A2
prerank,axoneme assembly (GO:0035082),0.20643782432574814,0.4977940416222736,0.982274741506647,1.0,1.0,4/30,16.16%,RSPH1;TOGARAM1;FOXJ1;DNAI4
prerank,modulation by host of viral genome replication (GO:0044827),0.23852498822726997,0.4972574078691929,0.9571183533447685,1.0,1.0,3/13,17.63%,TBC1D20;YTHDC2;EIF2AK4
prerank,regulation of lipid catabolic process (GO:0050994),0.22319403661912735,0.49721077636015004,0.970125786163522,1.0,1.0,2/19,10.90%,RARRES2;LONP2
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.24883141965216762,0.49635017085695754,0.9762340036563071,1.0,1.0,2/10,11.53%,RIF1;TERF2
prerank,histone exchange (GO:0043486),0.19850258922526862,0.4950324481062679,0.9860529986052998,1.0,1.0,9/37,18.57%,CENPP;CENPO;RUVBL1;ITGB3BP;SMARCA5;CENPW;CENPK;RSF1;VPS72
prerank,positive regulation of immune response (GO:0050778),0.18390307711804676,0.4938496303927201,0.9912390488110138,1.0,1.0,4/64,7.86%,IL2;CCL5;IL12RB1;TGFB2
prerank,cellular response to inorganic substance (GO:0071241),-0.17146142319391777,-0.4929822709265942,0.9970588235294118,0.9972791506477903,1.0,8/21,32.10%,FOXO1;KCNC2;BLM;FMR1;CDK2;ATRX;TIMELESS;MTR
prerank,negative regulation of phosphatase activity (GO:0010923),0.20842669389441126,0.4928738899888573,0.9808823529411764,1.0,1.0,2/25,7.86%,PPP1R26;TGFB2
prerank,central nervous system neuron development (GO:0021954),0.23201454840893604,0.49279208210176006,0.9627749576988156,1.0,1.0,4/15,18.53%,MAPT;ARHGAP35;PTEN;NPY
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.2188483014850764,0.4919228878822501,0.9554455445544554,1.0,1.0,3/17,12.98%,CALM1;SIRT2;DMTN
prerank,positive regulation of response to stimulus (GO:0048584),0.19350453157338376,0.48978398961898856,0.983402489626556,1.0,1.0,5/40,12.70%,CGAS;TGFB2;PRKCD;HOMER1;NSMCE4A
prerank,double-strand break repair via break-induced replication (GO:0000727),0.233569769631536,0.48706679495638405,0.9632224168126094,1.0,1.0,12/12,76.66%,MCMDC2;MCM4;MCM7;MCM2;MCM6;GINS2;MCM5;MCM3;CDC45;GINS4;MUS81;CDC7
prerank,histone H2A acetylation (GO:0043968),0.22584899150595256,0.48683382523991564,0.9720930232558139,1.0,1.0,3/16,12.55%,MSL3;RUVBL1;MORF4L1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.21416583991646085,0.4846384503146006,0.9721362229102167,1.0,1.0,3/23,7.68%,VEGFA;GDNF;SOX9
prerank,mitotic DNA replication (GO:1902969),-0.20901963826429393,-0.48391059355059934,0.9891304347826086,0.9979674079987129,1.0,6/10,41.62%,GINS3;LIG1;CDC45;GINS1;MCM3;POLA1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.23982154278984524,0.4834490158308394,0.9653284671532847,1.0,1.0,1/11,5.82%,ATP1B1
prerank,sensory perception of pain (GO:0019233),-0.1664716071871772,-0.48293128111937256,0.997229916897507,0.9974012479467766,1.0,12/21,48.72%,RETREG1;SCN9A;MME;PTGES;TRPA1;CCR2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;PROK2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.23126604900613695,0.48151570439996144,0.9744027303754266,1.0,1.0,2/14,11.85%,RELA;NECTIN2
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.21456526271295134,0.48126827846449594,0.9748892171344166,1.0,1.0,3/21,12.78%,MFHAS1;ENSA;ARPP19
prerank,regulation of neuron projection arborization (GO:0150011),0.22463105032664213,0.47817219983274145,0.9723577235772358,1.0,1.0,1/15,3.34%,FZD4
prerank,glial cell differentiation (GO:0010001),0.202716293335218,0.4770094390650423,0.9880418535127056,1.0,1.0,7/28,18.80%,TPPP;SOX9;CDH2;FGF10;STAT3;SOX10;METRN
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.22527456882219307,0.4766439094912728,0.9636048526863085,1.0,1.0,4/13,21.01%,AXL;GAS6;DHX9;TRIM44
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.17942734888190365,0.4745518333726294,0.9974160206718347,1.0,1.0,10/55,16.90%,FHL1;PSMC6;PSME4;PSMB1;PSMD5;PSMB2;PSMB7;PSMD3;PSMA2;PSMD14
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.19440225565726288,0.47358942331232273,0.9823269513991163,1.0,1.0,4/29,19.07%,ZCWPW1;SYCP2;RAD21;TERB1
prerank,cell junction maintenance (GO:0034331),-0.1813782857670046,-0.46601455155811056,0.9903147699757869,0.9987793857840394,1.0,7/14,42.02%,NLGN2;CLDN1;CHCHD10;CSF1R;F2R;CBLN1;PRTN3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.18543629799911365,-0.46538368070840586,0.9951923076923077,0.9981400715710008,1.0,6/13,33.03%,UPP2;SMUG1;DUT;OGG1;TDG;NEIL1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.20416752896050508,0.4641919872234851,0.9807073954983923,1.0,1.0,7/22,19.69%,NEDD4;TSG101;VPS36;STAM;VPS4A;TOM1L1;VPS37A
prerank,regulation of B cell activation (GO:0050864),0.19571116708738506,0.4634479567800732,0.9817629179331308,1.0,1.0,3/25,13.52%,SAMSN1;ZFP36L1;FOXJ1
prerank,cilium movement (GO:0003341),-0.1300079449948285,-0.4589487785332905,1.0,0.9980999676725604,1.0,31/47,50.93%,DNAAF5;ODAD1;CCDC39;DNHD1;SPEF2;GAS8;CFAP61;DNAH5;CFAP70;CFAP251;CFAP53;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;SPA17;DNAH9;DNAAF2;ODAD4;TEKT2;CFAP100;CFAP206;RSPH9;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5
prerank,pinocytosis (GO:0006907),0.22494234578955039,0.4581501773337226,0.975,1.0,1.0,2/10,14.68%,MAPKAPK2;RAB34
prerank,regulation of oxidative phosphorylation (GO:0002082),0.21331379542223994,0.4575880137179993,0.9784768211920529,1.0,1.0,4/16,20.50%,COX7A2L;MLXIPL;UQCC2;SLC25A33
prerank,response to hydroxyurea (GO:0072710),0.22325045521779077,0.457396494955725,0.9764309764309764,1.0,1.0,2/11,12.63%,KAT7;DDI2
prerank,negative regulation of centrosome duplication (GO:0010826),0.22368443903175833,0.4545799212222835,0.9786096256684492,1.0,1.0,5/11,24.76%,CCNF;RBM14;CENATAC;KAT2B;TRIM37
prerank,pigment granule transport (GO:0051904),0.20418733494589836,0.45456020306250333,0.9834162520729685,1.0,1.0,6/18,24.20%,MREG;BLOC1S5;MLPH;BBS5;MYO5A;BBS7
prerank,melanosome transport (GO:0032402),0.20418733494589836,0.45456020306250333,0.9834162520729685,1.0,1.0,6/18,24.20%,MREG;BLOC1S5;MLPH;BBS5;MYO5A;BBS7
prerank,negative regulation of cholesterol transport (GO:0032375),0.2263280355119569,0.45241951840799605,0.977818853974122,1.0,1.0,1/10,11.08%,SREBF2
prerank,outer dynein arm assembly (GO:0036158),0.2060316208263271,0.44766667052893094,0.9845890410958904,1.0,1.0,1/14,5.17%,DNAH17
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.19455698570731472,-0.4465364998733968,0.9953596287703016,0.9985170728933807,1.0,7/10,59.17%,NCKAP1L;TLR4;VSIR;IL12A;PRNP;FOXP3;IL12B
prerank,DNA-dependent DNA replication (GO:0006261),0.15371197100368025,0.4460738951305161,1.0,1.0,1.0,20/128,17.42%,GMNN;DDX23;PSMC6;WRNIP1;PRIM2;PSME4;PSMB1;MCMDC2;PSMD5;POLD1;POLG;PSMB2;ORC2;PSMB7;PSMD3;SRPK2;PSMA2;MGME1;PSMD14;REV3L
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.18545005558026478,0.4431557431622892,0.9913793103448276,1.0,1.0,5/33,16.99%,TESC;RUNX1;ZFP36L1;PRKCA;ACIN1
prerank,mitochondrial transcription (GO:0006390),0.22452309467758402,0.44087466714719065,0.9850746268656716,1.0,1.0,4/10,22.79%,TFB2M;TEFM;SLC25A33;TFAM
prerank,mesoderm development (GO:0007498),0.20145852851576967,0.4366400233212134,0.9904153354632588,1.0,1.0,4/18,17.54%,VEGFA;IKZF1;JAK2;GDF11
prerank,regulation of cilium movement (GO:0003352),0.21532331303606267,0.43599416869044505,0.9762340036563071,1.0,1.0,2/10,15.77%,DNAH11;CFAP43
prerank,cell differentiation in hindbrain (GO:0021533),-0.18332233541960938,-0.4350685977756096,0.9954128440366973,0.9987022603895155,1.0,7/11,46.95%,OPHN1;GRID2;ATP7A;LHX1;CBLN1;CEND1;NOG
prerank,phagosome-lysosome fusion (GO:0090385),-0.18205648162522142,-0.43365062958581074,0.9977578475336323,0.9980880944580078,1.0,3/10,29.86%,CLN3;SYT7;RAB39A
prerank,response to hexose (GO:0009746),0.18766633240945682,0.43289075894646967,0.9894419306184012,1.0,1.0,1/25,3.34%,LPL
prerank,regulation of response to interferon-gamma (GO:0060330),0.20756823881604136,0.4320072699610658,0.9847457627118644,1.0,1.0,4/14,19.25%,STAT1;JAK2;PIAS1;SUMO1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.1818794577697344,0.431799188495915,0.9937304075235109,1.0,1.0,4/29,15.25%,IL12RB1;RASGRP1;NECTIN2;STX7
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.19862747462960706,0.42873089623986593,0.9982964224872232,1.0,1.0,2/16,15.25%,IL12RB1;STX7
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.20768758902808934,0.42711615275596243,0.9809688581314879,1.0,1.0,1/12,7.27%,PIBF1
prerank,B cell activation involved in immune response (GO:0002312),0.19924670433144992,0.42409003867680795,0.9982238010657194,1.0,1.0,13/13,80.09%,CD180;MSH2;RNF168;CD40LG;GPR183;GAPT;CD19;RNF8;FCGR2B;LIG4;BATF;EXOSC3;MSH6
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.20155334142679204,0.420952272442494,0.9836363636363636,1.0,1.0,4/13,21.99%,EDEM2;SLC51B;BCAP31;SEC16A
prerank,determination of left/right symmetry (GO:0007368),0.16967243547568964,0.41994391769106865,0.9944827586206897,1.0,1.0,7/36,17.66%,KIF3B;DNAH11;CITED2;FOXJ1;RFX3;DAND5;GALNT11
prerank,lipid droplet organization (GO:0034389),0.1761344399044699,0.4112674253977244,0.9895052473763118,1.0,1.0,3/22,15.00%,AUP1;PNPLA3;PLA2G4C
prerank,cellular response to interleukin-7 (GO:0098761),0.18870144596859878,0.40885286670075843,0.9967585089141004,1.0,1.0,3/17,16.02%,IRS1;IRS2;STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.18870144596859878,0.40885286670075843,0.9967585089141004,1.0,1.0,3/17,16.02%,IRS1;IRS2;STAT3
prerank,axonemal dynein complex assembly (GO:0070286),0.17258092967613883,0.4087267844515321,0.9923430321592649,1.0,1.0,2/27,8.54%,DNAH17;CFAP73
prerank,phagolysosome assembly (GO:0001845),0.19789090178275104,0.4053550458703815,0.9948006932409013,1.0,1.0,6/12,25.65%,RAB14;RAB34;PIKFYVE;ARL8B;RAB7A;RAB7B
prerank,neutrophil chemotaxis (GO:0030593),0.15137509806154936,0.4014151237800954,1.0,1.0,1.0,10/53,22.40%,CCL5;TGFB2;CCL14;S100A8;S100A9;CCL25;CCL19;PIKFYVE;PPIB;CCL13
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.17197650352720456,-0.3994412610633347,1.0,0.9990602159758298,1.0,6/11,52.32%,HDAC2;TAF7;CIITA;XBP1;PF4;IL4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.19718408332351306,0.3891909249186818,0.996316758747698,1.0,1.0,2/10,14.82%,SIRT2;KNSTRN
prerank,receptor recycling (GO:0001881),0.19161488734073928,0.3779486066141193,0.9892086330935251,1.0,1.0,10/10,80.85%,PLEKHJ1;ARFGEF2;NSG1;RAB11B;LMTK2;SORL1;PHETA2;REP15;PHETA1;EHD3
prerank,nucleocytoplasmic transport (GO:0006913),0.14727999081592408,0.37534364224712297,1.0,1.0,1.0,9/40,21.68%,ATXN1;AAAS;LSG1;NUP98;XPO1;SNRPD3;GEMIN6;SNUPN;ANP32A
prerank,nuclear transport (GO:0051169),0.17326685661059296,0.3741705887447436,0.9933774834437086,1.0,1.0,5/16,23.13%,AAAS;NUP98;XPO1;ANP32A;RBM15B
prerank,dendritic cell differentiation (GO:0097028),0.15794813424655713,0.37299070188566524,0.9983766233766234,1.0,1.0,3/22,13.57%,AXL;TRPM2;GAS6
prerank,tetrapyrrole metabolic process (GO:0033013),0.1618210361067504,0.3572515840735734,0.9983050847457627,1.0,1.0,18/18,83.84%,ABCD4;MMAB;MMAA;ABCC1;MMACHC;CBLIF;CTRC;AMN;TCN1;MTRR;TCN2;ABCB6;MMADHC;CD320;MTR;MMUT;CUBN;LMBRD1
prerank,cobalamin metabolic process (GO:0009235),0.16181087529825428,0.3561756604051048,1.0,1.0,1.0,17/17,83.84%,ABCD4;MMAB;MMAA;ABCC1;MMACHC;CBLIF;CTRC;AMN;TCN1;MTRR;TCN2;MMADHC;CD320;MTR;MMUT;CUBN;LMBRD1
prerank,tRNA wobble uridine modification (GO:0002098),0.16931643062544566,0.3533352167197307,0.9966101694915255,1.0,1.0,2/14,15.85%,DPH3;ELP3
prerank,tRNA wobble base modification (GO:0002097),0.16430839202677378,0.34551104411331923,1.0,1.0,1.0,2/14,15.85%,DPH3;ELP3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.15829513460059264,0.3438636629620998,0.9983633387888707,0.9996902878049638,1.0,15/16,65.43%,MCMDC2;MCM4;MCM7;MCM2;PURA;SSBP1;RECQL;MCM6;RECQL5;RECQL4;HMGA1;WRN;TWNK;RPA1;RAD51
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.12620272538270189,0.3124151374095156,1.0,0.9997872949390272,1.0,7/32,23.16%,FAM3A;RNASE3;S100A9;RPL30;ROMO1;CCL13;GAPDH
